0001019687-13-002516.txt : 20130628 0001019687-13-002516.hdr.sgml : 20130628 20130628172443 ACCESSION NUMBER: 0001019687-13-002516 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20130331 FILED AS OF DATE: 20130628 DATE AS OF CHANGE: 20130628 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Integrated Healthcare Holdings Inc CENTRAL INDEX KEY: 0001051488 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 870573331 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-23511 FILM NUMBER: 13941944 BUSINESS ADDRESS: STREET 1: 1301 N. TUSTIN AVENUE CITY: SANTA ANA STATE: CA ZIP: 92705 BUSINESS PHONE: 714-953-3503 MAIL ADDRESS: STREET 1: 1301 N. TUSTIN AVENUE CITY: SANTA ANA STATE: CA ZIP: 92705 FORMER COMPANY: FORMER CONFORMED NAME: Integrated Healthcare Holdings DATE OF NAME CHANGE: 20040816 FORMER COMPANY: FORMER CONFORMED NAME: FIRST DELTAVISION INC DATE OF NAME CHANGE: 19971216 10-K 1 ihhi_10k-033113.htm FORM 10-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-K

(Mark One)

x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
   
For the fiscal year ended March 31, 2013; or
   
o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Commission File Number 0-23511

________________

 

Integrated Healthcare Holdings, Inc.

(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

 

Nevada 87-0573331
(STATE OF INCORPORATION) (I.R.S. EMPLOYER IDENTIFICATION NO.)

 

1301 North Tustin Avenue, Santa Ana, California 92705
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)

 

Registrant's telephone number, including area code: (714) 953-3652

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12(g) of the Act:

 

Common Stock, $.001 par value

(TITLE OF CLASS)

______________

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes o   No x

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o  No x

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x   No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x   No o

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of "large accelerated filer, accelerated filer or smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer o Accelerated filer o Non-accelerated filer o Smaller reporting company x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes o   No x

 

The aggregate market value of voting stock held by non-affiliates of the registrant was $1,867,760 as of September 30, 2012 (computed by reference to the last sale price of a share of the registrant's common stock on that date as reported by the OTCQB marketplace. For purposes of this computation, it has been assumed that the shares beneficially held by directors and officers of registrant were "held by affiliates"; this assumption is not to be deemed to be an admission by such persons that they are affiliates of registrant.

 

There were 255,307,262 shares outstanding of the registrant's common stock as of June 18, 2013.

 

DOCUMENTS INCORPORATED BY REFERENCE:

 

No portions of other documents are incorporated by reference into this Annual Report.

 

 

 
 

 

INTEGRATED HEALTHCARE HOLDINGS, INC.

 

FORM 10-K

 

ANNUAL REPORT FOR THE YEAR ENDED MARCH 31, 2013

 

TABLE OF CONTENTS

 

PART I    
       
  ITEM 1. BUSINESS 1
       
  ITEM 1A. RISK FACTORS 15
       
  ITEM 1B. UNRESOLVED STAFF COMMENTS 20
       
  ITEM 2. PROPERTIES 21
       
  ITEM 3. LEGAL PROCEEDINGS 22
       
  ITEM 4. MINE SAFETY DISCLOSURES 22
       
PART II    
       
  ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 23
       
  ITEM 6. SELECTED FINANCIAL DATA 24
       
  ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 24
       
  ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 33
       
  ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 34
       
  ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 34
       
  ITEM 9A. CONTROLS AND PROCEDURES 34
       
  ITEM 9B. OTHER INFORMATION 35
       
PART III  
       
  ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 36
       
  ITEM 11. EXECUTIVE COMPENSATION 40
       
  ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 42
       
  ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 44
       
  ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES 45
       
  ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES 46
       
    SIGNATURES 49

 

i
 

 

PART I

 

FORWARD-LOOKING INFORMATION

 

This Annual Report on Form 10-K contains forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks discussed under the caption "Risk Factors" herein that may cause our Company's or our industry's actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements.

 

Although we believe that the expectations reflected in the forward looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as may be required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

 

As used in this report, the terms "we," "us," "our," "the Company," "Integrated Healthcare Holdings" or "IHHI" mean Integrated Healthcare Holdings, Inc., a Nevada corporation, unless otherwise indicated.

 

ITEM 1. BUSINESS

 

BACKGROUND

 

Integrated Healthcare Holdings, Inc. is a predominantly physician owned company that, on March 8, 2005, acquired and began operating the following four hospital facilities in Orange County, California:

 

  • 282-bed Western Medical Center in Santa Ana
  • 188-bed Western Medical Center in Anaheim
  • 178-bed Coastal Communities Hospital in Santa Ana
  • 114-bed Chapman Medical Center in Orange

  

Together we believe that our hospitals currently represent approximately 11.2% of all hospital beds in Orange County, California (based on the most recent data, as of December 31, 2012, on the website of the Office of Statewide Health Planning and Development for California).

 

Prior to March 8, 2005, we were primarily a development stage company with no material operations. On September 29, 2004, the Company entered into a definitive agreement to acquire the four hospitals from subsidiaries of Tenet Healthcare Corporation ("Tenet"), and the transaction closed on March 8, 2005.

 

The transaction included operations of four licensed general acute care hospitals with a total of 762 beds. All four hospitals are accredited by the Joint Commission on Accreditation of Healthcare Organizations and other appropriate accreditation agencies that accredit specific programs. All properties are in Orange County, California, and operate as described below.

 

WESTERN MEDICAL CENTER - SANTA ANA. Western Medical Center - Santa Ana, located at 1001 North Tustin Avenue, Santa Ana, CA 92705, is Orange County's first hospital, founded over 100 years ago. The hospital is one of IHHI's two hospitals in Santa Ana, which are the only two general acute care hospitals in this city of 325,000 people. The hospital has 282 beds and provides quaternary, tertiary and secondary services. It serves the entire county as one of only three designated trauma centers in Orange County along with other tertiary services such as burn center, emergency and scheduled neurosurgical care, cardiac surgical services, a paramedic base station and receiving center. The hospital also maintains Intensive Care Units for adults and pediatrics, and a Neonatal Intensive Care Unit. Additionally, the hospital offers telemetry, neurosurgical definitive observation, medical, surgical, pediatric and obstetric inpatient services. Supporting these services the hospital offers operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories, pharmacy, physical and occupational therapy services on an inpatient and most on an outpatient basis. The hospital has approximately 115 active physicians and 415 employee nurses, and hospital staff.

 

WESTERN MEDICAL CENTER - ANAHEIM. Western Medical Center - Anaheim, located at 1025 South Anaheim Boulevard, Anaheim, CA 92805, has 188 beds and offers a full range of acute medical and psychiatric care services serving northern Orange County and providing tertiary services to Riverside County residents. The hospital offers special expertise in the tertiary services of The Heart and Vascular Institute, and Behavioral Health Services. Additionally, the hospital provides the Women and Children Health Services, and 24-hour Emergency Services. Supporting these services the hospital offers critical care, medical, surgical and psychiatric services supported by operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories, pharmacy, physical and occupational therapy services on an inpatient and outpatient basis. The hospital has approximately 88 active physicians and 221 employee nurses, and hospital staff.

  

1
 

COASTAL COMMUNITIES HOSPITAL - SANTA ANA. Coastal Communities Hospital, located in Santa Ana at 2701 South Bristol Street, Santa Ana, CA 92704, has served the community for more than 30 years, providing comprehensive medical and surgical services. The hospital is one of IHHI's two hospitals in Santa Ana, which are the only two general acute care hospitals in this city of 325,000 people. The 178-bed hospital offers critical care, medical, surgical obstetric, psychiatric and sub-acute services supported by operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories, pharmacy, physical and occupational therapy services on an inpatient and most on an outpatient basis. The hospital has approximately 62 active physicians and 182 employee nurses, and hospital staff.

 

CHAPMAN MEDICAL CENTER - ORANGE. Founded in 1969, Chapman Medical Center is a 114-bed acute care facility located at 2601 East Chapman Avenue, Orange, CA 92869. The hospital is a leader in specialty niche programs, including the following: Chapman Center for Obesity (surgical weight loss program); Neuro-spine Center; Center for Senior Mental Health; and Positive Achievement Center (Adult and Adolescent Chemical Dependency Program). Supporting these services the hospital offers critical care, medical, surgical and geriatric psychiatric services supported by operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories, pharmacy, physical and occupational therapy services. The hospital has approximately 34 active physicians and 113 employee nurses, and hospital staff.

 

EMPLOYEES AND MEDICAL STAFF

 

At March 31, 2013, the Company had approximately 3,012 employees. Of these employees, approximately 1,113 are represented by two labor unions, the California Nurses Association ("CNA") and Service Employee International Union – United Healthcare Workers ("SEIU"), who are covered by collective bargaining agreements. We believe that our relations with our employees are good. The Company also had approximately 134 individuals from contracting agencies at March 31, 2013, consisting primarily of outsourced housekeeping staff.

 

Our hospitals are fully staffed by physicians and other independently practicing medical professionals licensed by the State, who have been admitted to the medical staff of the individual hospital. Under state laws and licensing standards, hospitals' medical staffs are self-governing organizations subject to ultimate oversight by the hospital's local governing board. None of these physicians are employees of the hospitals. Physicians are not limited to medical staff membership at our hospitals, and many are on staff at our other hospitals, or hospitals not owned or operated by us. Physicians on our medical staffs are free to terminate their membership on our medical staffs and admit their patients to other hospitals, owned, or not owned by us. Non-physician staff, including nurses, therapists, technicians, finance, registration, maintenance, clerical, housekeeping, and administrative staff are generally employees of the hospital, unless the service is provided by a third party contracted entity. We are subject to federal and state minimum wage and hour laws and various state labor laws and maintain an employee benefit plan.

 

Our hospitals' operations depend on the abilities, efforts, experience and loyalty of our employees and physicians, most of who have a long-term relationship with our hospitals. Our ongoing business relies on our attraction of skilled, quality employees, physicians and other healthcare professionals in all disciplines.

 

We strive to successfully attract and retain key employees, physicians and healthcare professionals. Our operations, financial position and cash flows could be materially adversely affected by the loss of key employees or sufficient numbers of qualified physicians and other healthcare professionals. The relations we have with our employees, physicians, and other healthcare professionals are key to our success and they are a priority in our management philosophy.

  

COMPETITION

 

Hospital competition is unique to each facility and the community in which it operates.  A hospital’s competitive position within its geographic area is affected by several factors, including, but not limited to the following:

 

A hospital’s competitive position is affected by the services the hospital offers and whether other hospitals in the area offer the same or similar services.  Hospitals are dependent on physicians to admit patients to the hospital.  Thus, the number of physicians around the hospital, their specialties, and the quality of medicine they practice will have a major impact on hospital competition.  The ability of the hospital to employ and retain qualified nurses, other health care professionals, and administrative staff will also affect the hospitals’ competitiveness in the market place.  Further, a hospital’s reputation with patients, physicians, employees, and contracting health plans can influence the hospital’s competitive position.  Southern California is a highly competitive managed health care market; therefore, the relationship a hospital has with managed care organizations is also a key factor in its competitiveness.  The hospital’s location, the community immediately surrounding it and access to the hospital will also affect the hospital’s competitiveness.  Other hospitals or health care organizations serving the same locations determine the intensity of the competition.  The condition of the physical plant and the ability to invest in new equipment and technology can affect the community’s and physicians’ desire to use a particular hospital.  The amount the hospital charges for services is another factor in the hospital’s competitiveness.  The funding sources of the competition may also be a factor if a competitor is tax exempt. Tax-exempt institutions have advantages not available to for-profit hospitals, such as endowments, charitable contributions, tax-exempt financing, and exemptions from certain taxes.

 

2
 

Efforts to control health care costs are encouraging vertical integration in the health care services industry. Hospital systems are acquiring physician practices and other outpatient and sub-acute providers to position themselves for readmission, bundling, and other payment restructuring. Nonprofessional corporations in the State of California are prohibited from employment of physicians to provide patient services. Similarly, payers are consolidating and acquiring disease management service providers in an effort to offer more competitive programs. As integrated health systems come to dominate the markets of health insurance and medical services, the hospital industry will be dramatically affected.

 

Finally, laws and regulations governing antitrust, anti-kickback, physician referrals and other applicable regulations, such as requirements imposed on physician-owned hospitals, impact a hospital’s ability to compete.  Since these factors are individual to each hospital, and are subject to change, each hospital must develop its own strategies, to address the competitive factors in its local service area.

 

We endeavor to ensure our hospitals remain competitive. We believe our hospitals compete within local communities on the basis of many factors, including providing high quality of care, attracting and retaining quality physicians, and attracting and retaining skilled clinical personnel and other health care professionals. We also believe that the location of our hospitals, the scope of services we offer, and our prices for services help maintain our competitive position. We continue to focus our efforts and resources on these areas to maintain a competitive position in the communities we serve.

 

HEALTH CARE REGULATION AND LICENSING

 

Health care, as one of the largest industries in the United States, continues to attract much legislative interest and public attention.  Changes in the Medicare and Medicaid programs and other government health care programs, as well as hospital cost-containment initiatives by public and private payers, proposals to limit payments and health care spending, and industry-wide competitive factors greatly affect the health care industry.  The industry is also subject to extensive federal, state, and local regulations relating to licensure, operations, ownership of facilities, physician relationships, expansion of facilities and services, and charges and effective reimbursement rates for services.  The laws, rules, and regulations governing the health care industry are extremely complex, and the industry often has little or no regulatory or judicial interpretation for guidance.  Compliance with such regulatory requirements, as interpreted and amended from time to time, can increase operating costs and thereby adversely affect the financial viability of our business.  Failure to comply with current or future regulatory requirements could also result in the imposition of various civil and criminal sanctions including fines, restrictions on admission, denial of payment for services rendered, revocation of licensure, decertification, imposition of temporary management or the closure of a facility.

 

The Patient Protection and Affordable Care Act

 

In 2010, the U.S. Congress adopted and President Obama signed into law comprehensive reform legislation through the passage of the Patient Protection and Affordable Care Act (H.R.  3590) and the Health Care and Education Reconciliation Act (H.R.  4872) (collectively, “PPACA”). The primary goal of this comprehensive legislation is to extend health coverage to millions of uninsured legal residents through a combination of public program expansion and private sector health insurance reforms.  To fund the expansion of insurance coverage, the legislation contains measures designed to promote quality and cost efficiency in health care delivery and to generate budgetary savings in the Medicare and Medicaid programs. On June 23, 2012, the United States Supreme Court issued an opinion in National Federation of Independent Businesses v. Sebelius which upheld the constitutionality of the PPACA’s individual mandate. The Supreme Court also held that Congress is prohibited from penalizing states that choose not to expand their Medicaid programs by taking away their existing Medicaid funding.

 

Because of the many variables involved, the law’s complexity, and the limited amount of implementing regulations and interpretive guidance, we are unable to predict with certainty the full impact of the PPACA on our future revenues and operations. However, we expect that several provisions of the PPACA, including those described below, will have a material effect on our business.

 

Health Benefit Exchanges. The health insurance marketplace will be undergoing dramatic and rapid changes. Some of the core provisions of the PPACA have already been implemented. Still, many provisions of the PPACA, including the mandated minimum coverage provisions, do not take effect until 2014. Under the PPACA, beginning in 2014, individuals and small businesses will be able to purchase insurance through health benefit exchanges. California’s health benefit exchange, Covered California (“Exchange”), plans to begin enrollment in the fall of 2013.

 

We cannot predict the effect the Exchange will have on our reimbursement, because the utilization profile among enrollees of health plans offered through the Exchange is uncertain. The guaranteed issue provision will remove a barrier preventing those with pre-existing conditions from obtaining individual coverage. Therefore, there is a potential for higher utilization rates among Exchange enrollees. Also, Exchange plans will employ high cost-sharing for a population that may not have experience with significant out-of-pocket medical costs and may not always have the means to pay. Measurement and reporting will be critically important to the Exchange, so our hospitals may experience greater administrative burdens as a result of contracting with insurers and health benefit plans offering products through the Exchange.

 

3
 

Individual and Employer Mandates. The PPACA seeks to decrease the number of uninsured individuals through employer mandates and individual requirements, which may have a positive effect on our accounts receivable. However, due to the lack of implementing regulations and clear guidance, it is difficult to predict the full impact the PPACA will have on our results of operations.

 

By law, individuals will be required to carry insurance after January 1, 2014 or face a tax penalty. Large corporations, those with 50 or more full-time equivalent employees, will be required to provide insurance to full-time employees or pay a penalty. If employers shift from full-time to part-time workforces, this could reduce the impact of the PPACA with respect to increasing the number of individuals who obtain health insurance coverage in 2014.

 

Changes to Reimbursement

 

  • Decreases in Annual Market Basket Updates.  With varying effective dates, the annual Medicare market basket updates for many providers will be reduced, and adjustments to payment for expected productivity gains will be implemented.   Beginning in fiscal year 2012 (and for each following fiscal year), the PPACA reduces the market basket update for hospitals by a productivity adjustment equal to the 10-year moving average of changes in annual economy-wide private non-farm business multifactor productivity.  In addition to the productivity adjustment, the market basket will be reduced by 0.1% in 2013, by 0.3% in 2014, by 0.2% in 2015 and 2016, and by 0.75% in 2017, 2018 and 2019.  These reductions to the hospitals’ reimbursements for inpatient services under Medicare by the PPACA will adversely affect our business.
  • Decreases in Medicare and Medicaid DSH Payments.    Commencing in federal fiscal year 2014, Medicare Disproportionate Share Hospital (“DSH”) payments will be reduced initially by 75% and increased thereafter to account for the national rate of consumers who do not have health care insurance and are provided uncompensated care.   The PPACA also mandates reductions in Medicaid DSH allotment to states for the years 2014 through 2020.  The reduction of DSH payments is intended as a means of equalizing the benefit to providers of the increase in payments resulting from patients with newly-issued insurance coverage.  Any reductions to our reimbursement under Medicare and Medicaid programs by the PPACA could adversely affect our business.  Likewise, any reductions in Medicare and Medicaid DSH payments could adversely affect our business.
  • Medicaid Expansion.  States have the option to decide whether their state Medicaid programs will be expanded to a broader population with incomes up to 133% of federal poverty levels.  Further, the law permits states to create federally funded, non-Medicaid plans for low-income residents not eligible for Medicaid.  To a lesser extent, the PPACA also expands the Children’s Health Insurance Program (“CHIP”).  When California expands the Medi-Cal program, our hospitals may achieve increased revenues from providing care to individuals who, prior to the PPACA, were previously uninsured.

 

Quality Improvement and Cost-Saving Initiatives

 

The PPACA also contains several provisions intended to improve the quality and efficiency of medical care provided to Medicare and Medicaid beneficiaries.  We anticipate these provisions, including those described below, can have a material effect on our business:

 

  • Hospital Readmissions Reduction Program.  Commencing in federal fiscal year 2012, Medicare payments that would otherwise be made to hospitals are reduced by specified percentages to account for excess and “preventable” hospital readmissions.

 

4
 

 

  • Accountable Care Organizations.  The PPACA required the Secretary of the U.S. Department of Health and Human Services (“HHS”) to establish a Medicare Shared Savings Program that promotes accountability and coordination of care through the creation of Accountable Care Organizations (“ACOs”).  The first participation period for those ACOs accepted into the Medicare Shared Savings Program began on January 1, 2012.  If our hospitals choose to participate in the Shared Savings program, reimbursements for inpatient and outpatient services may be affected.
  • Bundled Payment Pilot and Duals Demonstration Project.  In addition to the Medicare Shared Savings Program, the PPACA requires the Secretary to establish a five-year, voluntary national bundled payment pilot program for Medicare services beginning no later than January 1, 2013.  If the hospitals participate in the pilot program, their reimbursements for inpatient and outpatient services may be affected.

 

As a result of the PPACA’s passage, the health care industry will be subjected to significant new statutory and regulatory requirements and consequently to structural and operational changes and challenges for a substantial period of time.  We will continue to assess the effect of the PPACA and additional legislation on current and projected operations, financial performance and general financial condition.

 

Medicare

 

Each of our hospitals participates in the Medicare program.  Medicare is a federal program that provides medical insurance benefits to persons age 65 and over, some disabled persons, and persons with end-stage renal disease.  Under the Medicare program, we are paid for inpatient and outpatient services performed by our hospitals.  Our hospitals continue to be affected by changes in laws and regulations pertaining to Medicare, which are often designed to reduce reimbursement rates.

 

Inpatient Acute Care Services.  Medicare pays most hospitals for services furnished to inpatients under a system known as the Prospective Payment System (“PPS”) where hospitals are paid for services based on predetermined rates.  Medicare payments under PPS are based on the DRG to which each Medicare patient is assigned.  The DRG is determined by the patient’s primary diagnosis and other factors for each particular Medicare inpatient stay.  The amount to be paid for each DRG is established prospectively by the Center for Medicare and Medicaid Services (“CMS”).  The DRG amounts are not directly related to a hospital’s actual costs or variations in service or length of stay.  Therefore, if a hospital incurs costs in treating Medicare inpatients that exceed the DRG level of reimbursement plus any outlier payments, then that hospital will experience a loss from such services, which will have to be made up from other revenue sources.  Payment limitations implemented by other third-party payers may restrict the ability of a hospital to engage in such “cost-shifting.”  In 2008, CMS replaced the existing 538 DRGs with 745 new severity-adjusted diagnosis related groups (“Medicare Severity DRGs” or “MS-DRGs”).  The new MS-DRGs are intended to more accurately reflect the cost of providing inpatient services and eliminate any incentives that hospitals may have to only treat the healthiest and most profitable patients.

 

The DRG rates are adjusted by an update factor on October 1 of each year.  The index used to adjust the DRG rates, known as the “market basket index,” takes into consideration the increase of costs experienced by hospitals in purchasing goods and services.  Generally, however, the percentage increases in the DRG payments have been lower than the projected increase in the cost of goods and services purchased by hospitals.  Also, as discussed above, the PPACA provides for annual percentage decreases to the market basket index.  Therefore, we cannot assure that in the future our hospitals will be paid amounts that will adequately reflect changes in the cost of providing health care services.  On August 31, 2012, CMS issued the “Changes to the Hospital Inpatient Prospective Payment systems for Acute Care Hospitals and Fiscal Year 2013 Rates” (“IPPS 2013 Final Rule”).  The IPPS 2013 Final Rule provides for a 2.6% market basket increase for federal fiscal year 2013, reduced by a 0.8% reduction mandated by the PPACA as well as an increase of 1.0% related to the claims coding adjustments. The net increase in the DRG rates is 2.8%.

 

Because of the uncertainty of factors that may influence the inpatient PPS payments to our hospitals, including admission volumes, length of stay and case mix, we cannot estimate the impact of the payment changes to the IPPS 2013 Final Rule will have on our annual Medicare inpatient net revenues.

 

Outpatient Services.  Hospital outpatient services, including hospital operating and capital costs, are reimbursed on a PPS basis.  All services paid under the outpatient PPS are classified into groups called Ambulatory Payment Classifications (“APCs”).  Services in each APC are similar clinically and in terms of the resources they require.  Using hospital outpatient claims data from the most recent available hospital cost reports, CMS determines the median costs for the services and procedures in each APC group, and a payment rate is established for each APC.  Depending on the services provided, hospitals may be paid for more than one APC per patient encounter.  CMS will make additional payment adjustments under outpatient PPS including “outlier” payments for services where the hospital’s cost exceeds 2.5 times the APC rate for that service.  In addition, certain other changes have reduced coinsurance payments below what they would have originally been under outpatient PPS.  Several Medicare Part B services are specifically excluded from this rule, including certain physician and non-physician practitioner services, ambulance, clinical diagnostic laboratory services and non-implantable orthotics and prosthetics, physical and occupational therapy, and speech language pathology services.

 

5
 

For calendar year 2012 and each subsequent calendar year, the PPACA requires that the annual market basket update for outpatient services also be reduced by a productivity adjustment. The amount of that reduction will be the projected nationwide productivity gains over the preceding 10 years. To determine the projection, the HHS will use the Bureau of Labor Statistics’ (“BLS”) 10-year moving average of changes in specified economy-wide productivity.  The PPACA does not contain guidelines for projecting the productivity figure. However, CMS estimates that the combined market basket and productivity adjustments will reduce Medicare payments under the outpatient PPS by approximately $26.3 billion from 2010 to 2019.

 

Value Based Purchasing. Under CMS’s Hospital Value-Based Purchasing Program, CMS will make value-based incentive payments to acute care hospitals based upon the hospital’s quality measure performance as well as overall improvements to quality of care. This program will commence in federal fiscal year 2013 and apply to payments for discharges occurring on or after October 1, 2012. Hospitals that do not take part in the quality reporting program or that did not successfully report their quality measures will have their market basket update reduced by two percentage points.

 

Medicare Managed Care.  The Medicare program allows various managed care plans, known as Medicare Advantage Plans, offered by private companies to engage in direct managed care risk contracting with the Medicare program.  Under the Medicare Advantage program, these private companies agree to accept a fixed, per-beneficiary payment from the Medicare program to cover all care that the beneficiary may require.  Health care providers must contract with Medicare Advantage plans to treat Medicare Advantage enrollees at agreed-upon rates.  Covered inpatient and emergency services rendered to a Medicare Advantage beneficiary by a hospital that is an out-of-plan provider (i.e., that has not entered into a contract with a Medicare Advantage plan) will be paid at Medicare fee-for-service payment rates.

 

The PPACA reduces, over a three year period, premium payments to managed Medicare plans such that CMS’s managed care per capita premium payments are, on average, equal to traditional Medicare.  The PPACA also implements fee payment adjustments based on service benchmarks and quality ratings.  The Congressional Budget Office (“CBO”) has estimated that, as a result of these changes, payments to plans will be reduced by $138 billion between 2010 and 2019, while CMS has estimated the reductions will total $145 billion.  In addition, the PPACA expands the Recovery Audit Contractors (“RAC”) program to include Medicare managed care plans.  In light of the recent economic downturn and the PPACA, managed Medicare plans may experience reduced premium payments, which may lead to decreased enrollment in such plans.  All or any of these outcomes may have a disproportionately negative effect upon those providers with relatively high dependence upon Medicare managed care revenues.

 

On Oct. 1, 2014, health care organizations will be required to transition from ICD-9 to ICD-10 for diagnosis and inpatient procedure coding. The mandate is expected to deliver better precision in reporting for episodes of care and morbidity, as well as more accurate reimbursement payments and reduced denial claims. This change may increase the administrative burden on our hospitals.

 

Medicaid and Medi-Cal (California’s Medicaid Program)

 

Generally, Medicaid programs are funded jointly by the federal government and the states and are administered by statutes under approved plans.  Medicaid reimbursement is often less than a hospital’s cost of services. California’s Medicaid program, known as “Medi-Cal,” is a joint federal/state program that provides health care services to certain persons who are financially needy.  Each of our hospitals participates in the Medi-Cal program.  The Medi-Cal program includes both a fee-for-service component and a managed care component.

 

As referenced above, the PPACA permits states to expand Medicaid coverage to all individuals under age 65 with incomes up to 133% of the federal poverty level by 2014.  However, the PPACA also permits states to apply a 5% income disregard to the Medicaid eligibility standard, so that Medicaid eligibility will effectively be extended to those with incomes up to 138% of the poverty level.

 

Many states, including California, are adopting budgets that reduce their Medicaid expenditures.  The recent economic downturn has increased the budgetary pressures on California, and these pressures have resulted in decreased Medi-Cal spending. A 10 percent rate cut to Medi-Cal providers that was approved in 2011 as a budget-cutting move has been delayed by court challenge. The Ninth Circuit Court of Appeals panel denied rehearing of its decision upholding the cuts.

 

Medi-Cal Fee-for-Service Program.  Inpatient hospital services under the Medi-Cal fee-for-service component are reimbursed primarily under the Selective Provider Contracting Program (“SPCP”).  Provider agreements under the SPCP are negotiated by the California Medical Assistance Commission (“CMAC”).  Our hospitals are located in areas which are currently “closed areas” under the SPCP.  In SPCP closed areas, private hospitals must hold a contract with the Medi-Cal program in order to be paid for their inpatient services (other than services performed in an emergency to stabilize a patient so that they can be transferred to a contracting hospital, and additional care rendered to emergency patients who cannot be so stabilized for transfer or where no contracting hospital accepts the patient).  Contracting hospitals are generally paid for these services on the basis of all-inclusive per diem rates they negotiate under their SPCP/CMAC contracts.

 

6
 

Outpatient hospital services under the fee-for service-component are paid for on the basis of a fee schedule, and it is not necessary for hospitals to hold SPCP/CMAC contracts in order to be paid for their outpatient services.  Each of our hospitals currently has an SPCP/CMAC contract in which it is contractually bound to continue until either party terminates the contract. There can be no assurance that each of our hospitals will maintain SPCP status or that the current Medi-Cal payment arrangements will continue.  Also, the SPCP/CMAC contract rates paid to our hospitals do not cover each hospital’s cost of providing care.  The Medi-Cal payment rates for outpatient services generally cover only a small portion of a Hospital’s cost of providing care.

 

Medi-Cal Managed Care.  In addition to the fee-for-service component of Medi-Cal, Orange County, California (where our hospitals are located) participates in the Medi-Cal managed care program.  Many Medi-Cal beneficiaries in Orange County are covered under Medi-Cal managed care, and not under fee-for-service Medi-Cal. Medi-Cal managed care in Orange County is provided through a County Organized Health System known as CalOptima.

 

In 2006, CalOptima focused on entering into contracts with hospitals on a fee-for-services basis for managed care Medi-Cal enrollees managed directly by CalOptima and CalOptima’s capitated hospitals.  The rates in these contracts are based on the greater of a county-wide rate established by CalOptima based on past average SPCP/CMAC rates or the individual hospital’s SPCP/CMAC rate.  Our hospitals entered into these CalOptima fee for service contracts effective June 2006, and all four hospitals maintained their Medi-Cal managed care contract at the end of the fourth quarter.  There can be no assurance that the amounts paid to our hospitals for services which are covered or not covered under the contracts between CalOptima and each of our hospitals will be adequate to reimburse the hospital’s costs of providing care.

 

Medi-Cal DSH Payments.  Some of our hospitals receive substantial additional Medi-Cal reimbursement as a DSH hospital from the DSH Replacement Fund and the Private Hospital Supplemental Fund.  Hospitals qualify for additional funding based on the proportion of services they provide to Medi-Cal beneficiaries and other low-income patients.  Payments to a hospital are determined on a formula basis set forth by state law and the Medi-Cal State Plan.  Hospitals receive funds from the Private Hospital Supplemental Fund pursuant to amendments to their SPCP contracts negotiated with the CMAC.  The Medi-Cal funding for DSH hospitals, however, is dependent on state general funding appropriations, and there can be no assurance that the state will fully fund the Medi-Cal DSH payment programs.  As referenced above, under the PPACA

 

Dual Eligible Demonstration Project. California's Medi-Cal program and the federal Medicare program are partnering to launch a three-year demonstration that would promote coordinated health care delivery to seniors and people with disabilities who are dually eligible for both programs. The duals demonstration -- now called the Cal MediConnect Program -- aims to create a seamless service delivery experience for individuals eligible for both Medicare and Medi-Cal coverage. On March 27, 2013, the State of California received federal approval to move forward with the demonstration, following the release of a Memorandum of Understanding between the Department of Health Care Services and the Centers for Medicare & Medicaid Services. The Cal MediConnect program will be implemented no sooner than January 2014. In April 2012, the State of California chose Orange County to participate in the demonstration project.

 

Medicare and Medicaid Recovery Audit Contractor Initiatives

 

Section 302 of the Tax Relief and Health Care Act of 2006 authorized a permanent program involving the use of third-party RACs to identify Medicare overpayments and underpayments made to health care providers.  RACs are compensated based on the amount of both overpayments and underpayments they identify by reviewing claims submitted to Medicare for correct coding and medical necessity.  Payment recoveries resulting from RAC audits are appealable through administrative and judicial processes.

 

The PPACA expanded the RAC program’s scope by requiring all states to enter into contracts with RACs by December 31, 2010 to audit payments to Medicaid providers.  CMS issued a letter to state Medicaid directors on October 1, 2010 that (1) provided preliminary guidance to states on the implementation of Medicaid RAC programs, (2) created a deadline of December 31, 2010 for states to establish RAC programs, and (3) established a deadline of April 1, 2011 for states to fully implement their Medicaid RAC programs.  On February 1, 2011, CMS issued a notice temporarily suspending the requirement that states implement their RAC programs until the final Medicaid RAC rule was issued. CMS issued the final Medicaid RAC rule on September 16, 2011. Among other things, the final Medicaid RAC rule clarifies the permissible scope of RAC audits, including a maximum three-year look-back period and limits on the number of medical records that may be audited. The Final Rule also requires each RAC to hire certified coders and at least one licensed medical director, subject to limited exceptions. We cannot predict with certainty the impact of the Medicare and Medicaid RAC programs will have on our future results of operations or business.

 

7
 

Workers’ Compensation Reimbursement

 

Fee Schedules.  A portion of our hospitals’ revenues is expected to come from Workers’ Compensation program reimbursements.  As part of an effort in 2003 to control costs under the Workers’ Compensation program, the California legislature enacted Labor Code Section 5307.1, which sets reimbursement for hospital inpatient and outpatient services, including outpatient surgery services, at a maximum of 120% of the current Medicare fee schedule for hospitals.  The Administrative Director of the Division of Workers’ Compensation is authorized to develop and, after public hearings, to adopt a fee schedule for outpatient surgery services, but this schedule may not be more than 120% of current Medicare payment rates for hospitals.  This fee limitation caps the amount that our hospitals can be paid for their services provided to Workers’ Compensation patients.  We can provide no assurance that the amount of revenues attributable to these payments will not be reduced in the future, which would have an adverse financial impact on the Company.

 

Provider Networks.  Under California law, employers may establish medical provider networks for Workers’ Compensation patients and may restrict their employees’ access to medical services to providers that are participants in those networks.  Employers are free to choose which providers will and will not participate in their networks, and employers pay participating providers on the basis of negotiated rates that may be lower than those that would otherwise be provided for by the Workers’ Compensation fee schedules.  Employers may also choose to contract with licensed Health Maintenance Organizations (“HMO”) and restrict access by their employees to participating providers of these HMOs.  Our hospitals are participating providers in Workers’ Compensation networks, and to the extent that our hospitals are required to negotiate and accept lower reimbursement rates to participate in these networks, there may be an adverse financial impact on the Company.  Also, network providers are required to provide treatment in accordance with utilization controls to be established by the Department of Workers’ Compensation.  Therefore, as network participants, such utilization controls may limit the services for which our hospitals are reimbursed, which could have an adverse financial impact on the Company.

 

Commercial Insurance

 

Many private insurance companies contract with hospitals on a “preferred” provider basis, and many insurers have introduced plans known as Preferred Provider Organizations (“PPO”).  Under PPO plans, patients who use the services of contracted providers are subject to more favorable copayments, coinsurance and deductibles than apply when they use non-contracted providers.  In addition, under most HMOs, private payers limit coverage to those services provided by selected hospitals.  With this contracting authority, private payers can direct patients away from non-selected hospitals by denying coverage for their services.

 

Our hospitals currently have several contracts with managed care organizations.  However, if the Company’s managed care rates become less favorable, or if the Company loses contracts and becomes out-of-network for more patients, the Company’s profitability may be unfavorably affected.

 

Electronic Health Records

 

The 2009 American Recovery and Reinvestment Act (“ARRA”) provides stimulus monies for hospitals and physicians that are meaningful users of electronic health records (“EHR”) and imposes penalties on providers who are not meaningful users by the end of 2015.  The intent of ARRA is to promote the use of technology to improve health outcomes and reduce health care costs.  To become a meaningful EHR user, a provider must adopt a “certified EHR system” according to HHS standards.  Also, the health care provider must demonstrate that it engages in the exchange of health information to promote quality of care and coordination, and reports on clinical quality measures.

 

On July 13, 2010, CMS issued two final rules related to the adoption and dissemination of EHRs (“Phase I Rules”). The Phase I Rules define the “meaningful use” requirements that hospitals and other providers must meet to qualify for federal incentive payments for adopting EHRs under ARRA. Also, to demonstrate that they are meaningful EHR users, hospitals must meet 14 clinical quality measures and five of 10 optional quality objectives.  In addition, the Phase I Rules describe the technical capabilities required for certified EHR technology. Hospitals and other providers must adopt certified EHR technology, as well as demonstrate their meaningful use thereof, to qualify for the federal incentive payments.

 

On March 2, 2012, CMS issued “Phase 2” of its EHR incentive plan (“Phase II Proposed Rules”). Under the Phase II Proposed Rules, hospitals must meet, or qualify for an exemption from, 16 core objectives and two of four optional quality objectives. The Phase II Proposed Rules also outline the process by which hospitals may submit quality data electronically, with the intent of reducing the burden associated with quality reporting.

 

8
 

Incentive payments made through the Medicare EHR Incentive Program are subject to the mandatory reductions in federal spending known as sequestration, required by the Budget Control Act of 2011. The American Taxpayer Relief Act of 2012 postponed sequestration for 2 months. As required by law, President Obama issued a sequestration order on March 1, 2013. Under these mandatory reductions, Medicare EHR incentive payments made to eligible professionals and eligible hospitals will be reduced by 2%. This 2% reduction will be applied to any Medicare EHR incentive payment for a reporting period that ends on or after April 1, 2013. These reductions will have a negative effect on our hospitals’ revenue.

 

The Company adopted certified EHR technology and it recognized other income of $6.8 million relative to the first year under the Medicaid EHR incentive program during fiscal year 2012.

 

Our hospitals will continue to endeavor to qualify for available EHR stimulus monies and to avoid penalties associated with failure to implement meaningful use of EHR systems.  However, the purchase and implementation of EHR systems can be expensive.  Further, as use of electronic health information becomes more pervasive, we anticipate that additional regulations and costs related to the exchange of health information on a regional and national basis will be implemented.

 

The Federal Emergency Medical Treatment and Active Labor Act

 

In response to concerns regarding inappropriate hospital transfers of emergency patients based on the patient’s inability to pay for the services provided, Congress enacted the Emergency Medical Treatment and Labor Act (“EMTALA”) in 1986.  This so-called “anti-dumping” law imposes certain requirements on hospitals with Medicare provider agreements to (1) provide a medical screening examination for any individual who comes to the hospital’s emergency department, (2) provide necessary stabilizing treatment for emergency medical conditions and labor, and (3) not transfer a patient until the individual is stabilized, unless the benefits of transfer outweigh the risks or the patient gives informed consent to the transfer.  Since our hospitals must provide emergency services without regard to a patient’s ability to pay, complying with EMTALA could have an adverse impact on the profitability of our hospitals, depending upon the number of such patients treated in or through our emergency rooms.  Failure to comply with EMTALA can result in exclusion of the physician from the Medicare and/or Medicaid programs or termination of the hospital’s Medicare provider agreements, as well as civil penalties.

 

Anti-kickback, Fraud and Self-Referral Regulations

 

Federal Anti-kickback Law.  The Social Security Act’s illegal remuneration provisions (the “Anti-kickback Statute”) prohibit the offer, payment, solicitation or receipt of remuneration (including any kickback, bribe or rebate), directly or indirectly, overtly or covertly, in cash or in kind, for (a) the referral of patients or arranging for the referral of patients to receive services for which payment may be made in whole or in part under a government-sponsored federal health care program, which includes Medicare, Medicaid and TRICARE (formerly CHAMPUS, which provides benefits to dependents of members of the uniformed services) and any state healthcare program, or (b) the purchase, lease, order, or arranging for the purchase, lease or order of any good, facility, service or item for which payment may be made under a government-sponsored health care program.  The Anti-kickback Statute contains both criminal and civil sanctions, which are enforced by the Office of Inspector General (“OIG”) of HHS and the United States Department of Justice.  The criminal sanctions for a conviction under the Anti-kickback Statute are imprisonment for not more than five years, a fine of not more than $50,000 for each offense, or both, with higher penalties potentially being imposed under the federal Sentencing Guidelines.  In addition to the imposition of criminal sanctions, the Secretary of HHS may exclude any person or entity that commits an act prohibited by the Anti-kickback Statute from participation in the Medicare program, and may also direct states to exclude that person from participation in state health care programs.   Violators of the Anti-kickback Statute may be subject to a civil money penalty of $50,000 for each prohibited act, and up to three times the total amount of remuneration offered, paid, solicited, or received, without regard to whether a portion of such remuneration was offered, paid, solicited, or received for a lawful purpose.

 

The PPACA amended the Anti-kickback Statute to provide that actual knowledge of the law or the specific intent to violate it is not required for a violation to occur. In addition, under the PPACA, submission of a claim for services or items generated in violation of the Anti-kickback Statute constitutes a false or fraudulent claim and may be subject to additional penalties under the federal False Claims Act.

 

There is increasing scrutiny by federal and state law enforcement authorities, OIG, HHS, the courts, and Congress of arrangements between health care providers and potential referral sources to ensure that the arrangements are not designed as an inappropriate mechanism to generate patient referrals.   Enforcement actions have increased and courts have broadly interpreted the scope of the Anti-kickback Statute to the extent that if “one purpose” of a payment arrangement is to induce referrals, a violation has occurred.

 

In addition, the OIG has long been on record that it believes that physician investments in healthcare companies can violate the Anti-kickback Statute and the OIG has demonstrated an aggressive attitude toward enforcement of the Anti-kickback Statute in the context of ownership relationships.

 

9
 

The OIG has issued regulations specifying certain payment practices that will not be treated as a criminal offense under the Anti-kickback Statute and that will not provide a basis for exclusion from the Medicare or Medicaid programs (the “Safe Harbor Regulations”).  These regulations include, among others, safe harbors for certain investments in both publicly traded and non-publicly traded companies.   However, physician investments in the Company will not be protected by either of these safe harbor regulations.  Nevertheless, the fact that a specific transaction does not meet all of the criteria of a “safe harbor” does not mean that such transaction constitutes a violation of the Anti-kickback Statute, and the OIG has indicated that any arrangement that does not meet all of the elements of a safe harbor will be evaluated on its specific facts and circumstances to determine whether the Anti-kickback Statute has been violated and, thus, if prosecution is warranted. Even in the absence of an enumerated safe harbor for physician-investment in the Company, however, the Company believes that it is not in violation of the Anti-kickback Statute.

 

California Anti-kickback Prohibitions.  California law prohibits the offer, delivery, receipt or acceptance by a licensed person of any remuneration as compensation or an inducement for referring patients.  The California statute applies to all patients, regardless of payer, and therefore is not limited to referrals of Medicare or Medi-Cal beneficiaries.  There are no “safe harbors” under California’s Anti-kickback Statute; however, there are exceptions that are not similarly reflected in the federal Anti-kickback Statute.  The California statute specifically provides that a medically necessary referral is not illegal where the referring physician has an ownership interest in the health care facility to which the referral is made, provided that the physician’s return on investment is based upon the amount of the physician’s capital investment or proportional ownership and such ownership is not based upon the number or value of patients referred.  The Company believes that the return on investment paid to the physician-investors is relative to their proportional ownership interest, and therefore the Company’s physician-investors are not in violation of California’s Anti-kickback Statute.

 

California law contains a separate prohibition against kickbacks for the referral of Medi-Cal patients.  California’s Medi-Cal fraud and abuse statute prohibits the solicitation or receipt of any remuneration including kickbacks, in return for the referral of any individual to a person for furnishing any services or merchandise which is paid for by Medi-Cal.  A violation of this law can result in punishment upon a first conviction by imprisonment in the county jail for not longer than one year, or state prison, or by a fine not exceeding $10,000, or by both imprisonment and fine.  California’s Attorney General has relied upon exceptions set forth in federal law when reviewing a physician’s ownership in a medical device company.  Therefore, as the Company believes that its physician-investors are not in violation of the federal Anti-kickback Statute by virtue of their relationships with the Company, they should similarly be considered compliant with California’s Medi-Cal Anti-kickback Statute.

 

The Federal False Claims Act.  The federal government is authorized to impose criminal, civil, and administrative penalties on any person or entity that files a false claim for payment from the Medicare or Medi-Cal programs.  In addition to other federal criminal and civil laws to punish health care fraud, the federal government, over the past several years, has accused an increasing number of health care providers of violating the federal civil False Claims Act.  The False Claims Act imposes civil liability (including substantial monetary penalties and damages) on any person or corporation which (1) knowingly presents a false or fraudulent claim for payment to the federal government, (2) knowingly uses a false record or statement to obtain payment or (3) engages in a conspiracy to defraud the federal government to obtain allowance for a false claim.  Recently, provisions of the False Claims Act were clarified under the Fraud Enforcement and Recovery Act of 2009 to eliminate the requirement that a false claim be presented to a federal official or that it directly involves federal funds.  False claims allegations could arise, for example, with respect to one of more of our hospital’s billings to the Medicare program for its services or the submission by the hospital of Medicare cost reports.  Also, under the PPACA, the False Claims Act is now implicated by the knowing failure to report and return an overpayment within 60 days of identifying the overpayment or by the date a corresponding cost report is due, whichever is later. The False Claims Act defines “knowingly” to include not only actual knowledge of a claim’s falsity, but also reckless disregard for, or intentional ignorance of, the truth or falsity of a claim.  A party that does not “knowingly” submit false claims is not liable under the False Claims Act.  Because our hospitals perform hundreds of procedures a year for which they submit claims to Medicare, submission of claims known to be erroneous, or submission of claims in reckless disregard of their truth or falsity, could result in significant civil penalties under the False Claims Act.  Our hospitals, however, have significant quality control measures in place to identify and correct any errors in coding and claim submission that could lead to False Claims Act violations.

 

Under the qui tam, or whistleblower, provisions of the False Claims Act, private parties may bring actions on behalf of the federal government.  These private parties, often referred to as relators, are entitled to share in any amounts recovered by the government through trial or settlement.  Both direct enforcement activity by the government and whistleblower lawsuits have increased significantly in recent years and have increased the risk that a health care company, like us, will have to defend a false claims action, pay fines or be excluded from the Medicare and Medicaid programs as a result of an investigation resulting from a whistleblower case.  Although the Company intends for its hospitals to comply with both federal and state laws related to the submission of claims, there can be no assurance that a determination that we have violated these claims-related laws will not be made, and any such determination would have a material adverse effect on the Company.

 

10
 

In addition to the False Claims Act, federal civil monetary penalties (“CMP”) provisions authorize the imposition of substantial civil money penalties against an entity that engages in activities including, but not limited to, (1) knowingly presenting or causing to be presented a claim for services not provided as claimed or which is otherwise false or fraudulent in any way, (2) knowingly giving or causing to be given false or misleading information reasonably expected to influence the decision to discharge a patient, (3) offering or giving remuneration to any beneficiary of a federal health care program likely to influence the selection of a particular provider, practitioner or supplier for the ordering or receipt of reimbursable items or services, (4) arranging for reimbursable services with an entity which is excluded from participation from a federal health care program, (5) knowingly or willfully soliciting or receiving remuneration for a referral of a federal health care program beneficiary or (6) using a payment intended for a federal health care program beneficiary for another use.

 

The Secretary of HHS, acting through the OIG, has both mandatory and permissive authority to exclude individuals and entities from participation in federal programs pursuant to the CMP statute.  Also, it is a federal offense to: (1) knowingly and willfully execute or attempt to execute any scheme to defraud any health care benefit program, including any private or governmental program or (2) to obtain, by means of false or fraudulent pretenses, any property owned or controlled by any health care benefit program.  Penalties for a violation of this federal law include fines and/or imprisonment, and a forfeiture of any property derived from proceeds traceable to the offense.  In addition, if an individual is convicted of a criminal offense related to participation in the Medicare program or any state health care program, or is convicted of a felony relating to health care fraud, the Secretary of HHS is required to bar the individual from participation in federal health care programs and to notify the appropriate state agencies to bar the individuals from participation in state health care programs.

 

While the criminal statutes are generally reserved for instances of fraudulent intent, the federal government is applying its criminal, civil, and administrative penalty statutes in an ever-expanding range of circumstances.  For example, the government has taken the position that a pattern of claiming reimbursement for unnecessary services violates these statutes if the claimant merely should have known the services were unnecessary, even if the government cannot demonstrate actual knowledge.  The government has also taken the position that claiming payment for low-quality services is a violation of these statutes if the claimant should have known that the care was substandard.  In addition, some courts have held that a violation of the Stark Law or the Anti-kickback Statute can result in liability under the federal False Claims Act.  The PPACA clarified this issue with respect to the Anti-kickback Statute by providing that submission of claims for services or items generated in violation of the Anti-kickback Statute constitutes a false or fraudulent claim under the False Claims Act.  Noncompliance with other regulatory requirements can also lead to liability under the False Claims Act if it can be established that compliance with those requirements are necessary in order for a hospital to be paid for its services.

 

Claims filed with private insurers can also lead to criminal and civil penalties under federal law, including, but not limited to penalties relating to federal mail and wire fraud statutes and the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) provisions which made the defrauding of any health care insurer, public or private, a crime.  Our hospitals are also subject to various state insurance statutes and regulations that prohibit the hospitals from submitting inaccurate, incorrect or misleading claims.  The Company intends for its hospitals to comply with all state insurance laws and regulations regarding the submission of claims.  However, the Company cannot guarantee that the hospitals’ insurance claims will not be challenged.  If a hospital is found to be in violation of a state insurance law or regulation, it could be subject to fines and criminal penalties which would have an adverse effect on the Company’s business and operating results.

 

Federal Physician Self-Referral Law.  Provisions of the Social Security Act commonly referred to as the Stark Law prohibit referrals by a physician of Medicare and Medicaid beneficiaries to providers for a broad range of health services if the physician (or his or her immediate family member) has an ownership or other financial arrangement with the provider, unless an exception applies.  The “designated health services” to which the Stark Law applies include all inpatient and outpatient services provided by hospitals.  Hospitals cannot bill for services they provide as a result of referrals that are made in violation of the Stark Law.  In addition, a violation of the Stark Law may result in a denial of payment, require refunds to the Medicare program and its beneficiaries, civil monetary penalties of up to $15,000 for each violation, civil monetary penalties of up to $100,000 for certain “circumvention schemes,” and exclusion from participation in Medicare, Medicaid, and other federal programs.  Violations of the Stark Law may also be actionable as violations of the federal False Claims Act.

 

Notwithstanding the breadth of the Stark Law’s general prohibition, the law contains an exception which protects ownership interests held by physicians in hospitals where the referring physician is authorized to perform services at the hospital and the physician’s ownership is in the hospital itself, and not merely in a subdivision of the hospital.  The Hospitals intend to rely upon this exception to protect the ownership interests that physicians hold in them.  The PPACA made changes to this exception by effectively preventing new physician-owned hospitals after March 23, 2010 and limiting the capacity and amount of physician ownership in existing physician-owned hospitals. As revised, the Stark Law prohibits physicians from referring Medicare patients to a hospital in which they have an ownership or investment interest unless the hospital has physician ownership and a Medicare provider agreement as of March 23, 2010 (or, for those hospitals under development at the time of the PPACA’s enactment, as of December 31, 2010). A physician-owned hospital that meets these requirements will still be subject to restrictions that limit the hospital’s aggregate physician ownership to the level that existed on March 23, 2010 and, with certain narrow exceptions for hospitals with a high percentage of Medicaid patients, prohibit expansion of the number of operating rooms, procedure rooms or beds. The legislation also subjects a physician-owned hospital to reporting requirements and extensive disclosure requirements on the hospital’s website and in any public advertisements.

 

11
 

In addition to physician ownership, our hospitals have various arrangements by which they compensate physicians for services.  Payments by the Company to such physicians who refer patients to our hospitals will constitute financial relationships for purposes of the Stark Law.  Exceptions exist under the Stark Law and its implementing regulations for various types of compensation relationships.  The Company strives to ensure that all of its financial relationships qualify for one or more exceptions to the Stark Law.  However, there can be no assurance that the Company will be successful in structuring all of its relationships with physicians so as to qualify for protection under one or more of the Stark Law’s exceptions.

 

California Physician Self-Referral Law.  In California, the legislature has enacted two laws which broadly prohibit physician self-referral of patients. The first law, codified in the California Labor Code, applies to workers’ compensation patients, while the second law, codified in the California Business and Professions Code, applies to all patient referrals, regardless of the payer source. The first law has applied to workers injured on or after January 1, 1994.  The other became operative on January 1, 1995, and applies to all patient referrals, regardless of the patient’s payer.  Generally, these laws prohibit physicians from referring patients to healthcare facilities in which they have an ownership interest, except in limited circumstances.

 

Both laws contain broad exceptions permitting physicians to refer patients to hospitals, so long as the referring physician is not compensated by the hospital for the referral, and any so long as equipment leases between the hospital and the physician satisfies certain requirements.   Based on the enumerated exceptions, the Company believes that referrals to its hospitals received from physician-owners are in compliance with both laws.

 

Disclosure of Financial Interests

 

California law provides that it is unlawful for a physician to refer a patient to an organization in which the physician or a member of the physician’s immediate family has a significant beneficial interest, unless the physician first discloses the interest to the patient in writing and advises the patient regarding alternative services, if such services are available.  A “significant beneficial interest” means any financial interest equal to or greater than the lesser of five percent of the total beneficial interest, or $5,000.  This disclosure requirement may be satisfied by the posting of a conspicuous sign likely to be seen by all patients who use the facility or by providing patients with written disclosure statements.  Physicians must disclose the names of entities in which they hold significant financial interests to a patient’s payer upon the request of the payer (not to be made more than once a year).  A violation of this disclosure requirement constitutes “unprofessional conduct,” and is grounds for the suspension or revocation of the physician’s license.  Further, it is deemed a misdemeanor punishable by imprisonment not to exceed six months, or by a fine not to exceed $2,500.

 

In addition, California’s general self-referral laws require that any physician who refers a person to, or seeks consultation from an organization in which the physician has a financial interest must disclose the financial interest to the patient in writing at the time of the referral.  This requirement applies regardless of whether the financial interest is otherwise protected by one of the exemptions under the self-referral law.  There is no minimum threshold of ownership required in order for this disclosure requirement to be triggered, and this disclosure requirement cannot be satisfied by the posting of a sign.  A violation of this disclosure requirement may be subject to civil penalties of up to $5,000 for each offense.  Physician investors in the Company are individually responsible for complying with these disclosure requirements with respect to their referrals to the hospital.  A failure to make the required disclosure by any physician who holds a financial interest in the Company could have an adverse impact on the Company.

 

Health Insurance Portability and Accountability Act

 

The HIPAA law mandates the adoption of uniform standards for the exchange of health information in an effort to encourage overall administrative simplification, protect the confidentiality of a patient’s confidential health information, and enhance the overall effectiveness and efficiency of the health care industry.  Under HIPAA, health care providers and other “covered entities,” such as health insurance companies and other third-party payers, must adopt uniform standards for the electronic transmission of billing statements and insurance claims forms.  These standards require the use of standard data formats and code sets when electronically transmitting information in connection with health claims and equivalent encounter information, healthcare payment and remittance advice and health claim status.  The PPACA requires HHS to adopt standards for additional electronic transactions and to establish operating rules to promote uniformity in the implementation of each standardized electronic transmission.

 

HHS also has promulgated security standards and privacy standards which are aimed, in part, at protecting the confidentiality, availability and integrity of health information by “covered entities,” including health plans, healthcare clearinghouses and healthcare providers, that receive, store, maintain or transmit health and related financial information in electronic form.  In addition, ARRA amended HIPAA to include “business associates,” i.e., those entities that perform business functions for health plans, health care clearinghouses and providers.  The privacy standards require compliance with rules governing the use and disclosure of patient health and billing information.  ARRA also created rights for patients in their health information, such as the right to amend their health information, and they require us to impose these rules, by contract, on any business associate to which we disclose such information to perform functions on our behalf.  These provisions required us to implement expensive computer systems, employee training programs and business procedures to protect the privacy and security of each patient’s health information and enable electronic billing and claims submissions consistent with HIPAA.  On January 25, 2013, HHS published a final rule to modify the HIPAA privacy, security, and enforcement rules and the breach notification requirements under the federal Health Information Technology for Economic and Clinical Health Act (“HITECH Act”).

 

12
 

The HIPAA security standards require us to maintain reasonable and appropriate administrative, technical, and physical safeguards to ensure the integrity, confidentiality and the availability of electronic health and related financial information.  The security standards were designed to protect electronic information against reasonably anticipated threats or hazards to the security or integrity of the information and to protect the information against unauthorized use or disclosure.  Under ARRA, covered entities, including our hospitals, must notify patients of most security breaches pursuant to HHS regulations.

 

HIPAA provides both criminal and civil fines and penalties for covered entities that fail to comply.  These fines and penalties were strengthened under ARRA to provide for penalties of (1) in the amount of $1,000 per violation due to “reasonable cause and not to willful neglect” (with a maximum penalty of $100,000), (2) up to $10,000 for each violation due to willful neglect that is corrected (subject to a $250,000 maximum) and (3) up to $50,000 for each willful violation that is not corrected properly (subject to a maximum penalty of $1.5 million dollars during a calendar year).

 

California Confidentiality of Medical Information Act

 

The Confidentiality of Medical Information Act (“CMIA”), California’s general health information privacy law, applies to California health care providers, including hospitals, and several other types of entities. The CMIA prohibits the disclosure of an individual’s confidential health information “for any purpose not necessary to provide health care services to the patient,” unless the individual authorizes it, or it is otherwise permitted by the CMIA.

 

The CMIA allows a person whose medical information has been used or disclosed in violation of the CMIA to recover (1) compensatory damages for resulting economic loss or personal injury, (2) nominal damages in the amount of $1,000 (whether or not actual damages were sustained), (3) punitive damages of up to $3,000, (4) attorneys’ fees of up to $1,000 and the (5) costs of litigation.  A violation of the CMIA that results in economic loss or personal injury to a patient is also a misdemeanor.  The CMIA further provides for civil penalties, ranging from $2,500 for negligent disclosures of medical information in violation of the CMIA to $250,000 for knowing and willful disclosures for the purposes of financial gain.  Any wrongful disclosure of patient medical information by our hospitals may result in significant financial penalties to our hospitals, and would have an adverse effect on the Company’s business.

 

California Security Breach Information Act

 

The California Security Breach Information Act, effective July 1, 2003, requires those businesses that own or license personal information about Californians to provide reasonable security measures to protect the confidentiality of such information and to inform those individuals if the security of their information is compromised. The disclosure must be made in the “most expedient time possible” and without unreasonable delay, consistent with the legitimate needs of law enforcement or any measures necessary to determine the extent of the breach.

 

On August 31, 2011, Governor Jerry Brown signed Senate Bill 24, which amended California’s security breach notification law. Senate Bill 24 applies to breaches occurring on or after January 1, 2012, and makes several important changes to disclosure requirements required under the law. As required by Senate Bill 24, notices to affected individuals must now also contain (1) the name and contact information of the reporting person or business, (2) the types of personal information subject to the breach, (3) the date or date range of the breach, and (4) the toll-free telephone numbers and addresses of the three major credit bureaus if the breach exposed an individual’s social security number and driver’s license or state identification card number. The bill also requires notification of California’s attorney general regarding the breach if more than 500 California residents are affected and amends the law’s substitute notice provisions. Also, a covered entity under HIPAA will be deemed to have complied with the notice requirements of California’s Security Breach Information Act if it has complied completely with Section 13402(f) of the HITECH Act.

 

Corporate Practice of Medicine

 

California has a body of law, known as the corporate practice of medicine prohibition, which prohibits non-professional corporations and other entities from employing or otherwise controlling the professional medical judgment of physicians. Although we exercise care in structuring our arrangements with physicians to comply with California law and we believe that such arrangements will comply with applicable laws in all material respects, we cannot provide any assurance that governmental officials charged with responsibility for enforcing these laws will not assert that the Company, or certain transactions that we are involved in, are in violation of such laws, or that the courts will ultimately interpret such laws in a manner consistent with our interpretations.

 

13
 

 

The addition of physician-investors in the Company could affect competition in the geographic areas in which its hospitals operate.  Such effects on competition could give rise to claims that our hospitals and physician-investors violate federal and state antitrust and unfair competition laws under a variety of theories.  There can be no assurance that the Federal Trade Commission, the Antitrust Division of the Department of Justice, or any other party, including a physician participating in the Company’s business, or a physician denied participation in the Company’s business, will not challenge or seek to delay or enjoin the activities of the Company on antitrust grounds.  If such a challenge is made, there can be no assurance that such challenge would be unsuccessful.  We have not obtained an analysis of any possible antitrust implications of the activities of the Company or of the continuing arrangements and anticipated operations of our hospitals.

 

Licensing, Certification, Accreditation, Surveys, Investigations and Audits

 

Health facilities, including our hospitals, are subject to numerous legal, regulatory, professional and private licensing, certification and accreditation requirements.  These include requirements relating to Medicare and Medi-Cal participation and payment, state licensing agencies, private payers and the Joint Commission on Accreditation of Healthcare Organizations. Renewal and continuance of these licenses, certifications and accreditations are based on inspections, surveys, audits, investigations or other reviews, some of which may require or include affirmative action or response by the Company.  Some investigations by licensing bodies may result in financial penalties to our hospitals.  These activities are generally conducted in the normal course of business of health care facilities.  Nevertheless, an adverse determination could result in a loss or reduction in a hospital’s scope of licensure, certification or accreditation, or could reduce the payment received or require repayment of amounts previously remitted.  Any failure to obtain, renew or continue a license, certification or accreditation required for operation of a hospital could result in the loss of utilization or revenues or the loss of the Company’s ability to operate all or a portion of a hospital, and, consequently, could have a material and adverse effect on the Company.

 

The hospital industry has seen a number of ongoing investigations related to referrals, physician recruiting practices, cost reporting and billing practices, laboratory and home health care services and physician ownership and joint ventures involving hospitals.  Federal and state government agencies have announced heightened and coordinated civil and criminal enforcement efforts.  The PPACA includes additional federal funding to fight health care fraud, waste and abuse, increasing incrementally through federal fiscal year 2020.  The operational mission of the OIG is to protect the integrity of the Medicare and Medicaid programs and the well-being of program beneficiaries by: detecting and preventing waste, fraud and abuse; identifying opportunities to improve program economy, efficiency and effectiveness; and holding accountable those who do not meet program requirements or who violate federal laws. The OIG carries out its mission by conducting audits, evaluations and investigations and, when appropriate, imposing civil monetary penalties, assessments and administrative sanctions. Although we have policies and procedures in place to facilitate compliance with the laws, rules and regulations affecting the health care industry, if a determination is made that we were in material violation of such laws, rules or regulations, our business, financial condition, results of operations or cash flows could be materially adversely affected.

 

The laws and regulations with which we must comply are complex and subject to change.  In the future, different interpretations or enforcement of these laws and regulations could subject our operations to allegations of impropriety or illegality or could require us to make changes in our facilities, equipment, personnel, services, capital expenditure programs and operating expenses.  If we fail to comply with applicable laws and regulations, we could suffer civil or criminal penalties, including the loss of our licenses to operate our hospitals and our ability to participate in the Medicare, Medicaid and other federal and state health care programs.

 

Earthquake Safety Compliance

 

Our hospitals are located in an area near active and substantial earthquake faults. Our hospitals carry earthquake insurance with a policy limit of $50.0 million. A significant earthquake could result in material damage and temporary or permanent cessation of operations at one or more of our hospitals.

 

The State of California has imposed hospital seismic safety requirements. Under these requirements, our hospitals must meet stringent seismic safety criteria in the future. In addition, there could be other remediation costs pursuant to this seismic retrofit.

 

The State of California has a seismic review methodology known as HAZUS. The HAZUS methodology may preclude the need for some structural modifications. All four hospitals requested HAZUS review and received a favorable notice pertaining to structural reclassification. All hospital buildings, with the exception of one (an administrative building), have been deemed compliant until January 1, 2030 for both structural and nonstructural retrofit. We do not have an estimate of the cost to remediate the seismic requirements for the administrative building as of March 31, 2013.

 

14
 

There are additional requirements that must be complied with by 2030. The costs of meeting these requirements have not yet been determined. Compliance with seismic ordinances will be costly and could have a material adverse effect on our cash flow.  In addition, remediation could possibly result in certain environmental liabilities, such as asbestos abatement.

 

Environmental Regulations

 

Our hospitals are subject to various federal, state and local statutes and ordinances regulating the discharge of materials into the environment.  Our health care operations generate medical waste, such as pharmaceuticals, biological materials and disposable medical instruments that must be disposed of in compliance with federal, state and local environmental laws, rules and regulations.  Our operations are also subject to various other environmental laws, rules and regulations.  Environmental regulations also may apply when we renovate or refurbish hospitals, particularly older facilities.  Remediation costs relating to toxic substances, if encountered during construction, could be material to the Company.

 

CORPORATE HISTORY

 

The Company was originally incorporated under the laws of the State of Utah on July 31, 1984 under the name “Aquachlor Marketing Inc.”  On December 23, 1988, the Company reincorporated in the State of Nevada.  From 1989 until 2003, the Company was a development stage company with no material assets, revenues or business operations.  On November 18, 2003, a group of investors purchased a controlling interest in the Company (then known as First Deltavision) with the objective of transforming the Company into a leading provider of high quality, cost-effective healthcare through the acquisition and management of financially distressed and/or underperforming hospitals and other healthcare facilities.  On September 29, 2004, the Company entered into a definitive agreement to acquire the four hospitals from Tenet and the transaction closed on March 8, 2005.

 

In the first quarter of 2004, the Company changed its fiscal year end from June 30 to December 31, and changed the Company’s name to Integrated Healthcare Holdings, Inc.  On December 21, 2006, the Company changed its fiscal year end from December 31 to March 31.  Our principal executive offices are located at 1301 North Tustin Avenue, Santa Ana, California 92705, and our telephone number is (714) 953-3652.

  

ITEM 1A.  RISK FACTORS

 

An investment in our common stock involves a high degree of risk. Our business is subject to a number of risks and uncertainties—many of which are beyond our control—that may cause our actual operating results or financial performance to be materially different from our expectations.  You should carefully consider the following information about these risks, together with the other information contained in this report, before you decide to buy our common stock.  The risks and uncertainties described below are not the only ones we face.  Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also harm our operations.  If any of the following risks actually occur, our business would likely suffer and our results could differ materially from those expressed in any forward-looking statements contained in this Annual Report on Form 10-K including our consolidated financial statements and related notes.  In such case, the trading price of our common stock could decline, and shareholders could lose all or part of their investment.

 

WE HAVE PREVIOUSLY EXPERIENCED SIGNIFICANT DIFFICULTIES WITH OUR LIQUIDITY

 

The consolidated financial statements have been prepared on a going concern basis, which assumes a continuing of our operations and the realization of assets and settlement of obligations in the normal course of business.  As of March 31, 2013, the Company has a total stockholders’ deficiency of $29.9 million and a working capital deficit of $36.7 million.  For the year ended March 31, 2013, the Company had a net loss of $15.5 million and negative cash flow from operations of $9.6 million. The consolidated financial statements do not include any adjustments that might result if we were forced to liquidate or discontinue operations.

 

WE HAVE INCURRED SIGNIFICANT LOSSES IN OPERATIONS TO DATE.  IF OUR SUBSTANTIAL LOSSES CONTINUE, THE MARKET VALUE OF OUR COMMON STOCK WILL LIKELY DECLINE FURTHER.  WE HAVE A HIGH DEGREE OF LEVERAGE AND SIGNIFICANT DEBT SERVICE OBLIGATIONS.

 

15
 

As of March 31, 2013, we had an accumulated deficit of $87.0 million.  We are attempting to improve our operating results and financial condition through a combination of contract negotiations, expense reductions, lowering the costs of borrowings through refinancing our debt, and new issues of equity.  However, new issues of equity are encumbered by warrant anti-dilution provisions and there can be no assurance that we will achieve profitability in the future.  If we are unable to achieve and maintain profitability, the market value of our common stock will likely decline further.

 

As of March 31, 2013, the debt service requirements on our $77.277 million debt were approximately $650,000 per month.  Our relatively high level of debt and debt service requirements have several effects on our current and future operations, including the following:  (i) we will need to devote a significant portion of our cash flow to service debt, reducing funds available for operations and future business opportunities and increasing our vulnerability to adverse economic and industry conditions and competition; (ii) our leveraged position increases our vulnerability to competitive pressures; (iii) the covenants and restrictions contained in agreements relating to our indebtedness restrict our ability to borrow additional funds, dispose of assets, issue additional equity or pay dividends on or repurchase common stock; and (iv) funds available for working capital, capital expenditures, acquisitions and general corporate purposes are limited.  Any default under the documents governing our indebtedness could have a significant adverse effect on our business and the market value of our common stock.

 

THE IMPACT OF THE PPACA ON OUR BUSINESS, FINANCIAL CONDITION, CASH FLOWS AND OPERATIONS IS UNCERTAIN

 

The extent to which the PPACA will be implemented through regulation and judicial interpretation will have a major impact upon the manner in which health care services are covered, delivered and reimbursed in the United States. The expansion of health insurance coverage under the law may result in a material increase in the number of patients using our facilities who have either private or public program coverage.  However, the PPACA also provides for significant reductions in the growth of Medicare spending and reductions in Medicare and Medicaid disproportionate share hospital payments. A significant portion of both our patient volumes and, as result, our revenues is derived from government health care programs, principally Medicare and Medicaid. Reductions to our reimbursement under the Medicare and Medicaid programs by the PPACA could adversely affect our business and results of operations to the extent such reductions are not offset by increased revenues from providing care to previously uninsured individuals.

 

We are unable to predict with certainty the full impact of the PPACA on our future revenues and operations at this time due to the law’s complexity and the limited amount of implementing regulations and interpretive guidance, as well as our inability to foresee how individuals and businesses will respond to the choices available to them under the law. Furthermore, many of the provisions of the PPACA that expand insurance coverage will not become effective until 2014 or later. In addition, PPACA will result in increased state legislative and regulatory changes in order for states to comply with new federal mandates, such as the requirement to establish health insurance exchanges and to participate in grants and other incentive opportunities. For a further discussion of the PPACA, see “ITEM 1. BUSINESS – HEALTH CARE REGULATION AND LICENSING.”

 

IF WE ARE UNABLE TO ENTER INTO MANAGED CARE PROVIDER ARRANGEMENTS ON ACCEPTABLE TERMS, OR IF WE HAVE DIFFICULTY COLLECTING FROM MANAGED CARE PAYERS, OUR RESULTS OF OPERATIONS COULD BE ADVERSELY AFFECTED

 

It would harm our business if we were unable to enter into managed care provider arrangements on acceptable terms.  Any material reductions in the payments that we receive for our services, coupled with any difficulties in collecting receivables from managed care payers, could have a material adverse effect on our financial condition, results of operations or cash flows.

 

FURTHER CHANGES IN THE MEDICARE AND MEDICAID PROGRAMS OR OTHER GOVERNMENT HEALTH CARE PROGRAMS COULD HAVE A MATERIAL ADVERSE EFFECT ON OUR BUSINESS

 

On August 2, 2011, the Budget Control Act of 2011 (the “Budget Control Act”) was enacted into law. The law mandates more than $900 billion in discretionary spending reductions over 10 years, and also provides for new spending initiatives aimed at reducing fraud and abuse in the Medicare program. The Budget Control Act also established the Joint Select Committee on Deficit Reduction (the “Joint Committee”), a bipartisan Congressional committee required to make recommendations regarding decreasing future federal budget deficits. Due to the Joint Committee’s failure to meet the November 2011 recommendation deadline for recommendations, the Budget Control Act requires automatic Medicare payment reductions. As discussed above, beginning April 1, 2013, the budget reduction process — more commonly known as sequestration — requires a reduction of spending of two percent for Medicare programs for one year. As a result, individual payments for services furnished under Medicare Parts A and B will be reduced. Monthly payments under Part C (Medicare Advantage) and Part D (the Prescription Drug Benefit) will also be cut. This reduction in payments from Medicare will have an adverse effect on our hospitals.

 

16
 

California Governor Jerry Brown has recently proposed expanding Medi-Cal in California up to 138 percent of the federal poverty level, but his proposed budget has not eliminated a cut in Medi-Cal payments to certain providers that would be applied retroactively to July 2012. If the rates paid by governmental payers are further reduced, if the scope of services covered by governmental payers is limited or if we, or one or more of our hospitals, are excluded from participation in the Medicare or Medi-Cal program or any other government healthcare program, there could be a material adverse effect on our business, financial condition, results of operations or cash flows.

 

In addition to the changes implemented by the PPACA, the Medicare and Medicaid programs are subject to statutory and regulatory changes, administrative rulings, interpretations and determinations concerning patient eligibility requirements, funding levels and the method of calculating payments or reimbursements, among other things; requirements for utilization review; and federal and state funding restrictions, all of which could materially increase or decrease payments from these government programs in the future, as well as affect the cost of providing services to our patients and the timing of payments to our facilities.  We are unable to predict the effect of future government healthcare funding policy changes on our operations.

 

OUR BUSINESS CONTINUES TO BE ADVERSELY AFFECTED BY A HIGH VOLUME OF UNINSURED AND UNDERINSURED PATIENTS

 

The primary collection risks associated with our accounts receivable relate to uninsured patient accounts and those patient accounts for which the primary insurance carrier has paid the amounts covered by the applicable agreement, but patient responsibility amounts (deductibles and co-payments) remain outstanding. The provision for doubtful accounts relates primarily to amounts due directly from patients. This risk has increased, and will likely continue to increase, if more individuals enroll in high deductible and co-payment insurance plans or forego health insurance coverage entirely. These trends will likely be exacerbated if general economic conditions remain challenging or if unemployment levels in the communities in which we operate rise. If unemployment rates increase, our business strategies to generate organic growth and to improve admissions and adjusted admissions at our hospitals may become more difficult to accomplish.

 

The amount of our provision for doubtful accounts is based on our assessments of historical collection trends, business and economic conditions, trends in federal and state governmental and private employer health coverage and other collection indicators. A continuation in trends that results in increasing the proportion of accounts receivable being comprised of uninsured or under-insured accounts could adversely affect our collections of accounts receivable, results of operations and cash flows.

 

COST CONTAINMENT, PAY FOR PERFORMANCE, AND OTHER PROGRAMS IMPOSED BY THIRD-PARTY PAYERS, INCLUDING GOVERNMENT HEALTH CARE PROGRAMS, MAY DECREASE THE COMPANY’S REVENUE

 

The health care industry is currently undergoing significant changes and is regularly subject to regulatory and political intervention.  We expect to derive a considerable portion of the Company’s revenue through our hospitals from government-sponsored health care programs and third-party payers (such as employers, private insurers, HMOs or preferred provider organizations).   It is possible that reimbursement from government and private third-party payers for hospital services may be reduced in the future due to a deterioration in general economic conditions and fiscal pressures placed upon federal and state governments.  Further reductions in payments or other changes in reimbursement for health care services could have a material adverse effect on the Company’s business, financial condition and/or results of operations.  Also, rates paid by private third-party payers are generally higher than Medicare, Medicaid and HMO payment rates.  Any decrease in the relative number of patients covered by private insurance would have a material adverse effect on the Company’s revenues and operations.

 

WE ARE REQUIRED TO TREAT PATIENTS WITH EMERGENCY MEDICAL CONDITIONS REGARDLESS OF THE PATIENT’S ABILITY TO PAY

 

In accordance with EMTALA, we are required to provide medical treatment to stabilize any patient who arrives at our hospitals with an emergency medical condition, regardless of the patient’s ability to pay. Accordingly, our results of operations may be negatively impacted by an increase in the number of indigent or charity care patients with emergency medical conditions treated at our hospitals.

 

CONTINUING TO PROVIDE QUALITY MEDICAL SERVICES FROM TALENTED PHYSICIANS IS CRITICAL TO OUR BUSINESS

 

Generally, physicians are responsible for making patient admission decisions at our hospitals. Physicians are not employees and may terminate their affiliation with our hospitals at any time. Our business depends, in large part, upon the number, quality, and success of the physicians who perform services at our hospitals, as well as the strength of our relationships with these physicians.  Any failure of these physicians to maintain the quality of medical care provided or to otherwise adhere to professional guidelines at our hospitals, or any damage to the reputation of a key physician or group of physicians, could damage the Company’s and our hospitals’ reputations in the medical marketplace and may subject us to liability and significantly reduce our revenue and increase our costs.

 

17
 

Also, like many hospitals, we face a growing shortage of primary care and specialty physicians.  Should this shortage continue or worsen, the utilization of our hospitals may be adversely impacted.  This could have a negative impact on our revenues and profitability.

 

WE MAY BE INVOLVED IN LITIGATION WITH OUR MEDICAL STAFF

 

The primary relationship between a hospital and the physicians who practice in it is through the hospital's organized medical staff. Medical staff bylaws, rules and policies establish the criteria and procedures at acute care hospitals by which a physician may have his or her privileges or membership curtailed, denied or revoked. Physicians who are denied medical staff membership or certain clinical privileges, or who have such membership or privileges curtailed, denied or revoked may file legal actions against hospitals. Such actions may include a wide variety of claims, some of which could result in substantial uninsured damages to a hospital. In addition, unanticipated failure of the governing body to adequately oversee the conduct of its medical staff may result in hospital liability to third parties.

 

WE FACE COMPETITION IN STAFFING QUALIFIED NURSES AND MEDICAL SUPPORT STAFF AT OUR HOSPITALS, WHICH COULD INCREASE OUR LABOR COSTS

 

Health care providers depend on qualified nurses, as well as other medical support staff, to provide quality health care services to patients. We must compete with other health care providers in attracting and retaining qualified nurses and medical support personnel, which may cause our labor expenses to rise. In addition, California has adopted legislation and regulations mandating a series of specific minimum patient-to-nurse ratios in all acute care hospital nursing units. Any failure to comply with nurse staff ratios could result in action by licensure authorities and/or subject our hospitals to liability which could have a material adverse effect on the Company’s results of operations.

 

UNION CONTRACTS HAVE BEEN RENEWED BUT THERE CAN BE NO ASSURANCE THAT THE CONTRACTS WILL BE RENEWED IN THE FUTURE

 

Approximately 37% of the Company’s employees are represented by labor unions as of March 31, 2013.  The CNA Agreement and the SEIU Agreement both expire on August 31, 2014, and there can be no assurance that such agreements will be renewed on or prior to their scheduled expiration. The agreements have “no strike” provisions and compensation caps which provide the Company with long term compensation and workforce stability. 

 

For both unions, all prior grievances regarding retiree medical benefits, the administration of pay adjustments and pay practices, changes in medical benefits and several wrongful terminations have been resolved in the form of settlement agreements.

 

IF EITHER THE COMPANY OR THE HOSPITALS FAIL TO COMPLY WITH APPLICABLE LAWS AND REGULATIONS, WE MAY SUFFER PENALTIES OR BE REQUIRED TO MAKE SIGNIFICANT CHANGES TO OUR OPERATIONS

 

The Company and our hospitals are subject to many laws and regulations at the federal, state and local levels.  These laws and regulations require our hospitals to meet various licensing, certification and other requirements, including those relating to:

 

  ● billing and coding for services and properly handling overpayments;
  ● licensure and certification issues;
  ● physician ownership;
  ● payments to specialty hospitals, should any of our hospitals be determined to be a specialty hospital;
  ● prohibited inducements for patient referrals and restrictions on payments for marketing;
  ● the adequacy of medical care, equipment, personnel, operating policies and procedures;
  ● confidentiality, maintenance, data breach, identify theft and security issues associate with health-related and personal information and medical records;
  ● activities regarding competitors;
  ● reimbursement audits; and
  ● environmental protection.

 

18
 

If the Company fails to comply with applicable laws and regulations, it could suffer civil or criminal penalties.  States are increasingly regulating the delivery of health care services.   The hospital industry is subject to extensive state and local regulation with respect to reimbursement, licensure, certification and health planning.  This regulation relates, among other things, to the adequacy of physical plant and equipment, qualifications of personnel, standards of medical care and operational requirements.  Compliance with such regulatory requirements, as interpreted and amended from time to time, can increase operating costs and thereby adversely affect the financial viability of the company.  In the future, different interpretations or enforcement of existing or new laws and regulations could subject the current practices to allegations of impropriety or illegality, or could require the Company to make changes in its facilities, equipment, personnel, services, capital expenditure programs and operating expenses.  Current or future legislative initiatives or government regulation may have a material adverse effect on our hospitals’ operations or reduce the demand for their services. For further discussion of laws and regulations applicable to the Company and our hospitals, see “ITEM 1. BUSINESS - HEALTH CARE REGULATION AND LICENSING.”

 

THE COMPANY CONDUCTS ON-GOING REVIEWS OF ITS COMPLIANCE WITH VARIOUS LAWS RELATED TO PHYSICIAN ARRANGEMENTS, WHICH MAY REVEAL VIOLATIONS THAT COULD SUBJECT THE COMPANY TO FINES OR PENALTIES

 

The Company and our hospitals have entered into a variety of relationships with physicians.  In an increasingly complex legal and regulatory environment, these relationships may pose a variety of legal or business risks.  The Company conducts reviews of its compliance with the federal Anti-kickback Statute, Stark Law and other applicable laws as they relate to the Company’s relationships with potential referral sources.

 

One of the Company’s largest shareholders, OC-PIN, is owned and controlled by physicians who also refer to and practice at our hospitals. Our hospitals have various contractual relationships with OC-PIN physicians as well as physicians who are not owners of the Company.

 

The Company entered into a sale leaseback transaction for substantially all of the real estate with Pacific Coast Holdings Investment, LLC (“PCHI”) whereby the Company leases substantially all of the real property of our hospitals from PCHI.  PCHI is owned by Ganesha Realty, LLC, which is managed by Dr. Kali P. Chaudhuri and various physician investors.

 

The Company has a review process in place to ensure that its agreements with potential referral sources are in writing and comply with applicable laws.  Additionally, the Company has reviewed the terms of the purchase of ownership interests in the Company by OC-PIN, as well as the real estate sale-leaseback agreement with PCHI, and has determined that these transactions should be determined to be permissible under applicable law. However, if the Company or any of our hospitals are not in compliance with federal and state fraud and abuse laws and physician self-referral laws, the Company could be subject to repayment obligations, fines, penalties, exclusion from participation in federal health care programs, and other sanctions which would have a material adverse effect on the Company’s profitability.

 

WE FACE INTENSE COMPETITION IN OUR BUSINESS

 

The health care industry is highly competitive.  We compete with a variety of other organizations in providing medical services, which may have greater financial resources available to them. Some of the hospitals that compete with our hospitals are owned by government agencies or are not-for-profit organizations.  Tax-exempt competitors may have certain financial advantages not available to our facilities, such as endowments, charitable contributions, tax-exempt financing, and exemptions from sales, property and income taxes.  Under certain conditions some not-for-profit hospitals may form foundations with physician groups of a certain size for the purpose of delivering the full range of hospital and physician services to consumers. Since the physician group can directly employ its own physicians and typically co-manages the foundation with the hospital, this foundation delivery model can be seen as very similar to the direct employment of physicians by hospitals. For-profit hospitals cannot form and operate such foundations.  We also face increasing competition from physician-owned specialty hospitals and freestanding surgery, diagnostic and imaging centers for market share in high-margin services and for quality physicians and personnel.  If competing health care providers are better able to attract more patients, recruit and retain physicians, expand services or obtain favorable managed care contracts at their facilities, we may continue to experience a decline in patient volume levels.

 

A SIGNIFICANT PORTION OF OUR BUSINESS IS CONCENTRATED IN CERTAIN MARKETS AND THE RESPECTIVE ECONOMIC CONDITIONS OR CHANGES IN THE LAWS AFFECTING OUR BUSINESS IN THOSE MARKETS COULD HAVE A MATERIAL ADVERSE EFFECT ON THE COMPANY

 

We receive all of our inpatient services revenue from operations in Orange County, California.  The economic condition of this market could affect the ability of our patients and third-party payers to reimburse us for our services, through its effect on disposable household income and the tax base used to generate state funding for Medicaid programs.  An economic downturn, or changes in the laws affecting our business in our market and in surrounding markets, could have a material adverse effect on the Company.

 

19
 

Further, many individuals receive health insurance coverage through their employers. If unemployment levels continue to increase, the number of individuals with health insurance may decrease. As a result, our hospitals may in turn experience a decrease in patient volumes or an increase in services provided to uninsured patients. These factors, although uncertain, could have a negative impact on our results of operations.

 

WE MUST EFFECTIVELY AND TIMELY IMPLEMENT ELECTRONIC HEALTH RECORD SYSTEMS IN ORDER TO AVOID MEDICARE PAYMENT REDUCTIONS

 

The Health Information Technology for Economic and Clinical Health Act (“HITECH”) was introduced as part of the American Recovery and Reinvestment Act of 2009. The legislation was created to both stimulate the adoption of electronic health records in the United States and to require enhanced privacy safeguards for protected health information. The HITECH Act provides for incentives to those providers who have adopted EHR systems and meet Medicare’s requirements for meaningful use thereof. Further, beginning in 2015, providers who fail to demonstrate meaningful use will receive negative adjustments in Medicare reimbursement. Failure to demonstrate meaningful use of an electronic health record system by the 2015 deadline could have an adverse effect on our results of operations.

 

WE MAY BE SUBJECT TO GOVERNMENTAL INVESTIGATIONS AND WHISTLEBLOWER ACTIONS

 

The federal False Claims Act imposes penalties on anyone who knowingly submits or causes the submission of a fraudulent reimbursement claim to the government. The law further allows a private party to initiate a False Claims Act suit on behalf of the government, known as a qui tam action. In past years, settlements and judgments related to False Claims Act violations have totaled in the billions of dollars. While we believe that our company operates in compliance with applicable laws and regulations, being named as a defendant in a False Claims Act lawsuit could have a material adverse effect on our results of operations.

 

WE MAY BE LIABLE FOR LOSSES NOT COVERED BY OR IN EXCESS OF OUR INSURANCE

 

We are subject to medical malpractice suits and other legal actions in the ordinary course of business. These actions may involve significant defense costs and large monetary claims. We cannot predict the frequency or the effect these lawsuits will have on our results of operations. While we believe that we have retained adequate insurance coverage to protect our operations, all general liability insurance we purchase is subject to policy limitations. If any insurance policy limitations are reached, we may be subject to payments not covered by insurance and which may have a material adverse effect on our results of operations.  

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

None.

 

 

20
 

  

ITEM 2. PROPERTIES

 

In March 2005, the Company completed the acquisition of our hospitals and their associated real estate from Tenet. At the closing of the acquisition, the Company transferred all of the fee interests in the acquired real estate to PCHI, a company owned indirectly by two of the Company's largest shareholders. As further discussed in the consolidated financial statements, the Company consolidates PCHI. The Company entered into a Triple Net Lease dated March 7, 2005 (amended and restated as of April 13, 2010) under which it leased back from PCHI all of the real estate that it transferred to PCHI. Additionally, the Company leases property from other lessors. As of March 31, 2013, the Company's principal facilities are listed in the following table:

 

PROPERTY  

APPROXIMATE

AGGREGATE

SQUARE

FOOTAGE

  

LEASE

RATE

  

INITIAL LEASE

EXPIRATION

             

Western Medical Center-Santa Ana

1001 North Tustin Avenue

Santa Ana, CA 92705

   360,000   See note 1.   February 28, 2030
             

Administrative Building

1301 N. Tustin Avenue

Santa Ana, CA

   40,000   See note 1.   February 28, 2030
             

Western Medical Center-Anaheim

1025 South Anaheim Boulevard

Anaheim, CA 92805

   132,000   See note 1.   February 28, 2030
             

Coastal Communities Hospital

2701 South Bristol Street

Santa Ana, CA 92704

   115,000   See note 1.   February 28, 2030
             

Chapman Medical Center

2601 East Chapman Avenue

Orange, CA 92869

   140,000   See note 2.   December 31, 2023

 

 

1.Effective April 13, 2010, the Company entered into an amended and restated lease with PCHI. The amended lease terminates on the 25-year anniversary of the original lease (March 7, 2005), grants the Company the right to renew for one additional 25-year period, and requires combined annual base rental payments of $8.3 million for all four properties. However, until PCHI refinances the related real estate loan, the annual base rental payments are reduced to $7.3 million. In addition, the Company may offset, against its rental payments owed to PCHI, interest payments that it makes on the related real estate loan. Lease payments to PCHI are eliminated in consolidation.

 

2.Leased from an unrelated party. Monthly lease payments are $144,652.

 

The State of California has imposed new hospital seismic safety requirements. Under these new requirements, the hospitals must meet stringent seismic safety criteria in the future. In addition, there could be other remediation costs pursuant to this seismic retrofit.

         

The State of California has introduced a new seismic review methodology known as HAZUS. The HAZUS methodology may preclude the need for some structural modifications. All four hospitals requested HAZUS review and received a favorable notice pertaining to structural reclassification. All hospital buildings, with the exception of one (an administrative building), have been deemed compliant until January 1, 2030 for both structural and nonstructural retrofit. The Company does not have an estimate of the cost to remediate the seismic requirements for the administrative building as of March 31, 2013.

 

There are additional requirements that must be complied with by 2030. The costs of meeting these requirements have not yet been determined. Compliance with seismic ordinances will be costly and could have a material adverse effect on the Company's cash flow.  In addition, remediation could possibly result in certain environmental liabilities, such as asbestos abatement.

 

The Company believes that its current leased space is adequate for its current purposes and for the next fiscal year.

   

 

21
 

   

ITEM 3. LEGAL PROCEEDINGS

 

LABOR AND EMPLOYMENT

 

From time to time, health care facilities receive requests for information in the form of a subpoena from licensing entities, such as the Medical Board of California, regarding members of their medical staffs. Also, California state law mandates that each medical staff is required to perform peer review of its members. As a result of the performance of such peer reviews, action is sometimes taken to limit or revoke an individual's medical staff membership and privileges in order to assure patient safety.

 

Approximately 37% of the Company’s employees are represented by labor unions as of March 31, 2013.  The CNA Agreement and the SEIU Agreement both expire on August 31, 2014. The agreements have “no strike” provisions and compensation caps which provide the Company with long term compensation and workforce stability.

  

For both unions, all prior grievances regarding retiree medical benefits, the administration of pay adjustments and pay practices, changes in medical benefits and several wrongful terminations have been resolved in the form of settlement agreements.

 

OTHER LEGAL PROCEEDINGS

 

The Company and our hospitals are subject to various legal proceedings, most of which relate to routine matters incidental to operations. The results of these claims cannot be predicted, and it is possible that the ultimate resolution of these matters, individually or in the aggregate, may have a material adverse effect on the Company's business (both in the near and long term), financial position, results of operations, or cash flows. Although the Company defends itself vigorously against claims and lawsuits and cooperates with investigations, these matters (1) could require payment of substantial damages or amounts in judgments or settlements, which individually or in the aggregate could exceed amounts, if any, that may be recovered under insurance policies where coverage applies and is available, (2) cause substantial expenses to be incurred, (3) require significant time and attention from the Company's management, and (4) could cause the Company to close or sell the hospitals or otherwise modify the way its business is conducted. The Company accrues for claims and lawsuits when an unfavorable outcome is probable and the amount is reasonably estimable.

 

On June 5, 2009, a potential class action lawsuit was filed against the Company by Alexandra Avery.  Ms. Avery purports to represent all 12-hourly employees and the complaint alleges causes of action for restitution of unpaid wages as a result of unfair business practices, injunctive relief for unfair business practices, failure to pay overtime wages, and penalties associated therewith. On December 23, 2009, the Company filed an answer to the complaint, generally denying all of the plaintiff's allegations.  On January 25, 2010, a potential class action lawsuit was filed against the Company by Julie Ross.  Ms. Ross purports to represent all similarly-situated employees and the complaint alleges causes of action for violation of the California Labor Code and unfair competition law.  On September 3, 2010 the plaintiffs in both the Avery and Ross actions filed a consolidated complaint (the "Consolidated Complaint") that alleges the causes of action found in the initial Ross complaint.  On October 12, 2010, the Company filed an answer to the Consolidated Complaint, which generally denied all allegations.  On July 18, 2011, the Company filed a motion to compel arbitration of the matter, which was denied on October 21, 2011.  The Company appealed this decision and the Court of Appeal decided against the Company on June 26, 2013. The Company intends to vigorously defend itself in connection with the claims in the Consolidated Complaint.   Discovery is ongoing and at this stage in the proceedings, the Company is unable to determine the cost of defending this lawsuit or the impact, if any, this action may have on its results of operations.

 

On February 13, 2013, the jury in Fitzgibbons v. IHHI, et. al., awarded $500,000 in punitive damages against the Company, bringing the jury’s total verdict in this lawsuit for intentional infliction of emotional distress to $5.7 million. The Company thereafter filed two post-trial motions, one seeking a new trial and another seeking a judgment in the Company’s favor notwithstanding the verdict. On April 30, 2013, the trial judge granted the Company’s motion for a judgment notwithstanding the verdict and in the alternative granted the Company’s motion for a new trial. The same day the trial judge signed a judgment in the Company’s favor by which Dr. Fitzgibbons took nothing by way of his complaint and the Company was entitled to recover its costs of suit from Dr. Fitzgibbons. Dr. Fitzgibbons filed a notice of appeal of the judgment in the Company’s favor on May 6, 2013. The Company estimates the appeal will take at least one year to resolve. Due to these favorable rulings, the Company reversed the $5.2 million contingent loss that was reserved on its financial statements as of December 31, 2012.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

 

 

   

22
 

   

PART II

 

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

   

The Company's common stock is listed for trading on the OTCQB marketplace under the symbol "IHCH." The trading market for the Company's common stock has been extremely thin. In view of the extreme thinness of the trading market, the prices reflected on the chart below as reported on the OTCQB marketplace may not be indicative of the price at which any prior or future transactions were or may be effected in the Company's common stock. Stockholders are cautioned against drawing any conclusions from the data contained herein, as past results are not necessarily indicative of future stock performance.

 

The following table sets forth the quarterly high and low bid price for the Company's common stock for each quarter for the period from April 1, 2011 through March 31, 2013, as quoted on the OTCQB marketplace. Such OTCQB marketplace quotations reflect inter dealer prices, without retail mark-up, mark-down or commission, and may not necessarily represent actual transactions.

 

PERIOD   HIGH   LOW
Apr 2011 - Jun 2011   $0.22   $0.01
Jul 2011 - Sep 2011   $0.09   $0.05
Oct 2011 - Dec 2011   $0.06   $0.03
Jan 2012 - Mar 2012   $0.08   $0.02
Apr 2012 - Jun 2012   $0.06   $0.04
Jul 2012 - Sep 2012   $0.11   $0.04
Oct 2012 - Dec 2012   $0.11   $0.06
Jan 2013 - Mar 2013   $0.10   $0.06

 

As of the date of this report, there were approximately 129 record holders of the Company's common stock; this number does not include an indeterminate number of stockholders whose shares may be held by brokers in street name. The Company has not paid and does not expect to pay any dividends on its shares of common stock for the foreseeable future, as any earnings will be retained for use in the business. While the Company is generally prohibited from paying dividends under its revolving line of credit, the Company is permitted to pay dividends under its term loan in the absence of default.

 

The following table provides summary information concerning the Company's equity compensation plan as of March 31, 2013.

 

Equity Compensation Plan Information

 

Plan Category

Number of Securities to

be issued upon exercise

of outstanding options,

warrants and rights

Weighted-average

exercise price of

outstanding options,

warrants and rights

Number of securities

remaining available for

future issuance under

equity compensation

plans (excluding

securities reflected in

column (a))

  (a) (b) (c)
       
Equity compensation plans approved by security holders     7,595,000 $  0.18 18,483,561
Equity compensation plans not approved by security holders 405,000,000 $  0.07 -
       
Total 412,595,000 $ 0.07 18,483,561

  

 

23
 

   

ITEM 6. SELECTED FINANCIAL DATA

 

Not applicable.

  

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

FORWARD-LOOKING INFORMATION

 

This Annual Report on Form 10-K contains forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks discussed under the caption "Risk Factors" herein that may cause our Company's or our industry's actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements.

 

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as may be required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

 

As used in this report, the terms "we," "us," "our," "the Company," "Integrated Healthcare Holdings" or "IHHI" mean Integrated Healthcare Holdings, Inc., a Nevada corporation, unless otherwise indicated.

 

Unless otherwise indicated, all amounts included in this Item 7 are expressed in thousands (except percentages and per share amounts).

 

OVERVIEW

 

On March 8, 2005, we completed our acquisition (the "Acquisition") of four Orange County, California hospitals and associated real estate, including: (i) 282-bed Western Medical Center - Santa Ana, CA; (ii) 188-bed Western Medical Center - Anaheim, CA; (iii) 178-bed Coastal Communities Hospital in Santa Ana, CA; and (iv) 114-bed Chapman Medical Center in Orange, CA (collectively, the "Hospitals") from Tenet Healthcare Corporation. The Hospitals were assigned to four of our wholly owned subsidiaries formed for the purpose of completing the Acquisition. We also acquired the following real estate, leases and assets associated with the Hospitals: (i) a fee interest in the Western Medical Center at 1001 North Tustin Avenue, Santa Ana, CA, a fee interest in the administration building at 1301 North Tustin Avenue, Santa Ana, CA, certain rights to acquire condominium suites located in the medical office building at 999 North Tustin Avenue, Santa Ana, CA; (ii) a fee interest in the Western Medical Center at 1025 South Anaheim Blvd., Anaheim, CA; (iii) a fee interest in the Coastal Communities Hospital at 2701 South Bristol Street, Santa Ana, CA, and a fee interest in the medical office building at 1901 North College Avenue, Santa Ana, CA; (iv) a lease for the Chapman Medical Center at 2601 East Chapman Avenue, Orange, CA, and a fee interest in the medical office building at 2617 East Chapman Avenue, Orange, CA; and (v) equipment and contract rights. At the closing of the Acquisition, we transferred all of the fee interests in the acquired real estate (the "Hospital Properties") to Pacific Coast Holdings Investment, LLC ("PCHI"), a company owned 51% by various physician investors and 49% by our largest shareholder.

 

SIGNIFICANT CHALLENGES

 

COMPANY - Our Acquisition involved significant cash expenditures, debt incurrence and integration expenses that has seriously strained our consolidated financial condition. If we are required to issue equity securities to raise additional capital or for any other reasons, existing stockholders will likely be substantially diluted, which could affect the market price of our stock. In April 2010 we issued warrants to existing shareholders and a lender. In February 2013 we repurchased certain warrants, issued new warrants, and extended the expiration dates of the remaining warrants. (see "WARRANTS”).

 

INDUSTRY - Our Hospitals receive a substantial portion of their revenues from Medicare and Medicaid. The healthcare industry is experiencing a strong trend toward cost containment, as the government seeks to impose lower reimbursement and resource utilization group rates, limit the scope of covered services and negotiate reduced payment schedules with providers. These cost containment measures generally have resulted in a reduced rate of growth in the reimbursement for the services that we provide relative to the increase in our cost to provide such services.

  

Changes to Medicare and Medicaid reimbursement programs have limited, and are expected to continue to have limited, payment increases. Also, the timing of payments made under the Medicare and Medicaid programs is subject to regulatory action and governmental budgetary constraints resulting in a risk that the time period between submission of claims and payment could increase. Further, within the statutory framework of the Medicare and Medicaid programs, a substantial number of areas are subject to administrative rulings and interpretations which may further affect payments.

 

24
 

Our business is subject to extensive federal, state and, in some cases, local regulation with respect to, among other things, participation in the Medicare and Medicaid programs, licensure and certification of facilities, and reimbursement. These regulations relate, among other things, to the adequacy of physical property and equipment, qualifications of personnel, standards of care, government reimbursement and operational requirements. Compliance with these regulatory requirements, as interpreted and amended from time to time, can increase operating costs and thereby adversely affect the financial viability of our business. Since these regulations are amended from time to time and are subject to interpretation, we cannot predict when and to what extent liability may arise. Failure to comply with current or future regulatory requirements could also result in the imposition of various remedies including (with respect to inpatient care) fines, restrictions on admission, denial of payment for all or new admissions, the revocation of licensure, decertification, imposition of temporary management or the closure of a facility or site of service.

 

We are subject to periodic audits by the Medicare and Medicaid programs, which have various rights and remedies against us if they assert that we have overcharged the programs or failed to comply with program requirements. Rights and remedies available to these programs include repayment of any amounts alleged to be overpayments or in violation of program requirements, or making deductions from future amounts due to us. These programs may also impose fines, criminal penalties or program exclusions. Other third-party payer sources also reserve rights to conduct audits and make monetary adjustments in connection with or exclusive of audit activities.

 

The healthcare industry is highly competitive. We compete with a variety of other organizations in providing medical services, many of which have greater financial and other resources and may be more established in their respective communities than we are. Competing companies may offer newer or different centers or services than we do and may thereby attract patients or customers who are presently our patients or customers or are otherwise receiving our services.

 

An increasing trend in malpractice litigation claims, rising costs of malpractice litigation, losses associated with these malpractice lawsuits and a constriction of insurers have caused many insurance carriers to raise the cost of insurance premiums or refuse to write insurance policies for hospital facilities. Also, a tightening of the reinsurance market has affected property, vehicle, and excess liability insurance carriers.

 

We receive all of our inpatient services revenue from operations in Orange County, California. The economic condition of this market could affect the ability of our patients and third-party payers to reimburse us for our services, through its effect on disposable household income and the tax base used to generate state funding for Medicaid programs. An economic downturn, or changes in the laws affecting our business in our market and in surrounding markets, could have a material adverse effect on our financial position, results of operations, and cash flows.

 

LIQUIDITY AND CAPITAL RESOURCES

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and settlement of obligations in the normal course of business. We had a total stockholders’ deficiency of $29.9 million and a working capital deficit of $36.7 million at March 31, 2013.  For the year ended March 31, 2013, we had a net loss of $15.5 million, and negative cash flow from operations of $9.6 million. We anticipate making payments for provider fees and other expenses relating to the 2013 hospital quality assurance fee program of approximately $105.8 million and receiving approximately $235.5 million in revenues from the State ($79.4 million from the fee-for-service portion and $156.1 million from the managed care portion).

 

Key items for the year ended March 31, 2013 included:

 

  1.   Net service patient revenues (patient service revenues, net of contractual allowances and discounts, less provision for doubtful accounts) for the years ended March 31, 2013 and 2012 were $383.5 million and $362.2 million, respectively, representing an increase of $21.3 million, or 5.9%. The Hospitals serve a disproportionate number of indigent patients and receive governmental revenues and subsidies in support of care for these patients. Governmental revenues include payments from Medicaid, Medicaid DSH, and Orange County, CA (CalOptima). Governmental net revenues increased $21.8 million for the year ended March 31, 2013 compared to the year ended March 31, 2012.  The increase was primarily related to Hospital Quality Assurance Fee (“QAF”) revenues received from the State of California. For the year ended March 31, 2013, we received $54.2 million in QAF payments compared to $31.9 million during the year ended March 31, 2012 (see “HOSPITAL QUALITY ASSURANCE FEES”).

 

Inpatient admissions decreased by 5.2% to 20.2 for the year ended March 31, 2013 compared to 21.3 for the year ended March 31, 2012. The decline in admissions is primarily related to reductions in managed care, shifts from inpatient to outpatient observation, and lower obstetrics admissions.

 

Uninsured patients, as a percentage of gross charges (retail charges), were 5.5% for the year ended March 31, 2013 compared to 5.3% for the year ended March 31, 2012.

 

25
 

 

  2.   Operating expenses: Management is working aggressively to reduce costs without reduction in service levels. These efforts have in large part been offset by inflationary pressures. Operating expenses for the year ended March 31, 2013 were $393.7 million, representing an increase of $41.1 million, or 11.7%, compared to the year ended March 31, 2012. The increase is primarily related to QAF expenses of $52.5 million incurred during the year ended March 31, 2013 compared to $15.9 million incurred during the year ended March 31, 2012.

 

DEBT –

 

As of March 31, 2013, we had the following credit agreements:

  

  — A $47.277 million Term Loan issued under the $80.0 million Restated Credit Agreement, bearing an interest rate of LIBOR plus 10%, with the LIBOR floor set at 2% (12% at March 31, 2013). If any event of default occurs and continues, the lender can increase the interest rate by 5% per year.  As of March 31, 2013, we were in compliance with all financial covenants.  The stated maturity date for this Restated Credit Agreement is April 13, 2016.
     
  — A $35.0 million Revolving Credit Agreement, bearing an interest rate of 4.25% plus LIBOR, with a 2.5% floor, per year (6.75% at March 31, 2013) and an unused commitment fee of 0.5% per year ($30.0 million outstanding balance at March 31, 2013).  For purposes of calculating interest, all payments we make on the Revolving Credit Agreement are subject to a five business day clearance period.  As of March 31, 2013, we were in compliance with all financial covenants.  The stated maturity date for this Revolving Credit Agreement is March 25, 2016. At March 31, 2013, we had $5.0 million in additional availability under this facility

 

Term loan - On August 1, 2012, we entered into Amendment No. 4 to Credit Agreement and Consent (the “Credit Agreement Amendment”), which amends the $80.0 million Credit Agreement, dated as of October 9, 2007, as amended, (the “Credit Agreement”) with SPCP Group IV, LLC, SPCP Group, LLC, and Silver Point Finance, LLC, as the Lender Agent (collectively, “Silver Point”), PCHI and Ganesha Realty, llc (“Ganesha”).  Under the Credit Agreement Amendment, Silver Point consented to and waived certain provisions under the Credit Agreement in connection with our execution of the Revolving Loan Amendment No. 3. In addition, the provisions in the Credit Agreement that provide for mandatory prepayment of our outstanding “A/R Financing,” as defined, upon receipt of certain federal matching funds under the QAF program were amended to replace 65% with 80%. In connection with the Credit Agreement Amendment, we agreed to pay Silver Point a one-time consent and amendment fee in an aggregate amount equal to $1.8 million, of which $450 was paid upon execution of the Credit Agreement Amendment and the balance was added to the principal amount under the Credit Agreement. The consent and amendment fee was recorded as a discount to the loan balance and is being amortized over the remaining life of the loan.

 

On February 7, 2013, we entered into an “Amendment and Restatement to the Credit Agreement” (the “Amendment”) with Silver Point, PCHI and Ganesha.

 

Under the Amendment, the Credit Agreement was amended and restated in its entirety in the form of the “Amended and Restated Credit Agreement ($47.277 million Term Loan)” attached as Exhibit A to the Amendment (the “Restated Credit Agreement”). The Restated Credit Agreement reflects changes to the terms of the Credit Agreement that were previously made under various amendments we entered into since inception of the Credit Agreement in October 2007. In connection with the Restated Credit Amendment, we agreed to pay Silver Point a one-time amendment fee of $841, which was added to the principal amount under the Restated Credit Agreement. The one-time amendment fee was recorded as a discount to the loan balance and, together with the amortized portion of the discount recorded under the Credit Agreement Amendment, is being amortized over the remaining life of the loan. In addition, the increase in the fair value of warrants issued to Silver Point on February 7, 2013 of $543 also were recorded as a discount from the loan balance and is being amortized over the remaining life of the loan. During the year ended March 31, 2013, we recognized $1.4 million in loan discount amortization expense relating to the Restated Credit Agreement.

 

In addition, the following new amendments were made to the Credit Agreement and reflected in the Restated Credit Agreement:

 

  — The Stated Maturity Date was extended to April 13, 2016. The Credit Agreement was previously due to mature on April 13, 2013.  
     
  — The annual interest rate applicable to the loans under the Credit Agreement was modified from the previous fixed rate of 14.5% to LIBOR plus 10%, with the LIBOR floor set at 2% (12% at March 31, 2013), except upon an Event of Default. We may elect from one, two or three months LIBOR interest periods, except in an Event of Default when the interest period may not exceed one month.  
     
  — The principal balance under the Credit Agreement was increased from $46.350 million to $47.277 million, to reflect our new borrowings under the Restated Credit Agreement.  
     
  — We repaid all amounts owing to SPCP Group IV, LLC under the Credit Agreement, consisting of a principal balance of $8.120 million plus accrued interest of $19.6, and increased the principal amount owing to SPCP Group, LLC under the Credit Agreement by $9.047 million to reflect the repayment to SPCP Group IV, LLC and other new borrowings.  
     
  — The financial covenants under the Credit Agreement were amended, including the covenants requiring us to maintain minimum levels of EBITDA (as defined in the Restated Credit Agreement).  

 

26
 

 

  — Upon our receipt of enhanced federal matching funds from Medi-Cal under the QAF program (defined as “Net QAF Funds” under the Restated Credit Agreement), we are required to make certain prepayments of principal under its Revolving Loan Agreement with MidCap Financial, LLC.  
     
  — A prepayment fee was established for voluntary prepayments under the Credit Agreement equal to 5% for prepayments made on or prior to December 31, 2013, and 2% for prepayments made after January 1, 2014 and before December 31, 2014.  

 

Revolving line of credit - On August 1, 2012, we entered into Amendment No. 3 to Credit and Security Agreement (the “Revolving Loan Amendment No. 3), which amends Credit and Security Agreement, dated as of August 30, 2012, as amended, (the “Revolving Loan Agreement”) with MidCap Funding IV, LLC and Silicon Valley Bank, as lenders (the “Lenders”), and MidCap Financial, LLC, as agent (the “Agent”). Under the Revolving Loan Amendment No. 3, the minimum Revolving Loan Commitment Amount under the Revolving Loan Agreement was increased from $14.0 million to $30.0 million, and we agreed to pay the Lenders an origination fee of 1.0% of the Lenders’ increased commitment under the Revolving Loan Amendment No. 3, or $160.

 

On February 7, 2013, we entered into “Amendment No. 4 to Credit and Security Agreement and Limited Consent” (the “Revolving Loan Amendment No. 4”) with the Lenders and the Agent.

 

The Revolving Loan Amendment No. 4 amends the Revolving Loan Agreement, to reflect the following changes:

 

  — The maximum face amount of the Letter of Credit Liabilities permitted under the Revolving Loan Agreement was increased to $761, and the Lenders consented to the issuance of a Letter of Credit in the same amount by Wells Fargo Bank, National Association.
     
  — The period during which the Prepayment Fee of 1% is applicable was extended from three years from the original closing date to the Commitment Expiry Date.
     
  — The Agent and Lenders consented to our entry into the Amendment with Silver Point and the Restated Credit Agreement thereunder.

 

On March 25, 2013, we entered into Amendment No. 5 to Credit and Security Agreement and Limited Waiver (the “Revolving Loan Amendment No. 5”), which amends the Revolving Loan Agreement with the Lenders and the Agent. We agreed to pay the Lenders an origination fee of 1.0% of the Lenders’ commitment under the Revolving Loan Amendment No. 5, or $350.

 

Among other things, the Revolving Loan Amendment No. 5 provides for the following:

 

  — An increase in the Revolving Loan Commitment amount from $30.0 million to $35.0 million;
     
  — The Applicable Margin was changed: (a) from 3.00% to 2.25% with respect to Revolving Loans bearing interest upon the Base Rate and (b) from 5.00% to 4.25% for all other Revolving Loans and Obligations;
     
  — The Commitment Expiry Date was extended to March 25, 2016;
     
  — Certain modifications were made to the definitions of Permitted Indebtedness and Prepayment Fee and the lockbox requirements; and
     
  — We were granted a waiver of certain prior Events of Default or Defaults under the Revolving Loan Agreement and a waiver of the requirement to comply with the Fixed Charge Coverage Ratio covenant for the Defined Period ending March 31, 2013.

 

WARRANTS – On April 13, 2010 we issued three-year warrants (the “Omnibus Warrants”) to purchase our common stock at an exercise price of $0.07 per share in the following denominations: 139.0 million shares to KPC or its designees and 96.0 million shares to Silver Point or its designees. The Omnibus Warrants also provide the holders with certain pre-emptive, information and registration rights. As of April 13, 2010, we recorded warrant expense and the related warrant liability of $2.9 million, representing fair value.  

 

27
 

In addition, on April 13, 2010, we issued a three-year warrant (the “Release Warrant”) to acquire up to 170.0 million shares of common stock at $0.07 per share to Dr. Chaudhuri who facilitated the release (see “DEBT”) enabling us to recover amounts due from our prior lender and a $1.0 million reduction in principal of our outstanding debt, among other benefits to us.  The Release Warrant also provides the holder with certain pre-emptive, information and registration rights. During the year ended March 31, 2010, we recorded the fair value of $2.1 million as an offsetting cost of the recovery.  

 

On February 7, 2013, in connection with the Restated Credit Agreement, we entered into the following transactions involving warrants:

 

We entered into a Warrant Repurchase Agreement with SPCP Group IV, LLC pursuant to which we repurchased the outstanding common stock warrant issued to SPCP Group IV, LLC on or about April 13, 2010 (the “Cancelled Warrant”). The Cancelled Warrant (part of the Omnibus Warrants) entitled the holder to purchase an aggregate of 16.8 million shares of our common stock at an exercise price of $0.07 per share. We repurchased the Cancelled Warrant for a purchase price of $0.12 per share minus the exercise price of $0.07 per share resulting in a net purchase price of $0.05 per share multiplied by 16.8 million shares for an aggregate purchase price of $840.9.

 

Immediately following the warrant repurchase, we issued a new common stock warrant (the “New Warrant”) to SPCP Group, LLC for a price of $0.05 per share (an aggregate price of $840.9) on the same terms as the Cancelled Warrant entitling the holder to purchase an aggregate of 16.8 million shares of common stock at an exercise price of $0.07 per share, except that the New Warrant expires on April 13, 2016.

 

Also simultaneous with the transactions described above, we extended the expiration date from April 13, 2013 to April 13, 2016 for the Omnibus Warrants issued to KPC and the remaining Omnibus Warrants held by Silver Point (to purchase 79.2 million shares) and the Release Warrant issued to Dr. Chaudhuri. The extension of the warrant expiration date was intended to conform the terms of the warrants to that of the Restated Credit Agreement.

 

We assessed the amended credit agreement entered into in August 2012 and February 2013 under the provisions of ASC 470-50 and determined that the debt amendments should be accounted for as a debt modification. Accordingly, the recorded change in fair value as of February 7, 2013, totaling $534, of the New Warrant and the Omnibus Warrant held by SPCP Group, LLC was recognized as a component of the debt discount on the Term Loan (Note 3) and will be amortized to interest expense over the term of the debt agreement using the effective interest method.

 

The warrant expense relating to the Release Warrant and the Omnibus Warrant held by Dr. Chaudhuri for the years ended March 31, 2013 and 2012 was $1.7 million and $0, respectively. The change in fair value of the Release Warrant and the Omnibus was immediately charged to expense.

 

The Omnibus Warrants, the Release Warrant, and the New Warrant are collectively referred to as the “IHHI Warrants.” As of March 31, 2013, the fair value of the IHHI Warrants was $5.3 million.

 

The net loss related to the change in fair value of the IHHI Warrants for the year ended March 31, 2013 and 2012 was $1.4 million and $1.5 million, respectively. The total loss on warrants was $3.1 million and $1.5 million for the years ended March 31, 2013 and 2012, respectively.

 

HOSPITAL QUALITY ASSURANCE FEES PROGRAM - In October 2009, the Governor of California signed legislation supported by the hospital industry to impose a provider fee on general acute care hospitals that, combined with federal matching funds, would be used to provide supplemental Medi-Cal payments to hospitals. The state submitted the plan to the Centers for Medicare and Medicaid Services (“CMS”) for a required review and approval process, and certain changes in the plan were required by CMS. Legislation amending the fee program to reflect the required changes was passed by the legislature and signed by the Governor on September 8, 2010. Among other changes, the legislation leaves distribution of “pass-through” payments received by Medi-Cal managed care plans that will be paid to hospitals under the program to the discretion of the plans.  The hospital quality assurance fee program (“QAF”) created by this legislation initially provided payments for up to 21 months retroactive to April 2009 and expiring on December 31, 2010 (“2010 QAF”).  In February 2011, CMS gave final approval for the 2010 QAF. During fiscal year 2011, we recognized $87.2 million in revenue and recorded expenses of $47.8 million relating to the 2010 QAF.

 

In December 2011, CMS gave final approval for the extension of the QAF for the six month period from January 1 through June 30, 2011 (“2011 QAF”).  Accordingly, for the year ended March 31, 2012 we recognized $31.9 million in revenue and recorded expenses of $15.9 million relating to the 2011 QAF.

 

In June 2012, CMS conditionally approved the extension of the QAF for the thirty month period from July 1, 2011 through December 31, 2013 (“2013 QAF”).  In June 2012, the California State Legislature amended the hospital fee statute to recognize separate CMS approval of the fee-for-service portion and managed care portion of the 2013 QAF, which was further clarified in legislation approved by the governor of California in September 2012.  As a result, during the year ended March 31, 2013, we recognized revenue of $54.2 million and expenses of $52.5 million relating to the fee-for-service portion of the 2013 QAF for the periods from July 1, 2011 through March 31, 2013.

 

In May 2013, CMS approved the managed care portion of the 2013 QAF for the period from July 1, 2011 through June 30, 2012.

 

Based on the most recent modeling prepared by the California Hospital Association, we anticipate making payments for provider fees and other expenses relating to the 2013 QAF of approximately $105.8 million and receiving approximately $235.5 million in revenues from the State ($79.4 million from the fee-for-service portion and $156.1 million from the managed care portion). 

 

28
 

We cannot provide any assurances or estimates in connection with CMS’s final managed care approval of the 2013 QAF (for the period from July 1, 2012 to December 31, 2013) or a possible continuation of the QAF program beyond December 31, 2013.

 

ELECTRONIC HEALTH RECORDS INCENTIVE PROGRAM – Provisions of the American Recovery and Reinvestment Act of 2009 provide incentive payments for the adoption and meaningful use of certified electronic health record (EHR) technology. The Medicare EHR incentive program provides incentive payments to eligible hospitals (and certain other providers) that are meaningful users of certified EHRs. The Medicaid EHR incentive program provides incentive payments to eligible hospitals (and certain other providers) for efforts to adopt, implement, upgrade, or meaningful use of certified EHR technology.

 

CMS has established the final rule which requires eligible providers in their first year of participation in the Medicaid incentive payment program to demonstrate that they have adopted (acquired, purchased, or secured access to), or implemented, or upgraded to certified EHR technology in order to qualify for an incentive payment. During the second and subsequent years of the program, eligible providers are required to meet other criteria, including meaningful use, to receive additional funds. We have been awarded a total amount of $13.6 million under the Medicaid EHR incentive program, which will be earned and received over a four year period. We adopted certified EHR technology and recognized other income of $6.8 million relative to the first year under the Medicaid EHR incentive program during fiscal year 2012.

 

LONG TERM LEASE COMMITMENT WITH VARIABLE INTEREST ENTITY – On April 13, 2010, we and PCHI entered into a Second Amendment to Amended and Restated Triple Net Hospital Building Lease (the “2010 Lease Amendment”).  Under the 2010 Lease Amendment, the annual base rent to be paid by us to PCHI was increased from $5.4 million to $7.3 million. The base rent is subject to an annual Consumer Price Index increase on January 1 of each year; provided, that, such increase shall not be less than 2% or more than 6% per year. The annual base rent is currently $7.8 million. If PCHI refinances the $47.277 million term loan, the annual base rent will increase to $8.3 million. This lease commitment with PCHI is eliminated in consolidation.

 

COMMITMENTS AND CONTINGENCIES – The State of California has imposed hospital seismic safety requirements. Under these requirements, the Hospitals must meet stringent seismic safety criteria in the future. In addition, there could be other remediation costs pursuant to this seismic retrofit.

         

The State of California has a seismic review methodology known as HAZUS. The HAZUS methodology may preclude the need for some structural modifications. All four Hospitals requested HAZUS review and received a favorable notice pertaining to structural reclassification. All Hospital buildings, with the exception of one (an administrative building), have been deemed compliant until January 1, 2030 for both structural and nonstructural retrofit. We do not have an estimate of the cost to remediate the seismic requirements for the administrative building as of March 31, 2013.

 

There are additional requirements that must be complied with by 2030. The costs of meeting these requirements have not yet been determined. Compliance with seismic ordinances will be costly and could have a material adverse effect on our cash flow.  In addition, remediation could possibly result in certain environmental liabilities, such as asbestos abatement.

 

On July 1, 2011, we entered into software and services agreements with McKesson Technologies Inc. (“McKesson”) to upgrade our information technology systems.

 

Under the agreements, McKesson will provide us with a variety of services, including new software implementation and education/training services for our personnel, software maintenance services and professional services related to movement and migration of data from legacy systems.  McKesson will also furnish to us and maintain new hardware to accommodate the upgraded software and systems.  The new hardware will include computers and servers, among other things, and will include installation, testing, and ongoing maintenance.  We have entered into the arrangement to enhance our clinical information systems and upgrade our billing and revenue management information systems.

 

The agreements will initially run for a period of five years, and the recurring services may be renewed by us for successive periods.  The agreements do not provide that they may be terminated by us prior to the initial expiration date.  The agreements provide for one-time fees and recurring fees which aggregate a total of $22.0 million.  Approximately 60% of the fees are for one-time charges, while the balance is for recurring services. During the year ended March 31, 2013 we completed conversion of one of our facilities to the McKesson system and are continuing to convert the remaining three facilities during the first quarter of our fiscal year 2014. We are also continuing to test and develop system applications where necessary.

 

29
 

CASH FLOW - Net cash provided (used) by operating activities for the years ended March 31, 2013 and 2012 was $(9.6) million and $4.5 million, respectively. Net income (loss), adjusted for depreciation and other non-cash items, excluding the provision for doubtful accounts and net income from non-controlling interests (not a measurement under accounting principles generally accepted in the United States of America (“GAAP”), totaled $(13.8) million and $14.2 million for the years ended March 31, 2013 and 2012, respectively. We used $2.9 million and $9.1 million in working capital for the years ended March 31, 2013 and 2012, respectively. Net cash provided in payment of accounts payable, accrued compensation and benefits and other current liabilities was $8.8 million and $4.3 million for the years ended March 31, 2013 and 2012, respectively. Cash provided (used) by accounts receivable, net of provision for doubtful accounts, was $(9.2) million and $1.1 million for the years ended March 31, 2013 and 2012, respectively.

 

Net cash used in investing activities during the years ended March 31, 2013 and 2012 was $10.3 million and $5.5 million, respectively. In the years ended March 31, 2013 and 2012, we invested $10.3 million and $5.5 million in cash, respectively, in new property and equipment.

 

Net cash provided by (used in) financing activities for the years ended March 31, 2013 and 2012 was $11.7 million and $(7.8) million, respectively.  

 

RESULTS OF OPERATIONS AND FINANCIAL CONDITION

 

The following table sets forth our consolidated statements of operations expressed as a percentage of net patient services revenues for the years ended March 31, 2013 and 2012.

 

   Year ended March 31, 
   2013   2012 
         
Revenues   100.0%    100.0% 
           
Operating expenses:          
Salaries and benefits   55.7%    59.9% 
Supplies   14.5%    15.1% 
Other operating expenses   30.5%    20.4% 
Depreciation and amortization   1.1%    1.1% 
    101.8%    96.5% 
           
Operating income (loss)   (1.8%)   3.5% 
           
Other income (expense):          
Interest expense, net   (3.0%)   (2.8%)
Income from electronic health records incentive program   0.0%    1.9% 
Loss on warrants   (0.8%)   (0.4%)
    (3.8%)   (1.3%)
           
Income (loss) before income tax benefit   (5.6%)   2.2% 
Income tax benefit   (1.5%)   0.0% 
Net income (loss)   (4.1%)   2.2% 
Net (income) loss attributable to noncontrolling interests   0.2%    (0.1%)
Net income (loss) attributable to          
Integrated Healthcare Holdings, Inc.   (3.9%)   2.1% 

 

FISCAL YEAR ENDED MARCH 31, 2013 COMPARED TO FISCAL YEAR ENDED MARCH 31, 2012

 

REVENUES – Net patient service revenues for the year ended March 31, 2013 increased 5.9% compared to fiscal year 2012, from $362.2 million to $383.5 million. The increase was primarily related to QAF revenues of $54.2 million recognized during the year ended March 31, 2013 compared to $31.9 million in fiscal 2012. The provision for bad debts for the year ended March 31, 2013 was $44.6 million compared to $40.4 million for the year ended March 31, 2012, representing a 10.4% increase. The primary reason for the increase in the provision for bad debts relates to the termination of Section 1011 of the Medicare Modernization Act of 2003 program in January 2012. Section 1011 provided federal funding of emergency health services for “eligible aliens.” Until its termination in January 2012, patient service revenues recorded under Section 1011 were reduced by contractual allowances and discounts whereas patient service revenues related to the same type of services provided after the termination of Section 1011 are adjusted to net patient service revenues through the provision for bad debts.

 

30
 

Admissions for the year ended March 31, 2013 decreased 5.2% compared to fiscal year 2012. The decline in admissions is the combined result of lower obstetrical deliveries and psychiatric admissions. Net patient service revenues per admission increased 11.7% during the year ended March 31, 2013. This increase was primarily due to an increase in orthopedic surgeries and an increase in QAF revenue.

 

Substantially all patient service revenues come from external customers. The largest payers are Medicare and Medicaid (including Medicare and Medicaid managed care plans), which combined accounted for 58% and 57% of patient service revenues for the years ended March 31, 2013 and 2012, respectively.

 

Uninsured patients, as a percentage of gross charges, increased to 5.5% from 5.3% for the year ended March 31, 2013 compared to the year ended March 31, 2012.

 

The Hospitals serve a disproportionate number of indigent patients and receive governmental revenues and subsidies in support of care for these patients. Governmental revenues include payments from Medicaid, Medicaid DSH, and Orange County, CA (CalOptima). Governmental revenues (net of contractual allowances and discounts), including QAF funds, increased $21.7 million for the year ended March 31, 2013 compared to the year ended March 31, 2012.  

 

Other operating revenues of $3.4 million and $3.1 million for the years ended March 31, 2013 and 2012, respectively, consist primarily of rental income and cafeteria sales.

 

OPERATING EXPENSES – Operating expenses for the year ended March 31, 2013 increased to $393.7 million from $352.6 million, an increase of $41.1 million, or 11.7%, compared to fiscal year 2012. Operating expenses expressed as a percentage of revenues for the years ended March 31, 2013 and 2012 were 101.8% and 96.5%, respectively. On a per admission basis, operating expenses increased 17.7%. The increase is primarily related to QAF expenses of $52.5 million incurred during the year ended March 31, 2013 compared to $15.9 million in fiscal year 2012.

 

Salaries and benefits decreased $3.2 million (1.5%) for the year ended March 31, 2013 compared to fiscal year 2012 due to lower admissions partially offset by wage increases.

 

Supplies increased $1.1 million (2.0%) for the year ended March 31, 2013 compared to fiscal year 2012. The increase primarily related to increases in orthopedic supplies and pacemakers.

 

Other operating expenses during the year ended March 31, 2013 increased to $118.1 million from $74.5 million, an increase of $43.6 million, or 58.5%, compared to fiscal year 2012. The increase is primarily related to QAF expenses of $52.5 million incurred during the year ended March 31, 2013 compared to $15.9 million during fiscal year 2012 and loss reserves for potential legal settlements.

 

OPERATING INCOME (LOSS) – The operating income (loss) for the years ended March 31, 2013 and 2012 was ($6.8) million and $12.7 million, respectively.

 

OTHER INCOME (EXPENSE) – Interest expense for the year ended March 31, 2013 was $11.8 million compared to $10.2 million for fiscal year 2012. The increase primarily related to increased net drawdowns of $15.5 million on our revolving line of credit. 

 

We adopted certified EHR technology and recognized other income of $0 and $6.8 million under the Medicaid EHR incentive program during the years ended March 31, 2013 and 2012, respectively.

 

As of March 31, 2013, the aggregate fair value of the IHHI Warrants was $5.3 million.  A loss relating to the change in fair value of the IHHI Warrants of $3.1 million and $1.5 million was recorded during the years ended March 31, 2013 and 2012, respectively. See “WARRANTS.”

   

NET INCOME (LOSS) - Net income (loss) for the years ended March 31, 2013 and 2012 was ($15.5) million and $7.5 million, respectively.

 

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

 

PATIENT SERVICE REVENUES – Patient service revenues are recognized in the period in which services are performed and are recorded based on established billing rates (gross charges) less contractual allowances and discounts, principally for patients covered by Medicare, Medicaid, managed care, and other health plans. Gross charges are retail charges. They are not the same as actual pricing, and they generally do not reflect what a hospital is ultimately paid and therefore are not displayed in the consolidated statements of operations. Hospitals are typically paid amounts that are negotiated with insurance companies or are set by the government. Gross charges are used to calculate Medicare outlier payments and to determine certain elements of payment under managed care contracts (such as stop-loss payments). Since Medicare requires that a hospital's gross charges be the same for all patients (regardless of payer category), gross charges are also what the Hospitals charge all other patients prior to the application of discounts and allowances.

 

31
 

Revenues under the traditional fee-for-service Medicare and Medicaid programs are based primarily on prospective payment systems. Discounts for retrospectively cost based revenues and certain other payments, which are based on the Hospitals' cost reports, are estimated using historical trends and current factors. Cost report settlements for retrospectively cost-based revenues under these programs are subject to audit and administrative and judicial review, which can take several years until final settlement of such matters are determined and completely resolved. Estimates of settlement receivables or payables related to a specific year are updated periodically and at year end and at the time the cost report is filed with the fiscal intermediary. Typically no further updates are made to the estimates until the final Notice of Program Reimbursement is received, at which time the cost report for that year has been audited by the fiscal intermediary. There could be a time lag of several years between the submission of a cost report and receipt of the Final Notice of Program Reimbursement. Since the laws, regulations, instructions and rule interpretations governing Medicare and Medicaid reimbursement are complex and change frequently, the estimates recorded by the Hospitals could change by material amounts. We have established settlement (payables) receivables of ($179) and $190 as of March 31, 2013 and 2012, respectively.

 

The Hospitals receive supplemental payments from the State of California to support indigent care (Medi-Cal Disproportionate Share Hospital payments or "DSH") and from the California Medical Assistance Commission ("CMAC") under the SB 1100 and SB 1255 programs. The Hospitals received supplemental payments of $13.4 million and $14.3 million during the years ended March 31, 2013 and 2012, respectively. The related revenue recorded for the years ended March 31, 2013 and 2012, was $14.3 million and $15.4 million, respectively. As of March 31, 2013 and 2012, estimated DSH receivables were $5.9 million and $5.0 million, respectively.

 

Revenues under managed care plans, including Medicare and Medicaid managed care plans (with patient service revenues of $84.7 million and $84.2 million for the years ended March 31, 2013 and 2012, respectively), are based primarily on payment terms involving predetermined rates per diagnosis, per-diem rates, discounted fee-for-service rates and/or other similar contractual arrangements. These revenues are also subject to review and possible audit by the payers. The payers are billed for patient services on an individual patient basis. An individual patient's bill is subject to adjustment on a patient-by-patient basis in the ordinary course of business by the payers following their review and adjudication of each particular bill. The Hospitals estimate the discounts for contractual allowances utilizing billing data on an individual patient basis. Management believes the estimation and review process allows for timely identification of instances where such estimates need to be revised. We do not believe there were any adjustments to estimates of individual patient bills that were material to patient service revenues.

 

The Hospitals provide charity care to patients whose income level is below 300% of the Federal Poverty Level. Patients with income levels between 300% and 350% of the Federal Poverty Level qualify to pay a discounted rate under AB 774 based on various government program reimbursement levels. Patients without insurance are offered assistance in applying for Medicaid and other programs they may be eligible for, such as state disability, Victims of Crime, or county indigent programs. Patient advocates from the Hospitals' Medical Eligibility Program ("MEP") screen patients in the hospital and determine potential linkage to financial assistance programs. They also expedite the process of applying for these government programs. The estimated costs of charity care (based on direct and indirect costs as a ratio of gross uncompensated charges associated with providing care to charity patients) for the years ended March 31, 2013 and 2012 were approximately $8.0 million and $7.0 million, respectively.

 

We are not aware of any material claims, disputes, or unsettled matters with any payers that would affect revenues that have not been adequately provided for in the accompanying unaudited condensed consolidated financial statements.

 

PROVISION FOR BAD DEBTS - We provide for accounts receivable that could become uncollectible by establishing an allowance to reduce the carrying value of such receivables to their estimated net realizable value. The Hospitals estimate this allowance based on the aging of their accounts receivable, historical collections experience for each type of payer and other relevant factors. There are various factors that can impact the collection trends, such as changes in the economy, which in turn have an impact on unemployment rates and the number of uninsured and underinsured patients, volume of patients through the emergency department, the increased burden of copayments to be made by patients with insurance and business practices related to collection efforts. These factors continuously change and can have an impact on collection trends and the estimation process.

 

Our policy is to attempt to collect amounts due from patients, including copayments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations, including, but not limited to, the Emergency Medical Treatment and Labor Act ("EMTALA"). Generally, as required by EMTALA, patients may not be denied emergency treatment due to inability to pay. Therefore, until the legally required medical screening examination is complete and stabilization of the patient has begun, services are performed prior to the verification of the patient's insurance, if any. In nonemergency circumstances or for elective procedures and services, it is the Hospitals' policy, when appropriate, to verify insurance prior to a patient being treated.

 

Effective March 31, 2012, we adopted Accounting Standards Update (“ASU”) 2011-07, “Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities,” which requires health care entities to present the provision for bad debts relating to patient service revenues as a deduction from patient service revenues in the statement of operations rather than as an operating expense.

 

32
 

INCOME TAXES - Deferred income tax assets and liabilities are determined based on the differences between the book and tax basis of assets and liabilities and are measured using the currently enacted tax rates and laws using the asset and liability method. We assess the realization of deferred tax assets to determine whether an income tax valuation allowance is required. We recorded a 58% and 100% valuation allowance on our net deferred tax assets as of March 31, 2013 and 2012, respectively.

 

There is a recognition threshold and measurement attribute for recognition and measurement of a tax position taken or expected to be taken in a tax return. It also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.

 

We and our subsidiaries file income tax returns in the U.S. federal jurisdiction and California. Certain tax attributes carried over from prior years continue to be subject to adjustment by taxing authorities. Any penalties or interest arising from federal or state taxes are recorded as a component of our income tax provision.

 

INSURANCE – We accrue for estimated general and professional liability claims, to the extent not covered by insurance, when they are probable and reasonably estimable. We have purchased as primary coverage a claims-made form insurance policy for general and professional liability risks. Estimated losses within general and professional liability retentions from claims incurred and reported, along with incurred but not reported (“IBNR”) claims, are accrued based upon projections and are discounted to their net present value using an interest rate of 5.0%. To the extent that subsequent claims information varies from estimates, the liability is adjusted in the period such information becomes available. As of March 31, 2013 and 2012, we had accrued $10.6 million and $11.5 million, respectively, which is comprised of $5.5 million and $4.5 million, respectively, in incurred and reported claims, along with $5.1 million and $7.0 million, respectively, in estimated IBNR. Estimated insurance recoveries of $2.1 million and $3.0 million are included in other prepaid expenses and current assets as of March 31, 2013 and 2012, respectively.

 

We have also purchased occurrence coverage insurance to fund our obligations under our workers compensation program. We have a "paid loss plan" policy, under which the carrier pays all workers compensation claims, with no deductible or reimbursement required of us. We accrue for estimated workers compensation claims, to the extent not covered by insurance, when they are probable and reasonably estimable. The ultimate costs related to this program include expenses for deductible amounts associated with claims incurred and reported in addition to an accrual for the estimated expenses incurred in connection with IBNR claims. Claims are accrued based upon projections and are discounted to their net present value using an interest rate of 5.0%. To the extent that subsequent claims information varies from estimates, the liability is adjusted in the period such information becomes available. As of March 31, 2013 and 2012, we had accrued $500 and $673, respectively, comprised of $200 and $338, respectively, in incurred and reported claims, along with $300 and $335, respectively, in estimated IBNR.

  

In addition, we have a self-insured health benefits plan for our employees. As a result, we have established and maintained an accrual for IBNR claims arising from self-insured health benefits provided to employees. Our IBNR accruals at March 31, 2013 and 2012 were based upon projections. We determine the adequacy of this accrual by evaluating our limited historical experience and trends related to both health insurance claims and payments, information provided by our insurance broker and third party administrator, and industry experience and trends. The accrual is an estimate and is subject to change. Such change could be material to our consolidated financial statements. As of March 31, 2013 and 2012, we had accrued $1.9 million and $2.2 million, respectively, in estimated IBNR.

 

We have also purchased umbrella liability policies with aggregate limits of $25 million. The umbrella policies provide coverage in excess of the primary layer and applicable retentions for insured liability risks such as general and professional liability, auto liability, and workers compensation (employers liability).

 

NEW ACCOUNTING STANDARDS

 

Effective March 31, 2012, we adopted ASU 2011-07, “Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities,” which requires health care entities to present the provision for bad debts relating to patient service revenue as a deduction from patient service revenue in the statement of operations rather than as an operating expense. Additional disclosures relating to sources of patient revenue and the allowance for doubtful accounts related to patient accounts receivable are also required. The adoption of this ASU did not have a material impact on our consolidated financial statements.

 

OFF BALANCE SHEET ARRANGEMENTS

 

As of March 31, 2013 we had no off-balance sheet arrangements.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

Not applicable.

  

33
 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

The following consolidated financial statements are filed as a part of this report beginning on page F-1:

 

  PAGE   DESCRIPTION
  F-1   Report of Independent Registered Public Accounting Firm
  F-2   Consolidated Balance Sheets as of March 31, 2013 and 2012
  F-3   Consolidated Statements of Operations for the years ended March 31, 2013 and 2012
  F-4   Consolidated Statements of Stockholders' Deficiency for the years ended March 31, 2013 and 2012
  F-5   Consolidated Statements of Cash Flows for the years ended March 31, 2013 and 2012
  F-6   Notes to Consolidated Financial Statements
  F-25   Schedule II - Valuation and Qualifying Accounts for the years ended March 31, 2013 and 2012

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None

 

ITEM 9A. CONTROLS AND PROCEDURES

 

DISCLOSURE CONTROLS AND PROCEDURES

 

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company's reports under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Security and Exchange Commission’s (the “SEC”) rules and forms, and that such information is accumulated and communicated to its management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. The Company’s disclosure controls and procedures are designed to provide a reasonable level of assurance of reaching the Company's desired disclosure control objectives. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives and management necessarily was required to apply its judgment in evaluating the cost benefit relationship of possible controls and procedures.

 

The Company conducted an evaluation under the supervision and with the participation of its management, including its Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of its disclosure controls and procedures as of March 31, 2013. The evaluation by management, including the Company’s Chief Executive Officer and Chief Financial Officer, as of March 31, 2013 concluded that the Company's disclosure controls and procedures are effective as of such date to ensure that the information required to be disclosed in its reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to its management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

 

MANAGEMENT'S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

 

Management of Integrated Healthcare Holdings, Inc. is responsible for the preparation, integrity and fair presentation of its published consolidated financial statements. The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and, as such, include amounts based on judgments and estimates made by management. The Company also prepared the other information included in the annual report and is responsible for its accuracy and consistency with the consolidated financial statements.

 

34
 

 

Management is also responsible for establishing and maintaining effective internal control over financial reporting. The Company's internal control over financial reporting includes those policies and procedures that pertain to the Company's ability to record, process, summarize and report reliable financial data. The Company maintains a system of internal control over financial reporting, which is designed to provide reasonable assurance to the Company's management and board of directors regarding the preparation of reliable published consolidated financial statements and safeguarding of the Company's assets. The system includes a documented organizational structure and division of responsibility, established policies and procedures, including a code of conduct to foster a strong ethical climate, which are communicated throughout the Company, and the careful selection, training and development of its people.

 

The Board of Directors, acting through its Audit Committee, is responsible for the oversight of the Company's accounting policies, financial reporting, and internal control. The Audit Committee of the Board of Directors is comprised entirely of outside directors who are independent of management. The Audit Committee is responsible for the appointment and compensation of the independent registered public accounting firm. It meets periodically with management, the independent registered public accounting firm, and the internal auditors to ensure that they are carrying out their responsibilities. The Audit Committee is also responsible for performing an oversight role by reviewing and monitoring the financial, accounting and auditing procedures of the Company in addition to reviewing the Company's financial reports. Internal auditors monitor the operation of the internal control system and report findings and recommendations to management and the Audit Committee. Corrective actions are taken to address control deficiencies and other opportunities for improving the internal control system as they are identified. The independent registered public accounting firm and the internal auditors have full and unlimited access to the Audit Committee, with or without management, to discuss the adequacy of internal control over financial reporting, and any other matters which they believe should be brought to the attention of the Audit Committee.

 

Management recognizes that there are inherent limitations in the effectiveness of any system of internal control over financial reporting, including the possibility of human error and the circumvention or overriding of internal control. Accordingly, even effective internal control over financial reporting can provide only reasonable assurance with respect to financial statement preparation and may not prevent or detect misstatements. Further, because of changes in conditions, the effectiveness of internal control over financial reporting may vary over time.

 

Management assessed the Company’s internal control system as of March 31, 2013 in relation to criteria for effective internal control over financial reporting described in "Internal Control – Integrated Framework" issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on its assessment, management has determined that, as of March 31, 2013, the Company’s system of internal control over financial reporting was effective.

 

This annual report does not include an attestation report of the Company's registered public accounting firm regarding internal control over financial reporting. Management's report was not subject to attestation by the Company's registered public accounting firm pursuant to an exemption for smaller reporting companies under Section 989G of the Dodd-Frank Wall Street Reform and Consumer Protection Act.

 

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

 

During the fiscal quarter ended March 31, 2013, there was no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting.

 

ITEM 9B. OTHER INFORMATION

 

None.

   

 

 

35
 

  

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

The following table contains certain information concerning our directors and executive officers as of March 31, 2013:

 

NAME AGE POSITION WITH COMPANY DATE BECAME DIRECTOR
Maurice J. DeWald 73 Chairman of the Board August 1, 2005
Hon. C. Robert Jameson 73 Director July 11, 2007
Ajay G. Meka, M.D. 62 Director September 28, 2006
Michael Metzler 66 Director September 5, 2007
J. Fernando Niebla 73 Director August 1, 2005
William E. Thomas 64 Director September 5, 2007
Kenneth K. Westbrook 62 Director, Chief Executive Officer & President December 2, 2008
Steven R. Blake 60 Chief Financial Officer & Executive Vice President, Finance  
Daniel J. Brothman 58 Chief Operating Officer & Executive Vice President, Operations  

 

MAURICE J. DEWALD has served as a member of the Board of Directors of the Company since August 1, 2005 and has served as Chairman of the Board of Directors since October 7, 2008. Mr. DeWald is chairman of the Audit Committee and sits on the Compensation Committee, Finance Committee, and Special Committee. As a senior finance executive, Mr. DeWald brings to our Board extensive qualifications and experience in management, finance, and public accounting, as well as his experience in the healthcare industry.  Mr. DeWald is Chairman and Chief Executive Officer of Verity Financial Group, Inc., a private investment firm that he founded in 1992. From 1962-1991, Mr. DeWald was with KPMG LLP, one of the world's largest international accounting and tax consulting firms, where he served at various times as director and as the Managing Partner of the Chicago, Orange County and Los Angeles Offices. Mr. DeWald is the non-executive Chairman of Targeted Medical Pharma, Inc. and a director of Healthcare Trust of America, Inc. and Emmaus Life Sciences, Inc. Mr. DeWald is a former director of Tenet Healthcare Corporation ("Tenet") and Quality Systems, Inc. He also sits on the Advisory Council of the University of Notre Dame Mendoza School of Business. Mr. DeWald is a past Chairman and director of United Way of Greater Los Angeles. Mr. DeWald received a B.B.A. from the University of Notre Dame in 1962. He is also a Certified Public Accountant (inactive) and a member of the American Institute of CPAs, the California Society of CPAs, and the National Association of Corporate Directors.

 

HON. C. ROBERT JAMESON has been a director of the Company since July 11, 2007. Judge Jameson is a retired Orange County Superior judge.  Judge Jameson brings to our Board extensive experience in the legal profession and negotiating skills.  He is now affiliated with Judicate West, a provider of alternative dispute resolution, handling complex alternative dispute resolution matters. Before leaving the bench, he was Presiding Judge of the Orange County Superior Court. Judge Jameson obtained his B.A. degree in Political Science from the University of California, Davis in 1963 and his Juris Doctor degree at the University of California, Hastings College of the Law in 1966. He served as a judge from 1984-2005 and also was President of the Banyard Inn of Court and an Adjunct Professor of Law at Whittier Law School during his tenure. Judge Jameson was awarded "Judge of the Year" nine times over the course of his career by organizations such as: the Orange County Bar Association Business Litigation section, Orange County Trial Lawyers, the American Board of Trial Advocates and the Consumer Attorneys of California.

 

AJAY G. MEKA, M.D has served as a member of the Board of Directors of the Company since September 28, 2006. Dr. Meka brings to our Board extensive experience in the healthcare industry.  Dr. Meka has been a licensed physician in California for the past 29 years. He is a board certified physician practicing in Orange County, California. Dr. Meka received his medical degree from Guntur Medical College in Gunter, India. He performed his postgraduate training at Brooklyn Jewish Hospital and Coney Island Hospital, both in Brooklyn, New York.

 

MICHAEL METZLER has been a member of the Board of Directors of the Company since September 5, 2007 and is Chairman of the Nominations and Governance Committee and sits on the Audit Committee and Special Committee. Mr. Metzler brings to our Board extensive leadership, organizational, and management skills. He is CEO of Trimoda Corporate Governance, aka Metzler and Associates, a consulting firm specializing in corporate governance and organization development. He also is the Chairman of the Board of The Values Institute, a nonprofit organization that specializes in the area of values-driven corporate culture. He served as President and Chief Executive Officer of the Santa Ana Chamber of Commerce for 27 years from 1983 – 2010. Mr. Metzler has served on numerous community boards, city, county, regional, state and national committees and task forces. He was a founder of the Santa Ana Business Bank. Mr. Metzler received a Ford Foundation Fellowship in Regionalism and Sustainable Development in 2008. He is a graduate of California State University, Fullerton and attended Loyola University School of Law and the Peter F. Drucker Graduate School of Management at Claremont University.

 

36
 

J. FERNANDO NIEBLA has served as a member of the Board of Directors of the Company since August 1, 2005. Mr. Niebla is the Chairman of the Compensation Committee and sits on the Audit Committee, Finance Committee, and Special Committee. Mr. Niebla brings to our Board extensive experience in executive leadership and board membership experience with large publicly traded companies.  He has served as Managing Partner of International Technology Partners, an information technology and business consulting services company based on Orange County, California since August 1998. He was also a founder of Infotec Development Inc. and Infotec Commercial Systems, two national information technology firms. He currently serves on the Board of Trustees of the Orange County Health Foundation, and is a member of the California Advisory Committee to Nacional Financiera, a Mexican Government agency similar to the U.S. Government Small Business Administration office. Until May 2012, Mr. Niebla served on the Boards of Directors of Union Bank of California, Pacific Life Corp., Life Modeler, Inc., and Granite Construction Corp. Mr. Niebla holds a B.S. degree in Electrical Engineering from the University of Arizona and an M.S. QBA from the University of Southern California.

 

WILLIAM E. THOMAS has served as a member of the Board of Directors of the Company since September 5, 2007. Mr. Thomas brings to our Board extensive experience in the legal profession and healthcare industry.  Mr. Thomas is the Executive Vice President and General Counsel of Strategic Global Management, Inc., a healthcare ventures firm in Riverside, California. He has served in such capacity since October of 1998. Prior to that Mr. Thomas was a founding and managing partner of a law firm in Riverside, California specializing in business, real estate, and other transactional matters.  He is a member of the board of directors of Provident Financial Holdings, Inc. Mr. Thomas graduated from the University of California at Santa Barbara with a Bachelor of Arts degree in History and Political Science. He holds a Juris Doctor degree from the University of California, Hastings College of the Law, and a Master of Laws degree from New York University. He is a member of the California Bar Association.

 

KENNETH K. WESTBROOK has served as President and Chief Executive Officer of the Company and as a director of the Company since December 2, 2008. Mr. Westbrook brings to our Board extensive experience as a healthcare executive with unique operational and management skills. Mr. Westbrook was Senior Vice President for Operations for OrNda HealthCorp (1996) and Senior Vice President of Operations for Tenet (1997 through 2004). Mr. Westbrook sold the four hospitals that created the Company as he left Tenet. During the years at OrNda and Tenet, Mr. Westbrook also had the experience of acting as each of the four hospitals' interim CEO when vacancies occurred. Prior to OrNda, Mr. Westbrook was the Chief Operating Officer for Hospital Corporation of America's Pacific Division and was previously a hospital CEO at several Southern California hospitals. He has graduate and undergraduate degrees in business from the University of Redlands and is currently a member of several healthcare professional associations. Mr. Westbrook is currently serving a two year term as a member of the Board of Trustees of the California Association of Hospitals and Healthcare Systems.

 

STEVEN R. BLAKE – FHFMA, CPA has served as Chief Financial Officer of the Company since July 1, 2005 and Executive Vice President, Finance since March 21, 2008. He is a California licensed Certified Public Accountant. Mr. Blake has over 36 years of experience in multi-hospital financial management, as well as attestation services and financial consulting for hospitals. He also has extensive experience serving in financial roles with public companies. Most recently, he served as Regional Vice President of Finance for Tenet, a position he held for over 17 years. In this position, Mr. Blake was responsible for the financial management of numerous Tenet assets covering five western states (California, Arizona, Washington, Nebraska and Texas). Mr. Blake is a past President for the Southern California Chapter of the Healthcare Financial Management Association; is a member of the Audit Committee for the Hospital Association of Southern California and a former Trustee for the California Hospital Association.

 

DANIEL J. BROTHMAN has served as Chief Operating Officer & Executive Vice President, Operations since May 6, 2008 and as Chief Executive Officer of Western Medical Center - Santa Ana since March 8, 2005. Mr. Brothman also served as Senior Vice President, Operations of the Company from March 8, 2005 to May 6, 2008. Mr. Brothman is an experienced single and multi-hospital operations executive. Since 1999, prior to the acquisition of the Hospitals by the Company he helped build the Western Medical Center in Santa Ana for Tenet. Mr. Brothman also ran HCA's Utah Division from 1996 to 1998. Mr. Brothman has in excess of 30 years experience in hospital administration. Mr. Brothman earned his Bachelor of Arts degree from Washington University at St. Louis and his Master's in Health Care Administration from the University of Colorado at Denver.

 

CORPORATE GOVERNANCE

 

Director Independence and Executive Sessions

 

The Board of Directors has determined that Directors DeWald, Jameson, Meka, Metzler, Niebla, and Thomas each satisfy the definition of "independent director" as established in the NASDAQ listing standards.  The independent directors regularly meet in executive sessions without the CEO or other members of management present to review the performance of management and other relevant matters.

 

Board’s Leadership Structure

 

The Board’s current leadership structure is characterized by an active and independent Chairman (who is not the same person as our CEO), robust Committee structure with oversight of various types of risks and an engaged and majority-independent Board.  The Board believes that its current leadership structure provides strong and independent board leadership while deriving the benefit of having our CEO serve as a member of our Board.  

 

37
 

Risk Oversight

 

Our Board oversees an enterprise-wide approach to risk management, designed to support the achievement of our strategic and organizational objectives, to improve long-term organizational performance and enhance shareholder value. A fundamental part of risk oversight is to understand the risks our Company faces, the steps management is taking to manage those risks and to assess management’s appetite for risk. It is management’s responsibility to manage risk and bring to the Board’s attention material risks facing our Company. Our Board receives regular reports from management on matters relating to strategic and operational initiatives, financial performance and legal developments which are each integrated with enterprise-risk exposures. The Compensation Committee of our Board also approves our CEO’s performance goals for each year. In doing so, the Committee has an opportunity to ensure that the CEO’s goals include responsibility for broad risk management. The involvement of the full Board in setting our strategic plan is a key part of its assessment of the risks inherent in our corporate strategy.

  

While the Board has the ultimate responsibility for overall risk oversight, each Committee of the Board also has responsibility for particular areas of risk oversight. For example, the Audit Committee focuses on financial risk and internal controls, and receives an annual risk assessment report from our internal auditors. In addition, the Compensation Committee evaluates and sets compensation programs that encourage decision making predicated upon a level of risk consistent with our business strategy. The Compensation Committee also reviews compensation and benefit plans affecting employees in addition to those applicable to executive officers.

 

Attendance at Meetings

 

Directors are elected at our annual meeting and each director serves until the following annual meeting and until his successor is elected and qualified.

 

Although we do not have a formal policy regarding attendance by Board members at our annual meeting of stockholders, directors are encouraged to attend our annual meetings. All of our current directors attended our last Annual Meeting of Stockholders.

 

Our Board of Directors held 13 meetings during fiscal 2013. Six of the seven directors attended or participated in 75% or more of the aggregate number of meetings of the Board and of meetings of the committees of the Board on which such director served. Dr. Meka attended less than 75% of the Board meetings during fiscal 2013.

 

SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

 

Section 16(a) of the Securities Exchange Act of 1934 requires our officers and directors, and persons who own more than 10% of a registered class of our equity securities, to file reports of ownership and changes in ownership with the SEC. Officers, directors and greater than 10% stockholders are required by SEC regulation to furnish us with copies of all Section 16(a) reports they file.

 

Based solely upon the copies of Section 16(a) reports filed by such persons or written representations from them regarding their transactions in our common stock, we believe that, during the year ended March 31, 2013, all such forms, if required to be filed, were filed in a timely fashion.

 

CODE OF ETHICS

 

We have adopted Standards of Conduct and Ethics that apply to our employees (including our principal executive officer, principal financial officer, principal accounting officer, and controller) and our directors. Our Standards of Conduct and Ethics can be accessed on our website at www.ihhioc.com under the Investor Relations section.

 

STOCKHOLDER COMMUNICATIONS

 

In order to facilitate communications with the Board of Directors, or any individual members or any committees of the Board of Directors, stockholders should direct all communication in writing to our General Counsel at Integrated Healthcare Holdings, Inc., 1301 North Tustin Avenue, Santa Ana, California 92705, who will forward all such correspondence to the Board of Directors, individual members of the Board of Directors or applicable chairpersons of any committee of the Board of Directors, as appropriate and as directed in the communication.

 

BOARD COMMITTEES

 

Our board of directors has established an Audit Committee, Compensation Committee, and Nominations and Governance Committee.  

 

38
 

Audit Committee

 

The Audit Committee of the Board of Directors was formed in August 2005 and consists of three of our independent directors, Maurice DeWald and J. Fernando Niebla, who joined the Board of Directors in August 2005, and Michael Metzler, who joined the Board of Directors in September 2007. The Board of Directors has determined that Maurice DeWald is an "audit committee financial expert" as defined in the rules and regulations of the SEC. The Audit Committee of the Board of Directors preapproves all audit and permissible non-audit services to be performed by the independent registered public accounting firm. The Audit Committee will also advise management on the engagement of experts with sufficient expertise to advise on accounting and financial reporting of complex financial transactions. Of the four audit committee meetings held during the year ended March 31, 2013, Messrs. DeWald and Niebla attended all meetings and Mr. Metzler attended three meetings. The Board of Directors has adopted and approved an Audit Committee Charter for the Audit Committee.  A current copy of this charter is posted on our website at www.ihhioc.com under the Investor Relations section.

 

Management is responsible for the Company's internal controls and financial reporting process. The independent registered public accounting firm is responsible for performing an independent audit of the Company's consolidated financial statements in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”) and to issue a report on the consolidated financial statements. The Audit Committee's responsibility is to oversee these activities.

 

In this context, the Audit Committee has met and held discussions with management and the independent registered public accounting firm. Management represented to the Audit Committee that the Company's consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America and the Audit Committee has reviewed and discussed the consolidated financial statements with management and the independent registered public accounting firm. The Audit Committee also discussed with the independent registered public accounting firm matters required to be discussed by Statement on Auditing Standards No. 61, "Communications with Audit Committees," as amended and adopted by the PCAOB in Rule 3200T, including the auditor's judgment about the quality, as well as the acceptability, of our accounting principles as applied in the financial reporting.

 

Our independent registered public accounting firm also provided to the Audit Committee the written disclosures required by Rule 3526 of the PCAOB (Communication with Audit Committees Concerning Independence), and the Audit Committee discussed with the independent registered public accounting firm that firm's independence as well as internal quality control procedures.

 

Based on the Audit Committee's discussions with management and the independent registered public accounting firm and the Audit Committee's review of the representations of management and the report of the independent registered public accounting firm to the Audit Committee, the Audit Committee recommended to the Board of Directors, and the Board has approved, that the audited consolidated financial statements be included in the Company's Annual Report on Form 10-K for the year ended March 31, 2013 for filing with the SEC. This report was submitted by Mr. DeWald, Chair, and Messrs. Metzler and Niebla.

 

Compensation Committee

 

The Compensation Committee of the Board of Directors was formed in October 2005 and consists of three directors, Mr. Maurice DeWald, Mr. J. Fernando Niebla, chair, and Mr. William E. Thomas. In our fiscal year ended March 31, 2013, the Compensation Committee held six meetings. The Compensation Committee is responsible for overseeing the administration of the Company's executive compensation programs, establishing and interpreting the Company's compensation policies and approving all compensation paid to executive officers, including the named executive officers listed in the Summary Compensation Table. The Board of Directors has adopted and approved a Compensation Committee Charter for the Compensation Committee.  

 

Nominations and Governance Committee

 

The Nominations and Governance Committee of the Board of Directors (the “Nominations Committee”) consists of three directors, Mr. Maurice DeWald, Mr. Michael Metzler, chair, and Judge C. Robert Jameson.  In our fiscal year ended March 31, 2013, the Nominations Committee held five meetings. The general purpose and authority of the Nominations Committee  is (1) to select, or recommend for the Board of Directors’ selection, the individuals to stand for election as directors at the annual meeting of shareholders or, if applicable, a special meeting of shareholders, (2) to receive communications from shareholders directed to the Board of Directors, including shareholder proposals regarding director nominations to the Board of Directors, (3) to oversee the selection and composition of Committees of the Board of Directors and, as applicable, oversee management continuity planning processes, and (4) to oversee and maintain the corporate governance principles that apply to the Company, the Board of Directors and Committees of the Board.

 

When considering a potential candidate for membership on our Board of Directors, our Nominations Committee considers relevant business and industry experience and demonstrated character and judgment. The Nominations Committee considers diversity in identifying candidates by generally seeking to achieve a diversity of occupational and personal backgrounds on the Board. However the Nominations Committee has no formal policy regarding diversity. The Nominations Committee will consider stockholder nominations for directors submitted in accordance with the procedures and the deadlines set forth in our Bylaws.  Such recommendations should be addressed to Michael Metzler, Chairman of the Nominations and Governance Committee, at the Company’s headquarters at 1301 North Tustin Avenue, Santa Ana, California 92705.  There are no differences in the manner in which the Nominations Committee evaluates a candidate that is recommended for nomination by our Board of Directors or by a stockholder.

 

39
 

ITEM 11. EXECUTIVE COMPENSATION

 

The following table sets forth summary information regarding compensation to (i) our Chief Executive Officer; and (ii) our two other most highly compensated executive officers employed by us as of March 31, 2013 whose salary and bonus for the fiscal year ended March 31, 2013 was in excess of $100,000 for their services rendered in all capacities to us. The listed individuals are referred to as the "Named Executive Officers."

 

SUMMARY COMPENSATION TABLE

 

Name and

Principal Position

   Year  

Salary (1)

($)

    

Bonus

($)

    

Option

awards

($)

    

All other

compensation

($)

    

Total

($)

  
                                   
Kenneth K. Westbrook   2013     554,216       -       -       21,197       575,413  
Principal Executive Officer (2)   2012     575,532       -       -       20,509       596,041  
                                             
Steven R. Blake   2013     428,085       -       -       16,445       444,530  

Principal Financial Officer &

Executive Vice President, Finance (3)

   2012     444,550       -       -       16,706       461,256  
                                             
Daniel J. Brothman   2013     428,085       -       -       16,445       444,530  
Chief Operating Officer (3)   2012     444,550       -       -       16,108       460,658  

 

 

(1) Salary amounts for 2013 include 26 pay periods compared to 27 pay periods in 2012.
(2) All other compensation for 2013 and 2012 includes auto allowance of $18,000 and the balance is Company contribution to the 401(k) plan.
(3)   All other compensation for 2013 and 2012 consists of an auto allowance of $12,000 and the balance is Company contribution to the 401(k) plan.   

 

The following table sets forth summary information regarding stock options the Company has granted to the Named Executive Officers as of March 31, 2013 under the Company's 2006 Stock Incentive Plan.

 

OUTSTANDING STOCK OPTIONS AWARDS AT FISCAL YEAR-END

   

Name  Grant
date		  Number of
securities
underlying
unexercised
options
exercisable		  Number of
securities
underlying
unexercised
options
unexercisable		  Equity
incentive
plan awards:
Number of
securities
underlying
unexercised
unearned
options		  Option
exercise
price
($)		  Option
expiration
date		  Grant date
fair value
per share
($)
                      
Kenneth K. Westbrook (1)  December 2, 2008  2,000,000  -  -  0.01  December 2, 2015  0.00
Steven R. Blake (2)  August 6, 2007  300,000  -  -  0.26  August 6, 2014  0.03
Daniel J. Brothman (3)  August 6, 2007  1,000,000  -  -  0.26  August 6, 2014  0.02

___________________

(1) 1/3 of the shares vested on the grant date, and an additional 1/12 of the shares vest on each subsequent fiscal quarter-end of the Company beginning on March 31, 2009, all options were fully vested as of March 31, 2013.
(2) 1/3 of the shares vested on the twelve month anniversary of the grant date, and an additional 1/12 of the shares vest on each subsequent fiscal quarter-end of the Company following such twelve month anniversary, all options were fully vested as of March 31, 2013.
(3) Vesting retroactively commenced on March 8, 2005, all options were fully vested as of March 31, 2013.

 

EMPLOYMENT AGREEMENTS

 

The Company has employment agreements with each of the Named Executive Officers.  The Employment Agreements provide for the following material terms:

   

40
 

 

  ● Each individual's employment is for a fixed term of employment of three years, commencing April 1, 2010, with automatic renewals for successive one year periods. The Company or the Named Executive may only terminate the employment relationship during the final 120 days of the initial three-year period or one-year renewal periods, except for a termination by either party "for cause" (as defined in the employment agreements).
  ● The base salary of Mr. Westbrook is set at $550,000 per annum, and the base salaries of each of Messrs. Blake and Brothman are set at $422,000 per annum.
  ● The agreements provide for the establishment of annual performance targets for each individual by the Compensation Committee and the Executive within 60 days after the end of each fiscal year. Each Executive's annual bonus will be determined based on his achievement in reaching his individual performance targets.
  ● The employment agreements provided for payment of a severance package to each Executive upon a termination by the Executive "for cause" or termination by the Company "without cause." The severance period is 24 months (36 months during the first year of effectiveness of the employment agreements). The employment agreements also provide for payment of severance in the event of (i) a termination of employment following a change of control of the Company or (ii) a non-renewal of the Executive's employment by the Company at the end of the fixed 3-year or 1-year employment term. In the case of Messrs. Westbrook and Brothman, the right to receive severance terminates if the individual accepts employment with a competing hospital in a specified geographic area during the severance period.

    

POTENTIAL PAYMENTS UPON TERMINATION

 

Each of the Company's Named Executive Officers have employment agreements which provide, generally, for payments in the event of resignation for cause. Cause includes, among other items, changes in job duties, reporting relationships, bankruptcy of the Company or change in shareholders of over 50% of the stock. As of March 31, 2013, unless otherwise noted, each Named Executive Officer would be entitled to up to 24 months’ salary, benefits and health insurance, but not any additional accruals of paid time off, vacation or sick pay.

 

The following table provides information concerning the estimated payments and benefits that would be provided in the circumstances described above for each of the Named Executive Officers. Payments and benefits are estimated assuming that the triggering event took place on March 31, 2013. There can be no assurance that a triggering event would produce the same or similar results as those estimated below if such event occurs on any other date or if any other assumption used to estimate potential payments and benefits is not correct. The amounts which would be due the Named Executive Officers as of March 31, 2013, if they resigned for cause is as follows.

 

PAYMENTS DUE UPON TERMINATION

 

Name and
principal
position		  Salary (1)   Employee
health
insurance		   Car
allowance		   Other
benefits		   Total 
                     
Kenneth K. Westbrook
Chief Executive Officer		  $1,100,000   $9,149   $36,000    –   $1,145,149 
                          
Steven R. Blake
Chief Financial Officer &
Executive Vice President,
Finance		  $844,000   $12,992   $24,000    –   $880,992 
                          
Daniel J. Brothman
Senior Vice President,
Operations		  $844,000   $9,149   $24,000    –   $877,149 

 

 

(1)     Represents payments for 24 months per employment agreement as of March 31, 2013.

 

COMPENSATION OF DIRECTORS

 

The following table provides information concerning the compensation of our non-management directors during the fiscal year ended March 31, 2013.

 

41
 

DIRECTOR COMPENSATION

 

Name  Fees earned
or paid in cash
($)		   Stock
options
($)		   Total
($)		 
             
Maurice J. DeWald   30,000    –    30,000 
Hon. C. Robert Jameson   30,000    –    30,000 
Ajay G. Meka, M.D.   19,500    –    19,500 
Michael Metzler   30,000    –    30,000 
J. Fernando Niebla   30,000    –    30,000 
William E. Thomas   30,000    –    30,000 

 

Our current compensation and reimbursement policy for Directors is as follows:

 

  1.   Cash:  Each non-employee Director earns an annual fee of $40,000 and an attendance fee of $2,500 for each Board meeting attended, and a separate $1,500 fee for each committee meeting attended. The Chairman of the Board earns an additional annual retainer of $25,000.  Committee chairmen earn an additional annual retainer of $10,000 or $20,000. The above fees were received in cash by the named Directors during the year ended March 31, 2013. For some directors, the fees listed may include fees which relate to service in a prior fiscal year but were paid in fiscal 2013.
  2.   Stock:  No options were granted to the Directors during the year ended March 31, 2013.
  3.   Travel Reimbursement:  All travel and related expenses incurred by Directors to attend Board meetings, committee meetings and other Company activities are reimbursed by the Company.

 

Employee directors receive no compensation for Board service and the Company does not provide any retirement benefits to non-employee directors. Director Westbrook is not included above as all compensation paid to him is included in the Summary Compensation Table.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

For a discussion of securities authorized for issuance under equity compensation plans, please refer to Item 5 above.

  

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

 

The following table sets forth information known to us with respect to the beneficial ownership of our common stock as of June 18, 2013 by:

  

  ● each stockholder known to us to own beneficially more than 5% of our common stock;
  ● each of our directors and executive officers; and
  ● all of our current directors and executive officers as a group.

     

Except as otherwise noted below, the address of each person or entity listed on the table is 1301 North Tustin Avenue, Santa Ana, California 92705.  The address of Dr. Kali P. Chaudhuri and KPC Resolution Company, LLC is 3321 Loma Linda Lane, Las Vegas, NV 89121. The address of William E. Thomas is 3192 American Saddler Drive, Park City, UT 84060.  The address of Silver Point Capital, L.P. is Two Greenwich Plaza, 1st Floor, Greenwich, CT 06830.  The address of Orange County Physicians Investment Network, LLC and Dr. Anil V. Shah is 2621 S. Bristol Street, Santa Ana, CA 92704.

 

NAME   BENEFICIAL OWNERSHIP (1)   PERCENTAGE OF TOTAL (2)
           
DIRECTORS AND EXECUTIVE OFFICERS          
Maurice J. DeWald (3)   350,000     *
Hon. C. Robert Jameson (3)   250,000     *
Ajay G. Meka, M.D. (3)(4)   300,000     *
Michael Metzler (3)   250,000     *
J. Fernando Niebla (3)   350,000     *
William E. Thomas (5)   9,998,498     3.91%
Kenneth K. Westbrook (3)   2,000,000     *
Steven R. Blake (3)   300,000     *
Daniel J. Brothman (3)   1,000,000     *
All current directors and executive officers as a group (9 persons)   14,798,498     5.80%

 

42
 

 

PRINCIPAL STOCKHOLDERS          
Kali P. Chaudhuri, M.D. (6)   437,601,334     77.55%
KPC Resolution Company, LLC (7)   139,000,000     35.25%
Silver Point Capital, L.P. (8)   96,000,000     27.33%
Orange County Physicians Investment Network, LLC   73,798,430     28.91%
Anil V. Shah, M.D. (9)   19,812,000     7.76%
* Less than 1%          

 

(1)

Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission and generally includes voting or investment power with respect to securities.  Except as reflected in the footnotes or pursuant to applicable community property laws, the persons named in this table have sole voting and investment power with respect to all shares of common stock beneficially owned.

 

(2)

Percentages are based on 255,307,262 shares of common stock outstanding as of June 18, 2013, which does not include up to 26,078,561 shares of common stock which may be issued under the Company’s 2006 Stock Incentive Plan, and are otherwise calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934. Shares of common stock subject to options and warrants that are exercisable within 60 days of June 18, 2013 are deemed outstanding for computing the percentage of the person holding such option or warrant, but are not deemed outstanding for computing the percentage of any other person.  

 

(3)Consists of a stock option award approved by the Board of Directors pursuant to the Company’s 2006 Stock Incentive Plan. 

 

(4)Dr. Meka is a member of Orange County Physicians Investment Network, LLC (“OC-PIN”) and disclaims beneficial ownership of shares held by OC-PIN except to the extent of his pecuniary interest therein. 

 

(5)

Consists of 9,748,498 issued and outstanding shares and a stock option award to purchase 250,000 shares approved by the Board of Directors pursuant to the Company’s 2006 Stock Incentive Plan. 

 

(6)Consists of 128,601,334 issued and outstanding shares, 170,000,000 shares which may be acquired by Kali P. Chaudhuri, M.D. pursuant to a three-year warrant issued to him on April 13, 2010, and 139,000,000 shares which may be acquired by KPC Resolution Company, LLC (“KPC Resolution”) pursuant to a three-year warrant issued to it on April 13, 2010.  On February 7, 2013, the expiration date of the warrants issued to Dr. Chaudhuri and KPC Resolution was extended to April 13, 2016. Dr. Chaudhuri is the manager of KPC Resolution and, as a result, he may be deemed to be the beneficial owner of the securities held by KPC Resolution.  Dr. Chaudhuri disclaims beneficial ownership of the reported securities held by KPC Resolution except to the extent of his pecuniary interest therein.

 

(7)Consists of 139,000,000 shares which may be acquired by KPC Resolution pursuant to a three-year warrant issued to it on April 13, 2010. On February 7, 2013, the expiration date of the warrant issued to KPC Resolution was extended to April 13, 2016.

 

(8)Consists of 96,000,000 shares which may be acquired by SPCP Group, LLC (“SPCP”) pursuant to two warrants issued to SPCP on April 13, 2010 and February 7, 2013. Both warrants expire on April 13, 2016. Silver Point Capital, L.P. (“Silver Point”) is the investment manager of SPCP and, by reason of such status, may be deemed to be the beneficial owner of all of the reported securities held by SPCP. Silver Point Capital Management, LLC (“Management”) is the general partner of Silver Point and, as a result, may be deemed to be the beneficial owner of the securities held by SPCP.  Messrs. Edward A. Mule and Robert J. O’Shea are each members of Management and, as a result, may be deemed to be the beneficial owner of all of the securities held by SPCP. Silver Point, Management and Messrs. Mule and O’Shea disclaim beneficial ownership of the reported securities held by SPCP except to the extent of their respective pecuniary interests therein.  

 

(9)

Consists of 14,700,000 issued and outstanding shares held by Dr. Shah and 5,112,000 issued and outstanding shares held by Coastal Heart Medical Group Inc. Defined Benefit Plan and Trust for which Dr. Shah is Trustee. The amount does not include any shares held of record by OC-PIN.  Dr. Shah is a member of OC-PIN.

 

43
 

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

CREDIT AGREEMENTS

 

On February 7, 2013, the Company entered into an “Amendment and Restatement to the Credit Agreement” (the “Amendment”) with SPCP Group IV, LLC, SPCP Group, LLC, and Silver Point Finance, LLC, as the Lender Agent (collectively, “Silver Point”), PCHI and Ganesha Realty, llc (“Ganesha”). Ganesha is a company owned and controlled by Dr. Chaudhuri, who is the majority shareholder of the Company.  Ganesha is a member of PCHI with a 49% membership interest in PCHI.

 

Under the Amendment, the $80.0 million Credit Agreement, dated as of October 9, 2007, as amended, to which the Company and Silver Point are parties (the “Credit Agreement”) was amended and restated in its entirety in the form of the “Amended and Restated Credit Agreement ($47.277 Term Loan)” attached as Exhibit A to the Amendment (the “Restated Credit Agreement”). The Restated Credit Agreement reflects changes to the terms of the Credit Agreement that were previously made under various amendments the Company entered into since inception of the Credit Agreement in October 2007.

 

On March 25, 2013, the Company entered into Amendment No. 5 to Credit and Security Agreement and Limited Waiver (the “Revolving Loan Amendment No. 5”), which amends the Revolving Loan Agreement, with MidCap Funding IV, LLC, as assigned to it from MidCap Financial, LLC, as administrative agent and a lender. Under the Revolving Loan Amendment No. 5, the minimum Revolving Loan Commitment Amount was increased to $35 million and the maturity date was extended to March 25, 2016.

 

The Amendment and the Revolving Loan Amendment No. 5, and the Company’s obligations thereunder, are discussed further above under “ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS – Liquidity and Capital Resources.”

 

REVIEW, APPROVAL OR RATIFICATION OF TRANSACTIONS WITH RELATED PARTIES

 

The Company's human resources written policies and procedures provide guidance for conflicts of interest and their relation to the standards of ethical behavior expected of employees. The policies specifically require immediate written disclosure of any business, financial, or other relationship that either creates, or is perceived to create a conflict of interest. The Corporate Compliance Officer is responsible for monitoring compliance with this policy.

 

As part of the quarterly disclosure control procedures, the Chief Financial Officer and Chief Executive Officer for each hospital disclose or certify that employees or officers have not acted in a manner inconsistent with the Company policy related to Conflict of Interest. The CFO and Director of Internal Audit monitor certifications for potential disclosure events.

 

Company policy requires the General Counsel to review and approve all contracts involving related parties, including contracts with related parties who are considered potential referral sources. The Audit Committee has requested that the General Counsel provide periodic updates of such transactions to the Committee.

 

During the initial acquisition of the Hospitals, the Company entered into agreements with the Medical Executive Committee ("MEC") at the largest hospital, Western Medical Center – Santa Ana ("WMC-SA") requiring MEC's advance review of all agreements involving hospital operations with related parties, excluding the lease arrangements between the Company and PCHI. The Company applies the disclosure provisions applicable to WMC-SA to all of its facilities.

 

DIRECTOR INDEPENDENCE

 

The information called for by this item in response to Item 407(a) of Regulation S-K concerning director independence is contained above under “ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.”

    

 

 

44
 

   

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

 

The following table sets forth the aggregate fees that we incurred for audit and non-audit services provided by BDO USA, LLP, which acted as our independent registered public accounting firm for the years ended March 31, 2013 and 2012, and performed audit services for us during those periods.

 

     For the year ended March 31,  
    2013     2012  
Audit fees   $ 750,000     $ 750,000  
Audit related fees     15,000       15,000  
Tax fees     154,000       113,000  
All other     -       -  
                 
Total fees   $ 919,000     $ 878,000  

 

Audit fees includes the aggregate fees for the annual audit of our financial statements and reviews of our quarterly financial statements.

 

Audit related fee includes the aggregate fees for the annual audit of our 401(k) Retirement Savings Plan.

 

Tax fees includes the aggregate fees for tax return preparation, compliance, tax advice and tax planning

 

The Audit Committee of the Board of Directors pre-approves all audit and permissible non-audit services to be performed by our independent registered public accounting firm. The Board of Directors of the Company considered that the provision of the services and the payment of the fees described above are compatible with maintaining the independent registered public accounting firm’s independence.

 

 

 

 

45
 

  

ITEM 15. EXHIBITS; FINANCIAL STATEMENT SCHEDULES

 

Exhibits required to be filed are listed below and except where incorporated by reference, immediately follow the Financial Statements. Each document filed with this report is marked with an asterisk (*).

 

3.1 Amended and Restated Articles of Incorporation (incorporated by reference to Appendix A to the Registrant’s Information Statement on Schedule 14C filed on March 17, 2009).
   
3.2 Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Registrant’s Quarterly Report on Form 10-Q filed with the Commission on February 10, 2012).
   
4.1 Warrant to purchase 170,000,000 shares of common stock, dated April 13, 2010, issued to Kali P. Chaudhuri, M.D. (incorporated by reference to Exhibit 99.2 to the Registrant’s Report on Form 8-K filed on April 19, 2010).
   
4.1.1 Amendment No. 1 to Common Stock Warrant (170,000,000 shares), dated February 7, 2013, by and between IHHI and Dr. Kali P. Chaudhuri, M.D. (incorporated by reference to Exhibit 10.16 to the Registrant’s Report on Form 10-Q filed on February 12, 2013).
   
4.2 Warrant to purchase 139,000,000 shares of common stock, dated April 13, 2010, issued to KPC Resolution Company, LLC (incorporated by reference to Exhibit 99.3 to the Registrant’s Report on Form 8-K filed on April 19, 2010).
   
4.2.1 Amendment No. 1 to Common Stock Warrant (139,000,000 shares), dated February 7, 2013, by and between IHHI and KPC Resolution Company, LLC  (incorporated by reference to Exhibit 10.15to the Registrant’s Report on Form 10-Q filed on February 12, 2013).
   
4.3 Warrant to purchase 79,182,635 shares of common stock, dated April 13, 2010, issued to SPCP Group, LLC (incorporated by reference to Exhibit 99.4 to the Registrant’s Report on Form 8-K filed on April 19, 2010).
   
4.3.1 Amendment No. 1 to Common Stock Warrant (79,182,635 shares), dated February 7, 2013, by and between IHHI and SPCP Group, LLC   (incorporated by reference to Exhibit 10.15 to the Registrant’s Report on Form 10-Q filed on February 12, 2013).
   
4.4 Warrant to purchase 16,817,365 shares of common stock, dated April 13, 2010, issued to SPCP Group IV, LLC (incorporated by reference to Exhibit 99.5 to the Registrant’s Report on Form 8-K filed on April 19, 2010).
   
4.4.1  Warrant Repurchase Agreement, dated February 7, 2013, by and between IHHI and SPCP Group IV, LLC (incorporated by reference to Exhibit 10.13 to the Registrant’s Report on Form 10-Q filed on February 12, 2013).
   
4.4.2 Warrant to purchase 16,817,365 shares of common stock, dated February 7, 2013, issued to SPCP Group, LLC (incorporated by reference to Exhibit 10.14 to the Registrant’s Report on Form 10-Q filed on February 12, 2013).
   
10.1 Amended and Restated Employment Agreement, executed as of March 29, 2010, by and between the Registrant and Kenneth K. Westbrook (incorporated by reference to Exhibit 10.17 to the Registrant’s Report on Form 10-K filed on June 29, 2010).
   
10.2 Amended and Restated Employment Agreement, executed as of March 29, 2010, by and between the Registrant and Steven R. Blake (incorporated by reference to Exhibit 10.18 to the Registrant’s Report on Form 10-K filed on June 29, 2010).
   
10.3 Amended and Restated Employment Agreement, executed as of March 29, 2010, by and between the Registrant and Daniel J. Brothman (incorporated by reference to Exhibit 10.19 to the Registrant’s Report on Form 10-K filed on June 29, 2010).
   
10.1 2006 Stock Incentive Plan (incorporated by reference to Appendix B to the Registrant’s Definitive Proxy Statement on Schedule 14A filed by the Registrant on November 14, 2006).
   
10.4.1 Form of Notice of Stock Option Award and Stock Option Agreement under 2006 Stock Incentive Plan (incorporated herein by reference from Exhibit 4.5 to the Registrant’s Registration Statement under the Securities and Exchange Act of 1933 on Form S-8 filed with the Commission on February 2, 2007).
   
10.5 Release, dated April 13, 2010, by and between the Registrant and Thomas A. Seaman, Receiver (incorporated by reference to Exhibit 99.7 to the Registrant’s Report on Form 8-K filed on April 19, 2010).

 

46
 

 

10.6 Amended and Restated Triple Net Hospital Building Lease, dated as of October 1, 2007, between Pacific Coast Holdings Investment, LLC and the Registrant (incorporated by reference to Exhibit 99.10 to the Registrant’s Report on Form 8-K filed on October 15, 2007).
   
10.6.1 Amendment to Amended and Restated Triple Net Hospital Building Lease, dated as of March 27, 2009, between Pacific Coast Holdings Investment, LLC and the Registrant (incorporated by reference to Exhibit 10.8 to the Registrant’s Report on Form 8-K filed on April 7, 2009).
   
10.6.2 Second Amendment to Amended and Restated Triple Net Hospital Building Lease, dated as of April 13, 2010, between Pacific Coast Holdings Investment, LLC and the Registrant (incorporated by reference to Exhibit 99.6 to the Registrant’s Report on Form 8-K filed on April 19, 2010).
   
10.7 Credit and Security Agreement, dated August 30, 2010, by and among the Company, MidCap Financial, LLC, as Administrative Agent and Lender, and Silicon Valley Bank as Lender (incorporated by reference to Exhibit 99.1 to the Registrant’s Report on Form 8-K filed on September 2, 2010).
   
10.7.1 Amendment No. 1 to the Credit and Security Agreement, dated October 29, 2010, by and among the Company, MidCap Funding IV, LLC, as Administrative Agent and Lender, and Silicon Valley Bank as Lender (incorporated by reference to Exhibit 99.1 to the Registrant’s Report on Form 8-K filed on November 4, 2010).
   
10.7.2 Amendment No. 2 to the Credit and Security Agreement, dated October 29, 2010, by and among the Company, MidCap Funding IV, LLC, as Administrative Agent and Lender, and Silicon Valley Bank as Lender (incorporated by reference to Exhibit 99.1 to the Registrant’s Report on Form 8-K filed on June 14, 2012).
   
10.7.3 Amendment No. 3 to Credit and Security Agreement, dated August 1, 2012, by and among the Company, MidCap Funding IV, LLC, as Agent and lender, and Silicon Valley Bank, as lender (incorporated by reference to Exhibit 99.1 to the Registrant’s Report on Form 8-K filed on August 6, 2012).
   
10.7.4 Amendment No. 4 to Credit and Security Agreement and Limited Consent, by and among the Company, MidCap Funding IV, LLC and Silicon Valley Bank, as lenders, and MidCap Financial, LLC, as agent (incorporated by reference to Exhibit 10.18 to the Registrant’s Report on Form 10-Q filed on February 12, 2013).
   
10.7.5 Amendment No. 5 to Credit and Security Agreement, dated March 25, 2013, by and among the Company and MidCap Funding IV, LLC, as agent and lender (incorporated by reference to Exhibit 99.1 to the Registrant’s Report on Form 8-K  filed on March 29, 2013).
   
10.8 $80,000,000 Credit Agreement, dated October 9, 2007, by and among the Company, its subsidiaries, Pacific Coast Holdings Investment, LLC, West Coast Holdings, LLC, Ganesha Realty, LLC, Orange County Physicians Investment Network, LLC, and Medical Provider Financial Corporation II (incorporated by reference to Exhibit 99.1 to the Registrant’s Report on Form 8-K filed on October 15, 2007).
   
10.8.1 Omnibus Credit Agreement Amendment, dated as of April 13, 2010, among the Registrant, WMC-SA, Inc., WMC-A, Inc., Chapman Medical Center, Inc., Coastal Communities Hospital, Inc., Pacific Coast Holdings Investment, LLC, Ganesha Realty, LLC, SPCP Group IV, LLC, SPCP Group, LLC, and Silver Point Finance, LLC, as the Lender Agent (incorporated by reference to Exhibit 99.1 to the Registrant’s Report on Form 8-K filed on April 19, 2010).
   
10.8.2 Amendment to $80,000,000 Credit Agreement, dated August 30, 2010, by and among the Company, Pacific Coast Holdings Investment, LLC, Ganesha Realty, LLC, SPCP Group IV, LLC, SPCP Group, LLC and Silver Point Finance, LLC (incorporated by reference to Exhibit 99.2 to the Registrant’s Report on Form 8-K filed on September 2, 2010).
   
10.8.3 Amendment No. 4 to Credit and Security Agreement and Limited Consent, dated August 1, 2012, by and among the Company, Pacific Coast Holdings Investment, LLC, Ganesha Realty, LLC, SPCP Group IV, LLC, SPCP Group, LLC and Silver Point Finance, LLC (incorporated by reference to Exhibit 99.2 to the Registrant’s Report on Form 8-K filed on August 6, 2012).

 

47
 

 

10.8.4 Amendment and Restatement to the Credit Agreement, dated February 7, 2013, by and among the Company, the Silver Point Entities, PCHI and Ganesha (incorporated by reference to Exhibit 10.12 to the Registrant’s Report on Form 10-Q filed on February 12, 2013).
   
10.9 Master Information System Agreement, dated March 31, 2008, between McKesson Information Solutions LLC and the Registrant (incorporated by reference to Exhibit 10.9 to the Registrant’s Quarterly Report on Form 10-Q filed with the Commission on November 9, 2011).
   
10.9.1 Contract Supplement, dated July 1, 2011, to Master Information System Agreement, dated March 31, 2008, between McKesson Information Solutions LLC and the Registrant (incorporated by reference to Exhibit 10.9.1 to the Registrant’s Quarterly Report on Form 10-Q filed with the Commission on November 9, 2011). **
   
21.1 The subsidiaries of the Registrant are WMC-SA, Inc., a California corporation, WMC-A, Inc., a California corporation, Chapman Medical Center, Inc., a California corporation, and Coastal Communities Hospital, Inc., a California corporation.
   
31.1 Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
   
31.2 Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
   
32.1 Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
   
32.2 Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

 

   
101.INS XBRL Instance Document *
   
101.SCH XBRL Taxonomy Extension Schema Document *
   
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document *
   
101.DEF XBRL Taxonomy Extension Definition Linkbase Document *
   
101.LAB XBRL Taxonomy Extension Labels Linkbase Document *
   
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document *

 

________________

 

* filed or furnished herewith

** Confidential treatment has been granted with respect to certain confidential portions of this exhibit pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, which confidential portions have been omitted from the exhibit and filed separately with the Securities and Exchange Commission.

 

 

 

48
 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  INTEGRATED HEALTHCARE HOLDINGS, INC.  
       
Dated: June 28, 2013 By: /s/ Kenneth K. Westbrook  
    Kenneth K. Westbrook  
    Chief Executive Officer & President (Principal Executive Officer)  
       

  

 Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

  

Dated: June 28, 2013 /s/ Kenneth K. Westbrook  
 

Kenneth K. Westbrook

Chief Executive Officer, President & Director

(Principal Executive Officer)

  
     
Dated: June 28, 2013 /s/ Steven R. Blake  
 

Steven R. Blake

Chief Financial Officer

(Principal Financial Officer)

  
     
Dated: June 28, 2013 /s/ Jeremiah R. Kanaly  
 

Jeremiah R. Kanaly

Chief Accounting Officer and Treasurer

(Principal Accounting Officer)

  
     
Dated: June 28, 2013 /s/ Maurice J. DeWald  
 

Maurice J. DeWald

Chairman of the Board of Directors

  
     
Dated: June 28, 2013 /s/ Hon. C. Robert Jameson  
 

Hon. C. Robert Jameson

Director

  
     
Dated: June 28, 2013  
 

Ajay Meka, M.D

Director

  
     
Dated: June 28, 2013 /s/ Michael Metzler  
 

Michael Metzler

Director

  
     
Dated: June 28, 2013 /s/ J. Fernando Niebla  
 

J. Fernando Niebla

Director

  
     
Dated: June 28, 2013 /s/ William E. Thomas   
 

William E. Thomas

Director

  

 

 

49
 

 

Report of Independent Registered Public Accounting Firm

 

Board of Directors and Stockholders

Integrated Healthcare Holdings, Inc.

Santa Ana, California

 

We have audited the accompanying consolidated balance sheets of Integrated Healthcare Holdings, Inc. (“Company”) as of March 31, 2013 and 2012 and the related consolidated statements of operations, stockholders’ deficiency, and cash flows for each of the two years in the period ended March 31, 2013. In connection with our audits of the financial statements, we have also audited the financial statement schedule listed in the accompanying index. These consolidated financial statements and schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements and schedule based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements and schedule. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Integrated Healthcare Holdings, Inc. at March 31, 2013 and 2012, and the results of its operations and its cash flows for each of the two years in the period ended March 31, 2013, in conformity with accounting principles generally accepted in the United States of America.

 

Also, in our opinion, the financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.

 

 

/s/ BDO USA, LLP

 

Costa Mesa, California

June 28, 2013

 

 

F-1
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

CONSOLIDATED BALANCE SHEETS

(amounts in 000's, except par value)

 

   March 31, 
   2013   2012 
ASSETS          
Current assets:          
Cash and cash equivalents  $3,545   $11,829 
Restricted cash   13    10 
Accounts receivable, net of allowance for doubtful accounts of $21,143 and $18,201, respectively   62,821    53,599 
Inventories of supplies   6,738    6,855 
Due from governmental payers   5,882    5,183 
Hospital quality assurance fee receivable   7,690    2,436 
Prepaid insurance   115    366 
Prepaid income taxes   –    892 
Deferred tax assets, net   6,328    – 
Other prepaid expenses and current assets   9,208    8,186 
Total current assets   102,340    89,356 
           
Property and equipment, net   63,988    55,529 
Deferred tax assets, net   380    – 
Total assets  $166,708   $144,885 
           
LIABILITIES AND STOCKHOLDERS' DEFICIENCY          
Current liabilities:          
Revolving line of credit, net of discount  $29,527   $13,783 
Accounts payable   62,515    52,700 
Accrued compensation and benefits   19,634    19,847 
Accrued insurance retentions   12,938    14,377 
Hospital quality assurance payable   7,226    – 
Due to governmental payers   179    – 
Income taxes payable   2,869    – 
Other current liabilities   4,111    3,242 
Total current liabilities   138,999    103,949 
           
Debt, noncurrent, net of discount   45,530    45,000 
Warrant liability, noncurrent   5,276    1,641 
Capital lease obligations, net of current portion of $1,101 and $891, respectively   6,789    5,944 
Total liabilities   196,594    156,534 
           
Commitments, contingencies and subsequent events          
           
Stockholders' deficiency:          
Integrated Healthcare Holdings, Inc. stockholders' deficiency:          
Common stock, $0.001 par value; 800,000 shares authorized; 255,307 shares issued and outstanding   255    255 
Additional paid in capital   62,911    62,911 
Accumulated deficit   (87,365)   (71,828)
Total Integrated Healthcare Holdings, Inc. stockholders' deficiency   (24,199)   (8,662)
Noncontrolling interests   (5,687)   (2,987)
Total stockholders' deficiency   (29,886)   (11,649)
           
Total liabilities and stockholders' deficiency  $166,708   $144,885 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

F-2
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(amounts in 000's, except per share amounts)

 

   For the year ended March 31,
    2013    2012 
Patient service revenues (net of contractual allowances and discounts)  $428,100   $402,564 
Provision for bad debts   (44,600)   (40,368)
Net patient service revenues   383,500    362,196 
           
Other operating revenues   3,370    3,089 
    386,870    365,285 
Operating expenses:          
Salaries and benefits   215,552    218,801 
Supplies   56,160    55,066 
Other operating expenses   118,055    74,515 
Depreciation and amortization   3,917    4,208 
    393,684    352,590 
           
Operating income (loss)   (6,814)   12,695 
           
Other income (expense):          
Interest expense, net   (11,752)   (10,218)
Income from electronic health records incentive program   –    6,802 
Loss on warrants   (3,101)   (1,474)
    (14,853)   (4,890)
           
Income (loss) before income tax benefit   (21,667)   7,805 
Income tax benefit   (5,806)   (139)
Net income (loss)   (15,861)   7,944 
           
Net (income) loss attributable to noncontrolling interests (Note 9)   324    (492)
           
Net income (loss) attributable to Integrated Healthcare Holdings, Inc.  $(15,537)  $7,452 
           
Per Share Data (Note 8):          
Earnings (loss) per common share attributable to Integrated Healthcare Holdings, Inc. stockholders          
Basic  $(0.06)  $0.03 
Diluted  $(0.06)  $0.03 
Weighted average shares outstanding          
Basic   255,307    255,307 
Diluted   255,307    256,840 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

   

F-3
 

 

INTEGRATED HEALTHCARE HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIENCY

(amounts in 000's)

 

   Integrated Healthcare Holdings, Inc. Stockholders         
           Additional   Receivable             
   Common Stock   Paid-in   from   Accumulated   Noncontrolling 
   Shares   Amount   Capital   Stockholders   Deficit   Interests   Total 
                             
Balance, March 31, 2011   255,307   $255   $62,911   $(882)  $(79,280)  $(1,565)  $(18,561)
                                    
Payment received on receivable from stockholders   –    –    –    882    –    –    882 
                                    
Net income   –    –    –    –    7,452    492    7,944 
                                    
Noncontrolling interests distributions   –    –    –    –    –    (1,914)   (1,914)
                                    
Balance, March 31, 2012   255,307    255    62,911    –    (71,828)   (2,987)   (11,649)
                                    
Net loss   –    –    –    –    (15,537)   (324)   (15,861)
                                    
Noncontrolling interests distributions   –    –    –    –    –    (2,376)   (2,376)
                                    
Balance, March 31, 2013   255,307   $255   $62,911   $–   $(87,365)  $(5,687)  $(29,886)

 

 

The accompanying notes are an integral part of these consolidated financial statements.

     

 

 

 

F-4
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(amounts in 000's)

 

    For the year ended March 31, 
    2013    2012 
Cash flows from operating activities:          
Net income (loss)  $(15,861)  $7,944 
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:          
Depreciation and amortization of property and equipment   3,917    4,208 
Provision for bad debts   44,600    40,368 
Amortization of debt discount   1,682    525 
Loss on warrants   3,101    1,474 
Deferred tax assets, net   (6,708)   – 
Noncash interest expense   86    – 
Changes in operating assets and liabilities:          
Accounts receivable   (53,822)   (39,318)
Inventories of supplies   117    (910)
Due from governmental payers   (699)   (831)
Hospital quality assurance fee receivable   (5,254)   (621)
Prepaid income taxes   892    (892)
Prepaid insurance, other prepaid expenses and current assets, and other assets   (771)   1,033 
Accounts payable   9,815    8,732 
Accrued compensation and benefits   (213)   1,140 
Hospital quality assurance payable   7,226    – 
Due to governmental payers   179    – 
Income taxes payable   2,869    (12,800)
Accrued insurance retentions and other current liabilities   (780)   (5,534)
Net cash provided (used) by operating activities   (9,624)   4,518 
           
Cash flows from investing activities:          
(Increase) decrease in restricted cash   (3)   14 
Additions to property and equipment   (10,340)   (5,486)
Net cash used in investing activities   (10,343)   (5,472)
           
Cash flows from financing activities:          
Proceeds from (paydown on) revolving line of credit, net   15,490    (5,081)
Payment to lender   (450)   – 
Payment received - receivable from stockholders   –    132 
Noncontrolling interests distributions   (2,376)   (1,914)
Payments on capital lease obligations   (981)   (893)
Net cash provided (used) in financing activities   11,683    (7,756)
           
Net decrease in cash and cash equivalents   (8,284)   (8,710)
Cash and cash equivalents, beginning of period   11,829    20,539 
Cash and cash equivalents, end of period  $3,545   $11,829 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2013

 

NOTE 1 - DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

BASIS OF PRESENTATION - The accompanying consolidated financial statements include the accounts of Integrated Healthcare Holdings, Inc. and its subsidiaries (collectively, the “Company”) and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

 

The Company has also determined that Pacific Coast Holdings Investment, LLC ("PCHI") (Note 9), is a variable interest entity as defined by GAAP and the Company is the primary beneficiary and, accordingly, the financial statements of PCHI are included in the accompanying consolidated financial statements.

 

All significant intercompany accounts and transactions have been eliminated in consolidation. Unless otherwise indicated, all amounts included in these notes to the consolidated financial statements are expressed in thousands (except per share amounts, percentages and stock option prices and values).

 

LIQUIDITY - As of March 31, 2013 and 2012, the Company had a total stockholders’ deficiency of $29.9 million and $11.6 million, respectively, and a working capital deficit of $36.7 million and $14.6 million, respectively.  For the years ended March 31, 2013 and 2012, the Company had net income (loss) of $(15.5) million and $7.5 million, respectively, and (negative) positive cash flow from operations of $(9.6) million and $4.5 million, respectively. At March 31, 2013, the Company had $5.0 million in additional availability under its revolving credit facility (Note 3). The Company anticipates making payments for provider fees and other expenses relating to the 2013 hospital quality assurance fee program of approximately $105.8 million and receiving approximately $235.5 million in revenues from the State ($79.4 million from the fee-for-service portion and $156.1 million from the managed care portion) (Notes 11 and 14). The Company is reliant on funds received under the hospital quality assurance fee program and not receiving such funding could have a material adverse effect on its liquidity and financial position and value of its common stock.

 

DESCRIPTION OF BUSINESS - Effective March 8, 2005, the Company acquired four hospitals (the "Hospitals") from subsidiaries of Tenet Healthcare Corporation (the "Acquisition"). The Company owns and operates the four community-based hospitals located in southern California, which are:


  ● 282-bed Western Medical Center in Santa Ana
  ● 188-bed Western Medical Center in Anaheim
  ● 178-bed Coastal Communities Hospital in Santa Ana
  ● 114-bed Chapman Medical Center in Orange

  

RECLASSIFICATION FOR PRESENTATION - Certain amounts previously reported have been reclassified to conform to the current period's presentation with no impact on the reported net income of the Company.

 

CONCENTRATION OF RISK - The Hospitals are subject to licensure by the State of California and accreditation by the Joint Commission on Accreditation of Healthcare Organizations. Loss of either licensure or accreditation would impact the ability to participate in various governmental and managed care programs, which provide the majority of the Company's revenues.

 

Substantially all patient service revenues come from external customers. The largest payers are Medicare and Medicaid (including Medicare and Medicaid managed care plans) and other state and local government payers, which combined accounted for 58% and 57% of the patient service revenues for the years ended March 31, 2013 and 2012, respectively. No other payers represent a significant concentration of the Company's patient services revenues.

 

The Company receives all of its inpatient services revenue from operations in Orange County, California. The economic conditions of this service area could affect the ability of patients and third-party payers to reimburse the Company for services through its effect on disposable household income and the tax base used to generate state funding for Medicaid programs.

 

USE OF ESTIMATES - The accompanying consolidated financial statements have been prepared in accordance with GAAP. The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Principal areas requiring the use of estimates include third-party cost report settlements, income taxes, accrued insurance retentions, self-insurance reserves, and net patient receivables. Management regularly evaluates the accounting policies and estimates that are used. In general, management bases the estimates on historical experience and on assumptions that it believes to be reasonable given the particular circumstances in which its Hospitals operate. Although management believes that all adjustments considered necessary for fair presentation have been included, actual results may materially vary from those estimates.

 

F-6
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2013

 

PATIENT SERVICE REVENUES – Patient service revenues are recognized in the period in which services are performed and are recorded based on established billing rates (gross charges) less contractual allowances and discounts, principally for patients covered by Medicare, Medicaid, managed care, and other health plans. Gross charges are retail charges. They are not the same as actual pricing, and they generally do not reflect what a hospital is ultimately paid and therefore are not displayed in the consolidated statements of operations. Hospitals are typically paid amounts that are negotiated with insurance companies or are set by the government. Gross charges are used to calculate Medicare outlier payments and to determine certain elements of payment under managed care contracts (such as stop-loss payments). Since Medicare requires that a hospital's gross charges be the same for all patients (regardless of payer category), gross charges are also what the Hospitals charge all other patients prior to the application of discounts and allowances.

 

The following is a summary of sources of patient service revenues (net of contractual allowances and discounts) before provision for doubtful accounts:

 

   Year ended March 31, 
   2013   2012 
         
Medicare  $55,570   $58,046 
Medicaid   100,561    80,153 
Managed care   203,058    201,758 
Indemnity, self-pay and other   68,911    62,607 
   $428,100   $402,564 

 

Revenues under the traditional fee-for-service Medicare and Medicaid programs are based primarily on prospective payment systems. Discounts for retrospectively cost based revenues and certain other payments, which are based on the Hospitals' cost reports, are estimated using historical trends and current factors. Cost report settlements for retrospectively cost-based revenues under these programs are subject to audit and administrative and judicial review, which can take several years until final settlement of such matters are determined and completely resolved. Estimates of settlement receivables or payables related to a specific year are updated periodically and at year end and at the time the cost report is filed with the fiscal intermediary. Typically no further updates are made to the estimates until the final Notice of Program Reimbursement is received, at which time the cost report for that year has been audited by the fiscal intermediary. There could be a time lag of several years between the submission of a cost report and receipt of the Final Notice of Program Reimbursement. Since the laws, regulations, instructions and rule interpretations governing Medicare and Medicaid reimbursement are complex and change frequently, the estimates recorded by the Hospitals could change by material amounts. The Company has established settlement (payables) receivables of $(179) and $190 as of March 31, 2013 and 2012, respectively.

 

The Hospitals receive supplemental payments from the State of California to support indigent care (Medi-Cal Disproportionate Share Hospital payments or "DSH") and from the California Medical Assistance Commission ("CMAC") under the SB 1100 and SB 1255 programs. The Hospitals received supplemental payments of $13.4 million and $14.3 million during the years ended March 31, 2013 and 2012, respectively. The related revenue recorded for the years ended March 31, 2013 and 2012, was $14.3 million and $15.4 million, respectively. As of March 31, 2013 and 2012, estimated DSH receivables were $5.9 million and $5.0 million, respectively, which are included as due from government payers in the accompanying consolidated balance sheets.

 

Revenues under managed care plans, including Medicare and Medicaid managed care plans (with patient service revenues of $84.7 million and $84.2 million for the years ended March 31, 2013 and 2012, respectively), are based primarily on payment terms involving predetermined rates per diagnosis, per-diem rates, discounted fee-for-service rates and/or other similar contractual arrangements. These revenues are also subject to review and possible audit by the payers. The payers are billed for patient services on an individual patient basis. An individual patient's bill is subject to adjustment on a patient-by-patient basis in the ordinary course of business by the payers following their review and adjudication of each particular bill. The Hospitals estimate the discounts for contractual allowances utilizing billing data on an individual patient basis. Management believes the estimation and review process allows for timely identification of instances where such estimates need to be revised. The Company does not believe there were any adjustments to estimates of individual patient bills that were material to patient service revenues.

 

F-7
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2013

 

The Hospitals provide charity care to patients whose income level is below 300% of the Federal Poverty Level. Patients with income levels between 300% and 350% of the Federal Poverty Level qualify to pay a discounted rate under AB 774 based on various government program reimbursement levels. Patients without insurance are offered assistance in applying for Medicaid and other programs they may be eligible for, such as state disability, Victims of Crime, or county indigent programs. Patient advocates from the Hospitals' Medical Eligibility Program ("MEP") screen patients in the hospital and determine potential linkage to financial assistance programs. They also expedite the process of applying for these government programs. The estimated costs of charity care (based on direct and indirect costs as a ratio of gross uncompensated charges associated with providing care to charity patients) for the years ended March 31, 2013 and 2012 were approximately $8.0 million and $7.0 million, respectively.

 

The Company is not aware of any material claims, disputes, or unsettled matters with any payers that would affect revenues that have not been adequately provided for in the accompanying consolidated financial statements.

 

PROVISION FOR BAD DEBTS - The Company provides for accounts receivable that could become uncollectible by establishing an allowance to reduce the carrying value of such receivables to their estimated net realizable value. The Hospitals estimate this allowance based on the aging of their accounts receivable, historical collections experience for each type of payer and other relevant factors. There are various factors that can impact the collection trends, such as changes in the economy, which in turn have an impact on unemployment rates and the number of uninsured and underinsured patients, volume of patients through the emergency department, the increased burden of copayments to be made by patients with insurance and business practices related to collection efforts. These factors continuously change and can have an impact on collection trends and the estimation process.

 

The Company's policy is to attempt to collect amounts due from patients, including copayments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations, including, but not limited to, the Emergency Medical Treatment and Labor Act ("EMTALA"). Generally, as required by EMTALA, patients may not be denied emergency treatment due to inability to pay. Therefore, until the legally required medical screening examination is complete and stabilization of the patient has begun, services are performed prior to the verification of the patient's insurance, if any. In nonemergency circumstances or for elective procedures and services, it is the Hospitals' policy, when appropriate, to verify insurance prior to a patient being treated.

 

CASH AND CASH EQUIVALENTS - The Company considers all highly liquid debt investments purchased with a maturity of three months or less to be cash equivalents. Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits. The Company has never experienced any losses related to these balances.

 

LETTER OF CREDIT – At March 31, 2013, the Company had an outstanding letter of credit totaling $761. This letter of credit correspondingly reduces the Company’s borrowing availability under its revolving line of credit (Note 3).

 

RECEIVABLES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS – The following is a summary of the principal components of accounts receivable and due from/to government payers as of March 31, 2013 and 2012:

 

   March 31, 
   2013   2012 
Accounts receivable:          
Patient accounts receivable  $83,964   $71,800 
Allowance for doubtful accounts   (21,143)   (18,201)
Accounts receivable, net  $62,821   $53,599 
           
Due from government payers:          
DSH  $5,882   $4,993 
Settlement receivables   –    190 
   $5,882   $5,183 
           
Due to government payers:          
Settlement payables  $179   $– 
   $179   $– 

 

F-8
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2013

 

The Company’s self-pay collection rate, which is the blended collection rate for uninsured and balance after insurance accounts receivable, was approximately 6.5% and 11.3% as of March 31, 2013 and 2012, respectively. These self-pay collection rates include payments made by patients, including co-payments and deductibles paid by patients with insurance. As of March 31, 2013 and 2012, the allowance for doubtful accounts for self-pay uninsured was 95.2% and 90.3%, respectively, of self-pay uninsured patient accounts receivable. As of March 31, 2013 and 2012, the allowance for doubtful accounts for self-pay balance after insurance was 78.0% and 77.4%, respectively, of self-pay balance after insurance patient accounts receivable, consisting primarily of co-pays and deductibles owed by patients with insurance. As of March 31, 2013 and 2012, the allowance for doubtful accounts for managed care was 20.3% and 16.1%, respectively, of managed care patient accounts receivable.

 

Receivables from patients who are potentially eligible for Medicaid are classified as Medicaid pending under the MEP, with appropriate contractual allowances recorded. If the patient does not qualify for Medicaid, the receivables are reclassified to charity care and written off, or they are reclassified to self-pay and adjusted to their net realizable value through the provision for bad debts. Reclassifications of pending Medicaid accounts to self-pay do not typically have a material impact on the results of operations as the estimated Medicaid contractual allowances initially recorded are not materially different than the estimated provision for bad debts recorded when the accounts are reclassified. All accounts classified as pending Medicaid, as well as certain other governmental receivables, over the age of 90 days were reserved in contractual allowances as of March 31, 2013 and 2012 based on historical collections experience.

 

INVENTORIES OF SUPPLIES - Inventories of supplies are valued at the lower of weighted average cost or market.

 

PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and any impairment write-downs related to assets held and used. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Capital leases are recorded at the beginning of the lease term as property and equipment and a corresponding lease liability is recognized. The value of the property and equipment under capital lease is recorded at the lower of either the present value of the minimum lease payments or the fair value of the asset. Such assets, including improvements, are amortized over the shorter of the lease term or their estimated useful life, where applicable.

 

The Company uses the straight-line method of depreciation for buildings and improvements, and equipment over their estimated useful lives of 25 years and 3 to 15 years, respectively.

 

LONG-LIVED ASSETS - The Company evaluates its long-lived assets for possible impairment whenever circumstances indicate that the carrying amount of the asset, or related group of assets, may not be recoverable from estimated future undiscounted cash flows. Fair value estimates are derived from established market values of comparable assets or internal calculations of estimated undiscounted future net cash flows. The estimates of future net cash flows are based on assumptions and projections believed by the Company to be reasonable and supportable. These assumptions take into account patient volumes, changes in payer mix, revenue, and expense growth rates and changes in legislation and other payer payment patterns.

 

FAIR VALUE MEASUREMENTS - The Company's financial assets and liabilities recorded in the consolidated balance sheets include cash and cash equivalents, restricted cash, receivables, debt, accounts payable, and other liabilities, all of which are recorded at book value which approximates fair value.

 

GAAP has established a hierarchy for ranking the quality and reliability of the information used to determine fair values and requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:

 

  Level 1: Unadjusted quoted market prices in active markets for identical assets or liabilities.
     
  Level 2: Unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.
     
  Level 3: Unobservable inputs for the asset or liability.

 

The Company utilizes the best available information in measuring fair value.  Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company currently has no financial or nonfinancial assets or liabilities subject to fair value measurement on a recurring basis except for warrants issued in April 2010 and February 2013 (Note 4).

 

F-9
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2013

 

The following table sets forth the Company’s financial assets and liabilities measured at fair value on a recurring basis and where they are classified within the hierarchy as of March 31, 2013 and 2012:

 

   Total   Level 1   Level 2   Level 3 
                 
Warrant liability at March 31, 2013  $5,276    –    –   $5,276 
Warrant liability at March 31, 2012  $1,641    –     .   $1,641 

  

 

Warrant liability - fair value measurements using significant unobservable inputs (Level 3)
     
Balance at March 31, 2011  $167 
Change in fair value of warrant liability included in earnings   1,474 
Balance at March 31, 2012   1,641 
Fair value of warrants issued and vested, net   1,692 
Fair value of warrants - loan discount on term loan   534 
Change in fair value of warrant liability included in earnings   1,409 
Balance at March 31, 2013  $5,276 

 

Additional quantitative information about Level 3 fair value measurements is discussed in Note 4.

 

WARRANTS - The Company has entered into complex transactions that contain warrants (Notes 3 and 4). If an instrument (or an embedded feature) that has the characteristics of a derivative instrument is indexed to an entity’s own stock, it is still necessary to evaluate whether it is classified in stockholders’ equity (or would be classified in stockholders’ equity if it were a freestanding instrument). The Company has concluded that the warrants should be classified as liabilities as the exercise price is subject to a weighted average ratchet down provision if the Company subsequently sells shares at a price lower than the then exercise price.

 

INCOME (LOSS) PER COMMON SHARE – Income (loss) per share is calculated under two different methods, basic and diluted. Basic income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period. Diluted income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period and dilutive potential shares of common stock. Dilutive potential shares of common stock, as determined under the treasury stock method, consist of shares of common stock issuable upon exercise of stock warrants or options, net of shares of common stock assumed to be repurchased by the Company from the exercise proceeds (Note 8).

 

SUPPLEMENTAL CASH FLOW INFORMATION - Interest paid during the years ended March 31, 2013 and 2012 was $9.4 million and $9.0 million, respectively.

 

The Company made cash payments for taxes of $0 and $14.0 million during the years ended March 31, 2013 and 2012, respectively.

 

The Company entered into new capital lease obligations of $2.1 million and $0 during the years ended March 31, 2013 and 2012, respectively.

 

INCOME TAXES - Deferred income tax assets and liabilities are determined based on the differences between the book and tax basis of assets and liabilities and are measured using the currently enacted tax rates and laws using the asset and liability method. The Company assesses the realization of deferred tax assets to determine whether an income tax valuation allowance is required. The Company recorded a 58% and 100% valuation allowance on its net deferred tax assets as of March 31, 2013 and 2012, respectively, since they did not meet the more-likely-than-not threshold.

 

There is a recognition threshold and measurement attribute for recognition and measurement of a tax position taken or expected to be taken in a tax return. It also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.

 

The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction and California. Certain tax attributes carried over from prior years continue to be subject to adjustment by taxing authorities. Any penalties or interest arising from federal or state taxes are recorded as a component of the Company’s income tax provision.

 

F-10
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2013

 

SEGMENT REPORTING - The Company operates in one line of business, the provision of healthcare services through the operation of general hospitals and related healthcare facilities. The Company's Hospitals generate substantially all of its net patient service revenues.

 

The Company's four Hospitals and related healthcare facilities operate in one geographic region in Orange County, California. There are similarities in the region's economic characteristics and the nature of the Hospitals' operations, the regulatory environment in which they operate and the manner in which they are managed. This region is an operating segment, as defined by GAAP. In addition, the Company's Hospitals and related healthcare facilities share certain resources and benefit from many common clinical and management practices. Accordingly, the Company aggregates the facilities into a single reportable operating segment.

 

NEW ACCOUNTING STANDARDS – Effective March 31, 2012, the Company adopted ASU 2011-07, “Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities,” which requires health care entities to present the provision for bad debts relating to patient service revenue as a deduction from patient service revenue in the statement of operations rather than as an operating expense. Additional disclosures relating to sources of patient revenue and the allowance for doubtful accounts related to patient accounts receivable are also required. The adoption of this ASU did not have a material impact on the Company’s consolidated financial statements.

 

NOTE 2 - PROPERTY AND EQUIPMENT

 

Property and equipment consists of the following:

 

   March 31,
2013		   March 31,
2012		 
Buildings  $36,536   $35,376 
Land and improvements   13,523    13,523 
Equipment   28,534    18,268 
Construction in progress   –    1,160 
Assets under capital leases   13,267    11,218 
    91,860    79,545 
Less accumulated depreciation   (27,872)   (24,016)
           
Property and equipment, net  $63,988   $55,529 

  

Accumulated depreciation on assets under capital leases as of March 31, 2013 and 2012 was $6.2 million and $5.0 million, respectively.

 

The Hospitals are located in an area near active and substantial earthquake faults. The Hospitals carry earthquake insurance with a policy limit of $50.0 million. A significant earthquake could result in material damage and temporary or permanent cessation of operations at one or more of the Hospitals.

 

The State of California has imposed hospital seismic safety requirements. Under these requirements, the Hospitals must meet stringent seismic safety criteria in the future. In addition, there could be other remediation costs pursuant to this seismic retrofit.

         

The State of California has a seismic review methodology known as HAZUS. The HAZUS methodology may preclude the need for some structural modifications. All four Hospitals requested HAZUS review and received a favorable notice pertaining to structural reclassification. All Hospital buildings, with the exception of one (an administrative building), have been deemed compliant until January 1, 2030 for both structural and nonstructural retrofit. The Company does not have an estimate of the cost to remediate the seismic requirements for the administrative building as of March 31, 2013.

 

There are additional requirements that must be complied with by 2030. The costs of meeting these requirements have not yet been determined. Compliance with seismic ordinances will be costly and could have a material adverse effect on the Company's cash flow.  In addition, remediation could possibly result in certain environmental liabilities, such as asbestos abatement.

 

F-11
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2013

 

NOTE 3 – DEBT

 

As of March 31, 2013, the Company had the following Credit Agreements:

 

  — A $47.277 million Term Loan issued under the $80.0 million Restated Credit Agreement, bearing an interest rate of LIBOR plus 10%, with the LIBOR floor set at 2% (12% at March 31, 2013). If any event of default occurs and continues, the lender can increase the interest rate by 5% per year. As of March 31, 2013, the Company was in compliance with all financial covenants. The stated maturity date for this Restated Credit Agreement is April 13, 2016.

 

  — A $35.0 million Revolving Credit Agreement, bearing an interest rate of 4.25% plus LIBOR, with a 2.5% floor, per year (6.75% at March 31, 2013) and an unused commitment fee of 0.5% per year ($30.0 million outstanding balance at March 31, 2013).  For purposes of calculating interest, all payments the Company makes on the Revolving Credit Agreement are subject to a five business day clearance period.  As of March 31, 2013, the Company was in compliance with all financial covenants. The stated maturity date for this Revolving Credit Agreement is March 25, 2016. At March 31, 2013, the Company had $5.0 million in additional availability under this facility.

 

Term loan - On August 1, 2012, the Company entered into Amendment No. 4 to Credit Agreement and Consent (the “Credit Agreement Amendment”), which amends the $80.0 million Credit Agreement, dated as of October 9, 2007, as amended, (the “Credit Agreement”) with SPCP Group IV, LLC, SPCP Group, LLC, and Silver Point Finance, LLC, as the Lender Agent (collectively, “Silver Point”), PCHI and Ganesha Realty, llc (“Ganesha”).  Under the Credit Agreement Amendment, Silver Point consented to and waived certain provisions under the Credit Agreement in connection with the Company’s execution of the Revolving Loan Amendment No. 3. In addition, the provisions in the Credit Agreement that provide for mandatory prepayment of the Company’s outstanding “A/R Financing,” as defined, upon receipt of certain federal matching funds under the QAF program were amended to replace 65% with 80%. In connection with the Credit Agreement Amendment, the Company agreed to pay Silver Point a one-time consent and amendment fee in an aggregate amount equal to $1.8 million, of which $450 was paid upon execution of the Credit Agreement Amendment and the balance was added to the principal amount under the Credit Agreement. The consent and amendment fee was recorded as a discount to the loan balance and is being amortized over the remaining life of the loan.

 

On February 7, 2013, the Company entered into an “Amendment and Restatement to the Credit Agreement” (the “Amendment”) with Silver Point, PCHI and Ganesha.

 

Under the Amendment, the Credit Agreement was amended and restated in its entirety in the form of the “Amended and Restated Credit Agreement ($47.277 million Term Loan)” attached as Exhibit A to the Amendment (the “Restated Credit Agreement”). The Restated Credit Agreement reflects changes to the terms of the Credit Agreement that were previously made under various amendments the Company entered into since inception of the Credit Agreement in October 2007. In connection with the Restated Credit Amendment, the Company agreed to pay Silver Point a one-time amendment fee of $841, which was added to the principal amount under the Restated Credit Agreement. The one-time amendment fee was recorded as a discount from the loan balance and, together with the amortized portion of the discount recorded under the Credit Agreement Amendment, is being amortized over the remaining life of the loan. In addition, the increase in the fair value of warrants issued to Silver Point on February 7, 2013 of $543 also were recorded as a discount from the loan balance and is being amortized over the remaining life of the loan. During the year ended March 31, 2013, the Company recognized $1.4 million in loan discount amortization relating to the Restated Credit Agreement.

 

In addition, the following new amendments were made to the Credit Agreement and reflected in the Restated Credit Agreement:

 

  — The Stated Maturity Date was extended to April 13, 2016. The Credit Agreement was previously due to mature on April 13, 2013.  
     
  — The annual interest rate applicable to the loans under the Credit Agreement was modified from the previous fixed rate of 14.5% to LIBOR plus 10%, with the LIBOR floor set at 2% (12% at March 31, 2013), except upon an Event of Default. The Company may elect from one, two or three months LIBOR interest periods, except in an Event of Default when the interest period may not exceed one month.  
     
  — The principal balance under the Credit Agreement was increased from $46.350 million to $47.277 million, to reflect the Company’s new borrowings under the Restated Credit Agreement.  
     
  — The Company repaid all amounts owing to SPCP Group IV, LLC under the Credit Agreement, consisting of a principal balance of $8.120 million plus accrued interest of $19.6, and increased the principal amount owing to SPCP Group, LLC under the Credit Agreement by $9.047 million to reflect the repayment to SPCP Group IV, LLC and other new borrowings.  
     
  — The financial covenants under the Credit Agreement were amended, including the covenants requiring the Company to maintain minimum levels of EBITDA (as defined in the Restated Credit Agreement).  

  

F-12
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2013

 

  — Upon the Company’s receipt of enhanced federal matching funds from Medi-Cal under the QAF program (defined as “Net QAF Funds” under the Restated Credit Agreement), the Company is required to make certain prepayments of principal under its Revolving Loan Agreement with MidCap Financial, LLC.  
     
  — A prepayment fee was established for voluntary prepayments under the Credit Agreement equal to 5% for prepayments made on or prior to December 31, 2013, and 2% for prepayments made after January 1, 2014 and before December 31, 2014.  

 

Revolving line of credit - On August 1, 2012, the Company entered into Amendment No. 3 to Credit and Security Agreement (the “Revolving Loan Amendment No. 3”), which amends Credit and Security Agreement, dated as of August 30, 2012, as amended, (the “Revolving Loan Agreement”) with MidCap Funding IV, LLC and Silicon Valley Bank, as lenders (the “Lenders”), and MidCap Financial, LLC, as agent (the “Agent”). Under the Revolving Loan Amendment No. 3, the minimum Revolving Loan Commitment Amount under the Revolving Loan Agreement was increased from $14.0 million to $30.0 million, and the Company agreed to pay the Lenders an origination fee of 1.0% of the Lenders’ increased commitment under the Revolving Loan Amendment No. 3, or $160.

 

On February 7, 2013, the Company entered into “Amendment No. 4 to Credit and Security Agreement and Limited Consent” (the “Revolving Loan Amendment No. 4”) with the Lenders and the Agent.

 

The Revolving Loan Amendment No. 4 amends the Revolving Loan Agreement, to reflect the following changes:

 

  — The maximum face amount of the Letter of Credit Liabilities permitted under the Revolving Loan Agreement was increased to $761, and the Lenders consented to the issuance of a Letter of Credit in the same amount by Wells Fargo Bank, National Association.  
     
  — The period during which the Prepayment Fee of 1% is applicable was extended from three years from the original closing date to the Commitment Expiry Date.  
     
  — The Agent and Lenders consented to the Company’s entry into the Amendment with Silver Point and the Restated Credit Agreement thereunder.  

 

On March 25, 2013, the Company entered into Amendment No. 5 to Credit and Security Agreement and Limited Waiver (the “Revolving Loan Amendment No. 5”), which amends the Revolving Loan Agreement, with the Lenders and the Agent. The Company agreed to pay the Lenders an origination fee of 1.0% of the Lenders’ commitment under the Revolving Loan Amendment No. 5, or $350.

 

Among other things, the Revolving Loan Amendment No. 5 provides for the following:

 

  — An increase in the Revolving Loan Commitment amount from $30.0 million to $35.0 million;
     
  — The Applicable Margin was changed: (a) from 3.00% to 2.25% with respect to Revolving Loans bearing interest upon the Base Rate and (b) from 5.00% to 4.25% for all other Revolving Loans and Obligations;
     
  — The Commitment Expiry Date was extended to March 25, 2016;
     
  — Certain modifications were made to the definitions of Permitted Indebtedness and Prepayment Fee and the lockbox requirements; and
     
  — The Company was granted a waiver of certain prior Events of Default or Defaults under the Revolving Loan Agreement and a waiver of the requirement to comply with the Fixed Charge Coverage Ratio covenant for the Defined Period ending March 31, 2013.

 

The Company's outstanding debt consists of the following:

 

   March 31,
2013		   March 31,
2012		 
Current:          
Revolving line of credit  $30,000   $14,000 
Discount   (473)   (217)
   $29,527   $13,783 
           
Noncurrent:          
Term loan  $47,277   $45,000 
Discount   (1,747)   – 
   $45,530   $45,000 

 

F-13
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2013

 

The Company’s noncurrent debt matures as follows:

 

Year ending March 31,  Amount 
     
2014  $– 
2015   – 
2016   – 
2017  $47,277 

 

NOTE 4 - COMMON STOCK WARRANTS

 

A summary of warrant activity for the years ended March 31, 2013 and 2012 is presented as follows.

 

       Weighted-     
   Shares issuable   average   Expiration 
   under warrants   exercise price   date 
             
Outstanding, March 31, 2012 and 2011   405,000   $0.07    April 13, 2013 
Repurchased   (16,800)  $0.07    April 13, 2013 
Issued   16,800   $0.07    April 13, 2016 
Amended (old expiration date)   (388,200)  $0.07    April 13, 2013 
Amended (new expiration date)   388,200   $0.07    April 13, 2016 
Outstanding, March 31, 2013   405,000   $0.07    April 13, 2016 

 

On April 13, 2010 the Company issued three-year warrants (the “Omnibus Warrants”) to purchase its common stock at an exercise price of $0.07 per share in the following denominations: 139.0 million shares to KPC or its designees and 96.0 million shares to Silver Point or its designees. The Omnibus Warrants also provide the holders with certain pre-emptive, information and registration rights. As of April 13, 2010, the Company recorded warrant expense and the related warrant liability of $2.9 million, representing fair value.  

 

In addition, on April 13, 2010, the Company issued a three-year warrant (the “Release Warrant”) to acquire up to 170.0 million shares of common stock at $0.07 per share to Dr. Chaudhuri who facilitated the release (see “DEBT”) enabling the Company to recover amounts due from its prior lender and a $1.0 million reduction in principal of its outstanding debt, among other benefits to the Company.  The Release Warrant also provides the holder with certain pre-emptive, information and registration rights. During the year ended March 31, 2010, the Company recorded the fair value of $2.1 million as an offsetting cost of the recovery.  

 

On February 7, 2013, in connection with the Restated Credit Agreement, the Company entered into the following transactions involving warrants:

 

The Company entered into a Warrant Repurchase Agreement with SPCP Group IV, LLC pursuant to which it repurchased the outstanding common stock warrant issued to SPCP Group IV, LLC on or about April 13, 2010 (the “Cancelled Warrant”). The Cancelled Warrant (part of the Omnibus Warrants) entitled the holder to purchase an aggregate of 16.8 million shares of the Company’s common stock at an exercise price of $0.07 per share. The Company repurchased the Cancelled Warrant for a purchase price of $0.12 per share minus the exercise price of $0.07 per share resulting in a net purchase price of $0.05 per share multiplied by 16.8 million shares for an aggregate purchase price of $840.9.

 

Immediately following the warrant repurchase, the Company issued a new common stock warrant (the “New Warrant”) to SPCP Group, LLC for a price of $0.05 per share (an aggregate price of $840.9) on the same terms as the Cancelled Warrant entitling the holder to purchase an aggregate of 16.8 million shares of common stock at an exercise price of $0.07 per share, except that the New Warrant expires on April 13, 2016.

 

Also simultaneous with the transactions described above, the Company extended the expiration date from April 13, 2013 to April 13, 2016 for the Omnibus Warrants issued to KPC and the remaining held by Silver Point (to purchase 79.2 million shares) and the Release Warrant issued to Dr. Chaudhuri. The extension of the warrant expiration date was intended to conform the terms of the warrants to that of the Restated Credit Agreement.

 

The Company assessed the amended credit agreement entered into in August 2012 and February 2013 under the provisions of ASC 470-50 and determined that the debt amendments should be accounted for as a debt modification. Accordingly, the recorded change in fair value as of February 7, 2013, totaling $534, of the New Warrant and the Omnibus Warrant held by SPCP Group, LLC was recognized as a component of the debt discount on the Term Loan (Note 3) and will be amortized to interest expense over the term of the debt agreement using the effective interest method.

 

The warrant expense relating to the Release Warrant and the Omnibus Warrant held by Dr. Chaudhuri for the years ended March 31, 2013 and 2012 was $1.7 million and $0, respectively. The change in fair value of the Release Warrant and the Omnibus was immediately charged to expense.

 

The Omnibus Warrants, the Release Warrant, and the New Warrant are collectively referred to as the “IHHI Warrants.” As of March 31, 2013, the fair value of the IHHI Warrants was $5.3 million.

 

The net loss related to the change in fair value of the IHHI Warrants for the year ended March 31, 2013 and 2012 was $1.4 million and $1.5 million, respectively. The total loss on warrants was $3.1 million and $1.5 million for the years ended March 31, 2013 and 2012, respectively.

 

The fair value of warrants issued by the Company is estimated using the Black-Scholes valuation model, which it believes is the appropriate valuation method under the circumstances. Since the Company’s stock is thinly traded, the expected volatility is based on an analysis of its stock and the stock of eight other publicly traded companies that own hospitals.

 

F-14
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2013

 

The risk-free interest rate is based on the average yield on U.S. Treasury notes with maturity commensurate with the terms of the warrants. The dividend yield reflects that the Company has not paid any cash dividends since inception and does not anticipate paying cash dividends in the foreseeable future.  The assumptions used in the Black-Scholes valuation model are as follows:

 

   March 31, 2013   February 7, 2013   March 31, 2012 
             
Expected dividend yield   0.0%    0.0%    0.0% 
Risk-free interest rate   0.4%    0.4%    0.2% 
Expected volatility   39.9%    40.3%    57.3% 
Expected term (in years)   3.05    3.18    1.04 

  

NOTE 5 - INCOME TAXES

 

The preparation of consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amount of tax-related assets and liabilities and income tax provisions. The Company assesses the recoverability of the deferred tax assets on an ongoing basis. In making this assessment the Company is required to consider all available positive and negative evidence to determine whether, based on such evidence, it is more likely than not that some portion or all of the net deferred assets will be realized in future periods. This assessment requires significant judgment. In addition, the Company has made significant estimates involving current and deferred income taxes, tax attributes relating to the interpretation of various tax laws, historical bases of tax attributes associated with certain tangible and intangible assets and limitations surrounding the realization of the deferred tax assets. The Company does not recognize current and future tax benefits until it is deemed more likely than not that certain tax positions will be sustained.

 

The income tax provision (benefit) consisted of the following:

 

   Year ended March 31, 
   2013   2012 
Income tax provision (benefit):          
           
Current:          
Federal  $655   $(136)
State   247    (3)
    902    (139)
Deferred:          
Federal   (4,853)   – 
State   (1,855)   – 
    (6,708)   – 
           
Income tax provision (benefit)  $(5,806)  $(139)

 

A reconciliation between the amount of reported income tax expense (benefit) and the amount computed by multiplying income before income tax provision (benefit) by the statutory federal income tax rate is as follows:

 

  Year ended March 31, 
   2013   2012 
         
U.S. federal statutory income taxes  $(7,584)  $2,654 
State and local income taxes, net of federal benefits   (1,245)   406 
Change in valuation allowance   1,366    (2,975)
Warrants   1,085    516 
Variable interest entity   237    (172)
Deferred tax adjustments   295    (593)
Other   40    25 
           
Income tax provision (benefit)  $(5,806)  $(139)

 

F-15
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2013

 

Deferred income taxes reflect the tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amount used for income tax purposes. The following table discloses those significant components of deferred tax assets and liabilities, including the valuation allowance at March 31:

 

   2013   2012 
Deferred tax assets (liabilities):          
Allowance for doubtful accounts  $449   $1,457 
Accrued vacation   2,982    2,813 
Net operating losses   7,961    1,023 
State taxes   (1,235)   (532)
Accrued insurance   3,755    3,445 
Legal   1,257    – 
Property and equipment   661    (212)
Other   281    43 
    16,111    8,037 
Valuation allowance   (9,403)   (8,037)
           
Net deferred tax assets  $6,708   $– 

   

The result of the allocation of the valuation allowance between short term and long term deferred tax assets before netting the deferred tax liabilities results in net deferred tax assets consisting of short term deferred tax assets of $6.3 million (net of valuation allowance) and long term deferred tax assets of $380. The valuation allowances above were recorded based on an assessment of the realization of deferred tax assets as described below.

  

  ● Cumulative losses in recent years
  ● Income/losses expected in future years
  ● Unsettled circumstances that, if unfavorably resolved, would adversely affect future operations and profit levels
  ● The availability, or lack thereof, of taxable income in prior carryback periods that would limit realization of tax benefits
  ● The carryforward period associated with the deferred tax assets and liabilities

 

The Company assesses the realization of deferred tax assets to determine whether an income tax valuation allowance is required. The Company recorded a partial valuation allowance on its net deferred tax assets based on income from near-term projections resulting from government subsidies.

 

ASU 2009-06, “Income Taxes (Topic 740),” prescribes a consistent financial reporting recognition threshold and measurement standard, as well as criteria for subsequently recognizing, derecognizing and measuring tax positions taken or expected to be taken in a tax return. ASU 2009-06 also requires certain disclosures with respect to the uncertainty in income taxes. A reconciliation of the change in the amount of gross unrecognized income tax benefits is a follows:

 

   March 31, 
   2013   2012 
         
Gross unrecognized income tax benefits at the beginning of the year  $21,814   $18,900 
Changes based on tax positions related to current year   –    2,914 
Increases for tax positions related to prior years   –    – 
Gross unrecognized income tax benefits at the end of the year  $21,814   $21,814 

 

As of March 31, 2013, approximately $21.8 million of unrecognized income tax benefits would affect the fiscal 2013 effective tax rate if released into income due to the impact of the valuation allowance.

  

F-16
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2013

 

The Company’s net operating losses of $17.1 million for federal and $22.4 million for state expire through 2033. The utilization of net operating losses and credit carryforwards are limited under the provisions of the IRC Section 382 and similar state provisions. Section 382 of the IRC of 1986 generally imposes an annual limitation on the amount of NOL carryforwards that may be used to offset taxable income where a corporation has undergone significant changes in stock ownership. In fiscal year 2009, the Company entered into an amended purchase agreement which resulted in a change in control. The Company conducted an analysis and determined that it is subject to significant IRC Section 382 limitations. For both Federal and state tax purposes, the Company's utilization of NOL and credit carryforwards is subject to significant IRC Section 382 limitations.  The Company evaluates its ability to utilize the net operating losses each period with regard to the limitations imposed under IRC 382 and also considering the continuing expiration of statutes of limitation for prior years; and in the prior period determined that a portion of the federal and state net operating losses were no longer realizable, and removed from the schedule of deferreds those net operating losses in excess of the IRC 382 limitation and also considering prior years statutes now closed.

 

PCHI TAX STATUS - PCHI is a limited liability corporation. PCHI's taxable income or loss will flow through to its owners and be their separate responsibility. Accordingly, the accompanying consolidated financial statements do not include any amounts for the income tax expense or benefit, or liabilities related to PCHI's income or loss.

 

NOTE 6 - STOCK INCENTIVE PLAN

 

The Company's 2006 Stock Incentive Plan (the "Plan"), which is shareholder-approved, permits the grant of share options to its employees and board members for up to a maximum aggregate of 12.0 million shares of common stock. In addition, as of the first business day of each calendar year in the period 2007 through 2015, the maximum aggregate number of shares shall be increased by a number equal to one percent of the number of shares of common stock of the Company outstanding on December 31 of the immediately preceding calendar year. Accordingly, as of March 31, 2013, the maximum aggregate number of shares under the Plan was 26.1 million. The Company believes that such awards better align the interests of its employees with those of its shareholders. In accordance with the Plan, incentive stock options, nonqualified stock options, and performance based compensation awards may not be granted at less than 100 percent of the estimated fair market value of the common stock on the date of grant. Incentive stock options granted to a person owning more than 10 percent of the voting power of all classes of stock of the Company may not be issued at less than 110 percent of the fair market value of the stock on the date of grant. Option awards generally vest based on 3 years of continuous service (1/3 of the shares vest on the twelve month anniversary of the grant date, and an additional 1/12 of the shares vest on each subsequent fiscal quarter-end of the Company following such twelve month anniversary). Certain option awards provide for accelerated vesting if there is a change of control, as defined. The option awards have 7-year contractual terms.

  

When the measurement date is certain, the fair value of each option grant is estimated on the date of grant using the Black-Scholes valuation model. Since there is limited historical data with respect to both pre-vesting forfeiture and post-vesting termination, the expected life of the options was determined utilizing the simplified method, whereby the expected term is calculated by taking the sum of the vesting term plus the original contractual term and dividing that quantity by two.

 

No options were granted or exercised during the years ended March 31, 2013 and 2012. All outstanding options were fully vested as of March 31, 2013 and 2012.

 

A summary of stock option activity for the years ended March 31, 2013 and 2012 is presented as follows.

  

   Shares   Weighted-average exercise price   Weighted-average grant date fair value   Weighted-average remaining contractual term(years)   Aggregate intrinsic value 
                     
Outstanding, March 31, 2011   8,370   $0.18                
Granted   –   $–   $-           
Exercised   –   $–                
Forfeited or expired   (135)  $0.25                
Outstanding, March 31, 2012   8,235   $0.18                
Granted   –   $–   $–           
Exercised   –   $–                
Forfeited or expired   (640)  $0.26                
Outstanding, March 31, 2013   7,595   $0.18         1.7   $-  
Exercisable at March 31, 2013   7,595   $0.18         1.7      

 

 

F-17
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2013

 

NOTE 7 - RETIREMENT PLAN

 

The Company has a 401(k) plan for its employees. All employees with 90 days of service are eligible to participate, unless they are covered by a collective bargaining agreement which precludes coverage. The Company matches employee contributions up to 3% of the employee's compensation, subject to IRS limits. During the years ended March 31, 2013 and 2012, the Company incurred expenses of $3.3 million and $3.1 million, respectively. These costs are included in salaries and benefits in the accompanying consolidated statements of operations.  At March 31, 2013 and 2012, accrued compensation and benefits in the accompanying consolidated balance sheets included $4.1 million and $3.9 million, respectively, in accrued employer contributions.

 

NOTE 8 - INCOME (LOSS) PER SHARE

 

Income (loss) per share is calculated under two different methods, basic and diluted. Basic income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period. Diluted income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period and dilutive potential shares of common stock. Dilutive potential shares of common stock, as determined under the treasury stock method, consist of shares of common stock issuable upon exercise of stock warrants or options, net of shares of common stock assumed to be repurchased by the Company from the exercise proceeds.

 

Since the Company incurred a loss for the year ended March 31, 2013, the potential shares of common stock consisting of approximately 413 million shares issuable under warrants and stock options were not included in the diluted calculations since they were anti-dilutive.

 

Income per share for the year ended March 31, 2012 was computed as shown below. Stock options and warrants aggregating approximately 411 million shares were not included in the diluted calculation since they were anti-dilutive.

 

   Year ended March 31, 
   2013   2012 
Numerator:          
Net income attributable to          
Integrated Healthcare Holdings, Inc.  $(15,537)  $7,452 
           
Denominator:          
Weighted average common shares   255,307    255,307 
Dilutive options   –    1,533 
Denominator for diluted calculation   255,307    256,840 
           
Income per share - basic  $(0.06)  $0.03 
Income per share - diluted  $(0.06)  $0.03 

 

NOTE 9 - VARIABLE INTEREST ENTITY

 

Concurrent with the close of the Acquisition, PCHI simultaneously acquired title to substantially all of the real property acquired by the Company in the Acquisition. The Company received $5.0 million and PCHI guaranteed the Company's $47.277 million term loan. The Company remains primarily liable as the borrower under the $47.277 million term loan notwithstanding its guarantee by PCHI. The $47.277 million term loan is cross-collateralized by substantially all of the Company's assets and all of the real property of the Hospitals. All of the Company's operating activities are directly affected by the real property that was sold to PCHI, which is a related party entity that is affiliated with the Company through common ownership and control. As of March 31, 2013, PCHI was owned 51% by various physician investors and 49% by Ganesha, which is managed by Dr. Chaudhuri (majority stockholder in the Company).

 

The Company entered into a lease agreement dated March 7, 2005 (amended and restated as of April 13, 2010) under which it leased back from PCHI all of the real estate that it transferred to PCHI (Note 13). The amended lease terminates on the 25-year anniversary of the original lease (March 7, 2005), grants the Company the right to renew for one additional 25-year period, and requires combined annual base rental payments of $8.3 million for all the properties. However, until PCHI refinances the related $47.277 million term loan, the annual base rental payments are reduced to $7.3 million. In addition, the Company offsets, against its rental payments owed to PCHI, interest payments that it makes on the related $47.277 million term loan. Lease payments to PCHI and offsetting interest payments are eliminated in consolidation.

 

GAAP defines variable interest entities (“VIE”) as entities with a level of invested equity that is not sufficient to fund future activities to permit them to operate on a stand-alone basis, or whose equity holders lack certain characteristics of a controlling financial interest. Then, for entities identified as a VIE, the guidance sets forth a model to a primary beneficiary based on an assessment of which party to a VIE, if any, bears a majority of the exposure to expected losses, or stands to gain from a majority of its expected returns and has the power to direct activities of the VIE that impacts economic performance. The primary beneficiary of a VIE should consolidate the VIE.

 

F-18
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2013

 

The Company determined that it provides the majority of financial support to PCHI through various sources including lease payments, remaining primarily liable under the $47.277 million term loan, and cross-collateralization of the Company's non-real estate assets to secure the $47.277 million term loan. The Company concluded that PCHI is a VIE and it is the primary beneficiary. Accordingly, the financial statements of PCHI are included in the accompanying consolidated financial statements.

 

PCHI's assets, liabilities, and deficiency are set forth below.

 

   March 31,
2013		   March 31,
2012		 
         
Cash  $147   $68 
Property, net   39,696    40,984 
Other   129    207 
Total assets  $39,972   $41,259 
           
           
Debt ($47,277, net of discount) (as guarantor)  $46,039   $45,000 
Other   488    641 
Total liabilities   46,527    45,641 
           
Deficiency   (6,555)   (4,382)
Total liabilities and accumulated deficit  $39,972   $41,259 

 

As noted above, PCHI is a guarantor on the $47.277 million term loan should the Company not be able to perform.  PCHI's total liabilities represent the Company's maximum exposure to loss. Additionally, the Company is responsible for seismic remediation under the terms of the lease agreement (Notes 2 and 13).

 

PCHI rental income and the Company’s related rental expense of $7.8 million and $7.5 million were eliminated upon consolidation for the years ended March 31, 2013 and 2012, respectively.

 

NOTE 10 - RELATED PARTY TRANSACTIONS

 

The Company leases substantially all of the real property of the acquired Hospitals from PCHI which is owned by various physician investors and Ganesha, which is managed by Dr. Chaudhuri. As of March 31, 2013 and 2012, Dr. Chaudhuri and Mr. Thomas are the beneficial holders of an aggregate of 447.5 million shares of the outstanding stock of the Company. As described in Note 9, PCHI is a variable interest entity and the Company is the primary beneficiary, accordingly, the Company has consolidated the financial statements of PCHI in the accompanying consolidated financial statements.

 

NOTE 11 - HOSPITAL QUALITY ASSURANCE FEES (“QAF”)

 

In October 2009, the Governor of California signed legislation supported by the hospital industry to impose a provider fee on general acute care hospitals that, combined with federal matching funds, would be used to provide supplemental Medi-Cal payments to hospitals. The state submitted the plan to the Centers for Medicare and Medicaid Services (“CMS”) for a required review and approval process, and certain changes in the plan were required by CMS. Legislation amending the fee program to reflect the required changes was passed by the legislature and signed by the Governor on September 8, 2010. Among other changes, the legislation leaves distribution of “pass-through” payments received by Medi-Cal managed care plans that will be paid to hospitals under the program to the discretion of the plans.  The hospital quality assurance fee program (“QAF”) created by this legislation initially provided payments for up to 21 months retroactive to April 2009 and expiring on December 31, 2010 (“2010 QAF”).  In February 2011, CMS gave final approval for the 2010 QAF. During fiscal year 2011, the Company recognized $87.2 million in revenue and recorded expenses of $47.8 million relating to the 2010 QAF.

 

In December 2011, CMS gave final approval for the extension of the QAF for the nine month period from January 1 through June 30, 2011 (“2011 QAF”).  Accordingly, for the year ended March 31, 2012 the Company recognized $31.9 million in revenue and recorded expenses of $15.9 million relating to the 2011 QAF.

 

In June 2012, CMS conditionally approved the extension of the QAF for the thirty month period from July 1, 2011 through December 31, 2013 (“2013 QAF”).  In June 2012, the California State Legislature amended the hospital fee statute to recognize separate CMS approval of the fee-for-service portion and managed care portion of the 2013 QAF, which was further clarified in legislation approved by the governor of California in September 2012.  As a result, during the year ended March 31, 2013, the Company recognized revenue of $54.2 million and expenses of $52.5 million relating to the fee-for-service portion of the 2013 QAF for the periods from July 1, 2011 through March 31, 2013. See Note 14.

 

F-19
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2013

 

 

NOTE 12 - ELECTRONIC HEALTH RECORDS INCENTIVE PROGRAM

 

Provisions of the American Recovery and Reinvestment Act of 2009 provide incentive payments for the adoption and meaningful use of certified electronic health record (EHR) technology. The Medicare EHR incentive program provides incentive payments to eligible hospitals (and certain other providers) that are meaningful users of certified EHRs. The Medicaid EHR incentive program provides incentive payments to eligible hospitals (and certain other providers) for efforts to adopt, implement, upgrade, or meaningful use of certified EHR technology.

 

CMS has established the final rule which requires eligible providers in their first year of participation in the Medicaid incentive payment program to demonstrate that they have adopted (acquired, purchased, or secured access to), or implemented, or upgraded to certified EHR technology in order to qualify for an incentive payment. During the second and subsequent years of the program, eligible providers are required to meet other criteria, including meaningful use, to receive additional funds. The Company has been awarded a total amount of $13.6 million under the Medicaid EHR incentive program, which will be earned and received over a four year period. The Company adopted certified EHR technology and it recognized other income of $6.8 million relative to the first year under the Medicaid EHR incentive program during fiscal year 2012.

 

NOTE 13 - COMMITMENTS AND CONTINGENCIES

 

INFORMATION TECHNOLOGY SYSTEMS – On July 1, 2011, the Company entered into software and services agreements with McKesson Technologies Inc. (“McKesson”) to upgrade the Company’s information technology systems.

 

Under the agreements, McKesson will provide the Company with a variety of services, including new software implementation and education/training services for the Company’s personnel, software maintenance services and professional services related to movement and migration of data from legacy systems.  McKesson will also furnish to the Company and maintain new hardware to accommodate the upgraded software and systems.  The new hardware will include computers and servers, among other things, and will include installation, testing, and ongoing maintenance.  The Company has entered into the arrangement to enhance its clinical information systems and upgrade its billing and revenue management information systems.

 

The agreements will initially run for a period of five years, and the recurring services may be renewed by the Company for successive periods.  The agreements do not provide that they may be terminated by the Company prior to the initial expiration date.  The agreements provide for one-time fees and recurring fees which aggregate a total of $22.0 million.  Approximately 60% of the fees are for one-time charges, while the balance is for recurring services. During the year ended March 31, 2013 the Company completed conversion of one of its facilities to the McKesson system and is continuing to convert the remaining three facilities during the first quarter of the Company’s fiscal year 2014. The Company is also continuing to test and develop system applications where necessary.

 

OPERATING LEASES AND LONG TERM LEASE COMMITMENT WITH VARIABLE INTEREST ENTITY – On April 13, 2010, the Company and PCHI entered into a Second Amendment to Amended and Restated Triple Net Hospital Building Lease (the “2010 Lease Amendment”).  Under the 2010 Lease Amendment, the annual base rent to be paid by the Company to PCHI was increased from $5.4 million to $7.3 million. The base rent is subject to an annual Consumer Price Index increase on January 1 of each year; such increase shall not be less than 2% or more than 6% per year. The annual base rent is currently $7.8 million. If PCHI refinances the $47.277 million term loan, the annual base rent will increase to $8.3 million. This lease commitment with PCHI is eliminated in consolidation.

 

F-20
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2013

 

Following is a schedule of the Company's future minimum operating lease payments, excluding the long term lease commitment with PCHI, that have initial or remaining non-cancelable lease terms in excess of one year as of March 31, 2013:

 

Year ended March 31,      
2014   $ 1,620  
2015     1,335  
2016     1,253  
2017     1,253  
2018     1,253  
Thereafter     11,627  
Total   $ 18,341  

 

Total rental expense (excluding PCHI rent) for the years ended March 31, 2013 and 2012 was $5.3 million and $4.8 million, respectively. The Company received sublease rental income in relation to certain leases of approximately $563 and $552 for the years ended March 31, 2013 and 2012, respectively.

 

CAPITAL LEASES - In connection with the Acquisition, the Company also assumed the leases for the Chapman facility, which include buildings and land with terms that were extended concurrently with the assignment of the leases to December 31, 2023. The Company leases equipment under capital leases expiring at various dates through 2017. Assets under capital leases with a net book value of $7.1 million and $6.2 million are included in the accompanying consolidated balance sheets as of March 31, 2013 and 2012, respectively. Interest rates used in computing the net present value of the lease payments are based on the interest rates implicit in the leases.

 

The following is a schedule of future minimum lease payments under the capitalized leases with the present value of the minimum lease payments as of March 31, 2013:

 

Year ended March 31,      
2014   $ 1,873  
2015     1,899  
2016     1,750  
2017     1,276  
2018     932  
Thereafter     4,279  
         
Total minimum lease payments     12,009  
Less amount representing interest (weighted average interest rate of 10.2%)     (4,119 )
         
Net present value of net minimum lease payments     7,890  
Less current portion     (1,101 )
Noncurrent portion   $ 6,789  

 

INSURANCE – The Company accrues for estimated general and professional liability claims, to the extent not covered by insurance, when they are probable and reasonably estimable. The Company has purchased as primary coverage a claims-made form insurance policy for general and professional liability risks. Estimated losses within general and professional liability retentions from claims incurred and reported, along with incurred but not reported (“IBNR”) claims, are accrued based upon projections and are discounted to their net present value using an interest rate of 5.0%. To the extent that subsequent claims information varies from estimates, the liability is adjusted in the period such information becomes available. As of March 31, 2013 and 2012, the Company had accrued $10.6 million and $11.5 million, respectively, which is comprised of $5.5 million and $4.5 million, respectively, in incurred and reported claims, along with $5.1 million and $7.0 million, respectively, in estimated IBNR. Estimated insurance recoveries of $2.1 million and $3.0 million are included in other prepaid expenses and current assets as of March 31, 2013 and 2012, respectively.

 

F-21
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2013

 

The Company has also purchased occurrence coverage insurance to fund our obligations under our workers compensation program. The Company has a "paid loss plan" policy, under which the carrier pays all workers compensation claims, with no deductible or reimbursement required of us. The Company accrues for estimated workers compensation claims, to the extent not covered by insurance, when they are probable and reasonably estimable. The ultimate costs related to this program include expenses for deductible amounts associated with claims incurred and reported in addition to an accrual for the estimated expenses incurred in connection with IBNR claims. Claims are accrued based upon projections and are discounted to their net present value using an interest rate of 5.0%. To the extent that subsequent claims information varies from estimates, the liability is adjusted in the period such information becomes available. As of March 31, 2013 and 2012, the Company had accrued $500 and $673, respectively, comprised of $200 and $338, respectively, in incurred and reported claims, along with $300 and $335, respectively, in estimated IBNR.

  

In addition, the Company has a self-insured health benefits plan for our employees. As a result, the Company has established and maintained an accrual for IBNR claims arising from self-insured health benefits provided to employees. Our IBNR accruals at March 31, 2013 and 2012 were based upon projections. The Company determines the adequacy of this accrual by evaluating our limited historical experience and trends related to both health insurance claims and payments, information provided by our insurance broker and third party administrator, and industry experience and trends. The accrual is an estimate and is subject to change. Such change could be material to our consolidated financial statements. As of March 31, 2013 and 2012, the Company had accrued $1.9 million and $2.2 million, respectively, in estimated IBNR.

 

The Company has also purchased umbrella liability policies with aggregate limits of $25 million. The umbrella policies provide coverage in excess of the primary layer and applicable retentions for insured liability risks such as general and professional liability, auto liability, and workers compensation (employers liability).

 

As of March 31, 2013, the Company finances various insurance policies at an interest rate of 4.4% per annum. The Company incurred finance charges relating to such policies of $32.2 and $32.9 for the years ended March 31, 2013 and 2012, respectively. As of March 31, 2013 and 2012, the accompanying consolidated balance sheets include the following balances relating to the financed insurance policies.

 

   March 31,
2013		   March 31,
2012		 
         
Prepaid insurance  $115   $366 
           
Accrued insurance premiums  $69   $60 
(Included in other current liabilities)          

 

PURCHASE COMMITMENTS - The Company has commitments with two unrelated party service provider vendors extending over one year.  Commitments total $3.8 million and $1.0 million for the years ending March 31, 2014 and 2015, respectively.

 

UNION CONTRACTS - Approximately 37% of the Company’s employees are represented by labor unions as of March 31, 2013.  The CNA Agreement and the SEIU Agreement both expire on August 31, 2014. The agreements have “no strike” provisions and compensation caps which provide the Company with long term compensation and workforce stability.   

For both unions, all prior grievances regarding retiree medical benefits, the administration of pay adjustments and pay practices, changes in medical benefits and several wrongful terminations have been resolved in the form of settlement agreements.

 

 

F-22
 

INTEGRATED HEALTHCARE HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2013

 

CLAIMS AND LAWSUITS – The Company and the Hospitals are subject to various legal proceedings, most of which relate to routine matters incidental to operations. The results of these claims cannot be predicted, and it is possible that the ultimate resolution of these matters, individually or in the aggregate, may have a material adverse effect on the Company's business (both in the near and long term), financial position, results of operations, or cash flows. Although the Company defends itself vigorously against claims and lawsuits and cooperates with investigations, these matters (1) could require payment of substantial damages or amounts in judgments or settlements, which individually or in the aggregate could exceed amounts, if any, that may be recovered under insurance policies where coverage applies and is available, (2) cause substantial expenses to be incurred, (3) require significant time and attention from the Company's management, and (4) could cause the Company to close or sell the Hospitals or otherwise modify the way its business is conducted. The Company accrues for claims and lawsuits when an unfavorable outcome is probable and the amount is reasonably estimable.

 

On June 5, 2009, a potential class action lawsuit was filed against the Company by Alexandra Avery.  Ms. Avery purports to represent all 12-hourly employees and the complaint alleges causes of action for restitution of unpaid wages as a result of unfair business practices, injunctive relief for unfair business practices, failure to pay overtime wages, and penalties associated therewith. On December 23, 2009, the Company filed an answer to the complaint, generally denying all of the plaintiff's allegations.  On January 25, 2010, a potential class action lawsuit was filed against the Company by Julie Ross.  Ms. Ross purports to represent all similarly-situated employees and the complaint alleges causes of action for violation of the California Labor Code and unfair competition law.  On September 3, 2010 the plaintiffs in both the Avery and Ross actions filed a consolidated complaint (the "Consolidated Complaint") that alleges the causes of action found in the initial Ross complaint.  On October 12, 2010, the Company filed an answer to the Consolidated Complaint, which generally denied all allegations.  On July 18, 2011, the Company filed a motion to compel arbitration of the matter, which was denied on October 21, 2011.  The Company appealed this decision and the Court of Appeal decided against the Company on June 26, 2013. The Company intends to vigorously defend itself in connection with the claims in the Consolidated Complaint.   Discovery is ongoing and at this stage in the proceedings, the Company is unable to determine the cost of defending this lawsuit or the impact, if any, this action may have on its results of operations.

 

On February 13, 2013, the jury in Fitzgibbons v. IHHI, et. al., awarded $500,000 in punitive damages against the Company, bringing the jury’s total verdict in this lawsuit for intentional infliction of emotional distress to $5.7 million. The Company thereafter filed two post-trial motions, one seeking a new trial and another seeking a judgment in the Company’s favor notwithstanding the verdict. On April 30, 2013, the trial judge granted the Company’s motion for a judgment notwithstanding the verdict and in the alternative granted the Company’s motion for a new trial. The same day the trial judge signed a judgment in the Company’s favor by which Dr. Fitzgibbons took nothing by way of his complaint and the Company was entitled to recover its costs of suit from Dr. Fitzgibbons. Dr. Fitzgibbons filed a notice of appeal of the judgment in the Company’s favor on May 6, 2013. The Company estimates the appeal will take at least one year to resolve. Due to these favorable rulings, the Company reversed the $5.2 million contingent loss that was reserved on its financial statements as of December 31, 2012.

 

NOTE 14 – SUBSEQUENT EVENTS (unaudited)

 

In May 2013, CMS approved the managed care portion of the 2013 QAF for the period from July 1, 2011 through June 30, 2012. On June 26, 2013, CMS approved the managed care portion of the 2013 QAF for the period from July 1, 2012 through June 30, 2013.

 

Based on the most recent modeling prepared by the California Hospital Association, the Company anticipates making payments for provider fees and other expenses relating to the 2013 QAF of approximately $105.8 million and receiving approximately $235.5 million in revenues from the State ($79.4 million from the fee-for-service portion and $156.1 million from the managed care portion).

 

In June 2013, the Company received $72.1 million in managed care QAF payments for the period from July 1, 2011 through June 30, 2012 (Note 11). The Company anticipates receiving approximately $60.0 million in revenues for the period from July 1, 2012 through June 30, 2013.

 

The Company cannot provide any assurances or estimates in connection with CMS’s final managed care approval of the 2013 QAF (for the period from July 1, 2013 to December 31, 2013) or a possible continuation of the QAF program beyond December 31, 2013.

 

In June 2013, the Company paid down $25 million on its revolving line of credit, resulting in an outstanding balance of $10 million.

 

F-23
 

  

The following financial statement schedule is the only schedule required to be filed under the applicable accounting regulations of the Securities and Exchange Commission.

 

INTEGRATED HEALTHCARE HOLDINGS, INC.

SCHEDULE II -- VALUATION AND QUALIFYING ACCOUNTS

[amounts in 000's]

 

PERIOD  

 

DESCRIPTION

   BALANCE AT BEGINNING OF PERIOD     ADDITIONS    

 

DEDUCTIONS

    

BALANCE AT

END OF

PERIOD

  
                             
Accounts Receivable:                            
Year ended March 31, 2013   Allowance for doubtful accounts   $ 18,201     $ 49,085     $ 46,143     $ 21,143  
Year ended March 31, 2012   Allowance for doubtful accounts   $ 20,076     $ 44,369     $ 46,244     $ 18,201  
                                     
Net deferred tax assets:                                    
Year ended March 31, 2013   Valuation allowance   $ 8,037     $ 8,074     $ 6,708     $ 9,403  
Year ended March 31, 2012   Valuation allowance   $ 11,012     $ 16,463     $ 19,438     $ 8,037  

 

 

 

 

F-24

 EX-31.1 2 ihh_10k-ex3101.htm CERTIFICATION

 

EXHIBIT 31.1

  

CERTIFICATION PURSUANT TO RULE 13a-14 AND 15d-14

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

  

I, Kenneth K. Westbrook, Chief Executive Officer of Integrated Healthcare Holdings, Inc., certify that:

 

1.    I have reviewed this Annual Report on Form 10-K of Integrated Healthcare Holdings, Inc.;

 

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

 

4.    The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)    designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated, or caused such disclosure controls and procedure to be designed under our supervision, subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

 

(b)    designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

 

(c)    evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)    disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and;

 

5.    The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):

 

(a)    all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b)    any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

 

Dated: June 28, 2013

 

/s/ Kenneth K. Westbrook

Kenneth K. Westbrook

Chief Executive Officer

 

 EX-31.2 3 ihh_10k-ex3102.htm CERTIFICATION

 

EXHIBIT 31.2

 

CERTIFICATION PURSUANT TO RULE 13a-14 AND 15d-14

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, Steven R. Blake, Chief Financial Officer of Integrated Healthcare Holdings, Inc., certify that:

 

1.    I have reviewed this Annual Report on Form 10-K of Integrated Healthcare Holdings, Inc.;

 

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

 

4.    The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)    designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated, or caused such disclosure controls and procedure to be designed under our supervision, subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

 

(b)    designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

 

(c)    evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)    disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and;

 

5.    The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):

 

(a)    all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b)    any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

 

Dated: June 28, 2013

 

/s/ Steven R. Blake

Steven R. Blake

Chief Financial Officer

 

 EX-32.1 4 ihh_10k-ex3201.htm CERTIFICATE

 

EXHIBIT 32.1

 

CERTIFICATE PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

   

In connection with the Report of Integrated Healthcare Holdings, Inc. (the "Company") on Form 10-K for the period from April 1, 2012 to March 31, 2013, as filed with the Securities and Exchange Commission (the "Report"), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1)    the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

 

2)    the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the period indicated. This Certificate has not been, and shall not be deemed, "filed" with the Securities and Exchange Commission.

  

Dated: June 28, 2013

 /s/ Kenneth K. Westbrook

Kenneth K. Westbrook

Chief Executive Officer

 

 

 EX-31.1 5 ihh_10k-ex3202.htm CERTIFICATION

 

EXHIBIT 32.2

 

CERTIFICATE PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

  

In connection with the Report of Integrated Healthcare Holdings, Inc. (the "Company") on Form 10-K for the period from April 1, 2012 to March 31, 2013, as filed with the Securities and Exchange Commission (the "Report"), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1)    the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

 

2)    the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the period indicated. This Certificate has not been, and shall not be deemed, "filed" with the Securities and Exchange Commission.

 

Dated: June 28, 2013

/s/ Steven R. Blake

Steven R. Blake

Chief Financial Officer

 

 

 

 EX-101.INS 6 ihch-20130331.xml XBRL INSTANCE FILE 0001051488 2012-04-01 2013-03-31 0001051488 IHCH:StockIncentive2006PlanMember 2012-04-01 2013-03-31 0001051488 2013-03-31 0001051488 2012-03-31 0001051488 us-gaap:CommonStockMember 2012-03-31 0001051488 us-gaap:AdditionalPaidInCapitalMember 2012-03-31 0001051488 us-gaap:FairValueInputsLevel1Member 2013-03-31 0001051488 us-gaap:FairValueInputsLevel2Member 2013-03-31 0001051488 us-gaap:FairValueInputsLevel3Member 2013-03-31 0001051488 IHCH:Total1Member 2013-03-31 0001051488 us-gaap:WarrantMember 2013-03-31 0001051488 us-gaap:WarrantMember 2011-04-01 2012-03-31 0001051488 IHCH:PCHIMember 2013-03-31 0001051488 IHCH:PCHIMember 2012-03-31 0001051488 2011-04-01 2012-03-31 0001051488 us-gaap:CommonStockMember 2013-03-31 0001051488 us-gaap:AdditionalPaidInCapitalMember 2013-03-31 0001051488 us-gaap:RetainedEarningsMember 2012-04-01 2013-03-31 0001051488 us-gaap:RetainedEarningsMember 2012-03-31 0001051488 us-gaap:RetainedEarningsMember 2013-03-31 0001051488 us-gaap:NoncontrollingInterestMember 2012-04-01 2013-03-31 0001051488 us-gaap:NoncontrollingInterestMember 2012-03-31 0001051488 us-gaap:NoncontrollingInterestMember 2013-03-31 0001051488 IHCH:MedicareMember 2011-04-01 2012-03-31 0001051488 IHCH:MedicareMember 2012-04-01 2013-03-31 0001051488 IHCH:MedicaidMember 2011-04-01 2012-03-31 0001051488 IHCH:MedicaidMember 2012-04-01 2013-03-31 0001051488 IHCH:ManagedCareMember 2012-01-01 2012-12-31 0001051488 IHCH:ManagedCareMember 2012-04-01 2013-03-31 0001051488 IHCH:IndemnitySelfPayAndOtherMember 2011-04-01 2012-03-31 0001051488 IHCH:IndemnitySelfPayAndOtherMember 2012-04-01 2013-03-31 0001051488 IHCH:TotalMember 2011-04-01 2012-03-31 0001051488 IHCH:TotalMember 2012-04-01 2013-03-31 0001051488 2011-03-31 0001051488 IHCH:MedicareMedicaidMember 2012-04-01 2013-03-31 0001051488 IHCH:MedicareMedicaidMember 2011-04-01 2012-03-31 0001051488 2012-09-30 0001051488 2013-06-18 0001051488 us-gaap:CommonStockMember 2011-03-31 0001051488 us-gaap:AdditionalPaidInCapitalMember 2011-03-31 0001051488 IHCH:ReceivableFromStockholdersMember 2011-04-01 2012-03-31 0001051488 IHCH:ReceivableFromStockholdersMember 2011-03-31 0001051488 us-gaap:RetainedEarningsMember 2011-04-01 2012-03-31 0001051488 us-gaap:RetainedEarningsMember 2011-03-31 0001051488 us-gaap:NoncontrollingInterestMember 2011-04-01 2012-03-31 0001051488 us-gaap:NoncontrollingInterestMember 2011-03-31 0001051488 IHCH:IncomePerShareMember 2011-04-01 2012-03-31 0001051488 IHCH:IncomePerShareMember 2012-04-01 2013-03-31 0001051488 us-gaap:WarrantMember 2012-04-01 2013-03-30 0001051488 us-gaap:WarrantMember 2013-03-31 0001051488 us-gaap:WarrantMember 2012-03-31 0001051488 us-gaap:WarrantMember 2011-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure Integrated Healthcare Holdings Inc 0001051488 10-K 2013-03-31 false --03-31 No No Yes Smaller Reporting Company FY 2013 1867760 255307262 3545000 11829000 20539000 13000 10000 62821000 53599000 6738000 6855000 5882000 5183000 7690000 2436000 892000 9208000 8186000 102340000 89356000 63988000 55529000 39696000 40984000 166708000 144885000 39972000 41259000 29527000 13783000 62515000 52700000 19634000 19847000 12938000 14377000 7226000 179000 4111000 3242000 138999000 103949000 45530000 45000000 5276000 1641000 6789000 5944000 196594000 156534000 46527000 45641000 255000 255000 62911000 62911000 -87365000 -71828000 -24199000 -8662000 -5687000 -2987000 166708000 144885000 39972000 41259000 21143000 18201000 1101000 891000 0.001 0.001 800000 800000 255307 255307 255307 255307 428100000 402564000 58046000 55570000 80153000 100561000 201758000 203058000 62607000 68911000 402564000 428100000 44600000 40368000 383500000 362196000 215552000 218801000 56160000 55066000 118055000 74515000 3917000 4208000 393684000 352590000 -6814000 12695000 -11752000 -10218000 6802000 -3101000 -1474000 -14853000 -4890000 -21667000 7805000 -324000 492000 -15537000 7452000 7452000 -15537000 -0.06 0.03 0.03 -.06 -0.06 0.03 0.03 -0.06 255307 255307 255307 255307 255307 256840 256840 255307 255307 255307 255307 -29886000 -11649000 255000 62911000 255000 62911000 -71828000 -87365000 -2987000 -5687000 -18561000 255000 62911000 -882000 -79280000 -1565000 882000 882000 -15861000 7944000 -15537000 -324000 7452000 492000 -2376000 -1914000 -2376000 -1914000 -10343000 -5472000 10340000 5486000 3000 -14000 -9624000 4518000 -780000 -5534000 2869000 -12800000 179000 7226000 -213000 1140000 9815000 8732000 -771000 1033000 892000 -892000 -5254000 -621000 -699000 -831000 117000 -910000 -53822000 -39318000 44600000 40368000 15490000 -5081000 132000 2376000 1914000 981000 893000 11683000 -7756000 -8284000 -8710000 <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0.9in 0pt 0">NOTE 2 - PROPERTY AND EQUIPMENT</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Property and equipment consists of the following:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <table align="center" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2013</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2012</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; color: black; font: 8pt Times New Roman, Times, Serif">Buildings</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">36,536</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">35,376</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Land and improvements</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">13,523</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">13,523</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; font: 8pt Times New Roman, Times, Serif">Equipment</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">28,534</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">18,268</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Construction in progress</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">1,160</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Assets under capital leases</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">13,267</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">11,218</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">91,860</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">79,545</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Less accumulated depreciation</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(27,872</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(24,016</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; padding-left: 1in; font: 8pt Times New Roman, Times, Serif">Property and equipment, net</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">63,988</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">55,529</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Accumulated depreciation on assets under capital leases as of March 31, 2013 and 2012 was $6.2 million and $5.0 million, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Hospitals are located in an area near active and substantial earthquake faults. The Hospitals carry earthquake insurance with a policy limit of $50.0 million. A significant earthquake could result in material damage and temporary or permanent cessation of operations at one or more of the Hospitals.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The State of California has imposed hospital seismic safety requirements. Under these requirements, the Hospitals must meet stringent seismic safety criteria in the future. In addition, there could be other remediation costs pursuant to this seismic retrofit.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The State of California has a seismic review methodology known as HAZUS. The HAZUS methodology may preclude the need for some structural modifications. All four Hospitals requested HAZUS review and received a favorable notice pertaining to structural reclassification. All Hospital buildings, with the exception of one (an administrative building), have been deemed compliant until January 1, 2030 for both structural and nonstructural retrofit. The Company does not have an estimate of the cost to remediate the seismic requirements for the administrative building as of March 31, 2013.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are additional requirements that must be complied with by 2030. The costs of meeting these requirements have not yet been determined. Compliance with seismic ordinances will be costly and could have a material adverse effect on the Company's cash flow.&#160;&#160;In addition, remediation could possibly result in certain environmental liabilities, such as asbestos abatement.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 6 - STOCK INCENTIVE PLAN</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company's 2006 Stock Incentive Plan (the "Plan"), which is shareholder-approved, permits the grant of share options to its employees and board members for up to a maximum aggregate of 12.0 million shares of common stock. In addition, as of the first business day of each calendar year in the period 2007 through 2015, the maximum aggregate number of shares shall be increased by a number equal to one percent of the number of shares of common stock of the Company outstanding on December 31 of the immediately preceding calendar year. Accordingly, as of March 31, 2013, the maximum aggregate number of shares under the Plan was 26.1 million. The Company believes that such awards better align the interests of its employees with those of its shareholders. In accordance with the Plan, incentive stock options, nonqualified stock options, and performance based compensation awards may not be granted at less than 100 percent of the estimated fair market value of the common stock on the date of grant. Incentive stock options granted to a person owning more than 10 percent of the voting power of all classes of stock of the Company may not be issued at less than 110 percent of the fair market value of the stock on the date of grant. Option awards generally vest based on 3 years of continuous service (1/3 of the shares vest on the twelve month anniversary of the grant date, and an additional 1/12 of the shares vest on each subsequent fiscal quarter-end of the Company following such twelve month anniversary). Certain option awards provide for accelerated vesting if there is a change of control, as defined. The option awards have 7-year contractual terms.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When the measurement date is certain, the fair value of each option grant is estimated on the date of grant using the Black-Scholes valuation model. Since there is limited historical data with respect to both pre-vesting forfeiture and post-vesting termination, the expected life of the options was determined utilizing the simplified method, whereby the expected term is calculated by taking the sum of the vesting term plus the original contractual term and dividing that quantity by two.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No options were granted or exercised during the years ended March 31, 2013 and 2012. All outstanding options were fully vested as of March 31, 2013 and 2012.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A summary of stock option activity for the years ended March 31, 2013 and 2012 is presented as follows.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table align="center" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Shares</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Weighted-average exercise price</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Weighted-average grant date fair value</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Weighted-average remaining contractual term(years)</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Aggregate intrinsic value</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 35%; color: black; text-align: left; text-indent: -9pt; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March&#160;31, 2011</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 9%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">8,370</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 9%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.18</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 9%; text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 9%; text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 9%; text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Granted</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">-</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Exercised</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Forfeited or expired</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(135</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.25</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; text-indent: -9pt; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March&#160;31, 2012</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">8,235</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.18</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Granted</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Exercised</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Forfeited or expired</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(640</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.26</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March&#160;31, 2013</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">7,595</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">0.18</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">1.7</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">-<font style="color: black">&#160;</font></td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Exercisable at March&#160;31, 2013</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">7,595</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">0.18</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">1.7</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> </tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 7 - RETIREMENT PLAN</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has a 401(k) plan for its employees. All employees with 90 days of service are eligible to participate, unless they are covered by a collective bargaining agreement which precludes coverage. The Company matches employee contributions up to 3% of the employee's compensation, subject to IRS limits. During the years ended March 31, 2013 and 2012, the Company incurred expenses of $3.3 million and $3.1 million, respectively. These costs are included in salaries and benefits in the accompanying consolidated statements of operations.&#160;&#160;At March 31, 2013 and 2012, accrued compensation and benefits in the accompanying consolidated balance sheets included $4.1 million and $3.9 million, respectively, in accrued employer contributions.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0.9in 0pt 0">NOTE 10 - RELATED PARTY TRANSACTIONS</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company leases substantially all of the real property of the acquired Hospitals from PCHI which is owned by various physician investors and Ganesha, which is managed by Dr. Chaudhuri. As of March 31, 2013 and 2012, Dr. Chaudhuri and Mr. Thomas are the beneficial holders of an aggregate of 447.5 million shares of the outstanding stock of the Company. As described in Note 9, PCHI is a variable interest entity and the Company is the primary beneficiary, accordingly, the Company has consolidated the financial statements of PCHI in the accompanying consolidated financial statements.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 12 - ELECTRONIC HEALTH RECORDS INCENTIVE PROGRAM</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Provisions of the American Recovery and Reinvestment Act of 2009 provide incentive payments for the adoption and meaningful use of certified electronic health record (EHR) technology. The Medicare EHR incentive program provides incentive payments to eligible hospitals (and certain other providers) that are meaningful users of certified EHRs. The Medicaid EHR incentive program provides incentive payments to eligible hospitals (and certain other providers) for efforts to adopt, implement, upgrade, or meaningful use of certified EHR technology.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">CMS has established the final rule which requires eligible providers in their first year of participation in the Medicaid incentive payment program to demonstrate that they have adopted (acquired, purchased, or secured access to), or implemented, or upgraded to certified EHR technology in order to qualify for an incentive payment. During the second and subsequent years of the program, eligible providers are required to meet other criteria, including meaningful use, to receive additional funds. The Company has been awarded a total amount of $13.6 million under the Medicaid EHR incentive program, which will be earned and received over a four year period. The Company adopted certified EHR technology and it recognized other income of $6.8 million relative to the first year under the Medicaid EHR incentive program during fiscal year 2012.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">BASIS OF PRESENTATION - The accompanying consolidated financial statements include the accounts of Integrated Healthcare Holdings, Inc. and its subsidiaries (collectively, the &#147;Company&#148;) and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#147;GAAP&#148;).</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has also determined that Pacific Coast Holdings Investment, LLC (&#34;PCHI&#34;) (Note 9), is a variable interest entity as defined by GAAP and the Company is the primary beneficiary and, accordingly, the financial statements of PCHI are included in the accompanying consolidated financial statements.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">All significant intercompany accounts and transactions have been eliminated in consolidation. Unless otherwise indicated, all amounts included in these notes to the consolidated financial statements are expressed in thousands (except per share amounts, percentages and stock option prices and values).</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="color: black">LIQUIDITY - As of March 31, 2013 and 2012, the Company had a total stockholders&#146; deficiency of $29.9 million and $11.6 million, respectively, and a working capital deficit of $36.7 million and $14.7 million, respectively.&#160;&#160;For the years ended March 31, 2013 and 2012, the Company had net income (loss) of $(15.2) million and $7.5 million, respectively, and (negative) positive cash flow from operations of $(9.6) million and $4.5 million, respectively. At March 31, 2013, the Company had $5.0 million in additional availability under its revolving credit facility (Note 3). The Company anticipates making payments for provider fees and other expenses relating to the 2013 hospital quality assurance fee program of approximately $105.8 million and receiving approximately $235.5 million in revenues from the </font><font style="color: #1F497D">S</font><font style="color: black">tate ($79.4 million from the fee-for-service portion and $156.1 million from the managed care portion) (Notes 11 and 14).DESCRIPTION OF BUSINESS - Effective March 8, 2005, the Company acquired four hospitals (the &#34;Hospitals&#34;) from subsidiaries of Tenet Healthcare Corporation (the &#34;Acquisition&#34;). The Company owns and operates the four community-based hospitals located in southern California, which are:</font></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 6%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; line-height: 115%; font-size: 8pt">&#160;</td> <td style="vertical-align: top; width: 2%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="width: 92%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif; color: black">282-bed Western Medical Center in Santa Ana</font></td></tr> <tr> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; line-height: 115%; font-size: 8pt">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif; color: black">188-bed Western Medical Center in Anaheim</font></td></tr> <tr> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; line-height: 115%; font-size: 8pt">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif; color: black">178-bed Coastal Communities Hospital in Santa Ana</font></td></tr> <tr> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; line-height: 115%; font-size: 8pt">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif; color: black">114-bed Chapman Medical Center in Orange</font></td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">RECLASSIFICATION FOR PRESENTATION - Certain amounts previously reported have been reclassified to conform to the current period's presentation with no impact on the reported net income of the Company.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">CONCENTRATION OF RISK - The Hospitals are subject to licensure by the State of California and accreditation by the Joint Commission. Loss of either licensure or accreditation would impact the ability to participate in various governmental and managed care programs, which provide the majority of the Company's revenues.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Substantially all patient service revenues come from external customers. The largest payers are Medicare and Medicaid (including Medicare and Medicaid managed care plans) and other State and local government payers, which combined accounted for 58% and 57% of the patient service revenues for the years ended March 31, 2013 and 2012, respectively. No other payers represent a significant concentration of the Company's patient services revenues.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 1.3pt 0 0; text-align: center; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company receives all of its inpatient services revenue from operations in Orange County, California. The economic conditions of this service area could affect the ability of patients and third-party payers to reimburse the Company for services through its effect on disposable household income and the tax base used to generate state funding for Medicaid programs.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">USE OF ESTIMATES - The accompanying consolidated financial statements have been prepared in accordance with GAAP. The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Principal areas requiring the use of estimates include third-party cost report settlements, income taxes, accrued insurance retentions, self-insurance reserves, and net patient receivables. Management regularly evaluates the accounting policies and estimates that are used. In general, management bases the estimates on historical experience and on assumptions that it believes to be reasonable given the particular circumstances in which its Hospitals operate. Although management believes that all adjustments considered necessary for fair presentation have been included, actual results may materially vary from those estimates.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">PATIENT SERVICE REVENUES &#150; Patient service revenues are recognized in the period in which services are performed and are recorded based on established billing rates (gross charges) less contractual allowances and discounts, principally for patients covered by Medicare, Medicaid, managed care, and other health plans. Gross charges are retail charges. They are not the same as actual pricing, and they generally do not reflect what a hospital is ultimately paid and therefore are not displayed in the consolidated statements of operations. Hospitals are typically paid amounts that are negotiated with insurance companies or are set by the government. Gross charges are used to calculate Medicare outlier payments and to determine certain elements of payment under managed care contracts (such as stop-loss payments). Since Medicare requires that a hospital's gross charges be the same for all patients (regardless of payer category), gross charges are also what the Hospitals charge all other patients prior to the application of discounts and allowances.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following is a summary of sources of patient service revenues (net of contractual allowances and discounts) before provision for doubtful accounts:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Year ended March 31,</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 48%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Medicare</font></td> <td style="width: 3%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 21%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">55,570</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 3%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 21%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">58,046</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Medicaid</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">100,561</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">80,153</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Managed care</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">203,058</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">201,758</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Indemnity, self-pay and other</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">68,911</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">62,607</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">428,100</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">402,564</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Revenues under the traditional fee-for-service Medicare and Medicaid programs are based primarily on prospective payment systems. Discounts for retrospectively cost based revenues and certain other payments, which are based on the Hospitals' cost reports, are estimated using historical trends and current factors. Cost report settlements for retrospectively cost-based revenues under these programs are subject to audit and administrative and judicial review, which can take several years until final settlement of such matters are determined and completely resolved. Estimates of settlement receivables or payables related to a specific year are updated periodically and at year end and at the time the cost report is filed with the fiscal intermediary. Typically no further updates are made to the estimates until the final Notice of Program Reimbursement is received, at which time the cost report for that year has been audited by the fiscal intermediary. There could be a time lag of several years between the submission of a cost report and receipt of the Final Notice of Program Reimbursement. Since the laws, regulations, instructions and rule interpretations governing Medicare and Medicaid reimbursement are complex and change frequently, the estimates recorded by the Hospitals could change by material amounts. The Company has established settlement (payables) receivables of $(179) and $190 as of March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Hospitals receive supplemental payments from the State of California to support indigent care (Medi-Cal Disproportionate Share Hospital payments or &#34;DSH&#34;) and from the California Medical Assistance Commission (&#34;CMAC&#34;) under the SB 1100 and SB 1255 programs. The Hospitals received supplemental payments of $13.4 million and $14.3 million during the years ended March 31, 2013 and 2012, respectively. The related revenue recorded for the years ended March 31, 2013 and 2012, was $14.3 million and $15.4 million, respectively. As of March 31, 2013 and 2012, estimated DSH receivables were $5.9 million and $5.0 million, respectively, which are included as due from government payers in the accompanying consolidated balance sheets.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 1.3pt 0 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Revenues under managed care plans, including Medicare and Medicaid managed care plans (with patient service revenues of $84.7 million and $84.2 million for the years ended March 31, 2013 and 2012, respectively), are based primarily on payment terms involving predetermined rates per diagnosis, per-diem rates, discounted fee-for-service rates and/or other similar contractual arrangements. These revenues are also subject to review and possible audit by the payers. The payers are billed for patient services on an individual patient basis. An individual patient's bill is subject to adjustment on a patient-by-patient basis in the ordinary course of business by the payers following their review and adjudication of each particular bill. The Hospitals estimate the discounts for contractual allowances utilizing billing data on an individual patient basis. Management believes the estimation and review process allows for timely identification of instances where such estimates need to be revised. The Company does not believe there were any adjustments to estimates of individual patient bills that were material to patient service revenues.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Hospitals provide charity care to patients whose income level is below 300% of the Federal Poverty Level. Patients with income levels between 300% and 350% of the Federal Poverty Level qualify to pay a discounted rate under AB 774 based on various government program reimbursement levels. Patients without insurance are offered assistance in applying for Medicaid and other programs they may be eligible for, such as state disability, Victims of Crime, or county indigent programs. Patient advocates from the Hospitals' Medical Eligibility Program (&#34;MEP&#34;) screen patients in the hospital and determine potential linkage to financial assistance programs. They also expedite the process of applying for these government programs. The estimated costs of charity care (based on direct and indirect costs as a ratio of gross uncompensated charges associated with providing care to charity patients) for the years ended March 31,&#160;2013 and 2012 were approximately $8.0 million and $7.0 million, respectively.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company is not aware of any material claims, disputes, or unsettled matters with any payers that would affect revenues that have not been adequately provided for in the accompanying consolidated financial statements.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">PROVISION FOR BAD DEBTS - The Company provides for accounts receivable that could become uncollectible by establishing an allowance to reduce the carrying value of such receivables to their estimated net realizable value. The Hospitals estimate this allowance based on the aging of their accounts receivable, historical collections experience for each type of payer and other relevant factors. There are various factors that can impact the collection trends, such as changes in the economy, which in turn have an impact on unemployment rates and the number of uninsured and underinsured patients, volume of patients through the emergency department, the increased burden of copayments to be made by patients with insurance and business practices related to collection efforts. These factors continuously change and can have an impact on collection trends and the estimation process.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company's policy is to attempt to collect amounts due from patients, including copayments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations, including, but not limited to, the Emergency Medical Treatment and Labor Act (&#34;EMTALA&#34;). Generally, as required by EMTALA, patients may not be denied emergency treatment due to inability to pay. Therefore, until the legally required medical screening examination is complete and stabilization of the patient has begun, services are performed prior to the verification of the patient's insurance, if any. In nonemergency circumstances or for elective procedures and services, it is the Hospitals' policy, when appropriate, to verify insurance prior to a patient being treated.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">CASH AND CASH EQUIVALENTS - The Company considers all highly liquid debt investments purchased with a maturity of three months or less to be cash equivalents. Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits. The Company has never experienced any losses related to these balances.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">LETTER OF CREDIT &#150; At March 31, 2013, the Company had an outstanding letter of credit totaling $761. This letter of credit correspondingly reduces the Company&#146;s borrowing availability under its revolving line of credit (Note 3).</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">RECEIVABLES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS &#150; The following is a summary of the principal components of accounts receivable and due from/to government payers as of March 31, 2013 and 2012:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">March 31,</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Accounts receivable:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 56%; padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Patient accounts receivable</font></td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">83,964</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">71,800</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Allowance for doubtful accounts</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(21,143</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(18,201</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Accounts receivable, net</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">62,821</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">53,599</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Due from government payers:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">DSH</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,882</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">4,993</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Settlement receivables</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">190</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,882</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,183</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Due to government payers:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Settlement payables</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">179</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">179</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company&#146;s self-pay collection rate, which is the blended collection rate for uninsured and balance after insurance accounts receivable, was approximately 6.5% and 11.3% as of March&#160;31, 2013 and 2012, respectively. These self-pay collection rates include payments made by patients, including co-payments and deductibles paid by patients with insurance. As of March&#160;31,&#160;2013 and 2012, the allowance for doubtful accounts for self-pay uninsured was 95.2% and 90.3%, respectively, of self-pay uninsured patient accounts receivable. As of March&#160;31,&#160;2013 and 2012, the allowance for doubtful accounts for self-pay balance after insurance was 78.0% and 77.4%, respectively, of self-pay balance after insurance patient accounts receivable, consisting primarily of co-pays and deductibles owed by patients with insurance. As of March 31, 2013 and 2012, the allowance for doubtful accounts for managed care was 20.3% and 16.1%, respectively, of managed care patient accounts receivable.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Receivables from patients who are potentially eligible for Medicaid are classified as Medicaid pending under the MEP, with appropriate contractual allowances recorded. If the patient does not qualify for Medicaid, the receivables are reclassified to charity care and written off, or they are reclassified to self-pay and adjusted to their net realizable value through the provision for bad debts. Reclassifications of pending Medicaid accounts to self-pay do not typically have a material impact on the results of operations as the estimated Medicaid contractual allowances initially recorded are not materially different than the estimated provision for bad debts recorded when the accounts are reclassified. All accounts classified as pending Medicaid, as well as certain other governmental receivables, over the age of 90 days were reserved in contractual allowances as of March 31, 2013 and 2012 based on historical collections experience.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">INVENTORIES OF SUPPLIES - Inventories of supplies are valued at the lower of weighted average cost or market.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and any impairment write-downs related to assets held and used. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Capital leases are recorded at the beginning of the lease term as property and equipment and a corresponding lease liability is recognized. The value of the property and equipment under capital lease is recorded at the lower of either the present value of the minimum lease payments or the fair value of the asset. Such assets, including improvements, are amortized over the shorter of the lease term or their estimated useful life, where applicable.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company uses the straight-line method of depreciation for buildings and improvements, and equipment over their estimated useful lives of 25 years and 3 to 15 years, respectively.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">LONG-LIVED ASSETS - The Company evaluates its long-lived assets for possible impairment whenever circumstances indicate that the carrying amount of the asset, or related group of assets, may not be recoverable from estimated future undiscounted cash flows. Fair value estimates are derived from established market values of comparable assets or internal calculations of estimated undiscounted future net cash flows. The estimates of future net cash flows are based on assumptions and projections believed by the Company to be reasonable and supportable. These assumptions take into account patient volumes, changes in payer mix, revenue, and expense growth rates and changes in legislation and other payer payment patterns.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">FAIR VALUE MEASUREMENTS - The Company's financial assets and liabilities recorded in the consolidated balance sheets include cash and cash equivalents, restricted cash, receivables, debt, accounts payable, and other liabilities, all of which are recorded at book value which approximates fair value.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">GAAP has established a hierarchy for ranking the quality and reliability of the information used to determine fair values and requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 6%; line-height: 115%">&#160;</td> <td style="width: 10%; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Level 1:</font></td> <td style="width: 84%; text-align: justify; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Unadjusted quoted market prices in active markets for identical assets or liabilities.</font></td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Level 2:</font></td> <td style="text-align: justify; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.</font></td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Level 3:</font></td> <td style="text-align: justify; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Unobservable inputs for the asset or liability.</font></td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company utilizes the best available information in measuring fair value.&#160;&#160;Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company currently has no financial or nonfinancial assets or liabilities subject to fair value measurement on a recurring basis except for warrants issued in April 2010 and February 2013 (Note 4).</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table sets forth the Company&#146;s financial assets and liabilities measured at fair value on a recurring basis and where they are classified within the hierarchy as of March 31, 2013 and 2012:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Total</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Level 1</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Level 2</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Level 3</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 36%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Warrant liability at March 31, 2013</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,276</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,276</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Warrant liability at March 31, 2012</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,641</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#160;.</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,641</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="5" style="border-bottom: black 1pt solid; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Warrant liability - fair value measurements using significant unobservable inputs (Level 3)</font></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 80%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Balance at March 31, 2011</font></td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 16%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">167</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Change in fair value of warrant liability included in earnings</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,474</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Balance at March 31, 2012</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,641</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Fair value of warrants issued and vested, net</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,692</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Fair value of warrants - loan discount on term loan</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">534</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Change in fair value of warrant liability included in earnings</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,409</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Balance at March 31, 2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,276</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 0 49.5pt; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Additional quantitative information about Level 3 fair value measurements is discussed in Note 4.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">INCOME (LOSS) PER COMMON SHARE &#150; Income (loss) per share is calculated under two different methods, basic and diluted. Basic income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period. Diluted income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period and dilutive potential shares of common stock. Dilutive potential shares of common stock, as determined under the treasury stock method, consist of shares of common stock issuable upon exercise of stock warrants or options, net of shares of common stock assumed to be repurchased by the Company from the exercise proceeds (Note 8).</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SUPPLEMENTAL CASH FLOW INFORMATION - Interest paid during the years ended March 31, 2013 and 2012 was $9.4 million and $9.0 million, respectively.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company made cash payments for taxes of $0 and $14.0 million during the years ended March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company entered into new capital lease obligations of $2.1 million and $0 during the years ended March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SEGMENT REPORTING - The Company operates in one line of business, the provision of healthcare services through the operation of general hospitals and related healthcare facilities. The Company's Hospitals generate substantially all of its net patient service revenues.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company's four Hospitals and related healthcare facilities operate in one geographic region in Orange County, California. There are similarities in the region's economic characteristics and the nature of the Hospitals' operations, the regulatory environment in which they operate and the manner in which they are managed. This region is an operating segment, as defined by GAAP. In addition, the Company's Hospitals and related healthcare facilities share certain resources and benefit from many common clinical and management practices. Accordingly, the Company aggregates the facilities into a single reportable operating segment.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="color: black">NEW ACCOUNTING STANDARDS &#150; </font>Effective March 31, 2012, the Company adopted ASU&#160;2011-07, &#147;Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities,&#148; which requires health care entities to present the provision for bad debts relating to patient service revenue as a deduction from patient service revenue in the statement of operations rather than as an operating expense. Additional disclosures relating to sources of patient revenue and the allowance for doubtful accounts related to patient accounts receivable are also required. The adoption of this ASU did not have a material impact on the Company&#146;s consolidated financial statements.</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Year ended March 31,</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 48%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Medicare</font></td> <td style="width: 3%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 21%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">55,570</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 3%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 21%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">58,046</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Medicaid</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">100,561</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">80,153</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Managed care</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">203,058</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">201,758</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Indemnity, self-pay and other</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">68,911</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">62,607</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">428,100</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">402,564</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">March 31,</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Accounts receivable:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 56%; padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Patient accounts receivable</font></td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">83,964</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">71,800</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Allowance for doubtful accounts</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(21,143</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(18,201</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Accounts receivable, net</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">62,821</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">53,599</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Due from government payers:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">DSH</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,882</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">4,993</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Settlement receivables</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">190</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,882</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,183</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Due to government payers:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Settlement payables</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">179</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">179</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Total</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Level 1</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Level 2</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Level 3</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 36%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Warrant liability at March 31, 2013</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,276</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,276</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Warrant liability at March 31, 2012</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,641</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#160;.</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,641</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="5" style="border-bottom: black 1pt solid; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Warrant liability - fair value measurements using significant unobservable inputs (Level 3)</font></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 80%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Balance at March 31, 2011</font></td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 16%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">167</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Change in fair value of warrant liability included in earnings</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,474</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Balance at March 31, 2012</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,641</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Fair value of warrants issued and vested, net</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,692</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Fair value of warrants - loan discount on term loan</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">534</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Change in fair value of warrant liability included in earnings</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,409</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Balance at March 31, 2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,276</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">March 31, </font><br /> <font style="font: 8pt Times New Roman, Times, Serif">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">March 31, </font><br /> <font style="font: 8pt Times New Roman, Times, Serif">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 68%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Buildings</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">36,536</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">35,376</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Land and improvements</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">13,523</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">13,523</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Equipment</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">28,534</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">18,268</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Construction in progress</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,160</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Assets under capital leases</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">13,267</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">11,218</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">91,860</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">79,545</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Less accumulated depreciation</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(27,872</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(24,016</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 1in; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Property and equipment, net</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">63,988</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">55,529</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">The Company's outstanding debt consists of the following:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <table align="center" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2013</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2012</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; font: 8pt Times New Roman, Times, Serif">Current:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Revolving line of credit</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">30,000</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">14,000</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Discount</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(473</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(217</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">29,527</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">13,783</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; font: 8pt Times New Roman, Times, Serif">Noncurrent:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Term loan</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">47,277</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">45,000</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Discount</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(1,747</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">45,530</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">45,000</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A summary of stock option activity for the years ended March 31, 2013 and 2012 is presented as follows.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table align="center" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Shares</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Weighted-average exercise price</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Weighted-average grant date fair value</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Weighted-average remaining contractual term(years)</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Aggregate intrinsic value</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 35%; color: black; text-align: left; text-indent: -9pt; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March&#160;31, 2011</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 9%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">8,370</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 9%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.18</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 9%; text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 9%; text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 9%; text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Granted</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">-</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Exercised</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Forfeited or expired</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(135</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.25</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; text-indent: -9pt; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March&#160;31, 2012</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">8,235</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.18</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Granted</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Exercised</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Forfeited or expired</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(640</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.26</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March&#160;31, 2013</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">7,595</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">0.18</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">1.7</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">-<font style="color: black">&#160;</font></td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Exercisable at March&#160;31, 2013</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">7,595</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">0.18</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">1.7</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> </tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table align="center" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2013</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2012</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Cash</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">147</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">68</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Property, net</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">39,696</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">40,984</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Other</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">129</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">207</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">Total assets</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">39,972</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">41,259</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Debt ($47,277, net of discount) (as guarantor)</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">46,039</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">45,000</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Other</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">488</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">641</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Total liabilities</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">46,527</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">45,641</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Deficiency</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(6,555</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(4,382</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">Total liabilities and accumulated deficit</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">39,972</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">41,259</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr></table> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">March 31, </font><br /> <font style="font: 8pt Times New Roman, Times, Serif">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">March 31, </font><br /> <font style="font: 8pt Times New Roman, Times, Serif">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 68%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Prepaid insurance</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">115</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">366</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Accrued insurance premiums</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">69</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">60</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(Included in other current liabilities)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Year ended March 31,</font></td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 79%; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2014</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 18%; text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,873</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2015</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,899</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2016</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,750</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2017</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,276</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2018</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">932</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Thereafter</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">4,279</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Total minimum lease payments</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">12,009</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Less amount representing interest (weighted average interest rate of 10.2%)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">(4,119</font></td> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Net present value of net minimum lease payments</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">7,890</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Less current portion</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">(1,101</font></td> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Noncurrent portion</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">6,789</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> 83964000 71800000 190000 5882000 4993000 179000 5276000 5276000 1641000 1641000 167000 1474000 1641000 1692000 534000 1409000 5276000 -27872000 -24016000 91860000 79545000 13267000 11218000 1160000 28534000 18268000 13523000 13523000 36536000 35376000 0 0 0.004 0.002 .399 .573 P3Y18D P1Y14D 129000 207000 147000 68000 488000 641000 46039000 45000000 -6555000 -4382000 655000 -136000 247000 -3000 902000 -139000 -4853000 -1855000 -6708000 -5806000 -139000 1620000 1335000 1253000 1253000 1253000 11627000 18341000 1873000 1899000 1750000 1276000 932000 4279000 12009000 115000 366000 69000 60000 6708000 -9403000 -8037000 16111000 8037000 449000 1457000 2982000 2813000 281000 43000 7961000 1023000 -1235000 -532000 3755000 3445000 1257000 661000 -212000 -1245000 406000 -7584000 2654000 40000 25000 1366000 -2975000 1085000 516000 237000 -172000 295000 -593000 21814000 18900000 2914000 21814000 21814000 -4119000 7890000 -1101000 6789000 6328000 380000 2869000 3370000 3089000 386870000 365285000 1682000 525000 -6708000 86000 -450000 -473000 -217000 29527000 13783000 47277000 45000000 -1747000 3101000 1474000 <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Year ended March 31,</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Income tax provision (benefit):</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Current:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 56%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Federal</font></td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">655</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(136</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">State</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">247</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(3</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">902</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(139</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Deferred:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Federal</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(4,853</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">State</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(1,855</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(6,708</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Income tax provision (benefit)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(5,806</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(139</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Year ended March 31,</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 68%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">U.S. federal statutory income taxes</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(7,584</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2,654</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">State and local income taxes, net of federal benefits</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(1,245</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">406</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Change in valuation allowance</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,366</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(2,975</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Warrants</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,085</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">516</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Variable interest entity</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">237</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(172</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Deferred tax adjustments</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">295</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(593</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Other</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">40</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">25</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Income tax provision (benefit)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(5,806</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(139</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Deferred tax assets (liabilities):</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 68%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Allowance for doubtful accounts</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">449</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,457</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Accrued vacation</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2,982</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2,813</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Net operating losses</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">7,961</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,023</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">State taxes</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(1,235</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(532</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Accrued insurance</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">3,755</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">3,445</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Legal</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,257</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Property and equipment</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">661</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(212</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Other</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">281</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">43</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">16,111</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">8,037</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Valuation allowance</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(9,403</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(8,037</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Net deferred tax assets</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">6,708</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">March 31,</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 68%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Gross unrecognized income tax benefits at the beginning of the year</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">21,814</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">18,900</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Changes based on tax positions related to current year</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">2,914</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Increases for tax positions related to prior years</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Gross unrecognized income tax benefits at the end of the year</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">21,814</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">21,814</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> .58 .57 50000000 The Company's 2006 Stock Incentive Plan (the "Plan"), which is shareholder-approved, permits the grant of share options to its employees and board members for up to a maximum aggregate of 12.0 million shares of common stock. In addition, as of the first business day of each calendar year in the period 2007 through 2015, the maximum aggregate number of shares shall be increased by a number equal to one percent of the number of shares of common stock of the Company outstanding on December 31 of the immediately preceding calendar year. Option awards generally vest based on 3 years of continuous service (1/3 of the shares vest on the twelve month anniversary of the grant date, and an additional 1/12 of the shares vest on each subsequent fiscal quarter-end of the Company following such twelve month anniversary). Certain option awards provide for accelerated vesting if there is a change of control, as defined. The option awards have 7-year contractual terms. 3300000 3100000 4100000 3900000 413000000 411000000 Concurrent with the close of the Acquisition, PCHI simultaneously acquired title to substantially all of the real property acquired by the Company in the Acquisition. The Company received $5.0 million and PCHI guaranteed the Company's $47.277 million term loan. The Company remains primarily liable as the borrower under the $47.277 million term loan notwithstanding its guarantee by PCHI. The $47.277 million term loan is cross-collateralized by substantially all of the Company's assets and all of the real property of the Hospitals. All of the Company's operating activities are directly affected by the real property that was sold to PCHI, which is a related party entity that is affiliated with the Company through common ownership and control. As of March 31, 2013, PCHI was owned 51% by various physician investors and 49% by Ganesha, which is managed by Dr. Chaudhuri. 47277000 As noted above, PCHI is a guarantor on the $47.277 million term loan should the Company not be able to perform. PCHI's total liabilities represent the Company's maximum exposure to loss. Additionally, the Company is responsible for seismic remediation under the terms of the lease agreement (Notes 2 and 13). 7800000 7500000 447500 447500 7595 8235 8370 405000 405000 405000 -640 -135 0.18 0.18 0.18 0.07 0.07 0.07 0.07 .26 0.25 P1Y8M12D P1Y8M12D .18 7595 1533 <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 1 - DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">BASIS OF PRESENTATION - The accompanying consolidated financial statements include the accounts of Integrated Healthcare Holdings, Inc. and its subsidiaries (collectively, the &#147;Company&#148;) and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#147;GAAP&#148;).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has also determined that Pacific Coast Holdings Investment, LLC ("PCHI") (Note 9), is a variable interest entity as defined by GAAP and the Company is the primary beneficiary and, accordingly, the financial statements of PCHI are included in the accompanying consolidated financial statements.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All significant intercompany accounts and transactions have been eliminated in consolidation. Unless otherwise indicated, all amounts included in these notes to the consolidated financial statements are expressed in thousands (except per share amounts, percentages and stock option prices and values).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="color: black">LIQUIDITY - As of March 31, 2013 and 2012, the Company had a total stockholders&#146; deficiency of $29.9 million and $11.6 million, respectively, and a working capital deficit of $36.7 million and $14.6 million, respectively.&#160;&#160;For the years ended March 31, 2013 and 2012, the Company had net income (loss) of $(15.5) million and $7.5 million, respectively, and (negative) positive cash flow from operations of $(9.6) million and $4.5 million, respectively. At March 31, 2013, the Company had $5.0 million in additional availability under its revolving credit facility (Note 3). The Company anticipates making payments for provider fees and other expenses relating to the 2013 hospital quality assurance fee program of approximately $105.8 million and receiving approximately $235.5 million in revenues from the </font><font style="color: #1F497D">S</font><font style="color: black">tate ($79.4 million from the fee-for-service portion and $156.1 million from the managed care portion) (Notes 11 and 14). The Company is reliant on funds received under the hospital quality assurance fee program and not receiving such funding could have a material adverse effect on its liquidity and financial position and value of its common stock.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="color: black">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="color: black"></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">DESCRIPTION OF BUSINESS - Effective March 8, 2005, the Company acquired four hospitals (the "Hospitals") from subsidiaries of Tenet Healthcare Corporation (the "Acquisition"). The Company owns and operates the four community-based hospitals located in southern California, which are:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><br /> </p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="width: 7%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="vertical-align: top; width: 3%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="width: 90%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">282-bed Western Medical Center in Santa Ana</font></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">188-bed Western Medical Center in Anaheim</font></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">178-bed Coastal Communities Hospital in Santa Ana</font></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">114-bed Chapman Medical Center in Orange</font></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RECLASSIFICATION FOR PRESENTATION - Certain amounts previously reported have been reclassified to conform to the current period's presentation with no impact on the reported net income of the Company.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">CONCENTRATION OF RISK - The Hospitals are subject to licensure by the State of California and accreditation by the Joint Commission on Accreditation of Healthcare Organizations. Loss of either licensure or accreditation would impact the ability to participate in various governmental and managed care programs, which provide the majority of the Company's revenues.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Substantially all patient service revenues come from external customers. The largest payers are Medicare and Medicaid (including Medicare and Medicaid managed care plans) and other state and local government payers, which combined accounted for 58% and 57% of the patient service revenues for the years ended March 31, 2013 and 2012, respectively. No other payers represent a significant concentration of the Company's patient services revenues.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company receives all of its inpatient services revenue from operations in Orange County, California. The economic conditions of this service area could affect the ability of patients and third-party payers to reimburse the Company for services through its effect on disposable household income and the tax base used to generate state funding for Medicaid programs.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">USE OF ESTIMATES - The accompanying consolidated financial statements have been prepared in accordance with GAAP. The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Principal areas requiring the use of estimates include third-party cost report settlements, income taxes, accrued insurance retentions, self-insurance reserves, and net patient receivables. Management regularly evaluates the accounting policies and estimates that are used. In general, management bases the estimates on historical experience and on assumptions that it believes to be reasonable given the particular circumstances in which its Hospitals operate. Although management believes that all adjustments considered necessary for fair presentation have been included, actual results may materially vary from those estimates.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">PATIENT SERVICE REVENUES &#150; Patient service revenues are recognized in the period in which services are performed and are recorded based on established billing rates (gross charges) less contractual allowances and discounts, principally for patients covered by Medicare, Medicaid, managed care, and other health plans. Gross charges are retail charges. They are not the same as actual pricing, and they generally do not reflect what a hospital is ultimately paid and therefore are not displayed in the consolidated statements of operations. Hospitals are typically paid amounts that are negotiated with insurance companies or are set by the government. Gross charges are used to calculate Medicare outlier payments and to determine certain elements of payment under managed care contracts (such as stop-loss payments). Since Medicare requires that a hospital's gross charges be the same for all patients (regardless of payer category), gross charges are also what the Hospitals charge all other patients prior to the application of discounts and allowances.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a summary of sources of patient service revenues (net of contractual allowances and discounts) before provision for doubtful accounts:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 70%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: -11pt; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="6" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Year ended March 31,</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: -11pt; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2013</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2012</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 26%; color: black; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Medicare</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">55,570</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">58,046</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Medicaid</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">100,561</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">80,153</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Managed care</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">203,058</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">201,758</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Indemnity, self-pay and other</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">68,911</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">62,607</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 2.5pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">428,100</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">402,564</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenues under the traditional fee-for-service Medicare and Medicaid programs are based primarily on prospective payment systems. Discounts for retrospectively cost based revenues and certain other payments, which are based on the Hospitals' cost reports, are estimated using historical trends and current factors. Cost report settlements for retrospectively cost-based revenues under these programs are subject to audit and administrative and judicial review, which can take several years until final settlement of such matters are determined and completely resolved. Estimates of settlement receivables or payables related to a specific year are updated periodically and at year end and at the time the cost report is filed with the fiscal intermediary. Typically no further updates are made to the estimates until the final Notice of Program Reimbursement is received, at which time the cost report for that year has been audited by the fiscal intermediary. There could be a time lag of several years between the submission of a cost report and receipt of the Final Notice of Program Reimbursement. Since the laws, regulations, instructions and rule interpretations governing Medicare and Medicaid reimbursement are complex and change frequently, the estimates recorded by the Hospitals could change by material amounts. The Company has established settlement (payables) receivables of $(179) and $190 as of March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Hospitals receive supplemental payments from the State of California to support indigent care (Medi-Cal Disproportionate Share Hospital payments or "DSH") and from the California Medical Assistance Commission ("CMAC") under the SB 1100 and SB 1255 programs. The Hospitals received supplemental payments of $13.4 million and $14.3 million during the years ended March 31, 2013 and 2012, respectively. The related revenue recorded for the years ended March 31, 2013 and 2012, was $14.3 million and $15.4 million, respectively. As of March 31, 2013 and 2012, estimated DSH receivables were $5.9 million and $5.0 million, respectively, which are included as due from government payers in the accompanying consolidated balance sheets.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenues under managed care plans, including Medicare and Medicaid managed care plans (with patient service revenues of $84.7 million and $84.2 million for the years ended March 31, 2013 and 2012, respectively), are based primarily on payment terms involving predetermined rates per diagnosis, per-diem rates, discounted fee-for-service rates and/or other similar contractual arrangements. These revenues are also subject to review and possible audit by the payers. The payers are billed for patient services on an individual patient basis. An individual patient's bill is subject to adjustment on a patient-by-patient basis in the ordinary course of business by the payers following their review and adjudication of each particular bill. The Hospitals estimate the discounts for contractual allowances utilizing billing data on an individual patient basis. Management believes the estimation and review process allows for timely identification of instances where such estimates need to be revised. The Company does not believe there were any adjustments to estimates of individual patient bills that were material to patient service revenues.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Hospitals provide charity care to patients whose income level is below 300% of the Federal Poverty Level. Patients with income levels between 300% and 350% of the Federal Poverty Level qualify to pay a discounted rate under AB 774 based on various government program reimbursement levels. Patients without insurance are offered assistance in applying for Medicaid and other programs they may be eligible for, such as state disability, Victims of Crime, or county indigent programs. Patient advocates from the Hospitals' Medical Eligibility Program ("MEP") screen patients in the hospital and determine potential linkage to financial assistance programs. They also expedite the process of applying for these government programs. The estimated costs of charity care (based on direct and indirect costs as a ratio of gross uncompensated charges associated with providing care to charity patients) for the years ended March 31,&#160;2013 and 2012 were approximately $8.0 million and $7.0 million, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is not aware of any material claims, disputes, or unsettled matters with any payers that would affect revenues that have not been adequately provided for in the accompanying consolidated financial statements.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">PROVISION FOR BAD DEBTS - The Company provides for accounts receivable that could become uncollectible by establishing an allowance to reduce the carrying value of such receivables to their estimated net realizable value. The Hospitals estimate this allowance based on the aging of their accounts receivable, historical collections experience for each type of payer and other relevant factors. There are various factors that can impact the collection trends, such as changes in the economy, which in turn have an impact on unemployment rates and the number of uninsured and underinsured patients, volume of patients through the emergency department, the increased burden of copayments to be made by patients with insurance and business practices related to collection efforts. These factors continuously change and can have an impact on collection trends and the estimation process.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company's policy is to attempt to collect amounts due from patients, including copayments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations, including, but not limited to, the Emergency Medical Treatment and Labor Act ("EMTALA"). Generally, as required by EMTALA, patients may not be denied emergency treatment due to inability to pay. Therefore, until the legally required medical screening examination is complete and stabilization of the patient has begun, services are performed prior to the verification of the patient's insurance, if any. In nonemergency circumstances or for elective procedures and services, it is the Hospitals' policy, when appropriate, to verify insurance prior to a patient being treated.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">CASH AND CASH EQUIVALENTS - The Company considers all highly liquid debt investments purchased with a maturity of three months or less to be cash equivalents. Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits. The Company has never experienced any losses related to these balances.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">LETTER OF CREDIT &#150; At March 31, 2013, the Company had an outstanding letter of credit totaling $761. This letter of credit correspondingly reduces the Company&#146;s borrowing availability under its revolving line of credit (Note 3).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RECEIVABLES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS &#150; The following is a summary of the principal components of accounts receivable and due from/to government payers as of March 31, 2013 and 2012:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 70%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="6" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31,</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2013</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2012</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Accounts receivable:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="width: 36%; color: black; text-align: left; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Patient accounts receivable</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">83,964</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">71,800</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Allowance for doubtful accounts</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(21,143</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(18,201</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Accounts receivable, net</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">62,821</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">53,599</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Due from government payers:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">DSH</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">5,882</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">4,993</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Settlement receivables</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">190</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">5,882</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">5,183</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Due to government payers:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Settlement payables</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">179</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">179</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#146;s self-pay collection rate, which is the blended collection rate for uninsured and balance after insurance accounts receivable, was approximately 6.5% and 11.3% as of March&#160;31, 2013 and 2012, respectively. These self-pay collection rates include payments made by patients, including co-payments and deductibles paid by patients with insurance. As of March&#160;31,&#160;2013 and 2012, the allowance for doubtful accounts for self-pay uninsured was 95.2% and 90.3%, respectively, of self-pay uninsured patient accounts receivable. As of March&#160;31,&#160;2013 and 2012, the allowance for doubtful accounts for self-pay balance after insurance was 78.0% and 77.4%, respectively, of self-pay balance after insurance patient accounts receivable, consisting primarily of co-pays and deductibles owed by patients with insurance. As of March 31, 2013 and 2012, the allowance for doubtful accounts for managed care was 20.3% and 16.1%, respectively, of managed care patient accounts receivable.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Receivables from patients who are potentially eligible for Medicaid are classified as Medicaid pending under the MEP, with appropriate contractual allowances recorded. If the patient does not qualify for Medicaid, the receivables are reclassified to charity care and written off, or they are reclassified to self-pay and adjusted to their net realizable value through the provision for bad debts. Reclassifications of pending Medicaid accounts to self-pay do not typically have a material impact on the results of operations as the estimated Medicaid contractual allowances initially recorded are not materially different than the estimated provision for bad debts recorded when the accounts are reclassified. All accounts classified as pending Medicaid, as well as certain other governmental receivables, over the age of 90 days were reserved in contractual allowances as of March 31, 2013 and 2012 based on historical collections experience.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">INVENTORIES OF SUPPLIES - Inventories of supplies are valued at the lower of weighted average cost or market.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and any impairment write-downs related to assets held and used. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Capital leases are recorded at the beginning of the lease term as property and equipment and a corresponding lease liability is recognized. The value of the property and equipment under capital lease is recorded at the lower of either the present value of the minimum lease payments or the fair value of the asset. Such assets, including improvements, are amortized over the shorter of the lease term or their estimated useful life, where applicable.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company uses the straight-line method of depreciation for buildings and improvements, and equipment over their estimated useful lives of 25 years and 3 to 15 years, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">LONG-LIVED ASSETS - The Company evaluates its long-lived assets for possible impairment whenever circumstances indicate that the carrying amount of the asset, or related group of assets, may not be recoverable from estimated future undiscounted cash flows. Fair value estimates are derived from established market values of comparable assets or internal calculations of estimated undiscounted future net cash flows. The estimates of future net cash flows are based on assumptions and projections believed by the Company to be reasonable and supportable. These assumptions take into account patient volumes, changes in payer mix, revenue, and expense growth rates and changes in legislation and other payer payment patterns.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FAIR VALUE MEASUREMENTS - The Company's financial assets and liabilities recorded in the consolidated balance sheets include cash and cash equivalents, restricted cash, receivables, debt, accounts payable, and other liabilities, all of which are recorded at book value which approximates fair value.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">GAAP has established a hierarchy for ranking the quality and reliability of the information used to determine fair values and requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 7%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 10%; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Level 1:</font></td> <td style="width: 83%; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Unadjusted quoted market prices in active markets for identical assets or liabilities.</font></td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Level 2:</font></td> <td style="text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.</font></td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Level 3:</font></td> <td style="text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Unobservable inputs for the asset or liability.</font></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company utilizes the best available information in measuring fair value.&#160;&#160;Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company currently has no financial or nonfinancial assets or liabilities subject to fair value measurement on a recurring basis except for warrants issued in April 2010 and February 2013 (Note 4).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth the Company&#146;s financial assets and liabilities measured at fair value on a recurring basis and where they are classified within the hierarchy as of March 31, 2013 and 2012:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Total</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Level 1</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Level 2</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Level 3</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 32%; color: black; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Warrant liability at March 31, 2013</td><td style="width: 2%; color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="width: 13%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">5,276</td><td style="width: 1%; padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="width: 13%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="width: 1%; padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="width: 13%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="width: 1%; padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="width: 13%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">5,276</td><td style="width: 1%; padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Warrant liability at March 31, 2012</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">1,641</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;.</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">1,641</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td colspan="5" style="color: black; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; padding-left: -11pt">Warrant liability - fair value measurements using significant unobservable inputs (Level 3)</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 63%; color: black; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Balance at March 31, 2011</td><td style="width: 2%; color: black; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">167</td><td style="width: 1%; color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Change in fair value of warrant liability included in earnings</td><td style="color: black; padding-bottom: 1pt; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left; padding-left: -11pt">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right; padding-left: -11pt">1,474</td><td style="padding-bottom: 1pt; color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Balance at March 31, 2012</td><td style="color: black; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">1,641</td><td style="color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Fair value of warrants issued and vested, net</td><td style="color: black; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">1,692</td><td style="color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Fair value of warrants - loan discount on term loan</td><td style="color: black; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">534</td><td style="color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Change in fair value of warrant liability included in earnings</td><td style="color: black; padding-bottom: 1pt; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left; padding-left: -11pt">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right; padding-left: -11pt">1,409</td><td style="padding-bottom: 1pt; color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-bottom: 2.5pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Balance at March 31, 2013</td><td style="color: black; padding-bottom: 2.5pt; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left; padding-left: -11pt">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right; padding-left: -11pt">5,276</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Additional quantitative information about Level 3 fair value measurements is discussed in Note 4.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WARRANTS - The Company has entered into complex transactions that contain warrants (Notes 3 and 4). If an instrument (or an embedded feature) that has the characteristics of a derivative instrument is indexed to an entity&#146;s own stock, it is still necessary to evaluate whether it is classified in stockholders&#146; equity (or would be classified in stockholders&#146; equity if it were a freestanding instrument). The Company has concluded that the warrants should be classified as liabilities as the exercise price is subject to a weighted average ratchet down provision if the Company subsequently sells shares at a price lower than the then exercise price.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">INCOME (LOSS) PER COMMON SHARE &#150; Income (loss) per share is calculated under two different methods, basic and diluted. Basic income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period. Diluted income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period and dilutive potential shares of common stock. Dilutive potential shares of common stock, as determined under the treasury stock method, consist of shares of common stock issuable upon exercise of stock warrants or options, net of shares of common stock assumed to be repurchased by the Company from the exercise proceeds (Note 8).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SUPPLEMENTAL CASH FLOW INFORMATION - Interest paid during the years ended March 31, 2013 and 2012 was $9.4 million and $9.0 million, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company made cash payments for taxes of $0 and $14.0 million during the years ended March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company entered into new capital lease obligations of $2.1 million and $0 during the years ended March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">INCOME TAXES - Deferred income tax assets and liabilities are determined based on the differences between the book and tax basis of assets and liabilities and are measured using the currently enacted tax rates and laws using the asset and liability method. The Company assesses the realization of deferred tax assets to determine whether an income tax valuation allowance is required. The Company recorded a 58% and 100% valuation allowance on its net deferred tax assets as of March 31, 2013 and 2012, respectively, since they did not meet the more-likely-than-not threshold.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is a recognition threshold and measurement attribute for recognition and measurement of a tax position taken or expected to be taken in a tax return. It also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction and California. Certain tax attributes carried over from prior years continue to be subject to adjustment by taxing authorities. Any penalties or interest arising from federal or state taxes are recorded as a component of the Company&#146;s income tax provision.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SEGMENT REPORTING - The Company operates in one line of business, the provision of healthcare services through the operation of general hospitals and related healthcare facilities. The Company's Hospitals generate substantially all of its net patient service revenues.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company's four Hospitals and related healthcare facilities operate in one geographic region in Orange County, California. There are similarities in the region's economic characteristics and the nature of the Hospitals' operations, the regulatory environment in which they operate and the manner in which they are managed. This region is an operating segment, as defined by GAAP. In addition, the Company's Hospitals and related healthcare facilities share certain resources and benefit from many common clinical and management practices. Accordingly, the Company aggregates the facilities into a single reportable operating segment.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="color: black">NEW ACCOUNTING STANDARDS &#150; </font>Effective March 31, 2012, the Company adopted ASU&#160;2011-07, &#147;Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities,&#148; which requires health care entities to present the provision for bad debts relating to patient service revenue as a deduction from patient service revenue in the statement of operations rather than as an operating expense. Additional disclosures relating to sources of patient revenue and the allowance for doubtful accounts related to patient accounts receivable are also required. The adoption of this ASU did not have a material impact on the Company&#146;s consolidated financial statements.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 3&#160;&#150; DEBT</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of March 31, 2013, the Company had the following Credit Agreements:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 6%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 2%; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Wingdings 2">&#151;</font></td> <td style="width: 92%; font: 8pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt">A $47.277 million Term Loan issued under the $80.0 million Restated Credit Agreement, bearing an interest rate of LIBOR plus 10%, with the LIBOR floor set at 2% (12% at March 31, 2013). If any event of default occurs and continues, the lender can increase the interest rate by 5% per year. As of March 31, 2013, the Company was in compliance with all financial covenants. The stated maturity date for this Restated Credit Agreement is April 13, 2016.</font></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 6%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 2%; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Wingdings 2">&#151;</font></td> <td style="width: 92%; font: 8pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt">A $35.0 million Revolving Credit Agreement, bearing an interest rate of 4.25% plus LIBOR, with a 2.5% floor, per year (6.75% at March 31, 2013) and an unused commitment fee of 0.5% per year ($30.0 million outstanding balance at March 31, 2013).&#160;&#160;For purposes of calculating interest, all payments the Company makes on the Revolving Credit Agreement are subject to a five business day clearance period.&#160;&#160;As of March 31, 2013, the Company was in compliance with all financial covenants. The stated maturity date for this Revolving Credit Agreement is March 25, 2016. <font style="color: black">At March 31, 2013, the Company had $5.0 million in additional availability under this facility.</font></font></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Term loan - On August 1, 2012, the Company entered into Amendment No. 4 to Credit Agreement and Consent (the &#147;Credit Agreement Amendment&#148;), which amends <font style="color: black">the $80.0 million Credit Agreement, dated as of October 9, 2007, as amended, (the &#147;Credit Agreement&#148;) with SPCP Group IV, LLC, SPCP Group, LLC, and Silver Point Finance, LLC, as the Lender Agent (collectively, &#147;Silver Point&#148;), PCHI and Ganesha Realty<font style="text-transform: uppercase">, llc (&#147;</font>Ganesha<font style="text-transform: uppercase">&#148;)</font></font>.&#160;&#160;Under the Credit Agreement Amendment, Silver Point consented to and waived certain provisions under the Credit Agreement in connection with the Company&#146;s execution of the Revolving Loan Amendment No. 3. In addition, the provisions in the Credit Agreement that provide for mandatory prepayment of the Company&#146;s outstanding &#147;A/R Financing,&#148; as defined, upon receipt of certain federal matching funds under the QAF program were amended to replace 65% with 80%. In connection with the Credit Agreement Amendment, the Company agreed to pay Silver Point a one-time consent and amendment fee in an aggregate amount equal to $1.8 million, of which $450 was paid upon execution of the Credit Agreement Amendment and the balance was added to the principal amount under the Credit Agreement. The consent and amendment fee was recorded as a discount to the loan balance and is being amortized over the remaining life of the loan.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 7, 2013, the Company entered into an &#147;Amendment and Restatement to the Credit Agreement&#148; (the &#147;Amendment&#148;) with Silver Point, PCHI and Ganesha<font style="text-transform: uppercase">. </font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="text-transform: uppercase">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="color: black">Under the Amendment, the Credit Agreement was amended and restated in its entirety in the form of the &#147;Amended and Restated Credit Agreement ($47.277 million Term Loan)&#148; attached as Exhibit A to the Amendment (the &#147;Restated Credit Agreement&#148;). The Restated Credit Agreement reflects changes to the terms of the Credit Agreement that were previously made under various amendments the Company entered into since inception of the Credit Agreement in October 2007. </font>In connection with the Restated Credit Amendment, the Company agreed to pay Silver Point a one-time amendment fee of $841, which was added to the principal amount under the Restated Credit Agreement. The one-time amendment fee was recorded as a discount from the loan balance and, together with the amortized portion of the discount recorded under the Credit Agreement Amendment, is being amortized over the remaining life of the loan. In addition, the increase in the fair value of warrants issued to Silver Point on February 7, 2013 of $543 also were recorded as a discount from the loan balance and is being amortized over the remaining life of the loan. During the year ended March 31, 2013, the Company recognized $1.4 million in loan discount amortization relating to the Restated Credit Agreement.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the following new amendments were made to the Credit Agreement and reflected in the Restated Credit Agreement:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 7%; padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="width: 90%; padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The Stated Maturity Date was extended to April 13, 2016. The Credit Agreement was previously due to mature on April 13, 2013.&#160;&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The annual interest rate applicable to the loans under the Credit Agreement was modified from the previous fixed rate of 14.5% to LIBOR plus 10%, with the LIBOR floor set at 2% (12% at March 31, 2013), except upon an Event of Default. The Company may elect from one, two or three months LIBOR interest periods, except in an Event of Default when the interest period may not exceed one month.&#160;&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The principal balance under the Credit Agreement was increased from $46.350 million to $47.277 million, to reflect the Company&#146;s new borrowings under the Restated Credit Agreement.&#160;&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The Company repaid all amounts owing to SPCP Group IV, LLC under the Credit Agreement, consisting of a principal balance of $8.120 million plus accrued interest of $19.6, and increased the principal amount owing to SPCP Group, LLC under the Credit Agreement by $9.047 million to reflect the repayment to SPCP Group IV, LLC and other new borrowings.&#160;&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The financial covenants under the Credit Agreement were amended, including the covenants requiring the Company to maintain minimum levels of EBITDA (as defined in the Restated Credit Agreement).&#160;&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; text-align: justify; width: 7%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; text-align: justify; width: 3%; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-right: 5.4pt; text-align: justify; width: 90%; font: 8pt Times New Roman, Times, Serif">Upon the Company&#146;s receipt of enhanced federal matching funds from Medi-Cal under the QAF program (defined as &#147;Net QAF Funds&#148; under the Restated Credit Agreement), the Company is required to make certain prepayments of principal under its Revolving Loan Agreement with MidCap Financial, LLC.&#160;&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-right: 5.4pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">A prepayment fee was established for voluntary prepayments under the Credit Agreement equal to 5% for prepayments made on or prior to December 31, 2013, and 2% for prepayments made after January 1, 2014 and before December 31, 2014.&#160;&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revolving line of credit - On August 1, 2012, the Company entered into Amendment No. 3 to Credit and Security Agreement (the &#147;Revolving Loan Amendment No. 3&#148;), which amends Credit and Security Agreement, dated as of August 30, 2012, as amended, (the &#147;Revolving Loan Agreement&#148;) with MidCap Funding IV, LLC and Silicon Valley Bank, as lenders (the &#147;Lenders&#148;), and MidCap Financial, LLC, as agent (the &#147;Agent&#148;). Under the Revolving Loan Amendment No. 3, the minimum Revolving Loan Commitment Amount under the Revolving Loan Agreement was increased from $14.0 million to $30.0 million, and the Company agreed to pay the Lenders an origination fee of 1.0% of the Lenders&#146; increased commitment under the Revolving Loan Amendment No. 3, or $160.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 7, 2013, the Company entered into &#147;Amendment No. 4 to Credit and Security Agreement and Limited Consent&#148; (the &#147;Revolving Loan Amendment No. 4&#148;) with the Lenders and the Agent.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99.85pt">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Revolving Loan Amendment No. 4 amends the Revolving Loan Agreement, to reflect the following changes:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 7%; padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="width: 90%; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The maximum face amount of the Letter of Credit Liabilities permitted under the Revolving Loan Agreement was increased to $761, and the Lenders consented to the issuance of a Letter of Credit in the same amount by Wells Fargo Bank, National Association.&#160;&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The period during which the Prepayment Fee of 1% is applicable was extended from three years from the original closing date to the Commitment Expiry Date.&#160;&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The Agent and Lenders consented to the Company&#146;s entry into the Amendment with Silver Point and the Restated Credit Agreement thereunder.&#160;&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 25, 2013, the Company entered into Amendment No. 5 to Credit and Security Agreement and Limited Waiver (the &#147;Revolving Loan Amendment No. 5&#148;), which amends the Revolving Loan Agreement, with the Lenders and the Agent. The Company agreed to pay the Lenders an origination fee of 1.0% of the Lenders&#146; commitment under the Revolving Loan Amendment No. 5, or $350.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Among other things, the Revolving Loan Amendment No. 5 provides for the following:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 7%; padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-left: 0pt; text-align: justify; width: 90%; font: 8pt Times New Roman, Times, Serif">An increase in the Revolving Loan Commitment amount from $30.0 million to $35.0 million;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The Applicable Margin was changed: (a) from 3.00% to 2.25% with respect to Revolving Loans bearing interest upon the Base Rate and (b) from 5.00% to 4.25% for all other Revolving Loans and Obligations;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">The Commitment Expiry Date was extended to March 25, 2016;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">Certain modifications were made to the definitions of Permitted Indebtedness and Prepayment Fee and the lockbox requirements; and</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The Company was granted a waiver of certain prior Events of Default or Defaults under the Revolving Loan Agreement and a waiver of the requirement to comply with the Fixed Charge Coverage Ratio covenant for the Defined Period ending March 31, 2013.</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company's outstanding debt consists of the following:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2013</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2012</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; font: 8pt Times New Roman, Times, Serif">Current:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Revolving line of credit</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">30,000</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">14,000</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Discount</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(473</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(217</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">29,527</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">13,783</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; font: 8pt Times New Roman, Times, Serif">Noncurrent:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Term loan</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">47,277</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">45,000</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Discount</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(1,747</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">45,530</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">45,000</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company&#146;s noncurrent debt matures as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 60%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Year ending March 31,</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Amount</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 45%; text-align: center; font: 8pt Times New Roman, Times, Serif">2014</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 11%; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; font: 8pt Times New Roman, Times, Serif">2015</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; font: 8pt Times New Roman, Times, Serif">2016</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">2017</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">47,277</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company&#146;s noncurrent debt matures as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 60%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Year ending March 31,</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Amount</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 45%; text-align: center; font: 8pt Times New Roman, Times, Serif">2014</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 11%; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; font: 8pt Times New Roman, Times, Serif">2015</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; font: 8pt Times New Roman, Times, Serif">2016</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">2017</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">47,277</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> 47277 <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 4 - COMMON STOCK WARRANTS</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A summary of warrant activity for the years ended March 31, 2013 and 2012 is presented as follows.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; font: 8pt Times New Roman, Times, Serif">Weighted-</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; font: 8pt Times New Roman, Times, Serif">Shares issuable</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; font: 8pt Times New Roman, Times, Serif">average</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; font: 8pt Times New Roman, Times, Serif">Expiration</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">under warrants</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">exercise price</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">date</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 49%; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March 31, 2012 and 2011</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; text-align: right; font: 8pt Times New Roman, Times, Serif">405,000</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2013</font></td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Repurchased</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">(16,800</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2013</font></td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Issued</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">16,800</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2016</font></td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Amended (old expiration date)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">(388,200</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2013</font></td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 9pt; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Amended (new expiration date)</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">388,200</td><td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2016</font></td><td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 0pt; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March 31, 2013</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif">405,000</td><td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2016</font></td><td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 13, 2010 the Company issued three-year warrants (the &#147;Omnibus Warrants&#148;) to purchase its common stock at an exercise price of $0.07 per share in the following denominations: 139.0 million shares to KPC or its designees and 96.0 million shares to Silver Point or its designees. The Omnibus Warrants also provide the holders with certain pre-emptive, information and registration rights. As of April 13, 2010, the Company recorded warrant expense and the related warrant liability of $2.9 million, representing fair value.&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, on April 13, 2010, the Company issued a three-year warrant (the &#147;Release Warrant&#148;) to acquire up to 170.0 million shares of common stock at $0.07 per share to Dr. Chaudhuri who facilitated the release (see &#147;DEBT&#148;) enabling the Company to recover amounts due from its prior lender and a $1.0 million reduction in principal of its outstanding debt, among other benefits to the Company.&#160;&#160;The Release Warrant also provides the holder with certain pre-emptive, information and registration rights. During the year ended March 31, 2010, the Company recorded the fair value of $2.1 million as an offsetting cost of the recovery.&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 7, 2013, in connection with the Restated Credit Agreement, the Company entered into the following transactions<b> </b>involving warrants:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company entered into a Warrant Repurchase Agreement with SPCP Group IV, LLC pursuant to which it repurchased the outstanding common stock warrant issued to SPCP Group IV, LLC on or about April 13, 2010 (the &#147;Cancelled Warrant&#148;). The Cancelled Warrant (part of the Omnibus Warrants) entitled the holder to purchase an aggregate of 16.8 million shares of the Company&#146;s common stock at an exercise price of $0.07 per share. The Company repurchased the Cancelled Warrant for a purchase price of $0.12 per share minus the exercise price of $0.07 per share resulting in a net purchase price of $0.05 per share multiplied by 16.8 million shares for an aggregate purchase price of $840.9.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Immediately following the warrant repurchase, the Company issued a new common stock warrant (the &#147;New Warrant&#148;) to SPCP Group, LLC for a price of $0.05 per share (an aggregate price of $840.9) on the same terms as the Cancelled Warrant entitling the holder to purchase an aggregate of 16.8 million shares of common stock at an exercise price of $0.07 per share, except that the New Warrant expires on April 13, 2016.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Also simultaneous with the transactions described above, the Company extended the expiration date from April 13, 2013 to April 13, 2016 for the Omnibus Warrants issued to KPC and the remaining held by Silver Point (to purchase 79.2 million shares) and the Release Warrant issued to Dr. Chaudhuri. The extension of the warrant expiration date was intended to conform the terms of the warrants to that of the Restated Credit Agreement.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 66pt">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company assessed the amended credit agreement entered into in August 2012 and February 2013 under the provisions of ASC 470-50 and determined that the debt amendments should be accounted for as a debt modification. Accordingly, the recorded change in fair value as of February 7, 2013, totaling $534, of the New Warrant and the Omnibus Warrant held by SPCP Group, LLC was recognized as a component of the debt discount on the Term Loan (Note 3) and will be amortized to interest expense over the term of the debt agreement using the effective interest method.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The warrant expense relating to the Release Warrant and the Omnibus Warrant held by Dr. Chaudhuri for the years ended March 31, 2013 and 2012 was $1.7 million and $0, respectively. The change in fair value of the Release Warrant and the Omnibus was immediately charged to expense.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Omnibus Warrants, the Release Warrant, and the New Warrant are collectively referred to as the &#147;IHHI Warrants.&#148; As of March 31, 2013, the fair value of the IHHI Warrants was $5.3 million.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The net loss related to the change in fair value of the IHHI Warrants for the year ended March 31, 2013 and 2012 was $1.4 million and $1.5 million, respectively. The total loss on warrants was $3.1 million and $1.5 million for the years ended March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of warrants issued by the Company is estimated using the Black-Scholes valuation model, which it believes is the appropriate valuation method under the circumstances. Since the Company&#146;s stock is thinly traded, the expected volatility is based on an analysis of its stock and the stock of&#160;eight other publicly traded companies that own hospitals.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The risk-free interest rate is based on the average yield on U.S. Treasury notes with maturity commensurate with the terms of the warrants. The dividend yield reflects that the Company has not paid any cash dividends since inception and does not anticipate paying cash dividends in the foreseeable future.&#160;&#160;The assumptions used in the Black-Scholes valuation model are as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, 2013</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">February 7, 2013</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, 2012</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 49%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Expected dividend yield</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.0%</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.0%</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.0%</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Risk-free interest rate</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.4%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.4%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.2%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Expected volatility</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">39.9%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">40.3%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">57.3%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Expected term (in years)</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">3.05</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">3.18</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">1.04</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOTE 5 - INCOME TAXES</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amount of tax-related assets and liabilities and income tax provisions. The Company assesses the recoverability of the deferred tax assets on an ongoing basis. In making this assessment the Company is required to consider all available positive and negative evidence to determine whether, based on such evidence, it is more likely than not that some portion or all of the net deferred assets will be realized in future periods. This assessment requires significant judgment. In addition, the Company has made significant estimates involving current and deferred income taxes, tax attributes relating to the interpretation of various tax laws, historical bases of tax attributes associated with certain tangible and intangible assets and limitations surrounding the realization of the deferred tax assets. The Company does not recognize <font style="background-color: White">current and future tax benefits until it is deemed more likely than not that certain tax positions will be sustained.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="background-color: White">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The income tax provision (benefit) consisted of the following:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 70%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="6" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Year ended March 31,</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2013</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2012</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Income tax provision (benefit):</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Current:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="width: 36%; color: black; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Federal</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">655</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(136</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-bottom: 1pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">State</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">247</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(3</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 1pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">902</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(139</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Deferred:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Federal</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(4,853</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-bottom: 1pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">State</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(1,855</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 1pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(6,708</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Income tax provision (benefit)</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(5,806</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(139</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A reconciliation between the amount of reported income tax expense (benefit) and the amount computed by multiplying income before income tax provision (benefit) by the statutory federal income tax rate is as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="background-color: White">&#160;</font></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif"></td> <td colspan="6" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Year ended March 31,</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2013</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2012</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">U.S. federal statutory income taxes</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(7,584</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">2,654</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">State and local income taxes, net of federal benefits</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(1,245</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">406</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Change in valuation allowance</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">1,366</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(2,975</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; font: 8pt Times New Roman, Times, Serif">Warrants</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">1,085</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">516</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Variable interest entity</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">237</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(172</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Deferred tax adjustments</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">295</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(593</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Other</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">40</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">25</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">Income tax provision (benefit)</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(5,806</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(139</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="background-color: White">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Deferred income taxes reflect the tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amount used for income tax purposes. The following table discloses those significant components of deferred tax assets and liabilities, including the valuation allowance at March 31:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="background-color: White">&#160;</font></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2013</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2012</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Deferred tax assets (liabilities):</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Allowance for doubtful accounts</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">449</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">1,457</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Accrued vacation</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">2,982</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">2,813</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Net operating losses</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">7,961</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">1,023</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">State taxes</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(1,235</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(532</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Accrued insurance</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">3,755</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">3,445</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; font: 8pt Times New Roman, Times, Serif">Legal</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">1,257</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Property and equipment</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">661</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(212</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Other</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">281</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">43</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">16,111</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">8,037</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Valuation allowance</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(9,403</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(8,037</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">Net deferred tax assets</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">6,708</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The result of the allocation of the valuation allowance between short term and long term deferred tax assets before netting the deferred tax liabilities results in net deferred tax assets consisting of short term deferred tax assets of $6.3 million (net of valuation allowance) and long term deferred tax assets of $380. The valuation allowances above were recorded based on an assessment of the realization of deferred tax assets as described below.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="width: 7%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="vertical-align: top; width: 4%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="width: 89%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Cumulative losses in recent years</font></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Income/losses expected in future years</font></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Unsettled circumstances that, if unfavorably resolved, would adversely affect future operations and profit levels</font></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">The availability, or lack thereof, of taxable income in prior carryback periods that would limit realization of tax benefits</font></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">The carryforward period associated with the deferred tax assets and liabilities</font></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company assesses the realization of deferred tax assets to determine whether an income tax valuation allowance is required. The Company recorded a partial valuation allowance on its net deferred tax assets based on income from near-term projections resulting from government subsidies.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ASU 2009-06, &#147;Income Taxes (Topic 740),&#148; prescribes a consistent financial reporting recognition threshold and measurement standard, as well as criteria for subsequently recognizing, derecognizing and measuring tax positions taken or expected to be taken in a tax return. ASU 2009-06 also requires certain disclosures with respect to the uncertainty in income taxes. A reconciliation of the change in the amount of gross unrecognized income tax benefits is a follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="background-color: White">&#160;</font></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="6" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31,</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2013</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2012</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; text-align: left; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Gross unrecognized income tax benefits at the beginning of the year</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; text-align: right; font: 8pt Times New Roman, Times, Serif">21,814</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; text-align: right; font: 8pt Times New Roman, Times, Serif">18,900</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Changes based on tax positions related to current year</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">2,914</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Increases for tax positions related to prior years</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">&#150;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">&#150;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Gross unrecognized income tax benefits at the end of the year</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">21,814</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">21,814</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="background-color: White">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of March 31, 2013, approximately $21.8 million of unrecognized income tax benefits would affect the fiscal 2013 effective tax rate if released into income due to the impact of the valuation allowance.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#146;s net operating losses of $17.1 million for federal and $22.4 million for state expire through 2033. The utilization of net operating losses and credit carryforwards are limited under the provisions of the IRC Section 382 and similar state provisions. Section 382 of the IRC of 1986 generally imposes an annual limitation on the amount of NOL carryforwards that may be used to offset taxable income where a corporation has undergone significant changes in stock ownership. In fiscal year 2009, the Company entered into an amended purchase agreement which resulted in a change in control. The Company conducted an analysis and determined that it is subject to significant IRC Section 382 limitations. For both Federal and state tax purposes, the Company's utilization of NOL and credit carryforwards is subject to significant IRC Section 382 limitations.&#160;&#160;The Company evaluates its ability to utilize the net operating losses each period with regard to the limitations imposed under IRC 382 and also considering the continuing expiration of statutes of limitation for prior years; and in the prior period determined that a portion of the federal and state net operating losses were no longer realizable, and removed from the schedule of deferreds those net operating losses in excess of the IRC 382 limitation and also considering prior years statutes now closed.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="background-color: White">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">PCHI TAX STATUS - PCHI is a limited liability corporation. PCHI's taxable income or loss will flow through to its owners and be their separate responsibility. Accordingly, the accompanying consolidated financial statements do not include any amounts for the income tax expense or benefit, or liabilities related to PCHI's income or loss.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <table align="center" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, 2013</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">February 7, 2013</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, 2012</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 49%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Expected dividend yield</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.0%</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.0%</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.0%</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Risk-free interest rate</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.4%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.4%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.2%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Expected volatility</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">39.9%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">40.3%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">57.3%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Expected term (in years)</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">3.05</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">3.18</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">1.04</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A summary of warrant activity for the years ended March 31, 2013 and 2012 is presented as follows.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; font: 8pt Times New Roman, Times, Serif">Weighted-</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; font: 8pt Times New Roman, Times, Serif">Shares issuable</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; font: 8pt Times New Roman, Times, Serif">average</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; font: 8pt Times New Roman, Times, Serif">Expiration</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">under warrants</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">exercise price</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">date</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 49%; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March 31, 2012 and 2011</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; text-align: right; font: 8pt Times New Roman, Times, Serif">405,000</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2013</font></td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Repurchased</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">(16,800</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2013</font></td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Issued</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">16,800</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2016</font></td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Amended (old expiration date)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">(388,200</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2013</font></td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 9pt; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Amended (new expiration date)</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">388,200</td><td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2016</font></td><td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 0pt; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March 31, 2013</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif">405,000</td><td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2016</font></td><td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 8 - INCOME (LOSS) PER SHARE</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Income (loss) per share is calculated under two different methods, basic and diluted. Basic income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period. Diluted income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period and dilutive potential shares of common stock. Dilutive potential shares of common stock, as determined under the treasury stock method, consist of shares of common stock issuable upon exercise of stock warrants or options, net of shares of common stock assumed to be repurchased by the Company from the exercise proceeds.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since the Company incurred a loss for the year ended March 31, 2013, the potential shares of common stock consisting of approximately 413 million shares issuable under warrants and stock options were not included in the diluted calculations since they were anti-dilutive.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Income per share for the year ended March 31, 2012 was computed as shown below. Stock options and warrants aggregating approximately 411 million shares were not included in the diluted calculation since they were anti-dilutive.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="6" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Year ended March 31,</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2013</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2012</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Numerator:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Net income attributable to</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Integrated Healthcare Holdings, Inc.</td><td style="width: 2%; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 13%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">(15,537</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="width: 2%; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 13%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">7,452</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Denominator:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Weighted average common shares</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">255,307</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">255,307</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Dilutive options</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">&#150;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">1,533</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Denominator for diluted calculation</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">255,307</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">256,840</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Income per share - basic</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">(0.06</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.03</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Income per share - diluted</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">(0.06</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.03</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="6" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Year ended March 31,</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2013</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2012</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Numerator:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Net income attributable to</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Integrated Healthcare Holdings, Inc.</td><td style="width: 2%; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 13%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">(15,537</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="width: 2%; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 13%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">7,452</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Denominator:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Weighted average common shares</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">255,307</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">255,307</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Dilutive options</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">&#150;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">1,533</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Denominator for diluted calculation</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">255,307</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">256,840</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Income per share - basic</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">(0.06</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.03</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Income per share - diluted</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">(0.06</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.03</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> -16800 16800 -388200 388200 0.07 April 13, 2016 April 13, 2013 April 13, 2013 April 13, 2013 April 13, 2016 April 13, 2013 April 13, 2016 <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 9 - VARIABLE INTEREST ENTITY</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Concurrent with the close of the Acquisition, PCHI simultaneously acquired title to substantially all of the real property acquired by the Company in the Acquisition. The Company received $5.0 million and PCHI guaranteed the Company's $47.277 million term loan. The Company remains primarily liable as the borrower under the $47.277 million term loan notwithstanding its guarantee by PCHI. The $47.277 million term loan is cross-collateralized by substantially all of the Company's assets and all of the real property of the Hospitals. All of the Company's operating activities are directly affected by the real property that was sold to PCHI, which is a related party entity that is affiliated with the Company through common ownership and control. As of March 31, 2013, PCHI was owned 51% by various physician investors and 49% by Ganesha, which is managed by Dr. Chaudhuri (majority stockholder in the Company).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company entered into a lease agreement dated March 7, 2005 (amended and restated as of April 13, 2010) under which it leased back from PCHI all of the real estate that it transferred to PCHI (Note 13). The amended lease terminates on the 25-year anniversary of the original lease (March 7, 2005), grants the Company the right to renew for one additional 25-year period, and requires combined annual base rental payments of $8.3 million for all the properties. However, until PCHI refinances the related $47.277 million term loan, the annual base rental payments are reduced to $7.3 million. In addition, the Company offsets, against its rental payments owed to PCHI, interest payments that it makes on the related $47.277 million term loan. Lease payments to PCHI and offsetting interest payments are eliminated in consolidation.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">GAAP defines variable interest entities (&#147;VIE&#148;) as entities with a level of invested equity that is not sufficient to fund future activities to permit them to operate on a stand-alone basis, or whose equity holders lack certain characteristics of a controlling financial interest. Then, for entities identified as a VIE, the guidance sets forth a model to a primary beneficiary based on an assessment of which party to a VIE, if any, bears a majority of the exposure to expected losses, or stands to gain from a majority of its expected returns and has the power to direct activities of the VIE that impacts economic performance. The primary beneficiary of a VIE should consolidate the VIE.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company determined that it provides the majority of financial support to PCHI through various sources including lease payments, remaining primarily liable under the $47.277 million term loan, and cross-collateralization of the Company's non-real estate assets to secure the $47.277 million term loan. The Company concluded that PCHI is a VIE and it is the primary beneficiary. Accordingly, the financial statements of PCHI are included in the accompanying consolidated financial statements.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">PCHI's assets, liabilities, and deficiency are set forth below.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2013</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2012</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Cash</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">147</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">68</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Property, net</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">39,696</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">40,984</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Other</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">129</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">207</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">Total assets</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">39,972</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">41,259</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Debt ($47,277, net of discount) (as guarantor)</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">46,039</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">45,000</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Other</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">488</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">641</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Total liabilities</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">46,527</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">45,641</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Deficiency</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(6,555</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(4,382</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">Total liabilities and accumulated deficit</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">39,972</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">41,259</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As noted above, PCHI is a guarantor on the $47.277 million term loan should the Company not be able to perform.&#160;&#160;PCHI's total liabilities represent the Company's maximum exposure to loss. Additionally, the Company is responsible for seismic remediation under the terms of the lease agreement (Notes 2 and 13).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">PCHI rental income and the Company&#146;s related rental expense of $7.8 million and $7.5 million were eliminated upon consolidation for the years ended March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0.9in 0pt 0; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0.9in 0pt 0">NOTE 11 - HOSPITAL QUALITY ASSURANCE FEES (&#147;QAF&#148;)</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0.9in 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October 2009, the Governor of California signed legislation supported by the hospital industry to impose a provider fee on general acute care hospitals that, combined with federal matching funds, would be used to provide supplemental Medi-Cal payments to hospitals. The state submitted the plan to the Centers for Medicare and Medicaid Services (&#147;CMS&#148;) for a required review and approval process, and certain changes in the plan were required by CMS. Legislation amending the fee program to reflect the required changes was passed by the legislature and signed by the Governor on September&#160;8, 2010. Among other changes, the legislation leaves distribution of &#147;pass-through&#148; payments received by Medi-Cal managed care plans that will be paid to hospitals under the program to the discretion of the plans.&#160;&#160;The hospital quality assurance fee program (&#147;QAF&#148;) created by this legislation initially provided payments for up to 21&#160;months retroactive to April 2009 and expiring on December&#160;31, 2010 (&#147;2010 QAF&#148;).&#160; In February 2011, CMS gave final approval for the 2010 QAF.&#160;During fiscal year 2011, the Company recognized $87.2 million in revenue and recorded expenses of $47.8 million relating to the 2010 QAF.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #1F497D">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December 2011, CMS gave final approval for the extension of the QAF for the nine month period from January 1 through June 30, 2011 (&#147;2011 QAF&#148;).&#160; Accordingly, for the year ended March 31, 2012 the Company recognized $31.9 million in revenue and recorded expenses of $15.9 million relating to the 2011 QAF.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="background-color: White">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In June 2012, CMS conditionally approved the extension of the QAF for the thirty month period from July 1, 2011 through December 31, 2013 (&#147;2013 QAF&#148;).&#160; In June 2012, the California State Legislature amended the hospital fee statute to recognize separate CMS approval of the fee-for-service portion and managed care portion of the 2013 QAF, which was further clarified in legislation approved by the governor of California in September 2012.&#160; As a result, during the year ended March 31, 2013, the Company recognized revenue of $54.2 million and expenses of $52.5 million relating to the fee-for-service portion of the 2013 QAF for the periods from July 1, 2011 through March 31, 2013. See Note 14.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTE 13 - COMMITMENTS AND CONTINGENCIES</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">INFORMATION TECHNOLOGY SYSTEMS &#150; On July 1, 2011, the Company entered into software and services agreements with McKesson Technologies Inc. (&#147;McKesson&#148;) to upgrade the Company&#146;s information technology systems.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the agreements, McKesson will provide the Company with a variety of services, including new software implementation and education/training services for the Company&#146;s personnel, software maintenance services and professional services related to movement and migration of data from legacy systems.&#160;&#160;McKesson will also furnish to the Company and maintain new hardware to accommodate the upgraded software and systems.&#160;&#160;The new hardware will include computers and servers, among other things, and will include installation, testing, and ongoing maintenance.&#160;&#160;The Company has entered into the arrangement to enhance its clinical information systems and upgrade its billing and revenue management information systems.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The agreements will initially run for a period of five years, and the recurring services may be renewed by the Company for successive periods.&#160;&#160;The agreements do not provide that they may be terminated by the Company prior to the initial expiration date.&#160;&#160;The agreements provide for one-time fees and recurring fees which aggregate a total of $22.0 million.&#160;&#160;Approximately 60% of the fees are for one-time charges, while the balance is for recurring services. During the year ended March 31, 2013 the Company completed conversion of one of its facilities to the McKesson system and is continuing to convert the remaining three facilities during the first quarter of the Company&#146;s fiscal year 2014. The Company is also continuing to test and develop system applications where necessary.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">OPERATING LEASES AND LONG TERM LEASE COMMITMENT WITH VARIABLE INTEREST ENTITY &#150; On April 13, 2010, the Company and PCHI entered into a Second Amendment to Amended and Restated Triple Net Hospital Building Lease (the &#147;2010 Lease Amendment&#148;).&#160;&#160;Under the 2010 Lease Amendment, the annual base rent to be paid by the Company to PCHI was increased from $5.4 million to $7.3 million. The base rent is subject to an annual Consumer Price Index increase on January 1 of each year; such increase shall not be less than 2% or more than 6% per year. The annual base rent is currently $7.8 million. If PCHI refinances the $47.277 million term loan, the annual base rent will increase to $8.3 million. This lease commitment with PCHI is eliminated in consolidation.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following is a schedule of the Company's future minimum operating lease payments, excluding the long term lease commitment with PCHI, that have initial or remaining non-cancelable lease terms in excess of one year as of March 31, 2013:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellspacing="0" cellpadding="0" align="center" style="width: 80%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Year ended March 31,</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="width: 62%; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2014</font></td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 15%; text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,620</font></td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2015</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,335</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2016</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,253</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2017</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,253</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2018</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,253</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Thereafter</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: black">11,627</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Total</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: black">18,341</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Total rental expense (excluding PCHI rent) for the years ended March 31, 2013 and 2012 was $5.3 million and $4.8 million, respectively. The Company received sublease rental income in relation to certain leases of approximately $563 and $552 for the years ended March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">CAPITAL LEASES - In connection with the Acquisition, the Company also assumed the leases for the Chapman facility, which include buildings and land with terms that were extended concurrently with the assignment of the leases to December 31, 2023. The Company leases equipment under capital leases expiring at various dates through 2017. Assets under capital leases with a net book value of $7.1 million and $6.2 million are included in the accompanying consolidated balance sheets as of March 31, 2013 and 2012, respectively. Interest rates used in computing the net present value of the lease payments are based on the interest rates implicit in the leases.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a schedule of future minimum lease payments under the capitalized leases with the present value of the minimum lease payments as of March 31, 2013:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="width: 80%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Year ended March 31,</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="width: 62%; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2014</font></td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 15%; text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,873</font></td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2015</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,899</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2016</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,750</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2017</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,276</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2018</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">932</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Thereafter</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: black">4,279</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Total minimum lease payments</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">12,009</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Less amount representing interest (weighted average interest rate of 10.2%)</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: black">(4,119</font></td> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Net present value of net minimum lease payments</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">7,890</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Less current portion</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: black">(1,101</font></td> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Noncurrent portion</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: black">6,789</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">INSURANCE &#150; The Company accrues for estimated general and professional liability claims, to the extent not covered by insurance, when they are probable and reasonably estimable. The Company has purchased as primary coverage a claims-made form insurance policy for general and professional liability risks. Estimated losses within general and professional liability retentions from claims incurred and reported, along with incurred but not reported (&#147;IBNR&#148;) claims, are accrued based upon projections and are discounted to their net present value using an interest rate of 5.0%. To the extent that subsequent claims information varies from estimates, the liability is adjusted in the period such information becomes available. As of March 31, 2013 and 2012, the Company had accrued $10.6 million and $11.5 million, respectively, which is comprised of $5.5 million and $4.5 million, respectively, in incurred and reported claims, along with $5.1 million and $7.0 million, respectively, in estimated IBNR. Estimated insurance recoveries of $2.1 million and $3.0 million are included in other prepaid expenses and current assets as of March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has also purchased occurrence coverage insurance to fund our obligations under our workers compensation program. The Company has a "paid loss plan" policy, under which the carrier pays all workers compensation claims, with no deductible or reimbursement required of us. The Company accrues for estimated workers compensation claims, to the extent not covered by insurance, when they are probable and reasonably estimable. The ultimate costs related to this program include expenses for deductible amounts associated with claims incurred and reported in addition to an accrual for the estimated expenses incurred in connection with IBNR claims. Claims are accrued based upon projections and are discounted to their net present value using an interest rate of 5.0%. To the extent that subsequent claims information varies from estimates, the liability is adjusted in the period such information becomes available. As of March 31, 2013 and 2012, the Company had accrued $500 and $673, respectively, comprised of $200 and $338, respectively, in incurred and reported claims, along with $300 and $335, respectively, in estimated IBNR.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Company has a self-insured health benefits plan for our employees. As a result, the Company has established and maintained an accrual for IBNR claims arising from self-insured health benefits provided to employees. Our IBNR accruals at March 31, 2013 and 2012 were based upon projections. The Company determines the adequacy of this accrual by evaluating our limited historical experience and trends related to both health insurance claims and payments, information provided by our insurance broker and third party administrator, and industry experience and trends. The accrual is an estimate and is subject to change. Such change could be material to our consolidated financial statements. As of March 31, 2013 and 2012, the Company had accrued $1.9 million and $2.2 million, respectively, in estimated IBNR.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has also purchased umbrella liability policies with aggregate limits of $25 million. The umbrella policies provide coverage in excess of the primary layer and applicable retentions for insured liability risks such as general and professional liability, auto liability, and workers compensation (employers liability).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of March 31, 2013, the Company finances various insurance policies at an interest rate of 4.4% per annum. The Company incurred finance charges relating to such policies of $32.2 and $32.9 for the years ended March 31, 2013 and 2012, respectively. As of March 31, 2013 and 2012, the accompanying consolidated balance sheets include the following balances relating to the financed insurance policies.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2013</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2012</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Prepaid insurance</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">115</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">366</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Accrued insurance premiums</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">69</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">60</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">(Included in other current liabilities)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">PURCHASE COMMITMENTS - The Company has commitments with two unrelated party service provider vendors extending over one year.&#160;&#160;Commitments total $3.8 million and $1.0 million for the years ending March 31, 2014 and 2015, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">UNION CONTRACTS - Approximately 37% of the Company&#146;s employees are represented by labor unions as of March 31, 2013.&#160;&#160;The CNA Agreement and the SEIU Agreement both expire on August 31, 2014. The agreements have &#147;no strike&#148; provisions and compensation caps which provide the Company with long term compensation and workforce stability.&#160;&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For both unions, all prior grievances regarding retiree medical benefits, the administration of pay adjustments and pay practices, changes in medical benefits and several wrongful terminations have been resolved in the form of settlement agreements.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">CLAIMS AND LAWSUITS &#150;&#160;The Company and the Hospitals are subject to various legal proceedings, most of which relate to routine matters incidental to operations. The results of these claims cannot be predicted, and it is possible that the ultimate resolution of these matters, individually or in the aggregate, may have a material adverse effect on the Company's business (both in the near and long term), financial position, results of operations, or cash flows. Although the Company defends itself vigorously against claims and lawsuits and cooperates with investigations, these matters (1) could require payment of substantial damages or amounts in judgments or settlements, which individually or in the aggregate could exceed amounts, if any, that may be recovered under insurance policies where coverage applies and is available, (2) cause substantial expenses to be incurred, (3) require significant time and attention from the Company's management, and (4) could cause the Company to close or sell the Hospitals or otherwise modify the way its business is conducted. The Company accrues for claims and lawsuits when an unfavorable outcome is probable and the amount is reasonably estimable.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 5, 2009, a potential class action lawsuit was filed against the Company by Alexandra Avery.&#160; Ms. Avery purports to represent all 12-hourly employees and the complaint alleges causes of action for restitution of unpaid wages as a result of unfair business practices, injunctive relief for unfair business practices, failure to pay overtime wages, and penalties associated therewith. On December 23, 2009, the Company filed an answer to the complaint, generally denying all of the plaintiff's allegations.&#160; On January 25, 2010, a potential class action lawsuit was filed against the Company by Julie Ross.&#160; Ms. Ross purports to represent all similarly-situated employees and the complaint alleges causes of action for violation of the California Labor Code and unfair competition law.&#160; On September 3, 2010 the plaintiffs in both the Avery and Ross actions filed a consolidated complaint (the "Consolidated Complaint") that alleges the causes of action found in the initial Ross complaint.&#160; On October 12, 2010, the Company filed an answer to the Consolidated Complaint, which generally denied all allegations.&#160; On July 18, 2011, the Company filed a motion to compel arbitration of the matter, which was denied on October 21, 2011.&#160; The Company appealed this decision and the Court of Appeal decided against the Company on June 26, 2013. The Company intends to vigorously defend itself in connection with the claims in the Consolidated Complaint.&#160;&#160; Discovery is ongoing and at this stage in the proceedings, the Company is unable to determine the cost of defending this lawsuit or the impact, if any, this action may have on its results of operations.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 13, 2013, the jury in Fitzgibbons v. IHHI, et. al., awarded $500,000 in punitive damages against the Company, bringing the jury&#146;s total verdict in this lawsuit for intentional infliction of emotional distress to $5.7 million. The Company thereafter filed two post-trial motions, one seeking a new trial and another seeking a judgment in the Company&#146;s favor notwithstanding the verdict. On April 30, 2013, the trial judge granted the Company&#146;s motion for a judgment notwithstanding the verdict and in the alternative granted the Company&#146;s motion for a new trial. The same day the trial judge signed a judgment in the Company&#146;s favor by which Dr. Fitzgibbons took nothing by way of his complaint and the Company was entitled to recover its costs of suit from Dr. Fitzgibbons. Dr. Fitzgibbons filed a notice of appeal of the judgment in the Company&#146;s favor on May 6, 2013. The Company estimates the appeal will take at least one year to resolve. Due to these favorable rulings, the Company reversed the $5.2 million contingent loss that was reserved on its financial statements as of December 31, 2012.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following is a schedule of the Company's future minimum operating lease payments, excluding the long term lease commitment with PCHI, that have initial or remaining non-cancelable lease terms in excess of one year as of March 31, 2013:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellspacing="0" cellpadding="0" align="center" style="width: 80%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Year ended March 31,</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="width: 62%; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2014</font></td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 15%; text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,620</font></td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2015</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,335</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2016</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,253</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2017</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,253</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2018</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,253</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Thereafter</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: black">11,627</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Total</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: black">18,341</font></td></tr></table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WARRANTS - The Company has entered into complex transactions that contain warrants (Notes 3 and 4). If an instrument (or an embedded feature) that has the characteristics of a derivative instrument is indexed to an entity&#146;s own stock, it is still necessary to evaluate whether it is classified in stockholders&#146; equity (or would be classified in stockholders&#146; equity if it were a freestanding instrument). The Company has concluded that the warrants should be classified as liabilities as the exercise price is subject to a weighted average ratchet down provision if the Company subsequently sells shares at a price lower than the then exercise price.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">INCOME TAXES - Deferred income tax assets and liabilities are determined based on the differences between the book and tax basis of assets and liabilities and are measured using the currently enacted tax rates and laws using the asset and liability method. The Company assesses the realization of deferred tax assets to determine whether an income tax valuation allowance is required. The Company recorded a 58% and 100% valuation allowance on its net deferred tax assets as of March 31, 2013 and 2012, respectively, since they did not meet the more-likely-than-not threshold.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is a recognition threshold and measurement attribute for recognition and measurement of a tax position taken or expected to be taken in a tax return. It also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction and California. Certain tax attributes carried over from prior years continue to be subject to adjustment by taxing authorities. Any penalties or interest arising from federal or state taxes are recorded as a component of the Company&#146;s income tax provision.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 14 &#150; SUBSEQUENT EVENTS (unaudited)</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In May 2013, CMS approved the managed care portion of the 2013 QAF for the period from July 1, 2011 through June 30, 2012. On June 26, 2013, CMS approved the managed care portion of the 2013 QAF for the period from July 1, 2012 through June 30, 2013.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="color: black">Based on the most recent modeling prepared by the California Hospital Association, the Company anticipates making payments for provider fees and other expenses relating to the 2013 QAF of approximately $105.8 million and receiving approximately $235.5 million in revenues from the </font><font style="color: #1F497D">S</font><font style="color: black">tate ($79.4 million from the fee-for-service portion and $156.1 million from the managed care portion).</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In June 2013, the Company received $72.1 million in managed care QAF payments for the period from July 1, 2011 through June 30, 2012 (Note 11). The Company anticipates receiving approximately $60.0 million in revenues for the period from July 1, 2012 through June 30, 2013.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company cannot provide any assurances or estimates in connection with CMS&#146;s final managed care approval of the 2013 QAF (for the period from July 1, 2013 to December 31, 2013) or a possible continuation of the QAF program beyond December 31, 2013.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In June 2013, the Company paid down $25 million on its revolving line of credit, resulting in an outstanding balance of $10 million.</p> EX-101.SCH 7 ihch-20130331.xsd XBRL SCHEMA FILE 0001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 0002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIENCY link:presentationLink link:calculationLink link:definitionLink 0006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0007 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 0008 - Disclosure - 2. PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 0009 - Disclosure - 3. DEBT link:presentationLink link:calculationLink link:definitionLink 0010 - Disclosure - 4. COMMON STOCK WARRANTS link:presentationLink link:calculationLink link:definitionLink 0011 - Disclosure - 5. INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 0012 - Disclosure - 6. STOCK INCENTIVE PLAN link:presentationLink link:calculationLink link:definitionLink 0013 - Disclosure - 7. RETIREMENT PLAN link:presentationLink link:calculationLink link:definitionLink 0014 - Disclosure - 8. INCOME (LOSS) PER SHARE link:presentationLink link:calculationLink link:definitionLink 0015 - Disclosure - 9. VARIABLE INTEREST ENTITY link:presentationLink link:calculationLink link:definitionLink 0016 - Disclosure - 10. RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 0017 - Disclosure - 11. HOSPITAL QUALITY ASSURANCE FEES (QAF) link:presentationLink link:calculationLink link:definitionLink 0018 - Disclosure - 12. ELECTRONIC HEALTH RECORDS INCENTIVE PROGRAM link:presentationLink link:calculationLink link:definitionLink 0019 - Disclosure - 13. COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 0020 - Disclosure - 14. SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 0021 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 0022 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 0023 - Disclosure - 2. PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 0024 - Disclosure - 3. DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 0025 - Disclosure - 4. COMMON STOCK WARRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 0026 - Disclosure - 5. INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 0027 - Disclosure - 6. STOCK INCENTIVE PLAN (Tables) link:presentationLink link:calculationLink link:definitionLink 0028 - Disclosure - 8. INCOME (LOSS) PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 0029 - Disclosure - 9. VARIABLE INTEREST ENTITY (Tables) link:presentationLink link:calculationLink link:definitionLink 0030 - Disclosure - 13. COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 0031 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 0032 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) link:presentationLink link:calculationLink link:definitionLink 0033 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) link:presentationLink link:calculationLink link:definitionLink 0034 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) link:presentationLink link:calculationLink link:definitionLink 0035 - Disclosure - 2. PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 0036 - Disclosure - 3. DEBT (Details) link:presentationLink link:calculationLink link:definitionLink 0037 - Disclosure - 3. DEBT (Details 1) link:presentationLink link:calculationLink link:definitionLink 0038 - Disclosure - 4. COMMON STOCK WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 0039 - Disclosure - 4. COMMON STOCK WARRANTS (Details 1) link:presentationLink link:calculationLink link:definitionLink 0040 - Disclosure - 5. INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 0041 - Disclosure - 5. INCOME TAXES (Details 1) link:presentationLink link:calculationLink link:definitionLink 0042 - Disclosure - 5. INCOME TAXES (Details 2) link:presentationLink link:calculationLink link:definitionLink 0043 - Disclosure - 5. INCOME TAXES (Details 3) link:presentationLink link:calculationLink link:definitionLink 0044 - Disclosure - 6. STOCK INCENTIVE PLAN (Details) link:presentationLink link:calculationLink link:definitionLink 0045 - Disclosure - 8. INCOME (LOSS) PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 0046 - Disclosure - 9. VARIABLE INTEREST ENTITY (Details) link:presentationLink link:calculationLink link:definitionLink 0047 - Disclosure - 13. COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 0048 - Disclosure - 13. COMMITMENTS AND CONTINGENCIES (Details 1) link:presentationLink link:calculationLink link:definitionLink 0049 - Disclosure - 13. COMMITMENTS AND CONTINGENCIES (Details 2) link:presentationLink link:calculationLink link:definitionLink 0050 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative 1) link:presentationLink link:calculationLink link:definitionLink 0051 - Disclosure - 2. PROPERTY AND EQUIPMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0052 - Disclosure - 6. STOCK INCENTIVE PLAN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0053 - Disclosure - 7. RETIREMENT PLAN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0054 - Disclosure - 8. INCOME (LOSS) PER SHARE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0055 - Disclosure - 9. VARIABLE INTEREST ENTITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0056 - Disclosure - 10. RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 ihch-20130331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 ihch-20130331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 ihch-20130331_lab.xml XBRL LABEL FILE Retained Earnings / Accumulated Deficit Equity Components [Axis] Noncontrolling Interest Stock Incentive 2006 Plan PlanName [Axis] Medicare [Member] HealthCareOrganizationRevenueSources [Axis] Medicaid [Member] Managed Care [Member] Indemnity Self Pay And Other [Member] Miscellaneous [Member] Total [Member] Term Loan Credit Agreement CreditFacility [Axis] Revolving Loan Agreement KPC Resolution Company ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTerms [Axis] Omnibus Warrants ClassOfWarrantOrRight [Axis] Term Loan Lender Release Warrant April Warrants Lease Amendment 2010 [Member] Commitments And Contingencies [Axis] General Professional Liability Workers Compensation Common Stock Additional Paid-In Capital Fair Value Inputs Level 1 FairValueByFairValueHierarchyLevel [Axis] Fair Value Inputs Level 2 Fair Value Inputs Level 3 Total Warrant FinancialInstrument [Axis] PCHI [Member] VariableInterestEntitiesByClassificationOfEntity [Axis] Accumulated Deficit VARIABLE INTEREST ENTITY Legal Entity [Axis] Self-pay uninsured Medicare and Medicaid Self-pay balance after insurance Self-insured health benefits ReceivableFromStockholders Income Per Share Dividends [Axis] Warrants Award [Axis] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Restricted cash Accounts receivable, net of allowance for doubtful accounts of $21,143 and $18,201, respectively Inventories of supplies Due from governmental payers Hospital quality assurance fee receivable Prepaid insurance Prepaid income taxes Deferred tax assets, net Other prepaid expenses and current assets Total current assets Property and equipment, net Deferred tax assets, net Total assets LIABILITIES AND STOCKHOLDERS' DEFICIENCY Current liabilities: Revolving line of credit, net of discount Accounts payable Accrued compensation and benefits Accrued insurance retentions Hospital quality assurance payable Due to governmental payers Income taxes payable Other current liabilities Total current liabilities Debt, noncurrent, net of discount Warrant liability, noncurrent Capital lease obligations, net of current portion of $1,101 and $891, respectively Total liabilities Commitments, contingencies and subsequent events Stockholders' deficiency: Integrated Healthcare Holdings, Inc. stockholders' deficiency: Common stock, $0.001 par value; 800,000 shares authorized; 255,307 shares issued and outstanding Additional paid in capital Accumulated deficit Total Integrated Healthcare Holdings, Inc. stockholders' deficiency Noncontrolling interests Total stockholders' deficiency Total liabilities and stockholders' deficiency Allowance for doubtful accounts (in Dollars) Current portion of Capial Lease Obligation (in Dollars) Common stock par value (in Dollars per share) Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Patient service revenues (net of contractual allowances and discounts) Provision for bad debts Net patient service revenues Other operating revenues Total operating revenue Operating expenses: Salaries and benefits Supplies Other operating expenses Depreciation and amortization Total Operating Expenses Operating income (loss) Other income (expense): Interest expense, net Income from electronic health records incentive program Loss on warrants Total Other Expense Income (loss) before income tax benefit Income tax benefit Net income (loss) Net (income) loss attributable to noncontrolling interests (Note 9) Net income (loss) attributable to Integrated Healthcare Holdings, Inc. Per Share Data (Note 8): Earnings (loss) per common share attributable to Integrated Healthcare Holdings, Inc. stockholders Basic Diluted Weighted average shares outstanding Basic Diluted Statement [Table] Statement [Line Items] Beginning Balance, Shares Beginning Balance, Amount Payment received on receivable from stockholders Noncontrolling interest distributions Ending Balance, Shares Ending Balance, Amount Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net income (loss) to net cash used in operating activities: Depreciation and amortization of property and equipment Provision for bad debts Amortization of debt discount Loss on warrants Deferred tax assets, net Noncash interest expense Changes in operating assets and liabilities: Accounts receivable Inventories of supplies Due from governmental payers Hospital quality assurance fees receivable Prepaid income taxes Prepaid insurance, other prepaid expenses and current assets, and other assets Accounts payable Accrued compensation and benefits Hospital quality assurance fees payable Due to governmental payers Income taxes payable Accrued insurance retentions and other current liabilities Net cash provided (used) by operating activities Cash flows from investing activities: (Increase) decrease in restricted cash Additions to property and equipment Net cash used in investing activities Cash flows from financing activities: Proceeds from (paydown on) revolving line of credit, net Payment to lender Payments received-receivable from stockholders Noncontrolling interests distributions Payments on capital lease obligations Net cash provided (used) in financing activities Net decrease in cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Description Of Business And Summary Of Significant Accounting Policies NOTE 1 - DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Property And Equipment NOTE 2 - PROPERTY AND EQUIPMENT Debt Disclosure [Abstract] NOTE 3 - DEBT Common Stock Warrants NOTE 4 - COMMON STOCK WARRANTS Income Tax Disclosure [Abstract] NOTE 5 - INCOME TAXES Stock Incentive Plan NOTE 6 - STOCK INCENTIVE PLAN Retirement Plan NOTE 7 - RETIREMENT PLAN Income Loss Per Share NOTE 8 - INCOME (LOSS) PER SHARE Variable Interest Entity NOTE 9 - VARIABLE INTEREST ENTITY Related Party Transactions [Abstract] NOTE 10 - RELATED PARTY TRANSACTIONS Hospital Quality Assurance Fees Qaf NOTE 11 - HOSPITAL QUALITY ASSURANCE FEES ("QAF") Electronic Health Records Incentive Program NOTE 12 - ELECTRONIC HEALTH RECORDS INCENTIVE PROGRAM Commitments And Contingencies NOTE 13 - COMMITMENTS AND CONTINGENCIES Subsequent Events [Abstract] 14. SUBSEQUENT EVENTS Description Of Business And Summary Of Significant Accounting Policies Policies BASIS OF PRESENTATION LIQUIDITY DESCRIPTION OF BUSINESS RECLASSIFICATION FOR PRESENTATION CONCENTRATION OF RISK USE OF ESTIMATES PATIENT SERVICE REVENUES PROVISION FOR DOUBTFUL ACCOUNTS CASH AND CASH EQUIVALENTS LETTER OF CREDIT RECEIVABLES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS INVENTORIES OF SUPPLIES PROPERTY AND EQUIPMENT LONG-LIVED ASSETS DEBT ISSUANCE COSTS FAIR VALUE MEASUREMENTS WARRANTS INCOME (LOSS) PER COMMON SHARE SUPPLEMENTAL CASH FLOW INFORMATION INCOME TAXES SEGMENT REPORTING NEW ACCOUNTING STANDARDS Description Of Business And Summary Of Significant Accounting Policies Tables PATIENT SERVICE REVENUES RECEIVABLES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS FAIR VALUE MEASUREMENTS: Warrant liability Warrant liability - fair value measurements using significant unobservable inputs Property And Equipment Tables Property and Equipment Debt Tables Outstanding Debt Noncurrent debt maturities Common Stock Warrants Tables Common Stock Warrants Assumptions used in the Black-Scholes valuation model Income Taxes Tables Schedule of income tax provision Schedule of statutory federal income tax rate Schedule of deferred tax assets and liabilities Schedule of the change in unrecognized income tax benefits Stock Incentive Plan Tables STOCK INCENTIVE PLAN Income Loss Per Share Tables Schedule of Earnings Per Share Variable Interest Entity Tables Variable Interest Entity Commitments And Contingencies Tables Schedule of minimum operating lease payments Schedule of minimum lease payments under capitalized leases INSURANCE Schedule of Revenue Sources, Health Care Organization [Table] Health Care Organization, Receivable and Revenue Disclosures [Line Items] Health Care Organization, Revenue Sources [Axis] Sources of patient service revenues Description Of Business And Summary Of Significant Accounting Policies Details 1 Accounts receivable: Patient accounts receivable Allowance for doubtful accounts Accounts receivable, net Due from government payers: Settlement receivables DSH Total Amount due from Government Due to government payers: Settlement payables Total Amount due to Government Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Hierarchy [Axis] Warrant liability at March 31, 2013 Warrant liability, March 31, 2012 Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Financial Instrument [Axis] Warrant liability - fair value measurements using significant unobservable inputs (Level 3) Balance at March 31, 2011 Change in fair value of warrant liability included in earnings Balance at March 31, 2012 Fair value of warrants issued and vested, net Fair value of warrants - loan discount on term loan Change in fair value of warrant liability included in earnings Balance at March 31, 2013 Property, Plant and Equipment [Abstract] Buildings Land and improvements Equipment Construction in progress Assets under capital leases Property and equipment, gross Less accumulated depreciation Debt Details Current: Revolving line of credit Discount Total Noncurrent: Term loan Discount Term loan Debt Details 1 2014 2015 2016 2017 Expected dividend yield Risk-free interest rate Expected volatility Expected term (in years) Award Type [Axis] Shares issuable under warrants Outstanding Repurchased Issued Amended (old expiration date) Amended (new expiration date) Weighted-average exercise price Weighted-average exercise price, Repurchased Weighted-average exercise price, Issued Expiration date Outstanding Expiration date, Repurchased Expiration date, Issued Expiration date, Amended (old expiration date) Expiration date, Amended (new expiration date) Income Taxes Details Income tax provision (benefit): Current: Federal State Total Current Deferred: Federal State Total Deferred Income tax provision (benefit) Income Taxes Details 1 U.S. federal statutory income taxes State and local income taxes, net of federal benefits Change in valuation allowance Warrants Variable interest entity Deferred tax adjustments Other Income Taxes Details 2 Deferred tax assets (liabilities): Allowance for doubtful accounts Accrued vacation Net operating losses State taxes Accrued insurance Legal Property and equipment Other Gross deferred tax assets Valuation allowance Net deferred tax assets Income Taxes Details 3 Gross unrecognized income tax benefits at the beginning of the year Changes based on tax positions related to current year Increases for tax positions related to prior years Gross unrecognized income tax benefits at the end of the year Stock Incentive Plan Details Outstanding, March 31, 2011, Shares Granted, Shares Exercised, Shares Forfeited or expired, Shares Outstanding, March 31, 2012, Shares Exercisable at March 31, 2012, Shares Weighted- Average Exercise Price Outstanding, March 31, 2012, exercise price Granted, exercise price Exercised, exercise price Forfeited or expired, exercise price Outstanding, March 31, 2013, exercise price Exercisable at March 31, 2013, exercise price Weighted- Average remaining contractual term (years) Outstanding, March 31, 2013, contractual term (years) Exercisable at March 31, 2013, contractual term (years) Aggregate intrinsic value Outstanding, March 31, 2013, intrinsic value Exercisable at March 31, 2013, intrinsic value Numerator: Net income attributable to Integrated Healthcare Holdings, Inc. Denominator: Weighted average common shares Dilutive options Denominator for diluted calculation Income per share - basic Income per share - diluted Variable Interest Entities [Axis] Cash Property, net Other Total assets Debt (as guarantor) Other Total liabilities Deficiency Total liabilities and accumulated deficit Commitments And Contingencies Details 2014 2015 2016 2017 2018 Thereafter Total Commitments And Contingencies Details 1 2014 2015 2016 2017 2018 Thereafter Total minimum lease payments Less amount representing interest (weighted average interest rate of 10.2%) Net present value of net minimum lease payments Less current portion Noncurrent portion Commitments And Contingencies Details 2 Accrued insurance premiums (Included in other current liabilities) Percentage of patient service revenue Property And Equipment Details Narrative Earthquake insurance with a policy limit Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Plan Name [Axis] Maximum aggregate number of shares under the plan Plan description Vesting rights description Options granted or exercised Retirement Plan Details Narrative Retirement Plan Expenses Incurred Accrued compensation and benefits Income Loss Per Share Details Narrative Shares excluded from the calculations of diluted loss per share Variable Interest Entity Details Narrative VIE, arrangements VIE, ownership VIE, Financial support Exposure amount, VIE Rental expense eliminated upon consolidation Related Party Transactions Details Narrative Common Stock Outstanding by beneficial owners Accrued insurance premiums(Included in other current liabilities) Aggregate intrinsic value AprilWarrantsMember Balance at March 31, 2012 Change in fair value of warrant liability included in earnings Commitments And Contingencies [Axis] Variable interest entity deficiency DSH Due from government payers Due to government payers Due to governmental payers Earthquake insurance with a policy limit Change in fair value of warrant liability included in earnings INSURANCE General Professional Liability [Member] Hospial quality assurance fees payable Hospial quality assurance fees payable Hospital Quality Assurance Fees text block Hospital quality assurance fees receivable Income from electronic health records incentive program Due to governmental payers IndemnitySelfPayAndOtherMember Integrated Healthcare Holdings, Inc. stockholders' deficiency: KPCResolutionCompanyMember Lease Amendment 2010 [Member] ManagedCareMember MedicaidMember Medicare medicaid member MedicareMember MiscellaneousMember OmnibusWarrantsMember Other expense: PCHI [Member] Patient accounts receivable PATIENT SERVICE REVENUES Payments received receivable from stockholders Per Share Data (Note 8): ReleaseWarrantMember Rental expense eliminated upon consolidation RevolvingLoanAgreementMember Self pay balance after insurance member Self insured health benefits member Settlement payables Settlement receivables Shares excluded from the calculations of diluted loss per share Denominator Numerator StockIncentive2006PlanMember Common Stock Outstanding by beneficial owners Stockholders' deficiency: TermLoanCreditAgreementMember TermLoanLenderMember Total1Member TotalMember Warrant liability WARRANTS Weighted- Average Exercise Price Weighted- Average remaining contractual term (years) Workers Compensation [Member] Assets, Current DeferredTaxAssetsNet1 Liabilities, Current Stockholders' Equity Attributable to Parent Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Health Care Organization, Patient Service Revenue Provision for Bad Debts Health Care Organization, Patient Service Revenue Operating Expenses Operating Income (Loss) Other Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Net Income (Loss) Attributable to Noncontrolling Interest Shares, Issued LossOnWarrants DeferredTaxAssetsNet2 Increase (Decrease) in Inventories Increase (Decrease) in Other Receivables Increase (Decrease) in Prepaid Taxes Increase (Decrease) in Accounts Payable Increase (Decrease) in Employee Related Liabilities RevolvingLoanAgreementMember Increase (Decrease) in Income Taxes Payable Net Cash Provided by (Used in) Operating Activities Increase (Decrease) in Restricted Cash Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Payments of Ordinary Dividends, Noncontrolling Interest Repayments of Debt and Capital Lease Obligations Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Schedule of Revenue Sources, Health Care Organization [Table Text Block] Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of Variable Interest Entities [Table Text Block] Finance charges related to policies Total [Default Label] Discount1 Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Deferred Federal Income Tax Expense (Benefit) Deferred State and Local Income Tax Expense (Benefit) Deferred Tax Assets, Other Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Other Assets Other Liabilities Operating Leases, Future Minimum Payments, Remainder of Fiscal Year Operating Leases, Future Minimum Payments, Due in Two Years Operating Leases, Future Minimum Payments, Due in Three Years Operating Leases, Future Minimum Payments, Due in Four Years Operating Leases, Future Minimum Payments Due Capital Leases, Future Minimum Payments, Remainder of Fiscal year Capital Leases, Future Minimum Payments Due in Two Years Capital Leases, Future Minimum Payments Due in Three Years Capital Leases, Future Minimum Payments Due in Four Years Capital Leases, Future Minimum Payments Due in Five Years Capital Leases, Future Minimum Payments Due Thereafter Accrued Employee Benefits, Current EX-101.PRE 11 ihch-20130331_pre.xml XBRL PRESENTATION FILE XML 12 R8.xml IDEA: 2. PROPERTY AND EQUIPMENT 2.4.0.80008 - Disclosure - 2. PROPERTY AND EQUIPMENTtruefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_PropertyAndEquipmentAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_PropertyPlantAndEquipmentDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0.9in 0pt 0">NOTE 2 - PROPERTY AND EQUIPMENT</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Property and equipment consists of the following:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <table align="center" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2013</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2012</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; color: black; font: 8pt Times New Roman, Times, Serif">Buildings</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">36,536</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">35,376</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Land and improvements</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">13,523</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">13,523</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; font: 8pt Times New Roman, Times, Serif">Equipment</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">28,534</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">18,268</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Construction in progress</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">1,160</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Assets under capital leases</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">13,267</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">11,218</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">91,860</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">79,545</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Less accumulated depreciation</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(27,872</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(24,016</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; padding-left: 1in; font: 8pt Times New Roman, Times, Serif">Property and equipment, net</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">63,988</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">55,529</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Accumulated depreciation on assets under capital leases as of March 31, 2013 and 2012 was $6.2 million and $5.0 million, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Hospitals are located in an area near active and substantial earthquake faults. The Hospitals carry earthquake insurance with a policy limit of $50.0 million. A significant earthquake could result in material damage and temporary or permanent cessation of operations at one or more of the Hospitals.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The State of California has imposed hospital seismic safety requirements. Under these requirements, the Hospitals must meet stringent seismic safety criteria in the future. In addition, there could be other remediation costs pursuant to this seismic retrofit.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The State of California has a seismic review methodology known as HAZUS. The HAZUS methodology may preclude the need for some structural modifications. All four Hospitals requested HAZUS review and received a favorable notice pertaining to structural reclassification. All Hospital buildings, with the exception of one (an administrative building), have been deemed compliant until January 1, 2030 for both structural and nonstructural retrofit. The Company does not have an estimate of the cost to remediate the seismic requirements for the administrative building as of March 31, 2013.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are additional requirements that must be complied with by 2030. The costs of meeting these requirements have not yet been determined. Compliance with seismic ordinances will be costly and could have a material adverse effect on the Company's cash flow.&#160;&#160;In addition, remediation could possibly result in certain environmental liabilities, such as asbestos abatement.</p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2921-110230 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.13-14) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false0false2. PROPERTY AND EQUIPMENTUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/PropertyAndEquipment12 XML 13 R6.xml IDEA: CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 2.4.0.80006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWStruefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$From2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2011-04-01to2012-03-31http://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 2us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 3us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-15861000-15861USD$falsetruefalse2truefalsefalse79440007944USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 false23true 2us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse04false 3us-gaap_DepreciationAndAmortizationus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse39170003917falsefalsefalse2truefalsefalse42080004208falsefalsefalsexbrli:monetaryItemTypemonetaryThe current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false25false 3us-gaap_ProvisionForDoubtfulAccountsus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse4460000044600falsefalsefalse2truefalsefalse4036800040368falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.5) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 5 -Article 5 false26false 3us-gaap_AmortizationOfDebtDiscountPremiumus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse16820001682falsefalsefalse2truefalsefalse525000525falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.8) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 8 -Article 5 false27false 3IHCH_LossOnWarrantsIHCH_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse31010003101falsefalsefalse2truefalsefalse14740001474falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false28false 3IHCH_DeferredTaxAssetsNet2IHCH_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-6708000-6708falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false29false 3IHCH_NoncashInterestExpenseIHCH_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse8600086falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false210true 2us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse011false 3us-gaap_IncreaseDecreaseInAccountsReceivableus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-53822000-53822falsefalsefalse2truefalsefalse-39318000-39318falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false212false 3us-gaap_IncreaseDecreaseInInventoriesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse117000117falsefalsefalse2truefalsefalse-910000-910falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false213false 3us-gaap_IncreaseDecreaseInOtherReceivablesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-699000-699falsefalsefalse2truefalsefalse-831000-831falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in other amounts due to the reporting entity, which are not otherwise defined in the taxonomy.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false214false 3us-gaap_IncreaseDecreaseInAccountsAndOtherReceivablesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-5254000-5254falsefalsefalse2truefalsefalse-621000-621falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false215false 3us-gaap_IncreaseDecreaseInPrepaidTaxesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse892000892falsefalsefalse2truefalsefalse-892000-892falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false216false 3us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssetsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-771000-771falsefalsefalse2truefalsefalse10330001033falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false217false 3us-gaap_IncreaseDecreaseInAccountsPayableus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse98150009815falsefalsefalse2truefalsefalse87320008732falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false218false 3us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-213000-213falsefalsefalse2truefalsefalse11400001140falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false219false 3IHCH_HospitalQualityAssuranceFeesPayable1IHCH_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse72260007226falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryHospial quality assurance fees payableNo definition available.false220false 3IHCH_IncreaseDecreaseDueToGovernmentalPayersIHCH_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse179000179falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryDue to governmental payersNo definition available.false221false 3us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayableus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse28690002869falsefalsefalse2truefalsefalse-12800000-12800falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false222false 3us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-780000-780falsefalsefalse2truefalsefalse-5534000-5534falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false223false 3us-gaap_NetCashProvidedByUsedInOperatingActivitiesus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-9624000-9624falsefalsefalse2truefalsefalse45180004518falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585 true224true 2us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse025false 3us-gaap_IncreaseDecreaseInRestrictedCashus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-3000-3falsefalsefalse2truefalsefalse1400014falsefalsefalsexbrli:monetaryItemTypemonetaryThe net cash inflow or outflow for the increase (decrease) associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as investing activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585 false226false 3us-gaap_PaymentsToAcquirePropertyPlantAndEquipmentus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-10340000-10340falsefalsefalse2truefalsefalse-5486000-5486falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585 false227false 3us-gaap_NetCashProvidedByUsedInInvestingActivitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-10343000-10343falsefalsefalse2truefalsefalse-5472000-5472falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585 true228true 2us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse029false 3us-gaap_ProceedsFromLinesOfCreditus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1549000015490falsefalsefalse2truefalsefalse-5081000-5081falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(f)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph f -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585 false230false 3IHCH_PaymentToLenderIHCH_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-450000-450falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false231false 3IHCH_PaymentsReceivedreceivableFromStockholdersIHCH_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;falsefalsefalse2truefalsefalse132000132falsefalsefalsexbrli:monetaryItemTypemonetaryPayments received receivable from stockholdersNo definition available.false232false 3us-gaap_PaymentsOfDividendsMinorityInterestus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-2376000-2376falsefalsefalse2truefalsefalse-1914000-1914falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585 false233false 3us-gaap_RepaymentsOfDebtAndCapitalLeaseObligationsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-981000-981falsefalsefalse2truefalsefalse-893000-893falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow during the period from the repayment of aggregate short-term and long-term debt and payment of capital lease obligations.No definition available.false234false 3us-gaap_NetCashProvidedByUsedInFinancingActivitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse1168300011683falsefalsefalse2truefalsefalse-7756000-7756falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585 true235false 3us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-8284000-8284falsefalsefalse2truefalsefalse-8710000-8710falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 230 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450594&loc=d3e33268-110906 true236false 3us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1truefalsefalse1182900011829falsefalsefalse2truefalsefalse2053900020539falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585 false237false 3us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse35450003545USD$falsetruefalse2truefalsefalse1182900011829USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585 false2falseCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/CondensedConsolidatedStatementsOfCashFlows237 XML 14 R53.xml IDEA: 7. RETIREMENT PLAN (Details Narrative) 2.4.0.80053 - Disclosure - 7. RETIREMENT PLAN (Details Narrative)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$From2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2011-04-01to2012-03-31http://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1IHCH_RetirementPlanDetailsNarrativeAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_CostsIncurredAssetRetirementObligationIncurredus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse33000003300USD$falsetruefalse2truefalsefalse31000003100USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of asset retirement obligations (ARO) costs incurred (whether capitalized or charged to expense) during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 410 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849 false23false 2us-gaap_AccruedEmployeeBenefitsCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse41000004100USD$falsetruefalse2truefalsefalse39000003900USD$falsetruefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Current Liabilities -URI http://asc.fasb.org/extlink&oid=6509677 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765 false2false7. RETIREMENT PLAN (Details Narrative) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/RetirementPlanDetailsNarrative23 XML 15 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
11. HOSPITAL QUALITY ASSURANCE FEES (QAF)
 12 Months Ended
Mar. 31, 2013
Hospital Quality Assurance Fees Qaf  
NOTE 11 - HOSPITAL QUALITY ASSURANCE FEES ("QAF")

NOTE 11 - HOSPITAL QUALITY ASSURANCE FEES (“QAF”)

 

In October 2009, the Governor of California signed legislation supported by the hospital industry to impose a provider fee on general acute care hospitals that, combined with federal matching funds, would be used to provide supplemental Medi-Cal payments to hospitals. The state submitted the plan to the Centers for Medicare and Medicaid Services (“CMS”) for a required review and approval process, and certain changes in the plan were required by CMS. Legislation amending the fee program to reflect the required changes was passed by the legislature and signed by the Governor on September 8, 2010. Among other changes, the legislation leaves distribution of “pass-through” payments received by Medi-Cal managed care plans that will be paid to hospitals under the program to the discretion of the plans.  The hospital quality assurance fee program (“QAF”) created by this legislation initially provided payments for up to 21 months retroactive to April 2009 and expiring on December 31, 2010 (“2010 QAF”).  In February 2011, CMS gave final approval for the 2010 QAF. During fiscal year 2011, the Company recognized $87.2 million in revenue and recorded expenses of $47.8 million relating to the 2010 QAF.

 

In December 2011, CMS gave final approval for the extension of the QAF for the nine month period from January 1 through June 30, 2011 (“2011 QAF”).  Accordingly, for the year ended March 31, 2012 the Company recognized $31.9 million in revenue and recorded expenses of $15.9 million relating to the 2011 QAF.

 

In June 2012, CMS conditionally approved the extension of the QAF for the thirty month period from July 1, 2011 through December 31, 2013 (“2013 QAF”).  In June 2012, the California State Legislature amended the hospital fee statute to recognize separate CMS approval of the fee-for-service portion and managed care portion of the 2013 QAF, which was further clarified in legislation approved by the governor of California in September 2012.  As a result, during the year ended March 31, 2013, the Company recognized revenue of $54.2 million and expenses of $52.5 million relating to the fee-for-service portion of the 2013 QAF for the periods from July 1, 2011 through March 31, 2013. See Note 14.
XML 16 R53.htm IDEA: XBRL DOCUMENT v2.4.0.8
7. RETIREMENT PLAN (Details Narrative) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Retirement Plan Details Narrative    
Retirement Plan Expenses Incurred $ 3,300 $ 3,100
Accrued compensation and benefits $ 4,100 $ 3,900
XML 17 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Income Statement [Abstract]    
Patient service revenues (net of contractual allowances and discounts) $ 428,100 $ 402,564
Provision for bad debts (44,600) (40,368)
Net patient service revenues 383,500 362,196
Other operating revenues 3,370 3,089
Total operating revenue 386,870 365,285
Operating expenses:    
Salaries and benefits 215,552 218,801
Supplies 56,160 55,066
Other operating expenses 118,055 74,515
Depreciation and amortization 3,917 4,208
Total Operating Expenses 393,684 352,590
Operating income (loss) (6,814) 12,695
Other income (expense):    
Interest expense, net (11,752) (10,218)
Income from electronic health records incentive program    6,802
Loss on warrants (3,101) (1,474)
Total Other Expense (14,853) (4,890)
Income (loss) before income tax benefit (21,667) 7,805
Income tax benefit (5,806) (139)
Net income (loss) (15,861) 7,944
Net (income) loss attributable to noncontrolling interests (Note 9) 324 (492)
Net income (loss) attributable to Integrated Healthcare Holdings, Inc. $ (15,537) $ 7,452
Earnings (loss) per common share attributable to Integrated Healthcare Holdings, Inc. stockholders    
Basic $ (0.06) $ 0.03
Diluted $ (0.06) $ 0.03
Weighted average shares outstanding    
Basic 255,307 255,307
Diluted 255,307 256,840
XML 18 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
4. COMMON STOCK WARRANTS
 12 Months Ended
Mar. 31, 2013
Common Stock Warrants  
NOTE 4 - COMMON STOCK WARRANTS

NOTE 4 - COMMON STOCK WARRANTS

 

A summary of warrant activity for the years ended March 31, 2013 and 2012 is presented as follows.

 

       Weighted-     
   Shares issuable   average   Expiration 
   under warrants   exercise price   date 
             
Outstanding, March 31, 2012 and 2011   405,000   $0.07    April 13, 2013 
Repurchased   (16,800)  $0.07    April 13, 2013 
Issued   16,800   $0.07    April 13, 2016 
Amended (old expiration date)   (388,200)  $0.07    April 13, 2013 
Amended (new expiration date)   388,200   $0.07    April 13, 2016 
Outstanding, March 31, 2013   405,000   $0.07    April 13, 2016 

 

On April 13, 2010 the Company issued three-year warrants (the “Omnibus Warrants”) to purchase its common stock at an exercise price of $0.07 per share in the following denominations: 139.0 million shares to KPC or its designees and 96.0 million shares to Silver Point or its designees. The Omnibus Warrants also provide the holders with certain pre-emptive, information and registration rights. As of April 13, 2010, the Company recorded warrant expense and the related warrant liability of $2.9 million, representing fair value.  

 

In addition, on April 13, 2010, the Company issued a three-year warrant (the “Release Warrant”) to acquire up to 170.0 million shares of common stock at $0.07 per share to Dr. Chaudhuri who facilitated the release (see “DEBT”) enabling the Company to recover amounts due from its prior lender and a $1.0 million reduction in principal of its outstanding debt, among other benefits to the Company.  The Release Warrant also provides the holder with certain pre-emptive, information and registration rights. During the year ended March 31, 2010, the Company recorded the fair value of $2.1 million as an offsetting cost of the recovery.  

 

On February 7, 2013, in connection with the Restated Credit Agreement, the Company entered into the following transactions involving warrants:

 

The Company entered into a Warrant Repurchase Agreement with SPCP Group IV, LLC pursuant to which it repurchased the outstanding common stock warrant issued to SPCP Group IV, LLC on or about April 13, 2010 (the “Cancelled Warrant”). The Cancelled Warrant (part of the Omnibus Warrants) entitled the holder to purchase an aggregate of 16.8 million shares of the Company’s common stock at an exercise price of $0.07 per share. The Company repurchased the Cancelled Warrant for a purchase price of $0.12 per share minus the exercise price of $0.07 per share resulting in a net purchase price of $0.05 per share multiplied by 16.8 million shares for an aggregate purchase price of $840.9.

 

Immediately following the warrant repurchase, the Company issued a new common stock warrant (the “New Warrant”) to SPCP Group, LLC for a price of $0.05 per share (an aggregate price of $840.9) on the same terms as the Cancelled Warrant entitling the holder to purchase an aggregate of 16.8 million shares of common stock at an exercise price of $0.07 per share, except that the New Warrant expires on April 13, 2016.

 

Also simultaneous with the transactions described above, the Company extended the expiration date from April 13, 2013 to April 13, 2016 for the Omnibus Warrants issued to KPC and the remaining held by Silver Point (to purchase 79.2 million shares) and the Release Warrant issued to Dr. Chaudhuri. The extension of the warrant expiration date was intended to conform the terms of the warrants to that of the Restated Credit Agreement.

 

The Company assessed the amended credit agreement entered into in August 2012 and February 2013 under the provisions of ASC 470-50 and determined that the debt amendments should be accounted for as a debt modification. Accordingly, the recorded change in fair value as of February 7, 2013, totaling $534, of the New Warrant and the Omnibus Warrant held by SPCP Group, LLC was recognized as a component of the debt discount on the Term Loan (Note 3) and will be amortized to interest expense over the term of the debt agreement using the effective interest method.

 

The warrant expense relating to the Release Warrant and the Omnibus Warrant held by Dr. Chaudhuri for the years ended March 31, 2013 and 2012 was $1.7 million and $0, respectively. The change in fair value of the Release Warrant and the Omnibus was immediately charged to expense.

 

The Omnibus Warrants, the Release Warrant, and the New Warrant are collectively referred to as the “IHHI Warrants.” As of March 31, 2013, the fair value of the IHHI Warrants was $5.3 million.

 

The net loss related to the change in fair value of the IHHI Warrants for the year ended March 31, 2013 and 2012 was $1.4 million and $1.5 million, respectively. The total loss on warrants was $3.1 million and $1.5 million for the years ended March 31, 2013 and 2012, respectively.

 

The fair value of warrants issued by the Company is estimated using the Black-Scholes valuation model, which it believes is the appropriate valuation method under the circumstances. Since the Company’s stock is thinly traded, the expected volatility is based on an analysis of its stock and the stock of eight other publicly traded companies that own hospitals.

 

The risk-free interest rate is based on the average yield on U.S. Treasury notes with maturity commensurate with the terms of the warrants. The dividend yield reflects that the Company has not paid any cash dividends since inception and does not anticipate paying cash dividends in the foreseeable future.  The assumptions used in the Black-Scholes valuation model are as follows:

 

   March 31, 2013   February 7, 2013   March 31, 2012 
             
Expected dividend yield   0.0%    0.0%    0.0% 
Risk-free interest rate   0.4%    0.4%    0.2% 
Expected volatility   39.9%    40.3%    57.3% 
Expected term (in years)   3.05    3.18    1.04 
XML 19 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 20 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
3. DEBT (Tables)
 12 Months Ended
Mar. 31, 2013
Debt Tables  
Outstanding Debt

 

The Company's outstanding debt consists of the following:

 

   March 31,
2013		   March 31,
2012		 
Current:          
Revolving line of credit  $30,000   $14,000 
Discount   (473)   (217)
   $29,527   $13,783 
           
Noncurrent:          
Term loan  $47,277   $45,000 
Discount   (1,747)   – 
   $45,530   $45,000 

 
Noncurrent debt maturities

The Company’s noncurrent debt matures as follows:

 

Year ending March 31,  Amount 
     
2014  $– 
2015   – 
2016   – 
2017  $47,277 
XML 21 R29.xml IDEA: 9. VARIABLE INTEREST ENTITY (Tables) 2.4.0.80029 - Disclosure - 9. VARIABLE INTEREST ENTITY (Tables)truefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_VariableInterestEntityTablesAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_ScheduleOfVariableInterestEntitiesTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table align="center" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2013</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2012</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Cash</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">147</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">68</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Property, net</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">39,696</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">40,984</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Other</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">129</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">207</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">Total assets</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">39,972</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">41,259</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Debt ($47,277, net of discount) (as guarantor)</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">46,039</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">45,000</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Other</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">488</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">641</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Total liabilities</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">46,527</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">45,641</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Deficiency</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(6,555</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(4,382</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">Total liabilities and accumulated deficit</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">39,972</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">41,259</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr></table>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=28200181&loc=d3e5710-111685 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 5A -URI http://asc.fasb.org/extlink&oid=28200181&loc=SL6759159-111685 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28200181&loc=d3e5747-111685 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=28200181&loc=d3e5728-111685 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=28200181&loc=SL6228884-111685 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Variable Interest Entity -URI http://asc.fasb.org/extlink&oid=6528138 false0false9. VARIABLE INTEREST ENTITY (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/VariableInterestEntityTables12 XML 22 R56.htm IDEA: XBRL DOCUMENT v2.4.0.8
10. RELATED PARTY TRANSACTIONS (Details Narrative)
Mar. 31, 2013
Mar. 31, 2012
Related Party Transactions Details Narrative    
Common Stock Outstanding by beneficial owners 447,500 447,500
XML 23 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
12. ELECTRONIC HEALTH RECORDS INCENTIVE PROGRAM
 12 Months Ended
Mar. 31, 2013
Electronic Health Records Incentive Program  
NOTE 12 - ELECTRONIC HEALTH RECORDS INCENTIVE PROGRAM

NOTE 12 - ELECTRONIC HEALTH RECORDS INCENTIVE PROGRAM

 

Provisions of the American Recovery and Reinvestment Act of 2009 provide incentive payments for the adoption and meaningful use of certified electronic health record (EHR) technology. The Medicare EHR incentive program provides incentive payments to eligible hospitals (and certain other providers) that are meaningful users of certified EHRs. The Medicaid EHR incentive program provides incentive payments to eligible hospitals (and certain other providers) for efforts to adopt, implement, upgrade, or meaningful use of certified EHR technology.

 

CMS has established the final rule which requires eligible providers in their first year of participation in the Medicaid incentive payment program to demonstrate that they have adopted (acquired, purchased, or secured access to), or implemented, or upgraded to certified EHR technology in order to qualify for an incentive payment. During the second and subsequent years of the program, eligible providers are required to meet other criteria, including meaningful use, to receive additional funds. The Company has been awarded a total amount of $13.6 million under the Medicaid EHR incentive program, which will be earned and received over a four year period. The Company adopted certified EHR technology and it recognized other income of $6.8 million relative to the first year under the Medicaid EHR incentive program during fiscal year 2012.
XML 24 R34.xml IDEA: 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) 2.4.0.80034 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$AsOf2013-03-31_WarrantMemberhttp://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse1false USDtruefalse$AsOf2013-03-31_WarrantMemberhttp://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00falsefalseWarrantus-gaap_FinancialInstrumentAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_WarrantMemberus-gaap_FinancialInstrumentAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse02true 4us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForwardus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse03false 5IHCH_BalanceAtMarch312011IHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse167000167USD$falsetruefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false24false 5IHCH_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings1IHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse14740001474USD$falsefalsefalsexbrli:monetaryItemTypemonetaryChange in fair value of warrant liability included in earningsNo definition available.false25false 5IHCH_BalanceAtMarch312012IHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse16410001641USD$falsefalsefalsexbrli:monetaryItemTypemonetaryBalance at March 31, 2012No definition available.false26false 5IHCH_FairValueOfWarrantsIssuedAndVestedNetIHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse16920001692USD$falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false27false 5IHCH_FairValueOfWarrantsLoanDiscountOnTermLoanIHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse534000534USD$falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false28false 5IHCH_ChangeInFairValueOfWarrantLiabilityIncludedInEarnings1IHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse14090001409USD$falsefalsefalsexbrli:monetaryItemTypemonetaryChange in fair value of warrant liability included in earningsNo definition available.false29false 5IHCH_BalanceAtMarch312013IHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse52760005276USD$falsetruefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false2false1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) (Warrant, USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails319 XML 25 R44.xml IDEA: 6. STOCK INCENTIVE PLAN (Details) 2.4.0.80044 - Disclosure - 6. STOCK INCENTIVE PLAN (Details)truefalsefalse1false USDfalsefalse$From2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2false USDfalsefalse$From2011-04-01to2012-03-31http://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$1true 1IHCH_StockIncentivePlanTablesAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberus-gaap_truenainstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1truefalsefalse82358235falsefalsefalse2truefalsefalse83708370falsefalsefalsexbrli:sharesItemTypesharesNumber of options outstanding, including both vested and non-vested options.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i)-(ii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false13false 2us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrossus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:sharesItemTypesharesGross number of share options (or share units) granted during the period.No definition available.false14false 2us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercisedus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:sharesItemTypesharesNumber of share options (or share units) exercised during the current period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28,29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30 -Article 5 false15false 2us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-640-640falsefalsefalse2truefalsefalse-135-135falsefalsefalsexbrli:sharesItemTypesharesFor presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(3)-(4) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false16false 2us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberus-gaap_truenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse75957595falsefalsefalse2truefalsefalse82358235falsefalsefalsexbrli:sharesItemTypesharesNumber of options outstanding, including both vested and non-vested options.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i)-(ii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false17false 2us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberus-gaap_truenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse75957595falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesThe number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false18true 2IHCH_WeightedAverageExercisePriceAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse09false 3us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceus-gaap_truenainstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1truefalsefalse0.180.18USD$falsetruefalse2truefalsefalse0.180.18USD$falsetruefalsenum:perShareItemTypedecimalWeighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false310false 3us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00&nbsp;&nbsp;falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsenum:perShareItemTypedecimalWeighted average per share amount at which grantees can acquire shares of common stock by exercise of options.No definition available.false311false 3us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePriceus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsenum:perShareItemTypedecimalWeighted average price at which option holders acquired shares when converting their stock options into shares.No definition available.false312false 3us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse0.260.26USD$falsetruefalse2truefalsefalse0.250.25USD$falsetruefalsenum:perShareItemTypedecimalWeighted average price of options that were either forfeited or expired.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(3)-(4) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false313false 3us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceus-gaap_truenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse0.180.18USD$falsetruefalse2truefalsefalse0.180.18USD$falsetruefalsenum:perShareItemTypedecimalWeighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false314false 3us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceus-gaap_truenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse0.180.18USD$falsetruefalse2falsefalsefalse00falsefalsefalsenum:perShareItemTypedecimalThe weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false315true 2IHCH_WeightedAverageRemainingContractualTermYearsAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse016false 3us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse001 year 8 months 12 daysfalsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaWeighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false017false 3us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse001 year 8 months 12 daysfalsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaWeighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false0false6. STOCK INCENTIVE PLAN (Details) (USD $)UnKnownNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://ihhioc.com/role/StockIncentivePlanDetails217 XML 26 R32.xml IDEA: 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) 2.4.0.80032 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$AsOf2013-03-31http://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$AsOf2012-03-31http://www.sec.gov/CIK0001051488instant2012-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 2us-gaap_AccountsReceivableNetCurrentAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 3IHCH_PatientAccountsReceivableIHCH_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse8396400083964USD$falsetruefalse2truefalsefalse7180000071800USD$falsetruefalsexbrli:monetaryItemTypemonetaryPatient accounts receivableNo definition available.false23false 3us-gaap_AllowanceForDoubtfulAccountsReceivableCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-21143000-21143falsefalsefalse2truefalsefalse-18201000-18201falsefalsefalsexbrli:monetaryItemTypemonetaryA valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 4 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=28368275&loc=d3e5074-111524 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.4) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false24false 3us-gaap_AccountsReceivableNetCurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse6282100062821falsefalsefalse2truefalsefalse5359900053599falsefalsefalsexbrli:monetaryItemTypemonetaryAmount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3-4) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 3 -Subparagraph a(1) -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 4 -Article 5 false25true 2IHCH_DueFromGovernmentPayerIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse06false 3IHCH_SettlementReceivablesIHCH_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;falsefalsefalse2truefalsefalse190000190falsefalsefalsexbrli:monetaryItemTypemonetarySettlement receivablesNo definition available.false27false 3IHCH_DisproportionateShareHospitalPaymentsIHCH_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse58820005882falsefalsefalse2truefalsefalse49930004993falsefalsefalsexbrli:monetaryItemTypemonetaryDSHNo definition available.false28false 3us-gaap_GovernmentContractReceivableus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse58820005882falsefalsefalse2truefalsefalse51830005183falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of receivables that are derived from government contracts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 912 -SubTopic 310 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6471842&loc=d3e55295-109406 false29true 3IHCH_DueToGovernmentPayersAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse010false 4IHCH_SettlementPayablesIHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse179000179falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetarySettlement payablesNo definition available.false211false 4IHCH_DueToGovernmentalPayersIHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse179000179USD$falsetruefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryDue to governmental payersNo definition available.false2false1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails1211 XML 27 R25.xml IDEA: 4. COMMON STOCK WARRANTS (Tables) 2.4.0.80025 - Disclosure - 4. COMMON STOCK WARRANTS (Tables)truefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_CommonStockWarrantsTablesAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A summary of warrant activity for the years ended March 31, 2013 and 2012 is presented as follows.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; font: 8pt Times New Roman, Times, Serif">Weighted-</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; font: 8pt Times New Roman, Times, Serif">Shares issuable</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; font: 8pt Times New Roman, Times, Serif">average</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; font: 8pt Times New Roman, Times, Serif">Expiration</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">under warrants</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">exercise price</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">date</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 49%; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March 31, 2012 and 2011</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; text-align: right; font: 8pt Times New Roman, Times, Serif">405,000</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2013</font></td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Repurchased</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">(16,800</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2013</font></td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Issued</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">16,800</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2016</font></td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Amended (old expiration date)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">(388,200</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2013</font></td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 9pt; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Amended (new expiration date)</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">388,200</td><td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2016</font></td><td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 0pt; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March 31, 2013</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif">405,000</td><td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2016</font></td><td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph i -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 28 -Article 5 false03false 2us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <table align="center" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, 2013</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">February 7, 2013</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, 2012</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 49%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Expected dividend yield</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.0%</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.0%</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.0%</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Risk-free interest rate</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.4%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.4%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.2%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Expected volatility</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">39.9%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">40.3%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">57.3%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Expected term (in years)</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">3.05</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">3.18</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">1.04</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false0false4. COMMON STOCK WARRANTS (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/CommonStockWarrantsTables13 XML 28 R48.htm IDEA: XBRL DOCUMENT v2.4.0.8
13. COMMITMENTS AND CONTINGENCIES (Details 1) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Commitments And Contingencies Details 1  
2014 $ 1,873
2015 1,899
2016 1,750
2017 1,276
2018 932
Thereafter 4,279
Total minimum lease payments 12,009
Less amount representing interest (weighted average interest rate of 10.2%) (4,119)
Net present value of net minimum lease payments 7,890
Less current portion (1,101)
Noncurrent portion $ 6,789
XML 29 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
4. COMMON STOCK WARRANTS (Details)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Warrant
Expected dividend yield 0.00% 0.00%
Risk-free interest rate 0.40% 0.20%
Expected volatility 39.90% 57.30%
Expected term (in years) 3 years 18 days 1 year 14 days
XML 30 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
6. STOCK INCENTIVE PLAN (Tables)
 12 Months Ended
Mar. 31, 2013
Stock Incentive Plan Tables  
STOCK INCENTIVE PLAN

A summary of stock option activity for the years ended March 31, 2013 and 2012 is presented as follows.

  

   Shares   Weighted-average exercise price   Weighted-average grant date fair value   Weighted-average remaining contractual term(years)   Aggregate intrinsic value 
                     
Outstanding, March 31, 2011   8,370   $0.18                
Granted   –   $–   $-           
Exercised   –   $–                
Forfeited or expired   (135)  $0.25                
Outstanding, March 31, 2012   8,235   $0.18                
Granted   –   $–   $–           
Exercised   –   $–                
Forfeited or expired   (640)  $0.26                
Outstanding, March 31, 2013   7,595   $0.18         1.7   $-  
Exercisable at March 31, 2013   7,595   $0.18         1.7      

 
XML 31 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
5. INCOME TAXES (Tables)
 12 Months Ended
Mar. 31, 2013
Income Taxes Tables  
Schedule of income tax provision
    Year ended March 31,  
    2013     2012  
Income tax provision (benefit):                
                 
Current:                
Federal   $ 655     $ (136 )
State     247       (3 )
      902       (139 )
Deferred:                
Federal     (4,853 )     –  
State     (1,855 )     –  
      (6,708 )     –  
                 
Income tax provision (benefit)   $ (5,806 )   $ (139 )
Schedule of statutory federal income tax rate
    Year ended March 31,  
    2013     2012  
             
U.S. federal statutory income taxes   $ (7,584 )   $ 2,654  
State and local income taxes, net of federal benefits     (1,245 )     406  
Change in valuation allowance     1,366       (2,975 )
Warrants     1,085       516  
Variable interest entity     237       (172 )
Deferred tax adjustments     295       (593 )
Other     40       25  
                 
Income tax provision (benefit)   $ (5,806 )   $ (139 )
Schedule of deferred tax assets and liabilities
    2013     2012  
Deferred tax assets (liabilities):                
Allowance for doubtful accounts   $ 449     $ 1,457  
Accrued vacation     2,982       2,813  
Net operating losses     7,961       1,023  
State taxes     (1,235 )     (532 )
Accrued insurance     3,755       3,445  
Legal     1,257       –  
Property and equipment     661       (212 )
Other     281       43  
      16,111       8,037  
Valuation allowance     (9,403 )     (8,037 )
                 
Net deferred tax assets   $ 6,708     $ –  
Schedule of the change in unrecognized income tax benefits
    March 31,  
    2013     2012  
             
Gross unrecognized income tax benefits at the beginning of the year   $ 21,814     $ 18,900  
Changes based on tax positions related to current year     –       2,914  
Increases for tax positions related to prior years     –       –  
Gross unrecognized income tax benefits at the end of the year   $ 21,814     $ 21,814  
XML 32 R56.xml IDEA: 10. RELATED PARTY TRANSACTIONS (Details Narrative) 2.4.0.80056 - Disclosure - 10. RELATED PARTY TRANSACTIONS (Details Narrative)truefalsefalse1false falsefalseAsOf2013-03-31http://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli02false falsefalseAsOf2012-03-31http://www.sec.gov/CIK0001051488instant2012-03-31T00:00:000001-01-01T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli01true 1IHCH_RelatedPartyTransactionsDetailsNarrativeAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2IHCH_StockOwnedByBeneficialOwnersIHCH_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse447500447500falsefalsefalse2truefalsefalse447500447500falsefalsefalsexbrli:sharesItemTypesharesCommon Stock Outstanding by beneficial ownersNo definition available.false1false10. RELATED PARTY TRANSACTIONS (Details Narrative)UnKnownNoRoundingUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/RelatedPartyTransactionsDetailsNarrative22 XML 33 R46.htm IDEA: XBRL DOCUMENT v2.4.0.8
9. VARIABLE INTEREST ENTITY (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Mar. 31, 2012
Property, net $ 63,988 $ 55,529
Total assets 166,708 144,885
Total liabilities 196,594 156,534
Total liabilities and accumulated deficit 166,708 144,885
PCHI [Member]
    
Cash 147 68
Property, net 39,696 40,984
Other 129 207
Total assets 39,972 41,259
Debt (as guarantor) 46,039 45,000
Other 488 641
Total liabilities 46,527 45,641
Deficiency (6,555) (4,382)
Total liabilities and accumulated deficit $ 39,972 $ 41,259
XML 34 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) (Warrant, USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Warrant
  
Warrant liability - fair value measurements using significant unobservable inputs (Level 3)  
Balance at March 31, 2011 $ 167
Change in fair value of warrant liability included in earnings 1,474
Balance at March 31, 2012 1,641
Fair value of warrants issued and vested, net 1,692
Fair value of warrants - loan discount on term loan 534
Change in fair value of warrant liability included in earnings 1,409
Balance at March 31, 2013 $ 5,276
XML 35 R19.xml IDEA: 13. COMMITMENTS AND CONTINGENCIES 2.4.0.80019 - Disclosure - 13. COMMITMENTS AND CONTINGENCIEStruefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_CommitmentsAndContingenciesAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_CommitmentsAndContingenciesDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTE 13 - COMMITMENTS AND CONTINGENCIES</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">INFORMATION TECHNOLOGY SYSTEMS &#150; On July 1, 2011, the Company entered into software and services agreements with McKesson Technologies Inc. (&#147;McKesson&#148;) to upgrade the Company&#146;s information technology systems.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the agreements, McKesson will provide the Company with a variety of services, including new software implementation and education/training services for the Company&#146;s personnel, software maintenance services and professional services related to movement and migration of data from legacy systems.&#160;&#160;McKesson will also furnish to the Company and maintain new hardware to accommodate the upgraded software and systems.&#160;&#160;The new hardware will include computers and servers, among other things, and will include installation, testing, and ongoing maintenance.&#160;&#160;The Company has entered into the arrangement to enhance its clinical information systems and upgrade its billing and revenue management information systems.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The agreements will initially run for a period of five years, and the recurring services may be renewed by the Company for successive periods.&#160;&#160;The agreements do not provide that they may be terminated by the Company prior to the initial expiration date.&#160;&#160;The agreements provide for one-time fees and recurring fees which aggregate a total of $22.0 million.&#160;&#160;Approximately 60% of the fees are for one-time charges, while the balance is for recurring services. During the year ended March 31, 2013 the Company completed conversion of one of its facilities to the McKesson system and is continuing to convert the remaining three facilities during the first quarter of the Company&#146;s fiscal year 2014. The Company is also continuing to test and develop system applications where necessary.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">OPERATING LEASES AND LONG TERM LEASE COMMITMENT WITH VARIABLE INTEREST ENTITY &#150; On April 13, 2010, the Company and PCHI entered into a Second Amendment to Amended and Restated Triple Net Hospital Building Lease (the &#147;2010 Lease Amendment&#148;).&#160;&#160;Under the 2010 Lease Amendment, the annual base rent to be paid by the Company to PCHI was increased from $5.4 million to $7.3 million. The base rent is subject to an annual Consumer Price Index increase on January 1 of each year; such increase shall not be less than 2% or more than 6% per year. The annual base rent is currently $7.8 million. If PCHI refinances the $47.277 million term loan, the annual base rent will increase to $8.3 million. This lease commitment with PCHI is eliminated in consolidation.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following is a schedule of the Company's future minimum operating lease payments, excluding the long term lease commitment with PCHI, that have initial or remaining non-cancelable lease terms in excess of one year as of March 31, 2013:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellspacing="0" cellpadding="0" align="center" style="width: 80%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Year ended March 31,</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="width: 62%; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2014</font></td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 15%; text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,620</font></td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2015</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,335</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2016</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,253</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2017</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,253</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2018</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,253</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Thereafter</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: black">11,627</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Total</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: black">18,341</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Total rental expense (excluding PCHI rent) for the years ended March 31, 2013 and 2012 was $5.3 million and $4.8 million, respectively. The Company received sublease rental income in relation to certain leases of approximately $563 and $552 for the years ended March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">CAPITAL LEASES - In connection with the Acquisition, the Company also assumed the leases for the Chapman facility, which include buildings and land with terms that were extended concurrently with the assignment of the leases to December 31, 2023. The Company leases equipment under capital leases expiring at various dates through 2017. Assets under capital leases with a net book value of $7.1 million and $6.2 million are included in the accompanying consolidated balance sheets as of March 31, 2013 and 2012, respectively. Interest rates used in computing the net present value of the lease payments are based on the interest rates implicit in the leases.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a schedule of future minimum lease payments under the capitalized leases with the present value of the minimum lease payments as of March 31, 2013:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="width: 80%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Year ended March 31,</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="width: 62%; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2014</font></td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 15%; text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,873</font></td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2015</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,899</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2016</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,750</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2017</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,276</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2018</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">932</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Thereafter</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: black">4,279</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Total minimum lease payments</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">12,009</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Less amount representing interest (weighted average interest rate of 10.2%)</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: black">(4,119</font></td> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Net present value of net minimum lease payments</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">7,890</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Less current portion</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: black">(1,101</font></td> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Noncurrent portion</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: black">6,789</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">INSURANCE &#150; The Company accrues for estimated general and professional liability claims, to the extent not covered by insurance, when they are probable and reasonably estimable. The Company has purchased as primary coverage a claims-made form insurance policy for general and professional liability risks. Estimated losses within general and professional liability retentions from claims incurred and reported, along with incurred but not reported (&#147;IBNR&#148;) claims, are accrued based upon projections and are discounted to their net present value using an interest rate of 5.0%. To the extent that subsequent claims information varies from estimates, the liability is adjusted in the period such information becomes available. As of March 31, 2013 and 2012, the Company had accrued $10.6 million and $11.5 million, respectively, which is comprised of $5.5 million and $4.5 million, respectively, in incurred and reported claims, along with $5.1 million and $7.0 million, respectively, in estimated IBNR. Estimated insurance recoveries of $2.1 million and $3.0 million are included in other prepaid expenses and current assets as of March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has also purchased occurrence coverage insurance to fund our obligations under our workers compensation program. The Company has a "paid loss plan" policy, under which the carrier pays all workers compensation claims, with no deductible or reimbursement required of us. The Company accrues for estimated workers compensation claims, to the extent not covered by insurance, when they are probable and reasonably estimable. The ultimate costs related to this program include expenses for deductible amounts associated with claims incurred and reported in addition to an accrual for the estimated expenses incurred in connection with IBNR claims. Claims are accrued based upon projections and are discounted to their net present value using an interest rate of 5.0%. To the extent that subsequent claims information varies from estimates, the liability is adjusted in the period such information becomes available. As of March 31, 2013 and 2012, the Company had accrued $500 and $673, respectively, comprised of $200 and $338, respectively, in incurred and reported claims, along with $300 and $335, respectively, in estimated IBNR.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Company has a self-insured health benefits plan for our employees. As a result, the Company has established and maintained an accrual for IBNR claims arising from self-insured health benefits provided to employees. Our IBNR accruals at March 31, 2013 and 2012 were based upon projections. The Company determines the adequacy of this accrual by evaluating our limited historical experience and trends related to both health insurance claims and payments, information provided by our insurance broker and third party administrator, and industry experience and trends. The accrual is an estimate and is subject to change. Such change could be material to our consolidated financial statements. As of March 31, 2013 and 2012, the Company had accrued $1.9 million and $2.2 million, respectively, in estimated IBNR.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has also purchased umbrella liability policies with aggregate limits of $25 million. The umbrella policies provide coverage in excess of the primary layer and applicable retentions for insured liability risks such as general and professional liability, auto liability, and workers compensation (employers liability).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of March 31, 2013, the Company finances various insurance policies at an interest rate of 4.4% per annum. The Company incurred finance charges relating to such policies of $32.2 and $32.9 for the years ended March 31, 2013 and 2012, respectively. As of March 31, 2013 and 2012, the accompanying consolidated balance sheets include the following balances relating to the financed insurance policies.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2013</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2012</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Prepaid insurance</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">115</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">366</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Accrued insurance premiums</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">69</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">60</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">(Included in other current liabilities)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">PURCHASE COMMITMENTS - The Company has commitments with two unrelated party service provider vendors extending over one year.&#160;&#160;Commitments total $3.8 million and $1.0 million for the years ending March 31, 2014 and 2015, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">UNION CONTRACTS - Approximately 37% of the Company&#146;s employees are represented by labor unions as of March 31, 2013.&#160;&#160;The CNA Agreement and the SEIU Agreement both expire on August 31, 2014. The agreements have &#147;no strike&#148; provisions and compensation caps which provide the Company with long term compensation and workforce stability.&#160;&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For both unions, all prior grievances regarding retiree medical benefits, the administration of pay adjustments and pay practices, changes in medical benefits and several wrongful terminations have been resolved in the form of settlement agreements.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">CLAIMS AND LAWSUITS &#150;&#160;The Company and the Hospitals are subject to various legal proceedings, most of which relate to routine matters incidental to operations. The results of these claims cannot be predicted, and it is possible that the ultimate resolution of these matters, individually or in the aggregate, may have a material adverse effect on the Company's business (both in the near and long term), financial position, results of operations, or cash flows. Although the Company defends itself vigorously against claims and lawsuits and cooperates with investigations, these matters (1) could require payment of substantial damages or amounts in judgments or settlements, which individually or in the aggregate could exceed amounts, if any, that may be recovered under insurance policies where coverage applies and is available, (2) cause substantial expenses to be incurred, (3) require significant time and attention from the Company's management, and (4) could cause the Company to close or sell the Hospitals or otherwise modify the way its business is conducted. The Company accrues for claims and lawsuits when an unfavorable outcome is probable and the amount is reasonably estimable.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 5, 2009, a potential class action lawsuit was filed against the Company by Alexandra Avery.&#160; Ms. Avery purports to represent all 12-hourly employees and the complaint alleges causes of action for restitution of unpaid wages as a result of unfair business practices, injunctive relief for unfair business practices, failure to pay overtime wages, and penalties associated therewith. On December 23, 2009, the Company filed an answer to the complaint, generally denying all of the plaintiff's allegations.&#160; On January 25, 2010, a potential class action lawsuit was filed against the Company by Julie Ross.&#160; Ms. Ross purports to represent all similarly-situated employees and the complaint alleges causes of action for violation of the California Labor Code and unfair competition law.&#160; On September 3, 2010 the plaintiffs in both the Avery and Ross actions filed a consolidated complaint (the "Consolidated Complaint") that alleges the causes of action found in the initial Ross complaint.&#160; On October 12, 2010, the Company filed an answer to the Consolidated Complaint, which generally denied all allegations.&#160; On July 18, 2011, the Company filed a motion to compel arbitration of the matter, which was denied on October 21, 2011.&#160; The Company appealed this decision and the Court of Appeal decided against the Company on June 26, 2013. The Company intends to vigorously defend itself in connection with the claims in the Consolidated Complaint.&#160;&#160; Discovery is ongoing and at this stage in the proceedings, the Company is unable to determine the cost of defending this lawsuit or the impact, if any, this action may have on its results of operations.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 13, 2013, the jury in Fitzgibbons v. IHHI, et. al., awarded $500,000 in punitive damages against the Company, bringing the jury&#146;s total verdict in this lawsuit for intentional infliction of emotional distress to $5.7 million. The Company thereafter filed two post-trial motions, one seeking a new trial and another seeking a judgment in the Company&#146;s favor notwithstanding the verdict. On April 30, 2013, the trial judge granted the Company&#146;s motion for a judgment notwithstanding the verdict and in the alternative granted the Company&#146;s motion for a new trial. The same day the trial judge signed a judgment in the Company&#146;s favor by which Dr. Fitzgibbons took nothing by way of his complaint and the Company was entitled to recover its costs of suit from Dr. Fitzgibbons. Dr. Fitzgibbons filed a notice of appeal of the judgment in the Company&#146;s favor on May 6, 2013. The Company estimates the appeal will take at least one year to resolve. Due to these favorable rulings, the Company reversed the $5.2 million contingent loss that was reserved on its financial statements as of December 31, 2012.</p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for commitments and contingencies.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.25) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 460 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 440 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308 false0false13. COMMITMENTS AND CONTINGENCIESUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/CommitmentsAndContingencies12 XML 36 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
5. INCOME TAXES (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Current:    
Federal $ 655 $ (136)
State 247 (3)
Total Current 902 (139)
Deferred:    
Federal (4,853)   
State (1,855)   
Total Deferred (6,708)   
Income tax provision (benefit) $ (5,806) $ (139)
XML 37 R49.htm IDEA: XBRL DOCUMENT v2.4.0.8
13. COMMITMENTS AND CONTINGENCIES (Details 2) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Mar. 31, 2012
Commitments And Contingencies Details 2    
Prepaid insurance $ 115 $ 366
Accrued insurance premiums (Included in other current liabilities) $ 69 $ 60
XML 38 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Medicare [Member]
Mar. 31, 2012
Medicare [Member]
Mar. 31, 2013
Medicaid [Member]
Mar. 31, 2012
Medicaid [Member]
Mar. 31, 2013
Managed Care [Member]
Dec. 31, 2012
Managed Care [Member]
Mar. 31, 2013
Indemnity Self Pay And Other [Member]
Mar. 31, 2012
Indemnity Self Pay And Other [Member]
Mar. 31, 2013
Total [Member]
Mar. 31, 2012
Total [Member]
Health Care Organization, Receivable and Revenue Disclosures [Line Items]                        
Sources of patient service revenues $ 428,100 $ 402,564 $ 55,570 $ 58,046 $ 100,561 $ 80,153 $ 203,058 $ 201,758 $ 68,911 $ 62,607 $ 428,100 $ 402,564
XML 39 R49.xml IDEA: 13. COMMITMENTS AND CONTINGENCIES (Details 2) 2.4.0.80049 - Disclosure - 13. COMMITMENTS AND CONTINGENCIES (Details 2)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$AsOf2013-03-31http://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$AsOf2012-03-31http://www.sec.gov/CIK0001051488instant2012-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1IHCH_CommitmentsAndContingenciesDetails2AbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_PrepaidInsuranceus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse115000115USD$falsetruefalse2truefalsefalse366000366USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Current Assets -URI http://asc.fasb.org/extlink&oid=6509628 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6787-107765 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (g)(1) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 340 -SubTopic 10 -Section 05 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6386993&loc=d3e5865-108316 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 340 -SubTopic 10 -Section 05 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6386993&loc=d3e5879-108316 false23false 2IHCH_AccruedInsurancePremiumsincludedInOtherCurrentLiabilitiesIHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse6900069USD$falsetruefalse2truefalsefalse6000060USD$falsetruefalsexbrli:monetaryItemTypemonetaryAccrued insurance premiums(Included in other current liabilities)No definition available.false2false13. COMMITMENTS AND CONTINGENCIES (Details 2) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/CommitmentsAndContingenciesDetails223 XML 40 R51.xml IDEA: 2. PROPERTY AND EQUIPMENT (Details Narrative) 2.4.0.80051 - Disclosure - 2. PROPERTY AND EQUIPMENT (Details Narrative)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$AsOf2013-03-31http://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1IHCH_PropertyAndEquipmentDetailsNarrativeAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2IHCH_EarthquakeInsuranceWithPolicyLimitIHCH_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse5000000050000USD$falsetruefalsexbrli:monetaryItemTypemonetaryEarthquake insurance with a policy limitNo definition available.false2false2. PROPERTY AND EQUIPMENT (Details Narrative) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/PropertyAndEquipmentDetailsNarrative12 XML 41 R9.xml IDEA: 3. DEBT 2.4.0.80009 - Disclosure - 3. DEBTtruefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1us-gaap_DebtDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_DebtDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 3&#160;&#150; DEBT</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of March 31, 2013, the Company had the following Credit Agreements:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 6%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 2%; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Wingdings 2">&#151;</font></td> <td style="width: 92%; font: 8pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt">A $47.277 million Term Loan issued under the $80.0 million Restated Credit Agreement, bearing an interest rate of LIBOR plus 10%, with the LIBOR floor set at 2% (12% at March 31, 2013). If any event of default occurs and continues, the lender can increase the interest rate by 5% per year. As of March 31, 2013, the Company was in compliance with all financial covenants. The stated maturity date for this Restated Credit Agreement is April 13, 2016.</font></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 6%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 2%; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Wingdings 2">&#151;</font></td> <td style="width: 92%; font: 8pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt">A $35.0 million Revolving Credit Agreement, bearing an interest rate of 4.25% plus LIBOR, with a 2.5% floor, per year (6.75% at March 31, 2013) and an unused commitment fee of 0.5% per year ($30.0 million outstanding balance at March 31, 2013).&#160;&#160;For purposes of calculating interest, all payments the Company makes on the Revolving Credit Agreement are subject to a five business day clearance period.&#160;&#160;As of March 31, 2013, the Company was in compliance with all financial covenants. The stated maturity date for this Revolving Credit Agreement is March 25, 2016. <font style="color: black">At March 31, 2013, the Company had $5.0 million in additional availability under this facility.</font></font></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Term loan - On August 1, 2012, the Company entered into Amendment No. 4 to Credit Agreement and Consent (the &#147;Credit Agreement Amendment&#148;), which amends <font style="color: black">the $80.0 million Credit Agreement, dated as of October 9, 2007, as amended, (the &#147;Credit Agreement&#148;) with SPCP Group IV, LLC, SPCP Group, LLC, and Silver Point Finance, LLC, as the Lender Agent (collectively, &#147;Silver Point&#148;), PCHI and Ganesha Realty<font style="text-transform: uppercase">, llc (&#147;</font>Ganesha<font style="text-transform: uppercase">&#148;)</font></font>.&#160;&#160;Under the Credit Agreement Amendment, Silver Point consented to and waived certain provisions under the Credit Agreement in connection with the Company&#146;s execution of the Revolving Loan Amendment No. 3. In addition, the provisions in the Credit Agreement that provide for mandatory prepayment of the Company&#146;s outstanding &#147;A/R Financing,&#148; as defined, upon receipt of certain federal matching funds under the QAF program were amended to replace 65% with 80%. In connection with the Credit Agreement Amendment, the Company agreed to pay Silver Point a one-time consent and amendment fee in an aggregate amount equal to $1.8 million, of which $450 was paid upon execution of the Credit Agreement Amendment and the balance was added to the principal amount under the Credit Agreement. The consent and amendment fee was recorded as a discount to the loan balance and is being amortized over the remaining life of the loan.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 7, 2013, the Company entered into an &#147;Amendment and Restatement to the Credit Agreement&#148; (the &#147;Amendment&#148;) with Silver Point, PCHI and Ganesha<font style="text-transform: uppercase">. </font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="text-transform: uppercase">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="color: black">Under the Amendment, the Credit Agreement was amended and restated in its entirety in the form of the &#147;Amended and Restated Credit Agreement ($47.277 million Term Loan)&#148; attached as Exhibit A to the Amendment (the &#147;Restated Credit Agreement&#148;). The Restated Credit Agreement reflects changes to the terms of the Credit Agreement that were previously made under various amendments the Company entered into since inception of the Credit Agreement in October 2007. </font>In connection with the Restated Credit Amendment, the Company agreed to pay Silver Point a one-time amendment fee of $841, which was added to the principal amount under the Restated Credit Agreement. The one-time amendment fee was recorded as a discount from the loan balance and, together with the amortized portion of the discount recorded under the Credit Agreement Amendment, is being amortized over the remaining life of the loan. In addition, the increase in the fair value of warrants issued to Silver Point on February 7, 2013 of $543 also were recorded as a discount from the loan balance and is being amortized over the remaining life of the loan. During the year ended March 31, 2013, the Company recognized $1.4 million in loan discount amortization relating to the Restated Credit Agreement.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the following new amendments were made to the Credit Agreement and reflected in the Restated Credit Agreement:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 7%; padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="width: 90%; padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The Stated Maturity Date was extended to April 13, 2016. The Credit Agreement was previously due to mature on April 13, 2013.&#160;&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The annual interest rate applicable to the loans under the Credit Agreement was modified from the previous fixed rate of 14.5% to LIBOR plus 10%, with the LIBOR floor set at 2% (12% at March 31, 2013), except upon an Event of Default. The Company may elect from one, two or three months LIBOR interest periods, except in an Event of Default when the interest period may not exceed one month.&#160;&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The principal balance under the Credit Agreement was increased from $46.350 million to $47.277 million, to reflect the Company&#146;s new borrowings under the Restated Credit Agreement.&#160;&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The Company repaid all amounts owing to SPCP Group IV, LLC under the Credit Agreement, consisting of a principal balance of $8.120 million plus accrued interest of $19.6, and increased the principal amount owing to SPCP Group, LLC under the Credit Agreement by $9.047 million to reflect the repayment to SPCP Group IV, LLC and other new borrowings.&#160;&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The financial covenants under the Credit Agreement were amended, including the covenants requiring the Company to maintain minimum levels of EBITDA (as defined in the Restated Credit Agreement).&#160;&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; text-align: justify; width: 7%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; text-align: justify; width: 3%; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-right: 5.4pt; text-align: justify; width: 90%; font: 8pt Times New Roman, Times, Serif">Upon the Company&#146;s receipt of enhanced federal matching funds from Medi-Cal under the QAF program (defined as &#147;Net QAF Funds&#148; under the Restated Credit Agreement), the Company is required to make certain prepayments of principal under its Revolving Loan Agreement with MidCap Financial, LLC.&#160;&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-right: 5.4pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">A prepayment fee was established for voluntary prepayments under the Credit Agreement equal to 5% for prepayments made on or prior to December 31, 2013, and 2% for prepayments made after January 1, 2014 and before December 31, 2014.&#160;&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revolving line of credit - On August 1, 2012, the Company entered into Amendment No. 3 to Credit and Security Agreement (the &#147;Revolving Loan Amendment No. 3&#148;), which amends Credit and Security Agreement, dated as of August 30, 2012, as amended, (the &#147;Revolving Loan Agreement&#148;) with MidCap Funding IV, LLC and Silicon Valley Bank, as lenders (the &#147;Lenders&#148;), and MidCap Financial, LLC, as agent (the &#147;Agent&#148;). Under the Revolving Loan Amendment No. 3, the minimum Revolving Loan Commitment Amount under the Revolving Loan Agreement was increased from $14.0 million to $30.0 million, and the Company agreed to pay the Lenders an origination fee of 1.0% of the Lenders&#146; increased commitment under the Revolving Loan Amendment No. 3, or $160.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 7, 2013, the Company entered into &#147;Amendment No. 4 to Credit and Security Agreement and Limited Consent&#148; (the &#147;Revolving Loan Amendment No. 4&#148;) with the Lenders and the Agent.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99.85pt">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Revolving Loan Amendment No. 4 amends the Revolving Loan Agreement, to reflect the following changes:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 7%; padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="width: 90%; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The maximum face amount of the Letter of Credit Liabilities permitted under the Revolving Loan Agreement was increased to $761, and the Lenders consented to the issuance of a Letter of Credit in the same amount by Wells Fargo Bank, National Association.&#160;&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The period during which the Prepayment Fee of 1% is applicable was extended from three years from the original closing date to the Commitment Expiry Date.&#160;&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The Agent and Lenders consented to the Company&#146;s entry into the Amendment with Silver Point and the Restated Credit Agreement thereunder.&#160;&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 25, 2013, the Company entered into Amendment No. 5 to Credit and Security Agreement and Limited Waiver (the &#147;Revolving Loan Amendment No. 5&#148;), which amends the Revolving Loan Agreement, with the Lenders and the Agent. The Company agreed to pay the Lenders an origination fee of 1.0% of the Lenders&#146; commitment under the Revolving Loan Amendment No. 5, or $350.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Among other things, the Revolving Loan Amendment No. 5 provides for the following:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 7%; padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-left: 0pt; text-align: justify; width: 90%; font: 8pt Times New Roman, Times, Serif">An increase in the Revolving Loan Commitment amount from $30.0 million to $35.0 million;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The Applicable Margin was changed: (a) from 3.00% to 2.25% with respect to Revolving Loans bearing interest upon the Base Rate and (b) from 5.00% to 4.25% for all other Revolving Loans and Obligations;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">The Commitment Expiry Date was extended to March 25, 2016;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">Certain modifications were made to the definitions of Permitted Indebtedness and Prepayment Fee and the lockbox requirements; and</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 0pt; text-align: left; font: 8pt Times New Roman, Times, Serif"><font style="font-family: Wingdings 2">&#151;</font></td> <td style="padding-left: 0pt; text-align: justify; font: 8pt Times New Roman, Times, Serif">The Company was granted a waiver of certain prior Events of Default or Defaults under the Revolving Loan Agreement and a waiver of the requirement to comply with the Fixed Charge Coverage Ratio covenant for the Defined Period ending March 31, 2013.</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company's outstanding debt consists of the following:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2013</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2012</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; font: 8pt Times New Roman, Times, Serif">Current:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Revolving line of credit</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">30,000</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">14,000</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Discount</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(473</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(217</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">29,527</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">13,783</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; font: 8pt Times New Roman, Times, Serif">Noncurrent:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Term loan</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">47,277</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">45,000</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Discount</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(1,747</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">45,530</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">45,000</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company&#146;s noncurrent debt matures as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 60%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Year ending March 31,</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Amount</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 45%; text-align: center; font: 8pt Times New Roman, Times, Serif">2014</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 11%; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; font: 8pt Times New Roman, Times, Serif">2015</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; font: 8pt Times New Roman, Times, Serif">2016</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">2017</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">47,277</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 20, 22 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19,20,22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false0false3. DEBTUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/Debt12 XML 42 R43.htm IDEA: XBRL DOCUMENT v2.4.0.8
5. INCOME TAXES (Details 3) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Mar. 31, 2012
Income Taxes Details 3    
Gross unrecognized income tax benefits at the beginning of the year $ 21,814 $ 18,900
Changes based on tax positions related to current year    2,914
Increases for tax positions related to prior years      
Gross unrecognized income tax benefits at the end of the year $ 21,814 $ 21,814
XML 43 R12.xml IDEA: 6. STOCK INCENTIVE PLAN 2.4.0.80012 - Disclosure - 6. STOCK INCENTIVE PLANtruefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_StockIncentivePlanAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 6 - STOCK INCENTIVE PLAN</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company's 2006 Stock Incentive Plan (the "Plan"), which is shareholder-approved, permits the grant of share options to its employees and board members for up to a maximum aggregate of 12.0 million shares of common stock. In addition, as of the first business day of each calendar year in the period 2007 through 2015, the maximum aggregate number of shares shall be increased by a number equal to one percent of the number of shares of common stock of the Company outstanding on December 31 of the immediately preceding calendar year. Accordingly, as of March 31, 2013, the maximum aggregate number of shares under the Plan was 26.1 million. The Company believes that such awards better align the interests of its employees with those of its shareholders. In accordance with the Plan, incentive stock options, nonqualified stock options, and performance based compensation awards may not be granted at less than 100 percent of the estimated fair market value of the common stock on the date of grant. Incentive stock options granted to a person owning more than 10 percent of the voting power of all classes of stock of the Company may not be issued at less than 110 percent of the fair market value of the stock on the date of grant. Option awards generally vest based on 3 years of continuous service (1/3 of the shares vest on the twelve month anniversary of the grant date, and an additional 1/12 of the shares vest on each subsequent fiscal quarter-end of the Company following such twelve month anniversary). Certain option awards provide for accelerated vesting if there is a change of control, as defined. The option awards have 7-year contractual terms.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When the measurement date is certain, the fair value of each option grant is estimated on the date of grant using the Black-Scholes valuation model. Since there is limited historical data with respect to both pre-vesting forfeiture and post-vesting termination, the expected life of the options was determined utilizing the simplified method, whereby the expected term is calculated by taking the sum of the vesting term plus the original contractual term and dividing that quantity by two.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No options were granted or exercised during the years ended March 31, 2013 and 2012. All outstanding options were fully vested as of March 31, 2013 and 2012.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A summary of stock option activity for the years ended March 31, 2013 and 2012 is presented as follows.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table align="center" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Shares</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Weighted-average exercise price</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Weighted-average grant date fair value</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Weighted-average remaining contractual term(years)</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Aggregate intrinsic value</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 35%; color: black; text-align: left; text-indent: -9pt; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March&#160;31, 2011</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 9%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">8,370</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 9%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.18</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 9%; text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 9%; text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 9%; text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Granted</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">-</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Exercised</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Forfeited or expired</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(135</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.25</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; text-indent: -9pt; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March&#160;31, 2012</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">8,235</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.18</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Granted</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Exercised</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Forfeited or expired</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(640</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.26</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March&#160;31, 2013</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">7,595</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">0.18</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">1.7</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">-<font style="color: black">&#160;</font></td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Exercisable at March&#160;31, 2013</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">7,595</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">0.18</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">1.7</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> </tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details.No definition available.false0false6. STOCK INCENTIVE PLANUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/StockIncentivePlan12 XML 44 R46.xml IDEA: 9. VARIABLE INTEREST ENTITY (Details) 2.4.0.80046 - Disclosure - 9. VARIABLE INTEREST ENTITY (Details)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$AsOf2013-03-31http://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$AsOf2012-03-31http://www.sec.gov/CIK0001051488instant2012-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1false 4us-gaap_PropertyPlantAndEquipmentNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse6398800063988USD$falsetruefalse2truefalsefalse5552900055529USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.13) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 13 -Subparagraph a -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 8 -Article 7 false22false 4us-gaap_Assetsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse166708000166708USD$falsefalsefalse2truefalsefalse144885000144885USD$falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 false23false 4us-gaap_Liabilitiesus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse196594000196594USD$falsefalsefalse2truefalsefalse156534000156534USD$falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19-26) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false24false 4us-gaap_LiabilitiesAndStockholdersEquityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse166708000166708USD$falsefalsefalse2truefalsefalse144885000144885USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.32) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 25 -Article 7 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 32 -Article 5 false25false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3false USDtruefalse$AsOf2013-03-31_PCHIMemberhttp://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00falsefalsePCHI [Member]us-gaap_VariableInterestEntitiesByClassificationOfEntityAxisxbrldihttp://xbrl.org/2006/xbrldiIHCH_PCHIMemberus-gaap_VariableInterestEntitiesByClassificationOfEntityAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse06false 4us-gaap_Cashus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse147000147USD$falsefalsefalse2truefalsefalse6800068USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false27false 4us-gaap_PropertyPlantAndEquipmentNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse3969600039696USD$falsefalsefalse2truefalsefalse4098400040984USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.13) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 13 -Subparagraph a -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 8 -Article 7 false28false 4us-gaap_OtherAssetsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse129000129USD$falsefalsefalse2truefalsefalse207000207USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate carrying amounts, as of the balance sheet date, of assets not separately disclosed in the balance sheet.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.17) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 17 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 10 -Article 7 false29false 4us-gaap_Assetsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse3997200039972USD$falsefalsefalse2truefalsefalse4125900041259USD$falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 false210false 4us-gaap_GuaranteeObligationsMaximumExposureus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse4603900046039USD$falsefalsefalse2truefalsefalse4500000045000USD$falsefalsefalsexbrli:monetaryItemTypemonetaryMaximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 460 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (b)(1) -URI http://asc.fasb.org/extlink&oid=6851643&loc=d3e12069-110248 false211false 4us-gaap_OtherLiabilitiesus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse488000488USD$falsefalsefalse2truefalsefalse641000641USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate carrying amount, as of the balance sheet date, of liabilities not separately disclosed in the balance sheet.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 15 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.15) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 false212false 4us-gaap_Liabilitiesus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse4652700046527USD$falsefalsefalse2truefalsefalse4564100045641USD$falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19-26) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false213false 4IHCH_DeficiencyVariableInterestEntityIHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-6555000-6555USD$falsefalsefalse2truefalsefalse-4382000-4382USD$falsefalsefalsexbrli:monetaryItemTypemonetaryVariable interest entity deficiencyNo definition available.false214false 4us-gaap_LiabilitiesAndStockholdersEquityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse3997200039972USD$falsetruefalse2truefalsefalse4125900041259USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.32) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 25 -Article 7 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 32 -Article 5 false2false9. VARIABLE INTEREST ENTITY (Details) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/VariableInterestEntityDetails214 XML 45 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
4. COMMON STOCK WARRANTS (Tables)
 12 Months Ended
Mar. 31, 2013
Common Stock Warrants Tables  
Common Stock Warrants

A summary of warrant activity for the years ended March 31, 2013 and 2012 is presented as follows.

 

       Weighted-     
   Shares issuable   average   Expiration 
   under warrants   exercise price   date 
             
Outstanding, March 31, 2012 and 2011   405,000   $0.07    April 13, 2013 
Repurchased   (16,800)  $0.07    April 13, 2013 
Issued   16,800   $0.07    April 13, 2016 
Amended (old expiration date)   (388,200)  $0.07    April 13, 2013 
Amended (new expiration date)   388,200   $0.07    April 13, 2016 
Outstanding, March 31, 2013   405,000   $0.07    April 13, 2016 

 
Assumptions used in the Black-Scholes valuation model

 

   March 31, 2013   February 7, 2013   March 31, 2012 
             
Expected dividend yield   0.0%    0.0%    0.0% 
Risk-free interest rate   0.4%    0.4%    0.2% 
Expected volatility   39.9%    40.3%    57.3% 
Expected term (in years)   3.05    3.18    1.04 

 
XML 46 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Cash flows from operating activities:    
Net income (loss) $ (15,861) $ 7,944
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization of property and equipment 3,917 4,208
Provision for bad debts 44,600 40,368
Amortization of debt discount 1,682 525
Loss on warrants 3,101 1,474
Deferred tax assets, net (6,708)  
Noncash interest expense 86   
Changes in operating assets and liabilities:    
Accounts receivable (53,822) (39,318)
Inventories of supplies 117 (910)
Due from governmental payers (699) (831)
Hospital quality assurance fees receivable (5,254) (621)
Prepaid income taxes 892 (892)
Prepaid insurance, other prepaid expenses and current assets, and other assets (771) 1,033
Accounts payable 9,815 8,732
Accrued compensation and benefits (213) 1,140
Hospital quality assurance fees payable 7,226   
Due to governmental payers 179   
Income taxes payable 2,869 (12,800)
Accrued insurance retentions and other current liabilities (780) (5,534)
Net cash provided (used) by operating activities (9,624) 4,518
Cash flows from investing activities:    
(Increase) decrease in restricted cash (3) 14
Additions to property and equipment (10,340) (5,486)
Net cash used in investing activities (10,343) (5,472)
Cash flows from financing activities:    
Proceeds from (paydown on) revolving line of credit, net 15,490 (5,081)
Payment to lender (450)   
Payments received-receivable from stockholders    132
Noncontrolling interests distributions (2,376) (1,914)
Payments on capital lease obligations (981) (893)
Net cash provided (used) in financing activities 11,683 (7,756)
Net decrease in cash and cash equivalents (8,284) (8,710)
Cash and cash equivalents, beginning of period 11,829 20,539
Cash and cash equivalents, end of period $ 3,545 $ 11,829
XML 47 R40.xml IDEA: 5. INCOME TAXES (Details) 2.4.0.80040 - Disclosure - 5. INCOME TAXES (Details)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$From2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2011-04-01to2012-03-31http://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 2us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 3us-gaap_CurrentFederalTaxExpenseBenefitus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse655000655USD$falsetruefalse2truefalsefalse-136000-136USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I.7) -URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Current Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6509736 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 6 -Section I -Paragraph Question 1-7 false23false 3us-gaap_CurrentStateAndLocalTaxExpenseBenefitus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse247000247falsefalsefalse2truefalsefalse-3000-3falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I.7) -URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Current Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6509736 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 6 -Section I -Subsection 7 false24false 3us-gaap_CurrentIncomeTaxExpenseBenefitus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse902000902falsefalsefalse2truefalsefalse-139000-139falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I.7) -URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Current Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6509736 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 6 -Section I -Subsection 7 false25true 2us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse06false 3us-gaap_DeferredFederalIncomeTaxExpenseBenefitus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-4853000-4853falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I.7) -URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 6 -Section I -Subsection 7 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Deferred Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6510177 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 false27false 3us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefitus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-1855000-1855falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I.7) -URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 6 -Section I -Subsection 7 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Deferred Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6510177 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 false28false 3us-gaap_DeferredIncomeTaxExpenseBenefitus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-6708000-6708falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I.7) -URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 6 -Section I -Subsection 7 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Deferred Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6510177 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 false29false 3us-gaap_IncomeTaxExpenseBenefitus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-5806000-5806USD$falsetruefalse2truefalsefalse-139000-139USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Income Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6515339 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 false2false5. INCOME TAXES (Details) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/IncomeTaxesDetails29 XML 48 R52.xml IDEA: 6. STOCK INCENTIVE PLAN (Details Narrative) 2.4.0.80052 - Disclosure - 6. STOCK INCENTIVE PLAN (Details Narrative)truefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli02false falsefalseFrom2011-04-01to2012-03-31http://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli01true 3us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 4us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercisedus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00&nbsp;&nbsp;falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:sharesItemTypesharesNumber of share options (or share units) exercised during the current period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28,29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30 -Article 5 false13false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3false truefalseFrom2012-04-01to2013-03-31_StockIncentive2006PlanMemberhttp://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00falsefalseStock Incentive 2006 Planus-gaap_PlanNameAxisxbrldihttp://xbrl.org/2006/xbrldiIHCH_StockIncentive2006PlanMemberus-gaap_PlanNameAxisexplicitMembernanafalse04true 3us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse05false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescriptionus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00The Company's 2006 Stock Incentive Plan (the "Plan"), which is shareholder-approved, permits the grant of share options to its employees and board members for up to a maximum aggregate of 12.0 million shares of common stock. In addition, as of the first business day of each calendar year in the period 2007 through 2015, the maximum aggregate number of shares shall be increased by a number equal to one percent of the number of shares of common stock of the Company outstanding on December 31 of the immediately preceding calendar year. falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringGeneral descriptive information regarding an arrangement under which employees and directors receive: (a) awards of equity shares, equity share options, or other equity instruments; or (b) the entity incurs liabilities to them: (1) in amounts based, at least in part, on the price of the entity's shares or other equity instruments; or (2) that require or may require settlement by issuance of the entity's shares. Such an arrangement is usually provided to employees and directors to compensate them, provide performance incentives to them, and to attract or retain their services. May also include pertinent information particular to a plan that is not elsewhere specified in the taxonomy.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false06false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Option awards generally vest based on 3 years of continuous service (1/3 of the shares vest on the twelve month anniversary of the grant date, and an additional 1/12 of the shares vest on each subsequent fiscal quarter-end of the Company following such twelve month anniversary). Certain option awards provide for accelerated vesting if there is a change of control, as defined. The option awards have 7-year contractual terms.falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringDescription of award terms as to how many shares or portion of an award are no longer contingent on satisfaction of either a service condition, market condition or a performance condition, thereby giving the employee the legal right to convert the award to shares, to sell the shares, and be entitled to the cash proceeds of such sale. For example, vesting may be expressed as being 25 percent of the shares under option on each anniversary of the grant date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false0false6. STOCK INCENTIVE PLAN (Details Narrative)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/StockIncentivePlanDetailsNarrative26 XML 49 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
2. PROPERTY AND EQUIPMENT
 12 Months Ended
Mar. 31, 2013
Property And Equipment  
NOTE 2 - PROPERTY AND EQUIPMENT

NOTE 2 - PROPERTY AND EQUIPMENT

 

Property and equipment consists of the following:

 

   March 31,
2013		   March 31,
2012		 
Buildings  $36,536   $35,376 
Land and improvements   13,523    13,523 
Equipment   28,534    18,268 
Construction in progress   –    1,160 
Assets under capital leases   13,267    11,218 
    91,860    79,545 
Less accumulated depreciation   (27,872)   (24,016)
           
Property and equipment, net  $63,988   $55,529 

  

Accumulated depreciation on assets under capital leases as of March 31, 2013 and 2012 was $6.2 million and $5.0 million, respectively.

 

The Hospitals are located in an area near active and substantial earthquake faults. The Hospitals carry earthquake insurance with a policy limit of $50.0 million. A significant earthquake could result in material damage and temporary or permanent cessation of operations at one or more of the Hospitals.

 

The State of California has imposed hospital seismic safety requirements. Under these requirements, the Hospitals must meet stringent seismic safety criteria in the future. In addition, there could be other remediation costs pursuant to this seismic retrofit.

         

The State of California has a seismic review methodology known as HAZUS. The HAZUS methodology may preclude the need for some structural modifications. All four Hospitals requested HAZUS review and received a favorable notice pertaining to structural reclassification. All Hospital buildings, with the exception of one (an administrative building), have been deemed compliant until January 1, 2030 for both structural and nonstructural retrofit. The Company does not have an estimate of the cost to remediate the seismic requirements for the administrative building as of March 31, 2013.

 

There are additional requirements that must be complied with by 2030. The costs of meeting these requirements have not yet been determined. Compliance with seismic ordinances will be costly and could have a material adverse effect on the Company's cash flow.  In addition, remediation could possibly result in certain environmental liabilities, such as asbestos abatement.
XML 50 R11.xml IDEA: 5. INCOME TAXES 2.4.0.80011 - Disclosure - 5. INCOME TAXEStruefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1us-gaap_IncomeTaxDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_IncomeTaxDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOTE 5 - INCOME TAXES</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amount of tax-related assets and liabilities and income tax provisions. The Company assesses the recoverability of the deferred tax assets on an ongoing basis. In making this assessment the Company is required to consider all available positive and negative evidence to determine whether, based on such evidence, it is more likely than not that some portion or all of the net deferred assets will be realized in future periods. This assessment requires significant judgment. In addition, the Company has made significant estimates involving current and deferred income taxes, tax attributes relating to the interpretation of various tax laws, historical bases of tax attributes associated with certain tangible and intangible assets and limitations surrounding the realization of the deferred tax assets. The Company does not recognize <font style="background-color: White">current and future tax benefits until it is deemed more likely than not that certain tax positions will be sustained.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="background-color: White">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The income tax provision (benefit) consisted of the following:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 70%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="6" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Year ended March 31,</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2013</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2012</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Income tax provision (benefit):</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Current:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="width: 36%; color: black; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Federal</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">655</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(136</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-bottom: 1pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">State</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">247</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(3</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 1pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">902</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(139</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Deferred:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Federal</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(4,853</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-bottom: 1pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">State</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(1,855</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 1pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(6,708</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Income tax provision (benefit)</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(5,806</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(139</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A reconciliation between the amount of reported income tax expense (benefit) and the amount computed by multiplying income before income tax provision (benefit) by the statutory federal income tax rate is as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="background-color: White">&#160;</font></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif"></td> <td colspan="6" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Year ended March 31,</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2013</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2012</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">U.S. federal statutory income taxes</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(7,584</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">2,654</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">State and local income taxes, net of federal benefits</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(1,245</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">406</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Change in valuation allowance</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">1,366</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(2,975</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; font: 8pt Times New Roman, Times, Serif">Warrants</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">1,085</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">516</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Variable interest entity</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">237</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(172</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Deferred tax adjustments</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">295</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(593</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Other</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">40</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">25</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">Income tax provision (benefit)</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(5,806</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(139</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="background-color: White">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Deferred income taxes reflect the tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amount used for income tax purposes. The following table discloses those significant components of deferred tax assets and liabilities, including the valuation allowance at March 31:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="background-color: White">&#160;</font></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2013</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2012</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Deferred tax assets (liabilities):</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Allowance for doubtful accounts</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">449</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">1,457</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Accrued vacation</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">2,982</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">2,813</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Net operating losses</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">7,961</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">1,023</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">State taxes</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(1,235</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(532</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Accrued insurance</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">3,755</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">3,445</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; font: 8pt Times New Roman, Times, Serif">Legal</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">1,257</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Property and equipment</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">661</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">(212</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Other</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">281</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">43</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">16,111</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">8,037</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Valuation allowance</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(9,403</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(8,037</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">Net deferred tax assets</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">6,708</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The result of the allocation of the valuation allowance between short term and long term deferred tax assets before netting the deferred tax liabilities results in net deferred tax assets consisting of short term deferred tax assets of $6.3 million (net of valuation allowance) and long term deferred tax assets of $380. The valuation allowances above were recorded based on an assessment of the realization of deferred tax assets as described below.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="width: 7%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="vertical-align: top; width: 4%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="width: 89%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Cumulative losses in recent years</font></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Income/losses expected in future years</font></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Unsettled circumstances that, if unfavorably resolved, would adversely affect future operations and profit levels</font></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">The availability, or lack thereof, of taxable income in prior carryback periods that would limit realization of tax benefits</font></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">The carryforward period associated with the deferred tax assets and liabilities</font></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company assesses the realization of deferred tax assets to determine whether an income tax valuation allowance is required. The Company recorded a partial valuation allowance on its net deferred tax assets based on income from near-term projections resulting from government subsidies.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ASU 2009-06, &#147;Income Taxes (Topic 740),&#148; prescribes a consistent financial reporting recognition threshold and measurement standard, as well as criteria for subsequently recognizing, derecognizing and measuring tax positions taken or expected to be taken in a tax return. ASU 2009-06 also requires certain disclosures with respect to the uncertainty in income taxes. A reconciliation of the change in the amount of gross unrecognized income tax benefits is a follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="background-color: White">&#160;</font></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="6" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31,</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2013</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2012</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; text-align: left; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Gross unrecognized income tax benefits at the beginning of the year</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; text-align: right; font: 8pt Times New Roman, Times, Serif">21,814</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; text-align: right; font: 8pt Times New Roman, Times, Serif">18,900</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Changes based on tax positions related to current year</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">2,914</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Increases for tax positions related to prior years</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">&#150;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">&#150;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Gross unrecognized income tax benefits at the end of the year</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">21,814</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">21,814</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="background-color: White">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of March 31, 2013, approximately $21.8 million of unrecognized income tax benefits would affect the fiscal 2013 effective tax rate if released into income due to the impact of the valuation allowance.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#146;s net operating losses of $17.1 million for federal and $22.4 million for state expire through 2033. The utilization of net operating losses and credit carryforwards are limited under the provisions of the IRC Section 382 and similar state provisions. Section 382 of the IRC of 1986 generally imposes an annual limitation on the amount of NOL carryforwards that may be used to offset taxable income where a corporation has undergone significant changes in stock ownership. In fiscal year 2009, the Company entered into an amended purchase agreement which resulted in a change in control. The Company conducted an analysis and determined that it is subject to significant IRC Section 382 limitations. For both Federal and state tax purposes, the Company's utilization of NOL and credit carryforwards is subject to significant IRC Section 382 limitations.&#160;&#160;The Company evaluates its ability to utilize the net operating losses each period with regard to the limitations imposed under IRC 382 and also considering the continuing expiration of statutes of limitation for prior years; and in the prior period determined that a portion of the federal and state net operating losses were no longer realizable, and removed from the schedule of deferreds those net operating losses in excess of the IRC 382 limitation and also considering prior years statutes now closed.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="background-color: White">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">PCHI TAX STATUS - PCHI is a limited liability corporation. PCHI's taxable income or loss will flow through to its owners and be their separate responsibility. Accordingly, the accompanying consolidated financial statements do not include any amounts for the income tax expense or benefit, or liabilities related to PCHI's income or loss.</p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319 false0false5. INCOME TAXESUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/IncomeTaxes12 XML 51 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
5. INCOME TAXES
 12 Months Ended
Mar. 31, 2013
Income Tax Disclosure [Abstract]  
NOTE 5 - INCOME TAXES

NOTE 5 - INCOME TAXES

 

The preparation of consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amount of tax-related assets and liabilities and income tax provisions. The Company assesses the recoverability of the deferred tax assets on an ongoing basis. In making this assessment the Company is required to consider all available positive and negative evidence to determine whether, based on such evidence, it is more likely than not that some portion or all of the net deferred assets will be realized in future periods. This assessment requires significant judgment. In addition, the Company has made significant estimates involving current and deferred income taxes, tax attributes relating to the interpretation of various tax laws, historical bases of tax attributes associated with certain tangible and intangible assets and limitations surrounding the realization of the deferred tax assets. The Company does not recognize current and future tax benefits until it is deemed more likely than not that certain tax positions will be sustained.

 

The income tax provision (benefit) consisted of the following:

 

   Year ended March 31, 
   2013   2012 
Income tax provision (benefit):          
           
Current:          
Federal  $655   $(136)
State   247    (3)
    902    (139)
Deferred:          
Federal   (4,853)   – 
State   (1,855)   – 
    (6,708)   – 
           
Income tax provision (benefit)  $(5,806)  $(139)

 

A reconciliation between the amount of reported income tax expense (benefit) and the amount computed by multiplying income before income tax provision (benefit) by the statutory federal income tax rate is as follows:

 

  Year ended March 31, 
   2013   2012 
         
U.S. federal statutory income taxes  $(7,584)  $2,654 
State and local income taxes, net of federal benefits   (1,245)   406 
Change in valuation allowance   1,366    (2,975)
Warrants   1,085    516 
Variable interest entity   237    (172)
Deferred tax adjustments   295    (593)
Other   40    25 
           
Income tax provision (benefit)  $(5,806)  $(139)

 

 

Deferred income taxes reflect the tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amount used for income tax purposes. The following table discloses those significant components of deferred tax assets and liabilities, including the valuation allowance at March 31:

 

   2013   2012 
Deferred tax assets (liabilities):          
Allowance for doubtful accounts  $449   $1,457 
Accrued vacation   2,982    2,813 
Net operating losses   7,961    1,023 
State taxes   (1,235)   (532)
Accrued insurance   3,755    3,445 
Legal   1,257    – 
Property and equipment   661    (212)
Other   281    43 
    16,111    8,037 
Valuation allowance   (9,403)   (8,037)
           
Net deferred tax assets  $6,708   $– 

   

The result of the allocation of the valuation allowance between short term and long term deferred tax assets before netting the deferred tax liabilities results in net deferred tax assets consisting of short term deferred tax assets of $6.3 million (net of valuation allowance) and long term deferred tax assets of $380. The valuation allowances above were recorded based on an assessment of the realization of deferred tax assets as described below.

  

  ● Cumulative losses in recent years
  ● Income/losses expected in future years
  ● Unsettled circumstances that, if unfavorably resolved, would adversely affect future operations and profit levels
  ● The availability, or lack thereof, of taxable income in prior carryback periods that would limit realization of tax benefits
  ● The carryforward period associated with the deferred tax assets and liabilities

 

The Company assesses the realization of deferred tax assets to determine whether an income tax valuation allowance is required. The Company recorded a partial valuation allowance on its net deferred tax assets based on income from near-term projections resulting from government subsidies.

 

ASU 2009-06, “Income Taxes (Topic 740),” prescribes a consistent financial reporting recognition threshold and measurement standard, as well as criteria for subsequently recognizing, derecognizing and measuring tax positions taken or expected to be taken in a tax return. ASU 2009-06 also requires certain disclosures with respect to the uncertainty in income taxes. A reconciliation of the change in the amount of gross unrecognized income tax benefits is a follows:

 

   March 31, 
   2013   2012 
         
Gross unrecognized income tax benefits at the beginning of the year  $21,814   $18,900 
Changes based on tax positions related to current year   –    2,914 
Increases for tax positions related to prior years   –    – 
Gross unrecognized income tax benefits at the end of the year  $21,814   $21,814 

 

As of March 31, 2013, approximately $21.8 million of unrecognized income tax benefits would affect the fiscal 2013 effective tax rate if released into income due to the impact of the valuation allowance.

   

The Company’s net operating losses of $17.1 million for federal and $22.4 million for state expire through 2033. The utilization of net operating losses and credit carryforwards are limited under the provisions of the IRC Section 382 and similar state provisions. Section 382 of the IRC of 1986 generally imposes an annual limitation on the amount of NOL carryforwards that may be used to offset taxable income where a corporation has undergone significant changes in stock ownership. In fiscal year 2009, the Company entered into an amended purchase agreement which resulted in a change in control. The Company conducted an analysis and determined that it is subject to significant IRC Section 382 limitations. For both Federal and state tax purposes, the Company's utilization of NOL and credit carryforwards is subject to significant IRC Section 382 limitations.  The Company evaluates its ability to utilize the net operating losses each period with regard to the limitations imposed under IRC 382 and also considering the continuing expiration of statutes of limitation for prior years; and in the prior period determined that a portion of the federal and state net operating losses were no longer realizable, and removed from the schedule of deferreds those net operating losses in excess of the IRC 382 limitation and also considering prior years statutes now closed.

 

PCHI TAX STATUS - PCHI is a limited liability corporation. PCHI's taxable income or loss will flow through to its owners and be their separate responsibility. Accordingly, the accompanying consolidated financial statements do not include any amounts for the income tax expense or benefit, or liabilities related to PCHI's income or loss.
XML 52 R14.xml IDEA: 8. INCOME (LOSS) PER SHARE 2.4.0.80014 - Disclosure - 8. INCOME (LOSS) PER SHAREtruefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_IncomeLossPerShareAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_EarningsPerShareTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 8 - INCOME (LOSS) PER SHARE</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Income (loss) per share is calculated under two different methods, basic and diluted. Basic income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period. Diluted income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period and dilutive potential shares of common stock. Dilutive potential shares of common stock, as determined under the treasury stock method, consist of shares of common stock issuable upon exercise of stock warrants or options, net of shares of common stock assumed to be repurchased by the Company from the exercise proceeds.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since the Company incurred a loss for the year ended March 31, 2013, the potential shares of common stock consisting of approximately 413 million shares issuable under warrants and stock options were not included in the diluted calculations since they were anti-dilutive.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Income per share for the year ended March 31, 2012 was computed as shown below. Stock options and warrants aggregating approximately 411 million shares were not included in the diluted calculation since they were anti-dilutive.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="6" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Year ended March 31,</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2013</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2012</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Numerator:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Net income attributable to</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Integrated Healthcare Holdings, Inc.</td><td style="width: 2%; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 13%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">(15,537</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="width: 2%; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 13%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">7,452</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Denominator:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Weighted average common shares</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">255,307</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">255,307</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Dilutive options</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">&#150;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">1,533</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Denominator for diluted calculation</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">255,307</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">256,840</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Income per share - basic</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">(0.06</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.03</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Income per share - diluted</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">(0.06</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.03</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for earnings per share.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 55 -Paragraph 52 -URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false0false8. INCOME (LOSS) PER SHAREUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/IncomeLossPerShare12 XML 53 R2.xml IDEA: CONDENSED CONSOLIDATED BALANCE SHEETS 2.4.0.80002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETStruefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$AsOf2013-03-31http://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$AsOf2012-03-31http://www.sec.gov/CIK0001051488instant2012-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 2us-gaap_AssetsCurrentAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 3us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse35450003545USD$falsetruefalse2truefalsefalse1182900011829USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585 false23false 3us-gaap_RestrictedCashAndCashEquivalentsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1300013falsefalsefalse2truefalsefalse1000010falsefalsefalsexbrli:monetaryItemTypemonetaryThe carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. This element is for unclassified presentations; for classified presentations there is a separate and distinct element.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false24false 3us-gaap_AccountsReceivableNetCurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse6282100062821falsefalsefalse2truefalsefalse5359900053599falsefalsefalsexbrli:monetaryItemTypemonetaryAmount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3-4) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 3 -Subparagraph a(1) -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 4 -Article 5 false25false 3us-gaap_InventoryNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse67380006738falsefalsefalse2truefalsefalse68550006855falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 35 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 false26false 3us-gaap_GovernmentContractReceivableus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse58820005882falsefalsefalse2truefalsefalse51830005183falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of receivables that are derived from government contracts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 912 -SubTopic 310 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6471842&loc=d3e55295-109406 false27false 3IHCH_HospitalQualityAssuranceFeesReceivableIHCH_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse76900007690falsefalsefalse2truefalsefalse24360002436falsefalsefalsexbrli:monetaryItemTypemonetaryHospital quality assurance fees receivableNo definition available.false28false 3us-gaap_PrepaidInsuranceus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse115000115falsefalsefalse2truefalsefalse366000366falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Current Assets -URI http://asc.fasb.org/extlink&oid=6509628 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6787-107765 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (g)(1) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 340 -SubTopic 10 -Section 05 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6386993&loc=d3e5865-108316 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 340 -SubTopic 10 -Section 05 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6386993&loc=d3e5879-108316 false29false 3us-gaap_PrepaidTaxesus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;falsefalsefalse2truefalsefalse892000892falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Current Assets -URI http://asc.fasb.org/extlink&oid=6509628 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6787-107765 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 340 -SubTopic 10 -Section 05 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6386993&loc=d3e5865-108316 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 340 -SubTopic 10 -Section 05 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6386993&loc=d3e5879-108316 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (g)(4) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 false210false 3us-gaap_DeferredTaxAssetsLiabilitiesNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse63280006328falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards, net of deferred tax liability attributable to taxable temporary differences.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319 false211false 3us-gaap_PrepaidExpenseAndOtherAssetsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse92080009208falsefalsefalse2truefalsefalse81860008186falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.No definition available.false212false 3us-gaap_AssetsCurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse102340000102340falsefalsefalse2truefalsefalse8935600089356falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.9) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 9 -Article 5 true213false 3us-gaap_PropertyPlantAndEquipmentNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse6398800063988falsefalsefalse2truefalsefalse5552900055529falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.13) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 13 -Subparagraph a -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 8 -Article 7 false214false 3IHCH_DeferredTaxAssetsNet1IHCH_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse380000380falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false215false 3us-gaap_Assetsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse166708000166708falsefalsefalse2truefalsefalse144885000144885falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 true216true 2us-gaap_LiabilitiesCurrentAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse017false 3us-gaap_LinesOfCreditCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2952700029527falsefalsefalse2truefalsefalse1378300013783falsefalsefalsexbrli:monetaryItemTypemonetaryThe carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 20 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Line-of-Credit Arrangement -URI http://asc.fasb.org/extlink&oid=6517033 false218false 3us-gaap_AccountsPayableCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse6251500062515falsefalsefalse2truefalsefalse5270000052700falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Subparagraph a -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false219false 3us-gaap_EmployeeRelatedLiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1963400019634falsefalsefalse2truefalsefalse1984700019847falsefalsefalsexbrli:monetaryItemTypemonetaryTotal of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false220false 3us-gaap_AccruedInsuranceCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1293800012938falsefalsefalse2truefalsefalse1437700014377falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Current Liabilities -URI http://asc.fasb.org/extlink&oid=6509677 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765 false221false 3IHCH_HospitalQualityAssuranceFeesPayableIHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse72260007226falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryHospial quality assurance fees payableNo definition available.false222false 3IHCH_DueToGovernmentalPayersIHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse179000179falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryDue to governmental payersNo definition available.false223false 3us-gaap_AccruedIncomeTaxesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse28690002869falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 15 -Article 9 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 15 -Subparagraph b(1) -Article 7 false224false 3us-gaap_OtherAccruedLiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse41110004111falsefalsefalse2truefalsefalse32420003242falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Current Liabilities -URI http://asc.fasb.org/extlink&oid=6509677 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e7018-107765 false225false 3us-gaap_LiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse138999000138999falsefalsefalse2truefalsefalse103949000103949falsefalsefalsexbrli:monetaryItemTypemonetaryTotal obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.21) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 21 -Article 5 true226false 3us-gaap_OtherLongTermDebtNoncurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse4553000045530falsefalsefalse2truefalsefalse4500000045000falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of debt not otherwise defined (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false227false 3us-gaap_WarrantsAndRightsOutstandingus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse52760005276falsefalsefalse2truefalsefalse16410001641falsefalsefalsexbrli:monetaryItemTypemonetaryValue of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph i -Article 4 false228false 3us-gaap_CapitalLeaseObligationsNoncurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse67890006789falsefalsefalse2truefalsefalse59440005944falsefalsefalsexbrli:monetaryItemTypemonetaryAmount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false229false 3us-gaap_Liabilitiesus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse196594000196594falsefalsefalse2truefalsefalse156534000156534falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19-26) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 true230true 2IHCH_IntegratedHealthcareHoldingsIncStockholdersDeficiencyAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse031false 3us-gaap_CommonStockValueus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse255000255falsefalsefalse2truefalsefalse255000255falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false232false 3us-gaap_AdditionalPaidInCapitalCommonStockus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse6291100062911falsefalsefalse2truefalsefalse6291100062911falsefalsefalsexbrli:monetaryItemTypemonetaryValue received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.30(a)(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false233false 3us-gaap_RetainedEarningsAccumulatedDeficitus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-87365000-87365falsefalsefalse2truefalsefalse-71828000-71828falsefalsefalsexbrli:monetaryItemTypemonetaryThe cumulative amount of the reporting entity's undistributed earnings or deficit.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.31(a)(3)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false234false 3us-gaap_StockholdersEquityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-24199000-24199falsefalsefalse2truefalsefalse-8662000-8662falsefalsefalsexbrli:monetaryItemTypemonetaryTotal of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 4.E) -URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section E Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 true235false 3us-gaap_MinorityInterestus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-5687000-5687falsefalsefalse2truefalsefalse-2987000-2987falsefalsefalsexbrli:monetaryItemTypemonetaryTotal of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.31) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 27 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 7 false236false 3us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-29886000-29886falsefalsefalse2truefalsefalse-11649000-11649falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568447-111683 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568740-111683 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4I -URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4590271-111686 true237false 3us-gaap_LiabilitiesAndStockholdersEquityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse166708000166708USD$falsetruefalse2truefalsefalse144885000144885USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.32) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 25 -Article 7 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 32 -Article 5 true2falseCONDENSED CONSOLIDATED BALANCE SHEETS (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/CondensedConsolidatedBalanceSheets237 ZIP 54 0001019687-13-002516-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001019687-13-002516-xbrl.zip M4$L#!!0````(`!V+W$(T7]?P/?X``,'="P`1`!P`:6AC:"TR,#$S,#,S,2YX M;6Q55`D``RG_S5$I_\U1=7@+``$$)0X```0Y`0``[%UM#5^`DWE]_CP38@`$+D-\2 MNJ9[$A`ZSWG1T9%T)+W_^\O$D9X0\;'G?CB23WI'$G(MS\;NXX>C7^\Z9W?G M5U='TM\__O=_2?#G_?]T.M)GC!S[5+KPK,Z5._+>2=_-"3J5?D(N(F;@D7?2 M/TQG!D]^^>>5&\`S*\!/")Z&9$XE]41[D#H=CCKOO!FQT*)"/![_T5-565;_ M&,V)K9Z\C(#:A1G`.Z4GJ]V>WE6,>Z5WJ@U/%9V31F`&,W]!H_=B],(_X>?O M7QZ(@T_IOQ((R_5/7WS\X6@[?^9])P^'PRY[&Q==*4F)QS34+GW]8/K+FBG`DO(K2."M M'2P^2!;6NN'+5%&<6U0/B^*XJ(TRY7QDG3QZ3UUXT:7*Z?3DCBK'Q0D:%4+6 MN_`V+HA]KZ_(@S+^PA+Q!S._\VB:T\4'(]-_8(6C%SE@X`WQ'.3G?L/>Y'SD M>JX[F^3CL@/2#>93U(5"'2B%"+86WZW_*/T!8*"/\]&Q-SGHKKZ]:)Y4U82=J$CN*60:WIU&XM&$C/$TS%3#QY;XT[\PYK<-XSWW>S'2W+=7'H1M2D(WK-7 M44`+(@%U-!^7[,0U+=^M?(9<._XHXGM)WDY]$C]/`8@?1B*M(^<_[@+/^O,* MFK]+O3!M73>.Z7Y#DP=$=J:$I5S1XP3>)EY$KVP`\S)UL(6#$*MD8R@9]E-1 M2SZEG%`G?O:"_:./U.1/R]A]W\VM.8FJFP_K51K-F7\].M@&&79J08Z0XC=" MA:0P:X@;^IY\*O?NAXXF(K?&_; MX>Q(WV>VC0,0F.G7 M%#Y&_J?YN6/Z/M"T3#H.O!ZQ-_.$^U\*X;6ZALR\0*OU?='Z1FAPU\0:83C,^!GVOR:+KX/VQF[Q8](7>& MP@T)?F)^+\U\NPS`&XFT1K,?1K-_4<=:3X/M-VPT,?.MIZGF:5JCV;71[*VG M4>C6J86G@?^HT9BN^8CL\S?;0V7YW[7IR#7\#5/E]OU-:SK[93K[Z77RXILK MUT83%UB]0\[HQIR?N?9U,$;D3=I1N3#:^(?7'[5&=1A&=5">BN4ROTD+2G#> M^B!>']2:RZ[-9?^\2[2N(!]DKF!BVEW>T5KNM$>V3 M$>U?[[Y,!AAVU-[ANNN(@4VOE>L=V3A<(44,;%1()[!N-83+Z;A/9 M]S>1?1NQ;%X8?8B+R-/%46A:R301N/E'F5UH+VSX+V MPK&T:>_[M$/F`/Q(:S#[LT]B5VZC37+>JR3GPW(AK?'LE?'L@3NY`FE,T`TB M=^-7DQ5T@9]HY79Z=7V5S]97\"=JM%;2KMB46TGO=1VR=?9L$OM^/D7[>K16 M`]/H;338R#UA3Y9[BCQ4U'YK%^+M8D>G:+7M_77MHY5;O1Y^W#]S<:C47^\N M5G0W0:8_(^AC=#'1*92)*XM?I4G0V@KJ9R&27T@BDAK0FB%\CU)MA=1W:]7+)T\RJ.WZ>DP"%0"&WI M!31KM#:%'_EU9B-\>LGL_Q8]8C^@[8K>?2-%]GE+;VPJNV^)#L(?0;+(EL+T M&)KQ(GWQ''K9FR]!4/Z^6T1D%<0Y\$?HV:@V>OD9S;E1))U286U)>Q MIBZRKWQ_ M!IT#+]GO7M(`"FI;)?L/SYFY$(3//V,'$;\FN4PM.>8=RN$633T20/L(+PGD MIO8[]3KK:ENERM"<@[@?/<+?I.XFI@/?28OJ)3HK9[KS)(14U7D-(51Y:,"? MX1D_LY]_3S>"E9J*R5$+JT:,_IQ';E'3JE1O9@\0;GQV/#-(D)=1B;(ND(],?G[DV_1^=P7TR'39Y&YQ#I#:' M\NP$^P*(3`.%8NJH1Q]5K:^!AW_?K41.&$:%!Z,L&\IPAR!E'I!*3U,%@+Q% MT(=C*T!V_N>U%2VK*7#KZ(C`Q:?<7B-<9Y;E0N(Y MQ&N$WC+\&2%?@*@&^C!LRA6("<+')3BEK^IU\2VN+R5H:F+[WGQ!53SQBX]/ M7>Q\.`K(+'G]+F^U7/P9P[2E)BLM('CY,D6NC^(=M2`$U*"'`?I&'H)<*DT1 M\8D$HL#:B,*G3;L2N:>H_707EZJX,E5.6U`UG9_H#?&FB$"$[)AN`%*A_>V4 M>I1&W84Z-++V4$RF*20^WZEIF4!RDY!RKE(I#\6'^C!KKAL7&#>Z?F]H]&NC M:^A:9%T?9)Q+6:.M'XSV^X:A-:)37>O#@2*",WY-RHHVY*#X%;LP,!V=$V3C MQB&U,M2408IH7O5U(?`I5QUD0B<>"'&8?6/.:430?&BAR5IN')\F4!\&GR=D MRJ@.XW(R=;PY0K?(H?/27['Y@!UVL4[CCG*HJVG_LI:6$'!\I@.^;]`,',@7 M@C_[RHT"S<;R4H:9X5@!A09`.'VF.AA4`;(V_HY,L/Y(1%$X(_V(D@AD!;(J M"OT9J8L9NO>6XS>ZM6R>G2*O9!.#X9+O@LKK`JC(7VP+88`=&H1`;]&7Y?0$ M33F=YJBXFH*J])4&J$1Z4]489N:+1-'GG-53A_VJ])FTOGKNXSTBDPOT$-"< MY*:&0J??5W623Z4A("[)L.GVNH"B[`P?HNU;_#@..%8IN&*!]+"CC$I31'S6 MH_?EVHBBC;E?D>FCZP<'/[*3)'P!MJ0/C.P,_QI20K#Q!73#?K\9MD3[;!+$ M`9"B9E^1(I^I:+JFBJ)8=>S6UU<'-0VYY:>M91M)">W$>F.SY4(E,R&?K;@. M8;[9VXJ$"[;K)SYK,(0;9H*/]<3$P.-;-!$`+[NK$$*8V63&1CH7:$0S`6M+ MKV,,5#VMR_74Q.#C$E]G(!N*T1!??3QZ&KBL5 MR7_#KD?@>;R+K#[SFFZD'6RVZCJD^?A6AA5))_POQ"D"32!G]G,=+1'8ZLZ8 M;@-;\UG6+4JPP0@W4+_HJF]W>+,'OGW)ICCORUF6C#'9L`=F;MLJ# M@)ZLJ7LA7SZ\T+XT7=XN8(Y;J=9DD$Z1[MD4<^ MF39=".3>9%7.`^L5U[/`C6H+3-:(5E2=QP=M@TDA6E,-5:NO-L'H*ZM#U15Y MR!.,<:'_:CYXA*[]ALE64?JV$#$K,DT*3L^YY5*KCZFR\!39,#*S0'R8[F;3 MJ8.1+U)`$$+I:3/,4*D!HK)$-*VGZU5`L+[SW/-97G)8Y'I*3RG(CBKKBD66 MC5YF2;*,9E-\E24VZ&?S3*O`NT!3`M6Q%@K%SR9TFW+88,4XMZ&<#KA*"#;$ M5KTGR6YCJ8!M(=!(P&(Z<'4(?5LZ9%HA5`M)=;>NA0L4M9"$A\A]]7PQ4NGH MAEP@E"6EFF`J"T96]*%6%4R\D!B6B.27W:Y16SPRC"33'5L1O2:X*DNJ0P\\ MR^XC+<>5.(*04KUTD!40S\56&%+<(LLCM@\%Z&E#3S2:>R3FI*842Q-VA8"H M+#((;)5E7F]E#*L.E.`GDQ;XR<0N-9%AF&`TLC,OI53;8ZQNB3[1K9SJ`1QZ2DI`KJ;&;LS^"ARI9[K M?T(P0D-A.;:Q-9N3`?USNI9PF?P;"L:>37>/^\%DY;B"VCI16&9&VI5MC84] MDU[U"!4"Z'V1';3IY7=G04#PPRR@B__W7OZYV()W`X3X-6YQFXO3+F,`G MT\=6+0,I2L_H]$YZ>F*/7Q[!VJC6FDY)THBZ15`<:MP%TGH&5ZCIYHJ^P,XL MR"1R;-@`(Y(-D&W("#<";&.&V!RM8&.LI?7?$-T)A>RS)PB/'M'W&25X/5K) M;:GI)CFS:BJA$,Y"N3D?*@OK3.D@^*K11';(5]3&RC/0MM!NBG!L@(V:;8?. M1.\Y&[7M;-]XVWH;XN6-,Y,UYZ+HRDC+$EHYGYSSQ;+>7['SB*]2]VNI^V0`*;LRMNB_ZT-A7F["_NFW]T-CGNBFWXI[H0Y.! MVEP&*UO2#TT&7,?9=V0CNWGB0/E\:SV=W/9TR;OAXVW<=$B=I,?G](UU1U\< MBACJ=/A#UM^_`O8;>'MZOM0&9<`RNF[,^81=-D1M%=G7;K'5"EF3CJVZ*O$- M@V[86)MRE9N]("K_P,CTI2DBE1%4ST+(G@[7C'[>O&0M%[.Z_"\>6(/&7YJ? M(T)KM:2VDL,A'E9]F97F`JT[K.D"680>*4*17=#+#*D;I8E?16[T2[&#J9'- MIV;.P10%;YMLUTA_'6;2Z`^1;<$-_[6:0J-(:%MV0J^Q,OTQVY1I(_O3_%>? M'B8>IF_"YV=6@)]6S]&LWSOWU,QI5OP(Q&*OWGBU_F#%W]:$'H5,H*TS"^): M@@KO]Q"S@:Z7O1>''X!8Z-5W(_:SUPK51@Y](VLS<=NY@D`U>0&>F/UCV33K M4I(B(-;9A-$(9('9+S9AB?890WTU-.0$(!9Z]61M+;/[JC[R527%Y]TG;Q*A M6R973L`7HX5!9GZB`:`-\U;#LV>/M=XHN9?ZCN?VC=K=:_(J$$["HL!RR+ATER7'#2RR$"%5OBA& M%H*S@7R*3;#X0B)1>]W6A1'%"$2CK[X]6^ZO:\)-T&=\L!"!#PUY97M<.5DA M.*M/)@_4["[SQCBC:SHOT`@1@C@N!:T?00SD->!YL&R.H^J6WE/7M5.A'*W> M65M7%]G[:\M)-@=8/1(0C3!N%['HEVL4@JQ;4[1U,60)!N$,5)>XKJQKGHWP M;T;J^G!=L+L9I#4,6ETGWNI(XRO:104>LKRRP[Z88F-XU67(3D87AV_U_'E! MKD`U%-Y^NOC^\[IXJXM5':HKI\14Q[LXV"_GA/\-G:U81K(I/`&G(E:$9R%D MLX,44E?EBFG86G^X(KI\>HV`U9AZZ1ER-6#)G`,_3CH@E1(BFAY-U(QZ]3A3 M7+/#JH]>A*@AXP33Z9^R:KB5^!4*6=8-KT3('@%CHU?WK M8*#I@J#3SYB._#%=8WLR':J[&T0P/>\G'3"(":0,QM,D/033\&B'_(!.O M-H%?N,QY@7W+\?P90?>`^).3O<^P1/H??W2"=U/)#^8.^G`T@H].)6,:2/=X M`O;W'3U+M][$=(_#!\?2'2`=O9,F)GG$[JG4@Z*]DR%VPY^.?GP,WGV_OK^4 M%*DCW=Q>WUS>WO\NG7V_D"Y_^?7JYMOE]WM*L#NE!7_\BZQ&_S0'P4C_:$ZF M[_XBZ[UW&Z+R3J)"[9C@E^#1OV9^@$?SZ"%VH:^`.GLG&G89G%AADNG:$HJU MQ;"`>GSL0]SIC208]$DCC]Z.!8WO=+/(5T&NEQE+K948SQ^.Z&&'-'G%0HXS M-6V:B/OAJ!?^[D]-*_X]`OO@$0A$.A:P9TY]="K%/[V3GK$=C$\E:"#_^T[B M9.IHB8X"(S&9)Q`SMDPGULR#%P3>I$:UM,&QJNV*XLZ396"SAZGJ(IEU0H3` M_C2H"#.71@8[2!F4`>I2%II(&FZHQ'=2I)T8RR?'!,\!B"3?<[!=#=H'ORJJ M<1S]_9N0UALY&5T''Q/1>:!2KU;YIQEVJ.3\0M%&=)1&9+A,+4U07B&8M#L' MC2IJ^(=U',IJ*45"#[JH1E+5CS557TM7,*,R4M59?^ZFO MO0U^ZIO/8FJA-7IQN&[DOT,5,X]UP_(S&(7!V%7 MFM+;,I#?QBKU#3:BI]6BUSJ9W3B98Z!U^#YF"^'**O>-IZ^BQ$_@`Q')"A<: MH6[31[QN:#NSB>FY\Z:SA>O&V+SM8`MP6(.*XWI%'U2;R=RI7V@M8UN6(1\K MW9M]RS#^5C8]==>ZLO?GJ#X;'6U]I0;#>AV%<8^DFF9Y^=;E_50;'QJ#BNK+(!O2WUB+VS2+ZQSVY>(%OZQ;QJH.O M35GPQCML,1-T<3^98HN38-F#ISF MYTK/\/H'_421)MAQZ'HH??.#=M*+'QQ+!/E31/?A(&=^LA?BV#/MW(^1%)\( M!/(F2'(\B^J*P<%4IO2I"?VD2223B9+)V9\]T'O6`@S:@E?!^-\S\T\DCRR1DGBR&W>C4(>D9!V/)E*8PNK+FDH,G.*`Z_T'KG?08ADB7)]*9 MY`-+>`2ABQLD*[.\F6-350-INB8^`?R$XK+-B?D8P@W09.H1$U!X1()``*3( M#E9$OL^LD=+T%E>V2R:`1Q*K M(OGZ.*T3:0+XI`E",%P/"'0%5,>9VBV"F7G$!LZV#W0!!:N9 MQ,;U`+S0WR5*UPX=&+RB.X]8/=,9\6?4+`,/OL/^@BA!`;L:?,/6PMD?B/GI M8`S-3*CA"0.*"0K&G@WAP.-<^M/UGFGO(WTY^[]?[R*/17],E0K;OSF7:,?E MS&S$[,5%8+Y`3/*]"9+"A!SP9XXT\6SFH)@7.6$?GSD.%)V1A)52"T8^[1!# M@A$ZZJ=(M!D=L(_,)_!8=,\8J\?U8-"&J.^BAZ_3NS?!UA*D*3[H2Q?DP6$" MY9@HJ^(AWG]Q'+I=R@IZL=#_L_>FS8T;2Z+H]XF8_X#H:8?5$1#-5:3L,,UG7\)W`F@8T``7Q[ M`!#;`D\$X6/)"BB/B!0IHYQ6*0ND:H,`PC]F#YI!4J[S891^OBR&@@3H0#AJ MA,^T_$*YSP7+4"^E&7(S%H*6X$,@L20R!G/#%< MDU@2U/L$QQ-4B'^0+_L:>]2@E_$;3#2LC)3^[P5..``Y MQV;^7#$G4_PVBMUW=Y),+&])H\F-IL[KAB^?@7M`JC9K\NCL1UM+C3@[C<[T%&F@11`6X$_T^Z5FJ7N>[H#T&-@*!X$UY`1X9KN$7@G M@K_&H*!Y:3T_DV@P0T!FV$XZ/H&\38@O:,P=<=:ATZ975`FHC=3CTL(U+D<] MYW(;O1DD(WAA;&#-_`VY'6@*+#ZA=7O$`J*/P03[67(K($Z%7B=:MIZ0*70* M8\M#I@4,^%CQ+UE$GH0<.N$:@8/JN"$JCC_!-#XX7J+NL%FNX2@;"/FBI6B_ MBJ87,B=1X)"4`@@1>H^/Z).FUV4!XBP3/P1DSJ?!(V=EE`CR6SD_9QB9%I,< MH&'#Y3/+L\B8VXI^78B"W+.+8U]/=3)PA#"?@7L*(H(3*03EX#L-4A-"%`%5 M?A(D>/D+']!7/ZK]U)!L3YMRSJ<'<+*$;Q)DT#;E;7%(H8,L,0]C*X`T,=&#W[Z'XI+MXEVM#W0<,8G* M,/!(RPS8D/MRJ`ZR6Z1WD?8Q:6OZG0,W"3@?.H'EB]&4RS/X8\QX&)8K;C!) M"?>KZ4.2"J",\#VY=B>!4I)$_"6(PCD5OI\J(,[C?(>,C%EH?4>T(+T9'-_U M0?7T3+X7NQ\Z=:#6RJIMET MF*VIEW#G"_`!S``8F14%.NP`&['Q]4!YTC)_8=0*?'?:[#'8J<"4T5F^"E+: M(K\)4\=I#S[:=[`Q+BK_01)*RG`3`(H4/BYXJ^#!F(PSIN\R3*1I0;M6\.A! M,-!BI6V,=M&W:8?[SAQ\#[V<*/I47(-F:+`#&OS!,%N##8[!.0_Q]56: M3-"E<"&1HI&<"43#WZS3OT1>3'%6?V&7CN@5U?% M.5T?BVM4)?O^GJZZ9:H M';O1+FX/L/?S'CQIG^URNW&*5BL+^I"4@J`[(.$NY7'[)8U[.)BADZ&3H=-> MO;[==#^5>"^M)&QDKA+%S(Y[A5I=.,P'1[-WJS#9$R",<<&]P;WA^$*O;IP MT2=>6H*%+U@I,'7#I5TATW%U5QU7:XWB9M5OLP'O`;I>U4I]CU1<@J=W2L!7 M8*:*-;2ADJ&2H5)9J72P(;&=)XA9"T?*'UZ09=>!,>2-/8\9.61R[6-YZZ89"%#+*^ZMBO#_X3C9A,/YKY7UY)!F'N'XB2@;-S(+*< M1>#\XZCBK\2-G[K^@#[\Z$1L<.,\X83LZ![6_N@% M_3]__>__0H;\A_S]#?,C-_#A1]KM:,_ M/]!?II[C6S@T&(AFL88#`G3HQLZW$]UA$L[N?Z-O]X(&%?/:W0U-N&4XNYE#VX*!B M$J`S"ADQE/4X=OLTYKSO)0,`A19P1JQBP>'4N29.W!_#7SDP`FX^3]#M)7P2 M=3)%Z!H_B"GCZG@_XJ*3*;"U0Y/1:8THZ?U'S%F_O+WC,]D!+>Z.@1'B\" MHB%6857$S@#^PXH!`/C!;-&:,?B3.^KZ9(HDO MP3%WJC!GZ5BS<3L)DZ!]F&612IZ^7%??S>K-6T93[V]`.I[N0P<0TJ=-]ZPJ M*Z>`EAFE6:N2UOS2O;\XMVZZM_?_MNYONU=WW;/[R^NKN[>L0#T&1C*2*@+? M[&/7P>'V\+^D8@F9XX'&0O&)G^2'3A]L+0K^YR":NK'C1=80*,N9_^;L\Z70 M="Z(WJ//->0#"'*01-9T_!2!1@5-[?H/+(J#D$OW;X[/HK'#-83Z.6``]",M M$`8KFNP<-P"0:(/$MX$KBP M(\10#0R%SYK-=J6E=%M$`ZPE2H(TZ<&BB?;R#QP(CG&"&A1_'Z24*[BK`)8^ MM2U"FHOV#/%$(5D7AXT"@K@9`-(`_O$(&0U,U@BG-0-?/*5'"9](9<%=!.!! M=3$+"1G/C&;";PQ='[038B*K/#ETOC(`Q?HM;X5<3;2"!IE5/G?`[2X<$]BU M"X`D@!I_=`,@],%2[-E%J]5!VUQ\N3B[O[V^NCRS/E]TO]Q_!OUS=GU[?F== M7IV!YW;Y^X5UM`.VV7`GG27.9=&+29]GS<$V6G@B@BG1`W<$,H!R:8F@7`TJ_7@@L48(- MX7_S-8@@X,N``T.J`ESL*>P]8,+9A&\OHA`"KY&@%`Q=,ODZ^WK'.1WU/8@- M6!87?,]4W7M6F``1R>`*YYQL>Y026-%/^+AN"+\,HYAN#4B1])*$PJ4[PHK/ MYGA("06PP8!-0`'$(9I99&5I9]!*/0BQ!9"/I-MA6],$S#[>\&TL/(D8W$/@ M"V"6Z'X6?*"/:1G%6^*[@L$&N&\1)^$1*(S'`0FLOQ)`[?")V)<?`0E4/.P^# M).3,!5ZG&PRRH`IVH%\74A"7=6/2V.`L_(UK$^8`MF!":N3]2:6C?#G!^>"2 M(-B`.BX>BLF?.VE&<0XX+PS!DP$$TN_1]\AU@Y;S968]H(].Y$;7PYE?//'_ MO2D/Z"<_""=P@&65TVJ7D8_=N\L[Z_H3.$(7=^`3=?$V1F@\)FJOYF+*B[0E MO=-$>*Z7@(%12+_[3$:N3T82_*H;IX\2"E]V0!U(U@'.D6ZH;7WY6O-OAU7#H\NLR08+$7.'*AU_-N?8MO-3-!MQF;W=#.1P"Q[-DAF^Z`-C1M+'017]AWT&Q1)%<*D@A`AVL*^XXZ M"VTVCXW(G6W\"`VE,Q*17!$@X9S>K+7\XH(C M!1[0T^:CDUOFYN>R,;]<_NO;Y?GE_;^%X7PF)A9G5%[JXQ$Y1.Q+&H^37T@; M@1OB]RGN][Y^FD:C>6"_5JN<%,2G%3D=ZS$(_R0C[M`U42S+7=^J5-5ZZ'BDOK_SX+B>TW,]$`6"A7NUZ/F$["'P'HA*X+``<89@]/![PGHU M/LSXX+Y\%<,0+9$W$VV1-QEKR(3(<_=;/11Q7UO8%Z%]B%HRFL#O7&0606#) M<8*UU*T1([13^,=WL((QX`88I]K2'/KT6D$O<-FOUALM+8XK/"Q``?-!\_!( M-KEZLQG..;+X/[5/S=/V.4GCW3(_2(47E:IU]+Y]6FDJ6-3><-9C0.2Q>)SD M]XL@C%,Y:9VD+T;I[V2\G-Q<\0/A@D16K4:_K34_5,XO[LYN+V_0Z48G_..W MN\NKB[L[#%X.AYSA!*MUD-.J+7ON]4\]`M!U30M7I6XR^#_JA4#SB`A:W=E& M'M/PA]O'#SFRS`]_-\`OPVW8V%OLZS7@\E MVUA]YGG1%"3;'_WS7?4=_5LD!]&_,Z!B,Q`Z>2]T;:"+]\`P51X`!!?E6$`I M9YU7JS_\8HG4)[PS.=.(_6S)_TJSX7GV_8*$+K'@R0]I*ED<3/'8[9:>\DX) M4/,?\TQX^:D'SO3QF/&OUFHM,EF#IKK"&W]]/5._1B?WOZ`BQ>*-@_G>-891@@Q M/(3L'3M6UW<6%;C,5Y0LP-O!,/*KYMY#Y=A:I_,,QP*O`@`3PZ^&7\O`KVW. MKQ0N0SX5KA:Z>=(9-'K6\&WI^+;6Y'P[=J;P_1P]>PW7T!%;A5W3)/./D]_-:-_CRC`!'^5ZFY[>R:4JUNNR+$P9.'+N_^S^+O MBVGF(L8:M`QISX7SHE1BSB'2F][;D/AI&("B"IA^BZC@K"2^_+^!"]R&-L^- M(@K/?PDBBF\P%X,)!$:Z!>839)9Y#!)O('F1'F-XO&XF%QW5D4RH'.&KN8]D MQ!@?`):-`?&`662KY'.*S*EHSL3Y3Q"Z:6JGX.X?*29(`;%2,_I^(;J;S9H5 MZ5S@[*!-$H4%*K)(6H2"7[`/%5DX]Y7@4PEXW@![1U$$8HYZVL/(,JG M@D6!KYYL3<5R>^@8\<2X_]4@ZG1!0EDRGG;I[* MJ_&P\(*E0\J3&OUEG^NYGY+BC)[\*]8-SSE"AP&D)Q*PR@Q&D6B;`IEF5RG! M$1(7Q0(R$)(XYIF6D2TY'S@>V4$6*KF^?,H+68Q9+P"_#3_TAL?ZGU#^ MS,*R=<*AW/(5TU\"DX`>B@/,P>*6'Y\W0WPQYT*/;W6SI'5A+>:YH!%)Z?2H MPB8*?'J@&8%"]84E15\/CV3UW;"?3-#/Z!,I9&U-'&E.K'CBXH]@70^S,D!/ MZ0=0F])Y,2]$N?^\$@3?:^G"@TFTF$Z$>FCHN&'VSI3*E$PH00+'"682LRCQ MXDCX'E3(B%FJZ!L]T(+\E3*(-"SFZK6LLI*J[/+SV>>?;S@SW'&5?"N,]R%E M/M[`E03+=^\N;G^_/+NP;B]^O[CZ)M1<.F'%NBER(WERL$IL%%/IT>C$"\R_3%YJ!\LRCFB M@D-!?"!S\,AY%/<`H]B7V3]2V7B-Z\B/2[KQF%Q0@S])VT#)'DG4Q"8GZU0IC_93F8O*DP(!^&;(A MYH,"BE&(TF0%<$>`\V6"P10-MU@(?A&$3&V-OH('+H#@HR!\^F#/+$<7,2\*.(O$F4@#_PZOKA37&;'/%*,T,F;E3*>>"-'@ MIDJ2N.PJ,3/W\H7WE&&`F$(%YHH[B@6FF')FL>@_2,(^B[2KP;R>/4+G@[N! MSVJY#\!').A36=!&S(0M7V(LR9!9GC^7!45;R1GI;"UE9''#QD7M%@L>#E9X MPWG!"G`<0)[_SWPY]]8E3(3@UGQH6<5M.0^ MY1TZ3>OEH6E>IHOLW;D=BKYAM-:-H*Q+T;W"\PI.M`9[Y#4S_I\+^G^+.$>8 MZ6;GA^W+E'3:U\M';!1#N`(5I%NR@^.^7^^<=80MI]'HML%MM>Q6N[H>S`O0 MN3IM#*&W3.B.76V>[(;0&U)DC]B5?0T#N&'5Y0X.R=,J[EF\;6S!I<]NG=0. M$%D'B>Y.U:ZUMGD)V)T[LG4YUL*.!\B>>V"N>K5A5UN=`T36@:*[9K>WBN[7 M8I(O_0&;8&V?>%J>.D_IP]'.V?6Y&,;V=]@#LYYT[-/:(9KYMTFMNGU2;9=? MLZSO)NR?A^J5NCX"H&PWSV5@W@-G-NL=&^X,KT61&"98BPFJ=;@T-G>KGV;' M4WAE?*'=>06/?!E7[?!X&4'HJ!XC,WTK"K+795(K94OP!"3>S\KUGBQJ"13( M]&^5'A(]13&;8-MZE0^!+^PAB],O>UI:(E\V39J:;TLJTG@YI,E0F<>-' M2TMTQ,3$,$U@&UA)A$D&,YF`<;E`")B6:^0MD_C0/B\:;['*#4J9.#G/&"B M99J+3#,8U)I:EJ=%R6)/_+]#WC":VL9:B"%JRD;=%2E[<\I3J'@:G,B,DJU_ M'-'&D8F^G"(S!P!@(@DKI8@+A'`]F37%&ZA1(T?JW#5AV+($V_VJ]"L_L(9) M2"S%@>!XF#@#V4F2YX:J\W)DI@U8KX(8105;LHGN-K*:Q7I#Q:9F3RZ2NF"IC'B,L"\$T7Y$X[&+/V$0T2Z-]$ME6 M;XKY?_P//*-MME"&@%#Z*,S@FV>>(BE!TUS*I]F, M+T*E6*"79L3*=+WYIC6S?7HUR3B2LO`A*R34KZI]^D$T!CJM8E[CHCY@V:Y: M)3$NY3-WV3)!(8(\`3&9BJ["F#JJ&E_))DQY%8.@"?!7I&'\@3M"@A(S'B$7 M'L,WT;#AH`7>M`E7H$%&:=&\W(A`P/[&LO?1^=UGK;L2TEF!HD$@"YJ[(*D\ MFURK4]3:5YY][9YIRZ6M;^\^@B-5K=(&^-_U5DLK3Y&,/(>Q@96/+M%2N#G7 M_RT='S-8;4*-J`28&2ZC+(I1),P.9/'57(U?7L_/11-K=EDE=P@Z M8L8E%MG+(D585EWJ;;KS'>+Y2DWKB/R/PN14E)Y.<[9[(GQ2SXP16KOH\H-= MZ)P+AQP=!^0?V3D0;*[6.I>J!@@$[`<*_L7(#T#O4"_0XX'+)OP;MDJA17F< MN3R$LD+J)S@%=]HC%T[GA-F( MUD5/3P,Q+="AE>67CWM/QYF%I0Q3VU_,;P9\AKR$JX>7$TQ>SQQ*<(;,C^8M M_36$X,8#+0.=.5@XGE8D(:R5F2IZJEV3`]A9UR"#[XK+HHDBKG@A4Q>K+8JM'\H?I MBI-Z>S[CMQ`JW7IPJ6I,]^`&`7XI4*#Q*A"NSWG_^K3N2MS4F'X7RCLV($=4 M,M`RRHVDK@#Y&F)GCMU!5C&GC*LW1,`"#2SB)#6$>Z03L+"WW!KU9D*53A+IBPJE#-9YB&B>U,*JI;XG'[Z(I2ZZ`!PIKAFX(=HDFI/@ M\W^H0%M$57065:KA$KP<*O'5I$0V2(NCHBCH:S5I7/9XI[ MCCOA;MXT(8VG/7G">'5FW?-WQ?/\N-G&3272K[G5=Z?]\"L)S41PFVME'%\I[ M^89LE[.;UL7M.1#B_^'A_)YHM26Y1(\6&O/&1 M;&T@L<-I*^./9"51D?`9+/AW<&-5<(P:>_NI1\F]^D'"`X;R"A82P6FH@`I7 MZ]=L'J$%_S?5AECVAV,OW;\))OKM`G?7C308]`<$+A4CW)^;HQ%B MB4\^A2A0)]]%?B!-@6W!33.9L$P[%]F1A:":,+`R.*Y@@&T\Q&P6_`MX7-AE M04;`DQ!8F%=VZA/M>B)HWWO2'+]LZ31-_)5WJBE>:D2#&_4VH2%1#+J35U*! M>F$XL2=%PKO:B?`PA9J=/"S.$48A4+OP""?`V*UE[!8V@B+%RJ^`?!@A6*+) M--:(J(KJ5?PLY<4THJ,Q$??R!@G75CF_F^$G6[Q$\2=#E_.VO,B!;'GB(8)T M&#>1'KZQ\@L!GZ2"2@@?1\2--_,^(D"T@6=CLI8T^IL8E0O&A1(9X?CR,"X( M"X\[X)I?G!YH'QRUF3J_%U_ONU^Z6O-]ZS?9+L&V5#\9_B+"OVNG.$!?GYMN M0)9/HS85&+'<6L4M@1Q@H/4N>/*A"NNM;>TUS6,C>I!3FT^$,\^=<\0A^^[0 M(!V:^Q"IATF)2MSE;V>V>9B\8?/GM%'BVT7--3)E_`_(K%I806N0]F.D\X!+ M+A.UGO$#/\5%IO&+#/J3)?#DVSC*_"`)Y5@=`96-76;$G"CM;L,Y'I4V\[EC M#/#28'N`F*!]TE2=.HL*/''ER2ADA&1B@_P9XYMR>N9:43K1N.L/\/]<`(7! M+B,['5+KE[/NW6>K>W5NT7]<_.O;Y>_=+Q=7]WJ+*^DKR98\Y%V`BS`:`VM[ MU#P6Q*876^D,83,W3M1S+%=N'&WB$8'+/LZ)HFCO0`R[DY:> MM%/!FZB/K\^:2S2@VP(V`^,+RE7`]Y>[52L]B7 MB_O[BUOLGW9V>W%^><^M;=I5:(D10N![Z-/,/3H\N4O\^#0T"O_ROGU20UT, MJF;N2_T@Q.MTX/-1=.)I#KWS2-\P'3<583.(D$>D]4E%5MZ4(LSNTC930XK* MXFKD]^3-X:59'9@>Y]0"GUZC@R_5Y7)*]0`NC;<79Q>@_3Y^N;@CC=C] M\N7ZC^[5V05/#X&+Y/GUMX_WG[Y]L;IG9]??0$E:&AO/=GBQ,MU=>%!,MKA# M*P]V5;PYYUT[R6\3OMI/V)A1A+J^U"8GI M[?(6>KN4M%JV.V]#<\;AE9`F@T)R[/5J,)K:>D3!_DX&IPB MLWV=HYZEYT5J18G2QA"^A2XIMLVO-#5T;-@;5!T/\G1"_UK'A=G,P MQ-^5][>'BY*-^27EX'I3C[YFNXQ._=4T-S$\L%:KQ(;=.CU]%;&BK$/8JC07 M>(0FB%&.@[T"U+P6"W]>6%II(J(E.M@K0,WKCA%@#7M)Y&5OSLX^'!F[T]GF MFYP66ZO"OL'36[L\>[B,UELOE-9*Y\!WL% MJ'DC-V79?O10KLGE\HOV?(5K;_.UTA"^M(3?2;3%7.'-_US'?%%OZ:BXT6RO7:V(?MLZZAL MBZ#CPAY!4VR+6=QRJF)U"\Z0[7TXTP6=6MXM3KNG3]4A4TI@H_/35J7.\7A: M!3S.=AJG+D5S/Y1]/P*2DFSUDU@KGZ*(@R2SM#N5*C]7NUUI+CQ7T5*S MI\PP)35M`8&B=MBJ9_90,(!@V!D&"![9T@R0U[5[623-]29'0M>K)"8H,">5 M6AY"LJW)BP]?ZMX;^X5(:^I!N6($B-Y;F+>1DDUA@67T/KA:\UP<3.(Y4>0. M7>JWJTU48KQ92SJMX>O%C2VZ`:6MGO1>W)P953]N-1:A8EUFFE6E#:UESV$= M*,Y_>D=%A!+^G<*IM755G>\?X9]P7((A&`ZI*R@U`L[[=6:,)V^?K9K]N&%N MO\9,8T!J.TE3+A#RGL,;*$45ZU9MQ-MTB2Y;0X7.%/62X75P!@&A)5:C@'CK MOK3Y:=K"CR,I2CS>A"28LM`1G9(RK_6/'SVY3A!2U(,%!K<)D^]1$=H#2Z0/JR=,4398]9]%(O>$>&?X@ MFIG&E09I:2:58B=NSO"/'(X1]?TYK5H#T*>\QR_@E84X9\3UB_"UL'5+VK3S MV4:7%'?:ANOMV M<_,%_IL(>6S)$[EB\I4NJ1/'K\`TZ@&HF15V32PC]9 MG$N4`L3-=^A%48R?;L#8QT`X;`@V12X\I+9R-[?7-Q>W]_^F1DK85>[F*Q!` MX%N>D-B=R>/Q>7$Q:0)JN1O%-F\,!Z*<3!+>3VW`IB"*KJ,F*E#+9U!J;DB+ MH!9GQX/@T<_.9XLB!KI@S+QT!EQ"T[U,70 M_3N%MV)=?"<%$U,#1.[BX/0O7[5J#1F"*MPN7(7ZD!.,*-,^>/D.N?,XH@_` M.^.[`"*<*+5D0K]RINPQH)"?]O3EWZ5A**3Q"HX@!]%E^Z*)'WNN['7&1[T% M(Q\/RGL.J];%PI+E+<^M?E^'7BZEPTX")4T<"C,7S$Q7X&NWSG M3*=F8"IT<\$IH4NG:/@.@FL;CBZGQ^?L MJU)FUR'.7PLBQ[L>?@G\T1<<7=8E1CXD6_#E^NJWXR^7OU^<6]V[NXO*4 MGXKU*=50:KR.4CS87AP/+-=4XQ:Y1\%_QR=B(,XX``([-%,`-!(.L`1/L2\; M+M.DI)3#=;@$K'A101`)#`&F/HB#EICY+C].=C@M`)),IJD=!>'[C_15Q=`A M-8M2TEP.+'*BP*^/@V#A?,&TL=7UT+>C1WHI36'YVWI M)^YW6\YK$.I`6%N@]2/<2%47>!Z,2'_O@76-O-3?4)-ZTWF]N#]B/[^WZSKR M/*L3D'-^1P;X"M@"6J1JY)`4P:?NY:WU>_?+MPOKZT7W[MOMQ=?\3L,_1MG1 M,TP$*:57XNH33L4`@`43`E5TM%_415C-:8SAJB7%ULY<^N@N:J?72I%Z8&M, MH8%G4XMDO"BH"8BZZ],+@C^%)A!?2$/&8A::TA7&:2B$Z+=N]V9V/*UP:LV/*_I3IV:@EXV>81@65+071)RO`U_YLOIL/.R=C=9M1%=6 MT^9ULVU>XV"ZZ+E?;':RT597U;S5?K$0!<<1W$;P@VF\X$T3,Z]6?M3D8]MJ MJ^8>"J`[S1\*^&/W)_GFJQCL7TD0IU[3-'2Y/V@Y?#X!_YP[E'S.8C^U,4%& MAU<*\;)2G?D2Y6ZX.E[/AG1-J)= M)-J-@Q5MC?6%N&Q(`G:0A71XEX],Q)*&1FM1RQ[<2.3,$"][J4!E1[=XFHFJ M7?/2$ZK_ZN;??6=>W?4)?Q11A[UI4*Z,/2^[,=R,)1V)9FD M$8;L$&EZD?!C3PR_T:?#`F/Y@3]W9<]J>9Z@EM$J8^L5Z8X-@->E+E@UB:NQO$-QWDV2",(.WOMS:4QY6#0@XG,NN"AN)3/,75$3C%6UWLS M`L6,0)$K',A0AWN<5G5(^>0'@E<1SS"8?1EF]6NNP>66N+1DW0`.2:4?VK7: MG,BF\1&YUB4DL]Y8,JG9/@-Y:$ M?R]]<.KMDY*0N"S\LL:&):;PVH62ALR&S*^`S$;[ET+[;\A_VGLO]^<]IMU? MT0]1.DHJ$37[I'E0\:J7L\"&=SDDVVA(O&=L='*B>8XH M36"XDYN;OF&V_"@[V\Q<;E;5V&]M#O7)?N90UT[:YAJ_"L+.J)X0<]6R5>J/ M<^I8E*I17AMS0BSK/YCNM@<^4L1NMIN[]1`/M(EYD;8^J&R1G.3MUWL5.4BE M^2E/5:J\7TSQ?&!8>[*?\=6'RGJGVY32UZ/C"ICOV/("Q[=D(P5*NL=.,/BI M8<'EYE0?@)'=N^XS#N-!.(S5US%P?5\.XS:38$U$O82O^66,J-/_USRMM'!N MP_Z+MN8WEQT*8:V_$E#^;NQ0H;9>5.CT@H0WM1+AV,*HKAN1]Y)$HL<(+X_+ M[5RT=->AV79%%\(.W;#P;NR$[)":%%U>G5U_O;".OES?W7VP;BYN":OPV=?K M*^ON<_?VPDH?@*U+OQ],F'7D!5'TP9HRT,]X8,2R;,3%.V]AU?ICH/6_Y9WL M`%RL?NN+WB]>$F.3Q8_TD:NO35`4K=_#QKH/[D"VN,%.79E?R]9;*4J_%S"X`8`XSD'=F:?[4-(0"R"TN(0IAA%65&= MK`M.+,ZSS%>Q8S`!H;H"#;0>UW%(LO(D$,FIK+JP4WO9?)3CM9;>59(I?,:^ ML[#O1N3S\;^K*T@06@'OA,:[5B$JBY=UL'$:[V)$S=:F"=A?JA>>Z<9&?>>H M'[/<>AH&?<8&D2BA[7S(51+/R+I4#9>?SS[_3(UO&>^H?.9$XT]>\'BI:;$R MZP7J&4P-R[I?K+/NW6="_J?KF^_=N\O04-@-V%@"RS!IC$*&E_R M5I)\\D11WV=L@/_^M-*T)J[GR99S\$%5?E#8>++LC[G[+,_'01@$"/5]4XUC MJ3N"\YU+S7M>//Z^UDR1O2+U#&W6H`U5W8FV;=34T8?-LGV#@QXLFW:T?%^O MU++R47V]A/K'3\MHSED'[(Z-\+NW#/MH`F(.KU?DW<5OJ&NMVXN;Z]O[RZO? MB"K9IK%\9`'O'X2M\JA#,#!(#S,76!39,Z,6X$]CYGCQF&8^8"*#:!V4SF50 M4Q#PRR/FP[\\:QQ$Q([IL!39*%9;;NCT9=^PF5:6G^7/Q8)@2Z.DAYZ+&)@@ M6D5BYULTYK*;J0!0MBV-2LVGI5$HV#LT2'A/\13SSQ)-,I/DI1$+1J$S'8,? M'K*1Z-MR'5)4[@Q#OT\V)1J!"/JN0R3'5M_(5[S55=KSQ)6S-G`9`(^!W`43 M6!A[OSM]G(T!I^MS(,DY=JC?KNC\J`[QHS:C0\XX&:%_'82H1A_<,.`CA6%# MWE44&VD0"/)P<@?`O$\CA+0O$O!BM`Z>A[JU\Y,C:')S3`GBVH5&9PS8D#Q@ M\":Q&V<%W!_+$1=66W_N@!7A//W\@CL-[]"*J4=XK!`?.N`CQYH`SA70_V!F-X-BD5GAGG'[:I0Q; M#EN8%>61*RUZ%,]C)M=17DHG9]QED!(QB@.^?H_,,Y09P+P)FZMY] MRXSOJAU7V[9MF!F/)F2M65Q]1AG\Y$WR? M!ZZ<3];L_"(D6#6BY:+$QQHQ\74^R8)/5%@P?8B+(_E1`;_KYULBE'M'#@S# M15`&B[XKM!\-]N`-GC*SAN#_JHY^3E;/$`BB37)I M3#D=EO2NUIPS5,LEA=%LV_$%FF/.2^R/@88>NQX*[KWC".03ST1-XRO-BJS-.3\G0WH=_^&^Y;L]>MY8LY>7NC>! MUI+EXAR2H)0A?>:03[2[[`)AIIN='232\[&.(5M1KF03G#=2-U"O[:=NH-6R M6^WJ>C!OM,F#(?26"=VQJTW3ZF$-U>4.#LG3VF,F<[5JMTX.L7?"0:*[4[5K MK9+UK"QILN-7;3K]`;+G'IBK7FW8U5;G`)%UH.BNV>VMHONUF.1+?\`FOHMO M?1'SAL=3YRD=][=S=GV32?8G'?MTY3+P,@CVVZ16W3ZIKEH;?E!NPOYYR%0K MK'.,9KUCPYWAM2@2PP1K,4&U#I?&'=BU]Q90H!IFM'7P+' MC[K^X!-_,/9'M^KIVCSB[CWJ7Z)'W-PKK'G'?9T/CN8=]RV\XY8T,M:=SZ): M==9F&1RRY1V7`XM%O0+4["KR)+R6%C9@$^[/L<>&"&!UN@-/5J:?YB0FKBA1 M;ZUE7F<_+Z*=AGVZ\LUC&T_?AM#;!;==LSLKQQGV^_2]A&NP#QW779RKO7// MX4U&=(_J-;O6W-"U86-0%3<;-L3?)/%K'1MN-P=#_%UY?WNX*.VGR:&)/6_L M&"=UNU-_-0^9A@?6ZWUHMTY?1\NXK$/8JC07>(0FB%&.@[T"U+P6"W^>,%XV M.PH`:EZV/W6>6!B9B&B)#O8*4/.Z8P3G=Y_+(B][),5JI]M,MS1771.9 M,0Z-88$-LD"M\_H[L\2YBKW#M;;Y6&L*7EO`[B;:8*[RYOQE=91C@P'76X@+?E8MR9^M[ MU12V+V+FI\LB,9!M<.W#`DF(LT]P9EAD*GM-K>)"&;D/8L<[)#5Y('CE4Q1;Z,XMY9ZR@=U(Y3@-Y:$_T#&E6^+Q&7AES4V+#&%U[[_&S(; M,K\",AOM7PKMOR'_:>\E2L][3+N_HA^B=)14(FKV2?.@XE4O9X$-[W)(ML]0 M;I>4FP&Z\K:(933M;C5MCL.1]R2YUCMBX6-D-XI8C$^9BU>#+UP%?IA9''_/ M^QJS_MAW_TI8](9GRZIX7VOIIX/=>W['UA`(;ST@Y:T))S.-'K:2B.:>PRG= M(9P8?I7X00^'0!-=7'^:P+>.Q,O#1EOWF(>#TH1P.]4=A'`_.AYU@YN]AJRJ M6]]:(\23_31"K)VL.@CDC5^XS\:./T*5J2O;8&@]SJECU^]["0[O6!U[3:S?:.YT<<:!5-D;8^J+P.L<+;N#0V!1S`;[Z9]XJ*QW:@8:O(#YCBTO<'QKX$:4^FL%/IBJ<$*?&A9L^XS`>A,-8?1T=/_?E,.Y^9)&)?6].D:_Q[K[-V//OTVU7ASPM(+K9\RV%]W#S/^[;"(]3KN M8$*_G'1V\4*0N-Y@#=]VQYF!>W,2]$2]/3@#C1.[U7B5.=B&T%E"M^R&2;=< ML38/8Y7X/^YD&@8/_'G]D,SU'@.6#;M5/RC7QF"[%+[)ME&E;GP'R)M[X*QZ MQ]YNX+>\*^Q#CCMV_:13?CG>NV4^"_PH#I,^QGXP@`[F>12RR!CGUY^R?I`8 MK]D`6OGEN@3VF4>#+0"*A5;?F;JQXUD>\*^Q@E?VJWFJWRRUL)+/D7\,=Q,GPR23PG M9@-KP*8AZ[OT8&ML^6XFQ;?M3GM#CU8;@\I,BM\1\9MVM;:A3(\=$-]X&MNQ M?0=VL%>`FMW9\)DY$JZ_?;4B4ZCH88S):/I^S-&?S.M/>[N>L%[^@=<%T92Q.G'#D`HVJ\-5J7KI; M'CZF*0XD(EZX,^UR/V;663"9.O[3CY$5)'$4@Y;&;@`#0`LB(G*C.,*"A!B^ M.@P\+WB$/_^\3:">/SI/HR6D_?.=0-I<%NULEFU6E.;38V?2:%=)]%O!:J^\ M[&)W129(2KLN-40-AZ.LM%>1_.UEW^>S2/.`F=&2'V?O5.OGA\J44)5^NV?\ M&+K,T:5>!OQLR)$/1[VC>J-CB__YL!&UH5OOU18\2\(0\/9S(88WSE@YE,,; MRU9%1_A,6]QA*T`_H"J+# MCAY@/V0#-R[$MM:29WU5LV;N]B8/_OZY$U)&=O&.:_!RHVI7J]5G]]WP09>0 M($/3M6E::Y:*I@?BEKS8+SL7#1L*$;_A_5X0>5K7#WZ.8Y85[AV`0W+#'Y>: M[>*;4RX5-BD6'PP[E(P=ZK5V>=BA7![=[/'KE=86H@:+&7]C>Z[`^K2G"F=O MDON+S?]N`$GYOGYJM^K+<[X@PXZ]/L,:^V"-6L-N=Y:WD;MDC=(ZCR:6-PR94C*U%H:0#\;UWY:38(+%KS4Z6+/;S1+%!PU#[)DA9AH0 M[(4I#L_;,H'DUQLM!-^@U2CV#4P@^4VSQB*WL4R!Y#29?Z-IY`)^UQ]@4,BJ M5EJN7YA:GI81+"H**"X@N)A,O>")L;L8OG;]Z+,P&KM3+$6XN+N^01?3"[`W M=3J0<7\%!O])HM@=/A7BIVM%R01^_X3Y7A$>B$@23*EODM./W0<<13`,0JH' M>&).&%G,QZD$V7[O5.R%Q[+<87\W=D+1.VG_V?1OE`9_4'D<&QP[($W.B%GL.PO[;L1` ME[I]5@8D&>(HXHQH4L_`B9DVQ*<,N#(T4C0*V<1Q<682.5\AN#*)X]%(KR/R M8HI#/H9>.Z!7=S0*V0@ER`7JN'[D]DLE1JO'>#;L[AS&R^PSG%/20QB<&)P8 MG)1BN=>"D]*^"8B;?J.U1.%1)C9Q?(K&--L_Z'15^WJ==IBP><0HQ6"C9BN8 MZ]5:K9!`KZ4H;?GZN]--%Z=U[$:[/+5IKX^TS]8;;IRBU8KHZEM:@NZ`A+N4 MQ^TG!^[A8(9.ADZ&3GOU^K:5+#=_Y-QH2?8]:M[EJZT<4_D-HZ-L4$B6PTO_ M7#GS83.\O2C[R:3LEB-EUY#J8$AU7!8*F?J8I78PN'\5N"]M9*PD[M*%>.DW M#I.QPF_`"I>/5,8D&'-L<&]P?QBNT*L+%WT*PB%S,5D\""WV?>J&2[M"IAQO M9_69C58A)&^S.O,`7:]JI;Y'*B[!TSLEX"LP4\4:VE#)4,E0J:Q4.MB0V,X3 MQ*R%@SX.+\BRZ\`8\D:QS3X-[@OE1>T*N+AIGD MJ=?WP'1X-'NS;X&&5`=#*F.PC;/T=G!_L"$CDT5E/"=CCE\_J8Q),.;8X-[@ M_C!017727+Y+K\FB*JGK5:W43_9'19/Y<="9'X9*ADJ&2N7Q M`TL1$A,-^?>27%4\?_8MS7)8UU/#OC/A9FBY6#,7;, M"J_0<.HVP8CPJ]7RM"*>63(0R-^-W6,R\1-.F4/.W2[ M-3]=/%[S43^Q\=0/2X<;3[U<+%(>+6X\=>.I&Q%^'5K>>.J&018RR/JJ8[\^ M>.Y(UO(-PMP_$"4#9^=`9#FK<)3NZN-QBT?M_NZ$+G+G)8[[8E%\X<=N[.YI MLFXA%C9*E(4$-]-@Y;)F,)^_G<%\Z5AGA*$76C_AIPOC#X8N^Z1+<7N,W=)E M+Q,3RY[,F\,HI0/98&!#D>EMSF\[.=GP+*E&?,VF$]GZVRQ4T83.$(3[;ELWC)"-VBIGRX=0-]' M>8UAB[VP1;VZ_/O;[MCBL#RR#;P)W@>QXUE.%+$X,B^1"V\DNWZ`!-_OM%T< M#32/U&^7-9HUN]Y:WJSNDC5*ZWV:SA'+O"L<5.<(@WO3M<,PV"ME,(/[PQ;N MO8205MGBG/5BZ^A]LVW7VVT*5%O!T!JX41^.$7^PCIS(&B4.-G`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`9T>?@O#,F;JQX]'')NP\3SS^@'`-.726C#EL M_0`UN]->]5'DT.(0NQ"!52-VA^(D[((!3[=Y_=ICS&`7?+=J#-'PG>*[=NM5 M7A]WP75MPW7K7:KF/X;CWHK519;1]X7%D66,\%&3%;(IB&+@!5=?V2Y(N/;.GHD>-C`L^ZY8;`F- M9STX7D*Z#+O3&?N\232W[[*R-;M6K1DK6TY- M'OBE%)-ZI:Z7EY;_I7J94Y1"'$_L=F?'=[[%E;+K9B5E"FAOG-B%GW3[U!DW MNF5]YC[P3"0M=ZD;70^U?"4K\5W^AV]WY^^L`>N[$\>+_OGNN/'NUT[C]*19 MK59%\E7A!NN#45\&C':M4ZVN"L8=BV./(0[3+T0K8.)[Y/[LNQZX06'"WED_ MK;?X4N>KG6JGRUTZL_FY&TW#0*@JN$3?C9V0?0XBXA+)-VO3O-7IU%-HEMIK M,]`MA:KFZ6GC)="EV(4_K\H2,U1KG^913:Z[QK8%&"CB1*E&OJ0IN9\<-_P= M+R.`F;X71*!4@(O`N&%0IOB@_Y_ZW:4_3>+H"WM@7NTKF_1PTGTIH*F7"II& M/C0SDE1OGQ"'K`C,%LY`D>,"@FX6:&+W/YP0^['+GSY1+F>CABR^92[<]/8K MLMVFMU^*SVHGS5JJB1;LO@DHE^>D]<#ZZ'B8UMV-TR_4%L$CUET.H'8*3]X^ MV78DDAQ?P>\"3D?E_8<;C[_Y02]BX0-O;(*4`AF`&P2_LRAF`XS@;0JTTWH.ZA?M_!RL7P+'/Q=#+J[]>Q9.\),-P=MJ MY''*^F?=O. M\5&MSR43_MMC^!_`1MT)^KQ_T^=RB/<-K!S#WR[^2MPIBOO:GNUQO=UIUS-> MP*9@VN59E[I0'->;U=K)3LY:^,7?PB!:_QYR6NN<5#,'6+S1R\%:[M)^VFJV M7@"6'O48=&GRZ>[6M.(N2YYYADL7;#(+SU>G/W9]%CYM3FKJ'6D$G]_D9>`LAYU._:2S M)CA?'']P.9F&P0-[6>BGUFC5&]G+W\S2ZVR]W/E7WOICXGI82AEUL]][&5LT M3EJ-K#58N,^+@5H*.8U6H_T"H)1?!'HEF4Q1WJ*+[U/61P/G/K@#Y@]N,1EG MR1+7%-8;%F+'.!W>RZM/[W[5(%UV\TT"7=.`KC_CL>WX"+=N].>GD*F6F!O& M>Z5:;2X&/`^`30*^$=S#,>K;.8:DV^\!^'=T-=@L!2J-T]/E."<+P69AWP01 M*JUV8]LGP9OETH7U-XU_USKGRX&$"V\"D.<1^>M-[=^UY@O`HBESW.-;=..\ M.?M\N=35N'Z:L13:\BON7%]QYWJUO>S.9TXTWLAAF[,.?31>=J]5CW?69 M+5\,WZI8/&XV,H_32\*G9)9G^7QB`Q8ZWKWS'?6R'[&/S(>5XM6]@#Q9:66# M'L_LN0$0/+T%_6\BLS^KW97;>&+BK([:Q,6@O M_7XP8=O!ZFFUG@=GP98O!W`=!CU]`82@%AA\?R#X>9NH/&YV6EFB+[?YYD!> M`KG/1?ODYAE&W2K6:IT9+;D*")L&?X,8W"K23MK53B[25L33;E&S592T.M6L M)5L2%3M57DO"=#T%RT_J M69=T;1#6.$K!NME<^0V7I]V,QWHT[W7!'Y]D#N-V3C"H[= MB9[LM&<<^_4`6/T<&]*1G=/3%>%?J"&7_?D&]&.[55T+\D+MN.0"F]"-,T]V MJ^Z\+N0OUHNGC?I:@! MU0[Y!09E-EDGN_`Z&R_WN'URLM3&%/$3,Q#2[L]B`H*K\OLH-BWB!E[P^")I.SYM5O/C1@MVVQ"`R]UB.]5&>^,`OC"![Z16JRV&*3?_97DP MED+-\YA9#@KX#_F9B`S<,LS,9YC40V(*6RKBM[U3NT93;O=4U_S\2EKIZD^H_%H^?6!6*[H]AD$+@F#NNV#=CQS MPO!I&(2/3CA87Y&U3T^>0T_AIAN&=SG=4ZT_A\IGX>7UQ/C6`3]Z@6-[7*LW MM+?^=,45-EK.E6@UZL_N,^N6KI_`V]8S&&:777G/Y:XPS>:R>WYA(\=[2>[')ED;F/S#. M2,;Z;Z+UF7*9%:'8PB%6?OMJ%CW';?0(!0]J79G`@LLG<1`^I;]?*\YS!'7@W'G"%B9PO63UO[/3_Z&^L@?7<9LLADI;%:7.5SN_IN&?772+*4^ M7@*[++1=-?"P+C5JL['!E\.UFY.NGC10/VTO1;XUCJJW7]B,E-2J'>^^2%(ULAW_]92HN1-OQM_9"/7QTX!U\,7 M/1[7:YV:UFQAC:VW`?J2-:FG>MNUEX+.55?T$2NX/;T(W6/EM>B&*7KCE.G?+ M97CIPA_L7O;4IIL%=SD>VA2XV/FW2UWY;[6F_-)._"$Z\G=Y0WZ]@O)ZB,WX MUP\I-6NU4ST^\2(P,D>Z8O$-7T)T>($/\MIEKA]*[.A-&)?=;@[M0JQO>$O" M%P3G:M5:%I/9E;/(40UL7[KO"4>#Q,+LNL_&3+7WXA<]!S?JSSP'9S?:`%SK M:+&\!^A%+8Z>B2)VJOE>C%IZORS[ M5M5^9@\^!&[]')!6O3VCY99;?LDV3NU.8]'R=]A>E#?">*:?Y3.!^G:]K9UC M9ME5MUSN<4N5\#^[I23<^L[@<:W=S.&$VO+;K",CF'1P[6\T5MS(7F0R&ZRX M]\H&*=L1-W]O::S260R8W1/X>+N['A8\8V6',"S=P88&2O!)",SSHJG3!]?B MG^^J[^C?4VRAWS$AGC2DC%`Q">S:PJ-NKU:C9Y9ID57X*UTM-813N0QKL=CAH/8#1X^N/ M;]X8HD1<(':^6]@#THTP]G?4XT;JP\^'Q)HKS!PL^=#+5XL:,VGUH,A5WA7V MCIK78P%$'-RH^A(=[!6@9E>J7EQ;6R<_;-^K%)FG*TJ*@+!>#.`*))"W]!V< M=M79G1*TS@_+S>C<,+@GK=::`&^2,(;*VP7WJ-8XV3B9-P9=*:M#NMPW'_#.TT-`GP6@(\ M\UIL[OZE\0Q!JZP:T7Q]6N5-TOZ0M)()`Y25BXY.[':U8S3(6Z3](6F0]?T: M`6I>R\U]<3YG.91OO5)OP=$&0=+S6/E>N)>!>1_FO&5WJJN^?;\1 M37EIW#I*X],0==;*.@Z)$$IPQ7OD$^TNTB',-HGG1UDJWZKW%6L(7_JA=5$ M.V7+55=(%JTH9'-]RY'=]0VK+8/"FMTXV2:SE7>%?>CDNGW:/AR=_%J\ M#-E1[`#9?"\:H=K9$(\:C?`CO!PGG2ET@$R_#^UP:LS]SI*,3@^GDNGU>`\T M06'G//XF,Z.;U0/4)6^24O5M:OT]>Q:OUA(=V,%>`6I>CQ4TN>NO-M/8Y*X; MCMIP&.,UYZZOGG!>G+P^-ZRJZP^T888F;[ULJ8TE3;\U6#TZ4;TJEV`S?F<]FGG$/L# M'RBR.UN]..W*3=DVGJZPDD*.2K>\`#Q\DQRQ%.;:]NE)[0!1=9#(KMG5^@&( M&](VR%I9#-0XG]=[0+O.\U3`YE?OR_ET_2D)33[4LVAIV>U-M MA8V_\#RRFYLJ<7WE_L(7-C+S!I9U0NLKQXK*@*J#1/8A-=+=NTF^"?$.'S]1 MPP3V5^).L@7=&;-`='IW:S>C@EN(;V MFZ3]!O73X=Q,C'-QV`=[!:AY/78;\V@&\[GRY=#?IM)MK<#@YJ;X[?\V;UC@ MD!XA%AGK=5)TF]_"X,H MLA+-"=$F/:BY#I836_&8P;]'KN]CH4(PI`^>F+/JP^9!U-6MY4/OLI*.J\": MW:GM:*Y)*19[S<2L=>S3ZJHM^DH^I$9[H0-=W+C+N\*N]';]NG*:KN< MSLE.!/S2[X<,A#NB[@V%TCT-7?@SRG9)HKZOZM7N\)6#H5'I-,QN\[;7N/`P M?_""J\X!/B4<[./!^A>BTNHF0^>]T3E'O^E/0NN\Y5#4#1AHS_7W?PE4UZ+'P'ZLWEOQ5KOK,&K.].'"_Z MY[O+JT_O?JVT.NG#UB)(7@IU38.Z_G*HVZM!372Z<,)X_%?B_`D4$@6S?[CQ M^`9LAZJ#VMI5!]NSO7(3INO/NU5>7_3W#$\SO--2L=`QX^ MXL7U+)A,F1_1:;HX%&W$L(3HXU/ZE1OG"3_J/CKAX)Q%_="=4J+BDLQR%P?] M/R\):>X#JU>K)S>>XPOD_WH/)@YA]H3&EKUK!E#OPX+CC M-]ADZ@5/#.0>*ZAZ`1S1FA!HW.M/IOA-QYHXW]U),K&5G!7VW(B:=:';AC%5B^)0#N`8S!PGO`O MS(%C@0L#]M_A=PH<98G?AR.YP0`1U(9_@S M3LQ%MX.N-7#<)SB9^"(#_O'PK(%/FR'R):QS:\T<4GY/T-$*DCB*`9\4L/6M M<]8GC%J-FORF.YF`$`*7CZP1J.\0*/9D/>!L,Q5D:O";)B&#VV?6 M4>VGAL2QH!7]/.!,%#_B6[L%A(O'P/`^0!%&3O@D?\)E90!TL4D>G)1W@3EJ M/]7J!8L3WT9)+P(V0L89NA$.;P:>"F.03,V=E3PR###-&:D>)?#;(L@^5*PS M<.L=D((@@Q_J5S]@)*1.O\\\;&6$K5[ MW++8#6G5ZQYX.K25_,*R*1L+[4JC(C!L_@0Y9OR9$]0V>@+1\N)"6`GI M4YV)@.ZZ]KLY"^7B?5X.U7*X.UT+*NZ4DCZX^-[WD@$;(/7.'*^?>(1=@.'< M]1(0SR]P"09_B;Z].L?R3>;P<\DO=[W@HA))=_M_Y6XD?!Y;LX^7UH1 MN"<>^`0,K!78-`>_0!FS;NPQ=#O0>,#?8Y=L'KHJ8BWP53S4]J+.7?X0?!?= MG`@O2=N8:W7Y=_0QP*8,K/8,(8$SM_P$3!1:)2!FZ,()/#Z'`$F>]?O`B8O3Z&G'C.7(R^!`6=X.>%J$Z/S9.8N0]01`KQX><@FKHQ M<'#%ZN8ME389='#``F4J6B@R`Z!C/T8(:/9"2M/L-O'8`38#/$;@Y2.GX.FU M&X"C8O%3![_/I\#RG^&?AT.:WP!_5[PJJ2;]:.'+!H_@HX@Z/ M-K!:M1\0QP\`#CJ-T_%3Y/9=9!8?W:8@Y!1OGM+7?@-I!3=/0_7$\>&62W0Z M!__\;.PD@W$2NL_B:)FC+H>T3ZX/UUO@W.N0JMOODNDT"./N!!MJ;\0':K9! MH#)F<`U(9@_S.7@$%J%\J`P@"I. M#RZ_@N8D%T)G@(,LW/]B;1&-@\3+Z#Y<%&^+I,7PE8N%2*J*11O\B!=H$'I+ MFP@`<@A7N0BM0E8#R,LI$^?&Y;#A*"@,=;GPGNRL/L?EHBG8.!'B_AN/[OP7/@RZIIO`#E827I_64F0%[)FNZ.[!LMNO3%X5W;&VZT7PTM7 MYFO47A^?N/])(D>:>CGWN\C1:B)TTLM:L,N+P%G>[UL5G!=?0'FX(;I.8S57 M/,SS$JRV6Z>M#5R.BV#;R^&7IF&GWGAUAZ\M??A&N_K:#B_C=G\XN&[,`W5P M0:O73NN-YA)"76UE'(G7@95Z'E;>*C)J;P09O^'IHDO_AIXA>#+#VO&;[Y'[ ML^]Z_WP7APE[9_VT)V"7"]`\"RP%]:,H88-SN`OY([XK_SFWY!RJB^\L[+O1 M.J':W<*R(;R\D(B?@G#(W!B\<2QS!+?1Y4^NBJX;BQ\>GS0W*(K/PET*1*T5 MG#RN;=+!V3FB-"7Y!Z5CL$'W@87.B$EQN`GQ$6W9J/Y-`9JJE5IG*ZI]$=0E M0E;NW=`@*Q]9\PZV0=9S8OB\0[X0A]7V6\;A<^Z[0=USLOIZ41>MY%@OC;YE MXYT*>2_V+;=[D&<#H8=RD'F*5'?`W)L[T\;1*5=_#3S^XK/LD,U?>E78'IEF M4X'K)SN\`>W2+FX_RFKDRDGO/`]-;V7#?4@8)?'Z69AMB:D%] MZ8?@F]J_.U]K]?,9U.T6VDTC3%`#7Z&7!&'9(H9M(&P-:#3IQPY/H_6U7X:I5W,KV^O[!JUK%U?G%W M=GMYO7[NW_\;/[RY_N[K\='G6O;JG M8K7NV=GUMZO[RZO?K)OK+Y=GEQ=W5+\V3I353HHOB# M#:RA9`<`5_(#%NE@QB]E,^%/$_PP&%J8@S;BE0Z?F>/%8RQHLSX''O(^'`28 MN4)93I@TBHF>[L!U0I=%!,H1)H,R3,-D,N%*H+'9_D6D7LD/.K]\H(6H$J+' MF(^%.E,GI,)E@BD<8*493ZL4,.+AIB$`[TX]IA>Q8(G&-*;?$B2X]3<0,?B$ MI(`.UYT`&?J.=90"]5NW>Z-!5"D%K4O&>GHB\MB)+%#'`4$R4.EK/!WVQNF[ M0[O6\0*B+Z'58\!)LX^@GL'7\&:W!B+-S'AW)GP]6<(#%_$7%>N MS.*`%QX\JTN14]AWS$V-Y$I!$@'HD77$OJ->PNQ641\J=K9E#:0S$K6AHM*1 M5XE-T1WE8.#?'APO8=%A:*<]`C93>3\_DO3R7]\NSR_O_RWL9EY2.]$"7:%L MOO#8&8"&XCG)1"E>$QQ)VW'R"ZFHOLO\/I4NO*^?5DXSA2#O:[7*B?S$IO1C M92H5I1WK,0C_Y,6J5/8@EJ5:V?>-DTI[9LUFT9H5C4[JOSX%H6KZ$6$7$ M[/D5)/DX\%DL^XH<88[U!X+KJ-:JM#YD(6M76@6'I;\?^5A'#!]\$%V/,"7= MB<;6T`L>"8@A^*2RN@-%GS8ZK9S,[-,LVJ=B=>.YBH79\V3*=5R]')4CXL%Q M/9Z!_B22P='Q"=E#X#T0E(,P?+1=[A):WS(EN]@00*X+.2'3!PB[Y1? MR7@5N"@V#:VAK!0GS44@,)[0+%I"X4^%8B)N'8OJ&"R%];BM%!7ZN!8N#-[< M!'%'U>O?P3124?3[6K55Z60PR4N8J)!&_RH!\;[>:*5X1D0!"IB?8.\J)!-Y M>K-M*W)D\7]JGYJG[7.2QKME?I`*+^I;Z^A]^[32E'"D;$+6G+%C0.:QK%7& M:HE43EHGE9J"7_U&5IR0ERM^\$&F\]=J/)^_.4--JAWP7"K[%S`DJ.Q5#5A: M-;`D>7`;K(=(24!%R[@L=^>Q>(),'W8*`&.)%L@98`TSF!XJ;R(XD#3`4I[[ M5P)^N1C;FMHLV5[,4C8%&8/W8]=:"LSW']F[R7F..69LTH$!7SJ0"V[HPFQ> M$,.APN;:M8/*M=K**E=52#D,DE#)023Z;*BB/K@%D##J5TEDRGN&EB:]@M+6 M9T$(,LKK1_@Z6CWFNQDI#1Y]H4K)A#!^.2!HD-LQ_O)TS-L>I-!Y05]ZE%&0 MH`[F`H[#!$"W^*XJ5P.8?BX%K7##7FC]E&WJDP/52G,4,M,1EC[&RF,45FH` MM[!5;!O@E%T;XV"*&&JWL&^C_##D#9)F/^8='N6G:S2D6ZH/UFSK.(!03:!H M[![RW!95M>K:@TQ.3]JGJ[;E$Z<_K6[D^+D2LR>@`2_?8V`HC&6]0,FI-+AEC9PK?S[$5UY3EL(I` MI%U.-WQ+6Q@?+]>SR^W%V9?NW1V]J=/5_M/U+4&B/RE;QZHAGGPDF8;LP>5] ME4*&03*FO]J&K.\Y4>0.73&,(J">*S)**1LY\?Z2/])J*E>!WG8)!#^P7+BW M]U4K0;63%G'.]OXYB->078-S=GUU!J2\[WEW?]I:0(J\$*O5E'2^P\# MG&/#%+?/?.J>(KHDT;,YHCR-??!^37T>\^8$%%_^W\`%&J,)@)+5'%PHXHU*+4Q;"+!@]OP*CM^4CA4,$N]"PK`O381L8)9:@= M%85L130*P%3X&'"7@7TX23;XRT.QD8SOR/Z//$K\GR!TTY94:>L9&04WO)@# MSMU<'S`@BPM?(G!DF%X]))"(4S`0E@-J@<;OPP[P:1CQT)X'L&!:P-1YPGXH M2#;9MH[XNR[&SO._($C/W_")_)[C1Q_2IQ?^ODO_QIB@IW&0V%XR M"H#=H]0$\6A-(<_0:G5^H%^WVC](MA&GMV9/SI\0GGV9TUXFL\]<5X&`6>`E M[9/D9)[9^WIGZ3E>)BAF0'R.P0VKYZ3(B&<@\7K/6]:YE&M0A%UK]JE3N3BP M*+#4DZTI82X*#(@98+YTXP$^C4$*[EO02?FK(-=L/T(++3';6\YOL`BPW<:!I0BBF!@5D1 MU$M;VG.9P$,3*AQ8/XFX#\'SND#^N!3*=S#<4HFP5-A&]>:`\^WN`HW_Q=W] MY=?N_<6==4QPK)$HN%QZ'N9C<<;DWU(J1M^`Z[G\;$3I-B)7JA6!\^@1278& M).T+[#%Q_@0)``Q,Z%V'O)(H2B:R]3KFHNG<+OQ8Z5(2'"*C:XGL'N[SI#BC M#*&*=SQ;6UM>@NR MA,-;Y<*G\OTX9#&FQP'\-OS0&Q[K?T+!I)_YW(&6FH?K)I1(.,%7A52")&2C M!"PLF&J&;\/JR4Q/O<2._ZY`>7HVCO"0RR]UI!>)F;9..)1POF+Z2V`2T%AQ M@&F9GDIW"#&+AJL'?*R>):V+C0,]%W0GJ:<>=?2,`I_>MT:@>D5'>W(%\4A6 MWPW[R02=D3Z10K:;.QA$A=H-/T`:E,Z+Z:1J61P:@`380X' M75E@&^I[CAIKZ+AA]M:3RI3,/T,"4_]O^%KBQ=QV3)PG]=KO45O-)YFY@+UP M%1;?I`;D`YC+J'MOX.X%5S#K[N+V]\NS"^OVXO>+JV\7_/4\G6)EW12X@R1) MF3%.^H`&Q;S*]I+[RKMGHA>*ZDHL$*(3J3K[`[^`A+C16&C`'B;#@%#SQ_&C M$6]C-"8?^X-%^9-Z9WH'^^ES`<(]P+;W92:CU(0>9WCE4O319^;]7*4;;BL# M;@L>3^]@MN9^C^F>R-WRBO6;#ILX7NRXGOR(3,\3_0'3:&B`@#.A[L@">DRH MA,/:TN=X2G/'>2IS(!)PAIB_#BA&"4_3=\"K`K&4R5-3]#_$0O"+(&1J:W1Y M//"<%-DR!B:;9IPZ?%SG9._F\=,4E:+:3A@QI6M]-@IBK?%PJOZYK:)$BI!? M\\$"B(MZ>HW)P2I!(7VPON@#KMVQ@B0BFN6N$@\!2>>`@E3QTQ+STF.+; M(BLJ<^F6_`7L1PE/#E=\8!"FQYA=J';Z4+'N7#R;@D6Y!G&65'`ISW`RF@?% M#S3,(;V'PK8XS20<\&3A(?=YQ:4P!OR&3Q_LF>7H*NE%`6>13(-J\1W>T5I< MR,0^?(:C"(DYTZF'R1=K>9U[!'Z!/)81W/Z+J9TJ2#?0LN=(T M(#WM9S8MB+;[YSMA96<&IJ\#U;YQ@,Q.NVC46 M%CZ`OD9NTI_,MK9C$6_5W^6#L6U.H^J$O6+$T`##SWNG07ED?<,LM0M^*1W( M!@-KL?3\T.EPU#NJ-SJV^)\/&V%[X=;53W[()FK,Y9&L*@[R(E>(5[GSW,;; M2B:2*>]S&^I*%4^[&@COGSMAK;%P1S%L>)4M6RV[U:X^N^^&#[J$K!B:KD_3 MCEUMGI2&IIM06'^,W9AM1$MM03.Y@R7]G&VQ[HY% M-\'*[,<4:YI,3.6%ZN?2'[`)%D.+-)*I\Z1UH"A3]"O["/'2>-9SCO*R,K$# M<$BX")Z3CGU:*_:K3M1UWNR MJ"]C("MO5%Y;]!3%;!)5K'.5R(4)0B&+TR][6K(W7S;-]H3]9=J<*N,1.>"J MU5":Q9G)./O1TM+',=T[3-."!U8288[43'YU'#+L54:[BM+,H=.';\`!SO)S MT?..0QL?SQQ%83]B64RF=8:\*";!GGF4[3:8N#X`B'F0#YP6_X$_4@X^5IVR M1U5FY<#9,>\_8MBFVQ.%4IB8[E'BOJ>!3'E@F%`(B(AEJ5C:K595`&*FI,+_37WY>,ZD8R&&J`#&?6AT\5 MZU[EC?J!-4Q"8BD.!,?#Q,$RA$!)29J-SY$I.^-ZUE40HZA@1US1J.Y6E@(1 M1MRTYYV-H'-*Y0+/R]OD<;&+,.6_$R?(?.2G!8?"1%O1!Z^'7?!H$\\9<1KI M'-%C\2,3)0#`=ZH@=0B_TB%2+0^GL:B%(R@^+7-RF8T:4U'B8X05>5@\(N=G+85WAU:[\[O/K_C M]%9;:SO*3@Y=D$E>C:/7C!^]._O:/8.?I_TS[SY:-7#::4'\[WJKI17^21:= MP\C`RD<'8%9FJ'9IL9"E#@(0*R.PCZADW[=F^Q9K+7)G._FF#HKJI"UR M^`>RK'6N<#JOF7JV3*+G>,0;H&?8UEJHURH-E+]I2><]S+BT^07KMK5DH;N5 M_L8Z(O^A,#<>9:33G.TS#9_4LVUWUZU7_V`7.M?"H4;#CUPB>RR#S=0F#5"Y M$B]6![R`?S#R`]`FU%#]>."R"?^&K3+X4>IFG/]0UHW^!*<0]?XNG,X)LR4! MVC`\DNLH6Z4E*KRC0&^DP=U6.OPT`,6&V?;-M$X38:W,]"F1 MZHJV&62N6/GE&[R*"3Q9]V\$0I:Y@6IQGD.D5A*K5WLJERIME4U'`DN$A9Y\ M;PX2^J7BLN>B2%/O!7E<]`MYAV"#`+\4 M*-!X^1G7VM1R5ZM&%3K4:VJAB6?0._BQ>H&33@L M]`6_6I&%JY&L.TR726]?N(RZ9C=:SZS)VZ,/105,C"&X%NQ^M=KN9 M!D/FV_NHENJ9FQ-!PB&<`3](8JURDHHD9&$5F6Z3@ ML/M'ZITKUU<5#SN#!VI9K;GZ6G1(^ML7!`CM1&#(2^W1NZ\7-^!P1_V0.CQ( MS`B]K\I?J2!.%7E.`^H\`)^#8OT3]"62+>V=H"$NA1?K/$7\WJX M%N4S"E(L\SC2/&F%Z4S=6+S5T\\S#'^DN&3@AFCX:&J5S_^AHG$1U0A;5(>+ M2_!BSP1YF@_58X.T]#.*@KY6<I4F/2Y94H[R1R[V9$.5`>Q[CCOA7N0T(7\2*)GX/.HQ M4(%%/IS,3]OED"G5^^THAY'^1*T?N`W'\->`_96D4S:$\N9.X+.W)#-N:MF& M#+?7OU_>B8:'UL?NN75^\?%>3C/0N4(0@+MR:@A5>D7F-)1A2+)[J"KXS#O\ M.WC#*D9&DU3\U#'EEX-!(N*&H#-"-4=,#>,@`Z'?R7F@%MSH5-]A\7+(X/!_ M$TSTVP5>LQMI,&3>$9P1PA@,^<,`[9)S:%M[0K#D83&`J;5J07R1,Q\_39FJ MI-?L8\C`_#KZ8P,/Z:+H"2O.+P_\SP+1Z*NG;?[2O2W^BF%;TI[R0*8R7+P[ MEHI/X*=)*/JNI&O".HG/)E,OX/?.]&8I&U/Y?&HKG"?QR4L0#3;(&Y$?2&5O M6W!A328LTU5+-L8BJ"8,[`C.AQI@CR0Q$0__`CX4MK#!T$<2`OOR;.5J,=;E>LGU/!3 M^I$8)::(LY.'Q3G"J,Y>VKU)F'FCH19;)NR0BEV6Q!V2"(^V9C*--?*I=B`J MS)9R81H2TMB'>W"#A.NIG-_-<)(MGJ*X:G`Y5\N;($B5)UXBR"QQ(^CA(RMW M[OD\.U0_^#HBKLR9!Q(!H@W<&I,]Q&E^G$6Y2%PH81%.+(_V@ICPP`6N^<7I M@=[I`CJ.WEU\O>]^Z>(0F-]D8Q?;4FVY^!,(_XZ=GAG]=&Z,`3D^-K!-9326 M6ZEP)J`?3*[>:U2^3&%_"%M[/O/8B%[@U.83X8AS1QMQQKX[-+Z0QFE%ZB52 MH@YW^=O1&C5R!T%X_?S];)3X=E$;H$S#D0=D4"T.H36C_#'2:>Z2$T0=O/S` M3W&1Z9\E8_VD\SWY&([2/4A"\:`MH;*Q69>8RZG=2SB'HWIF/G=R`5Y@%QLA M)FB?-*6FSJ(B5?R]D%&,";*AKFA_P/_@E3+XIG^"FW)-D_BZ=IU\=$"$8OX:F#BX$S-T[4@RK7 M3AQUXK&`"S..VZ1X[T#,!99&FM1+P:NFC^_'FC^P]E32>_D,K]C"'+ M`>?+Q?W]Q2VVGCR[O3B_O)?CGUM5#M`2$QG!LPC2<>O`47C1HML]'[5(,SCQ M+^_;)S74OZ!>YK[4#T*\#@<^'_MGYVZ*.'49!T M,S7S\:WKH-N+LPM0.Q^_7/!A[MTO7Z[_Z%Z=7?#,"KA\G5]_^WC_Z=L72PQS MO],8Q)KO[61I?9UXJ$CVW$1["19*/.KF7=7(XQ%>SD_84U8%DH0IY2\OB]Y* M34NG`VCI]`K*%W+:-NVVK.V5K6`8:&R=`8JKA_>%?<8&A1W9RJO M!+^.,N[NO`_R8A-K[:JWNSH'?$ MZOJMJQZ6)U0?#$27CB!JHH.H>.XK,IF>DCD7"5MS/I94WA,UX#M=`TXJ=N=^O*B8QI*O!W6:#7LUNEI*5FC MM`YL5FFV*LU#Z+!N8C\&]Z7%_6'Z4FLZ3>>%!<EC2X/VQUL(/0U4MC M4N=WGY?TA@^A*V^Q3[O9\0)VI[/L9!_3.WE?5&K:IZ>OH$M[J1HFKZY@[G)[ M@IG(9KDBFUKF\=Z"FR5-5#+<\4OM=/E.L*97\G*]DK<3LC$!S+T$,!?Z@R:T M_98YH]99_@7YT"+;FW--33C[-<90#.Y-_&H?D>U,`9N):Y>.-PWN#ULOO)Z0 ME.S%_=8C#BMZS%L+-+273P,Q\:?7S@VE#DJ6UK\RT:9O^C&)F1[?9[4FG]0&O5:I7&#WJCFA2OSXW0$9T=BXX7R:D= MV3DNLTTFLRT%CPM["DZQ)79Q<\J*U2TX0[8/\LQP%6I4NKC,C#Y5ATPI@?-3 M3EN5.L?C:17P.#O`A+H:SOU0]ME3=6P(2$JRU4]BK7R*(@Z2S-+N5*K\7.UV MI;GP7$5+S9XRPY34(PX$BN9OJ"$=0\$`:9M4G0&"1[8T`^2-"5D629/982A( MZ'J5Q`0%YJ12RT/()#,+I?CPIK-;[CR:M"=QIG$H@?,X#G@#2MD:'IA%[WZO MM$T7NT*4N^]KP1<9;OJ7CG[Y>W-BB[6#:)'+1V`\Y9ZEB76;:7*:S M,^2D`1THSGEZUV6$$OZ=PJDU=U=#=A[AGW!,^Y]>9V>I\4H?J M*NB&N3V=,\V#J34UCB);3>KT`<7D:2HFRYZS:*2NLH\, M?Q#-#.Y,(_0TOE*Q$S=D^$?1=INZ!YY6K0%H4M[I'_#*0AQ+J_OKV\N(.NU?>?;NY^0+_+9JG7OH/\'W`*N-#07&X MG"O4!(FJFMP)U.*-*!\9WEKP#SB<O'7`IB".KJ,& M.-$("%!L;DB+H"9GQX/@T<^.T[U`/9_3N%MV)=?"2$(PHUS[X M^`XY\SC1%\`[X[L`(IPHM69"QW)&[3&@DL_[_XN>U?!=FKU&6J_@"')N;;;# MJOBQY\JNJ7PR;##R\:!\-H$:<2"L6=[RW/+W=>CE4CKL)&32S#&7="]?%;0H M+)/9"@<,3Y*)6"T=!C@3G)")-%5* M/AK#1UP5S&"7[YR9Z`!,A4XN."9TY12C7SQ0XL8=??8RC]B+5(MTG"6-FO>8 MFO1.6#P.!DB$C`H@;R%Q/23IO`C;,UPI:9I/L@=N$^HM/N-'*8H&2F=-?&JF M\SS?.OKZZK?C+Y>_7YQ;W;N[B_L[ZWBN6S=#2>6!"Q!A+\#@/XU[%9J:AB?* MH8NZ?@<7D)I\9QK9TS2H/A^2(C2+',HBYBMHLU'X%N3G2PN!+Q]3:C\LU(0V M3@!5%AI^NO_@=2GEG&&"BAYU73KCC+JA#W&*8,7ZE*HD-;Y/:1J<.X('EFNJ M<"_X\.P$&<<`($=&BH$*@@'7(-[V)?S&&@28\K8.EP"5KR=((@$A@!3 MG\%%2\Q\EQ\G.[P>`$DFT]1P@LS]1SJH8JBAFE4M:2X'(CI1X%,X50J8F%W, M`S(\T*6O3\/BX;R!=.S579"/:0%Z:5-C^+R:B?O=E@.;A!80YA5H_0C74#4X ME,<>TM][8$XC+W4PQ%0X6E7.-9W2S"C?=([/`^=3]_+6^KW[Y=L%W/J[=]]N M+[[F3R_X,1??"&-"\LA25)#&%;*`>>W M;O=F=ER]\%K'+NADN$#S^$_H^'_*8=\4%Q(.*2AXY^70+R#C:0S&6Q M/1WGFZ^BM7\E09RZ6M/0Y4ZDY?`92/QS[H7RX<_]U$0%&1-0*43.2GDXFV+, M;7%C>==]NVC>M*#75Q7T<@OW0JF.W(F+<^IS91H'P!6LEM4(SRV$F\M=N0,A MGD4X1#:_R$T3_*&(?3G^S([J=T$/'Q8<^0ZG;K+ZGD]&'1EU]$K44>.PU9$F MKD+$-R2UL[EHY;L)["]^'..P36TZ7`\NCG(*G)>]^Z%J9DZ4A#2E7KN'I\=3 M_]7-#T[,9$!D)C+CRP;L[2$KRP<.X@.NT-T(+,?(I[=^/Y;C/;6;(X>-PMB5 M[,A'?!GR8T],/`RT&`JPE!_X@A7G[+X;.A.<--L2"27L2@)AU[+,/4&!8N'95/A MPMPA$0-,0S^O8N;?;L%Y-GBSC<&#*X5YEHWE;'!L7+;^Y+BVH6*I%>H,7ND< MLWL<\;ITAK\9)K<5(H@P7HG(L#?$[P;5*X[N,SR^*<3O?V[E7J:>[L)\[5HZ M2]K1P>#$X,3@9(?J<4>%Z7*4Y/QOMH6T*1Q*N.-R M9FV$7VDJF_5QAKOOL%=OGSP+V0^%="K+;,LWPT;+(VDO_+1$U;QA*L-4AJE> M/U,9@[=7)_30!U,^[VTN.T/$=,S942*P9B,\O57*U^6Q+XR1TJ60[)"*=`VLDDZ)4TF45'Y5L$C MZ,8:U.8\^!5X]<<%^7V1E428?J4G(28Y.:M'XF'UPUMYY]S2'L\_X!SPX0[@ M8>>D41@J6O,&_5'VXINY-Q<;W&>#5MOEN?D@S&K3+M:`:[D@U;.#-5\,1^VD MO4Q0:NOX>*4AJ9S!!RN+TQEU8,`T\FPCG\F*TI%Y_RK)6JBL):E`>&=<0VME,RLK)'63E=5E4=FJP?,67G=\?#EI%^[,8.M8G2FX0XO2")"1+Q#E;XG.9&Y+4FD6CM MR-M=;*O;!<=B=>=87/*%^(_N[6WW"AL_ZZU+"!;JYHD/OH0F',8"?_38=RL& MER5R1`MAZI&"TS-P)(>Z'5`/D'ZIR=OWUPCKZ"SK]=7UMWG[NV%E28? M6I<^"#6SCKP@BCY84T`Z$8,X770KY^W)D1R/@389B'?Y!Y"Q+4Q?-,SUDAA' M3WRDCUQ];4ZU@O5[.'+HP1W(OL#8SCSS:]F??([G!.OPUNN30`B6!:9`BHPU MX'VCY*P"G,@3`(SG'-B9?;8/(>_9LP!*BT.88A1UG)KQ57!B<9YEOBHF:$1I M*^6!-OTK#LE4/@E$#MXCDD MB,KB91WL+L_5.76DGR;@ACO1?,MZ:LX_H[J"/F,#88RLSMML:/4<.#1UB?J^ M=[]89]V[S]:G+]=_$"R75Y^N;[]V[R]!<^`\)G0%HIB/G-3XE89M6'Q*9]&D M+!P6^/ZTTK0F8&QEOW[XH"H_,,,Z5FJ?1^-"U70(-6"'^A8ZW[D?-W=[7 MFBF:5Z2;HLO#20&7YL&%VLE+0@V4=-0+D?;U2R\I$U9!H2R[1???_ M7>`]YYR!"Y.2B8PX"$U1\TG7']5%DOD.S<+`1=50%,MS'B/MZ[1)9H\G8<6S MEP7\7J0/<1*3,.DR3;.;.)9TU&3F+XB[$;_6*23RFQ-QLQHJ2]/$:#C##`SI M!`ZKU?E!(0)[T.4NA+<)``,]ACSP%O88G)U-"PCKBQZ&`[!G-`&3L5C=.B=! MR(X]]T_X\C%>1(YI8N<8%L%K6[Z<&8E+E2)WH1TYD@XI*7`K4$B4T?N8.G$< MNKU$S/;6?C?W38H`(.&G0<2_@8.'?'0M<790/U8.(_\<&XMSJ6%Q$OH5[MW` MCEX4\)OJ`!`Q2MR!9+,!.]8`L*WLN%>;SW2BCK4^S=!U/#%DAD^CH:EU/O^6 M.Q$>/?Q9C!1)PG2B$@53:!>CNY\QKS0S+E9M<2.XCCDT'G3H4AJ\4D*QA@RN.&"&_P/6-1JX?<589SB;.`A]UZE89V*T+"D5R8[IQ!@:2H<7 M#1F#`(;C)AH#8*Z/XX.)[;2FO;P[/;$MWEB<[S3I+`&%'/*I%%87CJ982`T, M(^8"4*GG,=YMY`&PDSW.WN321,Y>=IH12AV&Z@)?R$I!6U@-82I:LU,>W`>_ ME;>_[]W%;W@+LVXO;JYO[R^O?LN9Q8M`X1[:?S#G]LS8:OC3 M&,QZ/*;YV5@Q(@85I#.NU41I_/*(^<1CXR`BIS4=H"3G[VG+#9V^G*PR,ROL ML_HY7S`FB*"4_&`""\\&\3XD<8BPM"](,?W##P><3?%P/; MU"!X>3BY`V`?>##[1>YK.[XSXBXI>:C\Y`B:W!RKKM@(]Z$!Y.!S\BO`DX7C MSBK6)5@0\31EZUKVQVAEDO"@HQQM#MH?Z-H7'GX/A&CHQMP,3*BS/`^1]4'^ M^;PC=)#H.'SH(:(:)9U[.MT^F@8X#?J]>LS,&8W@V*10>$_[?CH-A6+\:'T\ M"KN)H8_SF#$R6E"5BOOD9070%ZXN>(BM>W9V_>V*M/W=???JO'M[?J?'Y^DT MN!+^Z`(NFWP^3C:O>X:H@V"*?-:]^Y9B!:N=CJMM6Z[=;/_RF?@0!!OX[@*? MR:0,']T'4Y#8TU;SP\_6#1_O["AWZ5RYL"BT-T)SWPG-?2OG>-XH&X3._$<' M?LAZ)U70X6IG(@&Q)U0$[2&@4Q`+Y3@;Y`XE\ M-4M3F\HD08*H[JW\(^?DNAXY#C3GZ_#D>.+L,:96@7^T?4' M.F]?#S_))>_4BBFOWX.X3 M,`;*Z7&U>5RMQ0'&)8ZKC>-&[=VO&U!-7*%D%[MI%(@`D)&@K)8<.X.989YGP+M@9+M@$CGU#V4JQ4K3/)<&.3,/HFS3/$^V M/\VSOKEAGG\`#?C4^WJF^4_MEXQY7QJTTQ5@6W#QS@'X.'+_9AQJ+DO6^V:[ M4F^WU1O%/>;X?\',?U$WDSX=O^]4M8>F6T::>3`G5S;XLPZ]<#A^&NH@EQWD M]LOEQ^M;:^HE$/"?_7X2']%K#IQ#K((+OW_J!T@0P\`/V."?F MG-4T^/0)UI^2IURRN70FO`*G5@P'U_OX/,ZMIT#=!"]'&,!'PR>&DH$I+40M MWE[X:"<$`D`Y*<>X,J/5C%8KEU9KM#*JZB'P'O)\@,6ZJEFIHRY`747:26@K M!S.$?^"JRE:JPCHZJ;1;>B'PG_GK!#VN3HE()!KIBFSA_XN^XTUZ, M0QXHT@+BH/;`_9&QX*\YTSW33`A%$>/AV1O^E*NPM@B+A-WFS*O6G^,MX,[F5]HG5L7?M6 M-QG!#PB4W$!*)O>Y"S0?$-VO@HK51$:>9W1\38([)J4WXTIIL&7NNVJ]-(3Q M@>?#\4"&@W^/GN>H><=K7H?1M5F\CE_WXZ`'C'.*)\:`$$8;)I1A8N<#S>-4 MO+ES-;^TQ\@)BYN M6+YP#ZP[(@2B,4Z?ZU.H^#H\LQ77TA%HW9Q]OJ3=?G-`N8P=$&#'BY]FT4@, M0B^O6$#PLY5,0>_T'6'Y;]+5H"<&_&U@&C)AK!:\?.HV,Z5R M]Z=;P9?PN1Y:3$/_-L]NI?#7E'80^.1!*?%".\%$>'JW35"&4_S^J_L)CS@* MG8G([N>2AS0"N$&HF74"MIZ0W*G^0!A*"9!>AA:P0J]V5\)'!56?5^K=-(L3JQI105&8+QO MMJIDE"EE5"8&9WFD^"@J6BG=&ES)&0A\<7:!FYH[1=/(@9IEY:SNX@:_^*2X M?O89756WBPW)>"@O"],1,.^+_,-)`'>#OV62`'^QF@!GR`BNYP[5,QN/()?M-'&?L8)YEIHDD<#1Y6G> M_*QF)"K6O&W8-QW6,G.2B4I]DIQ!\+JEU0QKKIIZ3!TG\;PK;A(N3U+$1Z>0 M44&_"#2#\RGD?X:YQ`HS89VL[H)K7U$D[H-NJN+8Z8^Y^KKX/G9["+/D^50H M9EB\,*"DL7Q%):,4AY]"-D27+<+7?G_$']RHJ`1`C0H5/A6JD3D$X_W@!DGD MB01WKLX?X`8.'Z;*.EJL"'AF)_ZOZ4)#@TD.PAM&5WA&^@HL;RZ19EAE)<.; M-4&8$MYIPG6$WP*6M'@*'X6DX::O8-,%=D]5U'@D>K!1)%1Q7AZ0#"_P587-(WW*CLY`DA_*668K> M\2L]/61>%):&NFQ/#VUMT!,UR_C9:E6:!1U4+QFX!S'M%&#J@)Y]^ MWOS#1W6G9T-'X(YKB:\RZ'U.S0ZPW\/W6$4D9EX2>8YOGANLN6T#G@(_$5F= M?G:11FZ$ZYG8]/9EH)R,;Z`R#%(64NQ$'>Y6!3J^CP',[*.N,YUZP$!H_K6( MW\(0.2K`23#@S524@R]5HC5TL1F-?#&N-?$I%Y;>3)J+#?H:;[D\M`J.^X5, M=SGGZ2[9B\?L%#.J>DULYN9NA?6@ M?C9A1C2RP&TQZQ-_3J6S8B-C#$HIZP<$E6$08PPV8@S2L)H,RCRC\64@2:C\ M]\V32J.5OL'CLU@V7&OS-SZZKQ<]2V(,`"Z&(44%=*.S(-)B5&@))>2`H#(, M8E3H1E1H&ENFQW[,N>-/%-AR442-YW.%%NA9U70,?TP='^:U-#V75&KU5/.2 M2^WT^V'"GX.X)XK?JYU63G@F4JJ\3C M`>$*Z#DE:P6,AB^E`!\05(9!C(;?B(;/2:%>Z"9K"6ZV&&N@>EJI!7C5J/Q< M&A$*(;N\I_#$]=U),K$\;.M,6007'R_OS[O6D5:2_]S[5WX"_(I9T>5[J7H; M4X[+V[/%O"`6*:%<+&J/C;M5\8N@:6R@)&I7JGW1.4Y7G;7];5I<<*]E.#-_ MC+[VP"I(;Z8`R%=0M\=G\,?\9. M`A_K]8)@Z+Q9$,JF75ER^5"IK9'-O/KIYG%6IVBM6J-8D.K4:3Z.];GR3Y:3OEL M&GA^N1:!0DMF:NTRA8H+-\J6((KS-*KR0`M*$+,@/5.**`UUPBN[]-#:G>NY M?9"3WQW/8T_61\?_D_;E31^BV6UY)6*4.2XN,^<*$$2RAM$9Y2"5JAGU/'KK MF^;>+*J/XY26U]^9[YZE5>)="EL2)$GAT@M?KS(=XO'M2J\P3UMVY2>VIY6; MLI4U:",7Q(%G#8NL]EJE^H-,79[![LDO&D!:]7OQ86;Q!&KM/0BT*:G:<$E5 M7CW5;/ES@6K!C[^X0$JF:J*+2ZP4?;DXS=.X.2?K&A^E+>5&>TX^/SVM=$HZ MY^M^3HRRI2N"KD*;+](@KS)Y2>2;COQ/ MG._D@PRQ0%V^DDI;'N/U`?XE[,$7;73&%$=%Q'&FUFM)QP2]D/9)+74^I++/ M-#:@=$,@YUY>&3C36>B0.\]67_0X+E/(.*!<`:O'-%EI1M%`?AVO"/_ MX01Y]BUB!BK#(&4AQ4YC2!O/1>19TV(*E.I9CIV896CID[A3_4#MRM.<]4P% MC\A%Q[QN/J-"):>+ZYEG8==:W(1Z7LE"P_0"=O%]ZH:\.,AHPE(R^@%!91C$ M:,(5-2%O!$:1A"+G+Z\+E1^'3SQ^D6UZP=N59=HP"-^RN*,%9N0Q)QV M]>ALBT=G&ZV"Z.S+F6.G+)C3;GX28'YRS,HMZ'40HE<):^?Z41H:^DGVF`!%_I!O\;!TY'[A>:E1PX#+H MHSHUM"<74PQ+QD^SRBU2+?%5=54B$TD_HDJ\E%@ M_34YYI2WDNISYV>^#2C5T;C\CSA^52587/HXNY0-:*0.^E`SSX4R3(C#*7O! M=UDN0WG@O]"4;\.U!B2CS4I%A(/59OHK!'I1(^RKC04`?`Q-J$U.$74KU$XN MTOO)X51H_I_1,NEC-,Y#6YXWW5!*#A4HS05[2I]0/E%OOK,QW(T17/BA,Z+[ MJQNH"G45FS\7%8PW/#V#\1J#;$.^RA[?`\OX$J>QP8_9J3MHK&1_%S49H"S/ M'^D3A?XD,?MD03CXYSM1G"X!*WQ[F)D]N;)B7*QL>T$P[XW(>%_C-V8;3*%X01G M4V=%_&7'+RQ[+L*V-L!Z?56S1GI$;<,'?__<"6N-A3NNPN5UA:B!HL9?V-[KL#ZM*MSPBE^+^8O._&T!2OJ^?VJWZ\IPOR+!CK\^PQCY8H]:PVYWE;>0N6:.T MSJ.)I1QX+,7@WL2Q7AJ>O@K\OHE0EXV[#.X/6[)W$.QY85XP"RMV4"R:\W6@B^0:M1[!N80/*;9HU%;F.9`LFY^?;> M]GH![3C]?I=ST51!RBY[*]WG=WCS542.UQ%,G#@)F>AJ%8DR@H(NY(=7*4)F\S^_C=SPKG*GM50!"\&BNSXW&NYNF_@D2^'`4H' M%:-2R67>0O[KMC-79/=9_H5ATK=[8@0XDPK@! M!FR9E[#5^:S$S+45I;$Y!!&?Q M^VP!JG<>L_G'3TET/'*,"-`,HNOAE\`?X6,^+G*/:ZO?8P,"/-4M&_[SW:5RMQ0'68A]7&\>-VKM?38S#Q#A,C,/$.$R,P\0X2NGNFQB'B7&4^GI@8AQO M^NYI8AR&SPY?B9D8AXEQ;"\O98OWZ322LFJ(9#;$HG\S7>%6MAJ&M6Y"U^^[ M4\>[]*]@E?M'YCVPKW"*<92)MW3ANUJ,Q4I\E__AV]WY.^M[Y/[LNQ[(89BP M=]9/+X(#K[SWC\%>MZ'U_836M8^OL M^NO7ZROK[O[Z[/^L/[JWM]VK^[NMQL1>05[7DLUBNU:43.#W3]@,[-$)L64P M#W=R7GBR9"M>/LZ8CV7(-N"E+L#(#3@8>1HR,2PT#9AN:PCA:D?=5`O:I6.> M9>\Y6[I@SV'&IW:+@9?>O_Y@Z*VQP?%K0DKI0#8AYYTQ]-W8`9,#IB=*R+]_ M16S]4M0XO+F^04FZ+TV:U&>WB.?`,X9M]9V'./$^,/L:=-M;]4H-!@P&2ONV*!,J3G_(G>NUR@[7Z=@C M.QNNJLMP5:T0RX>4;[%\PW=JA_[2[C75Q77(>SC605!IN5[U+R1.M5(M?GLS ME"F#_.#"^/VL/J]5E\N>!%?:`S!XU)W`Q=^G:MVD0NF$NLC;?:MVI-Q7P9 M18G1R7,[;%4E'ZRZ,+KY53'YYG3SR<'KYNWDVO)#OE!%=R<\.>@H\`864^]L M%D:I#\V[VX$WW>B`=37NM%'9KY&[C3N]PS*<0NW]XB=`I=)]^-+2*GVG'92+ M$;&K\>Q"/#;YL+NZ;7@][^BORIR\`;+L2=Q>ONW^;Q5E2M'875"^FF>:UJBZ M*W[B77G@WOZD93OMVY)M%7\D[TK[."\-JW,IQ1Q6I!`D4T6*/2#+A$QEB->XQEA"KUVCK" MRD+9@:W]R_7$=WM)9/TA4[/%7SJ_?+#BP))O\Y8;8UGS9`)7T2C&VE0GMAS? MRN8<8T7C>])A",R4@0N$I2*6ZU,](Z]-Q(9<<*)@XOITM8TPS^.T4K4FKN?A M53?BY26P^__=G%E!2'L/6`2X8?`YYI*=GN1^_\[UP-FR;@)7E%3._KAB81NZ MV3-;CA?!4*#6(^O1C<=6'_PW!XXP#=DQFTRQEM>&(PV#<,+O MY@A1R$9N%(O+.JF/J$(@="/$2I9>-FTBB16R/EJ1@:017ON9#SC%=?&+(?.< M6/N[YSH]U\-*4<1WO7(J46'#5T4U*&)YZ+@AP?#@>`FK:+*R[6K;39>)[A2< M2Z`H:,R8$!H(62-0\NDGA,W)$;=9:;ME'D-I$IPW(VQ._Z_$!7%)IOBO6KLZ MS^3!D`"9E402.BL5./CY>5BQSL9.,A@GH6L]C@-@ASYR#;&28"L"YBAB.HSG M%Q_O=<"8#RH=V4D_,VR`;`O2QDN7JH]`-YV;'> MU[0CA6R0]$E>2+A$*3WR-/XZ2.\:U!G2MF`3^.\`P`BM'O/9$+\&@,PHOUP^ M1[&?07Y&ZB--[#>`=(&R)]&(<+:(NT@+D*8$R;5(:H6(UQ36'-2`\.DP M8C%)>3^(8OP6)RG1)!\'I1"NDH$#IO03ZX4)EN.W^4W6)DB`\OW`]QEG4.*( MF'@HX@)T!MSKQE9W!"*//1VRQ*3*$_@6V*%@QO0!M_B10\M2'50/P2`7^"?Z M3]=_"+P'_*8TV?G-3[>$J3(2Z7X>LX)&J#25/*>9A"E9..7N;LYNK-_"`!3K MY>^V]>7+&3HV48*_@B4>QRZ()5`S3',1B6JZ#LJH7+UM@_2U@KQMX!>@`YT> MK#3KL\V8AC/'Q[8'L-*\<>!NR]PWK*.I$TK9)UAF/1O4WK$;>^(\0K_I?AWH M$F<$V!H!5^-*M9-*9][HZ,RM=^^=]P@)C`*O,#50XD!*]671/G]0[(CAI$#K MR];JFMT#GS+AO8-QG6?!@)VCQ",M"O+N6#Z+\S>IMO1-\"=3SP7X>D^Y"`-P MN5G4D9NS<*=9K9P>2JN.W?I@DPGH5T";]Y3J3D58Z5VEC%/@D>$C6I[@S@H? M'B'?)TMEF@LT<2*_WA3QQU&6[%EJ?T"5@)M'S@3\-!9.(C3I^6S/A5#_MAVX/6;87/,PP,RS/O4>NTC(OPMS9SK[>(X-D::$: M"@GS0$"HRV]JO_"ZG=XY)^#](NN-F4>*3K]<@_QH-J1]6JG/<-P'M="LU\VW MXWB8N:5PJT#GC7`I87<>=7[3SOX(<@.P".10VS/TSNDW7+"R"XC+@I.QF(4. MW3[5\LG)-'>`\+YYNA1`Z)Z#$T4LBB0[P1\3$>R3 M5B>J6P")$&]7@`O2_3`B*<4PSMV9U6Q7CUM5^M&`(9^Y/@FG$RLH:)(!@4+M MWD`F@@2%".#KTZ1T^`$9$M#]8NQ!,'"';I^XNV)U^W@7!.'SGFQUKZ/+(0B< M/Z*`FG9%=`@V>0*"0MYE@.5CARS(^U:C:4N)T-6X%-09WS&5^QD+B&*'\(Q\ M]V_><\Q!XS(-?,2S)EITL(&8#2_-'C;4L[X$8'V.K@(0X@;7%(^@/0@_DR", M:5TB$](L2@-B>+=5XBW/PI&M")U$PEYR3W0XQ"O<`TL7F[!X'`R,UU4@6C-! M2`*$`I"$UB!7IS_'0ME8U"KM[8#9"(+WM4H[#8'`7]]7,=@933EUO2=N.W+% M0_#)A&VEG&?XP%:,D%&*(:/N M@I*]@->&+`RY7A+^>GI]N/S\^5+M5$EO$!8/_F>9.X5DGDV[T@BN1+B?0NXV=40A;=NEYZ7BUA++N954FU2DN]Q`B].:N@R!QS M6#&LF*%T0X_RSJRWBM*<48REH%()F2;+#JHUE1;2`\N5C2I8X#^X$[HN*#># MYWP@[0XH+\C@(N'?/L-+C88Y[+'AA>N.AWSA1\2[BGX55&^Q5Y)P1% MZH3VW;"?3#`4V<(C>2SS"TG(@S<#7)-PB&*4FIOZ5XF)DF/<_MJWW),W1\ MEQY8\.;UZ%OC()JZ(`8[:E*[R^GQJW-AZ$9_'@^Q:;9T4+GF0*[024,VJGRCJ`VY+0NNI5XSC-`HD)0)N_[BK-75PIXLO?A@CNGEC+`5VU&S8*'"4Z(*WSE@RMA,IGRN$H2T8WO M>3$E>___4,,T=EV.2TH%L,&`PL);\[J&Y M8[&&7;W4[T)>(Z6OSF\DA5C6FM-M6GTN/'AMP^=>L7%=\=;K54'^\.RN>SNO M(:TAK2%MR4E;K@K531[Y=BZ(9H6+&K7OAI]WS,0;9MQF,>/N]6"&6H9:ATZM M^IZI5=H;RU9N*>ECEV':M9FV<5HY-3KF8,C5K%8:AEP'0ZY6>^_D>KVW`V4( M*&OTR/5Y$DUQ-S7#K\]:@TJU9;3+X5"KUC'4.A1JU2K59KE,0=K4Y1\_;6*N M_:___5](LG_(M2[]?C!A]\[WG.]B50\>\Y8-__GN4QA,\,GVN-H\KM;B`!_3 MCZN-XT;MW:\(Z+:ZS%Q=WU]8+>O8NKPZN_YZ8=UW_]_%'6%F;SE".T]4FX9L MZHCR*]6%PJ?7=TJ('+J^X_==Q[.HH(H7OO`J>JS*PF0TRC_[K=N]L4)&G2ZB MV9X2$^=/II(L>:L7/9^+$M`<*NE0%1X`5A`B`+P'!66U.=^/9<\4K!"*^4JR M;8HK5G:)[?#;6I5/MC)9U!=%>G,%K?=*6NDBD\-A+;$C3Z<,_%&`J6T])W)A M[4L?C\@S1]U(+$]E*S.)I@)!LJXMI0?-@TB%^5/)6?Z6`** MI2Z,7N7ZU`9$E2A9CV.&&9IVFE,8)?VQ^K*-.:JP\R0(&:#J3TQZ!WS[E*M' MB(\06XAL5U2U>YZ.!$S"5H@02)!E/2$#3ON;)^/Q_#TL,G6#`>$[BPG%&]BS MAXJBX,/_)(,15>59F>XL>@XLPH`)B1-GP#*_3?DI[:W03P!,402B@$X9`L6& M:!G'H=M+\+>S-3`4:0:AB*5(6`\.G$B6G\.//><1EH'3Q4&(_C,A/A(,JB\- MAP_Z+F_QH[<>B1U_Y"*I.;>F_]1Y>N)R"`!?<";TQO5*:8YX!2*OEYICUBS3 MJPQ-5>5%UE7O8E;@^I.RT%'+::TPHKJV@*"ZGF"X`19N#1;P78J.[X+I\;22 MM2+070Z6X/%LXDQ_M)V6'Z^`HAGUO@^8%^KZ/,U(T!P)"G[@2BE"EA5LI:KT M=]JNY`4%!]O-LFV7.\DVVQ_VN+:-%L)[S2T\V5-NX;]SBH<*,?2J,PQ?/8OM M*WW5I!"7@@:'F#A\%TZ:OLQQ3RSEFOQ<2)=M19M*/QIFM1W,6)Y7@?MR M/>B\4.0-AY60PPSN#UNZ=V#[7RCV9SR69$QZ>1C/X/ZPA7YS)EU$NAHGM,=CHU<$/!KN<89UD)WP$X)#P\.-#;4T;0[K6(??IO6R)!IY?U::^U7,EUBHE+& MO]Z/6:JQ=E!!60H@R=E.&)+'+'*&]\.^*&XTTRI2\=W M.TB<^C#X?==S'>KCT&/Q(V/I<*RT\8GJA:(5\,O9N6GIOASD)GZ'$]J2F(^[ MPVGE[M2C:5QBC1[#X5NY+0$TQ8^PB'%YV/XEB8/PR1KR)P_]MW*NV:YF;7E; M:\I@AG25.-!2;`%,@X#2-`@H.0\=2AVZZ06P?QH<8B^`\DGP+EBC="`;#)0Y MABK7781H]`5XAQ4RVU?@I1VVYUBKNK[JA>RI!R`Z2L MVR>MG5/RE<2&5\XEXKTF@W[F,H_?PZ:?P5!I,MG@<4D'T:3/Y:BHFEUO[J:Y MNLER7)],S06!]8/1.*6?X7,V=OP1!A^M!\=+>/C3P;"AX_?->+<7])BW&R=[ MYE]#KA5L0MT^;>_')I39L5EEP3^<,'1\XYF\2&E4.V;JR\&0JU4S'LKVJ?J[ M$[KT$J@FSS(_-J,&7W2S;Q2W[S!:IF3$.JJUBQ\_WJIC\K*3GF<&=`PP/X2F MZ1@N75^EG!K'Y6"(==0ZW4^5[X$X+"]^5K_&.5!+8MC4N.RHQJ59+83#-.5Y MLUQ1WV/!\($\=I4NG\'4U1C<'PKN#\3E6;J\R=0RO=;*%5/+9#C"U#*M7,OD M'<944E$@DP/&OLNOSO.F`Q,H(1MZ8A(UK[2BP=1\P"^;3(/0"9^L@0N?ACA@ M.9*%6_2#OA.&5&:55F\Y^:.JAT&H#=?F)5YRQ.\T":J>E*<,(S_E`O MVQ+?Y<-^U;A6BQ/>7C+@ MPZY97@*'Y<2J!L:4@9DRL#=;/F)*>/9/@T,LX2G)76S]QRUN.8XTLV'&=Y8H M.F!P?]B1F8W/^MIX'517^8+HK>(],1XFGN7T^^C'FAJH+13.-)O%UV8S`NP` M"5JSFZWBC*E#K(0JO1?3[??#!)R8!Z=/=]HEO6F3[9'C>MNGG=UDD)GDG(V0 MJ[/@NGHP&J:@ M6DKOO/"*[L4])@RW/K%[&0._ZOG9BUVK&H3H8>G7LZKY;$AV(:_5\G>;*AN[W MM1M_&AN[JWF]IW:SND<[:^;UEHTA%FO,G3/$J_:W3&K^4CN8LHA7@?M7XPBM MT18`TP,'\_53:UH_TY=@.WT)3NQVM;.T[=M"8X(7!Z,,9VR',Y9X^-LG>^RV M@<7"N;MY_X40[;L9!'9."%F4>-2P@1HN>#@6AVI`$"+Q:5ZS`]G](1H'80P; MA!,Q50<;)."_&\*UZ?1/'E+]@,_F0A MH]''(UZFIF2T/"Z4G[ ME&,!ETH-Q!(%E9W3C1P_5VCVA).S9))XH%Q`*?&:'!Q(!)H)%=`3<\*H$%,+ M+RP;D)4#$Y`W*!6O2Q)XR\2?A!2P[U/6CRD3W!HF<0+VVHB#$8>W(P[??'`K M8P\DH.^&_602Q=R!C<=.;%ONT$K\H?,0A."H/:%['G@/;&!;CT'B#2QG`$P1 M,?B+0XWCI`B)`E#PTLFAGH;!T(WAGO?`/"-91K+>AF3AW=!Y<%R/7V^?;"L( M+8K/8.X="X8V7?V<[V+V$G4Y!#,T#5WX(C57Q+BO!;+D!@,ND4+N/'<"\C1S M8\1+8F9XK1$R(V1O0!9.IXS^)0)9H)[L@CJ4C/0[@8PRPN3ZS'L<,]2$&Q;1.KWG1 M1Q?C@W\E+JS&(V\2!AEAXZU<@6M!TATO=PWX!ZC'PL"B"M$)4(9A,($O.^$Q MA1?!D?D/N#GDV/!0)88@Z4NC`!2,3S4:"$64]")W`!R5'YW;8TRN#.!T[[Y9 M]6KU]+AZ8EL"MF9;7,T(I'LL[;>.[H.IV[?:S>H'6WZM`VHI%!%0D%\9"\9` M1DZ+8>*-D>\2&\1C^.$X0,<5Q'["G`B<58K!HM<[`/5A8WSUD7D>_%^"`[8! MRKN.A;W=D*C`@/`#[TDN_#=L8@,O:?_45N?-B;];TR!R.=O$SI_,1T]`W3Q! M&GI,?`[FWZ$?A`P<:;]",&C8`DZ.`BD%D=4'F^;`;T3GXP0_(W4'_S&EOLX! M:;[$%]^,GW`+O0UTQ>K240!OH`>5+X%J50ZN5J*=]GD>A7!]AF7EJ3.]I947 M@A*+F$/IB[;5';DTS<3?=AOE+26F[6*/HDZ^)XH\V^[=*SN(V[L^^EK9*(9; M%O=]+E^W;8/9I3&[8@_MPQ7!LJ<1YI"_="`;#*S%O3M*9]0;/AY=8+6S%+5FRP/2%:N/2[X?,P107 MC%P6Z@S^V)BFO.SONK?I(K^]5QEN+(&^-OOHMA49-U1^O50^%!=IIF1DIU+;[7%:!ZYZK0D/B5D-C,-][B.;I4%Z6>LBQ\IK!Y M2L9T&@;?W0DXG=Z3];Y>JW14-58P?%Y#BV13GF**"GKH1F"S:`OZJ]RLD5*E[M1YII"D8PCTS1. M?N$)%'[./!BJGZNU*S7%!30@FH$J`JIB]L3[>KW2S/PUHHD/[/O4#1DF<@3) M:`P,T&CP5*`D=O6LH\RN!(?8&1>'B]'`C3-I8_`'6);2*H%G0/182$P!?/O@ M1G1I$FQR>7L&"*,<(*O1J=."$?S.&4`1B)X!'`CL;NM&)=^E(@ MT7&B5!6;@)7Y6?12I\LBGG`"#A=\-DU`7X"D6LXH9#P9YW'L]L-62,YC$3-)\\<_\=HECN1=/!#D6"4PXP`^QK0Y:D''4F, MJSBD(KJ]/"L9-^#@,97GDRNSS`&BB.Q*D6,TPH1+H4PU0`0C2SE"D*6D4/H2 M96S!7V0U,%+4]1/\)\FWHY]8 ME!F6ICD-YRA9J#RHG- M!RF'T^?B&`[`OO=9E-$V4G=HI\]%I8:.%&M^\&AA:A@;[-28O2K'YN;L\Z5U MW_U_UMU]]_[;G75LX2=I%?KRC]%LHC_6`N#U]!%LG#4$ MAT,9-1`HE$^N8(G4F!XX9BX8 UR,/!_#XD/=]/I`GV,0L6.,%[XOH')]"2 MY"-W(*=@:(,"?VFB)'$\:MT(''[@EACA\Y(!_!J3>\G:B!#BF.G.&:8O^A&= M0_AIW-?#`A>WZ-*__Q4Q(=CQQG^C//`[UWOI^KO,9[(,U'#PS/ MK__]7WB#^H?\[IV0L>OAW1AL^$=T^FZ<)SQ2%Y7I'5JKZRDI)M6'KQM%R81_ M=H]$4:N3+H)_W++A/]]]`CG&C)#C:O.X6HL#=#>/JXWC1NW=KWNY)6Q!$I;, M#N:YC3.YB\^E.KZ:W,8-AQ?VT=$O)Y>DN"'+5E,"T-;L=]$O54OXVVE*]6JC\\N^O>SFM(:TAK M2%MRTI8K+V631[YUHS^/AR'#F!D^?D0Q/4TN>>O9%C\?\@23:J59S+AFWHRA MEJ'6"ZA5WS.U2GMCV3Z/&UCV2%@AE]SK$&EVC+:Y7"H52N>+V.H53)JU2K5 MX@S^MS;7Q9O/5]IL#M*"#"==*E[U?`,YR?>-,,I5YXMT?!O+R7U;9]P^&JHD-CE\34DH'\EIWIK2)O"*V?BEJ'.`T9V10DKWOR[(6(_VEZ$.QA^:2O!I*>+L[ M[[;R-G#,OK.P[T94`]8O5D$&QR_`\6!1'H-IDKIO6U4ZD`T&#`8V])JS]9SD M%W8@*$5"N+O4[6^%[*7*S?@A;TZ;YGL@E)< ML;(MEBY[[]BCVHG=6:#[7P9_<<9%.?%=K-&WJ<5-8^0M87WGBKG$VG@KOOU+ MFRA'46)T\MP.6U7)!ZLNC&Y^54R^.=U\1I=HVOO%3X!*I?OPI:55^D[G5RPYPV7[ MXK')A]W5;4=_5>;D#9!E3^+V\FWW?ZLH4XK&[H+RU3S3M,9@C^(GWN6; M*&YYGLC2\W7V9)[6FB^RU$/PODZ^=P)O&,\K&;(-[_U"6_=*";PW"=[$QN6S M>9M$W\'4)JY6/3A;AGCAA#C`.KIA(14_[*7,D`Y\=7U_876L8^ORZNSZZX5U M].7Z[NZ#=7-Q:]U][MY>I&C81ZOTG587\D[YUA&VTO^`(R^L"&DC9Q.`Q]5/ M>`-^,=/F,;`&[G#(:%#PA,7C8`"`])S([?-Q*:Z7P-`&_F`1JP$SJ:%F#1`T+X6,] M*M8Y!W0Y"`F,8BBM+4"88A-'4TU!TOS8=3P^>29W/7&FS-<+MK:QS%6;;)(. M+(IQZ&L2/@D0.85M/B1B%QZFL*"?Y>U"SB\ M(>"ERS8?9#(LPIRY7 MI+9R=>55&K!QXCAT>PEW=./`,&%IF-#@_K`5P#9+K$].<@L""QYG7JHN+L&' M&X44H/[,'"\>]S'P\3GP<%7XYJ7?KQ122"LFW?';GU8[N;F7U7FT/_/.JU>? M;@L,DBU1Y->R6XVERH@+J+&MO&7#![OD@[;=;!5?DK;-!0?B6+WXXF1L=PEM MM\&]\9LV+^KGS`\FKF^B).5B.(/[PQ;V;1GSU2\Y?\SFJL@W>_ZV:MAN)@C? M:MD-4YKW9A!?6LN^9%G&2]6#RB@3:1J[?H#*/_R&GM4*+K-+,/-6`$BOL0*" MUJK/G%L78D/E#5*Y9K<:*[Z5EUC+[>+A9V&`]V6W&TISS$D66YH^6X[F;3V$ MMZX\;#1^]YR5WVW8SA![R\0^L3O-XF*\PXO1EC.&8VX5)8PB&-R;",Z&Y'LN M-_^8UV,=&,=MK?G%4;52/=D2CYF&56G5=?%=IL1R7$Z3G2/2XFYB^,T(]9L2 MZMQJ^)U50FVKY#NMKR\LBR\>XSO[$RJU[OH#4=*83Z-P+CTM_JT<7)=WV:7*)?I^-: MNQ.JSKKV!A??IVY(4)P[,=L6`S0ZG?H>B%&OMZ$;I]M23Z_W9W?%!P-I\[/'&P-`/,.FD6%AJW,:;K1]3"MYLV> MH%:KUFNG]4;SW:_9:>A9@`LW>C%4]3RH9H!I[`J8VK:`R7Y+H_!Z;)$F M"T"YC*)D,U"O;WL?OQR85U>W5_<7MS=6Q=7 M]Y?W_]ZUK[?'-@)G`9^<[*!+F%!$GE/EH-?"'':N1M3N905)3W4-3A7&__N>7*MD#D>3C>'FVNL M_5!,H!?SO`D$,0A9V[QBW6LSOT/69^X#_/9]JU)5LY5Q'#.!.$H<9&N&4*6_ M^C&RWC?;E7J[K7Z!P^0M+W"RRQ,((9LXKA\!O&`R02R>+,^E@C`GHD5[01@& MCW`'3^?0%ZZ.4YX1Q4K%NW&4`HD(0+`Y#&(1@F%^(3>R^F$01;RC`GP.M/Z; MX[`0[>GQG2AB8A1Y(5G$AY^#:.K&X"M4"))NWG+X"X?/N^['[@/0"3@5`Q(# MH&L_1BB&0_B/E,;9K>*Q$].X[2CP!L@YB`7;>AR[_3&>U('OXR'Y:/>I@[_! M>>WRI_B5X=`%NN`6DH<5D\3C,$A&8YFT%CSZ+(S&[I3.CXHG#+R*U:6I[[/3 MX8F-$#3\U(_L"@.0H[8YND/>-K?0$"B ML:.=!H07/"I"Q7E8L<[&3C(8@Q]E'4V<_P0AGHKFPX\!&V"-C&*L?A,P+TL9\^0$%$*TA6#'./B!B!(,N9GQ9P;ZQ%8,&B(8L M)/W)^=\ZN@K@&[7&!ZX/)%3\"*@)T)P"&@/.(/76,"_/\J<^8-MC?CP^JS<,!X/0I#`/`"Y,/\A\`&8P8"T,9Q$[CNE2X`M ML$8J/4*1`ZM/N/03^'(/]A9:U8]1!?!K+N'V?:?24"H3-T+5A#`(/0%*I0+J MZ)'!Z6S`?`R4($2%;`BG\_LL$O@E75&LA6UEX32HK%F(4'\!.9(^)\G[=@I= MQ;KT%0KL#,Z"X1!5*Z!AA%8C)@T_=]A'6I-`X*K.)5:%KZOO2,Z8.'^F-'[V M:!7K"Y$W748P$U*%PT9Z6NXG%*IV9.:YG+$&J'E`.U(:$_EM^:KGC2N2'_T?GE`VH7]2VR7ZBJ'AC9 M6FY6@!Z,XD#*Y($O`;8>[%[?154&E!Z".H+_%8-GK5MB^,L4U06G-O#1!#_B M1ILA:SD6.21P9)1M?!8$U`2HU]`!%-MRM8@"(N6Z,$&!#$VR*G M!7Y#^)D$`\`/:77NFCU9/=!1B`[Z;]+$Y`R2NQ-%I/`!0-+6FB=!2]!F+D#O M/]FPCH-&W%+V6.A1]GU*UQ;\"?PW]VC`28X8QQ=AD?"-PL\M0'85U`;RET(/ M`K5\[C&,A4=T"G? M1\ET"BRK-+'T1J7_&`5)B*;+]?M>0I<"+Z/";8O?0/`OZ@["+3F_ARQQ[^!6 M>?["0&I]WI_W`_]8]U+$=0&O=*Q/_/_<_21[2P/>PK/1+0SP1FAPA8@39"XI MM#B?7<$U[_>#$%'C/7&-H&$7`20\21>+FSL`TI6;"@_:@54('A%;D^P^R%W. M&+L<";0F7WF!<\;@NMN\'6PE?` MY?HA$J;_^4YHO9D\R@-NCYC7V&P7G=QVN._^N[NET0F$H1=:/U&*[*)N>H8N M^Z1+<9N)W=+E-73#W`6CE`YD@X$RI_#I':?$/CW4(R^M/SASHG$A2K5F0=D] M=]`C:).'7*X=4/&.:Z2JU9I+=7_:Y"F7D!%#T+4)>M(I#3W+52^PR2/?B'2`>A8L(2?%-Y+=`))*"/A^I^WE)W,(,I1*>QK6V`YK M-&MVO;6\6=TE:Y36^S3]%I9Y5SBH?@L&]Z;7A6&P5\I@!O>'+=Q["2&MLL4Y MZ\76T?MFVZZWVQ2HQK2V@1OUX1CQ!^O(484V05C-LAG&&)7#-&T&YWE4R"VSA#E\HAVEAZD M7<%X`ZA^/YDDO*\(K]U=-L?;)(B8W"'#&GMEC0/*'7J=+;KWV(RA2RV`L%M. M+WA@O%4=;SR$K3748Z?L'57 M$/%Q#PN1B(ZUH&OB1 MBV!A[Z"(N1%VO0G9A`U,<)RUOBI=MVTA+8_6]31S#L'\2\YXT\J9=V9?K3YMI MO2M;8OXK`13&3]T(OHH-ESXQ%OW+&>ZEJ6WEU/4SU,WAJ^UP4[HS[7*%C75K M->O8^GQ]=W-YW_UB_>M;]\OE_;^M[MW=M]ONU=F%]>GBXD[OAO:O[B>M&]IN M`"V9F%WZUG4_#GJ@N^K5ZFG:H_`W4.ZACWI\:)W!8B`"ONM8$:Q*W2!';L2' M4,I.4VF7U;%@5)#;`6P?4J\S=S+%KFZ.[%T56D-&7>!&S,>N4'`A2+!Q-#;O MD0M$JNF5G;9TI#YU0S:@'TV^?*'8C(#U2O_"K MKZ"UC\_TUHCP3;4I;R+%6U!%26_BQK%JO\6LJ0>F"[Y.2H@::%!O.%J3@$7*`S79&F"#WO6`MK1-1.BP#1 M^N#Y(Q;)5E,$&ZDSM1R0!/;#_HPIP:BE)R*->EHQZG0Y"IT)[[0QD-UINWOC2B3B\8!'QUY2/?,#&-*96WZD0='A+4S#`DP`@ M"C"K0>YG9Y9'R,&2/@`<`Q>XRNTE-`-5&-H4OPCAL6AWEB(ZI;5JW@P0*DZ8 MB.ZX1$+$HVB%^0A&`OEIBM34N40S^`)]G$4X9V`&6,CT-F>T9JXGOI6`!/>(Q M8BL.`VH%2-X2[T2+JH)HS;`).[(2'/0<\)HEKC",51UN_#=!E#V`AAGLFI99J7"H:TR[0)+*BMPD=$P`^B/GR16L7RM73?#E@A M&/G8P9I`>M\!7U7Y!2!4((S,3YAH+HO=X-A`.A:\>6Q3=RW(`R'!"F;`VK.J M5W>O_ZE]:IZVSTMJB20'I50G4!91'M8"8FAR!NA6?_3!8%C$QZ)-,.^-^;^. M3[Q54TT1_S>!+S:JQ*VU&6ZM686<2M!EN@3JCJ*5XR/6"]C/>M^H54Y78[U: M*_V%N/7,L5^M%.RG_$#<1\4L\J.:>:R)/]NB*[DRGQ*[<$S<).K)BZ=G?D\7S1 MK;GH_9UQZM`>H7.$WAHY#(*'X58\=:BU+^)$":HX,_SJ&/8YCKA#Q/O@@MKR.0!1XH$3.N!&99&$-XHLC))HE-U64S,TTJO+2'>KKEU19R5[!IM%"%-< MQADK6L!9=`:"0IZC`DAA%F\&W\S<85>ZC[?=_<7H`$$Q"U8^=K/,%U60L2X M!(M&)43!,'Z4MZA(7IY4Z$QT*?_:_S^X#@&_W[/^V`?C,<)7I4N_7]'UH?R6 M?L47+GHR!7=ZP(HB2:Y/S:QC'J\46SQ9T5,$2L*TZ,T#YYNZ#:7$XLUY%;'H M*B7OXSH'B,[SV)F:\3;6DO*VUI[:!Z@5>[@3>9M7%@1G)M"_?HI#T;=:+D-P M2%V80V]0CP"@SSP[W0%[7X/=%@W@)2/"/G""(1R(3Z%0?Y'!1V"N"5@:BO.2 M77-'?$@5'(O`&#BQP_4P6"NGKW%5SM4PBSNX=6*S?;!;T5B%(`0.N0T%D#$L M@*@:.^&`#H)]YOLT@T8U61?LSZU.5N06`(/WU,S*!)1H=XWQF6E"T1`INO#? M-K@0Z;4^QD@-CV)D?XL3*QR/&V[.-#&+T"[P[\(*`9)3(TDA@!(?8S[:(-4L MQ)KIT$OJI>^/B;S8';_O`=.#"V? MLXS1&P7-[C/J70RM2>,582+&LDCWF-K"%-)!0*]5J3YS*&CV)#=5DW+F]IW"/J&47W%. M'DCA[()B6LC?*03C/@QL8-HQB#>2'PPC>79!73Y!\N8;/[B]NO_(_:)Z_]?"`8XS?F]V3X'G!8\TSPR#0U%_#'RX'?9=WG3HU0O=9D[I0C+9W.L88WA<^!$CUW5AB1H@9`S,]< M2=-TETL+WD#V[TI+S,3O^6]KU=4R"FFI?^?X=?.!_H6IEQM/Z=S*3()MP;ZA M-/+_N:#_M]&9!/55QP5MCJW0@5Z1C;1N[=NB]KI;;`XO[]=$2NN'%Y>@;O`4 M-?ND7MTG>3KUM6-VP^EO1ZQW#[(;9WX!>O\>G(&<8BW:!^V?XF6K5WDM&H.YA MWZ*BV$T*#%YV=V^,C7E0,H,/XV46EWJEOD9U][XC2QL\RBZDL&,W1/^T/4MA M<1&[9^K75\TXHIR7;)$P07*4OL"IXN,/V=+?_&046?9+3]GO6^E#*Z\U;J9O MO#.%P7JRAZC@$*5I$I+G$0ENBTL8C;)(Q*K?_5^)&5"8R MDP6"&3Y.A(D*@[1=0*3(=39VI@"V3#9ZDE40,GFR)Y(]>,J7)XL)^,;TSLL+ M&:G*'4M1D.X`89J%H&`$*.#<],BLMRZ@A*F9TI-Z(YNJ)+Z(%:-3E;/"2R3[ M#L]*D5^1)8,`%*;\!DE$*6^1JD7`0$3%ZM(\,2MW#9$QC.WV>T'P)ZSC);+2 MOY:IB2+N/]&++3![F*-N(.MF*3\6CX%@I:D.F+HG\M6B,4-@\M[&BZK^@1DP MJR?BJ`CIA%253.D4F"PKW_KQ&+)?A3I)VCA"U6DBZ#W*DA&]-5RQ@\57QZ1H M[*,DC\61922W(.UTF$GCX+G0(I6#4/C^BTUXUR&KR(TQ^Q*$_+71.3\L0HMFW M?3'Y$6^!V=NM55/@2L/LKT&OF_R('3X9MW>O6(Q>-_D1>T#V::-^J*Q^\%K= M9$<<7'9$$VR#\?D/4..^O76-EM7R:0I>/DJB=U^_FU&KV]6J49S[DX(O6&OM M3'`TO*5&%-`#I'S(/7IDR"+8Y`$PXXQFWGCQ";%6K=1_^%`2H3'.RG,T/VK: MM=I6A6YSL!9SU6';L1)8@;>WKE'[4JRN\O)[,.G'^$-[]8?:=N?4A-/WZ@R) M)$39P+@DK&^\FF>]FII=JVXU-?Z`O)K78*)4/O`AB*(I?MF^A)_8[4XI8@6S MM2_>JZQ*N;R20\JT_I&SY2%.OQ\FHC0`&R1/*$==#=":;4XMIR(^X90$=P)P MBL:G5`804T?#/HY%X#UJ75^T\,<*`^;S;K8TCB$,>D0#F5"/705AAY[W),"` M/V;+`;#]\C0)^V-*5\=_A/"U\(GOAW$-1P!U/'%X_]I)"@#H(,_M\PZ]1:>#R"U*M4?@%H95J`2D2CI1>RO!/^M#I]V ML:;V[`(WDODB,:)+(1$SZ0?(ZZ(;KQQ,QJASLVBKF:[98UC6!+]Y<%R/J7G2C5\K8(G=6%6.1%D*1*,>AS]/99 MJA13JL8!C32T@B2T@AYLZG!%P.M.\-/'(/P3V^TC]P+)N$")07'SRMBQWB%] MN=8$U4CSZ-X)16N+9;E$\**6$#@JQ)@$`N_E[R:YG'C;#ZP!SF"(:4PN]2!U M)[TDC'A#?#E,4!:Y)%$6R'S;MG#;K5NSQ.-PP+I1G)GQ0#/VY%0^68FG9`?/ MH.&"1_Q1?J*@[_)S(<;X.82>S-,B()V.F$MLB<;&B"5]_)G"E-I<+<7;]F8* M$5&+B&TKUAG7\8[H$[Y)"V2M;GUX_=5&+9"ULO4A(-:U0*UJE6O=-R':UX\*ZOW)IZ,M4MC(T)6BXQHR8 M-SPF/0+8&S/'`W3WP)$&(XOR,P+BV>T,#9M!V4> MC05AY<06^JBZ)%#'_8L#D?$^<<)+"=0U@TH)BEPCK;PL+V>7P M@'QED-7<`\9G73#>KAS<^;\2'&Q#Y8XHCN)8H)09:@>'GCP1;=AB'#D3OA4' M(8U?034&4HXF4%8RQV`D!QGM"U?HL3QW:C(EIOR!UE5;EW>%&8`$MT]_V@L# M,#-BE(@;X@(XE<\98(0^BD%W!:&M#(8::YP%UN*`BK[OXM!X_E0(Y8@)T;&> M:OAIUFW%ND/MQ/\!VD),,<;?A#@>!+Z($.NUR00.;Q2/WZ!Q`'3H%_C0V@A* M4BGUM'!ZD6I1W&IJC=?S!9-)#]C;U*>3.=34(SE:0O9>F(FZ(-LX<:[K MUJPT?T!GBD9.S-PQE+\BUI?#?]3H2@Y(P!E%[81LW$`MPSV8.BB@%1JNS'9< M>%[O24]WN78/TK&/,]T"Q)?2HZFIG/SH@QR4;HMA5R[BUXOV9XOZ\XOX"^OQ M?[%D^6AUA0+_LE?Q%X6ET^4$"E4@OS9=]0E[S7K[^="'ZI8@8?GXDJ?*5'`0 MAEYH_82?4F.@'>/BC>.[O@=\K_X06C[)W`53E`YD@X$-/>.'H]Y1O=&QQ?]\ MV&C;CY,?LF^L6=?.8\,5Y?A&Q.N5JU&(7P%!?0Z`;3W9:TTE-GGB]\^=L-98 MN.,:N68UTRCV2BD8SPNRSZ8.Q;:>R;P7UY?(O<40`[>TC8 MZ8/6S;?;L\_=NPOK[/KKU\O[KQ=7]W<$R?%<>ELZ'EMV7WX,K,27.0/\.3]B MX8-+?@N]BH;6`_,'`3XR45MTRDIXP.PZ,0J[DI>\W6/?_:X^]H"`:K1_ ML+*SV&7F]4W[4^4P$*-\!GVN1\`MD/W3Y8F MDW.>CE2F7C9?TIE&/+>3IQV(I`#]59AD)ITYG_FY?)H'+L:GT5@\PN=BH62< M\@D(2;CFU,3$.4_@P,7:@M!E#_(M=^2$))9/JH[Q9X6=?NI=? M[ZSNU;GUI?O'W;=+8<_2DI\9?2)SH[DFL3X'$<+&'NJ#/ M&,T$L:U)$-$T#Y[;S0TB_@0N"K'K4XI9C,DUKM]W!S1L1F9J!%/&N5RDM/&D MQDBHU4@EW/4='W.O>Q00`.[F]3&8Z!9CKMLTB")*@Z8:DUA/JR9>3J0@\44% M/+;(@AVXH*L2$-LGB[*/N!#*;"@XGO/$A<-)D^6<`8@2+,6&0\2/&)8AD/EC M9/4P.QESH(Y(-XA%?6RZ3R-4I!K\8,_DV,%11,*HAHL433:"V'>BL37T@D?, MP_/B,4TTB3/IDD/*9P3!9][0>G!'`=`B@@,Z(\?UHUA/9/20V>J` MEO\D@Q%7:O!YJF`$<>08FL4D$OMCUAEFN?+%;;,X42,2>JF3!?#@J M1\C)3'K$;GTJG8UC!7/51,&*JR5SV]91'4[O)!'+'%4ERF,B*5.)2_#UQ@>% M)IR#XPY!4V-V.H@_SXJ+12H+JBIRV(J7 M1C@^('SH/`0AI0F!8N##IB)5*Z$TD&A>Y$;Y51.ET+);5_JJU';O1[WVK?]- M0(FWT'&LGMIBC,TT($8%9@>:8\LI7@(BJ$YCRH:NA^(H-([.F.`!=SWV'2@> M.E87!$WW]*ROJ-;P0RSOQ*H$DB/E05.M4*U^#&HO%)ZXYFL+)D+OTL/,=_PV M0[5#XL$'F'%0AU0_!(>/E7E(?'KP?B0]Y:19]OQO0\<-4Z%(?2]A1OZ3^'2C M0@/HLB&M7_PC"_[@X?`?.!JZ<@&%W":,;\YE&Y2(X\6D>-*R'I18AGJY8@%I MY,@L@J'>D#3*9F-Z(O??CQYQH%"0Q9`M$VH]-!P\8Q%1+*XV_$ONRR?\F@$O@Z2B:Y9!;JC`K8A!>ZN/"[=@! M)CD&FYKP$J9U.>7!#3Q'GDCJB9$MC+YIBF9SJ2M\-W9_H7SN07 MWGW@YE&>G1?FS9T_\=5E`*XF1$^"0FTT<[+K?AS@N6IU+AV<'9;@RGPH92%M MAE%=_#WPZ0*F3.";M0[AMI:7ILQ1-PG4L$,D%ZP8]ESM]D4#M>NG_<,11^H:R>SALEJ$KC%E`E]W9NG6/Q'O$J'!#H5$0QS M89U^K'N"KE)!RJN'_W:I\I+<;5D[JMU,=FF&RWBE!$GZQ'HAZG>KUIA-^O]/ M@J2&K[CQWR.WUT.E]%"Q+C]_OK0M%E=`/BM@"1Z=<"`J&.UJM8J_F":H2H`" M\F:0P^6VU<-!CG*,(6ZF!=FTZ"AP'-X+.5]IG,`+2H1335-.A^#G2]%F7/91 MTC#@@B8:6.U]J]+.EKTHCUIU\A;:(WX4=3;`C\NZ<`[VZT]#UK$95 M$(N^PS?';9@U@CN/<";R-A(:$7&G`;9@8WXS$M,W4AW#_S, M&<@((%O%'J\8%%=+4B:\F)LNP,B#>)6#/0D(;=_*'"#2)`$L^(K`I^VB(1!F M:&DF`8Q^A4/DF0;N,:10!I@>K6^A=%OT)/D;6(6W,P@=N7Q&A M>46((G`^,S6V5M<4]C]^2J+CD>-,?];>5+K^X$SNBS=^M%BP.SCC]Z``/WI! M_\]?__N_\`'Q'_+7=V)HY_7P$XWL_,J[*MY2,.M&5()^"L)K;C7\T1>:TGF/ M>%&+HJ%%%7O+AO]\]PEX`H$]KC:/J[4X0#(=5QO'C=J[7_<0P];'E%IR1*FT MA=G0ULS0TD`>>:;%I&VELZZI?%Y%_OGWTNU+"0 M&1?S`_^XCR$;"L&(U?@48KWT,&7=O/>5/4\\W69TP$Q3W7V?-C--M1S92&:: MJIFF>D#35$_JJ_8&-M-4MR-F9IKJ[KB^T=@]MDMH7_;'[&::ZNZ8O=Y:=6!V M:9C]->AU,TW5L/J;T>MFFJIA]K>@U\T\U&!OSD)F.669Q M,0,W=B"%';O1+!ZIHTF+IU>!I:]H&WD'DX]KEY_//O_\AQ/B^W!T0UW"]_E6 MEI/EZ6WE]8;^=Q.VF<9E3/?XHWM[V[WZ_]N[MMZV;2C\5P@L`VP@=N=^1$W7GGWD!OM'&V#9C(] MZ;PPQJ,P'(C+/V]_5Y:?1L)QH0,[(@Q*N>AHC"YCDC1^BHZZ*69`BC\4@";4 M"L.>RZ'5CK$LY0!*&,B$FZRFC^%A8HA`K/C).'>W2A1&14%=?FC-*<*$% M^%`!5.Z;Y.E6L_\+.OS`YH1&O'_S5SFW#7J89,#HW^GM]\_-3W8XNKKY/%9W ME[^-D;X^FKDIBF`3PXR#2F^#UTB6-`,=U@,>9>A-"ARS)[%S*LLPCV]JJHT1 MNP?:,^;?!!E$Y=(=5I)19P6!8(.*EK0PLLJQV!AP5A.%`K`=,F0W*52(.)Y1 M$5W.E33J>*12JT6>M%PO8%)4"M*'FT#O3JG]0WL,7.)Z*>Z:!M[2I3S)UJ$3 MGF$%JO]'%`^27`:ZH%E0(LG%W1GG-+;7P>&$$ M-80Q_IHQUMWUK>M"L2&0>!?R:%45=KJJC.-@A/MVKN2%'0/O:7$,3\N`[P7' M:N;%^HW[=[B9R*PQM'7(!'$WJ5@/W7/R2_5U91,?9HD91`TX#NO@3,OOH%#= M(&0<@_4$FI(XJ\M5=NEL0.B_DX`I"\'.>R2NY765^AL)>V%V2L+$[L`FUOFR MV-3$24B&.>#4[X>W0]HV)LQR_GU%V\/$87U18LW8&*HK>O?']I23B@_'TGD2 M):+1`-BFWUI0P(FR@B`6!0`Y;1!D:X(V(*14,.-Z5Y20"T[_0W5)CU9S>APP M68(KMM[P#P#6'L".,IOT-D@)^%Q:,N]C^9!G;J[L@81&'18V89T@R7TK_@X< M,NS8QFN\\7V7K0%'S?7-W5B-SF)'P]O[#[?C+_?CZSLU_A5Z'JJWRO0J@0U( M_WE#_<5/LHG`@@44?O59J.$:RA9K!]$5?BG8I&#RBD^K#RU>9K]=;3A]3;U[7A#B+TP[ MWXT^8"LL2%Q)M,SXIT2$O+/,$P/@M_C[.6NT%D/.DX[5I2,RMBV1%)C3,_O` MF]VE9DZ$1Q+S4'M!'6[%W!/XA$01Z-9MMX00+`*DK_5;X.5XWI+3P>/8-2?M MYJ4GI[%?HS//`JX]8]JSYVGO?%;KZ-(?1I_.WEU\Y$Z]?]S?FI[ MB;-MXI-@IW>*1"&84A>QS29D7>*Q0E`WYL?AZ5B^R'$#1J/6=Z-X-NZ=%V]_ MBO2G;*;J*7%(:N8&/'=ZEK__7OYMU_<2XBX>7]%3<9M;D6IRGPI$#8-WIS5' MJ(,DBLU#S#JR(-$U0E26])J[%))QKQD?DM%;,7**%-YF]ISV63RDEGMQFW$= M;Q!X9CC7S*EYS"G[[93S7PFSI^68QCK+`@?\/?;HI&%=7/-@UWG*TSW%QQ_J MU1DD=RHO2./>>'4&$8_`!?2N1C!;&H6LT/F2L??E@=XRWK_93HO4_H*_]/-/ M4$L#!!0````(`!V+W$)"2EO]?Q$``*K9```5`!P`:6AC:"TR,#$S,#,S,5]C M86PN>&UL550)``,I_\U1*?_-475X"P`!!"4.```$.0$``-5=6W?B.!)^WW/V M/W@S#]OS0,(EW=.=Z=XY#C@=SA"@,>F9>>ICC`@^8VQ:MM/)_/J5;""`++D, M%E+RD`M1R5_5)U65KO[XV]/"-QX1CKPP^'36.*^?&2APPZD7/'PZN[=KIMWN M=L^,*':"J>.'`?IT%H1GO_WOW_\RR-?'_]1JQHV'_.F5T0G=6C>8A;\:?6>! MKHS/*$#8B4/\J_'5\1/RR9<_NT%,/G-C[Q&13[.G7AFM\[<3HU8#U&F'"7;1 MID)O/O]6;[4:C=:WV3.>MLZ?9N1I'2Q\NKBXL?/WZ< M_VB=A_CAHEFO-R[^O.O9[APMG)H74#.ZZ&PM16O)DVM\^/#A(OWONBA3\FF" M_?4S6A=K.)N:R7\]0?DM))%W%:7P>J'KQ&DK*'R,P2U!_ZJMB]7H1[5&L]9J MG#]%T[.U\5,+XM!'(S0SZ,_[47?S5,*I%[KG;KBXH/^Z(/0D"Q3$9C"U@MB+ MGRE7>)%")?#3NN88S3Z=>7-W7J.TTR9!'_@31#9^7I(V'7F+I4_,<7$0QG88 M3%$0H2GY)0I];TI:X/3:\:F)[3E"<52$%%[#:?`.'4SL-D>QYSK^\>!SJY.F M">W!B/(>#6:#)75"A._#*!!759$&N4^SX]#]>Q[Z4^(E.VCFN1[QR\\`)0ZH M[21,M)UH?N.'/XXG@JFI"OP=%+G86U)^![/K)/("%$7$<=C)8N'@9V)"[R'P MB.4A@0?L66A3M747H6>0QR2=AP_4Y_X/?&6U*9%Z$4RU=A^ M4HAANTPU[76Q"(.T7_SA8$SL#FB87)$J$'5)WK5`8^>IN#GE%*T"0:H:J9O0 M2S*T(7'@14#X$E7@&9&`@=->#\&27[HZ9GIA%`T1MN^FD3[^'E,^D=$4WU`Z"V2JP+;;1@MO=CQOR2. M3]0VHRC!-$&Y02CZXLR*(`+%JT!J^+IE$Z'M"'F,](H#+YY57GW&< M)O.0D8$?(2OK@FE2+%E5!@:U['Y)2=D8#$ZA8,69&0P55T!. ME@8#520G)U,J8S"^G+RL"88/(BLY@L+[`Z@"]9Z\@V+'\R6[\KV':*-UXR1J M-[33NWD2O9O:Z=TZB=XMV3D+L,\"1*O*6L!>A"E:,0)`CV;+2LJ=@$8IEI2+ MK]!D`-&*\SN@Y?@2PN/":C@-7I`'!E9Q&L2%?J=$%=IDAWT:W&CG/\VP@'V< MY'QQ\\`C$D>F#JD^&XP87D/U*V)EL<*DI48;,%9X#=+C#QASN5IDKKB5;QGE MZA%A=QW?3?QTITR/_+TC@9YB%$S1=%T/5>*HK5_D8UI#O5YOC+;']JQ-, MC4SAU.^:8_'%M]LQ^VS+L M6\L:V^OM=&L-_-#=0>W3_7PAWF5^!3K=M#=SHDFZ0MI9_7/XB'!`(ST=F]+3$"^-AL." M6`3&REMEK$`4KI"EG*$$`?%-M(&KD`"H,(R*=\JH*&<$[;K.$*.EXTV[P0HV MARVV&(R77Y3QPE-,5P9V=A[G6W]5!&;Y]ZHMG[.56C^K6T]+.K(D>>`@GB.< MZ29F@2,"8^6#:E:$"FO'4@?-$-&(MJ4,:<]S)A[QLQZ*^!E6H11X;*F*+*#> MVO$E[#_E>HKDD7WNB".7%MULO)[/I_/-\?:D/K]#B$6T&++GNZQB3>5GN4Q? M)$]O0#U/5E:+H3;(SVSKIEW+WW*"XHF/O()*<0>(GK$DAO8*IFSRBRKVF'R[ M;[:;#,]@\VGYAQ8X31HM84^V(L19+/WQ&:+5Z!N[R`#G% M7AA&%UA_[9@C#0TGZ&7`7=BG\DLKGA`%=RJ1KMIQDXWU,M#@+E4DI'B2%,84 M3'.UTXFE0F.$+ M=-7.76WOJE'P9N<13G2>@S@N'&;K&RVA&T/E-C!M,1Q1,-DCB]Z<\+'C@,B47T M&;7D40115SN.VDZ:AO20$Z'!Q/<>LBO("KL20$Z?T4L>6V#%M:-L^[(U.@W\ M7`+:$<>JR`9Y?C)-#U!A5,SQS'V)DE,A__CD,8BNJ4M]`F4A_6I#["S/ZQR M[9SM,3;:;CB"YJ5;0[GS@A"GJ@LI9XMIYWZK(H]G$>VHV\HZZ;%):*I6+*;/ MM(%0+\Y<0CF^U`V]P;I5W-2%9OEXL6^5'OE;U?FR_,NV-X?-6H<<-C/>[-3Z M\VF/SQ7 M/ZF*0_*=:&(C_.BY:(0>4<`=E96J0:'_+8%SB,-'C[XB8A;B:V=*)]5X$[A' MUZK8>Q_`_\YB535&S?%R-;71.E^Q0WH"M^V?.)9)87I?0/J"Y#@DX_&5*PX> MQ'QPRBKN<4(-#NQ;VB:]Z>+$1MELZ4ZT!,,45=QIP&2)%-6/E37.U3D'7G#+ M*:=R`.5,0DR74+)-7RM,O&$3I[#BSL^U_,[H2*BH=JW)3I9+GXR0Q(0PI13W M;!`3'-6THR#U/NTP2O?_9U@W^HG<+5=$\80OB!R(TMHQU4%+C%POLV0P-1=T M2N"?G9MEF-,2`@G%*ZD@G@`J:T?37B2GMT$5QV3SESN(1-=\\(JK[D(@7G;O`!%KKIV/ MZR#L/3KT5TD/>A;M937S+ MKB;RUA#M\:#]^^V@U[%&]G^-CG73;7>M?OLO=J<>T2M=PB*6NGZ^C^A!E$T_-NF;Y47G/,I4H#`*$9B%`]Z],HH] M>7EFMCU+KK[:Y09*YHRD!9/C&'N-DTF;E>^;$'?"9!+/$G]]X0"'0+&(XCS] M.`8AUM".PNUV-IBE+U3RHA3S$*.%E_`&80`YQ5.XQY$)MHN:&XB:7/^86U;Q M6?UC/:-`?_GFI]L8"?C-&PB$$YB\PHH/Z!^93`@MH)U+(XD/ID?<.BC[V0W8 MNZ3Y4P4`4<6'_H\CLXQU7@&UZPNJ^2.4`AG%-P1436:./5X!B^E$R$O[@U/) M"BJ^B+5J/GF6>06DKOW*^K+90_@5UJ'Z'E=9CEA@L%=`.^!"ZR(A(+&:SKW` M3/)ZF%SGWV4NRSZT,B#SFL[A'&?"5]`B]FZ3+.W&2UY8UM!TI@=LF%=`*?_& M23"[HBJ`1&LZ"W2(N;2X3)!W0S5,%$B:IO-%9UAR*]#*Y^R^ MS13L6/;%]-SI(N!/[#SRK:+?"0GBU]*M9>/0=+\G'D;<%][P]E*4J$#/O3%` MCLM;2C^V.1:X\0(R-CG"2^56H'9/D(O0--T*V]M^)PQ_0Q"OO)Y^2<#8WFX@ ML1VTBZ/K7C:8=3RJ<3!E-CL7."*AI)X>",HFW#;ZN9X16K[`1Y,X?>UY[E7` M''[+5*#G%CX@S>4M527;G)''NNUERX%HBC?+@M2W;.^]+^B>D`KTW+17LI?" M+25_W+C"-`Y[]"P"%E/T4DK/'7OE>-C76;N(1U5,NW@TIQGDH^/3UC-$V*-' M=W;'%1SBRE6A.*,Y1-^]4P5EIQ-T//4ER0RBP0CM#G)UD&1 MB[UEMKO[.HEH@I[>A$KMAI\',]M["+R9Y]+Q938/F5YSZM.S;3DGP'XQ:@;= M(.Z'48(1^:-Q;G0LNSWJ#NE%F/2\U_6]W>U;MFV8_8YAW]_=F:._TI-NW<_] M[DVW;?;'AMEN#^[[XV[_LS$<].B1-UO:@;?U&#IW^+Q1[/V^8LUS8SBB-WR. M_THUL;[<=X?T4)LTH#018X%]V`?6HA:_E@=CZZY\9DITC:I1WT=U>6ZT!W=W MI`FD)QJ-/\S1B#`MC]:M11067F,?WMMSH]LG`"UC;/XIL;&E9GLYL^X[`0NN MN0_NW?G*:`0B:6#=KY8Q[)E]:2!'*/9P>H8S'V!K'^`OY\;(&G='Z:%.N=A> M3O,1!VW/'8Q8?)?[^-YOV'W3&]CVSP;IMH9]:XXL:3B_.MBC"??FL``A/&:/ M`C?>[F/]<&Y\-4==\[IG$=!C:V398X.R/I9WYG>UB6/H$#X]E(1;M;?CBS%C@;&`BD>EV8`^[8[-G M?+DW>UWJR&W[?I1>3GUC6;;QYHMY(^]"ZK(W6FQT86)1@P0CJV>UQZ-!O]LV M;BVS-[XEM+0'HXZ][35&@\\C\TYJ:/"R8_XTH4JO$7A`06ZJT&`"5Z.5Q8CN M.#L;3J-J>Y!F`59?:@I@)Y,(?4\(;NL1Y<6S)A//&B2@V??7-@G[U.=97RV9 MP>RX-(V;KC69.%A9NF:\63]57@1O%R6IR<3 MQ;D9K7S<-+7EX62B^2K!E8\J)]/E@63"."_?E8]Z*_'EH66B^%[Z*Q\DFP?S ML#*!FY,-G\JPVZDG#S,3H/D)J'S8^9DH#SH3E07YZ&EZ(">AX"C08B-U45IQ M"O=V3*#JT->>^3FJRHS>JX=J;I,&:Q29X7OU5*.AN5F:K%F8:"_!+$W-S=)B MS<(D%Q+,TCIMOL=U%TR.(DCX3M#])WRD3'ZR2?E.B2O'N3#)R#XPF:XA)QWE M6I#)0/CYJ'23\G'G6)C)/PJ!RS3Y5B[-,_4EDW`PR;1T"[,P6%LUY*S(H M&ZLNF1#.12HQXK!(V?!QR415+E*)08`=2W';*A/NN(.I$[79[=$4%S43N$3# M*>G`\\=37/!,+!,.J$[BC#DC*JX*[-QY\9!*`T5R?"`[-\]GU6?">'$6_Z*.@B`D4`6Z MT'U21787OXN5`"R&GQ0_-ZX*="BQ8'Y2782A5J!/F47U$S>N_(7V8I5*+KSS MM5KM+J/?)DZ$R"?_!U!+`P04````"``=B]Q"Y"YCWUT6```;+@$`%0`<`&EH M8V@M,C`Q,S`S,S%?9&5F+GAM;%54"0`#*?_-42G_S5%U>`L``00E#@``!#D! M``#M74MWV[B2WL\Y\Q\XOHM)+VSK82=Q;F?NH24ZYAE94DC:W5GYT!1D89HB M??E([/[U`Y`2+8D$"%(`"27N13JQ`?"K^O`H%`J%W__UO'25[R`(H>]]/NJ> M=(X4X#G^#'J/GX]NS6/5'.CZD1)&MC>S7=\#GX\\_^A?__.?_Z&@_W[_K^-C MY0H"=_9)&?K.L>[-_7\J8WL)/BE?@`<"._*#?RIWMANCGWS]4_?]:>^CU>M\.K_XU'O/^(W(CN(P^T;G^6,G_2^M_KL+O;\^X3\>[!`H M2'U>^.DYA)^/%E'T].GT],>/'R<_^B=^\'C:ZW2ZIW_>C$QG`9;V,?2P&AUP MM*Z%6RFJU[VXN#A-?KLNFBOY_!"XZV_T3]=PLI;1;V=15F&S\/EI^LO-HI#2 M]`;H$'X*$TE&OF-'28,?'7=[Q_WNR7,X.UKSE"@[\%U@ M@+F"_W]KZ-E7$?W0=TX,*W!,H&*X"=M+0(P M_WP$%\[B&/<0W'OP!__!4C=Z>4+=/X3+)Q>IX[06QH'OS8`7@AGZ2^B[<(8Z MZ^S2=K&*S04`45B&E+V%9O!.[0#I;0$BZ-CN_N`+FQ,F"1[L`/,>3N:3)SQ? M(;[K44!OBI,$A5\S(]_Y:^&[,S2A#L$<.A!-X2\,0M1HK1$F!G:XN'+]'_L3 MD6N)!_XA")T`/F%^)_/+.(0>"$,T<9CQ"C?AR]X#GQWS%\PCHM0T^KPT?W#Z48-LOPZ:_+I>\E MX^(/.PB0WADZ)K$*#T0Z,M&6P+*?R[M305$>"!+14-N(7F3,3=$$7@:$7(,' M'@,M&$$RZEFP%)?FQ\S(#\,I",P%6LS8""JJP0//G1U`^\$%B>4-PB@U;LHP MT6OQXLGH\L%W[X1.,;/=K;+M(;#4,XP`;*%<` MA%_M>1E$QNH\D&HN<*+`]Z!S#6PW6AC`\8-9^#K*`O\QL)=EB"LVPVM.A5&R M2J.E`BW?>!%#A@;#`LE0E(BR0_1!9 M>`H3+/7V-T1976R2E-?D98&Q:G:WI"!KC`U.:47.EAD;*F(%,58:&ZBR>F(L MI2H*(]<39S6QX6.I*W@%91\/3`VT/Y,/061#5_!4OO,1::3N-B)V5SJY>XW( MW9-.[GXC4DU1JHA!5#J14ZJ(050ZQ5*JB+'+&3M3:44QEGFEKDZI*,XV M9T3(5%FP=5YAQF5KH1F\3#,P8Q/-("Z==RHT(8UU.,:+&Q[\S6P+\I\3;"]F M']S#<,RU(73.9D;,W@+_$[&J6-EJ"UUMF+&RMR!\_6'&7*T5D2=NU7M&M79H MV.W`6<,O*KP)A!!'M@YGPP%DYPF^!6HB<.('<#R#J/^&20#7ZD.;^LE:@5YT MBHJ>KLJ<%C8@'G?VL>.9O[1A1=#YV@T@3KYTO`3+!Q!4A+M=53Q6VW6K(4PJ MB,?E^9%:%=JZ3J-]$LSMV(UJ=\IU]6W,Z,?0@WCZ&*%_;N$&SQ'P9F"V1HX; MW"OR$_T8M]#I=+K*L;*NL?E7VYLI:75EJ[X8S!7B.#/D/00W"V]#?Q],QD-M M;&I#_#=S,M*'JH7^<:F.U/%`4\QK3;/,]@0HCN7,I.G7D49YM]7J;XU*5Q+C MF4EVQB:9::'_W6AC)-7D2IE,-4.U=%1`H$QU0CXSL<[S8I&$,:W)X'^O)Z.A M9IC_K0RU*WV@:^/!MW5D]UHTUW>VY'%Q:+D?%,Y7R3PSM\.'9+*)P^-'VWXZ M30+]@1N%ZY\DYLIQI[N*)?_'ZL?W&7*D1*"COV;$N?8#<)-OW^O7@^NB@J<2 MX$Y.YN;GHV[G%87KHZ'Y^2@*X@)AVR`'[T&CEX&_?/*] MQ*'P#$O[5W$=KM05&K-4JK9)***))FH!:ZWRLX-UN#*."WDAE.7*1]Y.IY)! M5;5?"IW$2:]SV*3<=PL$X,7+VE3=:\+;B[A$/!)W_7:YVSAGNUGMW@IYRY6[ MYT[9]AZRB`[ZL/!+T,HYHZFS6:(QVYW:<*9[`SN)-J:20:TC8#!Q9*8<.I&F MNCP5>!@1D'L#.`!^QZOC%1)ETV:FZKZLVGW19"R-^IG0$Y>9=D>*@3V2'IAI M=N!![[&,IJ+"]T6SK43D$#$35X]V*1G['EY/D290TX]KYS>5&%J5^S.9Z2E% M3B+IK%V2DB.44`_#^-6OL+N%V2AR_Z$%$AAWEKLPB3-5RYO(UVDU[5VZY[CQ M+#F.#1(E1E$`'^((3\267]RQB+M-'HW+3#(_`8FS)E]+8FJ_8*G2M17,)AYY ME2606J$%B9FK*@6)GO-VUS00O9Y`DQ:QS3(2,Y+'2=+YAU9U?@,]/TA&>CIZ MA\`)@!TFW68(PW2X8]\\:;A?4X<7K^8E9IJKB*1.6H@X&D]NQI8^_*%.D MFX&N"=,`-:]$)M?'7;EZ)\K4P`=KUK=$$.WKK3[%Q(ECZJ$`U\4NKC[6]Z4P M%+3T$VM0WF=\H=J&(AF89P6I:;(T'5WT9V?*/H8X=,4 M2_U37$>CI*G(L/5VL;T_6:D,(42=2[_3E.E('8O"2$A?D>'K[^+[<*(8FJ4; MR9PE%!HEFT4&[VP7WL>,VG>CB6G^IJ`!JYC7JJ&)@EF2X"*#>KX+]>)$N5,- M7;T<:0BSI1F::2F8O)0B@PBO_-I8Y+)/3*JQQMK+K6)=M(R9MY;?^JK#!PS6C1J:2W*++427I-X4IA"$Q1R9F;NTFFK#" M81?D[\A@YM;PE44K'%1Y%H\,8V[Q)AFXPD&3DWQD8'-K]XZ]*QQC:_71WUH,GTT-X0$:9)/@T?;@WTGP\ZO''BG0`,A(B\&K$L)1 M2:CMOHVV>6CG+,`L=L%DOD*8)B@S^_CIA$[J5GF1KW6J6!%B*4*_-3D5O)(Y@;I%?:6.=F MNH"86&A"8,8-F"&K+P#4@+3M0FV$-=<80#X-/^\IE*I=.&/0[KI0*[')/-2[ M)0!1O[P5;'OV(Y@-2GOP;KE68I#W5'.A#,3E@K.F=;397"+EO)C`G4]M[-F; M1`L04-5.K]1*J/%^'#`(1)RY.1-B^65W(#9*M!(VO)^J=]&3]-IRZ#!5R#JF MT'U7IA6@_K:604B&5;BY("K..64S)YG(4YS55Y6NW)[#7EXKN4,?`5KIM>D\ MO+)AD#RHIX8A2)S'(V@_0!=Q`L(;8&.QT_C?.`B0RE"!L>\%ZW]>VB$L]25R M_D:+LR@/26@.1X[MR^&&%-*]-J=O[HP,=O?$77%N3,[C3/>>XBA,^A.=&$J- M5ORA>Q-5)A!W_Z@XYGJ5F>NUZ&(5PEQ/I+]5''/]RLSU6W3,"F&N+](QRX>Y M#2,\D^#5,Y)9XP06&6O?G[?)J*@]:A7A2>QSMD)6$;IK9"\WN-/VNZA@C\`@ MI<;/R5J9P#^?5_CU)97,_YF+)A?@_^RWZ?\\V-RC6337BLYP[$<@'/FVAWF_ M@I[M.8CBUZ,1MD#'BJW)X65D3$>RG\H.Q#&82F&[NA@SY#)+)N1=-KH_.09#,V2#X#K&8DWF!%*&%L(3%OZ*ZA/A^H@V_8`FEOBA9 M)?43'EB?D=?+V$Z_DCF7[,KVI6[,M\JTX:84,LCS&X"#<6/2]S_)AN?6\Q]" MI*KTEMM3C#-\^4@C+DRB7@:VZ\1N&@#CN^Z5'_RP`U*F0>'?;<4QQV9*-B-[ M0[Z`U1__@-$B)V.X+:2QX_=8 M^32^(#WC6[II7D8PT[UUQEI2#V@.P"_5KQI6*]&B%3ZSD-R+145_J1Y`5`#1 M1!0TLTSFZ_0-:7I>9%W=@3`"LS$@9;)EJOM+L7+8^L*_W]1K[I3K!'BHB M]8CWPM?A/OLZW/^EV"0J@,35AS;.^RAO;.CC5_YF/--J+ZFSW7/(0P?YRH?)D$-X;:\Q-P(C`; MPN]PAJQH`ZV892ZKDNJMA)%7/&=D$8'W<:$X$@T8_G45@"S1:D42BZH?&(E$ M$>2TXVC]\,['KA7LY:HY%K<;.#`B*4+P/F033R7V5M<@$%<[4-HRZ`RG;$T^ ME$7R^10XIW)YJ$N=/MA;)8'[Y,WM\^;VX?;V.O;H8VN8XNS9*2.KBZ=0%-D, M@B2G_Z6=O.6W?$("VZGB`GP4ENP_+E]>RZR>$TTD>Q7/F^&W#,;V$E`WZV(^ MU8*CIYC8W4>1!2E5.C?/@?<@:=T^K?2RG\OITX8E*W+H'UY,>ZDZ2-J8I.;] M)(["R/;P2^/CF,([]^^TEO*G/ M2]QW&E4!J1-RCF!;CX>-24A=)@Z5B3O3GI]@D`@Y)'L@*[0@,;=5I2#1\Z$I M>L;@QY[TY%HX2'J*I2#1\_$PI_"\I?`'@(^+",S4[R"P'X'V#`('AF`:0(?H M0FOFZQ+WHB8U0+3_.5\%6H\,&J!ZQEV-%B7F?E^IB'S6O2[4MK>GT/00,:WP M0R!Q]VI:"\3N*&9_N+W$;LR#]#F$6$UB)IF@$]7/V?[;1K$Q/Q'T3BPOL<+I MF(F:KFO*,6DZO5/(I.2TZ,'H=P,N4;47(E5;<7O)5OE@U%]K4UG[1*D*(:P; M2K;*AT9(M6UDKY593YV)JS MW,OA))@"+X#E@>;?*3K+O=Y$!-IK$&@^H>A9[D$E(M"^,*!)8!5"BT8@_`[P MH1FQG^;RG[X_6455(=#:V-+O-&4Z4L=-]5>JH;U=!'R+"/LY(\+6X?&T)]MWRL@:$58HBFQ']AE(:BA.KE0+ M<5C%ZBS2M^0A5+54+FW@4E5:&GVU)UU]URMOR6/"^:)MA!21>K%?#I7W#$-0 M:O+54/?&\1($F[6*7+>;Y22^;%",E:30=N>/:>#/881-2H+B7PNTHW&:+GTB MS(9[[Q!X_A)Z#/UWH^0!].!=M,2IMMWHSNT3B#0R;3)/A=APA^,\00[I%*!* M&ZV.!`(G_CZRD'BM>T(CD-;J$FL7+1Q:G)G!S#-7YAF!-"\"$8O1!]O+E7>Q8ERIQJZ M>CG2%'UL:89F6@KV4%O?WIR\;T[>G]/)6SAH(`@O7P:N'8;)@W=8ZY-Y.IPH MON!Z3L^@\G8TL=?M/%`;^)B1;DY&SU=_$:2.3#TJ:5/QLKD2KF\-?6Q M9J8:,&]O;E3C&_ZYJ7\9ZU?Z0!U;BCH83&X3W2C3R4C?5D_V_;<,MF]'63_9 M4=8UL-UH,;`#,`D>;0_^O7K?]SOP8F#Z<>``VE4&]NJR'EE558!L_B06_-0S MBRH-M'!$59F?BMQ*?BC5(+W2'D@UTP4:/8*Z`3-D\^#+#_C_<$8]CBHNW,;1 M5(T!Y;/((>?4BBQO?%DWO?6.GTZ9HD4'_LKDO42I-%W5KQ:U^271FWCK2UB^--PV%L`-?)VRF;O.TB+6WDN+/CDP24 MTQAA>G)"@N=&"G59H&O)]UTUU"WM_JD:)8WN@[;-GUZG\QZ#H>Z&:%7:V!.5 MOWY1AEC.":?V*KM]^5.-HX4?P+^)%WRX?^>^:.IH_265>C:)$-V0^IOD+S.1 M9-TX8^+=Q3::?NM5>77\9!-7\L<="/$1I(%OOW+?<.:_\-:MB%HA6H8MGV;B MQ3Q)$[N9!3V=:)-?3M9OO:99J8GK7N6&?J:^4D]XHEG:AAO2`!$,$A6PN>UR M.2@_G"B&9NF&EC@=B1Z[IC,[4D3(Y:5D2/'8@"C42\P4<7(9*UEN,S<@CP%< M.\*C*8A>+#300MM)!D.Y1+G[V=T.[F0CU=*&RE3%KF[+4,>F.L#1,44Q+BNA M5L,(__&`1C;ZR?\#4$L#!!0````(`!V+W$)R8A&$T%T``/$X!0`5`!P`:6AC M:"TR,#$S,#,S,5]L86(N>&UL550)``,I_\U1*?_-475X"P`!!"4.```$.0$` M`.U];7/C-I;N]UMU_P-N=F]MI\J=M-LSLTEV9[=D6>Y6C=MR)'7W3J6V4K0( MV=Q0I,(7=VM^_07`%Y'$"T&*!(Y2=S_,=JQS#A\`#PX.W@[^_3^_[GST@J/8 M"X._?G/YW9MO$`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`)4DQ.%R$"#DL1E?,"NMW$B+'<2 M30EC;D$,K70$]9^MMZP<4[-A"R'T2R8&)-YXCQT_>9X28(OHR0F\?[`5K"5^ MP4&*L\5"58BKKV[2.70M5-5QZ.I:IUY/P$U>ZJB;<$:>V^:,CA*&G5$36L,9 M%3];9X0>Y@SDC6M$[@/&%WJAYJ>"%S#2P#>&SCI@209I;`XEHZDT/3 M(8<>26O/`Q?O`C*Y7F%_^^`<)H&[2)YQ)&_Z-@UC/-"#7I)"+0Z#(5H8FW0I ME1#50D0-$3W$%$=W%EZ\P3Z!@\-4O&8K%S/G,.0@CRZ#EX%!"3DPSFU4)<=N M>+;Y(V_PVL_&&EH`JFS@RF\P&I8'U&Q0)C%Z0^)H=Q8HP6YQ5 M-*U:P5QCZP`_-K]*&@@A-"!R%"$ZB"JA3`N5:C"FJAFJ6V?C^62`4DQ*18(F MIY]RH-6))B]EG3JMT)J4J0N..TTD4]+0?_&")TI1#=^BEC?F6G1@EYY%)6R= M';H(^7W>7"5S+H-Y%0E/_O8P79(2^RE=QZ"[?$YPD+-$)6V,(^V02X;(16'P MHQ5?DQU$`1TU4*X"8\2AIP[=U,>+[>J9S)_C5?KX/WB3K,,/]"PG^>AAB##C=KM'#`T-50^V`P:E&K?-]Z))PVX.GV!UW+%[L M`N\QC3\[4>0$B6*R+A$TYEF50$NG*I2RSJ]6:$W"Y+*H$(;A1*>^$\>+;0YJ M$2V]I^=$%;W+Y8T&\6VP:[&\3-@ZB701_H>5/%HK%8SOA: M@0@FMT10%;+.A39D\@6!3'BTB9V/G1CG5%--Z$1R!B=R45!,2 MH;HT2B6_OY&WNES66-.WP2W;7R8(@P0MZ)I,8.*HE*>7`-^,O6U`YOP[+]FQ M<]N!.PV#Q`N><+#QA$>/]%2,T403?,F6%GD8I-$#R<6,1RVV:US3&S=VS*[* M^@]1N,4QO1/K^'>>\\B6I>5>1D?+&)'TBU!RJ5T%!IVT<389E2NBJB8J54?B MTN516`+'H05Q@& M[("_\NZ.0,[H(H<,9FUQHREDG2QMR$0#4Q@@)@B#'Q/7]1+FSAX!RA7@\&T6\>+6"*.>;!/D_@. MOV#_4LDSI89)EFE`KW),(0Z&8>T8F_RB&EDF%93I(*:$+H'1Z_I0_O.]1X*V M:/-\8$@52_VZRE9(IU4@(?^4FO"HJ`-7Q$JU,JA;U:)N][:S$WP+Q0F^[>8$ MWYZ!$WS;RPF^A4NOJ\[TNH)"KZMN]+HZ`WI=]:+7U9@'WL5!F.!WLT?>!0$6 M]Z/UII8A$IYZA^$C5-N;$AF3?D"ZK2D4L$X`%2INE6B8;.EQ=S$>IN_G\E&A^JNQ,8&' M5(X(QY^LMZ\8#Y=;@P@`2[_PR8D\Y]''18J@69!XB8?CZP,[@.5MO2REZ&++ M?E'=>NEGRJ0C.:6P52_3QXYUB@X`OLGGKJ8TG->(K7]RDL.W1MOP!4>/89DI M4]B4+3BYE6*HN0V%/#H\1-[.B0[7.&!8R3^5L6M7(]8=3VL!6UV.U`)L9],& MFW,SD^5\//=4_CRO8N]C+?D'TVZDC_] M>H>?'%\Z%`HE3!!-`8VR2/"S=8K(,?%'PH@4TAY"#%[/RA);*-U20\;HM2D1 MO-H5J*J`=4*H4'%7DXC,Z[US0"D9^.(TPN[HB>KTI#'3!4Y5!=YA?)X1-K.,X^5);[+@B#5!816%9,DT@%?I9!*'@R! M-$`*Z9,//>B9Z:''7'&T:TH;[+W0:/J6-`D[2_8<^BZ.%-QIUS%X?4D/?N4J MDUH!!GTT4?)7G&1JH^7&VX0[_(`C=I=;SABQG,$\>'*8E>QWO!`,-BB0\9GN MJ"@BLH@)PYC2W'@OGHL#5Y4]HB%C=TM0$K'-"A:K)AU+&[BIIQWU8 M<&NB8GB2+5D@&0HF7YS(79.O*#I=0\;H86L1O-KAZJH`F$XG0L4MB5.9GK&!N4LQRH%:1\DZ7[HBY1QW MKLJN'.:KE!5M&ZO4&8HE?O(H\B"A#SH(EE_%8J;6JU4@BT5KD8QUPK0`X]Y[ MRBAQE&6OE-JCQ91P-:)G2ES\]6_X("T<)V>6&!*8=68TA`!10XQ,PHU<&#%I M1,1ML*/P8W3(%!2K_K,I+HA`%12H_@:BY06`I(,%E;'9RN5SL_2M9459&G*F MVUT(LTF`FA`H)HB022F1"9,0PF4/8-M@1YEWX]9WG@3E:OQNB@U"6`4+:C^" M:'T1(F[F468XH4(VVGJ:1A'%Z,4;Q_\[=B*Y,Y"+FF)`&]B"##(Y$+QH`1RGW%JRAKS9<+(%=CVLE`B# M()$.0FZM.2XFI@ZBFJ]_HZJHT$69\G_:(]6GT$^#Q(D.MYZ/(]&Q*HF<61)) M8-;)TQ`"1!HQ,A592@W$5"PR)'>&2[P/(YK4B;Z\G,J)(A,W/(=5@FY,986R M@-BC!"@ET;_$J-1`F0K*+5ED$V/SE(RC3V$D7P%I2)GECA!BG3(U$4!,$>&2 MK'PP453(VB/$0_KH>YM;/W2:B_$2&;-D$,"K4Z$B`(@(/"H)#3)!Q"0MCC'' M=$Y9QOM%FL2)$[C$=\G=HE+)\'BC48#&J*/0`$0D#9BRI=5*ZJV+[*1%C"K: M-M?@LHE=MNQS2_XF"F<4LJ;7XJ1PF^MQG"`()K6ADZ[+Y?/O?'F.J=AG#5T- MT.-,1=(.8SBH8KZ48@#9TL36QA6V5C,X4TZXJ4(";_8VRV);7BI_"&-/<0BA MFZK1>RT="E.[[J*A9YU[/0:)"OCZ@Q0A.UCPQ)'!Y?C0$@=%$C$ZV M*>$PG9]@T&;JQ,\T3SSY?[/?4^_%\3'-')],G2@ZD""?I=:2%%Y3UVA6Y"[% MJ65*UE$$0[LN:#D:$B5V\6]#_X&/ZC`(N<2D$WF;!+OB0DIJI%W-)`UU"U%/ MG:'6`4,^3:#\O9U"C3$/!MLFFTV8$LS'2T7W.,D=M M#+LT0`JRLS`5%)4Z%RC`+(AW?#_\PFZI;L,(N6'ZF&Q3'SF%"A'YY[>7%Y=_ MNF(^\9\O?[@@5+D@IN(]WB3>"_:!O&@[#UY(%831@=2'I.[J(B:I*`)7I5[U M=S!4$X#BKYIE(O05'$*5.-WO??)O&(QX%[[@**#35?I<#XT\CYU&4F2UBDG& MZ("O,D@E#X91&B"Y]:^4N"92,^BIU'5\M'<.XUUH?1_&[)6#GU.'OL5#YC#9 MQ?U;C&,I@SII&KM;TZTHY>T:/37KM.J.MFCK885P9,&![M M(<)[]GQ'#E+2S7@QDYY+!K+JK9HRUJG4`HS+MYF)#9?48U!^K)VO6#81K(M8 MX$4-G(`3['=H?*B"DG.!7;M/J"@,.MS@+283`XH^6X@KWI9/0-R3N=+=O5`]1@"3&0Q3N<90<'@A>=OW^]]3;TPFD?.Q3JYAU1NW@ MZ\Y(+@_(&;6"Y*.K3(6Y'US(#S+DR=)J-,=E`NY2-/.4")I+G*$">LR4(9*" MDENG%>%YA3_*0,=&2",/7BR$*9K#C7*<@32^5.)UXLNJF?:H7TL.+:=,]-5- M,J9KH:J<%.%YLIV1( M]EH.!HA%S1))#K9.(5X.$'FDX/@C)2^A_T*O1Q)#F&[0;IA6N?OO>C';YX?! MI>*L=,FL(V#IB(`8N.EM0EP7!*"4]ZG&2?2<,@SVRW]\,#QDO, MGB'B7:RDZ!IZ)BFE78PJNUJ5P!!-%ZF`2&$Q.)@B&7&I^,4N46+HIP0L0)LVP<+,E=;]<3#J4: MB",EC4)HG2?)=:RSJ"/0#B=)!AHG9#)&IPH@-L23C&\;6!QRQZ>H&=<]`4+D+) M&P_LL`FL0#S;7\Z*HQV%MRF99)9>`:KT4FN`X9@63/%A@`V_``6#;=H,L\TJ M/2999D_K#HTV;>JG`L#1AK'Z+@R>UCC:W>#'Y)ZT8+N'DFD8=T]JZ)QO$HO# MK:RX%-%%!XU2Z]7C+,L&V88L%N;EQ>7;RZS2YL__`CRQF8EF&@/-ZQ% M:RUA&MCX3!F8@0O(:#(]+]GAS#73VX'$(>-@(^>&4L.HUVJ'7O-7CCAH7:%-58"XH3A]C_'M*?11^&2*9ANP1Y,H1GAN\]0B`8",[B*6E8>X) M9"WHQQ>0E>+6F:2/D<\Q=E3Z%^26:B)$^7YO@IXCN1F:/--.'W]^3SQ," MQ_-@TYU1)QHT^"#N``6OO)Q[@C48=!VB"/PZ;6$3'8VBPNH%(G:_0_%8E!]N M;,Y3Y"K377%BID=A$R="+U3I MW]`/;]YFA5Q#&;?K[TZI$+6/[&,9NE\] MH4QB7PS;S;;=+6Q?P9>H0;H-VK(Y(M2!Q5--M*W;*-DR-VA&3HIN73R;:<_NQFP^ATNT_Q:C/O+@;`!!M]4'.3H98LP*_(!/V&>&8GBK^%P67) M7KJ:O&U*`,XZ*.BIU@##1RV8L@O.E0,,U`YQLM>#$RTB]DJ. MRQ9R'W#$'H9K7_>5:UI:16\KBF1A7:8&AY_:6%7+[\=E]RHAT1Y'V1([/&IF M#Q1.RCV!]NKA-2Q1409=0L&F.$3J23"J=WRX?1V@)&./OFL3K)"V2JXZ9"6Q M,E&XI*KATR)4MAL(E$SM1Z;MOY/;!;R26Q"/3/=X(5?(,G`;S=D=NO)-PY9L M2%)IL^^(*"'7GQ01BH*AE1J?Y+[C\0%*:$]-9KM!4\+T1?3D!-X_V&QE24\[ M2D_,M.B8))86_"J]E`I@2*:#DLLX2F0HPV(37[=A=.VX](:5[.CUR5;M,[MS M%;1S7]NDF=[Q8]8[`OS$,NUT[B1=BR-(W)N)LC7%1X<>LWB$LKG9H1"5OGDBY"SJ^49"J>8@%R+X2,QF%$ M+])GR1SSXLC.64B$C9YF40*NG6$12H*AD!(>=Z'.\9VH.*$"*U_F*G\O5DT= M3LKHJ3\QQ-KQO;H(&):(<7'T`/5F+PNBIF',7H?)<)?^3Q6B256,1[PMX+G( M5R(/AD4:(-LBX6+<@D&Q&[R/\,9CTT-2ILF.GCG)9HN2*E!JF'T-L15Z_25$ MJ3@8>K5CY',_'378F.94=&!0C`OQ=$-!RX&U5D`-:]E'!D\\,3O&TC-0/JFQ MPG`7QJV4J4I:(0T/54B;HQA0XG``Y1.P_(G?5SX1/GF'1[*NPP;/#%/Q:*<5"# MKA]R$,M:)Y,F0%&Z$"I>A,QCOG.90;HE=3_S\2:)PL#;9)LH2[P)(Y?F/*'O M(;S07;^GR-F)^DL/(P83W/0L8"6I34<+UGEW$FS)H1M:I0B7EM`S,X6BS!;U M?9DQM,^LP?!]-SCR7AR*ZYWC!71X7P3'O\F=H(:>V2F?9C'J$[\6)>L\[8J4 M>WJ12"(R__N2YW.%P3D6#-R'05B/+=7+FVU*QE>P6@O`K6%)-8"%_#I8)1-' M%N;EDC#(=IRW4$^?)6E,2:'RZ4H8Q-=X&T:X\J9$,S'!)'#K5K([KQ]P\AR2 M7UZ("$OI*`UN#"(P?\S6:-7R1W>-?!Y6!S5?<$G(D\WPT2/[6C&[HT^.Y_MG MD#P`J8;<+UUGX)25*Y`VW[.DD/E>P(F""5W4^.0/]L#B$`FQ6M<<&S(F^2*$ M5V5)30`,-T2H1,<-!UU0'($0)Z3XZ6''&K'Z)N[I;`3:T>^^!1!Q^55&YF\1 M)3-R*L;H^W>!)-D5>G4?)AC]"(3]#U%(7+/"%U8%3/*5!U8EXO%7,"Z0@]3J M_SC.Z"3;&VEQM$@%<.,D#B7H#ZI-&(6PL<7.5L#EHJ94TCIUM.!Q]TS(O)PI M(*J1NY,?H.S`%'E)BU*UG+B5BQM]A+P%=.WM<8FL=3)I`FS2J1`O?!+-Z+') MKS,SEO5Q4K7$8#")>>W$WD:S"G-9FY2LP57QD0F")6,579.)[#>89+GQ_#21 M9OB02MLD3`.RBC*Y*%C2U/%QQ^.R7V$0YS.FC^QA=_*"(^<)WZ>[1QPMMEP> MB99AL;L9HP\E]BQD[?'$CC;`D+,G<.Z1Q=P,!%`.LIW:L28$9K(2S^!;XRR1(3`Y)AJ81UYP5X3OXI M6Z(5"5IA!P=4R)!2"AY+FM`43*&BB,E"H4M[*DI[^2?;DDY:RS2YQY$7NJ1= MHT0UZ&ADFKS&3UY`YZWHVO%IAJR+;)E6N?XU:J\$_GS'6Y`-/6S9-$@RV=$$ M:F-MZS@'ZJZRO/C8703'#/GTK%"UM,*]B2[JYK9^NA?JN!FDKVM]>.H)F,_O MQRS0\^O,!#U&')5&LM/N\-;KF^?<;O`FHJGQ::%OO#CK@_2$G*P/OA?2>GCS M-E\).[525*^+];5MO=N,5"#-U\QH2LRC:5MC?Y=PR\8X/`N4QW2$^+B=2S:_ M___1EEY$<@6PE8 MS&BA`5*^&L">[XF?$=,"EZK['B<4'4M0ZV+W^O`QQNX\**_Y3S:)]Y*]"*>F M8!]#AL^X]BQHXY!K1RM@2-P;.O>@`67SEK&9S0^.N8VK&@VH<6 M6_KPPDW^ULA#A'=>VLS.TD'/Z("K6XS:Z-FF!(9UNDBY<:WAZRCQRL=D1MH+ MR9)M?,X3:(C6VIL2QG8TQ-#*38OZSU`&/SFTL9.72!KX!F]Q%&%W[7R=Q#%. M8A*2O16!E@@::VXET++5A5*@&E^%D`]W,EEV(]QATF,F^Z)KA202+A8)Q1EI ME)+&V*"&6M)!+&9])&C')MHXH9.4> M\^CY;$I%:-_^F.)I5@WGK!BB"AJY+4XQ:9WEPY:#6VU[)O]%WZ6MS=B9*3;Y M\X_&@"RZ\?50S#6.QQ.TJU"D:I?O\L*H2"E5,C4%E($QX% MY&N>-`5YBXY=W@G@JPE748`2&78!RR<-*B7HK#`&]52'Q/W,2>_2FI=(&C!%9 M43R]H5E@X`S&:#GJ)G??A_'>HW3]/75(R'B@<60:T1,P:(OQ.8SA#Q'>.Y[+ MLAUJ5U1=R2Y71050D[.J`=^+"M#R6PM,I)))$NXHGF,M%JB*9Q#R'I?-Z+K6 M38LQ$/S4*K`6;Y66`'O7#O#E!,^]ZP4*6,FQ>OP767!X8&M-XC*K*UJ\NFA+H6I/CBDHP?%J_7`+%I;2L(S6UFB_K?R M!D&/<%!FP7I@J"Y::X@H5H?"U_[0Y>G\AW.,HR[+-Z)A>BHW*W*?2+*#10`+ M^5V*KK'"KV/.>BPP7!EDX6XG(KJ\-Z\F@SKA%:>C9^:M];@*]HM=%OD6/!^%]$=`LSAXX&N`.H](0 M`%9K%%2#W0HK8#QX;^AM=QB]P@*\.XS\J+7$-(O$)L$N+8;V8-=4LQN-B`NA M#CGJ.M#>C]'$VZ3BJT+O6^3FFO2P7U3J,H\,@XMYNJ!X'4XVOZ=>1-_,9??0 M'DB1Z'-SL^(JFJ2.NA@P>NVK<\%JE\"TM:%QMC-R_A*JZV7A;A*"OI6H/W2< M//9`#0I."P;.(M25XY:&NL5]:%$(`)JZMUY`IIP#Q+=*0P"HK%%0#4HKK$"/ M;]NAM\6WV\("O/B6%':#LI[WS`APOMM,(N]*G6Q7RAB^*JV$W;HF+A<$P MKPVAX'XXD\_H]6KO'-SP2X#"X%L2N;Z$_@OEFD_S((=;M&&6QKS2E\K.6HN\?Y83OQ(Y_E3AQUWN:/+3XM'WWMB1ZED<^$N M!DP2M7O!JGS5UX9&V\[(I0XV#,BL.#OYY+.ER/"H"X.\^G.DDR=94&>_I\UZ MSV(A1XY;>\_2"X337A@LIF5FO31^IDNL+XY/N]\#2XWO!+ISE/RF<6;R)O MG^76NTYCNF1';P*OTMW.B0Z+[-D!-Y8ZW_&SMY7&T6*+"O.(V$?Y!^C?*Y]`QV^@XB,PPK)%].0$ M>>[)*9GR$'!ND;GW@30)/9.?U6(>H#I^F>D_INDM_3!.([S&7Y-K`O,WB>L9 M_C,FP[NQ*JDZJ@S]#>O]<.2"<5'D8CU#E^@UNIFMILOYPWJ^N$>+6W3]<36_ MGZU6:')_@U8?/WR8+/]._[Z:O[N?W\ZGD_LUFDRGBX_WZ_G]._2PN)M/Y[/5 M6,OZ^8&1ZD$3U=BDEC>W=*\!^[A8KQ"VSDI=A(+MO^RD#W7R,U@G?:1'F/3] M=.Q>NL1.MK6^=G2>`%OK#M\0?/BP7#[/E^N_,`F;!)-JH!UY]L$$F"89@2'A_P/B;H*`WN3:=Z8=I\G53:'I&4 M'DPB"I1*6G[IBL5IUR=[(4F4-0UWNS!@V^Q%,G95D*44-Q9C:8`N0RR%K'5: M:`+DEI>8!F(JZ/-`N?&'-?"J8A7JF!J`H,S\,>3:^]P4VWC.@?KYT8N^7=P19OU-V,T0>K>Q:R M]HAU1QO6F7HB<*%W^POQ;EF41GS<['X]_S1##W>3^Y&\W!(G7L1V1=H\G$S2 MF'=30RT]FUC,.E?:L37I,*9$]$3AV5)VER=0MZD+VN%7756 M4F'K=-)%*'0W/QQGD*_N%JO5M^AAMD2K]Y/E;"2W\\F)/'K+KGR^D4Q22)2H M<#UM&L;[1"]C1)_TH3%?9 MI)_J5J"JT]+3M,[$7G"%[NQ'XLX^39;SR?7=C/BU]6PY6ZT1G3NN_PZ#G7DB M^@H\H#-H2K;2KF;T5J5>(^EU(M0X8%FH"Y>>H3`TQ/515!+K3W#9MYWDW6LQOT,*$'VM;+R?UJ,J4G?KI/B6;!-S[/16POO%ZN'^7IRAW[^.+F;T].ZJ]5'XM^F,W0[FZW0 MJV]^GMQ^\^U(Y)OY>)-$8>!MWF/'3YZ7>!-&;GS06'>MLZPA4=$@YUV07P6JZ,#R@HG#Z M\^>N1HSF6NE5P%H"ATX6K'/V)-AB3WF5GS.>K^DN;G8W=KI@-V!G]T-\'R2QSMXD9'[!;0M3%:(@N&.IE]F@UP)V*41#/C)YPYV\0S M(R>@^2,FHC&:D`989IIK)_;BQ;91*8?L?UOWR365C>Z3=RI0;9]<2],ZX7O! M;7+Y>K*:KVB"EH?E;$7<_(1N[\!@Y)WW>^JY7G+0GTBI54RR3P=\E7,J>3!, MTP#9Y-?=_.>/\QLPYRT$9THRKW_0/X12*E@^]=,`WG+2)Y<&PZ56B-RH*TXT M!8-7#Y$71ED:UB7>^$X-V3I")6Z05$IW,V9S`_4K9#T_4#<; M8/C:$SAW+F@VO9NL5BP5&J/R[6()<.R=AFS#*6+E6WKQ;]EC/?1?TN4RA8;9 M!&PN@F3!^3;>KG\^8X[SC$PW[`R7/HAG[X=%#. M#0:T;S:,&[A:ZO'=0,:M=XZQ2L3UH>7BTWQ5A((WBX_7Z]N/=T627"!=2?+N MA-;BH*8N@`=$VI<&M13!4+<+6BZ"G*S>9QO5]!\TD>FGR=V(^T!W.$EP)'F; M52AA+`000RO'^OK/UAM?CHE;FYNMU[,EC0:GR]G-'$B2VJ.?C=>1X^+B/GWA M8?7\L'+@'O839B^T#%\Y]1LOP]FWWA-&+)1@66=&'.3UW2P[W3.YNUM\SHZ3 MPQW4Z6/V`;%]6*7[O5_L?\HZC53:;+XW)>1ZJC>A*!A6JO%Q^1[NZ2&,Q7(^ M8[MUJX\/#W=@#HY)\Z?K!8CZZB`RX6N$B;JZ8,C8$;!@#@,VZ?U\MW>\B)9E M$=UX\3Z,'7^QO0N#ISOZTO,DCK'N3*:?*:/^\83"UIQG#SM@R'P">"Y$7MR_ M>WTW_S2[H3?$9E!&;IH#7H^R0DG3F?:KU4<6^DT7 M*RB$N24=@KTW^`$[]-C&T;7KT:B#ODER=2Y6E7+:RF"(V!5QDYZWD_D2?9K< M?9RA#[/)ZF.656ZL%9WB50&-31^IJ+$UGA:PY6*/1,XZ133`-=D`*]E],U^9 MGE]JU;*904[#![6H6*=5-YS\I+692JYX;6'$C')L.LU];/_PR#[9A ME&W+B/I-JXJY1.5ZX(_9RM7RUOG3`21WN8DN<;`!:G*7;4+O5" M4]?H[;DNQ:G=I--1!$.[+F@YYS9[QQ(Z+VNE-*&AOZU%#+$4\L9IT4[=BXJ^&SS]67D%?KR?W-9'D#\Y[EFNV>C7?+ MLFG_3.Y8BJMEH!N6=>,P&#Y"B4:Z79E]"\CXOGG&;NKCQ38_7KEB+1)G29ZF M9#ZUJ+S:SI"W#OLGF30:#0Q0^%J0<((]HYWH!4>/88SO5"'$Z64YKR.YQP(7 MQRKNPP3'=Z$34#=RZP5.L"']^'@D0[\C]+!HIQ_T+KJX&W0V![<7]"W*'^(X MCFAU_[.7/'\,PL<81R]98OY]R@XL$;YYOI==",*;-(I(_;"+X'>>\^C1Y)@L M^>\61_$]3EHR^1CYLNU]H9&JLFU':>#/6@\#S9=5,@O^@8P8F?G9\C`K"XK$;@/ M@ZA6=*J?A;)X\QQXOZ?YG%"[(XS[;2L=QT1U"CO:F!^&US$-E+:U(Z/7:$OP MH!<*".V.`V>,Z"K'$XHKBQII92!%'AM)Q[JKFQ_^K)[[;%_PT]$R=TM7NPC' M*[JM*M9)W`TGMQ*0*[*5LU(5U,*8]-AQ[R/CT`Z+]SLF#L^/:D.5LM"ILG"T M38Y'#<\EDC*XX2"#6-DV:(I8IX$:%[^$_PC+SQQ7F,HRZ*\KBE3L+!S*P8M7 M!GEYZT3J`++)J@6)@.B>*@V4J!(T:GUPDC1B<65VV6"-HUT/NNF:L4/!;H44 MTU+/!D"J=@+.[?>3:B:3"AJ"N=0_[DIC([Z,$0:KA$`J#@:WCXT:2D9?Q=`J M0.U-#*6&=5)U@BEZ#R,,$%-$A2;0@9:!?`Y]%TQQ8ZRHS&X^WK]"J)%?W"\I\?CKYV8/L%YH%.=R10%*GC&Z M]IW-;Z\)!((R9LN6S#S:A2[V1PI;RM/<.J<.%<+&PI16P&5X(I6TSC8M>-Q! M>B:/F`+0*(0,&?LPH"OLBVU9O-G7/0YB?(T#O/6Z3L]Z6+3C9WL77>Q4.YNS MSNGARL"=WL\MHG!+/"7K!(GS%>VC\,6+B7^$U@MFVRW>T-=#RT(OG037SV5T M[`9]3-KI!_T++^X(W>T![`F]"Z'J"G'B)"G-:(2VF$3ZCE_M'!&Q#ZU?W.`M MCB+LDN*+MH<[KQ-WLF9K";E'D66KRQU,`>P#??"KZ._F]AC='6:1;7KY1YMC M77D^CG#/!!WIU!_I$8;P*?#^@=VRB^=#G/#Z5V<3YJY$]RO<\8IT-WWK1#T! MM(J==#JW8;;HY"ZM6*MZZ$?N=>B`(1L M>B@Y=K%UN,K+].17H-/`V6[OAP>,L\62+P&.XF=O3P'/5HN'XVM6'=:C^YBT M%`#W+KPD`.YLSSK-!RP$UPO6B^G?JJ_=WTU.3DRA7!F["^,R#8ON`IE*Q_`Z M63O\QG*97,$ZK;J@E"R>43U$%!'3A.H^&]E_Z*G8#8F6;SP_36@`W6WIH)LU M2TZS3Y$E_K*+*>N<'@:_*A(M[!UI/Y*__.1$7G8-*<&D>I(9B5.20[O/U-,S MYC>[%*/TG3I*UKG6%6F3584J*G11I@S4C0I+ZG4).C4LV'&7VD43N\A6=;A' M&W2AZW)WQ,-@'GNCDBYS34.6+0,'>KE=.B@;/1S6J4"U0V):FC#\8U>XHE,S MN3Z["5*S`-13WJ8)F7M]\`)OE^Z6+'%@?N8AO@VCQ1[3IS"#ISOLQ)V7Z4^R M;<>[#E`=8K][@F'KG6.,TJC"UEUF%X6%'>130VB??P)T'V)EKE3&U-E[I'I. M[T"=#`/H/3TJ0J/K=+`*O=]T+XI.IZEW%90&+IG[;3+3;`^""8RU[9!ED*'[ M)G$:T7_5$I(I,Y-KJQH+?#H6I@Q[-/6L\[,'6#[#Z^KCDJ;[@>:3M;-\M?;9 M#I:`)WM3NUEM,]9Y>SIVE2/-;:'RQ^%/-6JR0PQ3`=6^<9I%,-UDD&(T>XRL4UR@HV%V)J?H M3A7;Z!=J'3'SRMYC@2U5/S+YZG7B15/WU[?0%M,Z(^_2[#6WB7ZA=D"V;NT31DD-L3!7H_EJ:]\38819GJ6-."TY(9)]297(Z7$KMI_TQ28HNK M9:"4V'7CUL>RL4HT4DKL&YPXGA^C2QBQ(?_\\CU.IMD5^9:$I7JJ)N.\+H6I MNG@=/>L\[P&6NV&8JQ*?7NB>G+!3ELXL&T5XL*+>JQ`VE[RL#?`Q9YE,TCI% MM.!QN:'R\=[AR6$I1%,]`'\L3DYY87_N8L!4"/=CUFX!?G(2[*I"N'[PN M6$';,$)N;J=L9EMMJ_!>75TSO.!;"ZV&5[Y``1XM/5N*;TF3O`M)>0+V>*ES MP)$PJ))(F@N"E5"/X:Q0#(8W5F+C0DPR2:;%1T^E.-VNP5$\UC"]PDF2O0IX MI*SX:I)8T-RM#Q70XU4/D10,(JB@<;/Q4K;B$T:;@'OQ/@K9\VEA0(8F=ACT M?1BS;<%B#U)(;3U%<]ZB2T&.SD-'"P:%ND#E7,OJO:41_^CZZ*$G.CL1Q]8Z M\O!&?"VTS<98AZ3!T&1'AWWD%D[_:&J\D7\=-D8B=8Y6M8+).*`=>#4Y.W`'<<8H ME;SK7:#),3-.Y4-%EW11&*@Z)/L(,J8D2:[^9?+ES#91Z\NB>!;T?Q!*6YL^JL!NIR7*62M MDT<38"M;+NI<>0O#H?5X6%GK\D%':\!?V6Z_A-#)E'5.#X-?=1FAL'>!F,4+ MQ&RR8*VT6CUQK3&+&C-2RR`Y_CR(DRAEF=-EH9E8%&`LU@*4"[X*>714`!5[ M=7E`EWMBNIZW=NKXF]3/SAZ'OG\;1C1/?EM0.]YWH3['?%(U]GVZN=='P;A4 M4R4=_259](I-V-#5MR-%M=>.3P^`39)C,'4IBKW$`BC9B05B:_;N[FM_$J/5X>-_9I&!W+>'FYK#UEJN:*GR>A]Q=N)/!RFU06 MYU;-.77A&H58SJ93YU118&1SXXFVE8)(W[<"K#))+@^%2 M*\0FJTHA&$R:AFP7?D.7C.ME=22BAOE50OH&JDDLG`8I0;(I>'(CL37LF(/E!%[ MY"F@BE=M2B`F?U*.J37`,$T+IFS.Q^(L7&AJ`X-QD\TFW='S,=B]P?L( M;[+]5?)O']-_D*).=C0=099D4EH-DFH;SKSA)'.#5DHCV]$@ML'TC($+Q,U3 M:`)&Y_@-Y%8^8N6:-'Y,6EX^XD7@G&QM`\CGQ'Q,BHR6,%S6ZIFPB6YN78=1 M%'YAZR'J%5*EAM%3\^W0:R?CY>)@NG\[1BZHSY*E*9-:C+FX0W.Z+K;3"+N> M*BV=2`Y.-]9"V:SY)7X)_1?VI!*]UQENT8;IC9=VBNTA"SU0^9O)Y%$U.-7\ M4.P'ZWU*A(;SQ_G/([492X,A@I7_8*RU:D#*IF)_A=('.43"G"(P!LV[,'BB M7IH.YRVCI5C4Z/J[`FS-10ODK'=B#7!-GMR3*M$8%$_*]+2A=R=4A[DX$8,Y MGH3@*@F>:K];;V$%*,X#C'QTJA@-A*>A*C\:'V3Y,TOE+Z#<=Q-5G^%V1$^X M2)YQ5/4D1U3^4ERRJ9/G@ M)&G$+@8NY6+[$'G!QMO3^[KW^&NR_H+]%_PA#))GZ4F#TVS:"HMZ%U\6 M/W4V:'T8'K(43?83`O[I##G_=^Q$ZR_A$!55F@++\$9A>Q,[MW.>?*Z#%]#X MS^=*8_)U68:4OL9@4[E:X-/(3"V=,9TK\`6$_LN9$OJ6U.I05939`DWG:G%/ M8C,U=+YDKJ`7T#U=[\5S<>`NG40G;;!:W5:: M4IU"R3*0JG3!\+(C8.[89BZ*W%P6'3SLNW#9N?3BWV[),#$/R(07QTE'=HK5 M;;-35:@V=HIT0;-3`9C;MB2BK[=$%GFY,(J(-%QV%MWI4T@3#]%[ASV]9].` M;8:J"Z;K0>O:H%FJA"SUHB^E-'R.TFBF1X5D:E#X6"V$+@NISEEPKP)4RCAV M1?^5%Z`#B3EC9;*Q,<]-TM1J:U)!LKR/-0%X.Q)B>-PIA!^&N[V.(C9"@=P7OT]TC]U[D MB-\Q>P1OI&JJ']P;^"-@'-58)>/2X%(C62XZ;%N4EIQK$'''EA,\VIGHKIM.%MX)NIPV7RUMG7`21_YK&4/G,_34_*TZ0H M15[AF&V@KY^=(.];[[+T4X&0H>8_?Q9>O6>E#N+L.W[;>B^T5.!FC\[RJXWL M]BL#S(1`=;&[\%T2;GM1=KN%G\]W5S<^''0H%#HC)7'68[Z'G\YA7<"=0"\DQ9*@W><+G3>R0!+>1?@+X/S#MPD\S/V MGIX3[$[(Q-QYPK.O.-IX,7Z(O(ULJ=38U\\B=.E7I2--4U6?MMX_[927>UP@ M5WGM9#JDBV=*:$^U1AY85(![S'%[F3,^\)Q0:&X@ZF'+.O$'*D!')M.77L]M MTAVW=/WZS&2,L6M(!*#&K^&KMM,8-MSGK7=G>V7N[`%,3-+K075E<%9X086. MZ=&I%7YS")(J6"=F%Y2"/ M"S<RTR)&YL?:B%'*6*%&'*6%#)@21"#5DK1P8=6BI`^NR]*NK:8DBV@N^ M>FH0:=1QF9.U\Q7%^N5>2#:15VABOVB&77)*+PN!/*SYNKY,I(*8Q5!:V-F8\1.&+%Q,B M7N,`;STU,7AA\[R0`>9IT90$Q@H)/`DI$NGD!DH.7*6 MR:$L&SVJ&L0X+]DT#!(O2,D<;[''F=MK2^)WBD&C"99/+G@M!7-O:]`.UYY< MDCYY!(WS_1:[!+[/E4]=*7(M"\QM*X*`GC(5Z_ZU&T[NB;Q,'!3!5@F-/`/W MCGRI*\W:="V03:\X`LJI%:$13PLM=P8Z`7/+3>V\>WE\2*-R]Y$7&L'4,(6) M*5&N"H-A-WB+"1QWN(#Q)(LFN3E`T:O$/<$<&%:?7@8^GUEF$4BX6,#)0XQN MCE57V0:)]0HDXJM:$]ITIA-JT(%E49):C-*/D'HF;-"R2^%$Y-31ATK1#M@! MAZ`M0T*_@0340-]C,#^7`5L9AQ:ZEFZM=V@-6>G`W61O`]IM2=G87M1EM\VH M2Q"[41QHQ7;4)9A(6Q.@SH84E/3`96F6F+:BYV>/1$GZPJ18#:1C7$H@'8[Z M\FP]`W_#Y.@S2O4(O>,0'[#>0<8L5;-7??QN]1W:9HHH+C215WIE*`]42BI# M'&%B6<[MSE8`=).V(FIT!)D)Z%1OP2V<,[`G+RD1_1J++U"`$_KP5$'V/,2` M3>_I,SU8/P^*0)4(9$_)TI1-V=E[WP^_.('T]L<0A@%T@AX5H=$O.EB%WE6Z M%X7;U686Z&/7+X4*<@J=D>\(BD+$XV_&;^]Q\73Q@W46B-!P5V3RGT=JLT]. MY-',2$7^S%F0>,E!A%,F::P]U5#+UA6+P6AK);9FRQ?"QW2EF(F/]094Q=>X M_Y/&";L!)BJ%3-+O,/`%TD[),UMB"W]MN"WYO02SX<:`5"WYOH2_X M-0%J+?B]A>'`N"C[713&NL="9$HV-H34!1#M!XDUK).L$TSU:,G4T"OBPAYI M*FT/QU".MG.%(_\H_I:O!BYQC*,7'$\"=[+91*GCQ^7$[S:,;L+T,=FF/OF- M/BXI&UW'^)!5>@]64^UN$+Y]3/NA>+ZV.T>]+7(9P-$P/: MJ?(3E<'3'1FQITX4'8A+H+ECM$HN<@'5^A+W^RWMIB/.)]N$$VCR4-F'NT>1"G MD6#S2R)CK#%E\,HF;0K`:%@)*MEPXA5R(S7R'7YRA#CS'XPU9PU(V8;LKS`: MK@JEV5KLMY%:Z"&B#CLYD+"$9EC?TR5F$3ZQG+'V4\$LFU,D!*-U%UHKA+E**OQ8RZV=EK_@["XJK^H M:MWM:,%K,H;]AEQ^*14HB[2/4($[(]7S$-0YG7+J?XSIT_"'ET8B()GPZI:> MB5JE6`6LDE-$#BZ)CN!$BP\CN"[M[>BK;MO15R"VHSG0BNWH*S`[A9H`M;:C MKT8B"!M+/P81WH1/@?>/RNVV8OEWDESC)R\(Z$WT[=^QTPRD^YLQ1J@3"ED2 MK8<-&`3L#UP<=Z454Y6#[^4Q=^0DB(3TY+]SF_0L//T#?;=W)!9G)XICE@M^ M$9"B/82QQU(F++'OT`>&PSP3B(S`72T8XVZ_HI6T[:8.@[&],(L/FF:!G3^0LG%/[61OG%L<\F>!>]I@7S$`:ICG"M9I@"^U M89"R#^33!G4N'@!3^0PJSI301YQN0V!3BI#;K!Y3=# MB2(J-1%5U4FH/.+D_DQ?HC=+B#U[H6B5.%&B6E0?KYC7 M%XB,).1_LU?K82QTG5HE]3>B5(O]HWP)U!-F_:MJR+XH^(SUH7;\LO%C,I'$ M+K#.QL8E]C!-]?W$#"+[,2]G\;A:\TVA4PP9[2J]"UKK"9VMP"%Z7^C\R0'HO'=J&ADG*) M.S,]NF@694_VZ/5?P$RS-(VXLC"-(--]LY.(J\Z3B+=_K-$@'^3H'+U.KH&K M7O"=<_+VTFH:L@]R'_GC]4!9$26Q%TO2X20C]4!9LAW%:\NJXP=Z>N:2]'0H MQC&!CX:2]1BC*U+IV]@H5T:%-F+JYQ\G#/Y&^S"?_L,O36H5OE.L47^V'2HS MAWO.OA<[A_L\G-T4FX67KNCILQ%0!-Q6044==.+GT*W4$02HV'F4"A[4`71" M8#V^L5ILQ2KH6?;^4]>9QG`&XV("Y1M,5+_1%=8_AN_\SK MC[V:JU5T_7G7U1]SK*LLJED8U;2_?D[C5\A=$_IJ)EVW3!U_C:,=.X_=8<59TXZM%>A.Q92M2&L9L1Z'G8J\ M?<4Z*JRAS=$<2H@]](H=OS_Y3;`!QZS']L[^V'F0E]7G6Y7;,8W$^%AFIZJY M<TF7T@/&'<1G]R]XQ M,A[+:B++I$7Q-Z&9BP19S"4B9I+9*@&>\QG*):S3D8-<%QV MPT*:/J*3B;,'L?X@:R65\5-)0`/?.Z?UD-9J&VGM$UA_,E7"3E$?W'XZS/!7 MKR$#,1WWP3,-W205-U*$UO@:T/7),DP3UN&2$-$W(Y\BEL+D/7;\Y'E#&@R]#WTZCL87-"G!=R/W MNALY( MO.AM1)VTDP'#_5@5*/?#+=LF04Z^2T*Z^RX,4`SHPI:PI#>>GY*_<<4]/F#: MI=YTK)D,54\LM&_@QDW*V"XY+?D)WM+(.QA()I],*D^)"3)ZZ^2A]W0G>ZI`4M*:A,F^)X!6Y4OE9VCDX*%U?NMHQ'J55VD.&KMTMWLZSZ,TTBVZZVE:;+[=2A*E4,: M:F#HI8^5GV(^)NB5$Z.GS$08`3GQQQS+'8GS/)^%=BH/51,S[MD%(#GW7I$! MZ>-Y?)`Y()@PL?>ISZ+LXBNGDH=X"$^\\J$NU<6Q+MKFW@KJ M7*3C.T':JM:9UP\OMT1R-("(!50SH?-L@L'@;D]/M1!P=]D+-"E-*_#!"VC` MFI^>BK.CZB[=.+GUXHWC"QYO&<">T7#QU&+7XLJ^QL`%H"<6I-D/".?^=#XT MOTG)J+_^$HJ>RCK!#C1:"XO9E+"ZMG"V)FR403]X:S(NW[&$7:VB?3%@1YV`%*7+V8/ MYAZ-G!MQ.>3<.EHI<%;L/:U60#+U!'Z>:4B@6MJUMFQ[>=JZ[27(A5NN4!U6 M;B_/;>FV";C7VBVZA.$/I\[>(]UAH+7;WM;,'I\\J]3$'SIZ<5`^Z: M;7NY=%9L.UN!1>;6U=J.)LZ/O.>U4JM;GK9UVAYV(!)7N4;;VSZJL;H%:UF2[FX'(7-5Z;%<;Y\K*M>C.UHXBQ9>W;KL5JE.J5&`-*T-SFMKY#U02L^6;O+Q)%/3:!] MKC72JNP=CN/)+DR#9(GWI"XP6Y`K#F@W,CP4?UXZ"5YL+]]\UTPX/XQ)8ZNW M`Q6^7-$]T9YU#@]8B":UJ57D,+,HJMBE*?ZRR^VOOC13&)4_T01E*-PB:O__ MCI5U^1XG#QDLEK%PL25_R'LNZ\Q%]Q75F;ZN,6YW+4Y)8EU%&&SMB%:4&B\G M8Y9BDM(L('\T[H2G:1213SR$$;W6*.N832FCKE(,L>;]ZB(P*"+%)?11FTP2 M[3/1L9P-J>[6!A<(F7,?,H!'/]&4@-':,EA[\%N>_- M%:K#OO?;<]OW;@+NM^_]=JSW)#:;*,7N/(C3R"'M2@;,G9?N8B_8^*E+?V"W MGG,?*;^,?JHQO$V])7`%QR,EC*^R`Q5S225N_%[)Z*E>,&J M4;V;OC''V:=8I:_LHFR==WT1RU*$L6&]-%(.Z:69D7@XPDO]"5`I4$NG>M*P_ES))D^N:=\`;'F\C;"_:QAC5]%EU-4!F#]*Z*W?/O4'QAA..4>Q0[\R["_N<3CNFV MSY*>Y-&!-H#>Y%Y MB1,O8ARECKK+UH>NIK$%Z&Y%*1>A]=2L^YKN6)OL.BHC-B@/OK`]9W@+A:L4_,#X&@=XZR7%^45)!;4IF62I7@%JK]@H-:`-VUIH9>=F-M6% M49HU_3%7'VF4SIX+I(^#EP\,=ABINV@;&ZV[%ZDC9U-R"+9V=?L6-@M:<+I\4'7N'PGMEH^42WT,F/X@?A>A6P\(-_)!@R" M]@`([I\FGQ-K!/.5T^@SH2@\7OE71QH5TM&.-M MOZ*5E.VF#H.MO3!K/LIZ@#HK$A=ZC:,=Z9_5TPZ2<*>#OLDHLW.Q6M\:%BE; MYVU?Q!QKY[,+Y%3D()/SY]3QO83UH45$_H/^D?W7/-B&T024;W+VB5T-VM@.%S;^CF?T MR'Q`'RC\N`^#*9E0AK[GBL*)CKH&=ZJZ%:>R5Z6G:)UL?=#R*_U4'>%,'^'2 M`$J)!;2IFAB-=^PAS`\KTD%B)F$Q_#1WS`7+UWPXVQQB7?2NF* MBC2,.+48^E?P![B!/QHKBH/09#(4$>3>AF5KXMM<+`>L194@N?8JSX![A7B6 M:%(9N%B$&:.#S9:8.Z;/^Y)9+`>=`_(J`Q/. MK5IA@CR14_/&GXX\L+;5`MLM,U7[%<&QFNJ&A;($QD&\CLJU59L"K,;21"O= M?2Y3H^)L]]DM[5EI+"_>1V&>1H^$.NPTQ_LP9IF0I8E&M;2`-5L'R,VVNUF] MM](V*:8'<]Z%+S@*V`EPYR"(^L1BP&I?A9&K;C(8L5-$3Z4X3>-J:5I,\\^' M#>"Q='E,*0VN35JABIHF"4$V#.O%HM4DB1SHQFB`;&T&Q[?8$..D@0+5/-IX MQT@'-5:[E5.)#]BANWJT!FBI/@;A(\W%E\4V^Y0^E$AMD1E!EN,/T\4I$FI> M.[$7E]./=XX7L"U%C1F9N4_#XI'Q>8GIZP/C1"31W:>!^]7$YN9\J]^3':J=W.,`1&;>B<(OCF`;9?LE3R7IE MNPJLUM'&VVR87!%5-5&IBG[)E*W,UHLI4';XXS")<^+=8AR3&*29Q$Y7!U;# MZ0-NMAS3)(WU>Z:)G$(5;8DN#;JH,M"&X\==':6S:SK96'>>;?>SLY4/:KJ* MY].&`M3"=J13G%P?E080M8`2HH\>J0%H;4G"-NR]=/:A1[7S:4<.L[05)=TQ M*@W8:,7LOB5=HYKY>)-$8>!MWF/'3YYI(!ZY-,2F"[8OF(SA3Y&SXQJTLP58 M;=L7ON3B*EN_PZ4E],Q,T4:FMNCD(C.&]IDU2VT>T3>B;G#^_S47E#3UP+5O M!]"P%YSF@8MW`?$A*^QO">Y)X+*3.))IAEH<6C-I8.7[G$K)3@LE^(F^_>=F M/F3#-EM\>MZ-.A)V".Z9_#CJ+!Z0=.D M?(?BBN5_J6PZ_F2#'G][F"Y)[?HIK2::0,T)9&L$ M7)R0$KJTE&_?7+Z1M(=,$%9KM*#DGP^D3T66\O2\TQNKJS(?G,!YPNZ4=&1) M.W`2L!I`!H_/M]N0LU+;V/4VCN?*JKKV,[!Z%F'C*KDF9*^&:1MKU'13#&*- M2S"*:YZ,QKMH:XLL]^(-]@DH'*:R,]H"&6!U+07(53@O M::/6%V3J\YC&+6?CA5*P:EX%DIB^GTN(?_P)5BUSN+@T\D3`:A#^X+!W*2>;#;WLKEK,ETH" MJ_(6F%P+9/+(R14LK]'G<%;9,Z'+[)70.#N#)=\RT]("V4Y:D+DVFZSGL_LU M6LV6G^;3&5K./LWN/\Y6=AHL.U:=$0V[1_K0?8;J6I>@U715H35=1]Q\G\L, MY'T-NY5.E^VJ5%?RK+1JD='429S[,,$_R)^5E4D":[,6F(+7BXM\K$0#O:(Z MZ(=OK0S\2^S3M:L\#I2$`"(A6$V@0"C(P<")VJGYL3.Z`&NA3JC'RNPR7FN^ MA/Z+%SS=A4XP>8HP.YHK[4]R86BMUHJ4;RFYBHV666&Z-5W<8-XF=&J6'QR1 M-$^K!JPVTH7+)5[&_I9NPJ/'XLHVU:U<,["WU$BAL4(4VYQ%KGUYBZGDP;67 M!EAA:WF96G$:IGA"P&I+)8F/\_M?-,849./A1*"UAP0?WP2%8''VTTK\?(1Q MG("K:KTB!;7B>8B*NC_.9^Q4OZ6T_[":KGR]^MU#)[DK`X54M4_T*?RI*% M6PIA8'7?CI1S2`H5:RTS2.9#>"VC1GIV&1`['DL]IW.GO0Z6KB"=&:5/9M`E MB2F90'E)VQ*-4AI6T^A`;;:,4L=FZ]SAP)4>Q!<)P6P+`4)9$U1%K=1\F#C^ MI:S&*S\"JVD>&5?#%1%K-:NJ6+#UVEZM]FJUF;50E5E3(0NKUMN!-EOADZP.WDA$\8G7+P2_Q!Y&_GI M.1TE8`VBCYAKG5SU-/1K#@T[R8M2NKX-";X.W84^>'Z M&`'=JEU*T-[*46&-[@@7YA!]H`:].E"+5G*@?PZCW\@4:%IY`EH2%D@E@;5A M"TRNH3)Y5%6P=32S?,V;OB:O?)R\*O#K6^L/1ZAQ<0G0F=0%RN4L)?+%Y./N MVOF:H;G'"9]21B@%H+HUP/$KY0)I2_2N/">AX#@O!:#F-8YJP,Z=)2)\[@M0>6;9#$B0\9-F< MJW#7X3TQ26.'T"?&GHK.%]&3$WC_8-&,\,C]0Q2^>#1;WS:,KAWW!C^*7Z4^T20@SS%4 M2;CD3]F!)VH852U?H.*.26X!>CD-9]G M27M%Q4TO:93(Z:U5,C:']1+DI!"VA%(#4J/H`17?XZWJE0V5J]IJJR.YV%D] M]M)/2O#EC`J#^!J3<1)G2$ M$0GB`Y@G>D3_"BM3O<7*LO+Z3O,Y&`!&P/W;N;").ZF,.\$E:?N8RCE/L M"J?NE=]_O0+38$)8XA/3I#\R,2O)W@@#%D&Q7\JMZ-9_!M`?5*BXE<2:&)1E M<_YH@U`*2EVKP>DLFYM^+K0R9M?2W,X#.@8&"1F5Q7,ZI0*`]NB&4Q`^,> MJM#[EK[G4E$%TTXL^);+N<$T5I'_1_"\B[82Z":38=5LM4(=/5AY(41>KMEN[X<' MC)?8IZD3*INF>FTHUP?=G!JP-5NVL(1R4ZABZX_X`H']F5$ON(!34BB=3I1B MM[(8U-6_BM5!=\UVU-H1Z7%QRK+?);.7J1,_LPU(EUYO^QC3$I:+]Y--XKU( MO:Z^-J"&[0%:M,)$;:#""+W5]XK:(FZ2QPGD;=):![R^%FO MO]9U`+6E-E3-GGG49NUKJ=&*M'CK<++Y/?4B>OR`4"HYT,N]=)F=+GSO=Y)C M/9)0#QY%+=Q% M'U`;]X+-I3"A+9QU6O*/BAT233%+2!!%V]I#WSQC-_7Q8IL?K5RQ^HS%QSKK M#\P+]]Q/L`>(!X,4@]O3SXU2QUZ<8,[M7B#9&5CT"[..J'G$[-NZ2W>LDV+M MF^:TCNER6TSZ3.F\CEM/FDSI;`XD4?J70L63PBH-[A+*$V:9>9?C:'$T#I$M M_(436I3B\,4B6M+[O;$F5SH:`\F4OF50\41X18N:O4"%811&*#,-D26?G,BC MH(I)RRQ(6/RCR8M6=9!,T$>M:OO"2CGA0X4=^PW-MG:FSP0Z*>2MXT6?'#\E M)6_F0LDNB-%X>N9$]&Y_S%\B[F<&RO[6B>B;!,B\/T:;9R=ZPO0ED&RS,@G1 MGN8VL;19R?(&<2W'_@J@!PK`"!,?H5]N\-9)_03=444KG>;&B]G0+[A,7_P" MI49Y0-SIOT+"UG0VNRU>;D'F-S7RI.RB4_NBY"RG6P/08@,6@IOX9B8K^[3% M[3'T*K?[[87D:L(OA75;H4AQ0/46DQC*\27U(J*#GB:@IN\(6':4%^7ZRO:V MW)JKA(R*9")V%VYZM:F./L"6[01;VK[,"IMK,CN0V[D\5LZ.OZI:M"X)L.TD M`*6M1)NC2`3$5&Q>Q[EV8NQ6,T!-:(C[Q,YB71^.(OE6UN2+$[F+/1L"\N1M M=,)RGS839XWV$4`$&*]LPMM%KQ^IG7JZKLK'Z-9$52[_(&)?)$S+OGF!*E^] M0-EWSY^`JJR$(]-2]>D_)EFU2FR,P@4:&$DE:]7]V%[=C^W5/0^2R`MB;\-6 M(2ZE=![E:]`8/&XAC9&V!(`8`IO)(K)01,2JRL^`:"!")<[YD`G9K-N6RQQ- M&6BUK',I(ZMJ>U(&W2W?']YMI(EHR!UYL;[V8S)!H M/EMAP_0U!JD%3RZ#/---9O("9491;K5P?>2'TC#=[\A,(VH;,#EN4C(LK+^$ M+,=Q7U+4C)P9&<383R`!,4C/FA.3K.TA>X:L[,\1Q@,T?VGF+`G`HQ^``M3H M>9#@EE3[Z1PHK9PC!7CPIS.`VCP'`IS0ZN?7U*>W+VU>:R=>CP>U3PSW>IH" MU."GEH`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`MZTHT0+I9UK< M%NQ?K_?-7K,?O;Z^>7U[??4UG+_:"S^18."[9$(6+?;_3Y/^X:L44\>WKVQ_ M_8;]Z@V%)UX3+VI[\YX7.=&6816L$U(I^]<:DXWE2BL>-[<^*%9$[_$OJN,Z<:.+^S7";BZ8J0*)11"A_A M//2.K8#*;44BQ[;<^L27#J>-$S:#"<,]'"U&&[8(4;RK02`>JB$.2K\VC7S[ MCY7OSNDJV24+QW;HNKP%,%%AM+,@T;'"U;WK?ZD/1&&D)NCODM`.G`W#=[2X MBT/'(V%(%XYIO%Y;P9:*T%EZ#I6<1=<3V_9CNJ!XRS&EC\I2RE,SHS?!YSCP MJ1Y'6[8F_AD[&R93&?6B/LW(_DE*0[9-,_JZ7OM>,B]^M8*`RAV@F-PN35#4 MI^>N-9E97^7J5-*T"0H2UNC8%%YZ0AO3!5Q&"+]'$_1,Z(81)+,>0DMYZ^:0 M&?AA.";!=$4W,QA`93V:H.>S%3C6DTN2XS0)H_1P(Z-)W*L9O%RV5M/=/MK. MZ/P(V5$?L/7*^C5!VX,?;IS(4X>.DX@]2B:L25,,]?Y;^@Z=<$X MD?=LZ@0&E>QI2TVG,1@YTHX-G\Q@5'$[Z#FEP8B2]=-S4E(1&+^?OE,3C#Y( M7\T[*'P^@`;`7\F[)+(<5_-2?O(18[B^/@O;U\;Q?7,6OF^,X_OV+'S?ZCZS M`.>J22 M$G310Y%T(1=TT4.1=(D5=-%S+@@/]#D)E=X/'QPEM^T7K<.;RKIWSNC8;^_-0CGH_UA0P+/E$A;<$76L M(-C2XTJ2J8/G*X/U177PX-MV0RHGGP";OANKJ!R,&9=\, ML'8!0^&$V(12^.22(8EV7/*60F$7U&L!,$@0MLT`J.^Q5ZA^L*4$<@#)-T&] M$``#4,:6&0+_X#^3P&/;*@LD9/0?E80#@+@+ZBT`&!`(VW4!XL32B![:2V4/ M[8SJ^@>CH"8*,R;,."`;RYGWO1VM'*"*S5#=_F!(>.P9)?Q<7IARP>^:H/KW M585>DNX&6^!=LB"4?$9:RLW`L9X<.ED=$O*W:&DO7+\_&!<@]V9`M5.BWM<- ML#W\<`.CC+.,T"G9Z4P: MI-QR:4L(BWQZ)DA:(D^H]*D&>TH09=]K\!<^<1U6729O* MYCDUPL0W`_#N4'3U&#Q5;PM4Q6/&R2)#->R"1]0!?%5@*G!&W_4,V(/6T:)# MEPU'XGHN;PJ%1\^Q'"!F7\:!27#L7>-C:\M\3;"[@-/&4$CTG-+5(!$S;`8H MO?7&];>$[!YM%AGDX`/H!X5*S[6:&E1@,9B!&M6L("9'UZ%T+I6WAB*DQTI2 MGDPBEA%N$';3NL+UP:$G%``]%I0:``JBT&6RQF3F'Z^3Z&'%VO)?:G!;0X6N MQQ92$[J$9<-6HT-*).!Z5&P/Q4;/;5K%%8G'MAGHI#[:E%;P]B[K!,5)C\6I MAA-,`&:`!0:H#BAZKN!4S14`$!?I]4G4;>![RQD)UBQ/X]#W;/EDX_6`QJ:9 M8(,"6#=CFNT30+:]^<19KB+`&QYQ%RA*)IBE$.;-@*EC)2?.`;%",GIRG65: M,DLZH0#]H("98)R"Q6`&:AGFY)L7'`D3C-`2UBY]NP(42SF=7:(>4#1-,*[` M=6(:MV3+2^A)WQZ).T%%;]8M$$P4FG!@R?66`?/XI76-;,KF`Z6%Z@$K;E0) MIIIC0E'4;01'68PPVCC!/#J;.1S.?.1S8$R[? MI:0L)=@V-3A4(_11^:6O$[(00+G_B-,-JC5Z[A$;UQJHG!K5!],2 MSXP3N:](Y-B6>^#XD(7FMDH6FM9WN5'_\2TKC1YKS77]+TFPB!]T_?@I6L1N M\:6\)&I`;8R+S&E314QFG"4X=Q1B2&6=+C()#DP2AJ!V=`'0=7`4)#S/$W?/ MOE**W/W%[XF:":`5>Z`FPVD`-)X,#`4K M27\-!FK?&C493F,@Y7DW%"!Y:$@CB5WUV*^-006+$3'`9#AP'(X6HPT)TMVW M:"Y\#S,7IC/ZO\?>D)H*H_O6:-R;M&=]V@#14$@#3@^T2Z\C.:T1YUAJ%7>H M7HV"I>4Y?R4@3<@S\;CW;9(^F,=]"2"Y('H(YV8LA.6DCNF?E,E!MRO"XO'CC)']<'_BA%,!L2]R$@]4@+'**!R+'K$E6Z)3.?=91 MR4E:T`$W"9ZJ_2CDVHPE;Q^.EB-55$Z`UQR*C!XK!R!N'\*%5@,__=P]);SG M$CL*?,^Q4Q_2A-A4/BRPC/+I/#-WXC*PUL+[`*5Q<-,+JJ)344QFS*@N"9QG MBY'WP7(\MC2/O.//1&G`I?V@*&HRF)10!(O!#-02YH:^Y^=W5K%!*^N$FQM2 M#2^8`"[]B'@\+['U)7TO'%-FC]?,=V3A!R23$>CT`0"U8/*CI/&[CR1:^7-6 MNB9,WR,+%^\S48";:K'*LG]6:%Z&-E-1[,1[1SRRX#ZMX[;&S?)814NX+)NQ MF=#=36J"GK3!S>.HAD$I>P9*OL;3IPKCX.8DK(&@WM=*IL4R4)N!KA>"B9EM M@)LC3PW3(F.:S-A]"'77BJRA'Y&?)/X<07MPH#*V.T?*LQG+W_X)^9Y<"3+\ MYK@IZQ2`D7%L)BYW5NC80%!V;7'3TTG%+(`DQZR9>'0=-XZX(?S1@-NKW)]/^UNKW[?J??&W9^,R/K@'*! M,F!?U`PW.PIG@DH=IXUDT[B@\\W/9254\NEE\KQD@^U,P(%.5=*G?^7Y3\H: MFH1'3H]*!9\A/'M#9X+P4_7I^.N-[[$UKOW5D>)0WN>R("GG(?-0#-.8S-/6 M]=>6PPOIY+0U"0R1BN5,RG)6=IB\P\4D\_CYD;`3$`>/DG9F9"R!HL!EU`R3 MCY.W5(B)I(\9&4F@^(`$H,E1?\PWQ.["LZ<0H?SEW()U/I1P^FO>B@D66 M.T*+T_2H3:D-"1R?N5B""']:O:3-3WY#"8FY:E&1JB>'#Z_0;[_;+ZV8G1W,@.U_,,B(*\ M@+.3BI*@'K`;XU:3>AF6T;%CA:M[U_]2DM#Q796$CIWV]*%U/QC]BIG0,7/; M=^`/?O5:T@7W?,4(2E+:4=3OMI]"5B+]\.:\;4?..XO81?4"Z=SJ09$:F9, M_*S6CA8L&W'7"1-"QP%9.S$OLPB@'ZIG\UQ(@^6GZ>8^39?QJQ4$%G]&GC8" M(J,G=/E5Z[[<1)XCA-4;-/GLN9,62,F.CI"PG[O>]&YXRF4O\G:HD/0=FRC=22$.9([:BY<'XH=<6^OSJ(4/&F]1,W8+VM49)651#@&5%_T M.-C.NC4(9&CJ'D$M_XWES)/$`R*;W$Q6#'Y]YZW>=GVJEU M*DI5+9$,!M4>;=5]SJ8](*F:ND[LE[BQM:UD+!SZH>&9P;]QT[F>8 MLQ*YO<1EGNYH04SFF235%J"79?*\C7#MH#'._*#-\$#X)8*T*`&ZM*[]'(`'([3P@<-!&X+!\)- M8-]0Z#9`5&8L#<7Y,B'L\9A-#2/&&'BC..T&A5&/DZD&+,(-H%PX+R"9??J& M-YSY;?O/V`E812RZOD7;L6MY24E4^M,-:\*+ZE08`+?`03.JH2ZPRU<2N.1J M;P=P)='CAVI&2=0%]D)/#O>.9WEV`R<'X4!0E3$CVJFZJ,PX.5#";4+F27FL M@>,1]B*3:BNW:I2@/6[UCAI`^"#VM+H8=QO1S!^PI[6\-%"%5KAU.1H2>3GK M>@4=[O.:`&86C)]=9IG4E.6JA,@!N!9%FM$-=8)>O)'#) MU3[P8A9"N&*.0>>+9=-D7&2;.74T\11$K4AH&IR5A-: M44VJ".UE*DJ;BC,(ME1RGRTW5M.00E^H:N@)]M"I&APQ86>3O!#-4,B5=:O' MC7)&W7@QJ;*Z)+0#9Y,^,K^+0^9^8'>Z?N^F$<$/J/ZZM6MS?M3/KC67\T9,FR[CY-^\/>=-IJ M#[NMZ:?'Q_;DMZ2L4?_#L'_?[[2'LU:[TQE]&L[ZPP^M\6C`ZAM5RZS%?1A= MAVN)_[&IP1$7BU&PM+Q=[H%C#K4T&\DXHWNCQ6YR6>XQO=H1_AE5Q3M*YA\< M237_&9_98L M(KV/G_ICEHROR36BC#99E6EA%UR'>_D-(WRNJ@V!.0\AP)VXWY6%@SYSF'.D M.%/>G\Z46[;[WE6;%TWE_WK*"%*Z=98W1LU?]J0P2[BM<33H+OKUJ=T>,C/7TFE3-;O[8G$WK(;/1$64*91->%/5`5 M/J!&#[642-^CY,3)(8(NBP]DOLP942JSHLZ0F%,'`&M^_M27'?HDR\2]%R?7 M]>GD^N&JU1_2Z=5KS=K_KFBE-1:/F-(-WFZ$/7`C*T_IDDTQ<1?,*02`Y21P M4LH[^A1)%@1**1V-SG5V<"S.E)O3F?+N:K?_T/E";97^YUYK/&@/F]R%BG1) M$X#S.V#7*: M*)\WMZ?SYL>KUJ0WZT^2=/N-3YD\.9+IPFN,:=H3+TP]04<\ MLG!47'+5A\.<.F(0<\9^37&A3Y]C@L0Q"9+Y7IQ"WY].H9\.A[3O!J/I]!^M M<6_2FCZT)[TFIU*1--#YJ[P#9C'M70W0/5&R.2-HCW_P$L&1*Z4M8QI=\S]; M@<-"``_)/.D^&6V+VO_#J?:_OVI];D_Z[;M!CTZ#66_2F\Y:[`0V^ZU)]2^G M3S(%9)T0I\'^"H/:P$^.EP`(WT>@G3$G"`RP["11$PGZC-EE*1E;0;2=!987 M4K9RL7.'.?.N<&W[EIVZ!DFMHW&;7;3,)NWAM-UAM[B85CZ/)^G)3=8--4RT MG#CX=%,:`?>D!H,O'Q2J+![TJ2?*(//16A1G8#%PXOJJ]3":CONS]J#U\5-[ MT&>WG=/I)SH/.[W6?:\W;7WWL7W_CR;W,`G9DDD&[GVN[$;TH[*9`^^..6T4 M<8'F,BJ3#_K4Z;G$C@+?<^P'8KG1BJ6'#^;AT3,2^,O`6A>G4"%.X/KFJM4; M]#JSR6C8[[0>>NW![(%N:YW1I#O-NN$FHP^3]F.3$PG(A&1"*8^"Z;,31;=( M/77`SIASL"*D.:>=DHS09R*[_7*B_256QT_()5YIY-]U(?;@^C:]=^W/TCJ9 M+%*G,TJ"^GK#IB/Z!*0"[F&E/3$#=_GTP<^'JH-@W[D"HYU[58(:&5OX3%F1W3MSF MF+O7"5'2#8O?'O4.20)%;C.2L8P^-^I%U'*#U&\*00R-!:FWOMM_M5&SK!E! M:(U;-RI^_J2"7X M2**5/_==?[D5GK(:'!^UT/0Y-N6&D3!#P3@Y5D"K"K`O:IWJ,^S@*A+4M#<, M2!210)*$\[01:GWH,]C&I3(Q8]9E*E;.`FM^+$Y7*'HL6F2$*WNSG\`M.*U? M670`8H:J[2LN;Z?Q9N/NQ<'3&FYKW-K4^A5`(B8SL.0F.@!:`>#NN$6GSW&8 M4Q.D&?#WUQO+"9(TXT'7"3=^:+FCQ<#WE@.68SN#63]8,&%)L9$_.0=`1X_.4VQRVG?`X[5RPH,^"< MDB53O`G9^(%J]!>P+VX9Y#-,7Q41:EIYA^3+D?AI9'ES*YCSBR"4-\8M+:P? M*+&0+CR$=Y:X5`_,'`)X"[F5&@S@3;]I4/AN2I#6X-W33V"NW?:*S&.7C!:[ M&_:I'P^Y3%A'^H''&]QX!I78<0+#CI6T;C*LKY\A2OS+?WJ1*M/ MGO\4DN`Y34JRB9.+0Y_*PW72`#]BQT%`I9,$Y^_+T*D&.-]4]/&<1>>@&&*PP0$#Q9.8-WG8%3AOLA32CNZJCVCR MJ3S!ID)90R.,S0-A<&NRK`MV91$5FX_/LAD'F2.ECU84!\G^ET;PS$BPK@`8 M=!ADFU\-1379H"]9)34\>"M8(74LKW2,EB6-2ZAZ)1DC%[R$PES*>N;[V9,\ M"B;.<@7(O%)]/.RL1B!PR^=<1=E=OJ\L(X+3X@;M+U8P3P0S2FRCHPW"DARN MTY\I+MC-?`1U.:^K:0V*&7WMS]0RXJWYA=3')Q6-M"SU!;J@E8H,O:NC.K?Q M/?9R;;0XT-K[NB%>2'95%10G8H41\9/M"P`MGVR5Y6;:>;FW6!`[+7RVXV)B M123O`E?4@"I#HBZ\%76@NNA,4X+N[H1!62CS)"H;NTJCH6;UJ0A])8'IBG,] M+DHKRUM2;?S$7+S^TG/^(O,#@_L:.?(%'#8*:C*>JJNVBH#0ST#%NF*\HU`A M!SVG9)V6(Q&/3.4*=D8>D'KKC>MO"4G/T5\\:L:MG`TCMS<=C8]"5S!_JPQI M5GT[I5VRL@#1)V"Q$!-O`A8RV/,+=VDT2XJ4*M?Q,G,.GKPC8?>6-MUQNXX; M1VP35CN>JHV&;YS(8>7,O"IB0Y]TY<6=>!.OD+Q>4#-,R\P3D5NIA)B1,["4 M5$AY")41S"LIIC+;P")JV+5K3&4)SA2]+:;!E]67T'9)(Z2\>KD)(Z?L?1Q1 M<3\ZGK..UY/D.=^^MO"]'XPVA.6>])8#8H7*%GZML;$O4C7^0Y<[XU'.*NO[8<7D8=E0$,@%E5I56QW;-Z M-'.;/-@_DCG=KJC%0=9/).`@47UW"M3QK2>8=J?(6VZ&&(M04,8]K35+N4XMR[3G1=DK"T4N MZX3Z;KR>_&'RT`3&S(\L5RCY7`O4U]3UQ%S"J1D.4"%;50XTANZF:F8;^$SS M(NZT&O&=71>=9SJ37>V^VKHVR'T6,06[UNH^._T$XLI1+!$Q)%$G#M@,E<@` MUO5R\U>5*T)V45$1GMZZ:D5*.*`)VJ.N^$JB+%9%X_-OQ@8MJKMRI'G'+V^^ MJ8V!:K%5A;.2G-2W[??IENF1I17MVAJ["E=8?9%MR?JM+=<4XC6^X*1E\GU2+"%=#TI(%*49P#/EL7A7?^5M<1-_B87F M2ZG7*EU68";PD^S,OD<7T20T]\$/DU"0?7`(;P[`^N+FO`)+7TD29IQ&CERQ M>!(V:Z7G1G$7W.JI8*@@?)NYP%S"\*Y]OV#?A:V>1P; MXE8G!4FM=`,Y9577[I&G,%DG*8TP73ZV1B[KJ"IF"=??O(\W1>]C(0.B!N_C MC4'>QS02:N((00VOEOHQH2.9@15%B6 MC#\LTBV,*U0U/%[EVHBXPDHJ5HA9N38Q:.7` M15JO(M$<,2["'JCW7;5A`@C#7-1NE%&[,2+H40MJ-Y>"VJTR:K=&A$IJ0>W6 M1-0R!ZL#S4=GR.&$Q4$0W!LS1$>+>98%6U&&FAR>NTRXA[I+CTQ%;Z]IPQL. M>L(>9AQ)=$$&$-;+>*E\6_1W%HI8:/!WWAKG[[P]@[_SU@A_9X4"A*`GRXJC M&6!&:M&;FK4>C?)<3BD%&YGXL:V@`P#55/0=E"8>FN/U2-BRW[U%5C)., M]0(_'Z_UR\*+RZ89?KM#U4NVW)#@V6%LC18E5(P&8W9'4F%%O-)&]0SN@X-+SFBFV@TJQ0T+53-S:>][UBN';OI M2S'?=>_]@-4BD3E,]'T7-WTR[S12M9IL+>%KLM/O+)>]/FA'1YOSFH-W>5,S M+'/MTO=EXUS:M3YX3W? M:L)S]Y4W->-V!'DU$3G]&EU-1HM]P;)^&,9D3L].GTD8D?F0\!Q3P+YFW)>@ MS&&(4,\'+#-FF7N5F;+\NN1(+?4B2:-J`.JMZ$2.'+VS8"IXR>.=9M)LN]15I=4 MM,+%3=@#U350"2B```Q!*E/08IX&.0EAXC9'-?NK821AW0R`N*R)8))U0C7A M*X$%$X,9D+5M.UXSLX+,NX2*UDZ-#?IWER02]N;M-YX5%- M^4IJT+1HS5`8+IE\9ZRX"ZI]WNS\%KM.SQT(^\2WJ]^=VM6W+)KUKJX5S8U$ M?8J`Q6^*#3$#_59T=C)WZ9T?!/Z7Q/R35)T6]<#-N,F#(!?.)V?8C$5HP()2 M1XM.0.:.)!]?>5-46QH#`" M>+[P'&L'4ZND3L./,ENK\2H+EVEM917DT8KB(+DLGY#-+E7K:#$.',]V-BP4 M?D@!FGTA[C-Y]+UHQ;WDJC!^V$HU*.U M!KA/9'2I*-.O\][95AWLP@[BZG*Z4*SO_9CWBJOB6+BIXO4@G942NI^YXZ_7 MOC>-?/N/?;PIU^W\T^E1Z/NK5F?T^#@:MJ:S4>>7UJ_MR:0]G&DJWUY"*NB@ M!.AGPG-T84*"DT8&/%P%HU'ZX/Q;2@`MCPB_O?0W&X9O#_B_/>#_]H`?T2K_ M]H`_R2\6KY,$06'OZX;8+,#%>7;F]-`XH0L8;^$%=[^@Y_1`49@+X,0)_[BG MAF/?BP@5U">&V]WVV&970S3A MY,B.-V=AX4-K381N##V?,@#Z4H7-!QGKX/R%.S-T!2+KTW<5I\:%QG))Q<>3 MWB@]]8[B*(PLC[TK'\8"E='P'=0+<)B=H$VZ>DL)L(O;.+!7C*INS))[C$G@ M^+SLE-)>J!?8,*2`G)MA>E=6*_;*BR7/.3AQD[#&V]3OP,(W?>^[IQ@O3A)]\MIS0":LROVHJ@()&S8S,D M7VIB4S("$!L]]=OK8L.5R(6OW,4#P:_$6:XB,F_3LZ2U)+VO)+"=D(P#Q^8Z MF<[U=:A%@.EW/S,4FM<&$0G53G.51H0"C^F\;T!D%[*8<$W?TA.&C@6E20J@ MNF6TP=<\)'H7EOQFFEGSQ*N'H!L41@/.?E+F-1JZ(9">T,CNPP1O9(UF,I$5##$=H9B@9F MN)2:(-!#-_H>_2N965\)]S'*]V]/(S9^N&KUAYW18Z\U:_^[I^D-2I$R27R& MJ$.3JG[XSCCPGYV00G!'/+)PI'05VV/&;\KEFU5K*=-F&"N[I#\':EFXE!>2 M':T=GU7@C%D<\H:DDU$:]%-C0-0;2S5XZ\OM\B\I=S*X)Q05RRT(0:P@_%ZH MP:$-X%K4$IF$C%H*DEV;5?BF7U(%5=87-894"[0P:1D%,$<`E=9SY.M^+9!* MY&,&EMW=CM']3CLI4TY*ZBJ''VZU),2[BF*"&8UW\]#C4&\;O MO',8VSE9?$_V_374.]GP,[(2XI0=E-=&/!T[T)4OH\?1K/;>_F=;24Q)VA[[ M\UW\#7_#+,=I`?C2"=JD=`U;CO.LE9\Q".]1EO(HAOE5JZ`O$Y'1^.XKI^YW M,MH@+;3$'BNG*+BN_X55UE2#7&E@5+]J,UI009":`_PDT7K(+D]%J9\RI4EV MGZW`22O1ILDP>O0`%VTYDN0U1O4[*LI5S+"NC.V9.3+_WSB,1"4[>8T-\^L) MI2QFV.@-(GECQ??C!6N0"O]R_YG MNQ5@0@4=/!.6OK!MVT%LN>'A-'[O!UT_?HH6L4M_QPJO0$XB37T(U?X%HBS2 MB\9D?3&ZE'NFX3ETM%D@28^.Y$C,]L`N6Z&JI2+O&D28K*\ ML\LO>LH4.`B+S9#+4Z@*E,>G)K$.R));#G/W.R-"7^`"S'&D26K[\M2`\NSE M38V($('+5,2OJ7LA\Y:`M[VTL1'A&75VN"S/+R<()R\1)7O8D)"-&ICF>#9T MKH&O[YJ\G[O6\W2R`5MTLMZ"G:RW MFIVLM\I.UMN:3E8.:0GJG[R`V/[2<_[*Q,7M+?AV=$>6CN$4A+>^T$I*>/`\0-&B."N%CZ"8?$Y0IPJB$832)!)WO/F MM1?"S!B&A?347@,+XD$_&R35#2BE=#3GF;`LT-Q<"]^?GA#>7>W*8M!S0F\X MZW_NM<:#]E!/SH4BH:#*&/)N)N@4/`XY1O]\T=)"BIM7E'Z-VRSN#0:LREGP'N43)^561*VM< M1>2]@A(D0I:8P+"NR)5&U/%7D0.T#/9$G2EIA1#&$E^PU^%OFW]<3 MO*--L;4FY+_0N*#:0MO+!56W%8E`C6-"4^]*2+V,\X34TDR"^OP MT0B0+T.G+^*,K.#ZT13A9O@Q^9M7B..I0-!I\-=Q:]YA:;0B.)?@7)H05@.< M3E&6\(_)+;;<&0G629"1FK,).!1VU;S:WB2GG">-&M$*= MFQ+<8GJUU.=T]<(!\65H,7_YY@G@6I,65Z($JL5ZKFU,T>(:(.IZ2[QZ-CLR0[W23&O-11>'@-\- M1M/I/UKCWJ0U?6A/>CJK*Y;0"GH7*.R'&A"[*]&9[*'<8-=\(]D$+.AF\[,0 MC$8A9TN&CZS;W00,!J=E4GDX9!H:@$6Y#I4*/D-XMA`PYIMPY]F9TQ4K;']U MN"D6\FTN0N0G-&>>&I@@[*[/#""9N/>M#!!XJ9J4RGM/]/&I4?.E=/=KWB,1 M1&.6-\5-A5B.?S&M;#F#NM*4)>\9^MXP7K-$:;XPO#7?#O>]&:2Z-I`OG&C`?YB5;8#[GHHK2+^<6ORH(XF^=XGGKQT/H/&YELA/3U24OH1#,]3^ MQ!^81GJ/%BG=&9_"G45-/MB=EFP,W$<=`D#XUU@Z'.5UD[@^XG>G/N+W5ZW/ M[4F_?3?HM?K#66_2F\Y:+"?,[#<]3F(AP;)JE]#.)K@J+\Q=K(;+-Y^Q`0Y, M@WW&I=KDD/!NVW&M,'06CIT6KEJD>B9P+5<;ZB(`K,::&8[J4PHYZX?(BZTV MA`&(UM'J7`I')<;UN,G'G8>^T#F>;8#J5JRB:3F/8X%3,^RHCA6N>#,C^97Y MKO,L"V8(=5^.@`6]1=F:!/Q$UN(NR!G*("A`>+Y\@S6I8)#FZ.8`F6N!G$H, M@EL)1Y7&>9OA1]M+XZZWC=^[I)3'J. MX$$]D9-:05!1D(`9D"5S?$#/*XZ;'!5%2U>N&7):)_#Z5<+;Y2]B&I-'(RO?I4(, MV0F2BY2\&^[UCNI\$/*.GN>]XZ_73G*[RPAEKZ$<;TDUS#DDMR]Z^7\\]?)? MWUZU.J/'Q_[LL3><35OM89?^>SCK#S_TAIU^IDA,H[Y^.>T2?[_*`)B;_*%\ M:%KP(689/1X=CQU+=H\6PO1!VYQ=\]Y3:"Q74&RAQGB8/@-UN'.GB;I"O/QC M!T0$W9CN*;,OOJBF2H5Q<#U\VA6G5&I_)X6A7R7-J$QF)%0?R[F4IB"YOY': MW/NQL'A3E8%0?3]G4IJ"W/Y..N,\-[/29`9"]4R=2V=.Y6:&D0BD?[:B9JZU MB+C7B17&076!G07UHM0N"O1Z4"/[S M"%G8H=((J!$%&R>RW(:\$)5',]L'(8QEK"G!RS_FR04`<4`HCV*X^Z&FSKQ0 M[P.4<9GOH<(XAGL>&M&7%^AX`+(N9`H@$)P_;:C[UH M0G:R2W-()@$U)T^H]S^>6!$9+:[?7O%R5M<>%34,J2:L#8E4$^!#$HU3HI(4 MCJ,%_<%.ZQ)%W*L>!UEX=]3XI)H0J@I)X^3LQ`%C=NP'3'""^7;:$/71>`-3 MJ)QQ7;/"]VR(H$O:X195JJOH/+XO("3ON%(>_.'O:_C#;\[L#[^I[0^_,<(? M3A?*C>7,^QX5N>5Q"^T4FYGMP2[`DW\,5LZSKGSYMAW$Y/@Y^OFU$Z]#Q[/= M>,Y^D;P2V*V8\KCZ&N,9[D,6HE9;C.B+8I>$=N!LTB>Z=S&EG)TUO?DT7J^M M8#M:3)VEE[SB]2+*+3N#4@F-?=?)R&AH!>Q6]9D4+Q1_>%M80*]:W=ZT,^F/ M9_W1L#6Z;]U]FO:'O6FZEDX_/3ZV)[^QGT_['X;]^WZG/9RUVIW.Z%.RRK;& MHT$_O]`>OM_P%62SPI&LSKH^9D(NCPM+JJ(7]V])6+0#>-%)6!Z(Y4:K#F5R M%"PMS_DKD=R$/!,O)E,_#FPBRND-[WX10,'9,2/!"H1>87H5E0$,0%!56U6Q MU9M.Y9',Z2K.TG&S_SMS86H57F/4$ZRZOF41$/-O1E0C/96SDEAIB>6)$_XQ M)@'[@;7D%ND1=[F`W"`0GM%MAWT"DVSNDM/#3]$@N#XU"&ZN6N/):-R;S'Y+ M+(#>QT_],7.NE!SP&SW>0^B7'-K5AFARY>I90;3Z,[;^(`?K\U M)J%Y?]K(`*#*E*M,UGI-\?S605EXQ[XK-,C%75#-O')=R'L@Y?R:88!77D?S M96[:<;3R`^N6&QB_59HY*E,S"=E]WH2%539^_B[[`F[26[-TBH^`(:J5;-MA&)-Y-P[8M6]2<#Q= M59-?YFN<\W>["@/A)N#5HRB5Y7G1C_,G)'*"1&HPM]_MJ=OOQZO6I#?K3WJ) MI_P<'C\QR1)O'[0SZCU3&(7]-'IUGN21/A)]S%N\;\"]>5(;!/.`J@9H_GJJ MBJC,6,!W,7N]]<;UMX3<$8\LG&@?'"Z.;^1V0CT55L<1)HN+7FC3LMNL>ZWO!J/I]!^M<6_2FCZT)SW=BZZU_30-A[JK`=R[5C-X$T/!3-S!(F.FJKCH2YKJIC5BSQ7$EPZ!>:PFIT@@GW M0Y7ZAIIF'(R'.A4/S3KVE),Z(\&:*EO61Z_$:FE_S$E9#59IV3>1H,PX[Y23 M_3&V7"=*>!X%]!_LA\F_^M["#]:6P(]69T#4]XEF<[ECL* MDF*/GN^0)B!T7>= MN6@UAW='S:Y3'SA5.:$?IB?$902.K8">,NCI(J2,,1-`?IPNE`N_?LN\A8/V MK-=MC=LLT'8V:0^G[0Y[@E?VD*YAQR&,$:D+4768QL,31E_HU+[;IGZ29*VG M/^`FL!)WP?7\54.DX+B7"$1I#NU^P_YXLD)"?_+_`5!+`P04````"``=B]Q" M1-DFPRP3``!PWP``$0`<`&EH8V@M,C`Q,S`S,S$N>'-D550)``,I_\U1*?_- M475X"P`!!"4.```$.0$``.T]6W?B.-+/WY[S_0=O7G;V@1"@D^EDNWF-@+>R_*2.TQE?*%VQA![FV\S?E*S(]*+G_96"Y4*:[Y!%#:3#, ME=(Y/9\KC4:%/C7;=6^J#B&BUR/QF.@3]^E?UQ?C[^;UX]J\7'S_SWKODG_]:4[ MH^-@R$]47^$U4D`V%OU\LG+=S56S^?3T=/K4.;6=9;-]=M9J_G(WU'RXDP#P MZMDDUH\\\-;EY673KXU`.:K'J.*(Y[AEI2`$\LZB)+3\$;;MP@ M"7S>#"I3H"07]"(`)1&H1QM+A#8Q[`+1N0\;5C29"C3.6HU.*]'$L4U,<]OX M-3F-+-NRO'4^N8;K--V7#6X"4`.@L$/TN%UYHW0#P($5YV/GU^1@-[CMW<8- M8$(06S_5[;4/R>8&3&`3K['EWMC.NH\7R#-!$K]YR"0+@HT3Q47.$KM,>>D& MZ;BPKTC_D679,$U@]H8EK&RS(3`/H.#_/C&%N6+\G`'6"OOQ,!WD]30@@V(HSOCVG@!;&(CQC,V);24**FR9_( M,I2@'R71T:=FMHM$QQ[%QMCZN_][XV`*W?B-AE`0-@Q!!(UT9.J>N5N;+2JY M3<*"B,][<+YG6P:VH$/X06V3&&`ZC6MDLLFKK3!V:<#_"G!B*;2!]/AH-^=P1_7W6%WU%,5[5959]J[,'*8/$$.D+K"+@$"JDHF MW4@LILX^8E)^2G7_UW>Q!1*(&4G'B_&&^4&`0-%D$C00B^M#-7%I,_C?G3H" M48UOE/%$G79G`P"HIZ!RV:VYMOYC99L&^*.P0!*=@,O[$LMJES9B<9WSXA() M29N->_^\'0_[ZE3[B])7;P:]@3KJ?:^GR(JG2@_1U8UI/U6=6EMXL:@N]IE9 MO:YVJ]P,Q]_J.+/ZF.H.V;`1QHMKCQ(+4PJ^FN:MU\AY@>E"EA:XFSH"%T[7 M;0]\+VLY`0'!O`E%]\H^Q.+\F7E^$)29-O4<#'^T3F%2:;WI8,(L(1/>]8,V M&*F:IG1'(->'N[ON]+L_$P=?1@.8?MW13.GV>N.'T6PP^J),0`=@2M91TA/' MAL7)?6&.^&\>V;`I$L@OMT8LE8]9J;1/EOR-^0X8"7B-8&O$'*T=9;EZ(=3,/MW M=V`H_'59^=:=3L$>U''R#RSXB6?H.;+9R0(Q2UM9EIZ?*H,1,%559MU?:FE& M?6T$[@$UY!%/(%H+&)I3+N9K.\O7B]-01X&[8#@'7U5E`L%:#?D[A7#4\?VW M+6\S96*^=K)\_?E4F:JSP=3W]NK*TF"N#VU*)]C15A#U)VU`JES,V@]9UGZ, M3<%/P[&F_54!!T#1;KM3M88L_HH<@N8F]G=),'6#%&7`9D&=F-7G659?GBI? MN]-!]WJH`L]GZE359@HS$[,Z1I93;++8<(+`99V!4T#9KE2MVZMK_N76IAOB(O.>[3U`H$"!42Q->8,QO4>+@/-E M0&(!\'$>!'JW8VTRF'6'ROU#=SA@H86F/4S]!.:-JFK*3_?=FSHF+543ZZYC M6T2_QLJMVAW. M;F&Z],;3OI;T7Z;C+]/N70TEQ,(6XOII*PBI>[:?[L#6-F%2!""6!!7.*?_.`&/41QX$D5RKDW"?'*=6<_2R>GY,R]G+1>TATGF.C,R M)ZF_Y*=4D[PLAQ/SG8NR"U&N=!5"0P<@N MIL5@0E%T^$"\+-U19X&\+ISJ8Q<1\R"16=256+!O&9N'H[]KP)YB:QU0!5H% M.O"6X7DXO-)ZUX(])=<^H!:T"[2`B_S?0`O:[UJPI^0Z!]2"3H$6<$F*-]"" M3AVU("\;EUKIBP#$\N*R'07YNEJOQW,WXU?-*W"7RW'$*;MW7J8\E$2)F)M< M$B/+S7IZ"3E)SI2J%M2+>%RDZE[@H97X]-3^1;DYI M?$ZYD-D?N-0$EX>NL8+SG&R)6%R@T!_*CIZ_ZW&&F6T1EPLBL`]<'"[D,4?G,J99K%U6*.QWF52 MP.M65:$4.9?\H?;*4JFGNUG.[G95N12YH[L?<:^Y@WJ0Y/R(I1F8;W7(W;]$ MIT)YG_-[_(=/_<>(U'/F%N3X8\Z4[@9L(<6RY`+V\FV!K6SJ*!EA7).12P4X ML52J?FG^+A-?)NDOS?/E40(CED6%K]/?Q5`_UU^'?V MBNQ/0+CMN(K%W;1==(%Z/&K!QSW<:D6+]=&D_@AJ1U`WK@H%SV[`?C6WCJN,7 M7EI?-'YNPR8V71J5O!(;_L+Y_='Q^]H#GPIW[5=1CF3+4="0*9,?SYQ'8\9 M-_:*PQ48/6(;,]\V&UYP[_2)$MCJX.6#*\->(V(-7+QF8$"I-Z=@$ST&^L6Q MO7@F2H^/)[+0$AL]GJ4Y%4?'=F`9 M>`T+Z(N&S<4$L13AV%UA)XUZ*=31Z6`OO&!`PL*V1S-\SZTZ.L8S\$3,-*;I MHN-CB)WUT$96SX%)YG:7#O8!,CB7`!V=BBE^M,U'8BT9E@(B2F".3L,_)[TI MIK;IM^S9ZPVR7M(4%$(<'?\Q&(^Y1Z-3KVG4195'QSI2[2$&\^?DJWVF[N@X M3Z$$W/R0F5DMSZT[.L[=C4/,?-W(KSHZQD/&QRZ4&:P<7.BS--H%]4?'/7@" MSIPX]@)3]M8;,H<$S0F[V3%-127(H]/SS79^8(34'AUO<*;!EP[?A>HN7.P,K/!FU4P( M60%0!FH6/EK8"&XDO0;SL2!9BUX.=G1*IEC'Y)'A<./8Z^2K0MGUM!3NZ+0$ M^ZC1'FHVJLNM.SK.10\+=J%/]EAI1$,U6!3^BFC:G<8``GJ!(.$`)!;=J+Q5 MJXC(RM"E9`6Y:#>JF@(%=F#"S]`SX(Y=.L)N M*Y:@H%)26HID`4:ZJMBVH'O3J?L1]]L)S<,S^XO]B!V+52"V!(%IB\4FK):5 MH/SGX;(&I0Q*.E/"CF$L';;?'ZRGS->Y!?RA=W8;>#6J7]F)=$SQ7>CPR49K M.<6/V/)PRK_.J=P!Z=]7<_U<:[!:J\\LB,%9^15!2"><`$_F,U6^\3[IL.S6 M4%JAQN?:D(M&MHL_9F5:`""=2,'XLX+`&6'G:<2^<4S>3DVD%2,[HCBVMJ^; MA0F@;.G^^/_^KEF[R#5K2TS,R+9T1%?QP<3`$D;4"&ME):>"_]C:P=>LY%0? MB50PW`[+F?9Q^/]BY[,ZN*P$A]9O9@<;"!FCF"B6G``:V6^GJL&OUD)6LE_W M!167O3A0;_+Y`SE?'''^32&,="3EW-Z3I:@01#J"^*^/1:\#5_WJI6"BH=@8=YB.RP#ML?P7&#SJ%` MP\XCT7&8&PT0?^$F>U5@&6;Z$+NPMHP7O3`=%!W4R93*@&KD.PJX+JZ6`7G- MVVR",F3V$%W=F/938D\V=BU+P60@9H2?MK-8^P MUB_;IWRV3_C&797057KRMN_*\7+E:Z1#7_A\6X4H7'KBN+?2\H.^7`#IB-'T M%38\$\.RND+@*@ZL!\L!#QELPW^P$5,2'?R*EX2=F\E@9T7OKY7G4J27H^B5 ML_*$A/2D%3TB5BTY(3V)I2]T[1#G24_L#;%8EL&(S\6FG`[.A:X.+H.)>9W; MY?I[?X=UY;)]2JR*"MMA+9&+_<4O2H%&^YVQA"H"RTIK>H\]V&'GS$HQ MD,3*&!Z2R-'$1(VL1UL/$9BWWR+:;TLL^S`XW'[2AAQ]U6FUSUKQ`:ABD/]E M;>B\A39T)-:&Z.LJ=ROC^'"5H$Y6^=\@XGQ%IH?O,&(?6K':;\1=/5CVG&+G M,0AF-I[O]MC@X)O$YRS\Y3F,G=>($AHK_1=$+!;<09AG>@9SFE7D6.QD>,R@ MWW5$6=F>HR7M`@V2V8+$\APOHA3:@%(/&S#AOX+[CXT1=CGAEP#_@8AE7_:S MVP^9%1M;T;?^!00+&\A*=)1BXVF)9V'!?-^[M:SLR)F?G8*YVY&8E$@-$V%' M]+>L*/L?Y*2^SI$868VM6=C(&@6^6%8"(H5H935$Y@D:&=HIWG@P"Q'%1M]C MGL/$QRV[-RX&V]?/9,$Z/2`A8W"&V)8QX.9?%(*-L6FHSQL2C-Y'+LX25:V) MO`2.\-.N!.8UD87`;Y@L5^#==!^Q@Y98?<:.3BB>./Y9F$IJNE\7N^>DO36K M]Q-.AV-`6C`)V66H+(*K;F[>).A+HY;@>'S0KP#@V!%K&K?`Y<['.ZZ3"^4R MNU<96DJRA-:N,O2QR>*?PBPXE4S1.;] M"LV%9<%'=GNF*%$BZ;9A5]4F6;!S*TFICVXNH#>VDTL%Q/ZVPVC@+CNHUD12 MNJNHL&H9N^M]LI&DM!=E>;(VK1JL=,8M@_84LZL@H6MVBI0AZB&39<9])2TA MN6);Z5C072X=<`YG$&N MO;V7EJ^0%OD^MNPUL?+03U5)1T#ATY%<`J,JM'1D;J](+$X15("3=3^N_#7X M'3XOD-]LE"//:>].3:0C>,A.]ZW9KO`4AR]2LHY#]P!SJ-VA[.QST(<]\BWN73K=RLN,EC%GMS;2D:PBQUW]YJ$?.)X0[,!V M<*?(D*RWNZ*5("7-O/`?79>)=9<6T@DU?_4Y6*;81YZ)1[[I>-$GI@=.=)*Z=%9@UZ;'/F!7&/<+9;QK*^GD/,7L,J3P M6FK5)'X:!QL/&_:@HT7!WAJI*Y1V@)=UCS[V400(>=[QK$)'YJ!D^%P\__`E!+`0(>`Q0````(`!V+W$(T7]?P/?X``,'= M"P`1`!@```````$```"D@0````!I:&-H+3(P,3,P,S,Q+GAM;%54!0`#*?_- M475X"P`!!"4.```$.0$``%!+`0(>`Q0````(`!V+W$)"2EO]?Q$``*K9```5 M`!@```````$```"D@8C^``!I:&-H+3(P,3,P,S,Q7V-A;"YX;6Q55`4``RG_ MS5%U>`L``00E#@``!#D!``!02P$"'@,4````"``=B]Q"Y"YCWUT6```;+@$` M%0`8```````!````I(%6$`$`:6AC:"TR,#$S,#,S,5]D968N>&UL550%``,I M_\U1=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`'8O<0G)B$83070``\3@% M`!4`&````````0```*2!`B`Q0````(`!V+W$+.D$&@PS<``+]X M`P`5`!@```````$```"D@2&%`0!I:&-H+3(P,3,P,S,Q7W!R92YX;6Q55`4` M`RG_S5%U>`L``00E#@``!#D!``!02P$"'@,4````"``=B]Q"1-DFPRP3``!P MWP``$0`8```````!````I($SO0$`:6AC:"TR,#$S,#,S,2YX`L``00E#@``!#D!``!02P4&``````8`!@`:`@``JM`!```` ` end XML 55 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
3. DEBT
 12 Months Ended
Mar. 31, 2013
Debt Disclosure [Abstract]  
NOTE 3 - DEBT

NOTE 3 – DEBT

 

As of March 31, 2013, the Company had the following Credit Agreements:

 

  — A $47.277 million Term Loan issued under the $80.0 million Restated Credit Agreement, bearing an interest rate of LIBOR plus 10%, with the LIBOR floor set at 2% (12% at March 31, 2013). If any event of default occurs and continues, the lender can increase the interest rate by 5% per year. As of March 31, 2013, the Company was in compliance with all financial covenants. The stated maturity date for this Restated Credit Agreement is April 13, 2016.

 

  — A $35.0 million Revolving Credit Agreement, bearing an interest rate of 4.25% plus LIBOR, with a 2.5% floor, per year (6.75% at March 31, 2013) and an unused commitment fee of 0.5% per year ($30.0 million outstanding balance at March 31, 2013).  For purposes of calculating interest, all payments the Company makes on the Revolving Credit Agreement are subject to a five business day clearance period.  As of March 31, 2013, the Company was in compliance with all financial covenants. The stated maturity date for this Revolving Credit Agreement is March 25, 2016. At March 31, 2013, the Company had $5.0 million in additional availability under this facility.

 

Term loan - On August 1, 2012, the Company entered into Amendment No. 4 to Credit Agreement and Consent (the “Credit Agreement Amendment”), which amends the $80.0 million Credit Agreement, dated as of October 9, 2007, as amended, (the “Credit Agreement”) with SPCP Group IV, LLC, SPCP Group, LLC, and Silver Point Finance, LLC, as the Lender Agent (collectively, “Silver Point”), PCHI and Ganesha Realty, llc (“Ganesha”).  Under the Credit Agreement Amendment, Silver Point consented to and waived certain provisions under the Credit Agreement in connection with the Company’s execution of the Revolving Loan Amendment No. 3. In addition, the provisions in the Credit Agreement that provide for mandatory prepayment of the Company’s outstanding “A/R Financing,” as defined, upon receipt of certain federal matching funds under the QAF program were amended to replace 65% with 80%. In connection with the Credit Agreement Amendment, the Company agreed to pay Silver Point a one-time consent and amendment fee in an aggregate amount equal to $1.8 million, of which $450 was paid upon execution of the Credit Agreement Amendment and the balance was added to the principal amount under the Credit Agreement. The consent and amendment fee was recorded as a discount to the loan balance and is being amortized over the remaining life of the loan.

 

On February 7, 2013, the Company entered into an “Amendment and Restatement to the Credit Agreement” (the “Amendment”) with Silver Point, PCHI and Ganesha.

 

Under the Amendment, the Credit Agreement was amended and restated in its entirety in the form of the “Amended and Restated Credit Agreement ($47.277 million Term Loan)” attached as Exhibit A to the Amendment (the “Restated Credit Agreement”). The Restated Credit Agreement reflects changes to the terms of the Credit Agreement that were previously made under various amendments the Company entered into since inception of the Credit Agreement in October 2007. In connection with the Restated Credit Amendment, the Company agreed to pay Silver Point a one-time amendment fee of $841, which was added to the principal amount under the Restated Credit Agreement. The one-time amendment fee was recorded as a discount from the loan balance and, together with the amortized portion of the discount recorded under the Credit Agreement Amendment, is being amortized over the remaining life of the loan. In addition, the increase in the fair value of warrants issued to Silver Point on February 7, 2013 of $543 also were recorded as a discount from the loan balance and is being amortized over the remaining life of the loan. During the year ended March 31, 2013, the Company recognized $1.4 million in loan discount amortization relating to the Restated Credit Agreement.

 

In addition, the following new amendments were made to the Credit Agreement and reflected in the Restated Credit Agreement:

 

  — The Stated Maturity Date was extended to April 13, 2016. The Credit Agreement was previously due to mature on April 13, 2013.  
     
  — The annual interest rate applicable to the loans under the Credit Agreement was modified from the previous fixed rate of 14.5% to LIBOR plus 10%, with the LIBOR floor set at 2% (12% at March 31, 2013), except upon an Event of Default. The Company may elect from one, two or three months LIBOR interest periods, except in an Event of Default when the interest period may not exceed one month.  
     
  — The principal balance under the Credit Agreement was increased from $46.350 million to $47.277 million, to reflect the Company’s new borrowings under the Restated Credit Agreement.  
     
  — The Company repaid all amounts owing to SPCP Group IV, LLC under the Credit Agreement, consisting of a principal balance of $8.120 million plus accrued interest of $19.6, and increased the principal amount owing to SPCP Group, LLC under the Credit Agreement by $9.047 million to reflect the repayment to SPCP Group IV, LLC and other new borrowings.  
     
  — The financial covenants under the Credit Agreement were amended, including the covenants requiring the Company to maintain minimum levels of EBITDA (as defined in the Restated Credit Agreement).  

  

 

  — Upon the Company’s receipt of enhanced federal matching funds from Medi-Cal under the QAF program (defined as “Net QAF Funds” under the Restated Credit Agreement), the Company is required to make certain prepayments of principal under its Revolving Loan Agreement with MidCap Financial, LLC.  
     
  — A prepayment fee was established for voluntary prepayments under the Credit Agreement equal to 5% for prepayments made on or prior to December 31, 2013, and 2% for prepayments made after January 1, 2014 and before December 31, 2014.  

 

Revolving line of credit - On August 1, 2012, the Company entered into Amendment No. 3 to Credit and Security Agreement (the “Revolving Loan Amendment No. 3”), which amends Credit and Security Agreement, dated as of August 30, 2012, as amended, (the “Revolving Loan Agreement”) with MidCap Funding IV, LLC and Silicon Valley Bank, as lenders (the “Lenders”), and MidCap Financial, LLC, as agent (the “Agent”). Under the Revolving Loan Amendment No. 3, the minimum Revolving Loan Commitment Amount under the Revolving Loan Agreement was increased from $14.0 million to $30.0 million, and the Company agreed to pay the Lenders an origination fee of 1.0% of the Lenders’ increased commitment under the Revolving Loan Amendment No. 3, or $160.

 

On February 7, 2013, the Company entered into “Amendment No. 4 to Credit and Security Agreement and Limited Consent” (the “Revolving Loan Amendment No. 4”) with the Lenders and the Agent.

 

The Revolving Loan Amendment No. 4 amends the Revolving Loan Agreement, to reflect the following changes:

 

  — The maximum face amount of the Letter of Credit Liabilities permitted under the Revolving Loan Agreement was increased to $761, and the Lenders consented to the issuance of a Letter of Credit in the same amount by Wells Fargo Bank, National Association.  
     
  — The period during which the Prepayment Fee of 1% is applicable was extended from three years from the original closing date to the Commitment Expiry Date.  
     
  — The Agent and Lenders consented to the Company’s entry into the Amendment with Silver Point and the Restated Credit Agreement thereunder.  

 

On March 25, 2013, the Company entered into Amendment No. 5 to Credit and Security Agreement and Limited Waiver (the “Revolving Loan Amendment No. 5”), which amends the Revolving Loan Agreement, with the Lenders and the Agent. The Company agreed to pay the Lenders an origination fee of 1.0% of the Lenders’ commitment under the Revolving Loan Amendment No. 5, or $350.

 

Among other things, the Revolving Loan Amendment No. 5 provides for the following:

 

  — An increase in the Revolving Loan Commitment amount from $30.0 million to $35.0 million;
     
  — The Applicable Margin was changed: (a) from 3.00% to 2.25% with respect to Revolving Loans bearing interest upon the Base Rate and (b) from 5.00% to 4.25% for all other Revolving Loans and Obligations;
     
  — The Commitment Expiry Date was extended to March 25, 2016;
     
  — Certain modifications were made to the definitions of Permitted Indebtedness and Prepayment Fee and the lockbox requirements; and
     
  — The Company was granted a waiver of certain prior Events of Default or Defaults under the Revolving Loan Agreement and a waiver of the requirement to comply with the Fixed Charge Coverage Ratio covenant for the Defined Period ending March 31, 2013.

 

The Company's outstanding debt consists of the following:

 

   March 31,
2013		   March 31,
2012		 
Current:          
Revolving line of credit  $30,000   $14,000 
Discount   (473)   (217)
   $29,527   $13,783 
           
Noncurrent:          
Term loan  $47,277   $45,000 
Discount   (1,747)   – 
   $45,530   $45,000 

 

 

The Company’s noncurrent debt matures as follows:

 

Year ending March 31,  Amount 
     
2014  $– 
2015   – 
2016   – 
2017  $47,277 
XML 56 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
5. INCOME TAXES (Details 1) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Income Taxes Details 1    
U.S. federal statutory income taxes $ (7,584) $ 2,654
State and local income taxes, net of federal benefits (1,245) 406
Change in valuation allowance 1,366 (2,975)
Warrants 1,085 516
Variable interest entity 237 (172)
Deferred tax adjustments 295 (593)
Other 40 25
Income tax provision (benefit) $ (5,806) $ (139)
XML 57 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
8. INCOME (LOSS) PER SHARE (Tables)
 12 Months Ended
Mar. 31, 2013
Income Loss Per Share Tables  
Schedule of Earnings Per Share

 

   Year ended March 31, 
   2013   2012 
Numerator:          
Net income attributable to          
Integrated Healthcare Holdings, Inc.  $(15,537)  $7,452 
           
Denominator:          
Weighted average common shares   255,307    255,307 
Dilutive options   –    1,533 
Denominator for diluted calculation   255,307    256,840 
           
Income per share - basic  $(0.06)  $0.03 
Income per share - diluted  $(0.06)  $0.03 

 
XML 58 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Mar. 31, 2012
Accounts receivable:    
Patient accounts receivable $ 83,964 $ 71,800
Allowance for doubtful accounts (21,143) (18,201)
Accounts receivable, net 62,821 53,599
Due from government payers:    
Settlement receivables    190
DSH 5,882 4,993
Total Amount due from Government 5,882 5,183
Due to government payers:    
Settlement payables 179   
Total Amount due to Government $ 179   
XML 59 R24.xml IDEA: 3. DEBT (Tables) 2.4.0.80024 - Disclosure - 3. DEBT (Tables)truefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_DebtTablesAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_ScheduleOfDebtTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">The Company's outstanding debt consists of the following:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <table align="center" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2013</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2012</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; font: 8pt Times New Roman, Times, Serif">Current:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Revolving line of credit</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">30,000</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">14,000</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Discount</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(473</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(217</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">29,527</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">13,783</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; font: 8pt Times New Roman, Times, Serif">Noncurrent:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Term loan</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">47,277</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">45,000</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Discount</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(1,747</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">45,530</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">45,000</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.No definition available.false03false 2us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company&#146;s noncurrent debt matures as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 60%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Year ending March 31,</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Amount</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 45%; text-align: center; font: 8pt Times New Roman, Times, Serif">2014</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 11%; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; font: 8pt Times New Roman, Times, Serif">2015</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; font: 8pt Times New Roman, Times, Serif">2016</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">2017</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">47,277</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601 false0false3. DEBT (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/DebtTables13 XML 60 R10.xml IDEA: 4. COMMON STOCK WARRANTS 2.4.0.80010 - Disclosure - 4. COMMON STOCK WARRANTStruefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_CommonStockWarrantsAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 4 - COMMON STOCK WARRANTS</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A summary of warrant activity for the years ended March 31, 2013 and 2012 is presented as follows.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; font: 8pt Times New Roman, Times, Serif">Weighted-</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; font: 8pt Times New Roman, Times, Serif">Shares issuable</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; font: 8pt Times New Roman, Times, Serif">average</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; font: 8pt Times New Roman, Times, Serif">Expiration</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">under warrants</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">exercise price</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">date</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 49%; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March 31, 2012 and 2011</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; text-align: right; font: 8pt Times New Roman, Times, Serif">405,000</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2013</font></td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Repurchased</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">(16,800</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2013</font></td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Issued</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">16,800</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2016</font></td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Amended (old expiration date)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">(388,200</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2013</font></td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 9pt; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Amended (new expiration date)</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">388,200</td><td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2016</font></td><td style="text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 0pt; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March 31, 2013</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif">405,000</td><td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif">0.07</td><td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">April 13, 2016</font></td><td style="text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 13, 2010 the Company issued three-year warrants (the &#147;Omnibus Warrants&#148;) to purchase its common stock at an exercise price of $0.07 per share in the following denominations: 139.0 million shares to KPC or its designees and 96.0 million shares to Silver Point or its designees. The Omnibus Warrants also provide the holders with certain pre-emptive, information and registration rights. As of April 13, 2010, the Company recorded warrant expense and the related warrant liability of $2.9 million, representing fair value.&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, on April 13, 2010, the Company issued a three-year warrant (the &#147;Release Warrant&#148;) to acquire up to 170.0 million shares of common stock at $0.07 per share to Dr. Chaudhuri who facilitated the release (see &#147;DEBT&#148;) enabling the Company to recover amounts due from its prior lender and a $1.0 million reduction in principal of its outstanding debt, among other benefits to the Company.&#160;&#160;The Release Warrant also provides the holder with certain pre-emptive, information and registration rights. During the year ended March 31, 2010, the Company recorded the fair value of $2.1 million as an offsetting cost of the recovery.&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 7, 2013, in connection with the Restated Credit Agreement, the Company entered into the following transactions<b> </b>involving warrants:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company entered into a Warrant Repurchase Agreement with SPCP Group IV, LLC pursuant to which it repurchased the outstanding common stock warrant issued to SPCP Group IV, LLC on or about April 13, 2010 (the &#147;Cancelled Warrant&#148;). The Cancelled Warrant (part of the Omnibus Warrants) entitled the holder to purchase an aggregate of 16.8 million shares of the Company&#146;s common stock at an exercise price of $0.07 per share. The Company repurchased the Cancelled Warrant for a purchase price of $0.12 per share minus the exercise price of $0.07 per share resulting in a net purchase price of $0.05 per share multiplied by 16.8 million shares for an aggregate purchase price of $840.9.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Immediately following the warrant repurchase, the Company issued a new common stock warrant (the &#147;New Warrant&#148;) to SPCP Group, LLC for a price of $0.05 per share (an aggregate price of $840.9) on the same terms as the Cancelled Warrant entitling the holder to purchase an aggregate of 16.8 million shares of common stock at an exercise price of $0.07 per share, except that the New Warrant expires on April 13, 2016.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Also simultaneous with the transactions described above, the Company extended the expiration date from April 13, 2013 to April 13, 2016 for the Omnibus Warrants issued to KPC and the remaining held by Silver Point (to purchase 79.2 million shares) and the Release Warrant issued to Dr. Chaudhuri. The extension of the warrant expiration date was intended to conform the terms of the warrants to that of the Restated Credit Agreement.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 66pt">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company assessed the amended credit agreement entered into in August 2012 and February 2013 under the provisions of ASC 470-50 and determined that the debt amendments should be accounted for as a debt modification. Accordingly, the recorded change in fair value as of February 7, 2013, totaling $534, of the New Warrant and the Omnibus Warrant held by SPCP Group, LLC was recognized as a component of the debt discount on the Term Loan (Note 3) and will be amortized to interest expense over the term of the debt agreement using the effective interest method.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The warrant expense relating to the Release Warrant and the Omnibus Warrant held by Dr. Chaudhuri for the years ended March 31, 2013 and 2012 was $1.7 million and $0, respectively. The change in fair value of the Release Warrant and the Omnibus was immediately charged to expense.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Omnibus Warrants, the Release Warrant, and the New Warrant are collectively referred to as the &#147;IHHI Warrants.&#148; As of March 31, 2013, the fair value of the IHHI Warrants was $5.3 million.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The net loss related to the change in fair value of the IHHI Warrants for the year ended March 31, 2013 and 2012 was $1.4 million and $1.5 million, respectively. The total loss on warrants was $3.1 million and $1.5 million for the years ended March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of warrants issued by the Company is estimated using the Black-Scholes valuation model, which it believes is the appropriate valuation method under the circumstances. Since the Company&#146;s stock is thinly traded, the expected volatility is based on an analysis of its stock and the stock of&#160;eight other publicly traded companies that own hospitals.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The risk-free interest rate is based on the average yield on U.S. Treasury notes with maturity commensurate with the terms of the warrants. The dividend yield reflects that the Company has not paid any cash dividends since inception and does not anticipate paying cash dividends in the foreseeable future.&#160;&#160;The assumptions used in the Black-Scholes valuation model are as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, 2013</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">February 7, 2013</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, 2012</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 49%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Expected dividend yield</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.0%</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.0%</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.0%</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Risk-free interest rate</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.4%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.4%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.2%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Expected volatility</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">39.9%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">40.3%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">57.3%</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Expected term (in years)</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">3.05</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">3.18</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">1.04</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5708775-113959 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624163-113959 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(n)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5708773-113959 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 25 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41635-113959 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4H -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624258-113959 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5618551-113959 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 30 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 30 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=7668309&loc=d3e80748-113994 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4E -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624181-113959 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 30 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7668309&loc=d3e80784-113994 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41620-113959 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4D -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624177-113959 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579245-113959 Reference 16: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1B -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5580258-113959 Reference 17: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579240-113959 Reference 18: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41641-113959 Reference 19: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41638-113959 Reference 20: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624171-113959 false0false4. COMMON STOCK WARRANTSUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/CommonStockWarrants12 XML 61 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
3. DEBT (Details 1) (USD $)
Mar. 31, 2013
Debt Tables  
2014   
2015   
2016   
2017 $ 47,277
XML 62 R5.xml IDEA: CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIENCY 2.4.0.80005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIENCYtruefalseIn Thousands, except Share data, unless otherwise specifiedfalse1false USDfalsefalse$From2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2011-04-01to2012-03-31http://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDtruefalse$AsOf2013-03-31_CommonStockMemberhttp://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00falsefalseCommon Stockus-gaap_StatementEquityComponentsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_CommonStockMemberus-gaap_StatementEquityComponentsAxisexplicitMemberSharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDtruefalse$AsOf2012-03-31_CommonStockMemberhttp://www.sec.gov/CIK0001051488instant2012-03-31T00:00:000001-01-01T00:00:00falsefalseCommon Stockus-gaap_StatementEquityComponentsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_CommonStockMemberus-gaap_StatementEquityComponentsAxisexplicitMemberSharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDtruefalse$AsOf2011-03-31_CommonStockMemberhttp://www.sec.gov/CIK0001051488instant2011-03-31T00:00:000001-01-01T00:00:00falsefalseCommon Stockus-gaap_StatementEquityComponentsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_CommonStockMemberus-gaap_StatementEquityComponentsAxisexplicitMemberSharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$6false USDtruefalse$AsOf2013-03-31_AdditionalPaidInCapitalMemberhttp://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00falsefalseAdditional Paid-In Capitalus-gaap_StatementEquityComponentsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_AdditionalPaidInCapitalMemberus-gaap_StatementEquityComponentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$7false USDtruefalse$AsOf2012-03-31_AdditionalPaidInCapitalMemberhttp://www.sec.gov/CIK0001051488instant2012-03-31T00:00:000001-01-01T00:00:00falsefalseAdditional Paid-In Capitalus-gaap_StatementEquityComponentsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_AdditionalPaidInCapitalMemberus-gaap_StatementEquityComponentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$8false USDtruefalse$AsOf2011-03-31_AdditionalPaidInCapitalMemberhttp://www.sec.gov/CIK0001051488instant2011-03-31T00:00:000001-01-01T00:00:00falsefalseAdditional Paid-In Capitalus-gaap_StatementEquityComponentsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_AdditionalPaidInCapitalMemberus-gaap_StatementEquityComponentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$9false USDtruefalse$From2011-04-01to2012-03-31_ReceivableFromStockholdersMemberhttp://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00falsefalseReceivableFromStockholdersus-gaap_StatementEquityComponentsAxisxbrldihttp://xbrl.org/2006/xbrldiIHCH_ReceivableFromStockholdersMemberus-gaap_StatementEquityComponentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$10false USDtruefalse$From2012-04-01to2013-03-31_RetainedEarningsMemberhttp://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00falsefalseAccumulated Deficitus-gaap_StatementEquityComponentsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_RetainedEarningsMemberus-gaap_StatementEquityComponentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$11false USDtruefalse$From2011-04-01to2012-03-31_RetainedEarningsMemberhttp://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00falsefalseAccumulated Deficitus-gaap_StatementEquityComponentsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_RetainedEarningsMemberus-gaap_StatementEquityComponentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$12false USDtruefalse$From2012-04-01to2013-03-31_NoncontrollingInterestMemberhttp://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00falsefalseNoncontrolling Interestus-gaap_StatementEquityComponentsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_NoncontrollingInterestMemberus-gaap_StatementEquityComponentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$13false USDtruefalse$From2011-04-01to2012-03-31_NoncontrollingInterestMemberhttp://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00falsefalseNoncontrolling Interestus-gaap_StatementEquityComponentsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_NoncontrollingInterestMemberus-gaap_StatementEquityComponentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1false 4us-gaap_SharesIssuedus-gaap_truenainstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse255307255307falsefalsefalse4truefalsefalse255307255307falsefalsefalse5truefalsefalse255307255307falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesNumber of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 false12false 4us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestus-gaap_truecreditinstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1truefalsefalse-11649000-11649USD$falsetruefalse2truefalsefalse-18561000-18561USD$falsetruefalse3truefalsefalse255000255USD$falsetruefalse4truefalsefalse255000255USD$falsetruefalse5truefalsefalse255000255USD$falsetruefalse6truefalsefalse6291100062911USD$falsetruefalse7truefalsefalse6291100062911USD$falsetruefalse8truefalsefalse6291100062911USD$falsetruefalse9truefalsefalse-882000-882USD$falsetruefalse10truefalsefalse-71828000-71828USD$falsetruefalse11truefalsefalse-79280000-79280USD$falsetruefalse12truefalsefalse-2987000-2987USD$falsetruefalse13truefalsefalse-1565000-1565USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568447-111683 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568740-111683 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4I -URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4590271-111686 false23false 4IHCH_PaymentReceivedOnReceivableFromStockholdersIHCH_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2truefalsefalse882000882falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9truefalsefalse882000882falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false24false 4us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-15861000-15861falsefalsefalse2truefalsefalse79440007944falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10truefalsefalse-15537000-15537falsefalsefalse11truefalsefalse74520007452falsefalsefalse12truefalsefalse-324000-324falsefalsefalse13truefalsefalse492000492falsefalsefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 false25false 4us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-2376000-2376falsefalsefalse2truefalsefalse-1914000-1914falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12truefalsefalse-2376000-2376falsefalsefalse13truefalsefalse-1914000-1914falsefalsefalsexbrli:monetaryItemTypemonetaryDecrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 false26false 4us-gaap_SharesIssuedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse255307255307falsefalsefalse4truefalsefalse255307255307falsefalsefalse5truefalsefalse255307255307falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesNumber of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 false17false 4us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse-29886000-29886USD$falsetruefalse2truefalsefalse-11649000-11649USD$falsetruefalse3truefalsefalse255000255USD$falsetruefalse4truefalsefalse255000255USD$falsetruefalse5truefalsefalse255000255USD$falsetruefalse6truefalsefalse6291100062911USD$falsetruefalse7truefalsefalse6291100062911USD$falsetruefalse8truefalsefalse6291100062911USD$falsetruefalse9falsefalsefalse00falsefalsefalse10truefalsefalse-87365000-87365USD$falsetruefalse11truefalsefalse-71828000-71828USD$falsetruefalse12truefalsefalse-5687000-5687USD$falsetruefalse13truefalsefalse-2987000-2987USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568447-111683 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568740-111683 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4I -URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4590271-111686 false2falseCONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIENCY (USD $)ThousandsNoRoundingUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/ConsolidatedStatementsOfStockholdersDeficiency137 XML 63 R55.htm IDEA: XBRL DOCUMENT v2.4.0.8
9. VARIABLE INTEREST ENTITY (Details Narrative) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Variable Interest Entity Details Narrative    
VIE, arrangements Concurrent with the close of the Acquisition, PCHI simultaneously acquired title to substantially all of the real property acquired by the Company in the Acquisition. The Company received $5.0 million and PCHI guaranteed the Company's $47.277 million term loan. The Company remains primarily liable as the borrower under the $47.277 million term loan notwithstanding its guarantee by PCHI. The $47.277 million term loan is cross-collateralized by substantially all of the Company's assets and all of the real property of the Hospitals. All of the Company's operating activities are directly affected by the real property that was sold to PCHI, which is a related party entity that is affiliated with the Company through common ownership and control.  
VIE, ownership As of March 31, 2013, PCHI was owned 51% by various physician investors and 49% by Ganesha, which is managed by Dr. Chaudhuri.  
VIE, Financial support $ 47,277  
Exposure amount, VIE As noted above, PCHI is a guarantor on the $47.277 million term loan should the Company not be able to perform. PCHI's total liabilities represent the Company's maximum exposure to loss. Additionally, the Company is responsible for seismic remediation under the terms of the lease agreement (Notes 2 and 13).  
Rental expense eliminated upon consolidation $ 7,800 $ 7,500
EXCEL 64 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\Y-#DY.#DV85]A-S5A7S0W,&9?8C1D9%]C93'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3E-/3$E$051%1%]35$%414U%3E137T]&7U-4 M3SPO>#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I7;W)K M#I7;W)K M#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C=?4D5425)%345.5%]03$%./"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C$P7U)%3$%4141?4$%25%E?5%)!3E-!0U1)3TY3 M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C-?1$5"5%]486)L97,\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I7;W)K#I7 M;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/CA? M24Y#3TU%7TQ/4U-?4$527U-(05)%7U1A8FQE#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/CE?5D%224%"3$5?24Y415)%4U1?14Y4 M25197U1A8CPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/C$S7T-/34U)5$U%3E137T%.1%]#3TY424Y'14Y#23$\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C%?1$530U))4%1)3TY? M3T9?0E5324Y%4U-?04Y$7S4\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I7;W)K#I7;W)K#I7;W)K M#I7;W)K#I7 M;W)K#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/C$S7T-/34U)5$U%3E137T%.1%]#3TY424Y'14Y#230\+W@Z3F%M93X- M"B`@("`\>#I7;W)K#I%>&-E;%=O#I. M86UE/@T*("`@(#QX.E=O#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C$P M7U)%3$%4141?4$%25%E?5%)!3E-!0U1)3TY37SPO>#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M6QE#I!8W1I=F53 M:&5E=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N M9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S M:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC'10 M87)T7SDT.3DX.39A7V$W-6%?-#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^26YT96=R871E9"!(96%L=&AC87)E M($AO;&1I;F=S($EN8SQS<&%N/CPO'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^665S M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2!0 M=6)L:6,@1FQO870\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S65R2!A&5S/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\"!A&5S('!A>6%B;&4\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0^)FYB2P@;F]N8W5R3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F5D/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,#`L,#`P/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\Y-#DY.#DV85]A-S5A7S0W,&9?8C1D9%]C93'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'!E;G-E'!E;G-E'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q M-"PX-3,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S"!B96YE9FET/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R,2PV M-C'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y-#DY M.#DV85]A-S5A7S0W,&9?8C1D9%]C93'0O:'1M;#L@8VAA&-E<'0@4VAA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$F%T:6]N(&]F(&1E8G0@9&ES8V]U M;G0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX M.3(\'!E M;G-E2!A;F0@97%U:7!M96YT/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,"PS-#`I/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S61O=VX@;VXI(')E=F]L=FEN9R!L:6YE(&]F(&-R961I="P@;F5T/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-2PT.3`\6UE;G0@=&\@;&5N9&5R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M/B@T-3`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)FYB6UE;G1S(&]N(&-A<&ET86P@;&5A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'`@6QE/3-$ M)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z M(#`N-6EN)SY"05-)4R!/1B!04D5314Y4051)3TX-"BT@5&AE(&%C8V]M<&%N M>6EN9R!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@:6YC;'5D M92!T:&4@86-C;W5N=',@;V8@26YT96=R871E9"!(96%L=&AC87)E($AO;&1I M;F=S+"!);F,N(&%N9"!I=',@28C,30X.RD@86YD(&AA=F4@8F5E;B!P2!A8V-E<'1E9"!I;@T*=&AE(%5N:71E9"!3=&%T97,@;V8@ M06UE'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^5&AE M($-O;7!A;GD@:&%S(&%L0T*1T%!4"!A;F0@=&AE($-O;7!A;GD@:7,@=&AE('!R:6UA2P@=&AE(&9I;F%N8VEA;"!S=&%T96UE M;G1S(&]F(%!#2$D@87)E(&EN8VQU9&5D(&EN('1H92!A8V-O;7!A;GEI;F<- M"F-O;G-O;&ED871E9"!F:6YA;F-I86P@6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O M;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SY!;&P@'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H-"@T*/'`@6QE/3-$)V-O;&]R.B!B;&%C:R<^3$E1 M54E$2519#0HM($%S(&]F($UA2!H860@82!T;W1A;"!S=&]C:VAO;&1E2!O9B`D,CDN.2!M:6QL:6]N(&%N9"`D,3$N-B!M:6QL:6]N+"!R97-P M96-T:79E;'DL#0IA;F0@82!W;W)K:6YG(&-A<&ET86P@9&5F:6-I="!O9B`D M,S8N-R!M:6QL:6]N(&%N9"`D,30N-B!M:6QL:6]N+"!R97-P96-T:79E;'DN M)B,Q-C`[)B,Q-C`[1F]R('1H92!Y96%R2!H860@)#4N,"!M:6QL:6]N(&EN(&%D9&ET:6]N86P-"F%V86EL86)I M;&ET>2!U;F1E2`H3F]T M92`S*2X@5&AE($-O;7!A;GD@86YT:6-I<&%T97,@;6%K:6YG('!A>6UE;G1S M(&9O2!A2`D,3`U+C@@;6EL;&EO;B!A;F0@ M&EM871E;'D-"B0R,S4N-2!M:6QL:6]N(&EN(')E M=F5N=65S(&9R;VT@=&AE(#PO9F]N=#X\9F]N="!S='EL93TS1"=C;VQO6QE/3-$)V-O M;&]R.B!B;&%C:R<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@6QE/3-$)V-O;&]R.B!B;&%C:R<^/"]F;VYT/CPO M<#X-"@T*/'`@2!A M8W%U:7)E9"!F;W5R(&AO2!O=VYS(&%N9"!O M<&5R871E6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\8G(@+SX-"CPO<#X-"@T*/'1A8FQE M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W!A9&1I M;F3L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W9E6QE/3-$)W!A9&1I M;F'0M86QI9VXZ(&IU6QE/3-$)W9E6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^4D5#3$%34TE&24-!5$E/3B!&3U(- M"E!215-%3E1!5$E/3B`M($-E2!T:&4@4W1A M=&4@;V8@0V%L:69O2!T:&4@2F]I M;G0@0V]M;6ES2!T;R!P87)T M:6-I<&%T92!I;B!V87)I;W5S(&=O=F5R;FUE;G1A;`T*86YD(&UA;F%G960@ M8V%R92!P6QE/3-$)V9O M;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE M'1E65R6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE M/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SY4:&4@0V]M<&%N>2!R96-E:79E2P@0V%L:69O2!O9B!P871I96YT2!F;W(@6EN9R!C;VYS;VQI9&%T960@9FEN M86YC:6%L('-T871E;65N=',@:&%V92!B965N('!R97!A2!E=F%L=6%T97,@=&AE(&%C8V]U;G1I;F<@<&]L:6-I97,@ M86YD(&5S=&EM871E2!F;W(@9F%I2!F6QE M/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE M/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SY0051)14Y4(%-%4E9)0T4@4D5614Y515,-"B8C,34P.R!0 M871I96YT('-E2!F;W(@<&%T:65N=',@8V]V M97)E9"!B>2!-961I8V%R92P@365D:6-A:60L#0IM86YA9V5D(&-A0T*9&\@;F]T(')E9FQE8W0@=VAA M="!A(&AO65D(&EN('1H92!C;VYS;VQI9&%T960@7!I8V%L;'D@ M<&%I9"!A;6]U;G1S('1H870@87)E(&YE9V]T:6%T960@=VET:"!I;G-U6UE;G1S(&%N9"!T;R!D971E'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;B<^5&AE(&9O;&QO=VEN9R!I6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQT86)L92!C96QL<&%D9&EN M9STS1#`@8V5L;'-P86-I;F<],T0P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$ M)V)O6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D M9&EN9RUB;W1T;VTZ(#%P=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)W=I9'1H.B`R-B4[(&-O;&]R.B!B M;&%C:SL@<&%D9&EN9RUL969T.B`P<'0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUL969T.B`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`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O'0M86QI9VXZ(&QE M9G0G/B0\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R M+C5P="!D;W5B;&4[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O'0M86QI9VXZ(&QE9G0G/B0\ M+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D M;W5B;&4[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T M>6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SY2979E;G5E2!O;B!P6UE;G1S+"!W M:&EC:"!A2!R97-O;'9E M9"X@17-T:6UA=&5S(&]F('-E='1L96UE;G0@65A7!I8V%L;'D@;F\@9G5R=&AE65A2!H87,@97-T86)L:7-H960@6UE M;G1S(&9R;VT@=&AE(%-T871E(&]F($-A;&EF;W)N:6$@=&\@6UE;G1S#0IO65A2X-"D%S M(&]F($UA2P@=VAI8V@@87)E(&EN8VQU9&5D(&%S#0ID=64@9G)O M;2!G;W9E65R6QE/3-$)V9O M;G0Z(#AP="!4:6UE6UE;G0@=&5R;7,@:6YV;VQV:6YG('!R M961E=&5R;6EN960@65R65RFEN9R!B:6QL:6YG(&1A=&$@;VX@86X@:6YD:79I9'5A M;"!P871I96YT(&)A0T* M:61E;G1I9FEC871I;VX@;V8@:6YS=&%N8V5S('=H97)E('-U8V@@97-T:6UA M=&5S(&YE960@=&\@8F4@2!A9&IU2!C87)E('1O('!A=&EE;G1S('=H;W-E(&EN8V]M92!L979E;"!I2!T;R!P87D@82!D M:7-C;W5N=&5D(')A=&4@=6YD97(@04(@-S6EN9R!F;W(@365D:6-A:60@86YD(&]T:&5R('!R;V=R86US M('1H97D@;6%Y(&)E(&5L:6=I8FQE(&9O2P@5FEC=&EM2!P871I96YT&EM871E;'D@ M)#@N,"!M:6QL:6]N(&%N9"`D-RXP(&UI;&QI;VXL(')E2X\ M+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T M>6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SY4:&4@0V]M<&%N>2!I2!M871E2!P87EE6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY04D]625-)3TX@1D]2($)!1"!$ M14)44PT*+2!4:&4@0V]M<&%N>2!P6EN M9PT*=F%L=64@;V8@F%B;&4@=F%L=64N(%1H92!(;W-P:71A;',@97-T:6UA M=&4@=&AI2!P871I96YT0T*8VAA;F=E(&%N9"!C86X@:&%V M92!A;B!I;7!A8W0@;VX@8V]L;&5C=&EO;B!T'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^5&AE($-O;7!A;GDG6EN9R!W:71H(&%L;"!F M961E2!%351!3$$L('!A=&EE;G1S(&UA>2!N;W0@ M8F4@9&5N:65D(&5M97)G96YC>2!TF%T:6]N(&]F('1H90T*<&%T:65N="!H87,@8F5G=6XL M('-E6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY#05-(($%.1"!#05-(($51 M54E604Q%3E13#0HM(%1H92!#;VUP86YY(&-O;G-I9&5R2!I;G-U'!E'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M3$545$52($]&($-2141)5"`F(S$U,#L-"D%T($UA2!H860@86X@;W5T'0M86QI9VXZ(&IU65R6QE M/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQT86)L92!C96QL<&%D9&EN9STS M1#`@8V5L;'-P86-I;F<],T0P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)V)O M6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@8V5N=&5R M.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`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`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O'0M86QI9VXZ(&QE9G0G/B0\ M+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D M;W5B;&4[(&9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4 M:6UE'0M86QI9VXZ(')I9VAT.R!F;VYT.B`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`\+W1D/CQT9"!S='EL M93TS1"=P861D:6YG+6)O='1O;3H@,7!T.R!C;VQO'0M M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT)SXU+#$X,SPO=&0^/'1D('-T>6QE/3-$)W!A M9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z M(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('!A9&1I;F6%B;&5S M/"]T9#X\=&0@6QE/3-$)V)O6QE/3-$)V-O M;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#%P=#L@9F]N=#H@.'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W!A M9&1I;F6QE/3-$)V-O;&]R.B!B M;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O'0M86QI9VXZ(&QE9G0G/B0\+W1D/CQT9"!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[(&9O;G0Z(#AP M="!4:6UE'0M86QI9VXZ M(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT)SXF(S$U,#L\+W1D/CQT9"!S='EL93TS1"=P861D:6YG+6)O M='1O;3H@,BXU<'0[(&-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@ M9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI M9VXZ(&-E;G1E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M5&AE($-O;7!A;GDF(S$T-CMS#0IS96QF+7!A>2!C;VQL96-T:6]N(')A=&4L M('=H:6-H(&ES('1H92!B;&5N9&5D(&-O;&QE8W1I;VX@&EM871E;'D@-BXU)2!A;F0@,3$N,R4@ M87,@;V8@36%R8V@F(S$V,#LS,2P@,C`Q,R!A;F0@,C`Q,BP@2!C;VQL96-T:6]N(')A=&5S(&EN8VQU9&4@ M<&%Y;65N=',-"FUA9&4@8GD@<&%T:65N=',L(&EN8VQU9&EN9R!C;RUP87EM M96YT2!P871I96YT2!B86QA;F-E(&%F=&5R(&EN2!B M86QA;F-E(&%F=&5R(&EN7,-"F%N9"!D M961U8W1I8FQE2!F;W(@365D:6-A:60L('1H92!R96-E:79A M8FQE2!D;R!N;W0@='EP:6-A;&QY(&AA=F4@82!M871E2!R96-O'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^24Y614Y43U))15,@3T8@4U504$Q)15,-"BT@ M26YV96YT;W)I97,@;V8@6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@ M=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$ M)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z M(#`N-6EN)SY04D]015)462!!3D0@15%525!-14Y4#0HM(%!R;W!EF5D(&%T(&-O6UE;G1S(&]R('1H92!F86ER('9A;'5E M(&]F('1H92!A65A2X\+W`^#0H-"CQP M('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O M;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SY,3TY'+4Q)5D5$($%34T544R`M#0I4:&4@0V]M<&%N>2!E=F%L=6%T M97,@:71S(&QO;F65R(&UI>"P@6QE/3-$)V9O;G0Z(#AP="!4 M:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V M,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY&04E2(%9!3%5%($U%05-5 M4D5-14Y44PT*+2!4:&4@0V]M<&%N>2=S(&9I;F%N8VEA;"!A2!F;W(@2!A M;F0@6QE/3-$)V9O;G0Z(#AP M="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF M(S$V,#L\+W`^#0H-"CQT86)L92!C96QL6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)W=I9'1H.B`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`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SY4:&4@9F]L;&]W:6YG('1A8FQE#0IS971S(&9O2!A6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T M>6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SX\+W`^#0H-"CQT86)L92!C96QL<&%D9&EN9STS1#`@ M8V5L;'-P86-I;F<],T0P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)V)O6QE/3-$ M)W9E6QE/3-$)W!A9&1I M;F6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@ M8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D M97(M8F]T=&]M.B!";&%C:R`Q<'0@6QE M/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#%P=#L@9F]N M=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&-E;G1E6QE M/3-$)W9E6QE/3-$)W!A M9&1I;F6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)W=I9'1H.B`S,B4[(&-O;&]R.B!B;&%C:SL@=&5X="UA;&EG M;CH@;&5F=#L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!P861D:6YG+6QE9G0Z M(#!P=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2!A="!-87)C:"`S,2P@,C`Q,SPO=&0^/'1D M('-T>6QE/3-$)W=I9'1H.B`R)3L@8V]L;W(Z(&)L86-K.R!P861D:6YG+6)O M='1O;3H@,BXU<'0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@8F]R M9&5R+6)O='1O;3H@0FQA8VL@,BXU<'0@9&]U8FQE.R!F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!C;VQO'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE'0M M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`Q M,R4[(&)O'0M86QI9VXZ(')I9VAT)SXF(S$U,#L\+W1D/CQT9"!S='EL93TS M1"=W:61T:#H@,24[('!A9&1I;F6QE/3-$)W=I M9'1H.B`R)3L@8V]L;W(Z(&)L86-K.R!P861D:6YG+6)O='1O;3H@,BXU<'0[ M(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F M=#L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!P861D:6YG+6QE9G0Z(#!P=#L@ M9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2!A="!-87)C:"`S,2P@,C`Q,CPO=&0^/'1D('-T>6QE M/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O'0M86QI9VXZ(&QE9G0G/B0\+W1D M/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B M;&4[(&9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V)O M'0M86QI9VXZ M(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT)SXQ+#8T,3PO=&0^/'1D('-T>6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@ M8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!A;&EG;CTS1&-E;G1E M6QE/3-$)W9E6QE/3-$)V-O;&]R.B!B;&%C:SL@8F]R9&5R+6)O M='1O;3H@0FQA8VL@,7!T('-O;&ED.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W=I9'1H.B`Q,R4[(&-O;&]R.B!B;&%C:SL@ M=&5X="UA;&EG;CH@'0M86QI M9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6QE9G0Z("TQ,7!T)SXQ M+#0W-#PO=&0^/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F M=#L@<&%D9&EN9RUL969T.B`M,3%P=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6QE9G0Z M("TQ,7!T.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W9E6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@ M<&%D9&EN9RUL969T.B`P<'0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@<&%D M9&EN9RUL969T.B`M,3%P=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6QE9G0Z("TQ,7!T M.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@ M;&5F=#L@<&%D9&EN9RUL969T.B`M,3%P=#L@9F]N=#H@.'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X M="UA;&EG;CH@;&5F=#L@<&%D9&EN9RUB;W1T;VTZ(#%P=#L@<&%D9&EN9RUL M969T.B`P<'0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T M;VTZ(#(N-7!T.R!P861D:6YG+6QE9G0Z("TQ,7!T.R!F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M:6YD M96YT.B`P+C5I;B<^061D:71I;VYA;"!Q=6%N=&ET871I=F4@:6YF;W)M871I M;VX@86)O=70-"DQE=F5L(#,@9F%I6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V9O M;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SY705)204Y44R`M(%1H92!#;VUP86YY#0IH87,@96YT97)E9"!I;G1O M(&-O;7!L97@@=')A;G-A8W1I;VYS('1H870@8V]N=&%I;B!W87)R86YT2!T M;R!E=F%L=6%T92!W:&5T:&5R#0II="!I2!I9B!I="!W97)E(&$@9G)E M97-T86YD:6YG#0II;G-T2!S=&]C M:R!M971H;V0L(&-O;G-I&5S(&]F("0P(&%N9"`D,30N,"!M:6QL:6]N(&1U M65A2X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4 M:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V M,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY4:&4@0V]M<&%N>2!E;G1E M"!B87-I2!AF%T:6]N(&]F(&1E9F5R"!A"!V M86QU871I;VX@86QL;W=A;F-E(&ES(')E<75I2!R M96-O"!A2P@2!D:60@ M;F]T(&UE970-"G1H92!M;W)E+6QI:V5L>2UT:&%N+6YO="!T:')E6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H- M"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@ M=&5X="UI;F1E;G0Z(#`N-6EN)SY4:&4@0V]M<&%N>2!A;F0@:71S#0IS=6)S M:61I87)I97,@9FEL92!I;F-O;64@=&%X(')E='5R;G,@:6X@=&AE(%4N4RX@ M9F5D97)A;"!J=7)I2!T87AI M;F<@875T:&]R:71I97,N($%N>2!P96YA;'1I97,@;W(@:6YT97)E&5S(&%R92!R96-O'0M86QI9VXZ(&IU2!A2P@=&AE($-O;7!A;GD@86=G'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^/&9O;G0@2!A9&]P=&5D($%3 M528C,38P.S(P,3$M,#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!!;F0@17%U:7!M96YT/"]S=')O;F<^/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O M;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^4')O M<&5R='D@86YD(&5Q=6EP;65N=`T*8V]N6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)O6QE/3-$ M)W9E6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)W=I9'1H.B`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`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X M="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)V-O;&]R.B!B M;&%C:SL@=&5X="UA;&EG;CH@'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE M6QE/3-$)W9E6QE/3-$)V-O M;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@<&%D9&EN9RUB;W1T;VTZ M(#%P=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W!A9&1I;F6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@ M;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M M86QI9VXZ(')I9VAT.R!F;VYT.B`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`^#0H- M"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@ M=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$ M)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z M(#`N-6EN)SY4:&4@2&]S<&ET86QS(&%R92!L;V-A=&5D#0II;B!A;B!A2!E87)T:'%U86ME(&EN6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T M>6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SY4:&4-"B!3=&%T92!O9B!#86QI9F]R;FEA#0IH87,@ M:6UP;W-E9"!H;W-P:71A;"!S96ES;6EC('-A9F5T>2!R97%U:7)E;65N=',N M(%5N9&5R('1H97-E(`T*6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$ M)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z M(#`N-6EN)SY4:&4-"B!3=&%T92!O9B!#86QI9F]R;FEA#0IH87,@82!S96ES M;6EC(')E=FEE=R!M971H;V1O;&]G>2!K;F]W;B!A2`R,#,P+B!4:&4@8V]S=',@;V8@;65E=&EN9R`- M"G1H97-E(')E<75I2!A;F0@8V]U;&0@:&%V92!A(&UA=&5R:6%L(&%D=F5R2!R M97-U;'0@:6X@8V5R=&%I;B!E;G9I'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\ M=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5VEN9V1I;F=S(#(G/B8C,34Q.SPO M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@.3(E.R!F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI M9VXZ(&IU6QE/3-$)V9O;G0M2!D871E(&9O'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\=&%B M;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5VEN9V1I;F=S(#(G/B8C,34Q.SPO9F]N M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@.3(E.R!F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ M(&IU6QE/3-$)V9O;G0M6UE;G1S('1H92!#;VUP86YY M(&UA:V5S(&]N('1H92!2979O;'9I;F<@0W)E9&ET($%G2!U;F1E6QE/3-$)V9O;G0Z(#AP="!4 M:6UE'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^5&5R;2!L;V%N("T@ M3VX@075G=7-T#0HQ+"`R,#$R+"!T:&4@0V]M<&%N>2!E;G1E3QF;VYT('-T>6QE/3-$)W1E>'0M=')A;G-F;W)M.B!U<'!E6QE/3-$)W1E M>'0M=')A;G-F;W)M.B!U<'!E6UE;G0@ M;V8@=&AE($-O;7!A;GDF(S$T-CMS(&]U='-T86YD:6YG("8C,30W.T$O4B!& M:6YA;F-I;F2!A9W)E960@=&\@<&%Y(%-I;'9EF5D(&]V97(@=&AE(')E;6%I;FEN9PT*;&EF M92!O9B!T:&4@;&]A;BX\+W`^#0H-"@T*#0H\<"!S='EL93TS1"=F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^3VX@1F5B6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SX\9F]N="!S='EL93TS1"=T97AT+71R86YS9F]R M;3H@=7!P97)C87-E)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P+C5I;B<^/&9O;G0@2!I;B!T:&4@9F]R;2!O M9B!T:&4@)B,Q-#<[06UE;F1E9"!A;F0@4F5S=&%T960@0W)E9&ET#0I!9W)E M96UE;G0@*"0T-RXR-S<@;6EL;&EO;B!497)M($QO86XI)B,Q-#@[(&%T=&%C M:&5D(&%S($5X:&EB:70@02!T;R!T:&4@06UE;F1M96YT("AT:&4@)B,Q-#<[ M4F5S=&%T960@0W)E9&ET($%G2!M861E('5N9&5R('9A2!A9W)E960@=&\@<&%Y(%-I;'9EF5D(&]V97(@=&AE(')E;6%I M;FEN9R!L:69E(&]F('1H92!L;V%N+B!$=7)I;F<@=&AE('EE87(@96YD960- M"DUA2!R96-O9VYI>F5D("0Q+C0@ M;6EL;&EO;B!I;B!L;V%N(&1I6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O M;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SY);B!A9&1I=&EO;BP@=&AE(&9O;&QO=VEN9PT*;F5W(&%M96YD;65N M=',@=V5R92!M861E('1O('1H92!#'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P+C5I;B<^/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP M861D:6YG/3-$,"!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N=#H@.'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3L@ M9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M3H@5VEN9V1I;F=S(#(G M/B8C,34Q.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@ M.3`E.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`P<'0[ M('1E>'0M86QI9VXZ(&IU2!$871E('=A M'1E;F1E9"!T;R!!<')I;"`Q,RP@,C`Q-BX@5&AE($-R961I="!!9W)E M96UE;G0@=V%S('!R979I;W5S;'D@9'5E('1O(&UA='5R92!O;B!!<')I;"`Q M,RP@,C`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`@/'1D('-T>6QE/3-$)W!A9&1I;F3L@9F]N=#H@.'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2!R M97!A:60@86QL(&%M;W5N=',@;W=I;F<@=&\@4U!#4"!'6QE/3-$ M)W!A9&1I;F'0M M86QI9VXZ(&IU6QE/3-$)W9E M6QE/3-$)W!A9&1I;F3L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P+C5I;B<^)B,Q-C`[)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;B<^/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P M(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N=#H@ M.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&IU28C,30V.W,@2!I6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F3H@5VEN9V1I;F=S(#(G/B8C,34Q.SPO9F]N=#X\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@=&5X="UA;&EG;CH@ M:G5S=&EF>3L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6UE;G0@9F5E('=A6UE;G1S('5N9&5R('1H92!#6UE;G1S M(&UA9&4@869T97(@2F%N=6%R>2`Q+"`R,#$T(&%N9"!B969O'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL M93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^4F5V;VQV:6YG(&QI;F4@;V8@8W)E9&ET#0HM($]N($%U M9W5S="`Q+"`R,#$R+"!T:&4@0V]M<&%N>2!E;G1E2!A9W)E960@=&\@<&%Y('1H92!, M96YD97)S#0IA;B!O6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE M/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SY/;B!&96)R=6%R>2`W+"`R,#$S+`T*=&AE($-O;7!A;GD@ M96YT97)E9"!I;G1O("8C,30W.T%M96YD;65N="!.;RX@-"!T;R!#'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^5&AE(%)E=F]L=FEN9R!,;V%N#0I!;65N9&UE;G0@3F\N M(#0@86UE;F1S('1H92!2979O;'9I;F<@3&]A;B!!9W)E96UE;G0L('1O(')E M9FQE8W0@=&AE(&9O;&QO=VEN9R!C:&%N9V5S.CPO<#X-"@T*/'`@6QE/3-$)V9O;G0Z(#AP="!4:6UE2<^/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG M/3-$,"!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N=#H@.'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E3L@9F]N=#H@ M.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3H@5VEN9V1I;F=S(#(G/B8C,34Q M.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@.3`E.R!P M861D:6YG+6QE9G0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@9F]N=#H@ M.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W9E6QE/3-$ M)W!A9&1I;F'0M M86QI9VXZ(&IU'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M9F%M:6QY.B!7:6YG9&EN9W,@,B<^)B,Q-3$[ M/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;F'1E;F1E9"!F6QE/3-$)W!A9&1I;F3L@9F]N=#H@ M.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)W9E6QE/3-$)W!A9&1I;F3L@9F]N=#H@.'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU28C,30V.W,@96YT6QE/3-$)V9O;G0Z(#AP="!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^3VX@36%R M8V@@,C4L(#(P,3,L#0IT:&4@0V]M<&%N>2!E;G1E2!A9W)E960@=&\@<&%Y('1H92!,96YD97)S M#0IA;B!O6QE/3-$ M)W=I9'1H.B`Q,#`E.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)W9E6QE/3-$)W=I M9'1H.B`W)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I;F6QE M/3-$)W=I9'1H.B`S)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I;F6QE/3-$)V9O;G0M M9F%M:6QY.B!7:6YG9&EN9W,@,B<^)B,Q-3$[/"]F;VYT/CPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4 M:6UE6QE/3-$)W9E6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU6QE/3-$)W9E6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP M="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!7:6YG9&EN M9W,@,B<^)B,Q-3$[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A M9&1I;F6QE/3-$ M)W9E6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[ M(&9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0M9F%M:6QY M.B!7:6YG9&EN9W,@,B<^)B,Q-3$[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W!A M9&1I;F6QE/3-$)W!A9&1I;F3H@5VEN9V1I;F=S(#(G/B8C,34Q.SPO9F]N=#X\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#!P=#L@=&5X M="UA;&EG;CH@:G5S=&EF>3L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E2!W87,@9W)A;G1E9"!A('=A:79E M6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY4:&4@0V]M<&%N>2=S(&]U M='-T86YD:6YG(&1E8G0@8V]N6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E'0M86QI9VXZ M(&QE9G0[(&9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE M9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q,R4[(&-O;&]R.B!B;&%C:SL@ M=&5X="UA;&EG;CH@'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP M="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q,R4[(&-O M;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@'0M86QI9VXZ(&QE M9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ M(#%P=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D M9&EN9RUB;W1T;VTZ(#%P=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E6QE/3-$)W!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXH,C$W/"]T9#X\ M=&0@6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O'0M86QI9VXZ(&QE9G0G/B0\ M+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D M;W5B;&4[(&9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O M;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!F;VYT.B`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`\+W1D/CQT9"!S='EL93TS1"=P M861D:6YG+6)O='1O;3H@,BXU<'0[(&-O;&]R.B!B;&%C:SL@=&5X="UA;&EG M;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M:6YD96YT.B`P+C5I;B<^5&AE($-O;7!A M;GDF(S$T-CMS(&YO;F-U6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E M6QE/3-$)W=I9'1H.B`T-24[('1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG M;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O M;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E'0M86QI M9VXZ(&QE9G0G/B0\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!" M;&%C:R`R+C5P="!D;W5B;&4[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W!A9&1I;F7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^/'`@6QE/3-$)V9O;G0Z(#AP="!4:6UE2!O9B!W87)R86YT#0IA8W1I=FET>2!F;W(@=&AE('EE87)S(&5N M9&5D($UA6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W!A9&1I;F&5R8VES92!P6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W=I M9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`R)3L@9F]N=#H@.'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4 M:6UE6QE M/3-$)W=I9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP M="!4:6UE6QE M/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'!I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4 M:6UE6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[(&9O;G0Z M(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F'0M:6YD96YT.B`P M+C5I;B<^)B,Q-C`[/"]P/@T*#0H-"@T*/'`@6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY/;B!!<')I;"`Q,RP@,C`Q M,"!T:&4-"D-O;7!A;GD@:7-S=65D('1H'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;B<^26X@861D:71I;VXL(&]N($%P65A65A'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^3VX@1F5B'0M86QI M9VXZ(&IU28C,30V.W,@8V]M;6]N('-T;V-K(&%T M(&%N#0IE>&5R8VES92!P&5R8VES92!P&5R8VES92!P'!I6QE/3-$ M)V9O;G0Z(#AP="!4:6UE2<^)B,Q-C`[/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^06QS;R!S:6UU;'1A;F5O=7,@=VET:`T* M=&AE('1R86YS86-T:6]N'!I2!3 M:6QV97(@4&]I;G0@*'1O('!U'!I6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#8V<'0G/B8C,38P.SPO<#X- M"@T*/'`@0T*-RP@,C`Q,RP@=&]T86QI;F<@)#4S-"P@;V8@ M=&AE($YE=R!787)R86YT(&%N9"!T:&4@3VUN:6)UF5D(&%S(&$@8V]M<&]N M96YT(&]F('1H90T*9&5B="!D:7-C;W5N="!O;B!T:&4@5&5R;2!,;V%N("A. M;W1E(#,I(&%N9"!W:6QL(&)E(&%M;W)T:7IE9"!T;R!I;G1E'!E M;G-E(&]V97(@=&AE('1E6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z M(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN M)SY4:&4@=V%R'!E;G-E#0IR96QA=&EN9R!T;R!T:&4@4F5L96%S M92!787)R86YT(&%N9"!T:&4@3VUN:6)U'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P+C5I;B<^5&AE(&YE="!L;W-S(')E;&%T960-"G1O('1H92!C:&%N9V4@ M:6X@9F%I28C,30V.W,@'0M86QI M9VXZ(&-E;G1E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M5&AE(')I6QE/3-$)W!A9&1I;F6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB M;W1T;VTZ(#%P=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z M(#AP="!4:6UE6EE;&0\+W1D/CQT9"!S='EL93TS1"=W:61T:#H@,B4[(&-O M;&]R.B!B;&%C:SL@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M86QI M9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT.R!F;VYT M.B`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`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`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M5&AE('!R97!A"UR96QA=&5D M(&%SF5D(&EN(&9U='5R92!P97)I M;V1S+B!4:&ES(&%S0T*:&%S(&UA9&4@"!A='1R:6)U=&5S(')E;&%T:6YG('1O M('1H92!I;G1E"!A6QE/3-$)V9O;G0Z(#AP="!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#AP="!4:6UE M"!P6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)V)O6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#%P=#L@9F]N M=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&-E;G1E6QE/3-$ M)W9E6QE/3-$)V-O;&]R.B!B;&%C:SL@ M=&5X="UA;&EG;CH@;&5F=#L@<&%D9&EN9RUL969T.B`P<'0[(&9O;G0Z(#AP M="!4:6UE"!P M6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E M6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D M9&EN9RUL969T.B`P<'0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP M="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O M;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`S-B4[(&-O M;&]R.B!B;&%C:SL@<&%D9&EN9RUL969T.B`P<'0[(&9O;G0Z(#AP="!4:6UE M6QE/3-$)W=I9'1H.B`R)3L@8V]L;W(Z(&)L86-K.R!F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@8V]L;W(Z(&)L86-K.R!T97AT+6%L M:6=N.B!L969T.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)W=I M9'1H.B`Q)3L@8V]L;W(Z(&)L86-K.R!T97AT+6%L:6=N.B!L969T.R!F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`R)3L@8V]L;W(Z(&)L86-K.R!F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@8V]L;W(Z(&)L86-K M.R!T97AT+6%L:6=N.B!L969T.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#%P M=#L@<&%D9&EN9RUL969T.B`P<'0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W!A M9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$ M)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#%P=#L@9F]N=#H@.'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V-O;&]R.B!B;&%C:SL@ M<&%D9&EN9RUB;W1T;VTZ(#%P=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE M/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUL969T.B`P<'0[(&9O;G0Z(#AP M="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!F;VYT.B`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`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)A8VMG6QE/3-$)V-O;&]R.B!B;&%C:SL@ M<&%D9&EN9RUB;W1T;VTZ(#%P=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI9VXZ(&-E;G1E6QE M/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#%P=#L@9F]N=#H@ M.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&-E;G1E6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@ M8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE&5S/"]T M9#X\=&0@'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q,R4[ M(&-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@'0M86QI9VXZ M(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`R)3L@8V]L;W(Z(&)L86-K M.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@8V]L;W(Z M(&)L86-K.R!T97AT+6%L:6=N.B!L969T.R!F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT.R!F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[ M(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA M;&EG;CH@6QE/3-$)V-O;&]R.B!B M;&%C:SL@=&5X="UA;&EG;CH@'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X M="UA;&EG;CH@'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B M;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@ M.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W9E6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X M="UA;&EG;CH@'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B M;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3PO=&0^/'1D('-T>6QE/3-$)V-O;&]R.B!B;&%C:SL@9F]N M=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI M9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B M;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP M="!4:6UE"!A9&IU6QE/3-$)V-O;&]R.B!B;&%C:SL@9F]N=#H@.'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&QE9G0[(&9O;G0Z M(#AP="!4:6UE'0M86QI9VXZ M(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG M;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB M;W1T;VTZ(#%P=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE M6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[('!A M9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)A8VMG'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^1&5F97)R960@:6YC;VUE('1A>&5S#0IR M969L96-T('1H92!T87@@969F96-T6QE/3-$)V)A8VMG6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#%P=#L@9F]N M=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&-E;G1E6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG M;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@6QE/3-$)W!A9&1I;F"!A6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$ M)W=I9'1H.B`V-B4[(&-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@ M9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&QE M9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q,R4[(&-O;&]R.B!B;&%C:SL@ M=&5X="UA;&EG;CH@'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4 M:6UE'0M M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q,R4[(&-O;&]R M.B!B;&%C:SL@=&5X="UA;&EG;CH@6QE/3-$)V-O;&]R.B!B;&%C:SL@ M=&5X="UA;&EG;CH@'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R M.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@ M9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V-O;&]R.B!B;&%C M:SL@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O M;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E&5S/"]T9#X\=&0@ M6QE M/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT.R!F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@ M;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F M=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI M9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA M;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$ M)V-O;&]R.B!B;&%C:SL@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N M=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V-O;&]R.B!B M;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT.R!F;VYT.B`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`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`P+C5I;B<^)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]P/@T*#0H\<"!S='EL M93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^5&AE(')E"!A"!A6QE/3-$)V9O;G0Z M(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN M)SXF(S$V,#LF(S$V,#L\+W`^#0H-"CQT86)L92!C96QL6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$ M)W=I9'1H.B`W)3L@<&%D9&EN9RUT;W`Z(#`N-S5P=#L@<&%D9&EN9RUR:6=H M=#H@,"XW-7!T.R!P861D:6YG+6QE9G0Z(#`N-S5P=#L@9F]N=#H@.'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`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`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP M('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SY!4U4@,C`P.2TP-BP@)B,Q-#<[26YC;VUE#0I4 M87AE'!E8W1E M9"!T;R!B92!T86ME;B!I;B!A('1A>"!R971U2!I;B!I;F-O;64@=&%X97,N($$@"!B96YE9FET'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^/&9O;G0@6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$ M)W!A9&1I;F6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4 M:6UEF5D(&EN8V]M M92!T87@@8F5N969I=',@870@=&AE(&)E9VEN;FEN9R!O9B!T:&4@>65A6QE/3-$)W=I9'1H.B`R)3L@9F]N=#H@.'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP M="!4:6UE6QE/3-$)W=I9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F=#L@9F]N M=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&QE9G0[(&9O M;G0Z(#AP="!4:6UE6QE/3-$)W9E"!P;W-I=&EO;G,@6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE"!P M;W-I=&EO;G,@6QE M/3-$)W!A9&1I;F'0M86QI9VXZ M(&QE9G0G/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E'0M86QI9VXZ(&QE9G0G/B0\+W1D/CQT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[ M(&9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0G/B0\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^/&9O;G0@6QE/3-$ M)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z M(#`N-6EN)SY!&EM871E;'D@ M)#(Q+C@@;6EL;&EO;B!O9B!U;G)E8V]G;FEZ960@:6YC;VUE('1A>"!B96YE M9FET'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;B<^)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;B<^5&AE($-O;7!A;GDF(S$T-CMS#0IN970@;W!E'!I2!B92!U M65A2!E;G1E7-I2=S('5T:6QI>F%T:6]N(&]F($Y/ M3"!A;F0-"F-R961I="!C87)R>69OF%B;&4L(&%N9"!R M96UO=F5D(&9R;VT@=&AE('-C:&5D=6QE(&]F(&1E9F5R&-E65A6QE/3-$)V9O;G0Z M(#AP="!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SY00TA)(%1!6"!35$%455,@+2!00TA)#0II2X-"D%C M8V]R9&EN9VQY+"!T:&4@86-C;VUP86YY:6YG(&-O;G-O;&ED871E9"!F:6YA M;F-I86P@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'`@ M6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY4:&4-"B!#;VUP86YY)W,@,C`P-@T* M4W1O8VL@26YC96YT:79E(%!L86X@*'1H92`B4&QA;B(I+"!W:&EC:"!I&EM=6T@86=G&EM=6T@#0IA9V=R96=A=&4@;G5M8F5R(&]F('-H87)E2`-"F]U='-T86YD:6YG(&]N($1E8V5M8F5R(#,Q(&]F('1H92!I M;6UE9&EA=&5L>2!P&EM=6T@86=G2!B96QI979E65A M6QE/3-$)V9O;G0Z M(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN M)SXF(S$V,#LF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4 M:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY7:&5N M#0H@=&AE(&UE87-U2`-"G1H M92!E>'!E8W1E9"!T97)M(&ES(&-A;&-U;&%T960@8GD@=&%K:6YG('1H92!S M=6T@;V8@=&AE#0IV97-T:6YG('1E6QE/3-$)V9O;G0Z(#AP="!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M3F\@;W!T:6]N'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^02!S=6UM M87)Y(&]F('-T;V-K#0IO<'1I;VX@86-T:79I='D@9F]R('1H92!Y96%R6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#LF(S$V M,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\+W`^#0H-"CQT86)L92!A M;&EG;CTS1&-E;G1E6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)W=I9'1H.B`S-24[(&-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@ M;&5F=#L@=&5X="UI;F1E;G0Z("TY<'0[('!A9&1I;F'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Y)3L@=&5X="UA;&EG M;CH@6QE/3-$)W=I9'1H.B`R)3L@ M9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI M9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@=&5X M="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)W=I9'1H M.B`Q)3L@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA M;&EG;CH@;&5F=#L@<&%D9&EN9RUB;W1T;VTZ(#%P=#L@=&5X="UI;F1E;G0Z M(#!P=#L@<&%D9&EN9RUL969T.B`Q,7!T.R!F;VYT.B`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`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@ M=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V-O M;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE M/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@<&%D9&EN9RUB M;W1T;VTZ(#%P=#L@=&5X="UI;F1E;G0Z(#!P=#L@<&%D9&EN9RUL969T.B`Q M,7!T.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'!I6QE/3-$)V)O'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^/'1D('-T>6QE M/3-$)V)O'0M86QI9VXZ(')I9VAT)SXH,3,U/"]T9#X\=&0@'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI9VXZ M(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI M9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E M6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X M="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z("TY<'0[('!A9&1I;F6QE M/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT.R!F M;VYT.B`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`Q,7!T.R!F;VYT.B`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`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`M.7!T.R!P861D:6YG+6QE9G0Z(#EP=#L@ M9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$ M)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO M=&0^/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXW+#4Y-3PO=&0^ M/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V-O M;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O'0M86QI9VXZ(&QE9G0G/B0\+W1D/CQT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[(&9O M;G0Z(#AP="!4:6UE6QE M/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT)SXM/&9O;G0@'0M86QI9VXZ(&QE9G0[ M(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('!A9&1I M;F'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4 M:6UE6QE/3-$)W!A9&1I;F6QE M/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O'0M86QI9VXZ(&QE9G0G/B8C,38P M.SPO=&0^/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/CQT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0[(&-O;&]R M.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O M;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@ M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y-#DY.#DV M85]A-S5A7S0W,&9?8C1D9%]C93'0O:'1M;#L@8VAA6QE/3-$)V9O;G0Z(#AP M="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY4 M:&4-"B!#;VUP86YY(&AA65E65E7,@;V8@2!I;F-U'!E;G-E2X@5&AE M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O M;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^26YC M;VUE("AL;W-S*2!P97(@2!D:79I M9&EN9R!T:&4@;F5T(&EN8V]M90T**&QO65A&EM871E;'D@-#$Q(&UI;&QI M;VX@6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP M="!4:6UE6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE M6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ M(#(N-7!T.R!T97AT+6%L:6=N.B!L969T.R!F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SXW+#0U,CPO=&0^/'1D('-T>6QE/3-$)W=I9'1H M.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!T97AT+6%L:6=N.B!L969T M.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O M;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W!A M9&1I;F6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^/'1D('-T>6QE M/3-$)V)O6QE/3-$ M)V)O6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F'0M M86QI9VXZ(')I9VAT)SXR-34L,S`W/"]T9#X\=&0@6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT M)SXR-38L.#0P/"]T9#X\=&0@6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP M="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4 M:6UE6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\Y-#DY.#DV85]A-S5A7S0W,&9?8C1D9%]C93'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M6QE M/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SY#;VYC=7)R96YT('=I=&@@=&AE#0IC;&]S92!O9B!T:&4@ M06-Q=6ES:71I;VXL(%!#2$D@2!A;&P@;V8@=&AE(')E86P@<')O<&5R='D@ M86-Q=6ER960@8GD@=&AE($-O;7!A;GD-"FEN('1H92!!8W%U:7-I=&EO;BX@ M5&AE($-O;7!A;GD@0T*2!00TA)+B!4 M:&4@)#0W+C(W-PT*;6EL;&EO;B!T97)M(&QO86X@:7,@8W)O2!A;&P@;V8@=&AE($-O;7!A;GDG M2!O9B!T:&4@ M2&]S<&ET86QS+@T*06QL(&]F('1H92!#;VUP86YY)W,@;W!E2!E;G1I='D@=&AA="!I2!V87)I;W5S('!H>7-I8VEA;B!I;G9E2!'86YE M'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^5&AE($-O;7!A;GD@96YT97)E9`T*:6YT;R!A(&QE87-E(&%G2!T:&4@6UE;G1S(&%R92!R961U M8V5D('1O("0W+C,@;6EL;&EO;BX@26X@861D:71I;VXL('1H92!#;VUP86YY M(&]F9G-E=',L(&%G86EN6UE;G1S('1O(%!#2$D@86YD(&]F9G-E='1I;F<@:6YT97)E6UE M;G1S(&%R92!E;&EM:6YA=&5D(&EN(&-O;G-O;&ED871I;VXN/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^1T%!4"!D969I;F5S('9A'!E8W1E9`T*6UE;G1S+"!R96UA:6YI;F<@<')I;6%R M:6QY#0IL:6%B;&4@=6YD97(@=&AE("0T-RXR-S<@;6EL;&EO;B!T97)M(&QO M86XL(&%N9"!C2=S(&YO;BUR96%L(&5S=&%T92!A6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)W9E6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE M/3-$)W9E6QE/3-$)W=I9'1H.B`V-B4[ M(&-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI M9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q,R4[(&-O;&]R.B!B M;&%C:SL@=&5X="UA;&EG;CH@'0M86QI9VXZ(&QE9G0[(&9O;G0Z M(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q,R4[ M(&-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@6QE M/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2P@;F5T M/"]T9#X\=&0@6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@ M9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X M="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)V-O;&]R.B!B M;&%C:SL@=&5X="UA;&EG;CH@'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG M;CH@;&5F=#L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#(N M-7!T.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O'0M86QI9VXZ(&QE M9G0G/B0\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R M+C5P="!D;W5B;&4[(&9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE M6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXT,2PR-3D\+W1D M/CQT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0[(&-O;&]R.B!B M;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4 M:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z M(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!F;VYT.B`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`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V-O M;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z M(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&9O;G0Z(#AP="!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXH-"PS M.#(\+W1D/CQT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T.R!C;VQO M'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V-O;&]R.B!B M;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O'0M86QI9VXZ(&QE9G0G/B0\+W1D/CQT9"!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[(&9O;G0Z(#AP M="!4:6UE'0M86QI M9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE2!I6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T M>6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SY00TA)(')E;G1A;"!I;F-O;64-"F%N9"!T:&4@0V]M M<&%N>28C,30V.W,@65A7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA2!4'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE M/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SY4:&4-"B!#;VUP86YY(&QE87-E2!A;&P@;V8@=&AE(')E86P@<')O<&5R='D@;V8@=&AE(&%C<75I2!V87)I;W5S M('!H>7-I8VEA;B!I;G9E2X@07,@9&5S8W)I8F5D(&EN($YO=&4@.2P@4$-( M22!I2P@ M=&AE(`T*0V]M<&%N>2!H87,@8V]N3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y-#DY.#DV85]A-S5A7S0W M,&9?8C1D9%]C93'0O:'1M M;#L@8VAA6QE M/3-$)V9O;G0Z(#AP="!4:6UE'0M:6YD96YT.B`P+C5I;B<^ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^26X@3V-T M;V)E2!T:&4@:&]S<&ET86P@:6YD=7-T M2!P M'!E;G-E6QE/3-$ M)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z M(#`N-6EN.R!C;VQO'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^26X@1&5C96UB97(@,C`Q,2P@0TU3#0IG879E(&9I;F%L M(&%P<')O=F%L(&9O6QE/3-$)V9O M;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SX\9F]N="!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^ M)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@'1E M;G-I;VX@;V8@=&AE(%%!1B!F;W(@=&AE('1H:7)T>2!M;VYT:"!P97)I;V0@ M9G)O;2!*=6QY(#$L(#(P,3$@=&AR;W5G:"!$96-E;6)E65A'!E;G-E2`Q M+"`R,#$Q('1H3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y M-#DY.#DV85]A-S5A7S0W,&9?8C1D9%]C93'0O:'1M;#L@8VAA6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE M'0M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S M=&EF>2<^4')O=FES:6]N2!A M;F0-"E)E:6YV97-T;65N="!!8W0@;V8@,C`P.2!P6UE;G1S('1O(&5L:6=I8FQE(&AO'0M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@ M:G5S=&EF>2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^0TU3 M#0H@:&%S(&5S=&%B;&ES:&5D('1H92!F:6YA;"!R=6QE('=H:6-H#0IR97%U M:7)E65A2!H879E M(&%D;W!T960@*&%C<75I3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\Y-#DY.#DV85]A-S5A7S0W,&9?8C1D9%]C93'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$6QE M/3-$)V9O;G0Z(#AP="!4:6UE2<^3D]412`Q,R`M M($-/34U)5$U%3E13($%.1"!#3TY424Y'14Y#2453/"]P/@T*#0H\<"!S='EL M93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE28C,30V.W,@:6YF;W)M871I;VX@=&5C:&YO;&]G M>2!S>7-T96US+CPO<#X-"@T*/'`@28C,30V.W,@<&5R2!S>7-T96US+B8C,38P.R8C,38P.TUC2V5S2!H87,@96YT97)E9"!I;G1O('1H92!A7-T96US#0IA;F0@ M=7!G'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^5&AE(&%G2!B92!T97)M:6YA=&5D(&)Y('1H92!#;VUP86YY('!R:6]R('1O M('1H92!I;FET:6%L(&5X<&ER871I;VX@9&%T92XF(S$V,#LF(S$V,#M4:&4@ M86=R965M96YT2X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H- M"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@ M=&5X="UI;F1E;G0Z(#`N-6EN)SY/4$52051)3D<@3$5!4T53($%.1`T*3$]. M1R!415)-($Q%05-%($-/34U)5$U%3E0@5TE42"!605))04),12!)3E1%4D53 M5"!%3E1)5%D@)B,Q-3`[($]N($%P2!A;F0@4$-(22!E;G1E2`D-RXX(&UI M;&QI;VXN($EF(%!#2$D@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY&;VQL;W=I;F<@:7,@ M82!S8VAE9'5L90T*;V8@=&AE($-O;7!A;GDG65A6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)W=I9'1H.B`V,B4[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@9F]N M=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I M9'1H.B`Q-24[('1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!F;VYT.B`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`N-6EN)SY4;W1A;"!R96YT86P@97AP M96YS90T**&5X8VQU9&EN9R!00TA)(')E;G0I(&9O65A&EM871E;'D@)#4V,R!A;F0@)#4U M,B!F;W(@=&AE('EE87)S(&5N9&5D($UA2P@=VAI8V@@:6YC;'5D92!B=6EL9&EN9W,@86YD(&QA;F0- M"G=I=&@@=&5R;7,@=&AA="!W97)E(&5X=&5N9&5D(&-O;F-U2!W M:71H('1H92!A6EN9R!C;VYS;VQI M9&%T960@8F%L86YC92!S:&5E=',@87,@;V8@36%R8V@@,S$L(#(P,3,@86YD M(#(P,3(L(')E2X@26YT97)E6UE;G1S(&%S M#0IO9B!-87)C:"`S,2P@,C`Q,SH\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)W9E M6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@9F]N=#H@.'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6UE;G1S/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)W9E6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`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`N-6EN)SY);B!A9&1I=&EO M;BP@=&AE($-O;7!A;GD-"FAA2!D971E M2!O9B!T:&ES(&%C8W)U86P@8GD@979A;'5A M=&EN9R!O=7(@;&EM:71E9"!H:7-T;W)I8V%L(&5X<&5R:65N8V4@86YD#0IT M2P@:6X@97-T M:6UA=&5D#0I)0DY2+CPO<#X-"@T*/'`@2!L87EE2!R:7-K6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T M>6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SY!6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)W=I9'1H.B`V-B4[(&-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@ M;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`R M)3L@8V]L;W(Z(&)L86-K.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)W=I M9'1H.B`Q)3L@8V]L;W(Z(&)L86-K.R!T97AT+6%L:6=N.B!L969T.R!F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI M9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@8V]L;W(Z M(&)L86-K.R!T97AT+6%L:6=N.B!L969T.R!F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$ M)W=I9'1H.B`R)3L@8V]L;W(Z(&)L86-K.R!F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@8V]L;W(Z(&)L86-K.R!T97AT+6%L:6=N.B!L M969T.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)W=I9'1H.B`Q M)3L@8V]L;W(Z(&)L86-K.R!T97AT+6%L:6=N.B!L969T.R!F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B M;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E6QE/3-$)V-O M;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^4%520TA!4T4@0T]-34E4345.5%,-"BT@5&AE M($-O;7!A;GD@:&%S(&-O;6UI=&UE;G1S('=I=&@@='=O('5N2!S97)V:6-E('!R;W9I9&5R('9E;F1O'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P+C5I;B<^54Y)3TX@0T].5%)!0U13("T@07!P0T*,S2XF(S$V,#LF(S$V,#LF(S$V,#L\+W`^#0H-"CQP('-T>6QE M/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SY&;W(@8F]T:"!U;FEO;G,L(&%L;`T*<')I;W(@9W)I979A M;F-E2!O2!A9V%I;G-T(&-L86EM2!I=',@8G5S:6YE2!E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2XF(S$V,#L@37,N($%V97)Y M('!U2!O=F5R=&EM92!W86=E2!F:6QE9"!A;B!A;G-W97(@=&\@=&AE(&-O;7!L86EN="P@9V5N97)A;&QY M(&1E;GEI;F<@86QL(&]F('1H92!P;&%I;G1I9F8G0T*,C4L(#(P,3`L(&$@<&]T96YT:6%L(&-L87-S M(&%C=&EO;B!L87=S=6ET('=A2US:71U871E9"!E;7!L;WEE97,@86YD M('1H92!C;VUP;&%I;G0@86QL96=E2`Q."P@,C`Q,2P-"G1H92!#;VUP86YY(&9I;&5D(&$@ M;6]T:6]N('1O(&-O;7!E;"!A2!O;B!* M=6YE(#(V+"`R,#$S+B!4:&4@0V]M<&%N>2!I;G1E;F1S('1O('9I9V]R;W5S M;'D@9&5F96YD(&ET2!I2!H879E(&]N(&ET M6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@ M=&5X="UI;F1E;G0Z(#`N-6EN)SY/;B!&96)R=6%R>2`Q,RP@,C`Q,RP-"G1H M92!J=7)Y(&EN($9I='IG:6)B;VYS('8N($E(2$DL(&5T+B!A;"XL(&%W87)D M960@)#4P,"PP,#`@:6X@<'5N:71I=F4@9&%M86=E28C,30V.W,-"G1O=&%L('9E28C,30V.W,@9F%V;W(@;F]T M=VET:'-T86YD:6YG('1H92!V97)D:6-T+@T*3VX@07!R:6P@,S`L(#(P,3,L M('1H92!T2!T:&4@=')I86P@:G5D9V4@2!W:&EC:"!$F=I8F)O;G,@ M=&]O:R!N;W1H:6YG(&)Y('=A>2!O9B!H:7,@8V]M<&QA:6YT(&%N9"!T:&4@ M0V]M<&%N>2!W87,@96YT:71L960@=&\@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SY);B!-87D@,C`Q,RP@0TU3#0IA<'!R;W9E9"!T:&4@ M;6%N86=E9"!C87)E('!O2`Q+"`R,#$Q('1H2`Q+"`R,#$R('1H6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE M/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SX\9F]N="!S='EL93TS1"=C;VQO2`D,C,U+C4@;6EL;&EO;B!I;@T*6QE/3-$)V-O;&]R.B`C,48T.3=$ M)SY3/"]F;VYT/CQF;VYT('-T>6QE/3-$)V-O;&]R.B!B;&%C:R<^=&%T92`H M)#6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^26X@2G5N92`R,#$S+`T*=&AE($-O M;7!A;GD@6UE;G1S(&9O2`Q+"`R,#$Q M('1H2!A;G1I8VEP871E2`D-C`N,"!M M:6QL:6]N(&EN(')E=F5N=65S(&9O2`Q M+"`R,#$R('1H6QE/3-$)V9O;G0Z(#AP="!4:6UE2`Q+"`R,#$S('1O($1E M8V5M8F5R(#,Q+"`R,#$S*2!O'0M:6YD96YT.B`P M+C5I;B<^26X@2G5N92`R,#$S+"!T:&4@0V]M<&%N>2!P86ED(&1O=VX@)#(U M#0IM:6QL:6]N(&]N(&ET'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0Z M(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SY"05-)4R!/1B!04D5314Y4051)3TX-"BT@5&AE(&%C8V]M<&%N>6EN M9R!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@:6YC;'5D92!T M:&4@86-C;W5N=',@;V8@26YT96=R871E9"!(96%L=&AC87)E($AO;&1I;F=S M+"!);F,N(&%N9"!I=',@28C,30X.RD@86YD(&AA=F4@8F5E;B!P2!A8V-E<'1E9"!I;@T*=&AE(%5N:71E9"!3=&%T97,@;V8@06UE M'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O M;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M5&AE($-O;7!A;GD@:&%S(&%L2!A M2!I2!B96YE9FEC:6%R>2!A;F0L(&%C8V]R9&EN9VQY+"!T:&4@9FEN86YC M:6%L('-T871E;65N=',@;V8@4$-(22!A6EN9PT*8V]N'!R97-S960@:6X@=&AO=7-A;F1S("AE>&-E<'0@<&5R('-H87)E(&%M M;W5N=',L('!E6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM M97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\9F]N="!S='EL M93TS1"=C;VQO65A M2!H860@;F5T(&EN8V]M92`H;&]S2P@86YD("AN96=A=&EV92D@ M<&]S:71I=F4@8V%S:"!F;&]W(&9R;VT-"F]P97)A=&EO;G,@;V8@)"@Y+C8I M(&UI;&QI;VX@86YD("0T+C4@;6EL;&EO;BP@0T*=6YD97(@:71S(')E=F]L=FEN M9R!C&EM871E M;'D@)#$P-2XX(&UI;&QI;VX@86YD(')E8V5I=FEN9R!A<'!R;WAI;6%T96QY M("0R,S4N-2!M:6QL:6]N(&EN#0IR979E;G5E2!A8W%U:7)E9"!F;W5R(&AO M'0M:6YD M96YT.B`P+C5I;B<^)B,Q-C`[)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'-P M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F;VYT.B`Q,7!T M($-A;&EBF4Z(#AP="<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W=I9'1H.B`Y,B4[('!A9&1I;F'0M86QI9VXZ(&IU6QE/3-$)W9E3L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E3L@;&EN92UH96EG:'0Z(#$Q-24G/CQF M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)W!A9&1I;FF4Z(#AP="<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W M(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY214-,05-3249)0T%424]. M#0I&3U(@4%)%4T5.5$%424].("T@0V5R=&%I;B!A;6]U;G1S('!R979I;W5S M;'D@'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P M/CQS<&%N/CPO'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^0T].0T5.5%)!5$E/ M3B!/1@T*4DE32R`M(%1H92!(;W-P:71A;',@87)E('-U8FIE8W0@=&\@;&EC M96YS=7)E(&)Y('1H92!3=&%T92!O9B!#86QI9F]R;FEA(&%N9"!A8V-R961I M=&%T:6]N(&)Y('1H92!*;VEN="!#;VUM:7-S:6]N+B!,;W-S(&]F(&5I=&AE M<@T*;&EC96YS=7)E(&]R(&%C8W)E9&ET871I;VX@=V]U;&0@:6UP86-T('1H M92!A8FEL:71Y('1O('!A2!O9B!T:&4@0V]M<&%N>2=S(')E=F5N=65S+CPO<#X- M"@T*/'`@65R65R'0M:6YD96YT M.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O M;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M5&AE($-O;7!A;GD@65R'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^55-% M($]&($535$E-051%4PT*+2!4:&4@86-C;VUP86YY:6YG(&-O;G-O;&ED871E M9"!F:6YA;F-I86P@0T*8V]S="!R97!O2!V87)Y(&9R;VT@=&AO'0^/'`@2!P86ED(&%M;W5N=',@=&AA="!A6UE;G0@=6YD97(@;6%N86=E M9"!C87)E(&-O;G1R86-T6UE;G1S M*2X@4VEN8V4@365D:6-A65R#0IC871E9V]R>2DL(&=R;W-S(&-H87)G97,@ M87)E(&%L6QE/3-$)V9O;G0Z(#AP M="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN M)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W=I9'1H.B`T."4[(&QI;F4M:&5I9VAT.B`Q,34E M)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`S)3L@;&EN92UH96EG M:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H M.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)W=I9'1H.B`R M,24[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O M;G0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U M)2<^/&9O;G0@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!A;F0@;W1H97(\+V9O;G0^/"]T9#X- M"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H M=#H@,3$U)2<^/&9O;G0@6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^ M#0H\+W1A8FQE/@T*/'`@6UE;G0@65A65A2!N;R!F=7)T:&5R('5P M9&%T97,@87)E(&UA9&4@=&\@=&AE#0IE'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`X<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^5&AE($AO65A2X-"D%S(&]F($UA2P@=VAI8V@@87)E(&EN8VQU9&5D(&%S#0ID=64@9G)O;2!G;W9E65R6QE/3-$)V9O;G0Z(#AP="]N;W)M M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^4F5V96YU97,@=6YD97(@;6%N86=E9`T* M8V%R92!P;&%N65A2DL(&%R92!B87-E9"!P2!T:&4@<&%Y97)S+B!4:&4@ M<&%Y97)S(&%R92!B:6QL960@9F]R('!A=&EE;G0@2!T:&4@<&%Y97)S#0IF;VQL;W=I;F<@=&AE:7(@2!D;V5S(&YO="!B96QI979E('1H97)E('=E'0M86QI M9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N M+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY4:&4@2&]S<&ET86QS('!R;W9I9&4- M"F-H87)I='D@8V%R92!T;R!P871I96YT2!B92!E;&EG:6)L92!F;W(L#0IS=6-H(&%S('-T M871E(&1I2!I M;F1I9V5N="!P2!P871I96YT&EM871E;'D@)#@N,"!M:6QL:6]N(&%N9"`D-RXP(&UI;&QI;VXL M(')E2X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N M;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF M(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM M97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY4:&4@0V]M<&%N M>2!I2!M871E2!P87EE'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^4%)/5DE324].($9/ M4B!"040-"D1%0E13("T@5&AE($-O;7!A;GD@<')O=FED97,@9F]R(&%C8V]U M;G1S(')E8V5I=F%B;&4@=&AA="!C;W5L9"!B96-O;64@=6YC;VQL96-T:6)L M92!B>2!E'!E6UE;G0-"G)A=&5S(&%N9"!T M:&4@;G5M8F5R(&]F('5N:6YS=7)E9"!A;F0@=6YD97)I;G-U6UE M;G1S('1O(&)E(&UA9&4@8GD@<&%T:65N=',@=VET:"!I;G-U2!%351! M3$$L('!A=&EE;G1S(&UA>2!N;W0@8F4@9&5N:65D(&5M97)G96YC>2!TF%T:6]N(&]F('1H M90T*<&%T:65N="!H87,@8F5G=6XL('-E6QE/3-$)V9O;G0Z M(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SY#05-(($%.1"!#05-(($5154E604Q%3E13#0HM(%1H92!#;VUP86YY M(&-O;G-I9&5R2!I;G-U'!E'0^/'`@0T*28C,30V.W,@8F]R2!U;F1E'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;B<^4D5#14E604),15,@04Y$($%,3$]704Y#10T*1D]2 M($1/54)41E5,($%#0T]53E13("8C,34P.R!4:&4@9F]L;&]W:6YG(&ES(&$@ M2!O9B!T:&4@<')I;F-I<&%L(&-O;7!O;F5N=',@;V8@86-C;W5N M=',@6QE/3-$)W9E M6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$ M,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\ M='(@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$ M)W=I9'1H.B`U-B4[('!A9&1I;F6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@ M;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W=I9'1H.B`R)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q M-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q."4[('1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)W!A9&1I;F6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M/&9O;G0@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U M<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U M<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E65R6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6%B;&5S/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^/&9O;G0@6QE/3-$)V)O6QE/3-$ M)V)O6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY4:&4@0V]M<&%N>28C M,30V.W,-"G-E;&8M<&%Y(&-O;&QE8W1I;VX@2`V+C4E(&%N9"`Q,2XS)2!A2!P871I96YT6UE;G1S(&%N9"!D961U M8W1I8FQE2P@;V8@ M'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O;F]R;6%L(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^4F5C96EV86)L M97,@9G)O;0T*<&%T:65N=',@=VAO(&%R92!P;W1E;G1I86QL>2!E;&EG:6)L M92!F;W(@365D:6-A:60@87)E(&-L87-S:69I960@87,@365D:6-A:60@<&5N M9&EN9R!U;F1E2!C87)E(&%N9"!W2!A;F0@ M861J=7-T960@=&\@=&AE:7(@;F5T(')E86QI>F%B;&4@=F%L=64@=&AR;W5G M:"!T:&4@<')O=FES:6]N(&9O2!D:69F97)E;G0@=&AA;B!T:&4@97-T M:6UA=&5D('!R;W9I7,@=V5R92!R97-E'0^/'`@'0^/'`@2!A;F0@97%U M:7!M96YT('5N9&5R(&-A<&ET86P@;&5A'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O;F]R;6%L(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^5&AE($-O;7!A;GD@=7-E M'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^3$].1RU,259%1"!!4U-%5%,-"BT@5&AE M($-O;7!A;GD@979A;'5A=&5S(&ET2!T:&4@0V]M M<&%N>2!T;R!B92!R96%S;VYA8FQE#0IA;F0@'!E;G-E M(&=R;W=T:"!R871E65R('!A>6UE;G0@<&%T=&5R;G,N/"]P/CQS<&%N/CPO6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N M+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY&04E2(%9!3%5%($U%05-54D5-14Y4 M4PT*+2!4:&4@0V]M<&%N>2=S(&9I;F%N8VEA;"!A2!F;W(@2!A M;F0@6QE/3-$)V9O;G0Z(#AP M="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN M)SXF(S$V,#L\+W`^#0H-"CQT86)L92!C96QL6QE/3-$)V9O;G0Z(#AP="!#86QI8G)I+"!(96QV971I M8V$L(%-A;G,M4V5R:68[('=I9'1H.B`Q,#`E.R!B;W)D97(M8V]L;&%P6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E.R!F;VYT+7-I>F4Z(#$Q<'0G/CQF;VYT('-T M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@;&EN92UH96EG:'0Z M(#$Q-24[(&9O;G0MF5S#0IT:&4@8F5S="!A=F%I;&%B;&4@ M:6YF;W)M871I;VX@:6X@;65A2!C=7)R96YT;'D@:&%S(&YO(&9I;F%N8VEA;"!O6QE/3-$)V9O;G0Z(#AP="]N M;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$ M)V)O6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L M6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$ M)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q M)3L@8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@;&EN92UH M96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q,R4[(&)O6QE/3-$)W=I9'1H.B`Q M)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@8F]R9&5R+6)O='1O M;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,R4[(&)O6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$ M)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE2!A="!- M87)C:"`S,2P@,C`Q,CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)V)O6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W M(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#LF(S$V,#L\+W`^ M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O M;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQT86)L M92!C96QL6QE/3-$)V9O M;G0Z(#AP="!#86QI8G)I+"!(96QV971I8V$L(%-A;G,M4V5R:68[('=I9'1H M.B`Q,#`E.R!B;W)D97(M8V]L;&%P6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\+W1R M/@T*/'1R('-T>6QE/3-$)W9E6QE M/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M/"]T6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG M:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE M/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H M=#H@,3$U)2<^/&9O;G0@6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0M:6YD M96YT.B`P+C5I;B<^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^5T%2 M4D%.5%,@+2!4:&4@0V]M<&%N>0T*:&%S(&5N=&5R960@:6YT;R!C;VUP;&5X M('1R86YS86-T:6]N&5D('1O(&%N(&5N=&ET>28C,30V M.W,@;W=N('-T;V-K+"!I="!I2!S96QL6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@ M=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$ M)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z M(#`N-6EN)SX\+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O M;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z M(#`N-6EN)SY)3D-/344@*$Q/4U,I(%!%4@T*0T]-34].(%-(05)%("8C,34P M.R!);F-O;64@*&QO2!T:&4@=V5I9VAT M960@879E2!T:&4@=V5I9VAT960@879E&5R8VES92!O9B!S=&]C:R!W87)R86YT2!T:&4@0V]M<&%N>2!F&5R8VES92!P M'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^4U504$Q%345.5$%,($-!4T@-"D9,3U<@ M24Y&3U)-051)3TX@+2!);G1E65A'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F M;VYT.B`X<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P+C5I;B<^5&AE($-O;7!A;GD@;6%D90T*8V%S:"!P87EM96YT'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^)B,Q-C`[/"]P/CQS<&%N/CPO'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^24Y# M3TU%(%1!6$53("T@1&5F97)R960-"FEN8V]M92!T87@@87-S971S(&%N9"!L M:6%B:6QI=&EE2!E;F%C=&5D('1A>"!R871E2!M971H;V0N(%1H92!#;VUP86YY(&%S M'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL M93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^5&AE"!P;W-I=&EO;B!T86ME;B!O'!E M8W1E9"!T;R!B92!T86ME;B!I;B!A('1A>"!R971U65A&EN9R!A=71H M;W)I=&EE'0^/'`@2!A2P@=&AE($-O;7!A M;GD@86=G'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^/&9O;G0@2!A9&]P=&5D M($%3528C,38P.S(P,3$M,#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'1A8FQE(&-E;&QS<&%C:6YG/3-$ M,"!C96QL<&%D9&EN9STS1#`@6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E M;G1E6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W=I9'1H.B`T."4[(&QI M;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG M:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H M.B`S)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT M('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`R,24[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE M:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT M('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT M('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S M='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!A;F0@;W1H M97(\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U M8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$ M)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/CPO='(^#0H\+W1A8FQE/CQS<&%N/CPO6QE/3-$)V9O;G0Z(#AP="!#86QI8G)I+"!(96QV971I M8V$L(%-A;G,M4V5R:68[('=I9'1H.B`Q,#`E.R!B;W)D97(M8V]L;&%P6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$-B!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E M;G1E6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q M<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W=I9'1H.B`R)3L@;&EN92UH M96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I M9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H M.B`Q."4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M/&9O;G0@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\ M9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH M96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)W!A9&1I;F6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q M<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@ M6QE/3-$)V)O6QE/3-$)V)O6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@ M6QE/3-$)W!A9&1I;F6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)V)O6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/CPO='(^#0H\='(@6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^/&9O;G0@6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R M+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\+W1A8FQE M/CQS<&%N/CPO6QE/3-$)V9O;G0Z(#AP="!#86QI8G)I+"!(96QV971I8V$L(%-A;G,M M4V5R:68[('=I9'1H.B`Q,#`E.R!B;W)D97(M8V]L;&%P6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$ M,B!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#AP="!4:6UE2!A="!-87)C:"`S,2P@,C`Q,SPO9F]N=#X\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@ M;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@8F]R9&5R+6)O='1O;3H@ M8FQA8VL@,BXR-7!T(&1O=6)L93L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT M('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q,R4[(&)O6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q M-24G/B8C,38P.SPO=&0^/"]T6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@ M9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@2`M(&9A:7(@=F%L=64@;65A6QE/3-$)V9O;G0Z(#AP="!#86QI8G)I+"!(96QV M971I8V$L(%-A;G,M4V5R:68[('=I9'1H.B`Q,#`E.R!B;W)D97(M8V]L;&%P M6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH M96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^/"]T6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N M="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R M+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y-#DY M.#DV85]A-S5A7S0W,&9?8C1D9%]C93'0O:'1M;#L@8VAA'0^/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS M1#`@6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@8V]L6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH M96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I M9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/CQF M;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE M+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG M:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z M(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN M92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M/&9O;G0@6QE/3-$)W9E6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE M/3-$)W9E6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O M;G0@6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)V9O M;G0Z(#AP="!4:6UE2!A;F0@97%U:7!M96YT+"!N970\+V9O;G0^/"]T M9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE M.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\+W1A8FQE/CQS<&%N/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$ M)W9E6QE/3-$)V-O;&]R.B!B;&%C:SL@ M9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`R)3L@8V]L;W(Z(&)L86-K.R!F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@8V]L;W(Z(&)L86-K.R!T97AT+6%L M:6=N.B!L969T.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$ M)W=I9'1H.B`Q)3L@8V]L;W(Z(&)L86-K.R!T97AT+6%L:6=N.B!L969T.R!F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`R)3L@8V]L;W(Z(&)L86-K.R!F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@8V]L;W(Z(&)L M86-K.R!T97AT+6%L:6=N.B!L969T.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@8V]L;W(Z(&)L86-K.R!T97AT+6%L M:6=N.B!L969T.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0[ M(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ M(#%P=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W!A9&1I;F6QE M/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP M="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O M;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N M=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I M9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA M;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V-O;&]R.B!B M;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN M9RUB;W1T;VTZ(#%P=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)V-O;&]R.B!B M;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#%P=#L@9F]N=#H@.'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W!A9&1I;F6QE/3-$)V-O M;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O'0M86QI9VXZ(&QE9G0G/B0\+W1D/CQT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[(&9O M;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT)SXT-2PP,#`\+W1D/CQT9"!S='EL93TS1"=P M861D:6YG+6)O='1O;3H@,BXU<'0[(&-O;&]R.B!B;&%C:SL@=&5X="UA;&EG M;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/CQS M<&%N/CPO6QE/3-$)V9O;G0Z(#AP="!4:6UE28C,30V.W,@;F]N8W5R6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4 M:6UE6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W!A9&1I;F6QE M/3-$)V)O'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^02!S=6UM87)Y(&]F('=A65A'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^)B,Q-C`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`Q,R4[('1E>'0M86QI M9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA M;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E6QE/3-$)W=I9'1H.B`Q)3L@=&5X M="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)W=I9'1H.B`Q,R4[('1E M>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F M=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE M/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4 M:6UE6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@,7!T.R!F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[ M(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@ M,BXU<'0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V9O M;G0Z(#AP="!4:6UE'0^/'`@6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@ M=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@ M6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X M="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`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`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`P+C5I;B<^)B,Q-C`[ M/"]P/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q M<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)W9E6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/CPO='(^#0H\='(@6QE/3-$)W=I9'1H.B`Q M)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W=I9'1H.B`R)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z M(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q."4[('1E>'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE M/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE M+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T M>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE M/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^/&9O;G0@6QE/3-$)V)O6QE M/3-$)V)O6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@2!F961E'0^/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL M<&%D9&EN9STS1#`@6QE/3-$)W9E6QE/3-$ M)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO M='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE&5S+"!N970@;V8@9F5D97)A;"!B96YE9FET M6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T M>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)W9E6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U M)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)W9E M3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z M(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N M="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE"!A M9&IU6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O M;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN M92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO M='(^#0H\='(@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V)O6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U M)2<^/&9O;G0@"!A6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)V)O6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\ M='(@6QE M/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q M-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@ M;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)W=I9'1H.B`Q,R4[('1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO M=&0^/"]T6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\ M9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z M(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E&5S/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N M="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^/&9O;G0@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T M>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH M96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M/&9O;G0@6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN M92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R M+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L M:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\+W1A8FQE/CQS<&%N/CPO"!B96YE9FET M'0^/'1A8FQE(&-E;&QS M<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@6QE/3-$)W9E M6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^ M#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/CPO='(^#0H\='(@6QE/3-$ M)W=I9'1H.B`V."4[(&QI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)W=I9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q,R4[('1E>'0M86QI M9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE M/3-$)W9E65A6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W!A9&1I;F"!P M;W-I=&EO;G,@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/CPO='(^#0H\='(@"!B96YE9FET6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^/&9O;G0@6QE M/3-$)V)O'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H M=#H@,3$U)2<^/&9O;G0@6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y-#DY.#DV85]A M-S5A7S0W,&9?8C1D9%]C93'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'`@ M2!O9B!S=&]C:PT*;W!T:6]N(&%C M=&EV:71Y(&9O65A'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^)B,Q-C`[)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^/"]P/@T*#0H\=&%B;&4@86QI9VX],T1C96YT97(@8V5L;'!A9&1I M;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P M6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E&5R8VES92!P6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E65A6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE M'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T M.R!P861D:6YG+6QE9G0Z(#EP=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE M'0M86QI9VXZ(')I M9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[ M(&9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Y)3L@8V]L;W(Z(&)L86-K.R!T97AT M+6%L:6=N.B!R:6=H=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE M6QE/3-$)W=I M9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`Y)3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`R)3L@9F]N=#H@.'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP M="!4:6UE'0M86QI9VXZ(&QE9G0[ M(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M:6YD96YT.B`P<'0[('!A9&1I;F6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@ M;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V-O;&]R.B!B;&%C M:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$ M)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z M(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@ M;&5F=#L@<&%D9&EN9RUB;W1T;VTZ(#%P=#L@=&5X="UI;F1E;G0Z(#!P=#L@ M<&%D9&EN9RUL969T.B`Q,7!T.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V-O M;&]R.B!B;&%C:SL@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z M(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N M=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('!A9&1I;F'0M:6YD96YT M.B`P<'0[('!A9&1I;F6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ M(#%P=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W!A9&1I;F6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@ M9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE M/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`M.7!T.R!P861D:6YG+6QE9G0Z(#EP=#L@9F]N=#H@.'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V-O;&]R.B!B;&%C:SL@ M9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R M.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP M="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O M;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('!A M9&1I;F'0M:6YD96YT.B`P<'0[('!A9&1I;F6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X M="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V-O M;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N M=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT M.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG M;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4 M:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@ M.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT M.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG M;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V-O;&]R.B!B;&%C M:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z M(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R M.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@<&%D9&EN9RUB;W1T;VTZ(#%P M=#L@=&5X="UI;F1E;G0Z(#!P=#L@<&%D9&EN9RUL969T.B`Q,7!T.R!F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'!I6QE/3-$ M)V)O'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0M86QI9VXZ(&QE9G0[(&9O M;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[ M(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE M9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ M(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@ M;&5F=#L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!T97AT+6EN9&5N=#H@+3EP M=#L@<&%D9&EN9RUL969T.B`Y<'0[(&9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O M;G0Z(#AP="!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V-O;&]R.B!B;&%C:SL@<&%D9&EN9RUB;W1T;VTZ(#(N M-7!T.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O'0M86QI9VXZ(&QE M9G0G/B0\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R M+C5P="!D;W5B;&4[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:R<^)B,Q-C`[/"]F;VYT/CPO=&0^ M/'1D('-T>6QE/3-$)W!A9&1I;F'0M M:6YD96YT.B`M.7!T.R!P861D:6YG+6QE9G0Z(#EP=#L@9F]N=#H@.'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E&5R8VES86)L92!A="!- M87)C:"8C,38P.S,Q+"`R,#$S/"]T9#X\=&0@'0M M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V)O M'0M86QI9VXZ(')I9VAT)SXP+C$X/"]T9#X\=&0@'0M86QI9VXZ(&QE M9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@ M<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE M/3-$)V)O'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT)SXQ+C<\+W1D/CQT9"!S='EL93TS1"=P861D M:6YG+6)O='1O;3H@,BXU<'0[(&-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@ M;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&QE M9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4 M:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\+W`^ M#0H-"@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P+C5I;B<^)B,Q-C`[/"]P/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^/'`@6QE/3-$)V)O6QE/3-$ M)W9E6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$ M)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ M(')I9VAT)SXH,34L-3,W/"]T9#X\=&0@'0M86QI9VXZ(&QE9G0[(&9O;G0Z M(#AP="!4:6UE6QE/3-$)W=I9'1H.B`R)3L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@8F]R9&5R+6)O M='1O;3H@0FQA8VL@,BXU<'0@9&]U8FQE.R!F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0G/B0\+W1D M/CQT9"!S='EL93TS1"=W:61T:#H@,3,E.R!B;W)D97(M8F]T=&]M.B!";&%C M:R`R+C5P="!D;W5B;&4[(&9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E M6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP M="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(')I9VAT)SXF(S$U,#L\+W1D/CQT9"!S='EL93TS1"=P M861D:6YG+6)O='1O;3H@,7!T.R!T97AT+6%L:6=N.B!L969T.R!F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(&QE M9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V)O'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP M="!4:6UE6QE/3-$)W9E6QE M/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP M="!4:6UE6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4 M:6UE6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA2!486)L97,\+W-T6QE/3-$)V)O M6QE M/3-$)W9E6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1E6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE M9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`R)3L@8V]L;W(Z(&)L86-K M.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@8V]L;W(Z M(&)L86-K.R!T97AT+6%L:6=N.B!L969T.R!F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT.R!F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@8V]L;W(Z(&)L86-K.R!T97AT+6%L M:6=N.B!L969T.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`R)3L@8V]L M;W(Z(&)L86-K.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q M)3L@8V]L;W(Z(&)L86-K.R!T97AT+6%L:6=N.B!L969T.R!F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I M9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$ M)W9E'0M86QI9VXZ M(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C M:SL@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE M6QE/3-$ M)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT.R!F;VYT M.B`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`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V)O'0M M86QI9VXZ(&QE9G0G/B0\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!";&%C:R`R+C5P="!D;W5B;&4[(&9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z M(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP M="!4:6UE6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)V9O;G0Z(#AP M="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C M:SL@=&5X="UA;&EG;CH@6QE M/3-$)V-O;&]R.B!B;&%C:SL@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE M6QE/3-$ M)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@6QE/3-$)V)O'0M86QI9VXZ(')I M9VAT)SXT.#@\+W1D/CQT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T M.R!C;VQO'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4 M:6UE6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXV-#$\+W1D/CQT M9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T.R!C;VQO'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE6QE/3-$ M)W9E6QE/3-$)V-O;&]R.B!B;&%C:SL@ M=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E6QE M/3-$)V-O;&]R.B!B;&%C:SL@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP="!4:6UE M'0M86QI9VXZ(&QE9G0[ M(&9O;G0Z(#AP="!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@=&5X="UA;&EG;CH@;&5F M=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI M9VXZ(')I9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V-O;&]R.B!B;&%C:SL@ M=&5X="UA;&EG;CH@;&5F=#L@9F]N=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0Z(#AP M="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O M;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!F;VYT.B`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`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^1F]L;&]W:6YG(&ES(&$@6UE;G1S+"!E>&-L=61I;F<@=&AE(&QO;F<@=&5R;2!L96%S92!C M;VUM:71M96YT('=I=&@@4$-(22P@=&AA="!H879E(&EN:71I86P-"F]R(')E M;6%I;FEN9R!N;VXM8V%N8V5L86)L92!L96%S92!T97)M&-E6QE/3-$)W=I9'1H.B`X M,"4[(&9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@9F]N M=#H@.'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E.R!F;VYT+7-I>F4Z(#$Q<'0G/CQF;VYT('-T>6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$ M)W9E6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@F4Z(#$Q<'0G/CQF M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@F4Z(#$Q<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!F M;VYT+7-I>F4Z(#$Q<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)3L@9F]N="US:7IE.B`Q M,7!T)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!F;VYT+7-I>F4Z(#$Q<'0G/CQF M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE M+6AE:6=H=#H@,3$U)3L@9F]N="US:7IE.B`Q,7!T)SX\9F]N="!S='EL93TS M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W9E6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)3L@9F]N="US:7IE.B`Q,7!T)SX\9F]N="!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\ M='(@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T* M/'1R('-T>6QE/3-$)W9E6UE;G1S/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@F4Z(#$Q<'0G/CQF;VYT M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO M='(^#0H\='(@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E.R!F;VYT+7-I>F4Z(#$Q<'0G/CQF;VYT('-T>6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)3L@9F]N="US:7IE.B`Q,7!T)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$ M)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!F M;VYT+7-I>F4Z(#$Q<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24[(&9O;G0M6QE/3-$)W9E6QE/3-$ M)V)OF4Z(#$Q<'0G/CQF;VYT('-T>6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0^/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN M9STS1#`@6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)W=I M9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^/"]T6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\+W1A8FQE/CQS<&%N/CPO M7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAAF%T M:6]N+"!296-E:79A8FQE(&%N9"!2979E;G5E($1I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M6%B;&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XQ-SD\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!A="!-87)C:"`S,2P@,C`Q,SPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)FYB2P@36%R8V@@ M,S$L(#(P,3(\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB M2P@36%R8V@@,S$L M(#(P,3(\+W1D/@T*("`@("`@("`\=&0@8VQA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2`M(&9A:7(@=F%L=64@;65A2!I;F-L=61E9"!I;B!E87)N:6YG3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\Y-#DY.#DV85]A-S5A7S0W,&9?8C1D9%]C93'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^)FYB2!A;F0@97%U:7!M96YT+"!G7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y-#DY M.#DV85]A-S5A7S0W,&9?8C1D9%]C93'0O:'1M;#L@8VAA'0^)FYB'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6EE M;&0\+W1D/@T*("`@("`@("`\=&0@8VQA'!E8W1E9"!V;VQA=&EL:71Y/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS.2XY,"4\'0^,R!Y96%R'0^,2!Y96%R(#$T(&1A>7,\'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S&5R8VES M92!P'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^07!R:6P@,3,L M(#(P,3,\'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^07!R:6P@,3,L(#(P,38\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!I'!I7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#"!A9&IU'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA"!A"!A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF5D(&EN8V]M92!T87@@8F5N969I M=',@870@=&AE(&)E9VEN;FEN9R!O9B!T:&4@>65A65AF5D(&EN M8V]M92!T87@@8F5N969I=',@870@=&AE(&5N9"!O9B!T:&4@>65A7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&5R8VES86)L92!A="!-87)C:"`S M,2P@,C`Q,BP@4VAA&5R8VES92!0 M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,2!Y96%R(#@@;6]N=&AS(#$R(&1A M>7,\65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\Y-#DY.#DV85]A-S5A7S0W,&9?8C1D9%]C M93'0O:'1M;#L@8VAA&-E<'0@4VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2P@;F5T/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#8S+#DX.#QS<&%N/CPO M'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\Y-#DY.#DV85]A-S5A7S0W,&9?8C1D9%]C93'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y M-#DY.#DV85]A-S5A7S0W,&9?8C1D9%]C93'0O:'1M;#L@8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\Y-#DY.#DV85]A-S5A7S0W,&9?8C1D9%]C93'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y-#DY M.#DV85]A-S5A7S0W,&9?8C1D9%]C93'0O:'1M;#L@8VAA2!L:6UI=#PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M&5R8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2=S(#(P,#8@4W1O8VL@26YC96YT:79E(%!L86X@*'1H M92`B4&QA;B(I+"!W:&EC:"!I2!O M9B!E86-H(&-A;&5N9&%R('EE87(@:6X@=&AE('!E&EM=6T@86=G2!O=71S=&%N9&EN9R!O;B!$96-E;6)E2!O9B!T:&4@9W)A;G0@9&%T92P@86YD(&%N(&%D9&ET:6]N86P@,2\Q M,B!O9B!T:&4@2!F;VQL;W=I;F<@65A'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y-#DY.#DV85]A-S5A7S0W M,&9?8C1D9%]C93'0O:'1M M;#L@8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y-#DY.#DV85]A M-S5A7S0W,&9?8C1D9%]C93'0O:'1M;#L@8VAA2!R96UA:6YS('!R M:6UA2!L:6%B;&4@87,@=&AE(&)OF5D(&)Y('-U8G-T86YT:6%L;'D@86QL M(&]F('1H92!#;VUP86YY)W,@87-S971S(&%N9"!A;&P@;V8@=&AE(')E86P@ M<')O<&5R='D@;V8@=&AE($AO2!T:&%T(&ES(&%F9FEL M:6%T960@=VET:"!T:&4@0V]M<&%N>2!T:')O=6=H(&-O;6UO;B!O=VYE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^07,@;V8@36%R8V@@,S$L(#(P,3,L(%!#2$D@ M=V%S(&]W;F5D(#4Q)2!B>2!V87)I;W5S('!H>7-I8VEA;B!I;G9E2!'86YE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2!N;W0@8F4@86)L M92!T;R!P97)F;W)M+B`@4$-(22=S('1O=&%L(&QI86)I;&ET:65S(')E<')E M2=S(&UA>&EM=6T@97AP;W-U2!I3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y-#DY.#DV85]A-S5A7S0W M,&9?8C1D9%]C93'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y-#DY.#DV85]A-S5A7S0W,&9? M8C1D9%]C93'0O:'1M;#L@ M8VAA&UL;G,Z;STS1")U XML 65 R39.xml IDEA: 4. COMMON STOCK WARRANTS (Details 1) 2.4.0.80039 - Disclosure - 4. COMMON STOCK WARRANTS (Details 1)truefalsefalse1false USDfalsefalse$From2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2false USDfalsefalse$From2011-04-01to2012-03-31http://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$3false USDfalsefalse$AsOf2011-03-31http://www.sec.gov/CIK0001051488instant2011-03-31T00:00:000001-01-01T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$4false USDtruefalse$From2012-04-01to2013-03-30_WarrantMemberhttp://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-30T00:00:00falsefalseWarrantsus-gaap_AwardTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_WarrantMemberus-gaap_AwardTypeAxisexplicitMemberSharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$5false USDtruefalse$AsOf2013-03-31_WarrantMember110219234http://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00falsefalseWarrantsus-gaap_AwardTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_WarrantMemberus-gaap_AwardTypeAxisexplicitMemberSharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$6false USDtruefalse$AsOf2012-03-31_WarrantMemberhttp://www.sec.gov/CIK0001051488instant2012-03-31T00:00:000001-01-01T00:00:00falsefalseWarrantsus-gaap_AwardTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_WarrantMemberus-gaap_AwardTypeAxisexplicitMemberSharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$7false USDtruefalse$AsOf2011-03-31_WarrantMemberhttp://www.sec.gov/CIK0001051488instant2011-03-31T00:00:000001-01-01T00:00:00falsefalseWarrantsus-gaap_AwardTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_WarrantMemberus-gaap_AwardTypeAxisexplicitMemberSharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$1false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse75957595falsefalsefalse2truefalsefalse82358235falsefalsefalse3truefalsefalse83708370falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse405000405000falsefalsefalse6truefalsefalse405000405000falsefalsefalse7truefalsefalse405000405000falsefalsefalsexbrli:sharesItemTypesharesNumber of options outstanding, including both vested and non-vested options.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i)-(ii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false12false 4IHCH_WarrantsRepurchasedDuringPeriodIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse-16800-16800falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesNo authoritative reference available.No definition available.false13false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse1680016800falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesThe number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false14false 4IHCH_WarrantsOutstandingAmendedOldExpirationDateIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse-388200-388200falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesNo authoritative reference available.No definition available.false15false 4IHCH_WarrantsOutstandingAmendedNewExpirationDateIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse388200388200falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesNo authoritative reference available.No definition available.false16false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse0.180.18USD$falsetruefalse2truefalsefalse0.180.18USD$falsetruefalse3truefalsefalse0.180.18USD$falsetruefalse4falsefalsefalse00falsefalsefalse5truefalsefalse0.070.07USD$falsetruefalse6truefalsefalse0.070.07USD$falsetruefalse7truefalsefalse0.070.07USD$falsetruefalsenum:perShareItemTypedecimalWeighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false37false 4IHCH_WarrantsWeightedAverageExercisePriceRepurchasedDuringPeriodIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse0.070.07USD$falsetruefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsenum:perShareItemTypedecimalNo authoritative reference available.No definition available.false38false 4us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse0.070.07USD$falsetruefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsenum:perShareItemTypedecimalWeighted average per share amount at which grantees can acquire shares of common stock by exercise of options.No definition available.false39false 4IHCH_WarrantExpirationDateOutstandingIHCH_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00April 13, 2016falsefalsefalse6falsefalsefalse00April 13, 2013falsefalsefalse7falsefalsefalse00April 13, 2013falsefalsefalsexbrli:stringItemTypestringNo authoritative reference available.No definition available.false010false 4IHCH_ExpirationDateRepurchasedIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00April 13, 2013falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringNo authoritative reference available.No definition available.false011false 4IHCH_ExpirationDateIssuedIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00April 13, 2016falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringNo authoritative reference available.No definition available.false012false 4IHCH_ExpirationDateAmendedOldExpirationDateIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00April 13, 2013falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringNo authoritative reference available.No definition available.false013false 4IHCH_ExpirationDateAmendedNewExpirationDateIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00April 13, 2016falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringNo authoritative reference available.No definition available.false0false4. COMMON STOCK WARRANTS (Details 1) (USD $)UnKnownNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://ihhioc.com/role/CommonStockWarrantsDetails1713 XML 66 R4.xml IDEA: CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 2.4.0.80004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONStruefalseIn Thousands, except Share data, unless otherwise specifiedfalse1false USDfalsefalse$From2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2011-04-01to2012-03-31http://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_IncomeStatementAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_HealthCareOrganizationRevenueus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse428100000428100USD$falsetruefalse2truefalsefalse402564000402564USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of revenues recognized by the entity from providing services to in-patients, outpatients, residents in facilities owned or operated by the entity, from insurance premiums, or from goods provided or services performed.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false23false 2us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebtsus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-44600000-44600falsefalsefalse2truefalsefalse-40368000-40368falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of the provision for bad debts related to patient service revenue.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 605 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=9156363&loc=SL9156442-115640 false24false 2us-gaap_HealthCareOrganizationPatientServiceRevenueus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse383500000383500falsefalsefalse2truefalsefalse362196000362196falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of revenue recognized for providing services to patients, net of provisions for contractual allowances and discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 605 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=9156363&loc=d3e8184-115640 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 605 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=9156363&loc=SL9156442-115640 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 605 -Section 50 -Paragraph 4 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=25502053&loc=SL9156464-115641 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 605 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=9156363&loc=d3e8195-115640 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 605 -Section 45 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=9156363&loc=SL9156442-115640 true25false 2us-gaap_OtherOperatingIncomeus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse33700003370falsefalsefalse2truefalsefalse30890003089falsefalsefalsexbrli:monetaryItemTypemonetaryThe total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false26false 2IHCH_TotalOperatingRevenueIHCH_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse386870000386870falsefalsefalse2truefalsefalse365285000365285falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false27true 2us-gaap_OperatingExpensesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse08false 3us-gaap_LaborAndRelatedExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse215552000215552falsefalsefalse2truefalsefalse218801000218801falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate amount of expenditures for salaries, wages, profit sharing and incentive compensation, and other employee benefits, including equity-based compensation, and pension and other postretirement benefit expense.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false29false 3us-gaap_SuppliesExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse5616000056160falsefalsefalse2truefalsefalse5506600055066falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of expense associated with supplies that were used during the current accounting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.14) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 false210false 3us-gaap_OtherCostAndExpenseOperatingus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse118055000118055falsefalsefalse2truefalsefalse7451500074515falsefalsefalsexbrli:monetaryItemTypemonetaryThe total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.3) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 3 -Article 5 false211false 3us-gaap_DepreciationAndAmortizationus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse39170003917falsefalsefalse2truefalsefalse42080004208falsefalsefalsexbrli:monetaryItemTypemonetaryThe current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false212false 3us-gaap_OperatingExpensesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse393684000393684falsefalsefalse2truefalsefalse352590000352590falsefalsefalsexbrli:monetaryItemTypemonetaryGenerally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.No definition available.true213false 3us-gaap_OperatingIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-6814000-6814falsefalsefalse2truefalsefalse1269500012695falsefalsefalsexbrli:monetaryItemTypemonetaryThe net result for the period of deducting operating expenses from operating revenues.No definition available.true214true 2IHCH_OtherIncomeExpenseAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse015false 3us-gaap_InterestIncomeExpenseNetus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-11752000-11752falsefalsefalse2truefalsefalse-10218000-10218falsefalsefalsexbrli:monetaryItemTypemonetaryThe net amount of operating interest income (expense).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.10) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 10 -Article 9 false216false 3IHCH_IncomeFromElectronicHealthRecordsIncentiveProgramIHCH_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;falsefalsefalse2truefalsefalse68020006802falsefalsefalsexbrli:monetaryItemTypemonetaryIncome from electronic health records incentive programNo definition available.false217false 3us-gaap_DerivativeGainLossOnDerivativeNetus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-3101000-3101falsefalsefalse2truefalsefalse-1474000-1474falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of increase (decrease) in the fair value of derivatives recognized in the income statement.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5618551-113959 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Subparagraph (a),(c),(d),(e) -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624171-113959 false218false 3us-gaap_OtherNonoperatingIncomeExpenseus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-14853000-14853falsefalsefalse2truefalsefalse-4890000-4890falsefalsefalsexbrli:monetaryItemTypemonetaryThe net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 9 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.9) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 true219false 3us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-21667000-21667falsefalsefalse2truefalsefalse78050007805falsefalsefalsexbrli:monetaryItemTypemonetarySum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)(1)(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 true220false 3us-gaap_IncomeTaxExpenseBenefitus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-5806000-5806falsefalsefalse2truefalsefalse-139000-139falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Income Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6515339 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 false221false 3us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-15861000-15861falsefalsefalse2truefalsefalse79440007944falsefalsefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 false222false 3us-gaap_NetIncomeLossAttributableToNoncontrollingInterestus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse324000324falsefalsefalse2truefalsefalse-492000-492falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of Net Income (Loss) attributable to noncontrolling interest.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4591551-111686 false223false 3us-gaap_ProfitLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-15537000-15537USD$falsetruefalse2truefalsefalse74520007452USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4591552-111686 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (a),(c) -URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4591551-111686 false224true 2us-gaap_EarningsPerShareAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse025false 3us-gaap_EarningsPerShareBasicus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-0.06-0.06USD$falsetruefalse2truefalsefalse0.030.03USD$falsetruefalsenum:perShareItemTypedecimalThe amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 55 -Paragraph 52 -URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.23) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 false326false 3us-gaap_EarningsPerShareDilutedus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-0.06-0.06USD$falsetruefalse2truefalsefalse0.030.03USD$falsetruefalsenum:perShareItemTypedecimalThe amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 false327true 2us-gaap_WeightedAverageNumberOfSharesOutstandingAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse028false 3us-gaap_WeightedAverageNumberOfSharesOutstandingBasicus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse255307255307falsefalsefalse2truefalsefalse255307255307falsefalsefalsexbrli:sharesItemTypesharesNumber of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Weighted-Average Number of Common Shares Outstanding -URI http://asc.fasb.org/extlink&oid=6528421 false129false 3us-gaap_WeightedAverageNumberOfDilutedSharesOutstandingus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse255307255307falsefalsefalse2truefalsefalse256840256840falsefalsefalsexbrli:sharesItemTypesharesThe average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256 false1falseCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)ThousandsNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://ihhioc.com/role/CondensedConsolidatedStatementsOfOperations229 XML 67 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 HtmlAndXml 52 282 1 false 20 0 false 4 false false R1.htm 0001 - Document - Document and Entity Information Sheet http://ihhioc.com/role/DocumentAndEntityInformation Document and Entity Information R1.xml true false R2.htm 0002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://ihhioc.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS R2.xml false false R3.htm 0003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://ihhioc.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) R3.xml false false R4.htm 0004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://ihhioc.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS R4.xml false false R5.htm 0005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIENCY Sheet http://ihhioc.com/role/ConsolidatedStatementsOfStockholdersDeficiency CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIENCY R5.xml false false R6.htm 0006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://ihhioc.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS R6.xml false false R7.htm 0007 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://ihhioc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES R7.xml false false R8.htm 0008 - Disclosure - 2. PROPERTY AND EQUIPMENT Sheet http://ihhioc.com/role/PropertyAndEquipment 2. PROPERTY AND EQUIPMENT R8.xml false false R9.htm 0009 - Disclosure - 3. DEBT Sheet http://ihhioc.com/role/Debt 3. DEBT R9.xml false false R10.htm 0010 - Disclosure - 4. COMMON STOCK WARRANTS Sheet http://ihhioc.com/role/CommonStockWarrants 4. COMMON STOCK WARRANTS R10.xml false false R11.htm 0011 - Disclosure - 5. INCOME TAXES Sheet http://ihhioc.com/role/IncomeTaxes 5. INCOME TAXES R11.xml false false R12.htm 0012 - Disclosure - 6. STOCK INCENTIVE PLAN Sheet http://ihhioc.com/role/StockIncentivePlan 6. STOCK INCENTIVE PLAN R12.xml false false R13.htm 0013 - Disclosure - 7. RETIREMENT PLAN Sheet http://ihhioc.com/role/RetirementPlan 7. RETIREMENT PLAN R13.xml false false R14.htm 0014 - Disclosure - 8. INCOME (LOSS) PER SHARE Sheet http://ihhioc.com/role/IncomeLossPerShare 8. INCOME (LOSS) PER SHARE R14.xml false false R15.htm 0015 - Disclosure - 9. VARIABLE INTEREST ENTITY Sheet http://ihhioc.com/role/VariableInterestEntity 9. VARIABLE INTEREST ENTITY R15.xml false false R16.htm 0016 - Disclosure - 10. RELATED PARTY TRANSACTIONS Sheet http://ihhioc.com/role/RelatedPartyTransactions 10. RELATED PARTY TRANSACTIONS R16.xml false false R17.htm 0017 - Disclosure - 11. HOSPITAL QUALITY ASSURANCE FEES (QAF) Sheet http://ihhioc.com/role/HospitalQualityAssuranceFeesQaf 11. HOSPITAL QUALITY ASSURANCE FEES (QAF) R17.xml false false R18.htm 0018 - Disclosure - 12. ELECTRONIC HEALTH RECORDS INCENTIVE PROGRAM Sheet http://ihhioc.com/role/ElectronicHealthRecordsIncentiveProgram 12. ELECTRONIC HEALTH RECORDS INCENTIVE PROGRAM R18.xml false false R19.htm 0019 - Disclosure - 13. COMMITMENTS AND CONTINGENCIES Sheet http://ihhioc.com/role/CommitmentsAndContingencies 13. COMMITMENTS AND CONTINGENCIES R19.xml false false R20.htm 0020 - Disclosure - 14. SUBSEQUENT EVENTS Sheet http://ihhioc.com/role/SubsequentEvents 14. SUBSEQUENT EVENTS R20.xml false false R21.htm 0021 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://ihhioc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) R21.xml false false R22.htm 0022 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://ihhioc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTables 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) R22.xml false false R23.htm 0023 - Disclosure - 2. PROPERTY AND EQUIPMENT (Tables) Sheet http://ihhioc.com/role/PropertyAndEquipmentTables 2. PROPERTY AND EQUIPMENT (Tables) R23.xml false false R24.htm 0024 - Disclosure - 3. DEBT (Tables) Sheet http://ihhioc.com/role/DebtTables 3. DEBT (Tables) R24.xml false false R25.htm 0025 - Disclosure - 4. COMMON STOCK WARRANTS (Tables) Sheet http://ihhioc.com/role/CommonStockWarrantsTables 4. COMMON STOCK WARRANTS (Tables) R25.xml false false R26.htm 0026 - Disclosure - 5. INCOME TAXES (Tables) Sheet http://ihhioc.com/role/IncomeTaxesTables 5. INCOME TAXES (Tables) R26.xml false false R27.htm 0027 - Disclosure - 6. STOCK INCENTIVE PLAN (Tables) Sheet http://ihhioc.com/role/StockIncentivePlanTables 6. STOCK INCENTIVE PLAN (Tables) R27.xml false false R28.htm 0028 - Disclosure - 8. INCOME (LOSS) PER SHARE (Tables) Sheet http://ihhioc.com/role/IncomeLossPerShareTables 8. INCOME (LOSS) PER SHARE (Tables) R28.xml false false R29.htm 0029 - Disclosure - 9. VARIABLE INTEREST ENTITY (Tables) Sheet http://ihhioc.com/role/VariableInterestEntityTables 9. VARIABLE INTEREST ENTITY (Tables) R29.xml false false R30.htm 0030 - Disclosure - 13. COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://ihhioc.com/role/CommitmentsAndContingenciesTables 13. COMMITMENTS AND CONTINGENCIES (Tables) R30.xml false false R31.htm 0031 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://ihhioc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) R31.xml false false R32.htm 0032 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) Sheet http://ihhioc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails1 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) R32.xml false false R33.htm 0033 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) Sheet http://ihhioc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails2 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) R33.xml false false R34.htm 0034 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) Sheet http://ihhioc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails3 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) R34.xml false false R35.htm 0035 - Disclosure - 2. PROPERTY AND EQUIPMENT (Details) Sheet http://ihhioc.com/role/PropertyAndEquipmentDetails 2. PROPERTY AND EQUIPMENT (Details) R35.xml false false R36.htm 0036 - Disclosure - 3. DEBT (Details) Sheet http://ihhioc.com/role/DebtDetails 3. DEBT (Details) R36.xml false false R37.htm 0037 - Disclosure - 3. DEBT (Details 1) Sheet http://ihhioc.com/role/DebtDetails1 3. DEBT (Details 1) R37.xml false false R38.htm 0038 - Disclosure - 4. COMMON STOCK WARRANTS (Details) Sheet http://ihhioc.com/role/CommonStockWarrantsDetails 4. COMMON STOCK WARRANTS (Details) R38.xml false false R39.htm 0039 - Disclosure - 4. COMMON STOCK WARRANTS (Details 1) Sheet http://ihhioc.com/role/CommonStockWarrantsDetails1 4. COMMON STOCK WARRANTS (Details 1) R39.xml false false R40.htm 0040 - Disclosure - 5. INCOME TAXES (Details) Sheet http://ihhioc.com/role/IncomeTaxesDetails 5. INCOME TAXES (Details) R40.xml false false R41.htm 0041 - Disclosure - 5. INCOME TAXES (Details 1) Sheet http://ihhioc.com/role/IncomeTaxesDetails1 5. INCOME TAXES (Details 1) R41.xml false false R42.htm 0042 - Disclosure - 5. INCOME TAXES (Details 2) Sheet http://ihhioc.com/role/IncomeTaxesDetails2 5. INCOME TAXES (Details 2) R42.xml false false R43.htm 0043 - Disclosure - 5. INCOME TAXES (Details 3) Sheet http://ihhioc.com/role/IncomeTaxesDetails3 5. INCOME TAXES (Details 3) R43.xml false false R44.htm 0044 - Disclosure - 6. STOCK INCENTIVE PLAN (Details) Sheet http://ihhioc.com/role/StockIncentivePlanDetails 6. STOCK INCENTIVE PLAN (Details) R44.xml false false R45.htm 0045 - Disclosure - 8. INCOME (LOSS) PER SHARE (Details) Sheet http://ihhioc.com/role/IncomeLossPerShareDetails 8. INCOME (LOSS) PER SHARE (Details) R45.xml false false R46.htm 0046 - Disclosure - 9. VARIABLE INTEREST ENTITY (Details) Sheet http://ihhioc.com/role/VariableInterestEntityDetails 9. VARIABLE INTEREST ENTITY (Details) R46.xml false false R47.htm 0047 - Disclosure - 13. COMMITMENTS AND CONTINGENCIES (Details) Sheet http://ihhioc.com/role/CommitmentsAndContingenciesDetails 13. COMMITMENTS AND CONTINGENCIES (Details) R47.xml false false R48.htm 0048 - Disclosure - 13. COMMITMENTS AND CONTINGENCIES (Details 1) Sheet http://ihhioc.com/role/CommitmentsAndContingenciesDetails1 13. COMMITMENTS AND CONTINGENCIES (Details 1) R48.xml false false R49.htm 0049 - Disclosure - 13. COMMITMENTS AND CONTINGENCIES (Details 2) Sheet http://ihhioc.com/role/CommitmentsAndContingenciesDetails2 13. COMMITMENTS AND CONTINGENCIES (Details 2) R49.xml false false R50.htm 0050 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative 1) Sheet http://ihhioc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative1 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative 1) R50.xml false false R51.htm 0051 - Disclosure - 2. PROPERTY AND EQUIPMENT (Details Narrative) Sheet http://ihhioc.com/role/PropertyAndEquipmentDetailsNarrative 2. PROPERTY AND EQUIPMENT (Details Narrative) R51.xml false false R52.htm 0052 - Disclosure - 6. STOCK INCENTIVE PLAN (Details Narrative) Sheet http://ihhioc.com/role/StockIncentivePlanDetailsNarrative 6. STOCK INCENTIVE PLAN (Details Narrative) R52.xml false false R53.htm 0053 - Disclosure - 7. RETIREMENT PLAN (Details Narrative) Sheet http://ihhioc.com/role/RetirementPlanDetailsNarrative 7. RETIREMENT PLAN (Details Narrative) R53.xml false false R54.htm 0054 - Disclosure - 8. INCOME (LOSS) PER SHARE (Details Narrative) Sheet http://ihhioc.com/role/IncomeLossPerShareDetailsNarrative 8. INCOME (LOSS) PER SHARE (Details Narrative) R54.xml false false R55.htm 0055 - Disclosure - 9. VARIABLE INTEREST ENTITY (Details Narrative) Sheet http://ihhioc.com/role/VariableInterestEntityDetailsNarrative 9. VARIABLE INTEREST ENTITY (Details Narrative) R55.xml false false R56.htm 0056 - Disclosure - 10. RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://ihhioc.com/role/RelatedPartyTransactionsDetailsNarrative 10. RELATED PARTY TRANSACTIONS (Details Narrative) R56.xml false false All Reports Book All Reports Process Flow-Through: 0002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Mar. 31, 2011' Process Flow-Through: 0003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 0004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: 0005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIENCY Process Flow-Through: 0006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS ihch-20130331.xml ihch-20130331.xsd ihch-20130331_cal.xml ihch-20130331_def.xml ihch-20130331_lab.xml ihch-20130331_pre.xml true true XML 68 R48.xml IDEA: 13. COMMITMENTS AND CONTINGENCIES (Details 1) 2.4.0.80048 - Disclosure - 13. COMMITMENTS AND CONTINGENCIES (Details 1)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$AsOf2013-03-31http://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1IHCH_CommitmentsAndContingenciesDetails1AbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYearus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse18730001873USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of minimum lease payments maturing in the remainder of the fiscal year following the latest fiscal year ended for capital leases.No definition available.false23false 2us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYearsus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse18990001899falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of minimum lease payments maturing in the second fiscal year following the latest fiscal year for capital leases.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737 false24false 2us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYearsus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse17500001750falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of minimum lease payments maturing in the third fiscal year following the latest fiscal year for capital leases.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737 false25false 2us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYearsus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse12760001276falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of minimum lease payments maturing in the forth fiscal year following the latest fiscal year for capital leases.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737 false26false 2us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYearsus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse932000932falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of minimum lease payments maturing in the fifth fiscal year following the latest fiscal year for capital leases.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737 false27false 2us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafterus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse42790004279falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of minimum lease payments maturing after the fifth fiscal year following the latest fiscal year for capital leases.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737 false28false 2us-gaap_CapitalLeasesFutureMinimumPaymentsDueus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1200900012009falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of minimum lease payments for capital leases.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737 false29false 2IHCH_LessAmountRepresentingInterestWeightedAverageInterestRateOf10.2IHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-4119000-4119falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false210false 2IHCH_NetPresentValueOfNetMinimumLeasePaymentsIHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse78900007890falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false211false 2IHCH_LessCurrentPortionIHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-1101000-1101falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false212false 2IHCH_NoncurrentPortionIHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse67890006789USD$falsetruefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false2false13. COMMITMENTS AND CONTINGENCIES (Details 1) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/CommitmentsAndContingenciesDetails1112 XML 69 R50.htm IDEA: XBRL DOCUMENT v2.4.0.8
1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative 1) (Medicare and Medicaid)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Medicare and Medicaid
    
Percentage of patient service revenue 58.00% 57.00%
XML 70 R45.htm IDEA: XBRL DOCUMENT v2.4.0.8
8. INCOME (LOSS) PER SHARE (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Numerator:    
Net income attributable to Integrated Healthcare Holdings, Inc. $ (15,537) $ 7,452
Denominator:    
Weighted average common shares 255,307 255,307
Denominator for diluted calculation 255,307 256,840
Income per share - basic $ (0.06) $ 0.03
Income per share - diluted $ (0.06) $ 0.03
Income Per Share
    
Numerator:    
Net income attributable to Integrated Healthcare Holdings, Inc. $ (15,537) $ 7,452
Denominator:    
Weighted average common shares 255,307 255,307
Dilutive options    1,533
Denominator for diluted calculation 255,307 256,840
Income per share - basic $ (0.06) $ 0.03
Income per share - diluted $ (0.06) $ 0.03
XML 71 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
In Thousands, except Share data, unless otherwise specified
Mar. 31, 2013
Mar. 31, 2012
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts (in Dollars) $ 21,143 $ 18,201
Current portion of Capial Lease Obligation (in Dollars) $ 1,101 $ 891
Common stock par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 800,000 800,000
Common stock, shares issued 255,307 255,307
Common stock, shares outstanding 255,307 255,307
XML 72 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
8. INCOME (LOSS) PER SHARE
 12 Months Ended
Mar. 31, 2013
Income Loss Per Share  
NOTE 8 - INCOME (LOSS) PER SHARE

NOTE 8 - INCOME (LOSS) PER SHARE

 

Income (loss) per share is calculated under two different methods, basic and diluted. Basic income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period. Diluted income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period and dilutive potential shares of common stock. Dilutive potential shares of common stock, as determined under the treasury stock method, consist of shares of common stock issuable upon exercise of stock warrants or options, net of shares of common stock assumed to be repurchased by the Company from the exercise proceeds.

 

Since the Company incurred a loss for the year ended March 31, 2013, the potential shares of common stock consisting of approximately 413 million shares issuable under warrants and stock options were not included in the diluted calculations since they were anti-dilutive.

 

Income per share for the year ended March 31, 2012 was computed as shown below. Stock options and warrants aggregating approximately 411 million shares were not included in the diluted calculation since they were anti-dilutive.

 

   Year ended March 31, 
   2013   2012 
Numerator:          
Net income attributable to          
Integrated Healthcare Holdings, Inc.  $(15,537)  $7,452 
           
Denominator:          
Weighted average common shares   255,307    255,307 
Dilutive options   –    1,533 
Denominator for diluted calculation   255,307    256,840 
           
Income per share - basic  $(0.06)  $0.03 
Income per share - diluted  $(0.06)  $0.03 

 
XML 73 R20.xml IDEA: 14. SUBSEQUENT EVENTS 2.4.0.80020 - Disclosure - 14. SUBSEQUENT EVENTStruefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1us-gaap_SubsequentEventsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_SubsequentEventsTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 14 &#150; SUBSEQUENT EVENTS (unaudited)</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In May 2013, CMS approved the managed care portion of the 2013 QAF for the period from July 1, 2011 through June 30, 2012. On June 26, 2013, CMS approved the managed care portion of the 2013 QAF for the period from July 1, 2012 through June 30, 2013.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="color: black">Based on the most recent modeling prepared by the California Hospital Association, the Company anticipates making payments for provider fees and other expenses relating to the 2013 QAF of approximately $105.8 million and receiving approximately $235.5 million in revenues from the </font><font style="color: #1F497D">S</font><font style="color: black">tate ($79.4 million from the fee-for-service portion and $156.1 million from the managed care portion).</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In June 2013, the Company received $72.1 million in managed care QAF payments for the period from July 1, 2011 through June 30, 2012 (Note 11). The Company anticipates receiving approximately $60.0 million in revenues for the period from July 1, 2012 through June 30, 2013.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company cannot provide any assurances or estimates in connection with CMS&#146;s final managed care approval of the 2013 QAF (for the period from July 1, 2013 to December 31, 2013) or a possible continuation of the QAF program beyond December 31, 2013.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In June 2013, the Company paid down $25 million on its revolving line of credit, resulting in an outstanding balance of $10 million.</p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.No definition available.false0false14. SUBSEQUENT EVENTSUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/SubsequentEvents12 XML 74 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIENCY (USD $)
In Thousands, except Share data, unless otherwise specified
 12 Months Ended 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Common Stock
Mar. 31, 2012
Common Stock
Mar. 31, 2011
Common Stock
Mar. 31, 2013
Additional Paid-In Capital
Mar. 31, 2012
Additional Paid-In Capital
Mar. 31, 2011
Additional Paid-In Capital
Mar. 31, 2012
ReceivableFromStockholders
Mar. 31, 2013
Accumulated Deficit
Mar. 31, 2012
Accumulated Deficit
Mar. 31, 2013
Noncontrolling Interest
Mar. 31, 2012
Noncontrolling Interest
Beginning Balance, Shares     255,307 255,307 255,307                
Beginning Balance, Amount $ (11,649) $ (18,561) $ 255 $ 255 $ 255 $ 62,911 $ 62,911 $ 62,911 $ (882) $ (71,828) $ (79,280) $ (2,987) $ (1,565)
Payment received on receivable from stockholders   882             882        
Net income (loss) (15,861) 7,944               (15,537) 7,452 (324) 492
Noncontrolling interest distributions (2,376) (1,914)                   (2,376) (1,914)
Ending Balance, Shares     255,307 255,307 255,307                
Ending Balance, Amount $ (29,886) $ (11,649) $ 255 $ 255 $ 255 $ 62,911 $ 62,911 $ 62,911   $ (87,365) $ (71,828) $ (5,687) $ (2,987)
XML 75 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Mar. 31, 2012
Current assets:    
Cash and cash equivalents $ 3,545 $ 11,829
Restricted cash 13 10
Accounts receivable, net of allowance for doubtful accounts of $21,143 and $18,201, respectively 62,821 53,599
Inventories of supplies 6,738 6,855
Due from governmental payers 5,882 5,183
Hospital quality assurance fee receivable 7,690 2,436
Prepaid insurance 115 366
Prepaid income taxes    892
Deferred tax assets, net 6,328   
Other prepaid expenses and current assets 9,208 8,186
Total current assets 102,340 89,356
Property and equipment, net 63,988 55,529
Deferred tax assets, net 380   
Total assets 166,708 144,885
Current liabilities:    
Revolving line of credit, net of discount 29,527 13,783
Accounts payable 62,515 52,700
Accrued compensation and benefits 19,634 19,847
Accrued insurance retentions 12,938 14,377
Hospital quality assurance payable 7,226   
Due to governmental payers 179   
Income taxes payable 2,869   
Other current liabilities 4,111 3,242
Total current liabilities 138,999 103,949
Debt, noncurrent, net of discount 45,530 45,000
Warrant liability, noncurrent 5,276 1,641
Capital lease obligations, net of current portion of $1,101 and $891, respectively 6,789 5,944
Total liabilities 196,594 156,534
Integrated Healthcare Holdings, Inc. stockholders' deficiency:    
Common stock, $0.001 par value; 800,000 shares authorized; 255,307 shares issued and outstanding 255 255
Additional paid in capital 62,911 62,911
Accumulated deficit (87,365) (71,828)
Total Integrated Healthcare Holdings, Inc. stockholders' deficiency (24,199) (8,662)
Noncontrolling interests (5,687) (2,987)
Total stockholders' deficiency (29,886) (11,649)
Total liabilities and stockholders' deficiency $ 166,708 $ 144,885
XML 76 R47.xml IDEA: 13. COMMITMENTS AND CONTINGENCIES (Details) 2.4.0.80047 - Disclosure - 13. COMMITMENTS AND CONTINGENCIES (Details)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$AsOf2013-03-31http://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1IHCH_CommitmentsAndContingenciesDetailsAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYearus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse16200001620USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of required minimum rental payments maturing in the remainder of the fiscal year following the latest fiscal year ended for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.No definition available.false23false 2us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYearsus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse13350001335falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of required minimum rental payments maturing in the second fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 55 -Paragraph 40 -Subparagraph (Note 3) -URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717 false24false 2us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYearsus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse12530001253falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of required minimum rental payments maturing in the third fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 55 -Paragraph 40 -Subparagraph (Note 3) -URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717 false25false 2us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYearsus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse12530001253falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of required minimum rental payments maturing in the forth fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 55 -Paragraph 40 -Subparagraph (Note 3) -URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717 false26false 2us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYearsus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse12530001253falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of required minimum rental payments maturing in the fifth fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 55 -Paragraph 40 -Subparagraph (Note 3) -URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717 false27false 2us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafterus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1162700011627falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of required minimum rental payments maturing after the fifth fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 55 -Paragraph 40 -Subparagraph (Note 3) -URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717 false28false 2us-gaap_OperatingLeasesFutureMinimumPaymentsDueus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse1834100018341USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 55 -Paragraph 40 -Subparagraph (Note 3) -URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717 false2false13. COMMITMENTS AND CONTINGENCIES (Details) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/CommitmentsAndContingenciesDetails18 XML 77 R7.xml IDEA: 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES 2.4.0.80007 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIEStruefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 1 - DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">BASIS OF PRESENTATION - The accompanying consolidated financial statements include the accounts of Integrated Healthcare Holdings, Inc. and its subsidiaries (collectively, the &#147;Company&#148;) and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#147;GAAP&#148;).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has also determined that Pacific Coast Holdings Investment, LLC ("PCHI") (Note 9), is a variable interest entity as defined by GAAP and the Company is the primary beneficiary and, accordingly, the financial statements of PCHI are included in the accompanying consolidated financial statements.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All significant intercompany accounts and transactions have been eliminated in consolidation. Unless otherwise indicated, all amounts included in these notes to the consolidated financial statements are expressed in thousands (except per share amounts, percentages and stock option prices and values).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="color: black">LIQUIDITY - As of March 31, 2013 and 2012, the Company had a total stockholders&#146; deficiency of $29.9 million and $11.6 million, respectively, and a working capital deficit of $36.7 million and $14.6 million, respectively.&#160;&#160;For the years ended March 31, 2013 and 2012, the Company had net income (loss) of $(15.5) million and $7.5 million, respectively, and (negative) positive cash flow from operations of $(9.6) million and $4.5 million, respectively. At March 31, 2013, the Company had $5.0 million in additional availability under its revolving credit facility (Note 3). The Company anticipates making payments for provider fees and other expenses relating to the 2013 hospital quality assurance fee program of approximately $105.8 million and receiving approximately $235.5 million in revenues from the </font><font style="color: #1F497D">S</font><font style="color: black">tate ($79.4 million from the fee-for-service portion and $156.1 million from the managed care portion) (Notes 11 and 14). The Company is reliant on funds received under the hospital quality assurance fee program and not receiving such funding could have a material adverse effect on its liquidity and financial position and value of its common stock.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="color: black">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="color: black"></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">DESCRIPTION OF BUSINESS - Effective March 8, 2005, the Company acquired four hospitals (the "Hospitals") from subsidiaries of Tenet Healthcare Corporation (the "Acquisition"). The Company owns and operates the four community-based hospitals located in southern California, which are:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><br /> </p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="width: 7%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="vertical-align: top; width: 3%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="width: 90%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">282-bed Western Medical Center in Santa Ana</font></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">188-bed Western Medical Center in Anaheim</font></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">178-bed Coastal Communities Hospital in Santa Ana</font></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">114-bed Chapman Medical Center in Orange</font></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RECLASSIFICATION FOR PRESENTATION - Certain amounts previously reported have been reclassified to conform to the current period's presentation with no impact on the reported net income of the Company.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">CONCENTRATION OF RISK - The Hospitals are subject to licensure by the State of California and accreditation by the Joint Commission on Accreditation of Healthcare Organizations. Loss of either licensure or accreditation would impact the ability to participate in various governmental and managed care programs, which provide the majority of the Company's revenues.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Substantially all patient service revenues come from external customers. The largest payers are Medicare and Medicaid (including Medicare and Medicaid managed care plans) and other state and local government payers, which combined accounted for 58% and 57% of the patient service revenues for the years ended March 31, 2013 and 2012, respectively. No other payers represent a significant concentration of the Company's patient services revenues.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company receives all of its inpatient services revenue from operations in Orange County, California. The economic conditions of this service area could affect the ability of patients and third-party payers to reimburse the Company for services through its effect on disposable household income and the tax base used to generate state funding for Medicaid programs.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">USE OF ESTIMATES - The accompanying consolidated financial statements have been prepared in accordance with GAAP. The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Principal areas requiring the use of estimates include third-party cost report settlements, income taxes, accrued insurance retentions, self-insurance reserves, and net patient receivables. Management regularly evaluates the accounting policies and estimates that are used. In general, management bases the estimates on historical experience and on assumptions that it believes to be reasonable given the particular circumstances in which its Hospitals operate. Although management believes that all adjustments considered necessary for fair presentation have been included, actual results may materially vary from those estimates.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">PATIENT SERVICE REVENUES &#150; Patient service revenues are recognized in the period in which services are performed and are recorded based on established billing rates (gross charges) less contractual allowances and discounts, principally for patients covered by Medicare, Medicaid, managed care, and other health plans. Gross charges are retail charges. They are not the same as actual pricing, and they generally do not reflect what a hospital is ultimately paid and therefore are not displayed in the consolidated statements of operations. Hospitals are typically paid amounts that are negotiated with insurance companies or are set by the government. Gross charges are used to calculate Medicare outlier payments and to determine certain elements of payment under managed care contracts (such as stop-loss payments). Since Medicare requires that a hospital's gross charges be the same for all patients (regardless of payer category), gross charges are also what the Hospitals charge all other patients prior to the application of discounts and allowances.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a summary of sources of patient service revenues (net of contractual allowances and discounts) before provision for doubtful accounts:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 70%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: -11pt; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="6" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Year ended March 31,</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: -11pt; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2013</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2012</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 26%; color: black; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Medicare</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">55,570</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">58,046</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Medicaid</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">100,561</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">80,153</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Managed care</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">203,058</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">201,758</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Indemnity, self-pay and other</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">68,911</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">62,607</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 2.5pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">428,100</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">402,564</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenues under the traditional fee-for-service Medicare and Medicaid programs are based primarily on prospective payment systems. Discounts for retrospectively cost based revenues and certain other payments, which are based on the Hospitals' cost reports, are estimated using historical trends and current factors. Cost report settlements for retrospectively cost-based revenues under these programs are subject to audit and administrative and judicial review, which can take several years until final settlement of such matters are determined and completely resolved. Estimates of settlement receivables or payables related to a specific year are updated periodically and at year end and at the time the cost report is filed with the fiscal intermediary. Typically no further updates are made to the estimates until the final Notice of Program Reimbursement is received, at which time the cost report for that year has been audited by the fiscal intermediary. There could be a time lag of several years between the submission of a cost report and receipt of the Final Notice of Program Reimbursement. Since the laws, regulations, instructions and rule interpretations governing Medicare and Medicaid reimbursement are complex and change frequently, the estimates recorded by the Hospitals could change by material amounts. The Company has established settlement (payables) receivables of $(179) and $190 as of March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Hospitals receive supplemental payments from the State of California to support indigent care (Medi-Cal Disproportionate Share Hospital payments or "DSH") and from the California Medical Assistance Commission ("CMAC") under the SB 1100 and SB 1255 programs. The Hospitals received supplemental payments of $13.4 million and $14.3 million during the years ended March 31, 2013 and 2012, respectively. The related revenue recorded for the years ended March 31, 2013 and 2012, was $14.3 million and $15.4 million, respectively. As of March 31, 2013 and 2012, estimated DSH receivables were $5.9 million and $5.0 million, respectively, which are included as due from government payers in the accompanying consolidated balance sheets.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenues under managed care plans, including Medicare and Medicaid managed care plans (with patient service revenues of $84.7 million and $84.2 million for the years ended March 31, 2013 and 2012, respectively), are based primarily on payment terms involving predetermined rates per diagnosis, per-diem rates, discounted fee-for-service rates and/or other similar contractual arrangements. These revenues are also subject to review and possible audit by the payers. The payers are billed for patient services on an individual patient basis. An individual patient's bill is subject to adjustment on a patient-by-patient basis in the ordinary course of business by the payers following their review and adjudication of each particular bill. The Hospitals estimate the discounts for contractual allowances utilizing billing data on an individual patient basis. Management believes the estimation and review process allows for timely identification of instances where such estimates need to be revised. The Company does not believe there were any adjustments to estimates of individual patient bills that were material to patient service revenues.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Hospitals provide charity care to patients whose income level is below 300% of the Federal Poverty Level. Patients with income levels between 300% and 350% of the Federal Poverty Level qualify to pay a discounted rate under AB 774 based on various government program reimbursement levels. Patients without insurance are offered assistance in applying for Medicaid and other programs they may be eligible for, such as state disability, Victims of Crime, or county indigent programs. Patient advocates from the Hospitals' Medical Eligibility Program ("MEP") screen patients in the hospital and determine potential linkage to financial assistance programs. They also expedite the process of applying for these government programs. The estimated costs of charity care (based on direct and indirect costs as a ratio of gross uncompensated charges associated with providing care to charity patients) for the years ended March 31,&#160;2013 and 2012 were approximately $8.0 million and $7.0 million, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is not aware of any material claims, disputes, or unsettled matters with any payers that would affect revenues that have not been adequately provided for in the accompanying consolidated financial statements.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">PROVISION FOR BAD DEBTS - The Company provides for accounts receivable that could become uncollectible by establishing an allowance to reduce the carrying value of such receivables to their estimated net realizable value. The Hospitals estimate this allowance based on the aging of their accounts receivable, historical collections experience for each type of payer and other relevant factors. There are various factors that can impact the collection trends, such as changes in the economy, which in turn have an impact on unemployment rates and the number of uninsured and underinsured patients, volume of patients through the emergency department, the increased burden of copayments to be made by patients with insurance and business practices related to collection efforts. These factors continuously change and can have an impact on collection trends and the estimation process.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company's policy is to attempt to collect amounts due from patients, including copayments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations, including, but not limited to, the Emergency Medical Treatment and Labor Act ("EMTALA"). Generally, as required by EMTALA, patients may not be denied emergency treatment due to inability to pay. Therefore, until the legally required medical screening examination is complete and stabilization of the patient has begun, services are performed prior to the verification of the patient's insurance, if any. In nonemergency circumstances or for elective procedures and services, it is the Hospitals' policy, when appropriate, to verify insurance prior to a patient being treated.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">CASH AND CASH EQUIVALENTS - The Company considers all highly liquid debt investments purchased with a maturity of three months or less to be cash equivalents. Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits. The Company has never experienced any losses related to these balances.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">LETTER OF CREDIT &#150; At March 31, 2013, the Company had an outstanding letter of credit totaling $761. This letter of credit correspondingly reduces the Company&#146;s borrowing availability under its revolving line of credit (Note 3).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RECEIVABLES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS &#150; The following is a summary of the principal components of accounts receivable and due from/to government payers as of March 31, 2013 and 2012:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 70%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="6" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31,</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2013</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2012</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Accounts receivable:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="width: 36%; color: black; text-align: left; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Patient accounts receivable</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">83,964</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">71,800</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Allowance for doubtful accounts</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(21,143</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(18,201</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Accounts receivable, net</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">62,821</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">53,599</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Due from government payers:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">DSH</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">5,882</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">4,993</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Settlement receivables</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">190</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">5,882</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">5,183</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Due to government payers:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Settlement payables</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">179</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">179</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#146;s self-pay collection rate, which is the blended collection rate for uninsured and balance after insurance accounts receivable, was approximately 6.5% and 11.3% as of March&#160;31, 2013 and 2012, respectively. These self-pay collection rates include payments made by patients, including co-payments and deductibles paid by patients with insurance. As of March&#160;31,&#160;2013 and 2012, the allowance for doubtful accounts for self-pay uninsured was 95.2% and 90.3%, respectively, of self-pay uninsured patient accounts receivable. As of March&#160;31,&#160;2013 and 2012, the allowance for doubtful accounts for self-pay balance after insurance was 78.0% and 77.4%, respectively, of self-pay balance after insurance patient accounts receivable, consisting primarily of co-pays and deductibles owed by patients with insurance. As of March 31, 2013 and 2012, the allowance for doubtful accounts for managed care was 20.3% and 16.1%, respectively, of managed care patient accounts receivable.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Receivables from patients who are potentially eligible for Medicaid are classified as Medicaid pending under the MEP, with appropriate contractual allowances recorded. If the patient does not qualify for Medicaid, the receivables are reclassified to charity care and written off, or they are reclassified to self-pay and adjusted to their net realizable value through the provision for bad debts. Reclassifications of pending Medicaid accounts to self-pay do not typically have a material impact on the results of operations as the estimated Medicaid contractual allowances initially recorded are not materially different than the estimated provision for bad debts recorded when the accounts are reclassified. All accounts classified as pending Medicaid, as well as certain other governmental receivables, over the age of 90 days were reserved in contractual allowances as of March 31, 2013 and 2012 based on historical collections experience.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">INVENTORIES OF SUPPLIES - Inventories of supplies are valued at the lower of weighted average cost or market.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and any impairment write-downs related to assets held and used. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Capital leases are recorded at the beginning of the lease term as property and equipment and a corresponding lease liability is recognized. The value of the property and equipment under capital lease is recorded at the lower of either the present value of the minimum lease payments or the fair value of the asset. Such assets, including improvements, are amortized over the shorter of the lease term or their estimated useful life, where applicable.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company uses the straight-line method of depreciation for buildings and improvements, and equipment over their estimated useful lives of 25 years and 3 to 15 years, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">LONG-LIVED ASSETS - The Company evaluates its long-lived assets for possible impairment whenever circumstances indicate that the carrying amount of the asset, or related group of assets, may not be recoverable from estimated future undiscounted cash flows. Fair value estimates are derived from established market values of comparable assets or internal calculations of estimated undiscounted future net cash flows. The estimates of future net cash flows are based on assumptions and projections believed by the Company to be reasonable and supportable. These assumptions take into account patient volumes, changes in payer mix, revenue, and expense growth rates and changes in legislation and other payer payment patterns.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FAIR VALUE MEASUREMENTS - The Company's financial assets and liabilities recorded in the consolidated balance sheets include cash and cash equivalents, restricted cash, receivables, debt, accounts payable, and other liabilities, all of which are recorded at book value which approximates fair value.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">GAAP has established a hierarchy for ranking the quality and reliability of the information used to determine fair values and requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 7%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 10%; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Level 1:</font></td> <td style="width: 83%; text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Unadjusted quoted market prices in active markets for identical assets or liabilities.</font></td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Level 2:</font></td> <td style="text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.</font></td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Level 3:</font></td> <td style="text-align: justify; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Unobservable inputs for the asset or liability.</font></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company utilizes the best available information in measuring fair value.&#160;&#160;Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company currently has no financial or nonfinancial assets or liabilities subject to fair value measurement on a recurring basis except for warrants issued in April 2010 and February 2013 (Note 4).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth the Company&#146;s financial assets and liabilities measured at fair value on a recurring basis and where they are classified within the hierarchy as of March 31, 2013 and 2012:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Total</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Level 1</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Level 2</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="color: black; text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Level 3</td><td style="padding-bottom: 1pt; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 32%; color: black; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Warrant liability at March 31, 2013</td><td style="width: 2%; color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="width: 13%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">5,276</td><td style="width: 1%; padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="width: 13%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="width: 1%; padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="width: 13%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="width: 1%; padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="width: 13%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">5,276</td><td style="width: 1%; padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Warrant liability at March 31, 2012</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">1,641</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#150;</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;.</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">1,641</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td colspan="5" style="color: black; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; padding-left: -11pt">Warrant liability - fair value measurements using significant unobservable inputs (Level 3)</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 63%; color: black; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Balance at March 31, 2011</td><td style="width: 2%; color: black; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">167</td><td style="width: 1%; color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Change in fair value of warrant liability included in earnings</td><td style="color: black; padding-bottom: 1pt; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left; padding-left: -11pt">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right; padding-left: -11pt">1,474</td><td style="padding-bottom: 1pt; color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Balance at March 31, 2012</td><td style="color: black; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">1,641</td><td style="color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Fair value of warrants issued and vested, net</td><td style="color: black; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">1,692</td><td style="color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Fair value of warrants - loan discount on term loan</td><td style="color: black; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">534</td><td style="color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Change in fair value of warrant liability included in earnings</td><td style="color: black; padding-bottom: 1pt; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left; padding-left: -11pt">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right; padding-left: -11pt">1,409</td><td style="padding-bottom: 1pt; color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; padding-bottom: 2.5pt; padding-left: 0pt; font: 8pt Times New Roman, Times, Serif">Balance at March 31, 2013</td><td style="color: black; padding-bottom: 2.5pt; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left; padding-left: -11pt">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right; padding-left: -11pt">5,276</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; padding-left: -11pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Additional quantitative information about Level 3 fair value measurements is discussed in Note 4.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WARRANTS - The Company has entered into complex transactions that contain warrants (Notes 3 and 4). If an instrument (or an embedded feature) that has the characteristics of a derivative instrument is indexed to an entity&#146;s own stock, it is still necessary to evaluate whether it is classified in stockholders&#146; equity (or would be classified in stockholders&#146; equity if it were a freestanding instrument). The Company has concluded that the warrants should be classified as liabilities as the exercise price is subject to a weighted average ratchet down provision if the Company subsequently sells shares at a price lower than the then exercise price.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">INCOME (LOSS) PER COMMON SHARE &#150; Income (loss) per share is calculated under two different methods, basic and diluted. Basic income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period. Diluted income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period and dilutive potential shares of common stock. Dilutive potential shares of common stock, as determined under the treasury stock method, consist of shares of common stock issuable upon exercise of stock warrants or options, net of shares of common stock assumed to be repurchased by the Company from the exercise proceeds (Note 8).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SUPPLEMENTAL CASH FLOW INFORMATION - Interest paid during the years ended March 31, 2013 and 2012 was $9.4 million and $9.0 million, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company made cash payments for taxes of $0 and $14.0 million during the years ended March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company entered into new capital lease obligations of $2.1 million and $0 during the years ended March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">INCOME TAXES - Deferred income tax assets and liabilities are determined based on the differences between the book and tax basis of assets and liabilities and are measured using the currently enacted tax rates and laws using the asset and liability method. The Company assesses the realization of deferred tax assets to determine whether an income tax valuation allowance is required. The Company recorded a 58% and 100% valuation allowance on its net deferred tax assets as of March 31, 2013 and 2012, respectively, since they did not meet the more-likely-than-not threshold.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is a recognition threshold and measurement attribute for recognition and measurement of a tax position taken or expected to be taken in a tax return. It also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction and California. Certain tax attributes carried over from prior years continue to be subject to adjustment by taxing authorities. Any penalties or interest arising from federal or state taxes are recorded as a component of the Company&#146;s income tax provision.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SEGMENT REPORTING - The Company operates in one line of business, the provision of healthcare services through the operation of general hospitals and related healthcare facilities. The Company's Hospitals generate substantially all of its net patient service revenues.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company's four Hospitals and related healthcare facilities operate in one geographic region in Orange County, California. There are similarities in the region's economic characteristics and the nature of the Hospitals' operations, the regulatory environment in which they operate and the manner in which they are managed. This region is an operating segment, as defined by GAAP. In addition, the Company's Hospitals and related healthcare facilities share certain resources and benefit from many common clinical and management practices. Accordingly, the Company aggregates the facilities into a single reportable operating segment.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="color: black">NEW ACCOUNTING STANDARDS &#150; </font>Effective March 31, 2012, the Company adopted ASU&#160;2011-07, &#147;Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities,&#148; which requires health care entities to present the provision for bad debts relating to patient service revenue as a deduction from patient service revenue in the statement of operations rather than as an operating expense. Additional disclosures relating to sources of patient revenue and the allowance for doubtful accounts related to patient accounts receivable are also required. The adoption of this ASU did not have a material impact on the Company&#146;s consolidated financial statements.</p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=28200181&loc=SL6228881-111685 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 720 -SubTopic 15 -URI http://asc.fasb.org/subtopic&trid=2122524 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=7668296&loc=d3e288-107754 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2197480 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 915 -SubTopic 235 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2209116 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 272 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2134480 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2122150 false0false1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIESUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies12 XML 78 R17.xml IDEA: 11. HOSPITAL QUALITY ASSURANCE FEES (QAF) 2.4.0.80017 - Disclosure - 11. HOSPITAL QUALITY ASSURANCE FEES (QAF)truefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_HospitalQualityAssuranceFeesQafAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2IHCH_HospitalQualityAssuranceFeesQafTextBlockIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0.9in 0pt 0; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0.9in 0pt 0">NOTE 11 - HOSPITAL QUALITY ASSURANCE FEES (&#147;QAF&#148;)</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0.9in 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October 2009, the Governor of California signed legislation supported by the hospital industry to impose a provider fee on general acute care hospitals that, combined with federal matching funds, would be used to provide supplemental Medi-Cal payments to hospitals. The state submitted the plan to the Centers for Medicare and Medicaid Services (&#147;CMS&#148;) for a required review and approval process, and certain changes in the plan were required by CMS. Legislation amending the fee program to reflect the required changes was passed by the legislature and signed by the Governor on September&#160;8, 2010. Among other changes, the legislation leaves distribution of &#147;pass-through&#148; payments received by Medi-Cal managed care plans that will be paid to hospitals under the program to the discretion of the plans.&#160;&#160;The hospital quality assurance fee program (&#147;QAF&#148;) created by this legislation initially provided payments for up to 21&#160;months retroactive to April 2009 and expiring on December&#160;31, 2010 (&#147;2010 QAF&#148;).&#160; In February 2011, CMS gave final approval for the 2010 QAF.&#160;During fiscal year 2011, the Company recognized $87.2 million in revenue and recorded expenses of $47.8 million relating to the 2010 QAF.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #1F497D">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December 2011, CMS gave final approval for the extension of the QAF for the nine month period from January 1 through June 30, 2011 (&#147;2011 QAF&#148;).&#160; Accordingly, for the year ended March 31, 2012 the Company recognized $31.9 million in revenue and recorded expenses of $15.9 million relating to the 2011 QAF.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="background-color: White">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In June 2012, CMS conditionally approved the extension of the QAF for the thirty month period from July 1, 2011 through December 31, 2013 (&#147;2013 QAF&#148;).&#160; In June 2012, the California State Legislature amended the hospital fee statute to recognize separate CMS approval of the fee-for-service portion and managed care portion of the 2013 QAF, which was further clarified in legislation approved by the governor of California in September 2012.&#160; As a result, during the year ended March 31, 2013, the Company recognized revenue of $54.2 million and expenses of $52.5 million relating to the fee-for-service portion of the 2013 QAF for the periods from July 1, 2011 through March 31, 2013. See Note 14.</p>falsefalsefalsenonnum:textBlockItemTypenaHospital Quality Assurance Fees text blockNo definition available.false0false11. HOSPITAL QUALITY ASSURANCE FEES (QAF)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/HospitalQualityAssuranceFeesQaf12 XML 79 R51.htm IDEA: XBRL DOCUMENT v2.4.0.8
2. PROPERTY AND EQUIPMENT (Details Narrative) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Property And Equipment Details Narrative  
Earthquake insurance with a policy limit $ 50,000
XML 80 R45.xml IDEA: 8. INCOME (LOSS) PER SHARE (Details) 2.4.0.80045 - Disclosure - 8. INCOME (LOSS) PER SHARE (Details)truefalseIn Thousands, except Share data, unless otherwise specifiedfalse1false USDfalsefalse$From2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2011-04-01to2012-03-31http://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 4IHCH_SharesInNumeratorIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 5us-gaap_ProfitLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-15537000-15537USD$falsetruefalse2truefalsefalse74520007452USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4591552-111686 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (a),(c) -URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4591551-111686 false23true 4IHCH_SharesInDenominatorIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse04false 5us-gaap_WeightedAverageNumberOfSharesOutstandingBasicus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse255307255307falsefalsefalse2truefalsefalse255307255307falsefalsefalsexbrli:sharesItemTypesharesNumber of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Weighted-Average Number of Common Shares Outstanding -URI http://asc.fasb.org/extlink&oid=6528421 false15false 5us-gaap_WeightedAverageNumberOfDilutedSharesOutstandingus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse255307255307falsefalsefalse2truefalsefalse256840256840falsefalsefalsexbrli:sharesItemTypesharesThe average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256 false16false 5us-gaap_EarningsPerShareBasicus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-0.06-0.06USD$falsetruefalse2truefalsefalse0.030.03USD$falsetruefalsenum:perShareItemTypedecimalThe amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 55 -Paragraph 52 -URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.23) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 false37false 5us-gaap_EarningsPerShareDilutedus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-0.06-0.06USD$falsetruefalse2truefalsefalse0.030.03USD$falsetruefalsenum:perShareItemTypedecimalThe amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 false38false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3false USDtruefalse$From2012-04-01to2013-03-31_IncomePerShareMemberhttp://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00falsefalseIncome Per Shareus-gaap_DividendsAxisxbrldihttp://xbrl.org/2006/xbrldiIHCH_IncomePerShareMemberus-gaap_DividendsAxisexplicitMemberSharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse09true 4IHCH_SharesInNumeratorIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse010false 5us-gaap_ProfitLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-15537000-15537USD$falsetruefalse2truefalsefalse74520007452USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4591552-111686 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (a),(c) -URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4591551-111686 false211true 4IHCH_SharesInDenominatorIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse012false 5us-gaap_WeightedAverageNumberOfSharesOutstandingBasicus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse255307255307falsefalsefalse2truefalsefalse255307255307falsefalsefalsexbrli:sharesItemTypesharesNumber of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Weighted-Average Number of Common Shares Outstanding -URI http://asc.fasb.org/extlink&oid=6528421 false113false 5us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;falsefalsefalse2truefalsefalse15331533falsefalsefalsexbrli:sharesItemTypesharesThe sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 false114false 5us-gaap_WeightedAverageNumberOfDilutedSharesOutstandingus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse255307255307falsefalsefalse2truefalsefalse256840256840falsefalsefalsexbrli:sharesItemTypesharesThe average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256 false115false 5us-gaap_EarningsPerShareBasicus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-0.06-0.06USD$falsetruefalse2truefalsefalse0.030.03USD$falsetruefalsenum:perShareItemTypedecimalThe amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 55 -Paragraph 52 -URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.23) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 false316false 5us-gaap_EarningsPerShareDilutedus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-0.06-0.06USD$falsetruefalse2truefalsefalse0.030.03USD$falsetruefalsenum:perShareItemTypedecimalThe amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 false3false8. INCOME (LOSS) PER SHARE (Details) (USD $)ThousandsNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://ihhioc.com/role/IncomeLossPerShareDetails216 XML 81 R16.xml IDEA: 10. RELATED PARTY TRANSACTIONS 2.4.0.80016 - Disclosure - 10. RELATED PARTY TRANSACTIONStruefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1us-gaap_RelatedPartyTransactionsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_RelatedPartyTransactionsDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0.9in 0pt 0">NOTE 10 - RELATED PARTY TRANSACTIONS</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company leases substantially all of the real property of the acquired Hospitals from PCHI which is owned by various physician investors and Ganesha, which is managed by Dr. Chaudhuri. As of March 31, 2013 and 2012, Dr. Chaudhuri and Mr. Thomas are the beneficial holders of an aggregate of 447.5 million shares of the outstanding stock of the Company. As described in Note 9, PCHI is a variable interest entity and the Company is the primary beneficiary, accordingly, the Company has consolidated the financial statements of PCHI in the accompanying consolidated financial statements.</p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph b -Article 3A Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(k)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph k -Article 4 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864 false0false10. RELATED PARTY TRANSACTIONSUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/RelatedPartyTransactions12 XML 82 R27.xml IDEA: 6. STOCK INCENTIVE PLAN (Tables) 2.4.0.80027 - Disclosure - 6. STOCK INCENTIVE PLAN (Tables)truefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_StockIncentivePlanTablesAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A summary of stock option activity for the years ended March 31, 2013 and 2012 is presented as follows.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table align="center" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Shares</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Weighted-average exercise price</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Weighted-average grant date fair value</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Weighted-average remaining contractual term(years)</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Aggregate intrinsic value</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 35%; color: black; text-align: left; text-indent: -9pt; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March&#160;31, 2011</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 9%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">8,370</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 9%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.18</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 9%; text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 9%; text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 9%; text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 1%; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Granted</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">-</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Exercised</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Forfeited or expired</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(135</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.25</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; text-indent: -9pt; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March&#160;31, 2012</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">8,235</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.18</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Granted</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Exercised</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">&#150;</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 11pt; font: 8pt Times New Roman, Times, Serif">Forfeited or expired</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(640</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">0.26</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Outstanding, March&#160;31, 2013</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">7,595</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">0.18</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">1.7</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">-<font style="color: black">&#160;</font></td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; font: 8pt Times New Roman, Times, Serif">Exercisable at March&#160;31, 2013</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">7,595</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">0.18</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">1.7</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td> </tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the details pertaining to each employee stock ownership plan.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929 false0false6. STOCK INCENTIVE PLAN (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/StockIncentivePlanTables12 XML 83 R18.xml IDEA: 12. ELECTRONIC HEALTH RECORDS INCENTIVE PROGRAM 2.4.0.80018 - Disclosure - 12. ELECTRONIC HEALTH RECORDS INCENTIVE PROGRAMtruefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_ElectronicHealthRecordsIncentiveProgramAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_SignificantAccountingPoliciesTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 12 - ELECTRONIC HEALTH RECORDS INCENTIVE PROGRAM</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Provisions of the American Recovery and Reinvestment Act of 2009 provide incentive payments for the adoption and meaningful use of certified electronic health record (EHR) technology. The Medicare EHR incentive program provides incentive payments to eligible hospitals (and certain other providers) that are meaningful users of certified EHRs. The Medicaid EHR incentive program provides incentive payments to eligible hospitals (and certain other providers) for efforts to adopt, implement, upgrade, or meaningful use of certified EHR technology.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">CMS has established the final rule which requires eligible providers in their first year of participation in the Medicaid incentive payment program to demonstrate that they have adopted (acquired, purchased, or secured access to), or implemented, or upgraded to certified EHR technology in order to qualify for an incentive payment. During the second and subsequent years of the program, eligible providers are required to meet other criteria, including meaningful use, to receive additional funds. The Company has been awarded a total amount of $13.6 million under the Medicaid EHR incentive program, which will be earned and received over a four year period. The Company adopted certified EHR technology and it recognized other income of $6.8 million relative to the first year under the Medicaid EHR incentive program during fiscal year 2012.</p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for all significant accounting policies of the reporting entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18861-107790 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18743-107790 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18854-107790 false0false12. ELECTRONIC HEALTH RECORDS INCENTIVE PROGRAMUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/ElectronicHealthRecordsIncentiveProgram12 XML 84 R3.xml IDEA: CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) 2.4.0.80003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)truefalseIn Thousands, except Share data, unless otherwise specifiedfalse1false USDfalsefalse$AsOf2013-03-31http://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$AsOf2012-03-31http://www.sec.gov/CIK0001051488instant2012-03-31T00:00:000001-01-01T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_StatementOfFinancialPositionAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_AllowanceForDoubtfulAccountsReceivableCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2114300021143USD$falsetruefalse2truefalsefalse1820100018201USD$falsetruefalsexbrli:monetaryItemTypemonetaryA valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 4 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=28368275&loc=d3e5074-111524 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.4) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false23false 2us-gaap_CapitalLeaseObligationsCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse11010001101USD$falsetruefalse2truefalsefalse891000891USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of capital lease obligation due within one year or the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735 false24false 2us-gaap_CommonStockParOrStatedValuePerShareus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse0.0010.001USD$falsetruefalse2truefalsefalse0.0010.001USD$falsetruefalsenum:perShareItemTypedecimalFace amount or stated value per share of common stock.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false35false 2us-gaap_CommonStockSharesAuthorizedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse800000800000falsefalsefalse2truefalsefalse800000800000falsefalsefalsexbrli:sharesItemTypesharesThe maximum number of common shares permitted to be issued by an entity's charter and bylaws.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false16false 2us-gaap_CommonStockSharesIssuedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse255307255307falsefalsefalse2truefalsefalse255307255307falsefalsefalsexbrli:sharesItemTypesharesTotal number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false17false 2us-gaap_CommonStockSharesOutstandingus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse255307255307falsefalsefalse2truefalsefalse255307255307falsefalsefalsexbrli:sharesItemTypesharesNumber of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false1falseCONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)ThousandsNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://ihhioc.com/role/CondensedConsolidatedBalanceSheetsParenthetical27 XML 85 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
9. VARIABLE INTEREST ENTITY (Tables)
 12 Months Ended
Mar. 31, 2013
Variable Interest Entity Tables  
Variable Interest Entity

 

   March 31,
2013		   March 31,
2012		 
         
Cash  $147   $68 
Property, net   39,696    40,984 
Other   129    207 
Total assets  $39,972   $41,259 
           
           
Debt ($47,277, net of discount) (as guarantor)  $46,039   $45,000 
Other   488    641 
Total liabilities   46,527    45,641 
           
Deficiency   (6,555)   (4,382)
Total liabilities and accumulated deficit  $39,972   $41,259 
XML 86 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
2. PROPERTY AND EQUIPMENT (Tables)
 12 Months Ended
Mar. 31, 2013
Property And Equipment Tables  
Property and Equipment
    March 31,
2013		     March 31,
2012		  
Buildings   $ 36,536     $ 35,376  
Land and improvements     13,523       13,523  
Equipment     28,534       18,268  
Construction in progress     –       1,160  
Assets under capital leases     13,267       11,218  
      91,860       79,545  
Less accumulated depreciation     (27,872 )     (24,016 )
                 
Property and equipment, net   $ 63,988     $ 55,529  
XML 87 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
6. STOCK INCENTIVE PLAN (Details) (USD $)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Stock Incentive Plan Tables    
Outstanding, March 31, 2011, Shares 8,235 8,370
Granted, Shares      
Exercised, Shares      
Forfeited or expired, Shares (640) (135)
Outstanding, March 31, 2012, Shares 7,595 8,235
Exercisable at March 31, 2012, Shares 7,595  
Weighted- Average Exercise Price    
Outstanding, March 31, 2012, exercise price $ 0.18 $ 0.18
Granted, exercise price      
Exercised, exercise price      
Forfeited or expired, exercise price $ 0.26 $ 0.25
Outstanding, March 31, 2013, exercise price $ 0.18 $ 0.18
Exercisable at March 31, 2013, exercise price $ 0.18  
Weighted- Average remaining contractual term (years)    
Outstanding, March 31, 2013, contractual term (years) 1 year 8 months 12 days  
Exercisable at March 31, 2013, contractual term (years) 1 year 8 months 12 days  
XML 88 R50.xml IDEA: 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative 1) 2.4.0.80050 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative 1)truefalsefalse1false falsefalseFrom2012-04-01to2013-03-31_MedicareMedicaidMemberhttp://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00PercentStandardhttp://www.xbrl.org/2003/instancepurexbrli02false falsefalseFrom2011-04-01to2012-03-31_MedicareMedicaidMemberhttp://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00PercentStandardhttp://www.xbrl.org/2003/instancepurexbrli01false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse1false truefalseFrom2012-04-01to2013-03-31_MedicareMedicaidMemberhttp://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00falsefalseMedicare and Medicaidus-gaap_HealthCareOrganizationRevenueSourcesAxisxbrldihttp://xbrl.org/2006/xbrldiIHCH_MedicareMedicaidMemberus-gaap_HealthCareOrganizationRevenueSourcesAxisexplicitMemberPercentStandardhttp://www.xbrl.org/2003/instancepurexbrli0nanafalse02false 4us-gaap_ConcentrationRiskPercentage1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truetruefalse0.580.58falsefalsefalse2truetruefalse0.570.57falsefalsefalsenum:percentItemTypepureFor an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13531-108611 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592 false0false1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative 1) (Medicare and Medicaid)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative122 XML 89 R54.htm IDEA: XBRL DOCUMENT v2.4.0.8
8. INCOME (LOSS) PER SHARE (Details Narrative)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Income Loss Per Share Details Narrative    
Shares excluded from the calculations of diluted loss per share 413,000,000 411,000,000
XML 90 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
4. COMMON STOCK WARRANTS (Details 1) (USD $)
 12 Months Ended 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Mar. 30, 2013
Warrants
Mar. 31, 2013
Warrants
Mar. 31, 2012
Warrants
Mar. 31, 2011
Warrants
Shares issuable under warrants Outstanding 7,595 8,235 8,370   405,000 405,000 405,000
Repurchased       (16,800)      
Issued       16,800      
Amended (old expiration date)       (388,200)      
Amended (new expiration date)       388,200      
Weighted-average exercise price $ 0.18 $ 0.18 $ 0.18   $ 0.07 $ 0.07 $ 0.07
Weighted-average exercise price, Repurchased       $ 0.07      
Weighted-average exercise price, Issued         $ 0.07      
Expiration date Outstanding         April 13, 2016 April 13, 2013 April 13, 2013
Expiration date, Repurchased       April 13, 2013      
Expiration date, Issued       April 13, 2016      
Expiration date, Amended (old expiration date)       April 13, 2013      
Expiration date, Amended (new expiration date)       April 13, 2016      
XML 91 R42.xml IDEA: 5. INCOME TAXES (Details 2) 2.4.0.80042 - Disclosure - 5. INCOME TAXES (Details 2)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$AsOf2013-03-31http://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$AsOf2012-03-31http://www.sec.gov/CIK0001051488instant2012-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 2us-gaap_DeferredTaxAssetsGrossAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 3us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse449000449USD$falsetruefalse2truefalsefalse14570001457USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 25 -Paragraph 20 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=29652012&loc=d3e28680-109314 false23false 3us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensationus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse29820002982falsefalsefalse2truefalsefalse28130002813falsefalsefalsexbrli:monetaryItemTypemonetaryAmount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 25 -Paragraph 20 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=29652012&loc=d3e28680-109314 false24false 3us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse79610007961falsefalsefalse2truefalsefalse10230001023falsefalsefalsexbrli:monetaryItemTypemonetaryAmount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 25 -Paragraph 20 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=29652012&loc=d3e28680-109314 false25false 3IHCH_StateTaxesIHCH_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-1235000-1235falsefalsefalse2truefalsefalse-532000-532falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false26false 3IHCH_AccruedInsuranceIHCH_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse37550003755falsefalsefalse2truefalsefalse34450003445falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false27false 3IHCH_LegalIHCH_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse12570001257falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false28false 3IHCH_PropertyAndEquipmentIHCH_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse661000661falsefalsefalse2truefalsefalse-212000-212falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false29false 3us-gaap_DeferredTaxAssetsOtherus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse281000281falsefalsefalse2truefalsefalse4300043falsefalsefalsexbrli:monetaryItemTypemonetaryAmount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences not separately disclosed.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 25 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=29652012&loc=d3e28680-109314 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319 false210false 3us-gaap_DeferredTaxAssetsGrossus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1611100016111falsefalsefalse2truefalsefalse80370008037falsefalsefalsexbrli:monetaryItemTypemonetaryAmount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Deferred Tax Asset -URI http://asc.fasb.org/extlink&oid=6510090 false211false 3us-gaap_DeferredTaxAssetsValuationAllowanceus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-9403000-9403falsefalsefalse2truefalsefalse-8037000-8037falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319 false212false 3us-gaap_DeferredTaxAssetsNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse67080006708USD$falsetruefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b),(c) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319 false2false5. INCOME TAXES (Details 2) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/IncomeTaxesDetails2212 XML 92 R31.xml IDEA: 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) 2.4.0.80031 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$From2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2011-04-01to2012-03-31http://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDtruefalse$From2012-04-01to2013-03-31_MedicareMemberhttp://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00falsefalseMedicare [Member]us-gaap_HealthCareOrganizationRevenueSourcesAxisxbrldihttp://xbrl.org/2006/xbrldiIHCH_MedicareMemberus-gaap_HealthCareOrganizationRevenueSourcesAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDtruefalse$From2011-04-01to2012-03-31_MedicareMemberhttp://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00falsefalseMedicare [Member]us-gaap_HealthCareOrganizationRevenueSourcesAxisxbrldihttp://xbrl.org/2006/xbrldiIHCH_MedicareMemberus-gaap_HealthCareOrganizationRevenueSourcesAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDtruefalse$From2012-04-01to2013-03-31_MedicaidMemberhttp://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00falsefalseMedicaid [Member]us-gaap_HealthCareOrganizationRevenueSourcesAxisxbrldihttp://xbrl.org/2006/xbrldiIHCH_MedicaidMemberus-gaap_HealthCareOrganizationRevenueSourcesAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$6false USDtruefalse$From2011-04-01to2012-03-31_MedicaidMemberhttp://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00falsefalseMedicaid [Member]us-gaap_HealthCareOrganizationRevenueSourcesAxisxbrldihttp://xbrl.org/2006/xbrldiIHCH_MedicaidMemberus-gaap_HealthCareOrganizationRevenueSourcesAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$7false USDtruefalse$From2012-04-01to2013-03-31_ManagedCareMemberhttp://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00falsefalseManaged Care [Member]us-gaap_HealthCareOrganizationRevenueSourcesAxisxbrldihttp://xbrl.org/2006/xbrldiIHCH_ManagedCareMemberus-gaap_HealthCareOrganizationRevenueSourcesAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$8false USDtruefalse$From2012-01-01to2012-12-31_ManagedCareMemberhttp://www.sec.gov/CIK0001051488duration2012-01-01T00:00:002012-12-31T00:00:00falsefalseManaged Care [Member]us-gaap_HealthCareOrganizationRevenueSourcesAxisxbrldihttp://xbrl.org/2006/xbrldiIHCH_ManagedCareMemberus-gaap_HealthCareOrganizationRevenueSourcesAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$9false USDtruefalse$From2012-04-01to2013-03-31_IndemnitySelfPayAndOtherMemberhttp://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00falsefalseIndemnity Self Pay And Other [Member]us-gaap_HealthCareOrganizationRevenueSourcesAxisxbrldihttp://xbrl.org/2006/xbrldiIHCH_IndemnitySelfPayAndOtherMemberus-gaap_HealthCareOrganizationRevenueSourcesAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$10false USDtruefalse$From2011-04-01to2012-03-31_IndemnitySelfPayAndOtherMemberhttp://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00falsefalseIndemnity Self Pay And Other [Member]us-gaap_HealthCareOrganizationRevenueSourcesAxisxbrldihttp://xbrl.org/2006/xbrldiIHCH_IndemnitySelfPayAndOtherMemberus-gaap_HealthCareOrganizationRevenueSourcesAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$11false USDtruefalse$From2012-04-01to2013-03-31_TotalMemberhttp://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00falsefalseTotal [Member]us-gaap_HealthCareOrganizationRevenueSourcesAxisxbrldihttp://xbrl.org/2006/xbrldiIHCH_TotalMemberus-gaap_HealthCareOrganizationRevenueSourcesAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$12false USDtruefalse$From2011-04-01to2012-03-31_TotalMemberhttp://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00falsefalseTotal [Member]us-gaap_HealthCareOrganizationRevenueSourcesAxisxbrldihttp://xbrl.org/2006/xbrldiIHCH_TotalMemberus-gaap_HealthCareOrganizationRevenueSourcesAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_HealthCareOrganizationReceivableAndRevenueDisclosuresLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 4us-gaap_HealthCareOrganizationRevenueus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse428100000428100USD$falsetruefalse2truefalsefalse402564000402564USD$falsetruefalse3truefalsefalse5557000055570USD$falsetruefalse4truefalsefalse5804600058046USD$falsetruefalse5truefalsefalse100561000100561USD$falsetruefalse6truefalsefalse8015300080153USD$falsetruefalse7truefalsefalse203058000203058USD$falsetruefalse8truefalsefalse201758000201758USD$falsetruefalse9truefalsefalse6891100068911USD$falsetruefalse10truefalsefalse6260700062607USD$falsetruefalse11truefalsefalse428100000428100USD$falsetruefalse12truefalsefalse402564000402564USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of revenues recognized by the entity from providing services to in-patients, outpatients, residents in facilities owned or operated by the entity, from insurance premiums, or from goods provided or services performed.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false2false1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails122 XML 93 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
2. PROPERTY AND EQUIPMENT (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Mar. 31, 2012
Property, Plant and Equipment [Abstract]    
Buildings $ 36,536 $ 35,376
Land and improvements 13,523 13,523
Equipment 28,534 18,268
Construction in progress    1,160
Assets under capital leases 13,267 11,218
Property and equipment, gross 91,860 79,545
Less accumulated depreciation (27,872) (24,016)
Property and equipment, net $ 63,988 $ 55,529
XML 94 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
3. DEBT (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Mar. 31, 2012
Current:    
Revolving line of credit $ 29,527 $ 13,783
Discount (473) (217)
Total 29,527 13,783
Noncurrent:    
Term loan 47,277 45,000
Discount (1,747)   
Term loan $ 45,530 $ 45,000
XML 95 R30.xml IDEA: 13. COMMITMENTS AND CONTINGENCIES (Tables) 2.4.0.80030 - Disclosure - 13. COMMITMENTS AND CONTINGENCIES (Tables)truefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_CommitmentsAndContingenciesTablesAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following is a schedule of the Company's future minimum operating lease payments, excluding the long term lease commitment with PCHI, that have initial or remaining non-cancelable lease terms in excess of one year as of March 31, 2013:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellspacing="0" cellpadding="0" align="center" style="width: 80%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Year ended March 31,</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="width: 62%; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2014</font></td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 15%; text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,620</font></td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2015</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,335</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2016</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,253</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2017</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,253</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2018</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,253</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Thereafter</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: black">11,627</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Total</font></td> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: black">18,341</font></td></tr></table>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717 false03false 2us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Year ended March 31,</font></td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 79%; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2014</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 18%; text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,873</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2015</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,899</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2016</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,750</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2017</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">1,276</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">2018</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">932</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Thereafter</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">4,279</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Total minimum lease payments</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">12,009</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Less amount representing interest (weighted average interest rate of 10.2%)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">(4,119</font></td> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Net present value of net minimum lease payments</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">7,890</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Less current portion</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">(1,101</font></td> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Noncurrent portion</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">6,789</font></td> <td style="line-height: 115%">&#160;</td></tr> </table>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of future minimum lease payments as of the date of the latest balance sheet presented, in aggregate and for each of the five years succeeding fiscal years, with separate deductions from the total for the amount representing executor costs, including any profit thereon, included in the minimum lease payments and for the amount of the imputed interest necessary to reduce the net minimum lease payments to present value.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737 false04false 2IHCH_FinancedInsurancePoliciesTableTextBlockIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">March 31, </font><br /> <font style="font: 8pt Times New Roman, Times, Serif">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">March 31, </font><br /> <font style="font: 8pt Times New Roman, Times, Serif">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 68%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Prepaid insurance</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">115</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">366</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Accrued insurance premiums</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">69</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">60</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(Included in other current liabilities)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> </table>falsefalsefalsenonnum:textBlockItemTypenaINSURANCENo definition available.false0false13. COMMITMENTS AND CONTINGENCIES (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/CommitmentsAndContingenciesTables14 XML 96 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
7. RETIREMENT PLAN
 12 Months Ended
Mar. 31, 2013
Retirement Plan  
NOTE 7 - RETIREMENT PLAN

NOTE 7 - RETIREMENT PLAN

 

The Company has a 401(k) plan for its employees. All employees with 90 days of service are eligible to participate, unless they are covered by a collective bargaining agreement which precludes coverage. The Company matches employee contributions up to 3% of the employee's compensation, subject to IRS limits. During the years ended March 31, 2013 and 2012, the Company incurred expenses of $3.3 million and $3.1 million, respectively. These costs are included in salaries and benefits in the accompanying consolidated statements of operations.  At March 31, 2013 and 2012, accrued compensation and benefits in the accompanying consolidated balance sheets included $4.1 million and $3.9 million, respectively, in accrued employer contributions.
XML 97 R21.xml IDEA: 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) 2.4.0.80021 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)truefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesPoliciesAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_BasisOfAccountingPolicyPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">BASIS OF PRESENTATION - The accompanying consolidated financial statements include the accounts of Integrated Healthcare Holdings, Inc. and its subsidiaries (collectively, the &#147;Company&#148;) and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#147;GAAP&#148;).</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has also determined that Pacific Coast Holdings Investment, LLC (&#34;PCHI&#34;) (Note 9), is a variable interest entity as defined by GAAP and the Company is the primary beneficiary and, accordingly, the financial statements of PCHI are included in the accompanying consolidated financial statements.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">All significant intercompany accounts and transactions have been eliminated in consolidation. Unless otherwise indicated, all amounts included in these notes to the consolidated financial statements are expressed in thousands (except per share amounts, percentages and stock option prices and values).</p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).No definition available.false03false 2us-gaap_LiquidityDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="color: black">LIQUIDITY - As of March 31, 2013 and 2012, the Company had a total stockholders&#146; deficiency of $29.9 million and $11.6 million, respectively, and a working capital deficit of $36.7 million and $14.7 million, respectively.&#160;&#160;For the years ended March 31, 2013 and 2012, the Company had net income (loss) of $(15.2) million and $7.5 million, respectively, and (negative) positive cash flow from operations of $(9.6) million and $4.5 million, respectively. At March 31, 2013, the Company had $5.0 million in additional availability under its revolving credit facility (Note 3). The Company anticipates making payments for provider fees and other expenses relating to the 2013 hospital quality assurance fee program of approximately $105.8 million and receiving approximately $235.5 million in revenues from the </font><font style="color: #1F497D">S</font><font style="color: black">tate ($79.4 million from the fee-for-service portion and $156.1 million from the managed care portion) (Notes 11 and 14).DESCRIPTION OF BUSINESS - Effective March 8, 2005, the Company acquired four hospitals (the &#34;Hospitals&#34;) from subsidiaries of Tenet Healthcare Corporation (the &#34;Acquisition&#34;). The Company owns and operates the four community-based hospitals located in southern California, which are:</font></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 6%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; line-height: 115%; font-size: 8pt">&#160;</td> <td style="vertical-align: top; width: 2%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="width: 92%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif; color: black">282-bed Western Medical Center in Santa Ana</font></td></tr> <tr> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; line-height: 115%; font-size: 8pt">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif; color: black">188-bed Western Medical Center in Anaheim</font></td></tr> <tr> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; line-height: 115%; font-size: 8pt">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif; color: black">178-bed Coastal Communities Hospital in Santa Ana</font></td></tr> <tr> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; line-height: 115%; font-size: 8pt">&#160;</td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif; color: black">&#9679;</font></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif; color: black">114-bed Chapman Medical Center in Orange</font></td></tr> </table>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for reporting when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). Disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities. If management's plans alleviate the substantial doubt about the entity's ability to continue as a going concern, disclosure of the principal conditions and events that initially raised the substantial doubt about the entity's ability to continue as a going concern would be expected to be considered. Disclose whether operations for the current or prior years generated sufficient cash to cover current obligations, whether waivers were obtained from creditors relating to the company's default under the provisions of debt agreements and possible effects of such conditions and events, such as: whether there is a possible need to obtain additional financing (debt or equity) or to liquidate certain holdings to offset future cash flow deficiencies. Disclose appropriate parent company information when parent is dependent upon remittances from subsidiaries to satisfy its obligations.No definition available.false04false 2us-gaap_PriorPeriodReclassificationAdjustmentDescriptionus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">RECLASSIFICATION FOR PRESENTATION - Certain amounts previously reported have been reclassified to conform to the current period's presentation with no impact on the reported net income of the Company.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for reclassifications that affects the comparability of the financial statements.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755 false05false 2us-gaap_ConcentrationRiskCreditRiskus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">CONCENTRATION OF RISK - The Hospitals are subject to licensure by the State of California and accreditation by the Joint Commission. Loss of either licensure or accreditation would impact the ability to participate in various governmental and managed care programs, which provide the majority of the Company's revenues.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Substantially all patient service revenues come from external customers. The largest payers are Medicare and Medicaid (including Medicare and Medicaid managed care plans) and other State and local government payers, which combined accounted for 58% and 57% of the patient service revenues for the years ended March 31, 2013 and 2012, respectively. No other payers represent a significant concentration of the Company's patient services revenues.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 1.3pt 0 0; text-align: center; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company receives all of its inpatient services revenue from operations in Orange County, California. The economic conditions of this service area could affect the ability of patients and third-party payers to reimburse the Company for services through its effect on disposable household income and the tax base used to generate state funding for Medicaid programs.</p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for credit risk.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 825 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=28088331&loc=SL29635902-196195 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13531-108611 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 55 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6875567&loc=d3e14489-108613 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 825 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6480020&loc=d3e61082-112788 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 825 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6480020&loc=d3e61044-112788 false06false 2us-gaap_UseOfEstimatesus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">USE OF ESTIMATES - The accompanying consolidated financial statements have been prepared in accordance with GAAP. The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Principal areas requiring the use of estimates include third-party cost report settlements, income taxes, accrued insurance retentions, self-insurance reserves, and net patient receivables. Management regularly evaluates the accounting policies and estimates that are used. In general, management bases the estimates on historical experience and on assumptions that it believes to be reasonable given the particular circumstances in which its Hospitals operate. Although management believes that all adjustments considered necessary for fair presentation have been included, actual results may materially vary from those estimates.</p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6143-108592 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6132-108592 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6061-108592 false07false 2IHCH_PatientServiceRevenuesPolicyTextBlockIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">PATIENT SERVICE REVENUES &#150; Patient service revenues are recognized in the period in which services are performed and are recorded based on established billing rates (gross charges) less contractual allowances and discounts, principally for patients covered by Medicare, Medicaid, managed care, and other health plans. Gross charges are retail charges. They are not the same as actual pricing, and they generally do not reflect what a hospital is ultimately paid and therefore are not displayed in the consolidated statements of operations. Hospitals are typically paid amounts that are negotiated with insurance companies or are set by the government. Gross charges are used to calculate Medicare outlier payments and to determine certain elements of payment under managed care contracts (such as stop-loss payments). Since Medicare requires that a hospital's gross charges be the same for all patients (regardless of payer category), gross charges are also what the Hospitals charge all other patients prior to the application of discounts and allowances.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following is a summary of sources of patient service revenues (net of contractual allowances and discounts) before provision for doubtful accounts:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Year ended March 31,</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 48%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Medicare</font></td> <td style="width: 3%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 21%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">55,570</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 3%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 21%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">58,046</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Medicaid</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">100,561</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">80,153</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Managed care</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">203,058</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">201,758</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Indemnity, self-pay and other</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">68,911</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">62,607</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">428,100</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">402,564</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Revenues under the traditional fee-for-service Medicare and Medicaid programs are based primarily on prospective payment systems. Discounts for retrospectively cost based revenues and certain other payments, which are based on the Hospitals' cost reports, are estimated using historical trends and current factors. Cost report settlements for retrospectively cost-based revenues under these programs are subject to audit and administrative and judicial review, which can take several years until final settlement of such matters are determined and completely resolved. Estimates of settlement receivables or payables related to a specific year are updated periodically and at year end and at the time the cost report is filed with the fiscal intermediary. Typically no further updates are made to the estimates until the final Notice of Program Reimbursement is received, at which time the cost report for that year has been audited by the fiscal intermediary. There could be a time lag of several years between the submission of a cost report and receipt of the Final Notice of Program Reimbursement. Since the laws, regulations, instructions and rule interpretations governing Medicare and Medicaid reimbursement are complex and change frequently, the estimates recorded by the Hospitals could change by material amounts. The Company has established settlement (payables) receivables of $(179) and $190 as of March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Hospitals receive supplemental payments from the State of California to support indigent care (Medi-Cal Disproportionate Share Hospital payments or &#34;DSH&#34;) and from the California Medical Assistance Commission (&#34;CMAC&#34;) under the SB 1100 and SB 1255 programs. The Hospitals received supplemental payments of $13.4 million and $14.3 million during the years ended March 31, 2013 and 2012, respectively. The related revenue recorded for the years ended March 31, 2013 and 2012, was $14.3 million and $15.4 million, respectively. As of March 31, 2013 and 2012, estimated DSH receivables were $5.9 million and $5.0 million, respectively, which are included as due from government payers in the accompanying consolidated balance sheets.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 1.3pt 0 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Revenues under managed care plans, including Medicare and Medicaid managed care plans (with patient service revenues of $84.7 million and $84.2 million for the years ended March 31, 2013 and 2012, respectively), are based primarily on payment terms involving predetermined rates per diagnosis, per-diem rates, discounted fee-for-service rates and/or other similar contractual arrangements. These revenues are also subject to review and possible audit by the payers. The payers are billed for patient services on an individual patient basis. An individual patient's bill is subject to adjustment on a patient-by-patient basis in the ordinary course of business by the payers following their review and adjudication of each particular bill. The Hospitals estimate the discounts for contractual allowances utilizing billing data on an individual patient basis. Management believes the estimation and review process allows for timely identification of instances where such estimates need to be revised. The Company does not believe there were any adjustments to estimates of individual patient bills that were material to patient service revenues.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Hospitals provide charity care to patients whose income level is below 300% of the Federal Poverty Level. Patients with income levels between 300% and 350% of the Federal Poverty Level qualify to pay a discounted rate under AB 774 based on various government program reimbursement levels. Patients without insurance are offered assistance in applying for Medicaid and other programs they may be eligible for, such as state disability, Victims of Crime, or county indigent programs. Patient advocates from the Hospitals' Medical Eligibility Program (&#34;MEP&#34;) screen patients in the hospital and determine potential linkage to financial assistance programs. They also expedite the process of applying for these government programs. The estimated costs of charity care (based on direct and indirect costs as a ratio of gross uncompensated charges associated with providing care to charity patients) for the years ended March 31,&#160;2013 and 2012 were approximately $8.0 million and $7.0 million, respectively.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company is not aware of any material claims, disputes, or unsettled matters with any payers that would affect revenues that have not been adequately provided for in the accompanying consolidated financial statements.</p>falsefalsefalsenonnum:textBlockItemTypenaPATIENT SERVICE REVENUESNo definition available.false08false 2us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicyus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">PROVISION FOR BAD DEBTS - The Company provides for accounts receivable that could become uncollectible by establishing an allowance to reduce the carrying value of such receivables to their estimated net realizable value. The Hospitals estimate this allowance based on the aging of their accounts receivable, historical collections experience for each type of payer and other relevant factors. There are various factors that can impact the collection trends, such as changes in the economy, which in turn have an impact on unemployment rates and the number of uninsured and underinsured patients, volume of patients through the emergency department, the increased burden of copayments to be made by patients with insurance and business practices related to collection efforts. These factors continuously change and can have an impact on collection trends and the estimation process.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company's policy is to attempt to collect amounts due from patients, including copayments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations, including, but not limited to, the Emergency Medical Treatment and Labor Act (&#34;EMTALA&#34;). Generally, as required by EMTALA, patients may not be denied emergency treatment due to inability to pay. Therefore, until the legally required medical screening examination is complete and stabilization of the patient has begun, services are performed prior to the verification of the patient's insurance, if any. In nonemergency circumstances or for elective procedures and services, it is the Hospitals' policy, when appropriate, to verify insurance prior to a patient being treated.</p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for determining the estimated allowance for doubtful accounts for premium amounts due from policyholders, insureds, and other insurance entities. May include factors that management considered, such as historical loss experience and current economic and competitive conditions.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=28368275&loc=d3e5144-111524 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 310 -URI http://asc.fasb.org/subtopic&trid=4738109 false09false 2us-gaap_CashAndCashEquivalentsPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">CASH AND CASH EQUIVALENTS - The Company considers all highly liquid debt investments purchased with a maturity of three months or less to be cash equivalents. Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits. The Company has never experienced any losses related to these balances.</p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 305 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2122427 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Financial Reporting Release (FRR) -Number 203 -Paragraph 02-03 false010false 2IHCH_LetterOfCreditIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">LETTER OF CREDIT &#150; At March 31, 2013, the Company had an outstanding letter of credit totaling $761. This letter of credit correspondingly reduces the Company&#146;s borrowing availability under its revolving line of credit (Note 3).</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>falsefalsefalsenonnum:textBlockItemTypenaNo authoritative reference available.No definition available.false011false 2us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicyus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">RECEIVABLES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS &#150; The following is a summary of the principal components of accounts receivable and due from/to government payers as of March 31, 2013 and 2012:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">March 31,</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Accounts receivable:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 56%; padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Patient accounts receivable</font></td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">83,964</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">71,800</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Allowance for doubtful accounts</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(21,143</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(18,201</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Accounts receivable, net</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">62,821</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">53,599</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Due from government payers:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">DSH</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,882</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">4,993</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Settlement receivables</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">190</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,882</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,183</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Due to government payers:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Settlement payables</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">179</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">179</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company&#146;s self-pay collection rate, which is the blended collection rate for uninsured and balance after insurance accounts receivable, was approximately 6.5% and 11.3% as of March&#160;31, 2013 and 2012, respectively. These self-pay collection rates include payments made by patients, including co-payments and deductibles paid by patients with insurance. As of March&#160;31,&#160;2013 and 2012, the allowance for doubtful accounts for self-pay uninsured was 95.2% and 90.3%, respectively, of self-pay uninsured patient accounts receivable. As of March&#160;31,&#160;2013 and 2012, the allowance for doubtful accounts for self-pay balance after insurance was 78.0% and 77.4%, respectively, of self-pay balance after insurance patient accounts receivable, consisting primarily of co-pays and deductibles owed by patients with insurance. As of March 31, 2013 and 2012, the allowance for doubtful accounts for managed care was 20.3% and 16.1%, respectively, of managed care patient accounts receivable.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Receivables from patients who are potentially eligible for Medicaid are classified as Medicaid pending under the MEP, with appropriate contractual allowances recorded. If the patient does not qualify for Medicaid, the receivables are reclassified to charity care and written off, or they are reclassified to self-pay and adjusted to their net realizable value through the provision for bad debts. Reclassifications of pending Medicaid accounts to self-pay do not typically have a material impact on the results of operations as the estimated Medicaid contractual allowances initially recorded are not materially different than the estimated provision for bad debts recorded when the accounts are reclassified. All accounts classified as pending Medicaid, as well as certain other governmental receivables, over the age of 90 days were reserved in contractual allowances as of March 31, 2013 and 2012 based on historical collections experience.</p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 4 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=28368275&loc=d3e5144-111524 false012false 2us-gaap_InventorySuppliesPolicyus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">INVENTORIES OF SUPPLIES - Inventories of supplies are valued at the lower of weighted average cost or market.</p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for the basis and manner that goods are added and removed from inventory for supplies to be consumed directly or indirectly in production. If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory and how cost is determined (such as FIFO, LIFO, average).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 6 -Subparagraph b -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=28360613&loc=d3e4492-108314 false013false 2us-gaap_PropertyPlantAndEquipmentPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and any impairment write-downs related to assets held and used. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Capital leases are recorded at the beginning of the lease term as property and equipment and a corresponding lease liability is recognized. The value of the property and equipment under capital lease is recorded at the lower of either the present value of the minimum lease payments or the fair value of the asset. Such assets, including improvements, are amortized over the shorter of the lease term or their estimated useful life, where applicable.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company uses the straight-line method of depreciation for buildings and improvements, and equipment over their estimated useful lives of 25 years and 3 to 15 years, respectively.</p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2155824 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.13(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 13 -Subparagraph a -Article 5 false014false 2us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">LONG-LIVED ASSETS - The Company evaluates its long-lived assets for possible impairment whenever circumstances indicate that the carrying amount of the asset, or related group of assets, may not be recoverable from estimated future undiscounted cash flows. Fair value estimates are derived from established market values of comparable assets or internal calculations of estimated undiscounted future net cash flows. The estimates of future net cash flows are based on assumptions and projections believed by the Company to be reasonable and supportable. These assumptions take into account patient volumes, changes in payer mix, revenue, and expense growth rates and changes in legislation and other payer payment patterns.</p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section CC -Subsection 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2155824 false015false 2us-gaap_FairValueMeasurementPolicyPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">FAIR VALUE MEASUREMENTS - The Company's financial assets and liabilities recorded in the consolidated balance sheets include cash and cash equivalents, restricted cash, receivables, debt, accounts payable, and other liabilities, all of which are recorded at book value which approximates fair value.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">GAAP has established a hierarchy for ranking the quality and reliability of the information used to determine fair values and requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 6%; line-height: 115%">&#160;</td> <td style="width: 10%; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Level 1:</font></td> <td style="width: 84%; text-align: justify; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Unadjusted quoted market prices in active markets for identical assets or liabilities.</font></td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Level 2:</font></td> <td style="text-align: justify; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.</font></td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Level 3:</font></td> <td style="text-align: justify; line-height: 115%; font-size: 11pt"><font style="font: 10pt Times New Roman, Times, Serif; color: black">Unobservable inputs for the asset or liability.</font></td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company utilizes the best available information in measuring fair value.&#160;&#160;Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company currently has no financial or nonfinancial assets or liabilities subject to fair value measurement on a recurring basis except for warrants issued in April 2010 and February 2013 (Note 4).</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table sets forth the Company&#146;s financial assets and liabilities measured at fair value on a recurring basis and where they are classified within the hierarchy as of March 31, 2013 and 2012:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Total</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Level 1</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Level 2</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Level 3</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 36%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Warrant liability at March 31, 2013</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,276</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,276</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Warrant liability at March 31, 2012</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,641</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#160;.</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,641</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="5" style="border-bottom: black 1pt solid; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Warrant liability - fair value measurements using significant unobservable inputs (Level 3)</font></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 80%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Balance at March 31, 2011</font></td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 16%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">167</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Change in fair value of warrant liability included in earnings</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,474</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Balance at March 31, 2012</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,641</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Fair value of warrants issued and vested, net</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,692</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Fair value of warrants - loan discount on term loan</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">534</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Change in fair value of warrant liability included in earnings</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,409</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Balance at March 31, 2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,276</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 0 49.5pt; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Additional quantitative information about Level 3 fair value measurements is discussed in Note 4.</p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.No definition available.false016false 2IHCH_WarrantsPolicyTextBlockIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WARRANTS - The Company has entered into complex transactions that contain warrants (Notes 3 and 4). If an instrument (or an embedded feature) that has the characteristics of a derivative instrument is indexed to an entity&#146;s own stock, it is still necessary to evaluate whether it is classified in stockholders&#146; equity (or would be classified in stockholders&#146; equity if it were a freestanding instrument). The Company has concluded that the warrants should be classified as liabilities as the exercise price is subject to a weighted average ratchet down provision if the Company subsequently sells shares at a price lower than the then exercise price.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>falsefalsefalsenonnum:textBlockItemTypenaWARRANTSNo definition available.false017false 2us-gaap_EarningsPerSharePolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">INCOME (LOSS) PER COMMON SHARE &#150; Income (loss) per share is calculated under two different methods, basic and diluted. Basic income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period. Diluted income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period and dilutive potential shares of common stock. Dilutive potential shares of common stock, as determined under the treasury stock method, consist of shares of common stock issuable upon exercise of stock warrants or options, net of shares of common stock assumed to be repurchased by the Company from the exercise proceeds (Note 8).</p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2144384 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257 false018false 2IHCH_SupplementalCashFlowInformationIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SUPPLEMENTAL CASH FLOW INFORMATION - Interest paid during the years ended March 31, 2013 and 2012 was $9.4 million and $9.0 million, respectively.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company made cash payments for taxes of $0 and $14.0 million during the years ended March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company entered into new capital lease obligations of $2.1 million and $0 during the years ended March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>falsefalsefalsenonnum:textBlockItemTypenaNo authoritative reference available.No definition available.false019false 2us-gaap_IncomeTaxPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">INCOME TAXES - Deferred income tax assets and liabilities are determined based on the differences between the book and tax basis of assets and liabilities and are measured using the currently enacted tax rates and laws using the asset and liability method. The Company assesses the realization of deferred tax assets to determine whether an income tax valuation allowance is required. The Company recorded a 58% and 100% valuation allowance on its net deferred tax assets as of March 31, 2013 and 2012, respectively, since they did not meet the more-likely-than-not threshold.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is a recognition threshold and measurement attribute for recognition and measurement of a tax position taken or expected to be taken in a tax return. It also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction and California. Certain tax attributes carried over from prior years continue to be subject to adjustment by taxing authorities. Any penalties or interest arising from federal or state taxes are recorded as a component of the Company&#146;s income tax provision.</p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2144681 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 30 -URI http://asc.fasb.org/subtopic&trid=2144749 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32840-109319 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 740 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 17 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32809-109319 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e32247-109318 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e32280-109318 false020false 2us-gaap_SegmentReportingPolicyPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SEGMENT REPORTING - The Company operates in one line of business, the provision of healthcare services through the operation of general hospitals and related healthcare facilities. The Company's Hospitals generate substantially all of its net patient service revenues.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company's four Hospitals and related healthcare facilities operate in one geographic region in Orange County, California. There are similarities in the region's economic characteristics and the nature of the Hospitals' operations, the regulatory environment in which they operate and the manner in which they are managed. This region is an operating segment, as defined by GAAP. In addition, the Company's Hospitals and related healthcare facilities share certain resources and benefit from many common clinical and management practices. Accordingly, the Company aggregates the facilities into a single reportable operating segment.</p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for segment reporting.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 false021false 2IHCH_NewAccountingStandardsIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="color: black">NEW ACCOUNTING STANDARDS &#150; </font>Effective March 31, 2012, the Company adopted ASU&#160;2011-07, &#147;Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities,&#148; which requires health care entities to present the provision for bad debts relating to patient service revenue as a deduction from patient service revenue in the statement of operations rather than as an operating expense. Additional disclosures relating to sources of patient revenue and the allowance for doubtful accounts related to patient accounts receivable are also required. The adoption of this ASU did not have a material impact on the Company&#146;s consolidated financial statements.</p>falsefalsefalsenonnum:textBlockItemTypenaNo authoritative reference available.No definition available.false0false1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies121 XML 98 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
13. COMMITMENTS AND CONTINGENCIES (Tables)
 12 Months Ended
Mar. 31, 2013
Commitments And Contingencies Tables  
Schedule of minimum operating lease payments

Following is a schedule of the Company's future minimum operating lease payments, excluding the long term lease commitment with PCHI, that have initial or remaining non-cancelable lease terms in excess of one year as of March 31, 2013:

 

Year ended March 31,      
2014   $ 1,620  
2015     1,335  
2016     1,253  
2017     1,253  
2018     1,253  
Thereafter     11,627  
Total   $ 18,341
Schedule of minimum lease payments under capitalized leases
Year ended March 31,      
2014   $ 1,873  
2015     1,899  
2016     1,750  
2017     1,276  
2018     932  
Thereafter     4,279  
         
Total minimum lease payments     12,009  
Less amount representing interest (weighted average interest rate of 10.2%)     (4,119 )
         
Net present value of net minimum lease payments     7,890  
Less current portion     (1,101 )
Noncurrent portion   $ 6,789  
INSURANCE
    March 31,
2013		     March 31,
2012		  
             
Prepaid insurance   $ 115     $ 366  
                 
Accrued insurance premiums   $ 69     $ 60  
(Included in other current liabilities)                
XML 99 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
5. INCOME TAXES (Details 2) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Mar. 31, 2012
Deferred tax assets (liabilities):    
Allowance for doubtful accounts $ 449 $ 1,457
Accrued vacation 2,982 2,813
Net operating losses 7,961 1,023
State taxes (1,235) (532)
Accrued insurance 3,755 3,445
Legal 1,257   
Property and equipment 661 (212)
Other 281 43
Gross deferred tax assets 16,111 8,037
Valuation allowance (9,403) (8,037)
Net deferred tax assets $ 6,708   
XML 100 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
10. RELATED PARTY TRANSACTIONS
 12 Months Ended
Mar. 31, 2013
Related Party Transactions [Abstract]  
NOTE 10 - RELATED PARTY TRANSACTIONS

NOTE 10 - RELATED PARTY TRANSACTIONS

 

The Company leases substantially all of the real property of the acquired Hospitals from PCHI which is owned by various physician investors and Ganesha, which is managed by Dr. Chaudhuri. As of March 31, 2013 and 2012, Dr. Chaudhuri and Mr. Thomas are the beneficial holders of an aggregate of 447.5 million shares of the outstanding stock of the Company. As described in Note 9, PCHI is a variable interest entity and the Company is the primary beneficiary, accordingly, the Company has consolidated the financial statements of PCHI in the accompanying consolidated financial statements.
XML 101 R22.xml IDEA: 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) 2.4.0.80022 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)truefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTablesAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00<table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Year ended March 31,</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 48%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Medicare</font></td> <td style="width: 3%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 21%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">55,570</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 3%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 21%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">58,046</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Medicaid</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">100,561</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">80,153</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Managed care</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">203,058</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">201,758</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Indemnity, self-pay and other</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">68,911</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">62,607</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">428,100</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">402,564</font></td> <td style="line-height: 115%">&#160;</td></tr> </table>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of patient service revenue (net of contractual allowances and discounts), by major payor source of revenue for health care organizations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 605 -Section 50 -Paragraph 4 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=25502053&loc=SL9156464-115641 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 605 -Section 55 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=9156477&loc=SL9156489-173031 false03false 2us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00<table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">March 31,</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Accounts receivable:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 56%; padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Patient accounts receivable</font></td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">83,964</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">71,800</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Allowance for doubtful accounts</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(21,143</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(18,201</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Accounts receivable, net</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">62,821</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">53,599</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Due from government payers:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">DSH</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,882</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">4,993</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Settlement receivables</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">190</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,882</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,183</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Due to government payers:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Settlement payables</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">179</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">179</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> </table>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3,4) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 3, 4 -Article 5 false04false 2us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Total</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Level 1</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Level 2</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Level 3</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 36%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Warrant liability at March 31, 2013</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,276</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,276</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Warrant liability at March 31, 2012</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,641</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#160;.</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,641</font></td> <td style="line-height: 115%">&#160;</td></tr> </table>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19190-110258 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 false05false 2us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="5" style="border-bottom: black 1pt solid; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Warrant liability - fair value measurements using significant unobservable inputs (Level 3)</font></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 80%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Balance at March 31, 2011</font></td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 16%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">167</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Change in fair value of warrant liability included in earnings</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,474</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Balance at March 31, 2012</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,641</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Fair value of warrants issued and vested, net</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,692</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Fair value of warrants - loan discount on term loan</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">534</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Change in fair value of warrant liability included in earnings</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,409</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Balance at March 31, 2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">5,276</font></td> <td style="line-height: 115%">&#160;</td></tr> </table>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the inputs and valuation techniques used to measure fair value, and a discussion of changes in valuation techniques and related inputs, if any, applied during the period to each separate class of assets, liabilities, and financial instruments classified in shareholders' equity that are measured on a recurring and/or nonrecurring basis.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 false0false1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTables15 XML 102 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
6. STOCK INCENTIVE PLAN
 12 Months Ended
Mar. 31, 2013
Stock Incentive Plan  
NOTE 6 - STOCK INCENTIVE PLAN

NOTE 6 - STOCK INCENTIVE PLAN

 

The Company's 2006 Stock Incentive Plan (the "Plan"), which is shareholder-approved, permits the grant of share options to its employees and board members for up to a maximum aggregate of 12.0 million shares of common stock. In addition, as of the first business day of each calendar year in the period 2007 through 2015, the maximum aggregate number of shares shall be increased by a number equal to one percent of the number of shares of common stock of the Company outstanding on December 31 of the immediately preceding calendar year. Accordingly, as of March 31, 2013, the maximum aggregate number of shares under the Plan was 26.1 million. The Company believes that such awards better align the interests of its employees with those of its shareholders. In accordance with the Plan, incentive stock options, nonqualified stock options, and performance based compensation awards may not be granted at less than 100 percent of the estimated fair market value of the common stock on the date of grant. Incentive stock options granted to a person owning more than 10 percent of the voting power of all classes of stock of the Company may not be issued at less than 110 percent of the fair market value of the stock on the date of grant. Option awards generally vest based on 3 years of continuous service (1/3 of the shares vest on the twelve month anniversary of the grant date, and an additional 1/12 of the shares vest on each subsequent fiscal quarter-end of the Company following such twelve month anniversary). Certain option awards provide for accelerated vesting if there is a change of control, as defined. The option awards have 7-year contractual terms.

  

When the measurement date is certain, the fair value of each option grant is estimated on the date of grant using the Black-Scholes valuation model. Since there is limited historical data with respect to both pre-vesting forfeiture and post-vesting termination, the expected life of the options was determined utilizing the simplified method, whereby the expected term is calculated by taking the sum of the vesting term plus the original contractual term and dividing that quantity by two.

 

No options were granted or exercised during the years ended March 31, 2013 and 2012. All outstanding options were fully vested as of March 31, 2013 and 2012.

 

A summary of stock option activity for the years ended March 31, 2013 and 2012 is presented as follows.

  

   Shares   Weighted-average exercise price   Weighted-average grant date fair value   Weighted-average remaining contractual term(years)   Aggregate intrinsic value 
                     
Outstanding, March 31, 2011   8,370   $0.18                
Granted   –   $–   $-           
Exercised   –   $–                
Forfeited or expired   (135)  $0.25                
Outstanding, March 31, 2012   8,235   $0.18                
Granted   –   $–   $–           
Exercised   –   $–                
Forfeited or expired   (640)  $0.26                
Outstanding, March 31, 2013   7,595   $0.18         1.7   $-  
Exercisable at March 31, 2013   7,595   $0.18         1.7      

 
XML 103 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Mar. 31, 2013
Description Of Business And Summary Of Significant Accounting Policies  
NOTE 1 - DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 - DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

BASIS OF PRESENTATION - The accompanying consolidated financial statements include the accounts of Integrated Healthcare Holdings, Inc. and its subsidiaries (collectively, the “Company”) and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

 

The Company has also determined that Pacific Coast Holdings Investment, LLC ("PCHI") (Note 9), is a variable interest entity as defined by GAAP and the Company is the primary beneficiary and, accordingly, the financial statements of PCHI are included in the accompanying consolidated financial statements.

 

All significant intercompany accounts and transactions have been eliminated in consolidation. Unless otherwise indicated, all amounts included in these notes to the consolidated financial statements are expressed in thousands (except per share amounts, percentages and stock option prices and values).

 

LIQUIDITY - As of March 31, 2013 and 2012, the Company had a total stockholders’ deficiency of $29.9 million and $11.6 million, respectively, and a working capital deficit of $36.7 million and $14.6 million, respectively.  For the years ended March 31, 2013 and 2012, the Company had net income (loss) of $(15.5) million and $7.5 million, respectively, and (negative) positive cash flow from operations of $(9.6) million and $4.5 million, respectively. At March 31, 2013, the Company had $5.0 million in additional availability under its revolving credit facility (Note 3). The Company anticipates making payments for provider fees and other expenses relating to the 2013 hospital quality assurance fee program of approximately $105.8 million and receiving approximately $235.5 million in revenues from the State ($79.4 million from the fee-for-service portion and $156.1 million from the managed care portion) (Notes 11 and 14). The Company is reliant on funds received under the hospital quality assurance fee program and not receiving such funding could have a material adverse effect on its liquidity and financial position and value of its common stock.

 

DESCRIPTION OF BUSINESS - Effective March 8, 2005, the Company acquired four hospitals (the "Hospitals") from subsidiaries of Tenet Healthcare Corporation (the "Acquisition"). The Company owns and operates the four community-based hospitals located in southern California, which are:


  ● 282-bed Western Medical Center in Santa Ana
  ● 188-bed Western Medical Center in Anaheim
  ● 178-bed Coastal Communities Hospital in Santa Ana
  ● 114-bed Chapman Medical Center in Orange

  

RECLASSIFICATION FOR PRESENTATION - Certain amounts previously reported have been reclassified to conform to the current period's presentation with no impact on the reported net income of the Company.

 

CONCENTRATION OF RISK - The Hospitals are subject to licensure by the State of California and accreditation by the Joint Commission on Accreditation of Healthcare Organizations. Loss of either licensure or accreditation would impact the ability to participate in various governmental and managed care programs, which provide the majority of the Company's revenues.

 

Substantially all patient service revenues come from external customers. The largest payers are Medicare and Medicaid (including Medicare and Medicaid managed care plans) and other state and local government payers, which combined accounted for 58% and 57% of the patient service revenues for the years ended March 31, 2013 and 2012, respectively. No other payers represent a significant concentration of the Company's patient services revenues.

 

The Company receives all of its inpatient services revenue from operations in Orange County, California. The economic conditions of this service area could affect the ability of patients and third-party payers to reimburse the Company for services through its effect on disposable household income and the tax base used to generate state funding for Medicaid programs.

 

USE OF ESTIMATES - The accompanying consolidated financial statements have been prepared in accordance with GAAP. The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Principal areas requiring the use of estimates include third-party cost report settlements, income taxes, accrued insurance retentions, self-insurance reserves, and net patient receivables. Management regularly evaluates the accounting policies and estimates that are used. In general, management bases the estimates on historical experience and on assumptions that it believes to be reasonable given the particular circumstances in which its Hospitals operate. Although management believes that all adjustments considered necessary for fair presentation have been included, actual results may materially vary from those estimates.

 

 

PATIENT SERVICE REVENUES – Patient service revenues are recognized in the period in which services are performed and are recorded based on established billing rates (gross charges) less contractual allowances and discounts, principally for patients covered by Medicare, Medicaid, managed care, and other health plans. Gross charges are retail charges. They are not the same as actual pricing, and they generally do not reflect what a hospital is ultimately paid and therefore are not displayed in the consolidated statements of operations. Hospitals are typically paid amounts that are negotiated with insurance companies or are set by the government. Gross charges are used to calculate Medicare outlier payments and to determine certain elements of payment under managed care contracts (such as stop-loss payments). Since Medicare requires that a hospital's gross charges be the same for all patients (regardless of payer category), gross charges are also what the Hospitals charge all other patients prior to the application of discounts and allowances.

 

The following is a summary of sources of patient service revenues (net of contractual allowances and discounts) before provision for doubtful accounts:

 

   Year ended March 31, 
   2013   2012 
         
Medicare  $55,570   $58,046 
Medicaid   100,561    80,153 
Managed care   203,058    201,758 
Indemnity, self-pay and other   68,911    62,607 
   $428,100   $402,564 

 

Revenues under the traditional fee-for-service Medicare and Medicaid programs are based primarily on prospective payment systems. Discounts for retrospectively cost based revenues and certain other payments, which are based on the Hospitals' cost reports, are estimated using historical trends and current factors. Cost report settlements for retrospectively cost-based revenues under these programs are subject to audit and administrative and judicial review, which can take several years until final settlement of such matters are determined and completely resolved. Estimates of settlement receivables or payables related to a specific year are updated periodically and at year end and at the time the cost report is filed with the fiscal intermediary. Typically no further updates are made to the estimates until the final Notice of Program Reimbursement is received, at which time the cost report for that year has been audited by the fiscal intermediary. There could be a time lag of several years between the submission of a cost report and receipt of the Final Notice of Program Reimbursement. Since the laws, regulations, instructions and rule interpretations governing Medicare and Medicaid reimbursement are complex and change frequently, the estimates recorded by the Hospitals could change by material amounts. The Company has established settlement (payables) receivables of $(179) and $190 as of March 31, 2013 and 2012, respectively.

 

The Hospitals receive supplemental payments from the State of California to support indigent care (Medi-Cal Disproportionate Share Hospital payments or "DSH") and from the California Medical Assistance Commission ("CMAC") under the SB 1100 and SB 1255 programs. The Hospitals received supplemental payments of $13.4 million and $14.3 million during the years ended March 31, 2013 and 2012, respectively. The related revenue recorded for the years ended March 31, 2013 and 2012, was $14.3 million and $15.4 million, respectively. As of March 31, 2013 and 2012, estimated DSH receivables were $5.9 million and $5.0 million, respectively, which are included as due from government payers in the accompanying consolidated balance sheets.

 

Revenues under managed care plans, including Medicare and Medicaid managed care plans (with patient service revenues of $84.7 million and $84.2 million for the years ended March 31, 2013 and 2012, respectively), are based primarily on payment terms involving predetermined rates per diagnosis, per-diem rates, discounted fee-for-service rates and/or other similar contractual arrangements. These revenues are also subject to review and possible audit by the payers. The payers are billed for patient services on an individual patient basis. An individual patient's bill is subject to adjustment on a patient-by-patient basis in the ordinary course of business by the payers following their review and adjudication of each particular bill. The Hospitals estimate the discounts for contractual allowances utilizing billing data on an individual patient basis. Management believes the estimation and review process allows for timely identification of instances where such estimates need to be revised. The Company does not believe there were any adjustments to estimates of individual patient bills that were material to patient service revenues.

 

 

The Hospitals provide charity care to patients whose income level is below 300% of the Federal Poverty Level. Patients with income levels between 300% and 350% of the Federal Poverty Level qualify to pay a discounted rate under AB 774 based on various government program reimbursement levels. Patients without insurance are offered assistance in applying for Medicaid and other programs they may be eligible for, such as state disability, Victims of Crime, or county indigent programs. Patient advocates from the Hospitals' Medical Eligibility Program ("MEP") screen patients in the hospital and determine potential linkage to financial assistance programs. They also expedite the process of applying for these government programs. The estimated costs of charity care (based on direct and indirect costs as a ratio of gross uncompensated charges associated with providing care to charity patients) for the years ended March 31, 2013 and 2012 were approximately $8.0 million and $7.0 million, respectively.

 

The Company is not aware of any material claims, disputes, or unsettled matters with any payers that would affect revenues that have not been adequately provided for in the accompanying consolidated financial statements.

 

PROVISION FOR BAD DEBTS - The Company provides for accounts receivable that could become uncollectible by establishing an allowance to reduce the carrying value of such receivables to their estimated net realizable value. The Hospitals estimate this allowance based on the aging of their accounts receivable, historical collections experience for each type of payer and other relevant factors. There are various factors that can impact the collection trends, such as changes in the economy, which in turn have an impact on unemployment rates and the number of uninsured and underinsured patients, volume of patients through the emergency department, the increased burden of copayments to be made by patients with insurance and business practices related to collection efforts. These factors continuously change and can have an impact on collection trends and the estimation process.

 

The Company's policy is to attempt to collect amounts due from patients, including copayments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations, including, but not limited to, the Emergency Medical Treatment and Labor Act ("EMTALA"). Generally, as required by EMTALA, patients may not be denied emergency treatment due to inability to pay. Therefore, until the legally required medical screening examination is complete and stabilization of the patient has begun, services are performed prior to the verification of the patient's insurance, if any. In nonemergency circumstances or for elective procedures and services, it is the Hospitals' policy, when appropriate, to verify insurance prior to a patient being treated.

 

CASH AND CASH EQUIVALENTS - The Company considers all highly liquid debt investments purchased with a maturity of three months or less to be cash equivalents. Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits. The Company has never experienced any losses related to these balances.

 

LETTER OF CREDIT – At March 31, 2013, the Company had an outstanding letter of credit totaling $761. This letter of credit correspondingly reduces the Company’s borrowing availability under its revolving line of credit (Note 3).

 

RECEIVABLES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS – The following is a summary of the principal components of accounts receivable and due from/to government payers as of March 31, 2013 and 2012:

 

   March 31, 
   2013   2012 
Accounts receivable:          
Patient accounts receivable  $83,964   $71,800 
Allowance for doubtful accounts   (21,143)   (18,201)
Accounts receivable, net  $62,821   $53,599 
           
Due from government payers:          
DSH  $5,882   $4,993 
Settlement receivables   –    190 
   $5,882   $5,183 
           
Due to government payers:          
Settlement payables  $179   $– 
   $179   $– 

 

 

The Company’s self-pay collection rate, which is the blended collection rate for uninsured and balance after insurance accounts receivable, was approximately 6.5% and 11.3% as of March 31, 2013 and 2012, respectively. These self-pay collection rates include payments made by patients, including co-payments and deductibles paid by patients with insurance. As of March 31, 2013 and 2012, the allowance for doubtful accounts for self-pay uninsured was 95.2% and 90.3%, respectively, of self-pay uninsured patient accounts receivable. As of March 31, 2013 and 2012, the allowance for doubtful accounts for self-pay balance after insurance was 78.0% and 77.4%, respectively, of self-pay balance after insurance patient accounts receivable, consisting primarily of co-pays and deductibles owed by patients with insurance. As of March 31, 2013 and 2012, the allowance for doubtful accounts for managed care was 20.3% and 16.1%, respectively, of managed care patient accounts receivable.

 

Receivables from patients who are potentially eligible for Medicaid are classified as Medicaid pending under the MEP, with appropriate contractual allowances recorded. If the patient does not qualify for Medicaid, the receivables are reclassified to charity care and written off, or they are reclassified to self-pay and adjusted to their net realizable value through the provision for bad debts. Reclassifications of pending Medicaid accounts to self-pay do not typically have a material impact on the results of operations as the estimated Medicaid contractual allowances initially recorded are not materially different than the estimated provision for bad debts recorded when the accounts are reclassified. All accounts classified as pending Medicaid, as well as certain other governmental receivables, over the age of 90 days were reserved in contractual allowances as of March 31, 2013 and 2012 based on historical collections experience.

 

INVENTORIES OF SUPPLIES - Inventories of supplies are valued at the lower of weighted average cost or market.

 

PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and any impairment write-downs related to assets held and used. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Capital leases are recorded at the beginning of the lease term as property and equipment and a corresponding lease liability is recognized. The value of the property and equipment under capital lease is recorded at the lower of either the present value of the minimum lease payments or the fair value of the asset. Such assets, including improvements, are amortized over the shorter of the lease term or their estimated useful life, where applicable.

 

The Company uses the straight-line method of depreciation for buildings and improvements, and equipment over their estimated useful lives of 25 years and 3 to 15 years, respectively.

 

LONG-LIVED ASSETS - The Company evaluates its long-lived assets for possible impairment whenever circumstances indicate that the carrying amount of the asset, or related group of assets, may not be recoverable from estimated future undiscounted cash flows. Fair value estimates are derived from established market values of comparable assets or internal calculations of estimated undiscounted future net cash flows. The estimates of future net cash flows are based on assumptions and projections believed by the Company to be reasonable and supportable. These assumptions take into account patient volumes, changes in payer mix, revenue, and expense growth rates and changes in legislation and other payer payment patterns.

 

FAIR VALUE MEASUREMENTS - The Company's financial assets and liabilities recorded in the consolidated balance sheets include cash and cash equivalents, restricted cash, receivables, debt, accounts payable, and other liabilities, all of which are recorded at book value which approximates fair value.

 

GAAP has established a hierarchy for ranking the quality and reliability of the information used to determine fair values and requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:

 

  Level 1: Unadjusted quoted market prices in active markets for identical assets or liabilities.
     
  Level 2: Unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.
     
  Level 3: Unobservable inputs for the asset or liability.

 

The Company utilizes the best available information in measuring fair value.  Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company currently has no financial or nonfinancial assets or liabilities subject to fair value measurement on a recurring basis except for warrants issued in April 2010 and February 2013 (Note 4).

 

 

The following table sets forth the Company’s financial assets and liabilities measured at fair value on a recurring basis and where they are classified within the hierarchy as of March 31, 2013 and 2012:

 

   Total   Level 1   Level 2   Level 3 
                 
Warrant liability at March 31, 2013  $5,276    –    –   $5,276 
Warrant liability at March 31, 2012  $1,641    –     .   $1,641 

  

 

Warrant liability - fair value measurements using significant unobservable inputs (Level 3)
     
Balance at March 31, 2011  $167 
Change in fair value of warrant liability included in earnings   1,474 
Balance at March 31, 2012   1,641 
Fair value of warrants issued and vested, net   1,692 
Fair value of warrants - loan discount on term loan   534 
Change in fair value of warrant liability included in earnings   1,409 
Balance at March 31, 2013  $5,276 

 

Additional quantitative information about Level 3 fair value measurements is discussed in Note 4.

 

WARRANTS - The Company has entered into complex transactions that contain warrants (Notes 3 and 4). If an instrument (or an embedded feature) that has the characteristics of a derivative instrument is indexed to an entity’s own stock, it is still necessary to evaluate whether it is classified in stockholders’ equity (or would be classified in stockholders’ equity if it were a freestanding instrument). The Company has concluded that the warrants should be classified as liabilities as the exercise price is subject to a weighted average ratchet down provision if the Company subsequently sells shares at a price lower than the then exercise price.

 

INCOME (LOSS) PER COMMON SHARE – Income (loss) per share is calculated under two different methods, basic and diluted. Basic income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period. Diluted income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period and dilutive potential shares of common stock. Dilutive potential shares of common stock, as determined under the treasury stock method, consist of shares of common stock issuable upon exercise of stock warrants or options, net of shares of common stock assumed to be repurchased by the Company from the exercise proceeds (Note 8).

 

SUPPLEMENTAL CASH FLOW INFORMATION - Interest paid during the years ended March 31, 2013 and 2012 was $9.4 million and $9.0 million, respectively.

 

The Company made cash payments for taxes of $0 and $14.0 million during the years ended March 31, 2013 and 2012, respectively.

 

The Company entered into new capital lease obligations of $2.1 million and $0 during the years ended March 31, 2013 and 2012, respectively.

 

INCOME TAXES - Deferred income tax assets and liabilities are determined based on the differences between the book and tax basis of assets and liabilities and are measured using the currently enacted tax rates and laws using the asset and liability method. The Company assesses the realization of deferred tax assets to determine whether an income tax valuation allowance is required. The Company recorded a 58% and 100% valuation allowance on its net deferred tax assets as of March 31, 2013 and 2012, respectively, since they did not meet the more-likely-than-not threshold.

 

There is a recognition threshold and measurement attribute for recognition and measurement of a tax position taken or expected to be taken in a tax return. It also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.

 

The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction and California. Certain tax attributes carried over from prior years continue to be subject to adjustment by taxing authorities. Any penalties or interest arising from federal or state taxes are recorded as a component of the Company’s income tax provision.

 

 

SEGMENT REPORTING - The Company operates in one line of business, the provision of healthcare services through the operation of general hospitals and related healthcare facilities. The Company's Hospitals generate substantially all of its net patient service revenues.

 

The Company's four Hospitals and related healthcare facilities operate in one geographic region in Orange County, California. There are similarities in the region's economic characteristics and the nature of the Hospitals' operations, the regulatory environment in which they operate and the manner in which they are managed. This region is an operating segment, as defined by GAAP. In addition, the Company's Hospitals and related healthcare facilities share certain resources and benefit from many common clinical and management practices. Accordingly, the Company aggregates the facilities into a single reportable operating segment.

 

NEW ACCOUNTING STANDARDS – Effective March 31, 2012, the Company adopted ASU 2011-07, “Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities,” which requires health care entities to present the provision for bad debts relating to patient service revenue as a deduction from patient service revenue in the statement of operations rather than as an operating expense. Additional disclosures relating to sources of patient revenue and the allowance for doubtful accounts related to patient accounts receivable are also required. The adoption of this ASU did not have a material impact on the Company’s consolidated financial statements.
XML 104 R54.xml IDEA: 8. INCOME (LOSS) PER SHARE (Details Narrative) 2.4.0.80054 - Disclosure - 8. INCOME (LOSS) PER SHARE (Details Narrative)truefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli02false falsefalseFrom2011-04-01to2012-03-31http://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli01true 1IHCH_IncomeLossPerShareDetailsNarrativeAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2IHCH_SharesExcludedFromCalculationsOfDilutedLossPerShareIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse413000000413000000falsefalsefalse2truefalsefalse411000000411000000falsefalsefalsexbrli:sharesItemTypesharesShares excluded from the calculations of diluted loss per shareNo definition available.false1false8. INCOME (LOSS) PER SHARE (Details Narrative)UnKnownNoRoundingUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/IncomeLossPerShareDetailsNarrative22 XML 105 R52.htm IDEA: XBRL DOCUMENT v2.4.0.8
6. STOCK INCENTIVE PLAN (Details Narrative)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Options granted or exercised      
Stock Incentive 2006 Plan
    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Plan description The Company's 2006 Stock Incentive Plan (the "Plan"), which is shareholder-approved, permits the grant of share options to its employees and board members for up to a maximum aggregate of 12.0 million shares of common stock. In addition, as of the first business day of each calendar year in the period 2007 through 2015, the maximum aggregate number of shares shall be increased by a number equal to one percent of the number of shares of common stock of the Company outstanding on December 31 of the immediately preceding calendar year.  
Vesting rights description Option awards generally vest based on 3 years of continuous service (1/3 of the shares vest on the twelve month anniversary of the grant date, and an additional 1/12 of the shares vest on each subsequent fiscal quarter-end of the Company following such twelve month anniversary). Certain option awards provide for accelerated vesting if there is a change of control, as defined. The option awards have 7-year contractual terms.  
XML 106 R37.xml IDEA: 3. DEBT (Details 1) 2.4.0.80037 - Disclosure - 3. DEBT (Details 1)truefalsefalse1false USDfalsefalse$AsOf2013-03-31http://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1IHCH_DebtTablesAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonthsus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of long-term debt, sinking fund requirements, and other securities redeemable at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601 false23false 2us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwous-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of long-term debt, sinking fund requirements, and other securities redeemable at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601 false24false 2us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThreeus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of long-term debt, sinking fund requirements, and other securities redeemable at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601 false25false 2us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFourus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse4727747277USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of long-term debt, sinking fund requirements, and other securities redeemable at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601 false2false3. DEBT (Details 1) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/DebtDetails115 XML 107 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 108 R47.htm IDEA: XBRL DOCUMENT v2.4.0.8
13. COMMITMENTS AND CONTINGENCIES (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Commitments And Contingencies Details  
2014 $ 1,620
2015 1,335
2016 1,253
2017 1,253
2018 1,253
Thereafter 11,627
Total $ 18,341
XML 109 R13.xml IDEA: 7. RETIREMENT PLAN 2.4.0.80013 - Disclosure - 7. RETIREMENT PLANtruefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_RetirementPlanAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 7 - RETIREMENT PLAN</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has a 401(k) plan for its employees. All employees with 90 days of service are eligible to participate, unless they are covered by a collective bargaining agreement which precludes coverage. The Company matches employee contributions up to 3% of the employee's compensation, subject to IRS limits. During the years ended March 31, 2013 and 2012, the Company incurred expenses of $3.3 million and $3.1 million, respectively. These costs are included in salaries and benefits in the accompanying consolidated statements of operations.&#160;&#160;At March 31, 2013 and 2012, accrued compensation and benefits in the accompanying consolidated balance sheets included $4.1 million and $3.9 million, respectively, in accrued employer contributions.</p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for pension and other postretirement benefits.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 715 -URI http://asc.fasb.org/topic&trid=2235017 false0false7. RETIREMENT PLANUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/RetirementPlan12 XML 110 R38.xml IDEA: 4. COMMON STOCK WARRANTS (Details) 2.4.0.80038 - Disclosure - 4. COMMON STOCK WARRANTS (Details)truefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00PercentStandardhttp://www.xbrl.org/2003/instancepurexbrli02false truefalseFrom2011-04-01to2012-03-31_WarrantMemberhttp://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00falsefalseWarrantus-gaap_FinancialInstrumentAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_WarrantMemberus-gaap_FinancialInstrumentAxisexplicitMemberPercentStandardhttp://www.xbrl.org/2003/instancepurexbrli01false 4us-gaap_FairValueAssumptionsExpectedDividendRateus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truetruefalse00falsefalsefalse2truetruefalse00falsefalsefalsenum:percentItemTypepureExpected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 false02false 4us-gaap_FairValueAssumptionsRiskFreeInterestRateus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truetruefalse0.0040.004falsefalsefalse2truetruefalse0.0020.002falsefalsefalsenum:percentItemTypepureRisk-free interest rate assumption used in valuing an instrument.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 false03false 4us-gaap_FairValueAssumptionsExpectedVolatilityRateus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truetruefalse0.3990.399falsefalsefalse2truetruefalse0.5730.573falsefalsefalsenum:percentItemTypepureMeasure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 false04false 4us-gaap_FairValueAssumptionsExpectedTermus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse003 years 18 daysfalsefalsefalse2falsefalsefalse001 year 14 daysfalsefalsefalsexbrli:durationItemTypenaPeriod the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 false0false4. COMMON STOCK WARRANTS (Details)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/CommonStockWarrantsDetails24 XML 111 R23.xml IDEA: 2. PROPERTY AND EQUIPMENT (Tables) 2.4.0.80023 - Disclosure - 2. PROPERTY AND EQUIPMENT (Tables)truefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_PropertyAndEquipmentTablesAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_PropertyPlantAndEquipmentTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">March 31, </font><br /> <font style="font: 8pt Times New Roman, Times, Serif">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">March 31, </font><br /> <font style="font: 8pt Times New Roman, Times, Serif">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 68%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Buildings</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">36,536</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">35,376</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Land and improvements</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">13,523</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">13,523</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Equipment</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">28,534</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">18,268</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Construction in progress</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,160</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Assets under capital leases</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">13,267</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">11,218</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">91,860</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">79,545</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Less accumulated depreciation</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(27,872</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(24,016</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 1in; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Property and equipment, net</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">63,988</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">55,529</font></td> <td style="line-height: 115%">&#160;</td></tr> </table>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.13) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 13 -Subparagraph b -Article 5 false0false2. PROPERTY AND EQUIPMENT (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/PropertyAndEquipmentTables12 XML 112 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Total
  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant liability at March 31, 2013 $ 5,276
Warrant liability, March 31, 2012 1,641
Fair Value Inputs Level 1
  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant liability at March 31, 2013   
Warrant liability, March 31, 2012   
Fair Value Inputs Level 2
  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant liability at March 31, 2013   
Warrant liability, March 31, 2012   
Fair Value Inputs Level 3
  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant liability at March 31, 2013 5,276
Warrant liability, March 31, 2012 $ 1,641
XML 113 R36.xml IDEA: 3. DEBT (Details) 2.4.0.80036 - Disclosure - 3. DEBT (Details)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$AsOf2013-03-31http://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$AsOf2012-03-31http://www.sec.gov/CIK0001051488instant2012-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 2us-gaap_ShortTermBorrowingsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 3us-gaap_LinesOfCreditCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse2952700029527USD$falsetruefalse2truefalsefalse1378300013783USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 20 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Line-of-Credit Arrangement -URI http://asc.fasb.org/extlink&oid=6517033 false23false 3IHCH_DiscountIHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-473000-473falsefalsefalse2truefalsefalse-217000-217falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false24false 3IHCH_TotalIHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse2952700029527falsefalsefalse2truefalsefalse1378300013783falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false25true 2us-gaap_LongTermDebtAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse06false 3IHCH_SecuredTermLoanIHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse4727700047277falsefalsefalse2truefalsefalse4500000045000falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false27false 3IHCH_Discount1IHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-1747000-1747falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false28false 3us-gaap_OtherLongTermDebtNoncurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse4553000045530USD$falsetruefalse2truefalsefalse4500000045000USD$falsetruefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of debt not otherwise defined (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2false3. DEBT (Details) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/DebtDetails28 XML 114 R55.xml IDEA: 9. VARIABLE INTEREST ENTITY (Details Narrative) 2.4.0.80055 - Disclosure - 9. VARIABLE INTEREST ENTITY (Details Narrative)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$From2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2011-04-01to2012-03-31http://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1IHCH_VariableInterestEntityDetailsNarrativeAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_VariableInterestEntityTermsOfArrangementsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Concurrent with the close of the Acquisition, PCHI simultaneously acquired title to substantially all of the real property acquired by the Company in the Acquisition. The Company received $5.0 million and PCHI guaranteed the Company's $47.277 million term loan. The Company remains primarily liable as the borrower under the $47.277 million term loan notwithstanding its guarantee by PCHI. The $47.277 million term loan is cross-collateralized by substantially all of the Company's assets and all of the real property of the Hospitals. All of the Company's operating activities are directly affected by the real property that was sold to PCHI, which is a related party entity that is affiliated with the Company through common ownership and control.falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringDescription of the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, that could require the reporting entity to provide financial support (for example, liquidity arrangements and obligations to purchase assets) to the Variable Interest Entity (VIE), including events or circumstances that could expose the reporting entity to a loss.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=28200181&loc=d3e5728-111685 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=28200181&loc=d3e5710-111685 false03false 2us-gaap_VariableInterestEntityQualitativeOrQuantitativeInformationus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00As of March 31, 2013, PCHI was owned 51% by various physician investors and 49% by Ganesha, which is managed by Dr. Chaudhuri.falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringDescription of qualitative and quantitative information about the reporting entity's involvement (giving consideration to both explicit arrangements and implicit variable interests) with the Variable Interest Entity (VIE), including, but not limited to, the nature, purpose, size, and activities of the VIE, including how the entity is financed.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 5A -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=28200181&loc=SL6759159-111685 false04false 2us-gaap_VariableInterestEntityFinancialOrOtherSupportAmountus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse4727700047277USD$falsetruefalse2falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of financial or other support the reporting entity has provided (explicitly or implicitly) to the Variable Interest Entity (VIE) that it was not previously contractually required to provide or that the reporting entity intends to provide, including, for example, situations in which the reporting entity assisted the VIE in obtaining another type of support.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 5A -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=28200181&loc=SL6759159-111685 false25false 2us-gaap_HowTheMaximumExposureToLossIsDeterminedQualitativeus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00As noted above, PCHI is a guarantor on the $47.277 million term loan should the Company not be able to perform. PCHI's total liabilities represent the Company's maximum exposure to loss. Additionally, the Company is responsible for seismic remediation under the terms of the lease agreement (Notes 2 and 13).falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringDescribes and explains the methodology (for example, procedures or techniques) for estimating the maximum exposure to loss of the reporting entity as a result of its involvement with the Variable Interest Entity (VIE).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph b -URI http://asc.fasb.org/extlink&oid=28200181&loc=d3e5728-111685 false06false 2IHCH_RentalExpenseEliminatedUponConsolidationIHCH_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse78000007800USD$falsetruefalse2truefalsefalse75000007500USD$falsetruefalsexbrli:monetaryItemTypemonetaryRental expense eliminated upon consolidationNo definition available.false2false9. VARIABLE INTEREST ENTITY (Details Narrative) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/VariableInterestEntityDetailsNarrative26 XML 115 R43.xml IDEA: 5. INCOME TAXES (Details 3) 2.4.0.80043 - Disclosure - 5. INCOME TAXES (Details 3)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$AsOf2013-03-31http://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$AsOf2012-03-31http://www.sec.gov/CIK0001051488instant2012-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1IHCH_IncomeTaxesDetails3AbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2IHCH_GrossUnrecognizedIncomeTaxBenefitsAtBeginningOfYearIHCH_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2181400021814USD$falsetruefalse2truefalsefalse1890000018900USD$falsetruefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false23false 2IHCH_ChangesBasedOnTaxPositionsRelatedToCurrentYearIHCH_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;falsefalsefalse2truefalsefalse29140002914falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false24false 2IHCH_IncreasesForTaxPositionsRelatedToPriorYearsIHCH_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;falsefalsefalse2falsefalsefalse00&nbsp;&nbsp;falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false25false 2IHCH_GrossUnrecognizedIncomeTaxBenefitsAtEndOfYearIHCH_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2181400021814USD$falsetruefalse2truefalsefalse2181400021814USD$falsetruefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false2false5. INCOME TAXES (Details 3) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/IncomeTaxesDetails325 XML 116 R26.xml IDEA: 5. INCOME TAXES (Tables) 2.4.0.80026 - Disclosure - 5. INCOME TAXES (Tables)truefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_IncomeTaxesTablesAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Year ended March 31,</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Income tax provision (benefit):</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Current:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 56%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Federal</font></td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">655</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(136</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">State</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">247</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(3</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">902</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(139</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Deferred:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Federal</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(4,853</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">State</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(1,855</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(6,708</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Income tax provision (benefit)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(5,806</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(139</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> </table>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 false03false 2us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Year ended March 31,</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 68%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">U.S. federal statutory income taxes</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(7,584</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2,654</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">State and local income taxes, net of federal benefits</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(1,245</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">406</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Change in valuation allowance</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,366</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(2,975</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Warrants</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,085</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">516</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Variable interest entity</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">237</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(172</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Deferred tax adjustments</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">295</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(593</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Other</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">40</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">25</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Income tax provision (benefit)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(5,806</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(139</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> </table>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319 false04false 2us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Deferred tax assets (liabilities):</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 68%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Allowance for doubtful accounts</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">449</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,457</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Accrued vacation</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2,982</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">2,813</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Net operating losses</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">7,961</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,023</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">State taxes</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(1,235</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(532</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Accrued insurance</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">3,755</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">3,445</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Legal</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">1,257</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Property and equipment</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">661</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(212</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Other</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">281</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">43</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">16,111</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">8,037</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Valuation allowance</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(9,403</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">(8,037</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">Net deferred tax assets</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">6,708</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif; color: black">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> </table>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319 false05false 2IHCH_ScheduleOfChangeInUnrecognizedIncomeTaxBenefitsIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">March 31,</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">2013</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">2012</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 68%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Gross unrecognized income tax benefits at the beginning of the year</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">21,814</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">18,900</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Changes based on tax positions related to current year</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">2,914</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Increases for tax positions related to prior years</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Gross unrecognized income tax benefits at the end of the year</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">21,814</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">21,814</font></td> <td style="line-height: 115%">&#160;</td></tr> </table>falsefalsefalsenonnum:textBlockItemTypenaNo authoritative reference available.No definition available.false0false5. INCOME TAXES (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/IncomeTaxesTables15 XML 117 R28.xml IDEA: 8. INCOME (LOSS) PER SHARE (Tables) 2.4.0.80028 - Disclosure - 8. INCOME (LOSS) PER SHARE (Tables)truefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_IncomeLossPerShareTablesAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="6" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">Year ended March 31,</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2013</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">2012</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Numerator:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Net income attributable to</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Integrated Healthcare Holdings, Inc.</td><td style="width: 2%; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 13%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">(15,537</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="width: 2%; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 13%; border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">7,452</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Denominator:</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Weighted average common shares</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">255,307</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">255,307</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt; font: 8pt Times New Roman, Times, Serif">Dilutive options</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">&#150;</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">1,533</td><td style="padding-bottom: 1pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Denominator for diluted calculation</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">255,307</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">256,840</td><td style="padding-bottom: 2.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Income per share - basic</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">(0.06</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.03</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="padding-left: 5.4pt; font: 8pt Times New Roman, Times, Serif">Income per share - diluted</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">(0.06</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.03</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 false0false8. INCOME (LOSS) PER SHARE (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/IncomeLossPerShareTables12 XML 118 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
13. COMMITMENTS AND CONTINGENCIES
 12 Months Ended
Mar. 31, 2013
Commitments And Contingencies  
NOTE 13 - COMMITMENTS AND CONTINGENCIES

NOTE 13 - COMMITMENTS AND CONTINGENCIES

 

INFORMATION TECHNOLOGY SYSTEMS – On July 1, 2011, the Company entered into software and services agreements with McKesson Technologies Inc. (“McKesson”) to upgrade the Company’s information technology systems.

 

Under the agreements, McKesson will provide the Company with a variety of services, including new software implementation and education/training services for the Company’s personnel, software maintenance services and professional services related to movement and migration of data from legacy systems.  McKesson will also furnish to the Company and maintain new hardware to accommodate the upgraded software and systems.  The new hardware will include computers and servers, among other things, and will include installation, testing, and ongoing maintenance.  The Company has entered into the arrangement to enhance its clinical information systems and upgrade its billing and revenue management information systems.

 

The agreements will initially run for a period of five years, and the recurring services may be renewed by the Company for successive periods.  The agreements do not provide that they may be terminated by the Company prior to the initial expiration date.  The agreements provide for one-time fees and recurring fees which aggregate a total of $22.0 million.  Approximately 60% of the fees are for one-time charges, while the balance is for recurring services. During the year ended March 31, 2013 the Company completed conversion of one of its facilities to the McKesson system and is continuing to convert the remaining three facilities during the first quarter of the Company’s fiscal year 2014. The Company is also continuing to test and develop system applications where necessary.

 

OPERATING LEASES AND LONG TERM LEASE COMMITMENT WITH VARIABLE INTEREST ENTITY – On April 13, 2010, the Company and PCHI entered into a Second Amendment to Amended and Restated Triple Net Hospital Building Lease (the “2010 Lease Amendment”).  Under the 2010 Lease Amendment, the annual base rent to be paid by the Company to PCHI was increased from $5.4 million to $7.3 million. The base rent is subject to an annual Consumer Price Index increase on January 1 of each year; such increase shall not be less than 2% or more than 6% per year. The annual base rent is currently $7.8 million. If PCHI refinances the $47.277 million term loan, the annual base rent will increase to $8.3 million. This lease commitment with PCHI is eliminated in consolidation.

 

Following is a schedule of the Company's future minimum operating lease payments, excluding the long term lease commitment with PCHI, that have initial or remaining non-cancelable lease terms in excess of one year as of March 31, 2013:

 

Year ended March 31,      
2014   $ 1,620  
2015     1,335  
2016     1,253  
2017     1,253  
2018     1,253  
Thereafter     11,627  
Total   $ 18,341  

 

Total rental expense (excluding PCHI rent) for the years ended March 31, 2013 and 2012 was $5.3 million and $4.8 million, respectively. The Company received sublease rental income in relation to certain leases of approximately $563 and $552 for the years ended March 31, 2013 and 2012, respectively.

 

CAPITAL LEASES - In connection with the Acquisition, the Company also assumed the leases for the Chapman facility, which include buildings and land with terms that were extended concurrently with the assignment of the leases to December 31, 2023. The Company leases equipment under capital leases expiring at various dates through 2017. Assets under capital leases with a net book value of $7.1 million and $6.2 million are included in the accompanying consolidated balance sheets as of March 31, 2013 and 2012, respectively. Interest rates used in computing the net present value of the lease payments are based on the interest rates implicit in the leases.

 

The following is a schedule of future minimum lease payments under the capitalized leases with the present value of the minimum lease payments as of March 31, 2013:

 

Year ended March 31,      
2014   $ 1,873  
2015     1,899  
2016     1,750  
2017     1,276  
2018     932  
Thereafter     4,279  
         
Total minimum lease payments     12,009  
Less amount representing interest (weighted average interest rate of 10.2%)     (4,119 )
         
Net present value of net minimum lease payments     7,890  
Less current portion     (1,101 )
Noncurrent portion   $ 6,789  

 

INSURANCE – The Company accrues for estimated general and professional liability claims, to the extent not covered by insurance, when they are probable and reasonably estimable. The Company has purchased as primary coverage a claims-made form insurance policy for general and professional liability risks. Estimated losses within general and professional liability retentions from claims incurred and reported, along with incurred but not reported (“IBNR”) claims, are accrued based upon projections and are discounted to their net present value using an interest rate of 5.0%. To the extent that subsequent claims information varies from estimates, the liability is adjusted in the period such information becomes available. As of March 31, 2013 and 2012, the Company had accrued $10.6 million and $11.5 million, respectively, which is comprised of $5.5 million and $4.5 million, respectively, in incurred and reported claims, along with $5.1 million and $7.0 million, respectively, in estimated IBNR. Estimated insurance recoveries of $2.1 million and $3.0 million are included in other prepaid expenses and current assets as of March 31, 2013 and 2012, respectively.

 

The Company has also purchased occurrence coverage insurance to fund our obligations under our workers compensation program. The Company has a "paid loss plan" policy, under which the carrier pays all workers compensation claims, with no deductible or reimbursement required of us. The Company accrues for estimated workers compensation claims, to the extent not covered by insurance, when they are probable and reasonably estimable. The ultimate costs related to this program include expenses for deductible amounts associated with claims incurred and reported in addition to an accrual for the estimated expenses incurred in connection with IBNR claims. Claims are accrued based upon projections and are discounted to their net present value using an interest rate of 5.0%. To the extent that subsequent claims information varies from estimates, the liability is adjusted in the period such information becomes available. As of March 31, 2013 and 2012, the Company had accrued $500 and $673, respectively, comprised of $200 and $338, respectively, in incurred and reported claims, along with $300 and $335, respectively, in estimated IBNR.

  

In addition, the Company has a self-insured health benefits plan for our employees. As a result, the Company has established and maintained an accrual for IBNR claims arising from self-insured health benefits provided to employees. Our IBNR accruals at March 31, 2013 and 2012 were based upon projections. The Company determines the adequacy of this accrual by evaluating our limited historical experience and trends related to both health insurance claims and payments, information provided by our insurance broker and third party administrator, and industry experience and trends. The accrual is an estimate and is subject to change. Such change could be material to our consolidated financial statements. As of March 31, 2013 and 2012, the Company had accrued $1.9 million and $2.2 million, respectively, in estimated IBNR.

 

The Company has also purchased umbrella liability policies with aggregate limits of $25 million. The umbrella policies provide coverage in excess of the primary layer and applicable retentions for insured liability risks such as general and professional liability, auto liability, and workers compensation (employers liability).

 

As of March 31, 2013, the Company finances various insurance policies at an interest rate of 4.4% per annum. The Company incurred finance charges relating to such policies of $32.2 and $32.9 for the years ended March 31, 2013 and 2012, respectively. As of March 31, 2013 and 2012, the accompanying consolidated balance sheets include the following balances relating to the financed insurance policies.

 

   March 31,
2013		   March 31,
2012		 
         
Prepaid insurance  $115   $366 
           
Accrued insurance premiums  $69   $60 
(Included in other current liabilities)          

 

PURCHASE COMMITMENTS - The Company has commitments with two unrelated party service provider vendors extending over one year.  Commitments total $3.8 million and $1.0 million for the years ending March 31, 2014 and 2015, respectively.

 

UNION CONTRACTS - Approximately 37% of the Company’s employees are represented by labor unions as of March 31, 2013.  The CNA Agreement and the SEIU Agreement both expire on August 31, 2014. The agreements have “no strike” provisions and compensation caps which provide the Company with long term compensation and workforce stability.   

For both unions, all prior grievances regarding retiree medical benefits, the administration of pay adjustments and pay practices, changes in medical benefits and several wrongful terminations have been resolved in the form of settlement agreements.

 

 

CLAIMS AND LAWSUITS – The Company and the Hospitals are subject to various legal proceedings, most of which relate to routine matters incidental to operations. The results of these claims cannot be predicted, and it is possible that the ultimate resolution of these matters, individually or in the aggregate, may have a material adverse effect on the Company's business (both in the near and long term), financial position, results of operations, or cash flows. Although the Company defends itself vigorously against claims and lawsuits and cooperates with investigations, these matters (1) could require payment of substantial damages or amounts in judgments or settlements, which individually or in the aggregate could exceed amounts, if any, that may be recovered under insurance policies where coverage applies and is available, (2) cause substantial expenses to be incurred, (3) require significant time and attention from the Company's management, and (4) could cause the Company to close or sell the Hospitals or otherwise modify the way its business is conducted. The Company accrues for claims and lawsuits when an unfavorable outcome is probable and the amount is reasonably estimable.

 

On June 5, 2009, a potential class action lawsuit was filed against the Company by Alexandra Avery.  Ms. Avery purports to represent all 12-hourly employees and the complaint alleges causes of action for restitution of unpaid wages as a result of unfair business practices, injunctive relief for unfair business practices, failure to pay overtime wages, and penalties associated therewith. On December 23, 2009, the Company filed an answer to the complaint, generally denying all of the plaintiff's allegations.  On January 25, 2010, a potential class action lawsuit was filed against the Company by Julie Ross.  Ms. Ross purports to represent all similarly-situated employees and the complaint alleges causes of action for violation of the California Labor Code and unfair competition law.  On September 3, 2010 the plaintiffs in both the Avery and Ross actions filed a consolidated complaint (the "Consolidated Complaint") that alleges the causes of action found in the initial Ross complaint.  On October 12, 2010, the Company filed an answer to the Consolidated Complaint, which generally denied all allegations.  On July 18, 2011, the Company filed a motion to compel arbitration of the matter, which was denied on October 21, 2011.  The Company appealed this decision and the Court of Appeal decided against the Company on June 26, 2013. The Company intends to vigorously defend itself in connection with the claims in the Consolidated Complaint.   Discovery is ongoing and at this stage in the proceedings, the Company is unable to determine the cost of defending this lawsuit or the impact, if any, this action may have on its results of operations.

 

On February 13, 2013, the jury in Fitzgibbons v. IHHI, et. al., awarded $500,000 in punitive damages against the Company, bringing the jury’s total verdict in this lawsuit for intentional infliction of emotional distress to $5.7 million. The Company thereafter filed two post-trial motions, one seeking a new trial and another seeking a judgment in the Company’s favor notwithstanding the verdict. On April 30, 2013, the trial judge granted the Company’s motion for a judgment notwithstanding the verdict and in the alternative granted the Company’s motion for a new trial. The same day the trial judge signed a judgment in the Company’s favor by which Dr. Fitzgibbons took nothing by way of his complaint and the Company was entitled to recover its costs of suit from Dr. Fitzgibbons. Dr. Fitzgibbons filed a notice of appeal of the judgment in the Company’s favor on May 6, 2013. The Company estimates the appeal will take at least one year to resolve. Due to these favorable rulings, the Company reversed the $5.2 million contingent loss that was reserved on its financial statements as of December 31, 2012.
XML 119 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
9. VARIABLE INTEREST ENTITY
 12 Months Ended
Mar. 31, 2013
Variable Interest Entity  
NOTE 9 - VARIABLE INTEREST ENTITY

NOTE 9 - VARIABLE INTEREST ENTITY

 

Concurrent with the close of the Acquisition, PCHI simultaneously acquired title to substantially all of the real property acquired by the Company in the Acquisition. The Company received $5.0 million and PCHI guaranteed the Company's $47.277 million term loan. The Company remains primarily liable as the borrower under the $47.277 million term loan notwithstanding its guarantee by PCHI. The $47.277 million term loan is cross-collateralized by substantially all of the Company's assets and all of the real property of the Hospitals. All of the Company's operating activities are directly affected by the real property that was sold to PCHI, which is a related party entity that is affiliated with the Company through common ownership and control. As of March 31, 2013, PCHI was owned 51% by various physician investors and 49% by Ganesha, which is managed by Dr. Chaudhuri (majority stockholder in the Company).

 

The Company entered into a lease agreement dated March 7, 2005 (amended and restated as of April 13, 2010) under which it leased back from PCHI all of the real estate that it transferred to PCHI (Note 13). The amended lease terminates on the 25-year anniversary of the original lease (March 7, 2005), grants the Company the right to renew for one additional 25-year period, and requires combined annual base rental payments of $8.3 million for all the properties. However, until PCHI refinances the related $47.277 million term loan, the annual base rental payments are reduced to $7.3 million. In addition, the Company offsets, against its rental payments owed to PCHI, interest payments that it makes on the related $47.277 million term loan. Lease payments to PCHI and offsetting interest payments are eliminated in consolidation.

 

GAAP defines variable interest entities (“VIE”) as entities with a level of invested equity that is not sufficient to fund future activities to permit them to operate on a stand-alone basis, or whose equity holders lack certain characteristics of a controlling financial interest. Then, for entities identified as a VIE, the guidance sets forth a model to a primary beneficiary based on an assessment of which party to a VIE, if any, bears a majority of the exposure to expected losses, or stands to gain from a majority of its expected returns and has the power to direct activities of the VIE that impacts economic performance. The primary beneficiary of a VIE should consolidate the VIE.

 

The Company determined that it provides the majority of financial support to PCHI through various sources including lease payments, remaining primarily liable under the $47.277 million term loan, and cross-collateralization of the Company's non-real estate assets to secure the $47.277 million term loan. The Company concluded that PCHI is a VIE and it is the primary beneficiary. Accordingly, the financial statements of PCHI are included in the accompanying consolidated financial statements.

 

PCHI's assets, liabilities, and deficiency are set forth below.

 

   March 31,
2013		   March 31,
2012		 
         
Cash  $147   $68 
Property, net   39,696    40,984 
Other   129    207 
Total assets  $39,972   $41,259 
           
           
Debt ($47,277, net of discount) (as guarantor)  $46,039   $45,000 
Other   488    641 
Total liabilities   46,527    45,641 
           
Deficiency   (6,555)   (4,382)
Total liabilities and accumulated deficit  $39,972   $41,259 

 

As noted above, PCHI is a guarantor on the $47.277 million term loan should the Company not be able to perform.  PCHI's total liabilities represent the Company's maximum exposure to loss. Additionally, the Company is responsible for seismic remediation under the terms of the lease agreement (Notes 2 and 13).

 

PCHI rental income and the Company’s related rental expense of $7.8 million and $7.5 million were eliminated upon consolidation for the years ended March 31, 2013 and 2012, respectively.
XML 120 R33.xml IDEA: 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) 2.4.0.80033 - Disclosure - 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$AsOf2013-03-31_Total1Memberhttp://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse1false USDtruefalse$AsOf2013-03-31_Total1Memberhttp://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00falsefalseTotalus-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldiIHCH_Total1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse02true 3us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse03false 4us-gaap_LiabilitiesFairValueDisclosureRecurringus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse52760005276USD$falsetruefalsexbrli:monetaryItemTypemonetaryAggregation of the liabilities reported on the balance sheet measured at fair value on a recurring basis by the entity.No definition available.false24false 4IHCH_WarrantLiabilityMarch312012IHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse16410001641USD$falsefalsefalsexbrli:monetaryItemTypemonetaryWarrant liabilityNo definition available.false25false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2false USDtruefalse$AsOf2013-03-31_FairValueInputsLevel1Memberhttp://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00falsefalseFair Value Inputs Level 1us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse06true 3us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse07false 4us-gaap_LiabilitiesFairValueDisclosureRecurringus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAggregation of the liabilities reported on the balance sheet measured at fair value on a recurring basis by the entity.No definition available.false28false 4IHCH_WarrantLiabilityMarch312012IHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;USD$falsefalsefalsexbrli:monetaryItemTypemonetaryWarrant liabilityNo definition available.false29false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse3false USDtruefalse$AsOf2013-03-31_FairValueInputsLevel2Memberhttp://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00falsefalseFair Value Inputs Level 2us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel2Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse010true 3us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse011false 4us-gaap_LiabilitiesFairValueDisclosureRecurringus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAggregation of the liabilities reported on the balance sheet measured at fair value on a recurring basis by the entity.No definition available.false212false 4IHCH_WarrantLiabilityMarch312012IHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;USD$falsefalsefalsexbrli:monetaryItemTypemonetaryWarrant liabilityNo definition available.false213false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse4false USDtruefalse$AsOf2013-03-31_FairValueInputsLevel3Memberhttp://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00falsefalseFair Value Inputs Level 3us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel3Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse014true 3us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse015false 4us-gaap_LiabilitiesFairValueDisclosureRecurringus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse52760005276USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAggregation of the liabilities reported on the balance sheet measured at fair value on a recurring basis by the entity.No definition available.false216false 4IHCH_WarrantLiabilityMarch312012IHCH_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse16410001641USD$falsetruefalsexbrli:monetaryItemTypemonetaryWarrant liabilityNo definition available.false2false1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails2116 XML 121 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Mar. 31, 2013
Description Of Business And Summary Of Significant Accounting Policies Tables  
PATIENT SERVICE REVENUES
    Year ended March 31,  
    2013     2012  
             
Medicare   $ 55,570     $ 58,046  
Medicaid     100,561       80,153  
Managed care     203,058       201,758  
Indemnity, self-pay and other     68,911       62,607  
    $ 428,100     $ 402,564  
RECEIVABLES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS
    March 31,  
    2013     2012  
Accounts receivable:                
Patient accounts receivable   $ 83,964     $ 71,800  
Allowance for doubtful accounts     (21,143 )     (18,201 )
Accounts receivable, net   $ 62,821     $ 53,599  
                 
Due from government payers:                
DSH   $ 5,882     $ 4,993  
Settlement receivables     –       190  
    $ 5,882     $ 5,183  
                 
Due to government payers:                
Settlement payables   $ 179     $ –  
    $ 179     $ –  
Warrant liability
    Total     Level 1     Level 2     Level 3  
                         
Warrant liability at March 31, 2013   $ 5,276       –       –     $ 5,276  
Warrant liability at March 31, 2012   $ 1,641       –        .     $ 1,641  
Warrant liability - fair value measurements using significant unobservable inputs
Warrant liability - fair value measurements using significant unobservable inputs (Level 3)
       
Balance at March 31, 2011   $ 167  
Change in fair value of warrant liability included in earnings     1,474  
Balance at March 31, 2012     1,641  
Fair value of warrants issued and vested, net     1,692  
Fair value of warrants - loan discount on term loan     534  
Change in fair value of warrant liability included in earnings     1,409  
Balance at March 31, 2013   $ 5,276  
XML 122 R15.xml IDEA: 9. VARIABLE INTEREST ENTITY 2.4.0.80015 - Disclosure - 9. VARIABLE INTEREST ENTITYtruefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:001true 1IHCH_VariableInterestEntityAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_BusinessCombinationDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 9 - VARIABLE INTEREST ENTITY</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Concurrent with the close of the Acquisition, PCHI simultaneously acquired title to substantially all of the real property acquired by the Company in the Acquisition. The Company received $5.0 million and PCHI guaranteed the Company's $47.277 million term loan. The Company remains primarily liable as the borrower under the $47.277 million term loan notwithstanding its guarantee by PCHI. The $47.277 million term loan is cross-collateralized by substantially all of the Company's assets and all of the real property of the Hospitals. All of the Company's operating activities are directly affected by the real property that was sold to PCHI, which is a related party entity that is affiliated with the Company through common ownership and control. As of March 31, 2013, PCHI was owned 51% by various physician investors and 49% by Ganesha, which is managed by Dr. Chaudhuri (majority stockholder in the Company).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company entered into a lease agreement dated March 7, 2005 (amended and restated as of April 13, 2010) under which it leased back from PCHI all of the real estate that it transferred to PCHI (Note 13). The amended lease terminates on the 25-year anniversary of the original lease (March 7, 2005), grants the Company the right to renew for one additional 25-year period, and requires combined annual base rental payments of $8.3 million for all the properties. However, until PCHI refinances the related $47.277 million term loan, the annual base rental payments are reduced to $7.3 million. In addition, the Company offsets, against its rental payments owed to PCHI, interest payments that it makes on the related $47.277 million term loan. Lease payments to PCHI and offsetting interest payments are eliminated in consolidation.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">GAAP defines variable interest entities (&#147;VIE&#148;) as entities with a level of invested equity that is not sufficient to fund future activities to permit them to operate on a stand-alone basis, or whose equity holders lack certain characteristics of a controlling financial interest. Then, for entities identified as a VIE, the guidance sets forth a model to a primary beneficiary based on an assessment of which party to a VIE, if any, bears a majority of the exposure to expected losses, or stands to gain from a majority of its expected returns and has the power to direct activities of the VIE that impacts economic performance. The primary beneficiary of a VIE should consolidate the VIE.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company determined that it provides the majority of financial support to PCHI through various sources including lease payments, remaining primarily liable under the $47.277 million term loan, and cross-collateralization of the Company's non-real estate assets to secure the $47.277 million term loan. The Company concluded that PCHI is a VIE and it is the primary beneficiary. Accordingly, the financial statements of PCHI are included in the accompanying consolidated financial statements.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">PCHI's assets, liabilities, and deficiency are set forth below.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2013</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif">March 31, <br />2012</td><td style="text-align: center; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="width: 66%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Cash</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">147</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="width: 13%; color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">68</td><td style="width: 1%; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Property, net</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">39,696</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">40,984</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Other</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">129</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">207</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">Total assets</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">39,972</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">41,259</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Debt ($47,277, net of discount) (as guarantor)</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">46,039</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">$</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">45,000</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Other</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">488</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">641</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">Total liabilities</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">46,527</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; text-align: right; font: 8pt Times New Roman, Times, Serif">45,641</td><td style="color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238); font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">Deficiency</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(6,555</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td><td style="color: black; padding-bottom: 1pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">(4,382</td><td style="padding-bottom: 1pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">)</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">Total liabilities and accumulated deficit</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">39,972</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td><td style="color: black; padding-bottom: 2.5pt; font: 8pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; color: black; text-align: right">41,259</td><td style="padding-bottom: 2.5pt; color: black; text-align: left; font: 8pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As noted above, PCHI is a guarantor on the $47.277 million term loan should the Company not be able to perform.&#160;&#160;PCHI's total liabilities represent the Company's maximum exposure to loss. Additionally, the Company is responsible for seismic remediation under the terms of the lease agreement (Notes 2 and 13).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">PCHI rental income and the Company&#146;s related rental expense of $7.8 million and $7.5 million were eliminated upon consolidation for the years ended March 31, 2013 and 2012, respectively.</p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6996-128479 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7000-128479 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4922-128472 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4926-128472 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4934-128472 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1383-128463 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1486-128463 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6927-128479 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1497-128463 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1490-128463 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7008-128479 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1500-128463 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1524-128463 false0false9. VARIABLE INTEREST ENTITYUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/VariableInterestEntity12 XML 123 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
14. SUBSEQUENT EVENTS
 12 Months Ended
Mar. 31, 2013
Subsequent Events [Abstract]  
14. SUBSEQUENT EVENTS

NOTE 14 – SUBSEQUENT EVENTS (unaudited)

 

In May 2013, CMS approved the managed care portion of the 2013 QAF for the period from July 1, 2011 through June 30, 2012. On June 26, 2013, CMS approved the managed care portion of the 2013 QAF for the period from July 1, 2012 through June 30, 2013.

 

Based on the most recent modeling prepared by the California Hospital Association, the Company anticipates making payments for provider fees and other expenses relating to the 2013 QAF of approximately $105.8 million and receiving approximately $235.5 million in revenues from the State ($79.4 million from the fee-for-service portion and $156.1 million from the managed care portion).

 

In June 2013, the Company received $72.1 million in managed care QAF payments for the period from July 1, 2011 through June 30, 2012 (Note 11). The Company anticipates receiving approximately $60.0 million in revenues for the period from July 1, 2012 through June 30, 2013.

 

The Company cannot provide any assurances or estimates in connection with CMS’s final managed care approval of the 2013 QAF (for the period from July 1, 2013 to December 31, 2013) or a possible continuation of the QAF program beyond December 31, 2013.

 

In June 2013, the Company paid down $25 million on its revolving line of credit, resulting in an outstanding balance of $10 million.
XML 124 R35.xml IDEA: 2. PROPERTY AND EQUIPMENT (Details) 2.4.0.80035 - Disclosure - 2. PROPERTY AND EQUIPMENT (Details)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$AsOf2013-03-31http://www.sec.gov/CIK0001051488instant2013-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$AsOf2012-03-31http://www.sec.gov/CIK0001051488instant2012-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_PropertyPlantAndEquipmentAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_BuildingsAndImprovementsGrossus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse3653600036536USD$falsetruefalse2truefalsefalse3537600035376USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 4 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6812-107765 false23false 2us-gaap_LandImprovementsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1352300013523falsefalsefalse2truefalsefalse1352300013523falsefalsefalsexbrli:monetaryItemTypemonetaryAmount before accumulated deprecation and depletion of additions or improvements to real estate held for productive use. Examples include, but are not limited to, walkways, driveways, fences, and parking lots.No definition available.false24false 2us-gaap_MachineryAndEquipmentGrossus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2853400028534falsefalsefalse2truefalsefalse1826800018268falsefalsefalsexbrli:monetaryItemTypemonetaryAmount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 4 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6812-107765 false25false 2us-gaap_ConstructionInProgressGrossus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;falsefalsefalse2truefalsefalse11600001160falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 false26false 2us-gaap_CapitalLeasedAssetsGrossus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1326700013267falsefalsefalse2truefalsefalse1121800011218falsefalsefalsexbrli:monetaryItemTypemonetaryAmount before accumulated depreciation of leased physical assets used in the normal conduct of business to produce goods and services.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6455314&loc=d3e45014-112735 false27false 2us-gaap_PropertyPlantAndEquipmentGrossus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse9186000091860falsefalsefalse2truefalsefalse7954500079545falsefalsefalsexbrli:monetaryItemTypemonetaryAmount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.13) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false28false 2us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-27872000-27872falsefalsefalse2truefalsefalse-24016000-24016falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.14) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 14 -Article 5 false29false 2us-gaap_PropertyPlantAndEquipmentNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse6398800063988USD$falsetruefalse2truefalsefalse5552900055529USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.13) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 13 -Subparagraph a -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 8 -Article 7 false2false2. PROPERTY AND EQUIPMENT (Details) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/PropertyAndEquipmentDetails29 XML 125 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information (USD $)
 12 Months Ended
Mar. 31, 2013
Jun. 18, 2013
Sep. 30, 2012
Document And Entity Information      
Entity Registrant Name Integrated Healthcare Holdings Inc    
Entity Central Index Key 0001051488    
Document Type 10-K    
Document Period End Date Mar. 31, 2013    
Amendment Flag false    
Current Fiscal Year End Date --03-31    
Is Entity a Well-known Seasoned Issuer? No    
Is Entity a Voluntary Filer? No    
Is Entity's Reporting Status Current? Yes    
Entity Filer Category Smaller Reporting Company    
Entity Public Float     $ 1,867,760
Entity Common Stock, Shares Outstanding   255,307,262  
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2013    
XML 126 R41.xml IDEA: 5. INCOME TAXES (Details 1) 2.4.0.80041 - Disclosure - 5. INCOME TAXES (Details 1)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$From2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2011-04-01to2012-03-31http://www.sec.gov/CIK0001051488duration2011-04-01T00:00:002012-03-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1IHCH_IncomeTaxesDetails1AbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRateus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-7584000-7584USD$falsetruefalse2truefalsefalse26540002654USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Subparagraph 2 -Article 4 false23false 2us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-1245000-1245falsefalsefalse2truefalsefalse406000406falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Subparagraph 1 -Article 4 false24false 2us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowanceus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse13660001366falsefalsefalse2truefalsefalse-2975000-2975falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e32123-109318 false25false 2IHCH_WarrantsIHCH_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse10850001085falsefalsefalse2truefalsefalse516000516falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false26false 2IHCH_VariableInterestEntityIHCH_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse237000237falsefalsefalse2truefalsefalse-172000-172falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false27false 2IHCH_DeferredTaxAdjustmentsIHCH_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse295000295falsefalsefalse2truefalsefalse-593000-593falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false28false 2us-gaap_IncomeTaxReconciliationOtherReconcilingItemsus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse4000040falsefalsefalse2truefalsefalse2500025falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319 false29false 2us-gaap_IncomeTaxExpenseBenefitus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-5806000-5806USD$falsetruefalse2truefalsefalse-139000-139USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Income Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6515339 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 false2false5. INCOME TAXES (Details 1) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/IncomeTaxesDetails129 XML 127 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Mar. 31, 2013
Description Of Business And Summary Of Significant Accounting Policies Policies  
BASIS OF PRESENTATION

BASIS OF PRESENTATION - The accompanying consolidated financial statements include the accounts of Integrated Healthcare Holdings, Inc. and its subsidiaries (collectively, the “Company”) and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

 

The Company has also determined that Pacific Coast Holdings Investment, LLC ("PCHI") (Note 9), is a variable interest entity as defined by GAAP and the Company is the primary beneficiary and, accordingly, the financial statements of PCHI are included in the accompanying consolidated financial statements.

 

All significant intercompany accounts and transactions have been eliminated in consolidation. Unless otherwise indicated, all amounts included in these notes to the consolidated financial statements are expressed in thousands (except per share amounts, percentages and stock option prices and values).
LIQUIDITY

LIQUIDITY - As of March 31, 2013 and 2012, the Company had a total stockholders’ deficiency of $29.9 million and $11.6 million, respectively, and a working capital deficit of $36.7 million and $14.7 million, respectively.  For the years ended March 31, 2013 and 2012, the Company had net income (loss) of $(15.2) million and $7.5 million, respectively, and (negative) positive cash flow from operations of $(9.6) million and $4.5 million, respectively. At March 31, 2013, the Company had $5.0 million in additional availability under its revolving credit facility (Note 3). The Company anticipates making payments for provider fees and other expenses relating to the 2013 hospital quality assurance fee program of approximately $105.8 million and receiving approximately $235.5 million in revenues from the State ($79.4 million from the fee-for-service portion and $156.1 million from the managed care portion) (Notes 11 and 14).DESCRIPTION OF BUSINESS - Effective March 8, 2005, the Company acquired four hospitals (the "Hospitals") from subsidiaries of Tenet Healthcare Corporation (the "Acquisition"). The Company owns and operates the four community-based hospitals located in southern California, which are:

  

  ● 282-bed Western Medical Center in Santa Ana
  ● 188-bed Western Medical Center in Anaheim
  ● 178-bed Coastal Communities Hospital in Santa Ana
  ● 114-bed Chapman Medical Center in Orange
RECLASSIFICATION FOR PRESENTATION

RECLASSIFICATION FOR PRESENTATION - Certain amounts previously reported have been reclassified to conform to the current period's presentation with no impact on the reported net income of the Company.

 
CONCENTRATION OF RISK

CONCENTRATION OF RISK - The Hospitals are subject to licensure by the State of California and accreditation by the Joint Commission. Loss of either licensure or accreditation would impact the ability to participate in various governmental and managed care programs, which provide the majority of the Company's revenues.

 

Substantially all patient service revenues come from external customers. The largest payers are Medicare and Medicaid (including Medicare and Medicaid managed care plans) and other State and local government payers, which combined accounted for 58% and 57% of the patient service revenues for the years ended March 31, 2013 and 2012, respectively. No other payers represent a significant concentration of the Company's patient services revenues.

 

The Company receives all of its inpatient services revenue from operations in Orange County, California. The economic conditions of this service area could affect the ability of patients and third-party payers to reimburse the Company for services through its effect on disposable household income and the tax base used to generate state funding for Medicaid programs.
USE OF ESTIMATES

USE OF ESTIMATES - The accompanying consolidated financial statements have been prepared in accordance with GAAP. The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Principal areas requiring the use of estimates include third-party cost report settlements, income taxes, accrued insurance retentions, self-insurance reserves, and net patient receivables. Management regularly evaluates the accounting policies and estimates that are used. In general, management bases the estimates on historical experience and on assumptions that it believes to be reasonable given the particular circumstances in which its Hospitals operate. Although management believes that all adjustments considered necessary for fair presentation have been included, actual results may materially vary from those estimates.
PATIENT SERVICE REVENUES

PATIENT SERVICE REVENUES – Patient service revenues are recognized in the period in which services are performed and are recorded based on established billing rates (gross charges) less contractual allowances and discounts, principally for patients covered by Medicare, Medicaid, managed care, and other health plans. Gross charges are retail charges. They are not the same as actual pricing, and they generally do not reflect what a hospital is ultimately paid and therefore are not displayed in the consolidated statements of operations. Hospitals are typically paid amounts that are negotiated with insurance companies or are set by the government. Gross charges are used to calculate Medicare outlier payments and to determine certain elements of payment under managed care contracts (such as stop-loss payments). Since Medicare requires that a hospital's gross charges be the same for all patients (regardless of payer category), gross charges are also what the Hospitals charge all other patients prior to the application of discounts and allowances.

 

The following is a summary of sources of patient service revenues (net of contractual allowances and discounts) before provision for doubtful accounts:

 

    Year ended March 31,  
    2013     2012  
             
Medicare   $ 55,570     $ 58,046  
Medicaid     100,561       80,153  
Managed care     203,058       201,758  
Indemnity, self-pay and other     68,911       62,607  
    $ 428,100     $ 402,564  

 

Revenues under the traditional fee-for-service Medicare and Medicaid programs are based primarily on prospective payment systems. Discounts for retrospectively cost based revenues and certain other payments, which are based on the Hospitals' cost reports, are estimated using historical trends and current factors. Cost report settlements for retrospectively cost-based revenues under these programs are subject to audit and administrative and judicial review, which can take several years until final settlement of such matters are determined and completely resolved. Estimates of settlement receivables or payables related to a specific year are updated periodically and at year end and at the time the cost report is filed with the fiscal intermediary. Typically no further updates are made to the estimates until the final Notice of Program Reimbursement is received, at which time the cost report for that year has been audited by the fiscal intermediary. There could be a time lag of several years between the submission of a cost report and receipt of the Final Notice of Program Reimbursement. Since the laws, regulations, instructions and rule interpretations governing Medicare and Medicaid reimbursement are complex and change frequently, the estimates recorded by the Hospitals could change by material amounts. The Company has established settlement (payables) receivables of $(179) and $190 as of March 31, 2013 and 2012, respectively.

 

The Hospitals receive supplemental payments from the State of California to support indigent care (Medi-Cal Disproportionate Share Hospital payments or "DSH") and from the California Medical Assistance Commission ("CMAC") under the SB 1100 and SB 1255 programs. The Hospitals received supplemental payments of $13.4 million and $14.3 million during the years ended March 31, 2013 and 2012, respectively. The related revenue recorded for the years ended March 31, 2013 and 2012, was $14.3 million and $15.4 million, respectively. As of March 31, 2013 and 2012, estimated DSH receivables were $5.9 million and $5.0 million, respectively, which are included as due from government payers in the accompanying consolidated balance sheets.

 

Revenues under managed care plans, including Medicare and Medicaid managed care plans (with patient service revenues of $84.7 million and $84.2 million for the years ended March 31, 2013 and 2012, respectively), are based primarily on payment terms involving predetermined rates per diagnosis, per-diem rates, discounted fee-for-service rates and/or other similar contractual arrangements. These revenues are also subject to review and possible audit by the payers. The payers are billed for patient services on an individual patient basis. An individual patient's bill is subject to adjustment on a patient-by-patient basis in the ordinary course of business by the payers following their review and adjudication of each particular bill. The Hospitals estimate the discounts for contractual allowances utilizing billing data on an individual patient basis. Management believes the estimation and review process allows for timely identification of instances where such estimates need to be revised. The Company does not believe there were any adjustments to estimates of individual patient bills that were material to patient service revenues.

 

The Hospitals provide charity care to patients whose income level is below 300% of the Federal Poverty Level. Patients with income levels between 300% and 350% of the Federal Poverty Level qualify to pay a discounted rate under AB 774 based on various government program reimbursement levels. Patients without insurance are offered assistance in applying for Medicaid and other programs they may be eligible for, such as state disability, Victims of Crime, or county indigent programs. Patient advocates from the Hospitals' Medical Eligibility Program ("MEP") screen patients in the hospital and determine potential linkage to financial assistance programs. They also expedite the process of applying for these government programs. The estimated costs of charity care (based on direct and indirect costs as a ratio of gross uncompensated charges associated with providing care to charity patients) for the years ended March 31, 2013 and 2012 were approximately $8.0 million and $7.0 million, respectively.

 

The Company is not aware of any material claims, disputes, or unsettled matters with any payers that would affect revenues that have not been adequately provided for in the accompanying consolidated financial statements.
PROVISION FOR DOUBTFUL ACCOUNTS

PROVISION FOR BAD DEBTS - The Company provides for accounts receivable that could become uncollectible by establishing an allowance to reduce the carrying value of such receivables to their estimated net realizable value. The Hospitals estimate this allowance based on the aging of their accounts receivable, historical collections experience for each type of payer and other relevant factors. There are various factors that can impact the collection trends, such as changes in the economy, which in turn have an impact on unemployment rates and the number of uninsured and underinsured patients, volume of patients through the emergency department, the increased burden of copayments to be made by patients with insurance and business practices related to collection efforts. These factors continuously change and can have an impact on collection trends and the estimation process.

 

The Company's policy is to attempt to collect amounts due from patients, including copayments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations, including, but not limited to, the Emergency Medical Treatment and Labor Act ("EMTALA"). Generally, as required by EMTALA, patients may not be denied emergency treatment due to inability to pay. Therefore, until the legally required medical screening examination is complete and stabilization of the patient has begun, services are performed prior to the verification of the patient's insurance, if any. In nonemergency circumstances or for elective procedures and services, it is the Hospitals' policy, when appropriate, to verify insurance prior to a patient being treated.
CASH AND CASH EQUIVALENTS

CASH AND CASH EQUIVALENTS - The Company considers all highly liquid debt investments purchased with a maturity of three months or less to be cash equivalents. Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits. The Company has never experienced any losses related to these balances.
LETTER OF CREDIT

LETTER OF CREDIT – At March 31, 2013, the Company had an outstanding letter of credit totaling $761. This letter of credit correspondingly reduces the Company’s borrowing availability under its revolving line of credit (Note 3).

 
RECEIVABLES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS

RECEIVABLES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS – The following is a summary of the principal components of accounts receivable and due from/to government payers as of March 31, 2013 and 2012:

 

    March 31,  
    2013     2012  
Accounts receivable:                
Patient accounts receivable   $ 83,964     $ 71,800  
Allowance for doubtful accounts     (21,143 )     (18,201 )
Accounts receivable, net   $ 62,821     $ 53,599  
                 
Due from government payers:                
DSH   $ 5,882     $ 4,993  
Settlement receivables     –       190  
    $ 5,882     $ 5,183  
                 
Due to government payers:                
Settlement payables   $ 179     $ –  
    $ 179     $ –  

 

The Company’s self-pay collection rate, which is the blended collection rate for uninsured and balance after insurance accounts receivable, was approximately 6.5% and 11.3% as of March 31, 2013 and 2012, respectively. These self-pay collection rates include payments made by patients, including co-payments and deductibles paid by patients with insurance. As of March 31, 2013 and 2012, the allowance for doubtful accounts for self-pay uninsured was 95.2% and 90.3%, respectively, of self-pay uninsured patient accounts receivable. As of March 31, 2013 and 2012, the allowance for doubtful accounts for self-pay balance after insurance was 78.0% and 77.4%, respectively, of self-pay balance after insurance patient accounts receivable, consisting primarily of co-pays and deductibles owed by patients with insurance. As of March 31, 2013 and 2012, the allowance for doubtful accounts for managed care was 20.3% and 16.1%, respectively, of managed care patient accounts receivable.

 

Receivables from patients who are potentially eligible for Medicaid are classified as Medicaid pending under the MEP, with appropriate contractual allowances recorded. If the patient does not qualify for Medicaid, the receivables are reclassified to charity care and written off, or they are reclassified to self-pay and adjusted to their net realizable value through the provision for bad debts. Reclassifications of pending Medicaid accounts to self-pay do not typically have a material impact on the results of operations as the estimated Medicaid contractual allowances initially recorded are not materially different than the estimated provision for bad debts recorded when the accounts are reclassified. All accounts classified as pending Medicaid, as well as certain other governmental receivables, over the age of 90 days were reserved in contractual allowances as of March 31, 2013 and 2012 based on historical collections experience.
INVENTORIES OF SUPPLIES

INVENTORIES OF SUPPLIES - Inventories of supplies are valued at the lower of weighted average cost or market.
PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and any impairment write-downs related to assets held and used. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Capital leases are recorded at the beginning of the lease term as property and equipment and a corresponding lease liability is recognized. The value of the property and equipment under capital lease is recorded at the lower of either the present value of the minimum lease payments or the fair value of the asset. Such assets, including improvements, are amortized over the shorter of the lease term or their estimated useful life, where applicable.

 

The Company uses the straight-line method of depreciation for buildings and improvements, and equipment over their estimated useful lives of 25 years and 3 to 15 years, respectively.
LONG-LIVED ASSETS

LONG-LIVED ASSETS - The Company evaluates its long-lived assets for possible impairment whenever circumstances indicate that the carrying amount of the asset, or related group of assets, may not be recoverable from estimated future undiscounted cash flows. Fair value estimates are derived from established market values of comparable assets or internal calculations of estimated undiscounted future net cash flows. The estimates of future net cash flows are based on assumptions and projections believed by the Company to be reasonable and supportable. These assumptions take into account patient volumes, changes in payer mix, revenue, and expense growth rates and changes in legislation and other payer payment patterns.
FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS - The Company's financial assets and liabilities recorded in the consolidated balance sheets include cash and cash equivalents, restricted cash, receivables, debt, accounts payable, and other liabilities, all of which are recorded at book value which approximates fair value.

 

GAAP has established a hierarchy for ranking the quality and reliability of the information used to determine fair values and requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:

 

  Level 1: Unadjusted quoted market prices in active markets for identical assets or liabilities.
     
  Level 2: Unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.
     
  Level 3: Unobservable inputs for the asset or liability.

 

The Company utilizes the best available information in measuring fair value.  Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company currently has no financial or nonfinancial assets or liabilities subject to fair value measurement on a recurring basis except for warrants issued in April 2010 and February 2013 (Note 4).

 

The following table sets forth the Company’s financial assets and liabilities measured at fair value on a recurring basis and where they are classified within the hierarchy as of March 31, 2013 and 2012:

 

    Total     Level 1     Level 2     Level 3  
                         
Warrant liability at March 31, 2013   $ 5,276       –       –     $ 5,276  
Warrant liability at March 31, 2012   $ 1,641       –        .     $ 1,641  

  

 

Warrant liability - fair value measurements using significant unobservable inputs (Level 3)
       
Balance at March 31, 2011   $ 167  
Change in fair value of warrant liability included in earnings     1,474  
Balance at March 31, 2012     1,641  
Fair value of warrants issued and vested, net     1,692  
Fair value of warrants - loan discount on term loan     534  
Change in fair value of warrant liability included in earnings     1,409  
Balance at March 31, 2013   $ 5,276  

 

Additional quantitative information about Level 3 fair value measurements is discussed in Note 4.
WARRANTS

 

WARRANTS - The Company has entered into complex transactions that contain warrants (Notes 3 and 4). If an instrument (or an embedded feature) that has the characteristics of a derivative instrument is indexed to an entity’s own stock, it is still necessary to evaluate whether it is classified in stockholders’ equity (or would be classified in stockholders’ equity if it were a freestanding instrument). The Company has concluded that the warrants should be classified as liabilities as the exercise price is subject to a weighted average ratchet down provision if the Company subsequently sells shares at a price lower than the then exercise price.

 
INCOME (LOSS) PER COMMON SHARE

INCOME (LOSS) PER COMMON SHARE – Income (loss) per share is calculated under two different methods, basic and diluted. Basic income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period. Diluted income (loss) per share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding during the period and dilutive potential shares of common stock. Dilutive potential shares of common stock, as determined under the treasury stock method, consist of shares of common stock issuable upon exercise of stock warrants or options, net of shares of common stock assumed to be repurchased by the Company from the exercise proceeds (Note 8).
SUPPLEMENTAL CASH FLOW INFORMATION

SUPPLEMENTAL CASH FLOW INFORMATION - Interest paid during the years ended March 31, 2013 and 2012 was $9.4 million and $9.0 million, respectively.

 

The Company made cash payments for taxes of $0 and $14.0 million during the years ended March 31, 2013 and 2012, respectively.

 

The Company entered into new capital lease obligations of $2.1 million and $0 during the years ended March 31, 2013 and 2012, respectively.

 
INCOME TAXES

INCOME TAXES - Deferred income tax assets and liabilities are determined based on the differences between the book and tax basis of assets and liabilities and are measured using the currently enacted tax rates and laws using the asset and liability method. The Company assesses the realization of deferred tax assets to determine whether an income tax valuation allowance is required. The Company recorded a 58% and 100% valuation allowance on its net deferred tax assets as of March 31, 2013 and 2012, respectively, since they did not meet the more-likely-than-not threshold.

 

There is a recognition threshold and measurement attribute for recognition and measurement of a tax position taken or expected to be taken in a tax return. It also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.

 

The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction and California. Certain tax attributes carried over from prior years continue to be subject to adjustment by taxing authorities. Any penalties or interest arising from federal or state taxes are recorded as a component of the Company’s income tax provision.
SEGMENT REPORTING

SEGMENT REPORTING - The Company operates in one line of business, the provision of healthcare services through the operation of general hospitals and related healthcare facilities. The Company's Hospitals generate substantially all of its net patient service revenues.

 

The Company's four Hospitals and related healthcare facilities operate in one geographic region in Orange County, California. There are similarities in the region's economic characteristics and the nature of the Hospitals' operations, the regulatory environment in which they operate and the manner in which they are managed. This region is an operating segment, as defined by GAAP. In addition, the Company's Hospitals and related healthcare facilities share certain resources and benefit from many common clinical and management practices. Accordingly, the Company aggregates the facilities into a single reportable operating segment.
NEW ACCOUNTING STANDARDS

NEW ACCOUNTING STANDARDS – Effective March 31, 2012, the Company adopted ASU 2011-07, “Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities,” which requires health care entities to present the provision for bad debts relating to patient service revenue as a deduction from patient service revenue in the statement of operations rather than as an operating expense. Additional disclosures relating to sources of patient revenue and the allowance for doubtful accounts related to patient accounts receivable are also required. The adoption of this ASU did not have a material impact on the Company’s consolidated financial statements.
XML 128 R1.xml IDEA: Document and Entity Information 2.4.0.80001 - Document - Document and Entity Informationtruefalsefalse1false falsefalseFrom2012-04-01to2013-03-31http://www.sec.gov/CIK0001051488duration2012-04-01T00:00:002013-03-31T00:00:002false falsefalseAsOf2013-06-18http://www.sec.gov/CIK0001051488instant2013-06-18T00:00:000001-01-01T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli03false USDfalsefalse$AsOf2012-09-30http://www.sec.gov/CIK0001051488instant2012-09-30T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1IHCH_DocumentAndEntityInformationAbstractIHCH_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2dei_EntityRegistrantNamedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Integrated Healthcare Holdings Incfalsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:normalizedStringItemTypenormalizedstringThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false03false 2dei_EntityCentralIndexKeydei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse000001051488falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsedei:centralIndexKeyItemTypenaA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false04false 2dei_DocumentTypedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse0010-Kfalsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsedei:submissionTypeItemTypestringThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".No definition available.false05false 2dei_DocumentPeriodEndDatedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse002013-03-31falsefalsetrue2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:dateItemTypedateThe end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.No definition available.false06false 2dei_AmendmentFlagdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:booleanItemTypenaIf the value is true, then the document is an amendment to previously-filed/accepted document.No definition available.false07false 2dei_CurrentFiscalYearEndDatedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00--03-31falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:gMonthDayItemTypemonthdayEnd date of current fiscal year in the format --MM-DD.No definition available.false08false 2dei_EntityWellKnownSeasonedIssuerdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Nofalsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsedei:yesNoItemTypenaIndicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.No definition available.false09false 2dei_EntityVoluntaryFilersdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Nofalsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsedei:yesNoItemTypenaIndicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.No definition available.false010false 2dei_EntityCurrentReportingStatusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Yesfalsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsedei:yesNoItemTypenaIndicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.No definition available.false011false 2dei_EntityFilerCategorydei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Smaller Reporting Companyfalsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsedei:filerCategoryItemTypestringIndicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.No definition available.false012false 2dei_EntityPublicFloatdei_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse18677601867760USD$falsetruefalsexbrli:monetaryItemTypemonetaryState aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.No definition available.false213false 2dei_EntityCommonStockSharesOutstandingdei_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2truefalsefalse255307262255307262falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesIndicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.No definition available.false114false 2dei_DocumentFiscalPeriodFocusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00FYfalsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsedei:fiscalPeriodItemTypenaThis is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.No definition available.false015false 2dei_DocumentFiscalYearFocusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse002013falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:gYearItemTypepositiveintegerThis is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.No definition available.false0falseDocument and Entity Information (USD $)NoRoundingNoRoundingUnKnownUnKnowntruefalsefalseSheethttp://ihhioc.com/role/DocumentAndEntityInformation315